<SEC-DOCUMENT>0001140361-22-018278.txt : 20220509
<SEC-HEADER>0001140361-22-018278.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509124448
ACCESSION NUMBER:		0001140361-22-018278
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		65
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			U S PHYSICAL THERAPY INC /NV
		CENTRAL INDEX KEY:			0000885978
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				760364866
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11151
		FILM NUMBER:		22904117

	BUSINESS ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
		BUSINESS PHONE:		7132977000

	MAIL ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>brhc10037138_10q.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:usph="http://usph.com/20220331" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="background-color: #ffffff; color: #000000;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_afdb6aba6e4f4c2dbb99262c1237ae93" contextRef="c20220101to20220331" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_f857e35cf36748209c4eacafb44c29c3" contextRef="c20220101to20220331" format="ixt:datemonthday">12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="Fact_50201d596e9040218dd2e34e9905e3dd" contextRef="c20220101to20220331">2022</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="Fact_b469147f93c143339645a6060867edfd" contextRef="c20220101to20220331">Q1</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_469b7c771c454cb09cd0a19f157c4dfb" contextRef="c20220101to20220331">U S PHYSICAL THERAPY INC /NV</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_c4ade041a1924240a28ce9c66d6a85dc" contextRef="c20220101to20220331">0000885978</ix:nonNumeric><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_d1e892b91f6d423c82463ad2953c7c0d" contextRef="c20220101to20220331">NV</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_beb2c2c75a9a4fe19363c09899aa39e5" contextRef="c20220101to20220331">TX</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_c14f91b399c145c8a8ea00d2ca948500" contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_02de141ed1d4420c98a9952012a0ab54" contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_b13cf1c74cd446babb6cdd78fa4c8294" contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="Fact_40b721ca5dc3493aaa09b990a340fe57" contextRef="c20220101to20220331_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_e7d74d21eab74c899fb44317a7932e6a" contextRef="c20220101to20220331_TitleOfIndividualAxis_DirectorMember">P1Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_5ace032f12924d2eb4cdbde0f9b532c6" contextRef="c20220101to20220331_TitleOfIndividualAxis_EmployeeMember">P4Y</ix:nonNumeric><ix:nonNumeric name="usph:TermOfEmploymentAgreement" id="Fact_366532ba69814de1ad518109bf840391" contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="usph:NonCompeteAgreementBasicTerm" id="Fact_384e0904d90e46f581ffc1a642cdf595" contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">P5Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_c5b38f9523db408b8ed6c53ba95605c1" contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MinimumMember">P6Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_c992237d92cd47c78ded2f3204d6bdd7" contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember">P5Y</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="usph-20220331.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220101to20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_ProductOrServiceAxis_NetPatientRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ProductOrServiceAxis_NetPatientRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_March2022AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2022AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_September2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_December2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:December2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_June2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:June2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_March2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_November2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_March2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_June2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:June2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_March2022AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2022AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_December2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:December2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_September2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_November2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_MultiClinicPracticesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:MultiClinicPracticesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_ManagementContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200430_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_MeasurementInputTypeAxis_MeasurementInputOptionVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_MeasurementInputTypeAxis_MeasurementInputDiscountRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_TitleOfIndividualAxis_DirectorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_TitleOfIndividualAxis_EmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_TitleOfIndividualAxis_OfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211130_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331to20220331_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-30</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210331_OwnershipAxis_PreviousOwnersMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_OwnershipAxis_PreviousOwnersMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ReturnToWorkAndErgonomicServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-30</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ReturnToWorkAndErgonomicServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ProductOrServiceAxis_ManagementContractRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ProductOrServiceAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_ProductOrServiceAxis_OtherRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_ProductOrServiceAxis_ManagementContractRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ProductOrServiceAxis_OtherRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_ProductOrServiceAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_UnusualOrInfrequentItemAxis_FromTwoThousandSeventeenThroughTwoThousandNineteenMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandSeventeenThroughTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usph:CentersForMedicareAndMedicaidServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20130401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211102_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usph:CentersForMedicareAndMedicaidServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20240930_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-02-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20151102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2015-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ProgressiveHealthCompaniesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ProgressiveHealthCompaniesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_DebtInstrumentAxis_PromissoryNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_DebtInstrumentAxis_PromissoryNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211130_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MinimumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MinimumMember_VariableRateAxis_BaseRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MaximumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MaximumMember_VariableRateAxis_BaseRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210131_DebtInstrumentAxis_CreditAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210131_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_DebtInstrumentAxis_CreditAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20090331_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2009-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20081231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2008-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20090301to20090331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2009-03-01</xbrli:startDate><xbrli:endDate>2009-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>usph:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>usph:Location</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U007"><xbrli:measure>usph:Clinic</xbrli:measure></xbrli:unit><xbrli:unit id="U008"><xbrli:measure>usph:State</xbrli:measure></xbrli:unit><xbrli:unit id="U009"><xbrli:measure>usph:Facility</xbrli:measure></xbrli:unit><xbrli:unit id="U010"><xbrli:measure>usph:Region</xbrli:measure></xbrli:unit><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_693f99992f5a43bdbf253cd7cd64b971" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_bccf762daaa94483b40081c81b457ca0" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_539c6bc318bc4fb6a6708940d611942a" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_7eeced21a3bf49b6b7cea15928eef383" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_fa848cbb3cef4ce9ac4701987e6c1c17" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_449b5876417b495586b69cf0134fddcd" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_fe86c41d0a8e40589aee50f8b258e5e3" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_f746be88a8e04e8e93c2d060b41e7ffd" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_34be6c8c2f1344f682ff5a6e05e0b232" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_118b64f338854f27b3f6923be9878e34" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_b78ab4e4488a42088efca947c8a4d214" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_435e62fbec4649a6b558725ff793bd1c" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_be7f633d83a2408a9ca0e8336e9f12af" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_c9ccddd842e04e09b614b6e5f3295a3a" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_2ca63305da874a06a17209af72a504b1" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_1712aa9b24ae465e9fb9172ba536bd78" toRefs="Foot_5e0179a59a7444dfb4650c9e2788869a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_a86a9f81f8e6415ba5caf3f8f5a6c41a" toRefs="Foot_73f4cf38380b4d879f24c52224424feb" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_e1dc057bc3e04a67ae8164ee0e07cd9b" toRefs="Foot_73f4cf38380b4d879f24c52224424feb" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_d858a7400c8b4646aabbd6bf18a9f0a4" toRefs="Foot_78cb7964484c42eaaaccb3a7770e93b6" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_fb559091d7c74f0785b5cc150f4935e4" toRefs="Foot_78cb7964484c42eaaaccb3a7770e93b6" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship></ix:resources></ix:header></div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
<div>UNITED STATES</div>
</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_ee42d298997b4145b564e61ed3c6c67e" contextRef="c20220101to20220331">10-Q</ix:nonNumeric></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(MARK ONE)</div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:DocumentQuarterlyReport" id="Fact_18b8db23807c466589e4ebaf97cdf299" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
          </td>

  </tr>


</table>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR THE QUARTERLY PERIOD ENDED <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_82dc67adc894406fb5b4b9f19e65f84d" contextRef="c20220101to20220331" format="ixt:datemonthdayyearen">March 31, 2022</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;OR</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonNumeric name="dei:DocumentTransitionReport" id="Fact_17f52c9ceec94d518582d9cfb40cc990" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
          </td>

  </tr>


</table>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR THE TRANSITION PERIOD FROM _____TO _____</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMMISSION FILE NUMBER <ix:nonNumeric name="dei:EntityFileNumber" id="Fact_923ea2865fa3400b9392b6a3b0cbfb2e" contextRef="c20220101to20220331">1-11151</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_469b7c771c454cb09cd0a19f157c4dfb">U.S. PHYSICAL THERAPY, INC.</span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_d1e892b91f6d423c82463ad2953c7c0d">NEVADA</span></div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_8fc937649c004e4ab4c18642aaa140c2" contextRef="c20220101to20220331">76-0364866</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(I.R.S. EMPLOYER IDENTIFICATION NO.)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_21798bc52c69492a9a3e196050da6fbd" contextRef="c20220101to20220331">1300 WEST SAM HOUSTON PARKWAY SOUTH</ix:nonNumeric>,
              <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_e391b5fd93744de5b5a1aedcf2de682d" contextRef="c20220101to20220331">SUITE 300</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_8b6a9950a6ca4435bd29d61a799cca07" contextRef="c20220101to20220331">HOUSTON</ix:nonNumeric>,
              <span style="-sec-ix-hidden:Fact_beb2c2c75a9a4fe19363c09899aa39e5">TEXAS</span></div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_2ebbcb8fb6154a5a9f10220cf588d442" contextRef="c20220101to20220331">77042</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(ZIP CODE)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
<div>REGISTRANT&#8217;S TELEPHONE NUMBER, INCLUDING AREA CODE: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_2e3f53db9f944c42a1dff9f5e045ca89" contextRef="c20220101to20220331">713</ix:nonNumeric>)
      <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_6fa578accef449c98386e7c493594229" contextRef="c20220101to20220331">297-7000</ix:nonNumeric></div>

      <div><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0); border: 2px solid rgb(0, 0, 0);">


  <tr>

    <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Title of each class</div>
              </td>

    <td style="width: 21.99%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Trading</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Symbol(s)</div>
              </td>

    <td style="width: 46.03%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Name of each exchange on which registered</div>
              </td>

  </tr>

  <tr>

    <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_303cdcc928444aafaee33a08471621e0" contextRef="c20220101to20220331">Common Stock, $.01 par value</ix:nonNumeric></div>
              </td>

    <td style="width: 21.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_b20abf7154a347ecbe285552bdc563d8" contextRef="c20220101to20220331">USPH</ix:nonNumeric></div>
              </td>

    <td style="width: 46.03%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_49866b8590e74496a24c1b6fc5b4e5c3" contextRef="c20220101to20220331" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></div>
              </td>

  </tr>


</table>
      </div>

    </div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
      preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160; &#160; <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9746;</span>&#160;
      <ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="Fact_f5ebe3408ab24c9ab9aa99bc031e3d2b" contextRef="c20220101to20220331">Yes</ix:nonNumeric>&#160; &#160;&#160; <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span>&#160; No</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and pursuant to Rule 405 of Regulation S-T
      during the preceding 12 months (or for such shorter period that the registrant was required to submit and such files).&#160;&#160; <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9746;</span>&#160; <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="Fact_602f1641850247be87751ec8e2ae086d" contextRef="c20220101to20220331">Yes</ix:nonNumeric>&#160; &#160;&#160; <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span>&#160; No</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
      company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 23%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityFilerCategory" id="Fact_d74498ab9e614493bd04175b4e1fc6f2" contextRef="c20220101to20220331" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonNumeric></div>
          </td>

    <td style="width: 47%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#9745;</div>
          </td>

    <td style="width: 22.01%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Accelerated filer</div>
          </td>

    <td style="width: 7.99%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#9744;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 23%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Non-accelerated filer</div>
          </td>

    <td style="width: 47%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span><br />
            </div>
          </td>

    <td style="width: 22.01%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Smaller reporting company</div>
          </td>

    <td style="width: 7.99%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntitySmallBusiness" id="Fact_de0c820cca6943689c29f0bfa8cbc542" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 47%; vertical-align: bottom;">&#160;</td>

    <td style="width: 22.01%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company</div>
          </td>

    <td style="width: 7.99%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_696ac05904a542af97835548c2eb6890" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided to Section 13(a) of the Exchange Act. <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span></div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160; &#160; <span style="font-size: 10pt; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:EntityShellCompany" id="Fact_48ad9a9d660f4fa0afb2f36b8d9f4228" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span>&#160; Yes&#160; &#160; <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9746;</span>&#160; No</div>

    <div><br /></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A<span style="font-size: 10pt; font-family: 'Times New Roman';">s of May 9, 2022, the</span> number of shares outstanding (issued less treasury stock) of the registrant&#8217;s
      common stock, par value $.01 per share, was: <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" id="Fact_74dea15f6141483f8374e7af1d01e076" contextRef="c20220509" unitRef="U001" decimals="INF" scale="0" format="ixt:numdotdecimal">12,991,436</ix:nonFraction>.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="PARTIFINANCIALINFORMATION"><!--Anchor--></a>PART I<a id="PARTI"><!--Anchor--></a>&#8212;FINANCIAL INFORMATION - UNAUDITED</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 5.83%; vertical-align: bottom;"> </td>

    <td style="width: 89.55%; vertical-align: bottom;">&#160;</td>

    <td style="width: 4.62%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Item 1.</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#FINANCIALSTATEMENTS.">Financial Statements.</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#BALANCESHEETS">Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#STATEMENTSOFINCOME">Consolidated Statements of Income for the three months ended March 31, 2022 and 2021</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">4</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#CASHFLOWS">Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">5</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#CHANGESINEQUITY">Consolidated Statements of Changes in Equity for the three months ended March 31, 2022 and 2021</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">6</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#NOTESTOCONSOLIDATEDFINANC">Notes to Consolidated Financial Statements</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">7</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Item 2.</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#MANAGEMENTSDISCUSSIONANDA">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">28<br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Item 3.</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#QUANTITATIVEANDQUALITATIV">Quantitative and Qualitative Disclosure About Market Risk</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">37<br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Item 4.</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#CONTROLSANDPROCEDURES.">Controls and Procedures</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">38<br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 95.38%; vertical-align: bottom; background-color: #FFFFFF;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 95.38%; vertical-align: bottom; background-color: #CCEEFF;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART II&#8212;OTHER INFORMATION</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 95.38%; vertical-align: bottom; background-color: #FFFFFF;" colspan="2">&#160;</td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -31.5pt; margin-left: 31.5pt; font-family: 'Times New Roman'; font-size: 10pt;">Item 1.</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -31.5pt; margin-left: 31.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#LEGALPROCEEDINGS.">Legal Proceedings</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center;">39<br />
          </td>

  </tr>

  <tr>

    <td style="width: 95.38%; vertical-align: bottom; background-color: #FFFFFF;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Item 6.</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#EXHIBITS.">Exhibits</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center;">40<br />
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#SIGNATURES">Signatures</a></div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center;">40<br />
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.83%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 89.55%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Certifications</div>
          </td>

    <td style="width: 4.62%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">2</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <a id="FINANCIALSTATEMENTS."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ITEM 1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: left;">FINANCIAL STATEMENTS.</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONSOLIDATED BALANCE SHEETS<a id="BALANCESHEETS"><!--Anchor--></a></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(IN THOUSANDS, EXCEPT SHARE DATA)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
            <div style="text-align: center; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">ASSETS</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(unaudited)</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Current assets:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_8561396c88be4705b7cd93a9d57fbf44" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">24,229</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_c382f7f32c7446fe9626faea5b3fc443" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">28,567</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Patient accounts receivable, less allowance for credit
                losses of </span> $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" id="Fact_e2c8e2a564c64c9690e9906d84e822ae" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,799</ix:nonFraction></span>&#160; and $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" id="Fact_75686405ea744686b2b0e9ba7fd5c3f8" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,768</ix:nonFraction></span>,
              respectively</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" id="Fact_63b9525d592a494897b275220a0e8b6c" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">49,335</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" id="Fact_a33badb328c94e929cc5568c1e79fcc0" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">46,272</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Accounts receivable - other</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" id="Fact_95f993755d19437ba4e6a8386ce8f796" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">18,239</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" id="Fact_f4bf838fd1ea43de9cb3a511b17d9bd7" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">16,144</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Other current assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" id="Fact_a68ddb8e7df8414e905432e96083dd3a" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,040</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" id="Fact_e1963d8dd490442bba14bd7f27cb4515" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,183</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_521a066e27b547b1914e0180d2f9fdd8" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">95,843</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_98e563d053854d758b2a9a6f74b93025" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">95,166</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Furniture and equipment</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" id="Fact_2c345c41e33f41998afc2c8bded5ec2c" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">60,205</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" id="Fact_9de1223686124a9f83712b30d7e5db05" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">58,743</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Leasehold improvements</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" id="Fact_acad4b3d757340f9810558284673990f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">40,541</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" id="Fact_f8d643a3444a477c9513e073c086a8b3" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">39,194</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets, gross</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_96d90d3088694460bac57a9891e73453" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">100,746</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_a947b36198f24b91ab803bb5aae2c7dc" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">97,937</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Less accumulated depreciation and amortization</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_607cb574051c44aba9e94e85735d0f4e" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">76,601</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_0f4892455e674666b1cc54321acaea79" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">74,958</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets, net</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_7d0d8740e81241f9b6681f22f15bb44f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">24,145</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_4483c25555a3453ba8b196817d29fb7d" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,979</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_d5ad9423b58941b9b905b15e8450f4c7" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">94,243</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_95e7be2ed17744d695f199d575963109" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">96,427</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">Investment in unconsolidated affiliate <br />
          </td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" id="Fact_d89bc5876e5443a6a644bafc70aacb0f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,422</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" id="Fact_4564a7ce59094643b7a97bd04730e1b3" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,215</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_1909ce68dcf049e19be34fddb124fb6c" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">443,692</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_b03a91e46c124bf3a33b9be664061973" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">434,679</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other identifiable intangible assets, net</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_7710454a343340bf885af3853072adc9" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">91,546</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_96badc6c90df40549c2593e276f12438" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">86,382</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_6e23e0bbd00443c0b4cb23a696ab8cc5" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,972</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_ae03d2ad1f6b4d20a7fe2c92d8f4d21d" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,578</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 28.85pt; font-family: 'Times New Roman'; font-size: 10pt;">Total assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_f2396e94bd604bb798c41309c1ada184" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">763,863</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_c437e2f632ba4bdaab7290447a40ba7c" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">749,426</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH SHAREHOLDERS&#8217; EQUITY AND NON-CONTROLLING INTEREST</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Current liabilities:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Accounts payable - trade</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" id="Fact_0420515c240f41df9d75f385f871e375" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,272</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" id="Fact_e80a5e9a90074087843dfd7799b563d4" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,268</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="margin: 0px; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">Accounts payable - due to seller of acquired business <br />
            </div>
          </td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="usph:AccountsPayableDueToSellerOfAcquiredBusiness" id="Fact_3a50a50c7bb04b588d6e16b43fe83a4e" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,203</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="usph:AccountsPayableDueToSellerOfAcquiredBusiness" id="Fact_b614be928c7a43548a17e4f82c28265c" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,203</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Accrued expenses</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_c992809b3c96471185889b9ecbadc8ea" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">51,121</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_abc4cf07f8ff436ca9f20e9642e6b90e" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">45,705</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Current portion of operating lease liabilities</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_36b098a2dd6f4578a358cbf08732a1c3" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">30,625</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_c4f20c759428431d81d0d7ad385479ae" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">30,475</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Current portion of notes payable</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_3e812a339b3d49a4b8ba9bacd806695b" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">799</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_ba7f0a298b014a4584ff1e1523eb5dad" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">830</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total current liabilities</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_0dffdaf0744741648be3cb6bb8bb69b0" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">89,020</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_c823c78104084b1cada66996af06025d" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">83,481</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Notes payable, net of current portion</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermNotesPayable" id="Fact_abee34b2fd894efea6347fccf3fbcacd" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,128</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermNotesPayable" id="Fact_d021a2c4356b44b7af70ad8098c4b83c" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,587</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revolving line of credit</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" id="Fact_00eb079672ba44178301fa161f9b4dbb" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">118,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" id="Fact_4beaf570e63e445cb6403252d178a7c3" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">114,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Deferred taxes</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" id="Fact_f922dc7dcf4247b6bb639e441a28e71f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">16,067</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" id="Fact_ce071d6467cc44b0aefe92611e909a0a" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,385</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities, net of current portion</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_e54ef92ec4df4489be7f3dbb8458383d" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">72,162</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_b7b53204e0154d8b9fb1aa2aad488aa6" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">74,185</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other long-term liabilities</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_f9896e2cf8b54c3daf2ca59d73cfd04f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,262</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_916191bd806d4340b2e57dec93ee2ffb" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,345</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 28.85pt; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_d970840db4bb4622bb704353e8440d7a" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">303,639</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_aa94b0ccfc0b43ed989c1ad07fc727bc" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">296,983</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_a2e6b567ae9640de994e4b23d5b5e543" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">158,008</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_060c915c2a9e488a9814ec86114d4bd8" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">155,262</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Commitments and Contingencies</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_2f58095c069643339f81fc7004023662" contextRef="c20220331" unitRef="U002" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_09158755baec4ec380f01cf40599643e" contextRef="c20211231" unitRef="U002" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc. (&#8220;USPH&#8221;) shareholders&#8217; equity:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_e661e292b4484ac9b86dde706aebf863" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_1c961fe0ccd84135b14ffd888592e53a" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction></span>
              par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_416317c9057844c284d70d6e19981df8" contextRef="c20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_3205c7054ba64a1b9399f636bf2ff620" contextRef="c20220331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">500,000</ix:nonFraction></ix:nonFraction></span> shares authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_e2f766760766417f82d26801f968f2ed" contextRef="c20220331" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_cd8625a94fc045bf8a79dc4ec6aedb8d" contextRef="c20211231" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_9672728e875246549fd313e945b5c174" contextRef="c20220331" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_90e24575a5f643759c3bacc24797953e" contextRef="c20211231" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span> shares issued and outstanding</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_f9e6cec8c98347908c5921635d55df7d" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_cfbe9d651e3c4ebf9630f00652329736" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_5b7b8330f202445d826385cafb195b1f" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_4fc5f583d6554173b588f87ec9c63fb7" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction></span>
              par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_50ae49a0f6e64db991383e1e727989da" contextRef="c20220331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_298ac01db8174bc6a9e6478da9f7c921" contextRef="c20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction></span> shares authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_c246996a576243b0933f2d9910f0cd70" contextRef="c20220331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">15,206,173</ix:nonFraction></span> and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_ec9d179e963d4db0ad5b65b2800faf21" contextRef="c20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">15,126,160</ix:nonFraction></span> shares issued, respectively</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_336110f448f0432b8d18992aa1e752e0" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_f940e188d74040cc8e421c0d90d0c769" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Additional paid-in capital</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_f733303449084189b302e96be5ef14dc" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">105,205</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_a8eb9616d30a4a6389b14098ae306fba" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">102,688</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Retained earnings</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_611a248b8e7a4146890a0212ac3fa7da" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">227,243</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_cad466ab94ef4a74aadd1d67eb8dbdc2" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">224,395</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Treasury stock at cost, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_599daf18ed66483ea720dcffd067e677" contextRef="c20220331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_1fcf992ba5924feab5f83c8959342928" contextRef="c20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">2,214,737</ix:nonFraction></ix:nonFraction></span>
              shares</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_f83e1aa020a5491396d23e64de98dc7c" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_5387b26a348c43558b98311428764d04" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total USPH shareholders&#8217; equity</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_702ebe2c60d4425d84090225a37c4d15" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">300,971</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_1a00bffa4d1143d0b987d319f29ea4eb" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">295,606</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_997ec6d286e443d4803d59f60b58b66c" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,245</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_7ffdbe489fc64a6b842ba0d28129423f" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,575</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total USPH shareholders&#8217; equity and non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_8f6a2d4e21284881bbc5f7cb03ea07fe" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">302,216</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_469f4ac21aec4bae8ecbcccc5e66fb7d" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">297,181</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 28.85pt; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities, redeemable non-controlling interest,</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -9pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">USPH shareholders&#8217; equity and non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_4ac49a3868aa41959a984ab2e948ae0d" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">763,863</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_22443dd67833480184f3349362dff19b" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">749,426</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>

    <div><br /></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">3</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONSOLIDATED STATEMENTS OF INCOME<a id="STATEMENTSOFINCOME"><!--Anchor--></a></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(IN THOUSANDS, EXCEPT PER SHARE DATA)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(unaudited)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Three Months Ended</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenue</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_2dd37337eafd407c87d01ee8d9cc547c" contextRef="c20220101to20220331_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">109,538</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_fc30ba3c58bd4862bb2554194bd17537" contextRef="c20210101to20210331_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">99,254</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other revenue</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_8ffbd269610b4b92b7786267eebc3581" contextRef="c20220101to20220331_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,166</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_6bd697cabb434e5682570c8056b83ecb" contextRef="c20210101to20210331_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13,114</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Net revenue</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_243b13a5fcee4e9aa1aa72d2bde1220e" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">131,704</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_1e5cfc3fd6314f1484706ab5f74e4180" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">112,368</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating cost:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" id="Fact_2258c5166017428ba1868ddb8695e0a2" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">75,149</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" id="Fact_9359596dafe84736aa4a71791ebf913c" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">63,815</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Rent, supplies, contract labor and other</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1"><ix:nonFraction name="usph:RentSuppliesContractLaborAndOther" id="Fact_238f80d8f4ae42a3a11c207002a517c6" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">28,662</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1"><ix:nonFraction name="usph:RentSuppliesContractLaborAndOther" id="Fact_e032293d6aad495a9d259d1f38026bbf" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21,457</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Provision for credit losses</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_b0d448eb678a4b4594d5c0529ecc9e33" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,305</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_15d3cd228fa448c5a3f69917b52e9dcd" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,200</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total operating cost</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:CostsAndExpenses" id="Fact_f0cc043f4a2c4fd3abbabd231eb85c93" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">105,116</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:CostsAndExpenses" id="Fact_b5a4e86677864f9ea7f1a476854c3702" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">86,472</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_c73319059c6c42a783d6b08a75f2b9d0" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26,588</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_ef44c1443374467eb76eb0ef8aa7d95f" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,896</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Corporate office costs</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_62eac50a4e074616b646bcb10271dbd3" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,556</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_a87f571e83084eccbddc41f22ba42b08" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,874</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating income</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_e37708849b814a3490420002236035f4" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">15,032</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_b1741368bc0446eabe8edd17716fd484" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">15,022</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Other income and expense</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">Equity in earnings of unconsolidated affiliate <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_6f4c604922244db4b3a25c683ed8a2d6" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">339</ix:nonFraction><br />
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_c22638e0788243ac837b8c5d8420c1b4" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction><br />
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Interest and other income, net</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" id="Fact_92615c031560465eb6fe1ed6d6b4d9db" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" id="Fact_cabe0f81491b45d4b6dad40ff9e44431" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">54</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">Gain on revaluation of put-right liability <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" rowspan="1"><ix:nonFraction name="usph:GainLossOnRevaluationOfPutRightLiability" id="Fact_e9b0c18b5edb4fb2879e801c326122fc" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">603</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" rowspan="1"><ix:nonFraction name="usph:GainLossOnRevaluationOfPutRightLiability" id="Fact_5f853dae4def43cfbdc862b0c4d8be2a" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Interest expense - debt and other</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">(<ix:nonFraction name="usph:InterestExpenseDebtAndOther" id="Fact_98897cd25117492ea917d45da4d48895" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">540</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">(<ix:nonFraction name="usph:InterestExpenseDebtAndOther" id="Fact_24dc7db48f9e4ddcb8f7f4846e07e531" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">246</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 23.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Total other income and expense</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_29742cf44954451e912ec53e7449b9af" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">448</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1"></td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_a00d46dd2a58478a9fbc8764abfc0e14" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">192</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Income before taxes</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_a82f65c1e53f40b0834703028929f3a5" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">15,480</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_4a94579c62cc438a89ef0aa97d554154" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,830</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Provision for income taxes</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_7f49048ccc674f0ab9217a40f2ff43fb" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,498</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_53081d987803473fa650d1849c99bf6d" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,944</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_3103bae7c7924e9395e98e43fcef47c7" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,982</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_79dc646c50c24f189ecabd15d88fb4f4" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,886</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Less: net income attributable to non-controlling interest:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">(<ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_3c3a8266b4744ca5961b7cbe15301302" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,557</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">(<ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_45b91a63cbba4cc3867f9617d5f8a4d7" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,453</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">(<ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_d8f20fe738b9454f8bd0880a110ee30b" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">626</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">(<ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_ceae4a1a34134d5cbd8aa0303e5a7f50" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,260</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" id="Fact_6701d6ab66cf4179b69e50943cabdf08" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,183</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" id="Fact_b6a3314ef201412e8b3fa707fb44a388" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,713</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_264e671f5507413da912c39b6fa5b656" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,799</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_379310f16d2b49fda29ebdc9b7f1460c" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,173</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_25bd018a390f4e15861bf1c2af0ea43c" contextRef="c20220101to20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_10127377e2154cc7bc51de66b78706bf" contextRef="c20220101to20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.67</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_ae78532abd34469eb984c8d9df0b23d8" contextRef="c20210101to20210331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_661740cbfb444e2da1bd29e185d781ee" contextRef="c20210101to20210331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.21</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation - basic and diluted</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_f002025b3d9f47c596bc13815ffffe6e" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_1871917bf20e497f8b7cd645025e647a" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,937</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_9dddded5d8614e6bb41982a9e315b9c8" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_5cdb4654858f441da886cae5ce71b997" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,870</ix:nonFraction></ix:nonFraction><br />
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Dividends declared per common share</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact_860faf1d104349839f290701f790893a" contextRef="c20220101to20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.41</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact_64d518e51bb249beb49ebdb916c24afa" contextRef="c20210101to20210331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.35</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">4</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONSOLIDATED STATEMENTS OF CASH FLOWS<a id="CASHFLOWS"><!--Anchor--></a></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(IN THOUSANDS)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(unaudited)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OPERATING ACTIVITIES</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income including non-controlling interest and earnings from unconsolidated affiliates, net<br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_f0c13ff17a214c4f9df776e2cd6f80de" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,982</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_4653f81c8a3f4d148277bb6af025a904" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,886</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_be731ed749c74eeaa16c716bb038d6f7" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,824</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_bc9f4352a65940ffa48c9848d833bcb8" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,681</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Provision for credit losses</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_f3b27e9ee8974c8fa16fe057a64bfdc2" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,305</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_62993a01884142aaa8e62f87364685dd" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,200</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Equity-based awards compensation expense</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_7a0c84a44a4e47a49ef5645bef379159" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,846</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_8c22c860a47d499cac4297693f444818" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,651</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Deferred income taxes</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_996134f15de24125ad02d7e6f41eab13" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,132</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_2dcc27fa0322482cb8b385cf4009e354" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,181</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" rowspan="1">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">&#160;&#160; Gain on revaluation of put-right liability <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="usph:GainLossOnRevaluationOfPutRightLiability" id="Fact_c2e0cefc4709418c914b2036a162ab5a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">603</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="usph:GainLossOnRevaluationOfPutRightLiability" id="Fact_968d6d1c31a140c39c77393a88839532" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">
            <div style="margin: 0px 0px 0px 21.6pt; text-indent: -7.2pt;">Earnings in unconsolidated affiliate <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_23b8128366d04dcf9a7fb118f4b0cb50" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">339</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_fd8b35e838834643b42d61f06affea59" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" rowspan="1">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">&#160;&#160; Other <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" id="Fact_30f5da033d0a4e9fb062b31931832f5a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">93</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" id="Fact_30da66c98ed542e184dda89d64c9e11d" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">96</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Changes in operating assets and liabilities:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Increase in patient accounts receivable</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" id="Fact_22f3a501a6a54371bf227fe55f04710f" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,676</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" id="Fact_bfdeb586c85e471b8fa3e1abfeb507ab" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,688</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">(Increase) decrease in accounts receivable - other</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" id="Fact_1877e35d4c0e43518f2b36502e373bac" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,145</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" id="Fact_c4207c9c3c664057b849b1f1d90f420f" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">220</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">(Increase) decrease in other assets</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_d0b831ba1ac842578a5e1b28cf089211" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">735</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_5f2c2c1daa754beca86cef8f9caf5e2a" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">221</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Increase in accounts payable and accrued expenses</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_376e02da40574b0fb5effb948e7627ea" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,445</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_a66e1035e9044e2da5a50ac5f4cd4d04" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,969</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Decrease in other long-term liabilities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" id="Fact_a6ffa484c62d4dbb94a6cbdd1b0f63f1" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,480</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" id="Fact_4b36f8448b1b428eb8d2092eda86ea4a" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,743</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net cash provided by operating activities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_e14a1f2856fc49db96ce17eb6a78b1d2" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,649</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_e21a609e4ff44a66a2b9367d6e2d6747" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">17,674</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INVESTING ACTIVITIES</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt; text-indent: -9pt;">Purchase of fixed assets</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_f00703ee905e42fdb41cf8a89631bfda" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,528</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_8a6c0d78461f453e8282895f40ff1dad" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,608</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt; text-indent: -9pt;">Purchase of majority interest in businesses, net of cash acquired</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_4ba8ec8d7b224d79b8f1b61487fbcdd1" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,242</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_f34dad44ee2842698e5582913d84b528" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,747</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt; text-indent: -9pt;">Purchase of redeemable non-controlling interest, temporary equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PaymentsToAcquireRedeemableNonControllingInterest" id="Fact_0634aef93d4f4993bdafe7986841e334" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,211</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireRedeemableNonControllingInterest" id="Fact_a4b93a5737ea4efeb28a6c49679d0f99" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt; text-indent: -9pt;">Purchase of non-controlling interest, permanent equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" id="Fact_1711a52bb2f54b208cd41be0617223f8" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">99</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" id="Fact_2ff448df45d745e482af47f6c49be8b3" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt; text-indent: -9pt;">Proceeds on sales of partnership interest, clinics and fixed assets</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_fa19e18483a74cb79aea19511bf68fd7" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_0301a40012534f2d9d7d467751a71ce8" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">152</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">&#160;Distributions from unconsolidated affiliate <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="usph:DistributionsFromUnconsolidatedAffiliate" id="Fact_d721d9c82c2b478f86975d14b7aee4e8" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">132</ix:nonFraction><br />
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="usph:DistributionsFromUnconsolidatedAffiliate" id="Fact_ab9acf9fe7194ee7a61554cfeb32865f" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction><br />
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1">
            <div style="margin-left: 18pt; text-indent: -9pt;">Sales of non-controlling interest-permanent<br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="usph:ProceedsFromSalesOfNonControllingInterestPermanent" id="Fact_64ed33e04e69485d9e0107993c15de35" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="usph:ProceedsFromSalesOfNonControllingInterestPermanent" id="Fact_dafe4e43c10d43b4a58a59dcb47912b0" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net cash used in investing activities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_94ef0c8230f8401a98da072be31edc00" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">15,944</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_13d50103b4ba40198cafb183efee69fe" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">13,203</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FINANCING ACTIVITIES</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest, permanent and temporary equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" id="Fact_d61da74eb3e9429eb594bdcfddf7aa03" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,711</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" id="Fact_acc4ff8634134dde9f3baf4f41302414" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,265</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash dividends paid to shareholders</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" id="Fact_1c3c2c9e4c8b4b1a830991269c7c2e94" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" id="Fact_6a236e4482b5472687716a945db7acf6" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Proceeds from revolving line of credit</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" id="Fact_4a99c25b3b42427b9344d8bb885ac7cd" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">35,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" id="Fact_d5879261dd734640a36425d6a73ec62b" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">60,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Payments on revolving line of credit</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" id="Fact_008a55a6c89b468da2c410aac6a3ed89" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">31,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" id="Fact_b52dd0cb71c24cfea15a3e37c5114f1e" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">60,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Principal payments on notes payable</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_c7ca9cc58f844e1a93fb2d65f74cebce" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">332</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_58f0c7a3ab774d9391f6ad4b40f26794" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">145</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">(Payment) receipt of Medicare Accelerated and Advance Funds</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentOfMedicareAcceleratedAndAdvanceFunds" id="Fact_ffac465da7164dd8a3e09a8500b2d9a9" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PaymentOfMedicareAcceleratedAndAdvanceFunds" id="Fact_7288a00742494f259e6e867d9e5bf0f2" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,054</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" id="Fact_c10babe75ab24f13bd1f3d7ca70bcf44" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" id="Fact_2f36d438fb1b464c9567a748a37e4ff6" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net cash used in financing activities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_4dec0786c77649c8861b48c002c66e9d" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">43</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_5d5c5c2e8c7c4e8ca6859f0c7488968a" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">19,452</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net decrease in cash and cash equivalents</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_9f0a5421cf0f49858b92efb530860e33" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,338</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_5c6ac038701d4cc6bd3a6d29b0f259ce" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">14,981</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents - beginning of period</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_d79019a2053346c48df19a09a9619d82" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">28,567</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_cfd478c2d07d40d88e338db7db1030d4" contextRef="c20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">32,918</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents - end of period</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_2187887532084076914329feecfc1319" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">24,229</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_72024558b43d4d0e9840d2697ab03685" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">17,937</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid during the period for:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Income taxes</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_faa759c93548453f83be7f8a4351f07d" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">81</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_b1116b63ce314c76aaf7ebefc6daed2c" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">62</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Interest paid<br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_64a622d37ea04fef8513a5b9c9a6aed3" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">525</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_ba23d3a721674d36a0a0840cd9e4727b" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">298</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-cash investing and financing transactions during the period:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of businesses - seller financing portion</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfBusinessSellerFinancingPortion" id="Fact_e12a00d11a03423ca3924f5de2f24e1f" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">300</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfBusinessSellerFinancingPortion" id="Fact_8d96a0da5c754fb880e45dda93c0d113" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">300</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">Notes payable related to purchase of redeemable non-controlling interest, temporary equity <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_87edb7a51a5341beaa4d1800d92142aa" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">246</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_6891246fdf774a9c8585770d2875b043" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,829</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Notes payable due to purchase of non-controlling interest, permanent equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="Fact_cdf452b7dd88499e902f01069e9aea82" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">296</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="Fact_542e5dd8893346229844859b1f1b5a61" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">
            <div style="margin: 0px 0px 0px 14pt; text-indent: -7.2pt;">Notes receivable related to sale of partnership interest - redeemable non-controlling interest&#160; <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" id="Fact_0cd27103b667400294fe876890828c4f" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" id="Fact_16df3c72822548629d39fc4542542edb" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">287</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" rowspan="1">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">Dividends payable to USPH shareholders <br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPayableCurrentAndNoncurrent" id="Fact_0ba696a7c25346abbd920eb5728519cf" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,327</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:DividendsPayableCurrentAndNoncurrent" id="Fact_b383c533459a441c91eefdbd3cd0e359" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,514</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">5</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY<a id="CHANGESINEQUITY"><!--Anchor--></a></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(IN THOUSANDS)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(unaudited)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="26" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S.Physical Therapy, Inc.</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Paid-In Capital</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retained</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Earnings</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Treasury Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Shareholders&#8217;</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equity</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Controlling</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Interests</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For&#160;the&#160;three&#160;months&#160;ended&#160;March&#160;31,&#160;2022</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Balance December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_2cf2e837b028465aacb0227cb20e7699" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">15,126</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_c53ed5e99e4d43ddb20d9204f3f2494b" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_8a7086d7a7e943129ea95ec26d80ec71" contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">102,688</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_56c9db9a0c47400e98476cf668692fdf" contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">224,395</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_d5302120a59a45cd98e05d47446e6255" contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_5d7903d9dba74201bbfb48cd2755d035" contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_c7f89ed3ed4e427d88d302bf54ae2860" contextRef="c20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">295,606</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_5bf7fb35a0264536ad1429bc9721fc04" contextRef="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,575</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a0d68c8679694482a5f07107c2754f52" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">297,181</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Issuance of restricted stock, net of cancellations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_7fef89c14e9b4345988a5718024e0a56" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">80</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_894f5a2e4ddb44049b0f18bd2a38e2e9" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_9446c5af9c2347b79f269f1d376c9cf6" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_2e1bf32bfefe4d3a95527cc7f5489a36" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_5d478a0c4e2e49389dd48c65125a6619" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_a511165ad7fe4787b37ba6df7f2149d4" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_84a9b0d010a34c2ca61cb3ea40cd382b" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_bdafc29b17214b60857cd9eb47142ee6" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_115c6027a4834b0bb2e5776396f1de3e" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest, net of tax</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_95f378fb0e6f4dbbae752e18c5c04d2b" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_3ae2506044d04606874e1f0b965016b7" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_dbab644ed28649a6af3116e92f8800bc" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_25eef081cca44bdba8a3cd6608fa1a74" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">113</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_e9a9464d23bc48e7be482d45ee7f516f" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_c12de7f92aa04fb8824d7c01d122cd5e" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_f6332a81bb9e4533bb9801d0b463730e" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">113</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_74f4885b82414e9ca0c115a217b1ed64" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_c1d31e2a7d2949239cca30bc3c178963" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">113</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense - equity-based awards</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_b91aec925335405d8bb4a2452721bfaa" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_b0beb5546af24985b70a1365fc1e05f5" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,846</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_cd1f7596f512422a971075953b5db463" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_9a959ecabca645c395e3b8c06b4a098d" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_36fb5cbcf81546f3b6b865a4ca922e93" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,846</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_7a48bde1c0c64f41afd1d96a54643840" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_989f7c98645b4144ad9f5116f742b5c3" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,846</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 10%; background-color: #CCEEFF;">
            <div style="margin-left: 9pt;">
              <div>Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans <br />
              </div>
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_898a7c41dbd547739402626f34223622" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_1cb550e51c774efa98f5ed0f154f217d" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">706</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_991d311060c948a594dd65d2dab5c802" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_cc87d9e625e6443e9494b1f59d276e6e" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_5935aafa2f5f4799a8005579431aa9f6" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">706</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_39f0dee0f95f4cff859f1fcf4dce225b" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_fadffa57068a41a99da8edd2300e9196" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">706</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 10%; background-color: #FFFFFF;">
            <div style="margin-left: 9pt;">Purchase of partnership interests - non-controlling interest<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_910b626e73004f1b8b875530f6bfea6f" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_5ec9d516dbc34ad0824dd5f6065287fa" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_fa2a9b6344d2410dbc8720c1fee76ca1" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_4465697560de4af687b15fbecda83ec1" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_d8487720d9904273a9f0af836296cc35" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_325c64bc9d23401aaaaa9750d2998681" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">334</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_48e2e18e3d0e4f249d1f3963c1c40823" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">380</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 10%; background-color: #CCEEFF;">
            <div style="margin-left: 9pt;">Sale of non-controlling interest, net of purchases and tax<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfPurchasesAndTax" id="Fact_70917b248eae46648eee1210e5ebdaaf" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfPurchasesAndTax" id="Fact_6c76a7cac6a049f7b5bf95796da5286f" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfPurchasesAndTax" id="Fact_9679bf28f1734c89bbf29a5962372ebf" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfPurchasesAndTax" id="Fact_a8f6f1d03dab4d4088532a7681d8ca16" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfPurchasesAndTax" id="Fact_cd3faf4bbbca47e9acb3531002393d26" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfPurchasesAndTax" id="Fact_280b9103072b4ca2ad0687e6b7f8563b" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfPurchasesAndTax" id="Fact_600c07cdd4e44a1695f8381e680854f9" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Dividends payable to USPH shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_8b46354337eb41d7937d173b858ccd51" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_03d2c6fc6799493f925687fd29a75d24" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_ebbbbabf01154bd88019b8b5d33aba04" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,327</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_0a896d4277da4d0f8abe6118abb1968e" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_e1ac9e627770416bb9f1618485c98650" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,327</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_e6c4a8298a404e9295d191038e300fe0" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_72beac2c6f3d4c3f85f963d153d47fce" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,327</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest partners - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_0fa57d23efd74a69a0373e016d1cdff5" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_9893c29117ef482b8ad765e2f4226271" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_73019957c80c4ccf85ade38116a398eb" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_6d7bf888924340b0adde1659eebf24a0" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_781b5147cb4b45629be849d0a58e5ca2" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_5761493ad7be431d87c9c32882c2272b" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,308</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_8d96551342464a4380dd684ed715f259" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,308</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_a665cb5da9234bcabba47ea4c4c0f7fb" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_ed3d198a8197402c9c69795cac1311e8" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_64de025f2679473ea835ec5886318b39" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">511</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_f826af9ad213424fb47377b8401d0716" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_ba0c97253eee4dc2b7aa32c824451c0b" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">500</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_64b07eeec2fd4840977c52af304767cf" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">686</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_57ab21603ee84778b25c28f14ac6797d" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">186</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_1ec6aba99a9c43c697cf470f0d47da6a" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_6a79f7333a0a4cd7a39f0dcd5b4cfe1b" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_4747057d2ff54be9a28bbfcdf7ac7575" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_6f8550d49c2243ceae3acf6d31720f4a" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_395d42fd718e43bab7298d1ab90828c0" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_ea03aa070c4346e5ae6d460f830fa725" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">626</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_8d9385b7549c4e189ad9d9d2a9c4d40b" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">626</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_0a4f475712c04555a5e2767032b46baf" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_4934fa6e36f640cd836b556cb4495c74" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_e523db27ab28484da88ff1dd8c81fb89" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,799</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_b21947f5f6c84edc897d3257963bade1" contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_0abbee72dcaf4b4baddf0b81eec0d0ae" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,799</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_6a072279b67340f1b77687cb206df900" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_ea68f31794bb436291ca6376b8eba279" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,799</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Balance March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_2788f61fe613420581eb6806e9c8b074" contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">15,206</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_82f0eec4d51f46a086e7290c03ce537c" contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_743c86d21b0641f5bbae924fd028bef4" contextRef="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">105,205</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7bd570de8f7347e6b45cadcfd5fe37a5" contextRef="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">227,243</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_c90231581cb04ed287e7f594f4f28c60" contextRef="c20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a7b4d6d893b948d98319b5f8e297807e" contextRef="c20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_f11e90c5d5b749fabd05bb8bc6253ddd" contextRef="c20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">300,971</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_2e175a5f68ba4afe81ecd214b1d7ff3e" contextRef="c20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,245</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_07ff0f19b8ac44bebaefdee84789bb20" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">302,216</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="26" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S.Physical Therapy, Inc.</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Paid-In Capital</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retained</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Earnings</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Treasury Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Shareholders&#8217;</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equity</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Controlling</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Interests</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For&#160;the&#160;three&#160;months&#160;ended&#160;March&#160;31,&#160;2021</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Balance December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_619d0a908dc541e8a480345309025ed7" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">15,065</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_c9bacfb7a7fb4109872c9a972716cb5f" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_ec0cda55ef6446ffa9323576c6a47ddf" contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">95,622</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_fda6739c74bd468e87eae1e7ab01570a" contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">212,015</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_1a1a97c41fe54cedbdef47215862c241" contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_fe91b33de615478e928bff975b5cf056" contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_829f4eb9c52641e6a31371ddf86a4d86" contextRef="c20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">276,160</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_49a8c88ca0f24e23be113b87de392819" contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,470</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_b133a4f5420a41eea8d55bc527bec3dd" contextRef="c20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">277,630</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Issuance of restricted stock, net of cancellations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_af63d00f740d4de2aec75de9949cc816" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_1cc2c57b4f654cdd801ac63b54d7a4f3" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_3a15288034474ae39c25aad7387aaf72" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_5dbbe695911d495abf6a99d059291ac5" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_5e7e368ea772476e995d2436c7bdb3d0" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_81eac31184544eed9e4b1319793e36c3" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_156773c87f1e4c66a2f92535abb4f3f3" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_51c8991788eb44fdb5a06bb2436a950a" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_be54096ce0854268b9303591b86f4442" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest, net of tax</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_f5a34657f6194e94a07a0c9ac97b3c08" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_baa1d03aade540d4bcf2e110e49c664b" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_01b39f7234fe44738fac42189bb897fd" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_d13ff828154b468e9779bcb637d3590b" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5,413</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_52c00ba72dfb418b8d8fa9e1fe676228" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_ba1bfb948b6b42cb836fddebaa1de398" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_07ead7ab48c6467da2838987debf0bf1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5,413</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_6597fb62f16e4067bd8f38d8c49394d1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_cce87546740447cfa2238f466e42647f" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5,413</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense - equity-based awards</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_8070ace992ff49f0a31676258835397e" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_649e7cb68ca344f886663017cd13eb9f" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,651</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_e9ee4417f822428691069f4e801f7c6d" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_e767a90cff544cdeb43b0c2ea7e107c7" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_1a160231ebde4edfa779903913f8aea2" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,651</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_593306c0dd384a5cbeb807b38bff904f" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_75bf4de9b34141269ef7060555a5f9e7" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,651</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Dividends payable to USPT shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_45901373a62c400d97abe41766128cd1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_bd47eb18aa7941e1912b6585071b8381" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_a54504bafdfe46d0bde05e5c57c84119" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,514</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_50abcba85e724629b3cb02d03f4895a0" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_676bc9fd4dd04d8cb9a8122d6cde107e" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,514</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_87a64f9723024d96a94147ef1ccadc27" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_39403a5d225f4f67954cf56603461ac2" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,514</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest partners - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_366391b70ee64e7495803513041b3996" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_c1b34f94d29a4194a8ff472be8f15010" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_0780fd61e99f48b99a9c03403dc34677" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_2c671126b7be405fac60eb127131c1b3" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_3b2f9980a3ca48afa57e9b0c303dfce1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_9b426d5843fe497281fe6514cf18b346" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,672</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_e82f283a2c5d44b897970bfeea6c430d" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,672</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 10%; background-color: #CCEEFF;">Short swing profit settlement <br />
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_39751bd17b414bbc9664edd434e3c32f" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_0dfebb173ce4486e989c527b261b6d67" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_51b59adac95448b4a6465d92c3a41288" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_22a1cbc9ac7546e59975b8cc3a9f52e1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_25825b87d0f2473faa21158992208ddc" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_a34f41140e984e3d9273800e0664c681" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_ddc212d1cd7a448d97f2674dbfde9473" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_f81e6ad44f1e4b109263872390cec200" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_6115705a4ec6497f8a5f3feb96f3f8c1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_6adb588501b141d1ab670c22b86e2265" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">114</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_1834dbd1e17a410a84c375ee94136ac7" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_586efe39514c49f39a3820a0663dc3e1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">114</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_cdb768fb657540caa759c76dcb18f8c1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_1d1263ad8fad474f8e2ac6db11ec1d86" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">113</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_f36d7106e1f040debbae786bae2c690f" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_5054248594e74d4c9c5b81b3c12bf829" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_bbce184bf4e941abab9c4cc7a9b86398" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_af823ef1280b42c5b86762c36a1d68f4" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_60e9a522ed5443d3b6d5d88039617a33" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_ef396419040d4bb8b4a8cf789abb9109" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,260</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_ec45917eeb604449b98268e8354a17cf" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,260</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_06edd65024c64f9a81b829d24a20e911" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_3564dabca3864512a2a4d2f1974ee462" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_0388af69cd28467c8e64c379b770867f" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,173</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a187a9ee168a4141b46c04270aa78b50" contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_2f24589d4fb947dd8ce612939ed5ea88" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,173</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_566f9e8be9764641a502e5b0a0a2cf41" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_4a33329afcf641358a8b0fa2a15156de" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,173</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 10%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Balance March 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_88b8d5740df04f43a6691d405abfa8f7" contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">15,111</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_2d42ef83eb71432d818cdc7840084857" contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a9f8ecc56404427aa3490909946859c1" contextRef="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">97,286</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_33813016db5748fbb38a971b03192d7f" contextRef="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">210,375</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_535dee3a4e9e417d9ee5d43cc5c3a616" contextRef="c20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_5f687a822006473883321b588702e1ae" contextRef="c20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_49046fb4b19b4943b980427941db02fd" contextRef="c20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">276,184</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_0e8f2fdd9fb8420b9ae417a1ad54a189" contextRef="c20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,057</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_578e2f2621724ee69c289b324748935d" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">277,241</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.<br />
      <br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">6</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="NOTESTOCONSOLIDATEDFINANC"><!--Anchor--></a>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(unaudited)</div>

    <div><br />
    </div>


    <ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Text_f8c8c378a1854161b798b6296dc4e750" contextRef="c20220101to20220331" escape="true" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae61">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</div>
</ix:nonNumeric>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae61" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae62">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae62" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae63">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#8220;Company&#8221;). All significant intercompany transactions
      and balances have been eliminated.</div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae63" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae64">
<div><br />
    </div>
</ix:continuation>
    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae64" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae65">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company operates its business through </span><ix:nonFraction name="us-gaap:NumberOfReportableSegments" id="Fact_5e22b210f5344209a0bd1d67821b39d0" contextRef="c20220101to20220331" unitRef="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman';"> reportable business segments. The Company&#8217;s reportable segments include the physical therapy operations segment and the
          industrial injury prevention services segment. The Company&#8217;s physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders,
          sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance
          optimization and ergonomic assessments.</span></div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae65" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae66">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </span></div>
</ix:continuation>

      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae66" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae67"><ix:nonNumeric name="usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" id="Text_459d04a2ecf74b2cbd20d216b393f3c1" contextRef="c20220101to20220331" escape="true" continuedAt="Text_8be220fc9ec24e35b2148ed86f516ba31">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">During the 2021 year and the three months ended March 31, 2022, the Company completed the acquisitions of <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_724fecc6c1294d1e95f1610b47947a18" contextRef="c20220101to20220331_BusinessAcquisitionAxis_MultiClinicPracticesMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction>
          multi-clinic practices and <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_df8ef88f36d54071a785a32f2d5396ca" contextRef="c20220101to20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> industrial injury prevention businesses as detailed below.</span> </div>
</ix:nonNumeric></ix:continuation>
      <div>
        <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae67" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae68"><ix:continuation id="Text_8be220fc9ec24e35b2148ed86f516ba31" continuedAt="Text_8be220fc9ec24e35b2148ed86f516ba32">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae68" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae69"><ix:continuation id="Text_8be220fc9ec24e35b2148ed86f516ba32" continuedAt="Text_8be220fc9ec24e35b2148ed86f516ba33">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 48%; white-space: nowrap;">
                <div>Acquisition</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 15%; white-space: nowrap;">
                <div style="text-align: center;">Date</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center;">Acquired</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center;">Clinics</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>March 2022 Acquisition</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_8fcb5dbaa9874ecaaa3a46d608fd238c" contextRef="c20220101to20220331_BusinessAcquisitionAxis_March2022AcquisitionMember" format="ixt:datemonthdayyearen">March 31, 2022</ix:nonNumeric></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_42842e95572745e98a3f84336ec4db83" contextRef="c20220331_BusinessAcquisitionAxis_March2022AcquisitionMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="text-align: center;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_e070ba4470244407bff0ac6d7914774c" contextRef="c20220101to20220331_BusinessAcquisitionAxis_March2022AcquisitionMember" unitRef="U007" decimals="INF" scale="0" format="ixt:numdotdecimal">6</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 48%; white-space: nowrap;">
                <div>December 2021 Acquisition</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; white-space: nowrap;">
                <div style="text-align: center;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_29e13c5545c3412199ad7db9aed9235c" contextRef="c20220101to20220331_BusinessAcquisitionAxis_December2021AcquisitionMember" format="ixt:datemonthdayyearen">December 31, 2021</ix:nonNumeric></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_14f2f3dffcd94fffac685ab8927bc644" contextRef="c20220331_BusinessAcquisitionAxis_December2021AcquisitionMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" colspan="1">
                <div style="text-align: center;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_f8876f5bd03245488ff606b751897182" contextRef="c20220101to20220331_BusinessAcquisitionAxis_December2021AcquisitionMember" unitRef="U007" decimals="INF" scale="0" format="ixt:numdotdecimal">3</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 48%; white-space: nowrap;">
                <div>November 2021 Acquisition</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;">
                <div style="text-align: center;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_8d3dd52a9c2f41efacba83fa79584979" contextRef="c20220101to20220331_BusinessAcquisitionAxis_November2021AcquisitionMember" format="ixt:datemonthdayyearen">November 30, 2021</ix:nonNumeric></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_88a3c2c37da345ccb21c95f197060398" contextRef="c20220331_BusinessAcquisitionAxis_November2021AcquisitionMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">
                <div>%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_d858a7400c8b4646aabbd6bf18a9f0a4" contextRef="c20220101to20220331_BusinessAcquisitionAxis_November2021AcquisitionMember" unitRef="U007" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction><br />
                </div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">IIPS*</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 48%; white-space: nowrap;">
                <div>September 2021 Acquisition</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; white-space: nowrap;">
                <div style="text-align: center;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_e49056cd1a0340428d0e7682d3073d0e" contextRef="c20220101to20220331_BusinessAcquisitionAxis_September2021AcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2021</ix:nonNumeric></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_586d44e098f44ca696aa5cfac7ef5024" contextRef="c20220331_BusinessAcquisitionAxis_September2021AcquisitionMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>%</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_fb559091d7c74f0785b5cc150f4935e4" contextRef="c20220101to20220331_BusinessAcquisitionAxis_September2021AcquisitionMember" unitRef="U007" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction><br />
                </div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; white-space: nowrap;">IIPS*</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>June 2021 Acquisition</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_d4e41a0e5a9949b69a5450657857417b" contextRef="c20220101to20220331_BusinessAcquisitionAxis_June2021AcquisitionMember" format="ixt:datemonthdayyearen">June 30, 2021</ix:nonNumeric></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_2f6b36ddd90c4e0199e43f6b2f58d0ea" contextRef="c20220331_BusinessAcquisitionAxis_June2021AcquisitionMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="text-align: center;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_8066777ced20487abdebb56c7b727c32" contextRef="c20220101to20220331_BusinessAcquisitionAxis_June2021AcquisitionMember" unitRef="U007" decimals="INF" scale="0" format="ixt:numdotdecimal">8</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 48%; white-space: nowrap;">
                <div>March 2021 Acquisition</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 15%; white-space: nowrap;">
                <div style="text-align: center;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_11d4b7f42d0148cfb3c556b649312615" contextRef="c20220101to20220331_BusinessAcquisitionAxis_March2021AcquisitionMember" format="ixt:datemonthdayyearen">March 31, 2021</ix:nonNumeric></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_c6329705ab3e4436bcd7e6b82718b188" contextRef="c20220331_BusinessAcquisitionAxis_March2021AcquisitionMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" colspan="1">
                <div style="text-align: center;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_e8fc0fc279c9449b9b3ebe29d3f64e92" contextRef="c20220101to20220331_BusinessAcquisitionAxis_March2021AcquisitionMember" unitRef="U007" decimals="INF" scale="0" format="ixt:numdotdecimal">6</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae69" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae610"><ix:continuation id="Text_8be220fc9ec24e35b2148ed86f516ba33" continuedAt="Text_8be220fc9ec24e35b2148ed86f516ba34">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation></ix:continuation>
        <div>
          <div>
            <ix:continuation id="Text_8be220fc9ec24e35b2148ed86f516ba34"><ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae610" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae611">
<div>
              <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 9pt;">
                      <div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"><span style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 7.2pt; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">*</span></span></div>
                    </td>

    <td style="align: left; vertical-align: top; width: auto;">
                      <div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:footnote id="Foot_78cb7964484c42eaaaccb3a7770e93b6" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Industrial injury prevention services business</ix:footnote></span></div>
                    </td>

  </tr>


</table>
               </div>
</ix:continuation></ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae611" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae612">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae612" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae613">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">As of March 31, 2022, the Company operated <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_ced41f05862b4872a31cfa6c7ade5cc7" contextRef="c20220101to20220331" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">601</ix:nonFraction> clinics in <ix:nonFraction name="us-gaap:NumberOfStatesInWhichEntityOperates" id="Fact_faea8a7d6aec491b974e9c5599138ca1" contextRef="c20220331" unitRef="U008" decimals="0" scale="0" format="ixt:numdotdecimal">39</ix:nonFraction> states. The Company also manages physical therapy facilities for third parties,
          primarily hospital and physicians, with <ix:nonFraction name="usph:NumberOfThirdPartyFacilities" id="Fact_310d269962664063b42b69172214ef20" contextRef="c20220101to20220331_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U009" decimals="0" scale="0" format="ixt:numdotdecimal">38</ix:nonFraction> third-party facilities under management as of March 31, 2022.</div>
</ix:continuation>
        <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae613" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae614">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"> <br />
        </div>
</ix:continuation>
      </div>

    </div>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae614" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae615">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Physical Therapy Operations</div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae615" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae616">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae616" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae617">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The physical therapy operations segment</span> primarily operates through subsidiary clinic partnerships, in
      which the Company generally owns a <ix:nonFraction name="usph:PercentageOfGeneralPartnershipInterestOwned" id="Fact_486d4d1ad5464e238a11b5f885888674" contextRef="c20220101to20220331" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% general partnership interest in all the Clinic Partnerships. Our limited partnership interests
      typically range from <ix:nonFraction name="usph:PercentageOfLimitedPartnershipInterestOwned" id="Fact_2ff387af9cad45bdaf80cbfe5f958312" contextRef="c20220101to20220331_RangeAxis_MinimumMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% to <ix:nonFraction name="usph:PercentageOfLimitedPartnershipInterestOwned" id="Fact_818eb86bb3f04f61af10ad1a1265d84b" contextRef="c20220101to20220331_RangeAxis_MaximumMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>%
      in the Clinic Partnerships. The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, the Company
      operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae617" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae618">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae618" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae619">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources, by offering these
      therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue as employees to
      manage the clinic operations, retain a non-controlling ownership interest in the clinics and receive a competitive salary for managing the clinic operations. In addition, the Company has developed satellite clinic facilities as part of existing
      Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than <ix:nonFraction name="usph:NumberOfOperatingClinicLocations" id="Fact_c765432ac0834d95b364965e142b3655" contextRef="c20220331_RangeAxis_MaximumMember" unitRef="U005" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> clinic location.</div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae619" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae620">
<div><br /></div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">7</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <div><ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae620" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae621">
<div><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Clinic Partnerships </span></div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae621" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae622">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae622" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae623">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or
        indirectly, are recorded within the balance sheets as non-controlling interest &#8211; permanent equity and within the income statements as net income attributable to non-controlling interest &#8211; permanent equity<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae623" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae624">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae624" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae625">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For acquired Clinic Partnerships with redeemable non-controlling interest, the earnings attributable to the redeemable non-controlling interest are recorded within the
        consolidated statements of income line item &#8211; <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">net income attributable to non-controlling interest &#8211; redeemable non-controlling interest &#8211; temporary equity </span>and



        the equity interest is recorded on the consolidated balance sheet as <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">redeemable non-controlling interest &#8211; temporary equity</span>.&#160; In accordance with current
        accounting guidance, the revaluation of redeemable non-controlling interest, net of tax, is not included in net income but charged directly to retained earnings and is included in the basic and diluted earnings per share calculation<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae625" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae626">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae626" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae627">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Wholly-Owned Facilities</div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae627" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae628">
<div><br />
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae628" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae629">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due to the profit sharing therapists. The
      amount is expensed as compensation and included in operating cost &#8211; salaries and related costs. The respective liability is included in current liabilities &#8211; accrued expenses on the balance sheets.</div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae629" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae630">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae630" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae631">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Industrial Injury Prevention Services</div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae631" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae632">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae632" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae633">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Services provided in the industrial injury prevention services segment include onsite services for clients&#8217; employees including injury prevention and rehabilitation,
      performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies.
      Other clients include large insurers and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and certified athletic trainers.</div>
</ix:continuation><ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae633" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae634">
<div><br />

    <span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Basis of Presentation</span></div>
</ix:continuation>
    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae634" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae635">
<div><br />
      </div>
</ix:continuation>
    </div>

    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae635" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae636">
<div style="text-align: left; margin-right: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The accompanying unaudited consolidated financial statements were prepared in
          accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions for Form </span>10<span style="font-size: 10pt; font-family: 'Times New Roman';">-Q.


          However, the statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. Management believes this report contains all
          necessary adjustments (consisting only of normal recurring adjustments) to present fairly, in all material respects, the Company&#8217;s financial position, results of operations and cash flows for the interim periods presented. For further information
          regarding the Company&#8217;s accounting policies, please read the audited financial statements included in the Company&#8217;s Annual Report on Form </span>10<span style="font-size: 10pt; font-family: 'Times New Roman';">-K for the year ended </span>December


        31, 2021<span style="font-size: 10pt; font-family: 'Times New Roman';"> filed with the Securities and Exchange Commission on </span>March 1, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>
</ix:continuation>
    </div>

    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae636" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae637">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae637" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae638">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company believes, and the Chief Executive Officer and Chief Financial Officer have certified, that the financial statements included in this report present fairly, in
        all material respects, the Company&#8217;s financial position, results of operations and cash flows for the interim periods presented.</div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae638" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae639">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae639" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae640">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Operating results for the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';">
          months ended March</span> 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';"> are not necessarily indicative of the results the Company expects for the entire year.</span></div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae640" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae641">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae641" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae642">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Impact of COVID</span>-19</div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae642" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae643">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>
</ix:continuation>
    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae643" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae644">
<div><span style="text-decoration: underline;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Medicare Accelerated and Advance
            Payment Program (&#8220;MAAPP Funds&#8221;)</span></span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae644" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae645">
<div><span style="text-decoration: underline;"><span style="font-weight: bold;"> <br />
          </span></span></div>
</ix:continuation>
    </div>

    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae645" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae646">
<div style="text-align: left; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On March 27, 2020, in response to the COVID-19 pandemic, the federal government
          approved the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act provided waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $<ix:nonFraction name="usph:GrantsAndOtherFunds" id="Fact_7323cd95660842f5928605e04eb479ac" contextRef="c20220331_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember" unitRef="U002" decimals="-8" scale="9" format="ixt:numdotdecimal">100.0</ix:nonFraction> billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for
          preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.</span></div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae646" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae647">
<div style="text-align: left; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">8</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

        </div>

      </div>

    </div>

    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae647" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae648">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The CARES <span style="font-size: 10pt; font-family: 'Times New Roman';">Act allowed for qualified healthcare providers to receive advanced payments under the MAAPP
          Funds during the COVID</span>-19<span style="font-size: 10pt; font-family: 'Times New Roman';"> pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. The Company
          applied for and received approval from Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. The Company recorded the $<ix:nonFraction name="us-gaap:GrantsReceivable" id="Fact_5f496f65478d40969d44fd91388ad7da" contextRef="c20200430_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction>
          million in advance payments received as a liability. During the three months ended March 31, 2021, the Company repaid the MAAPP Funds of </span>$<ix:nonFraction name="usph:RepaymentOfFunds" id="Fact_ffd38b2ff1044a5aabd5cbee97cee22f" contextRef="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction>
        million <span style="font-size: 10pt; font-family: 'Times New Roman';">rather than applying them to future services performed</span>. During the three months ended March 31, 2022 and 2021, the Company did <ix:nonFraction name="us-gaap:GrantsReceivable" id="Fact_ee01b1720c544c26ac892f8ef1e5ee91" contextRef="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember" unitRef="U002" decimals="-6" scale="6" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:GrantsReceivable" id="Fact_69371f90a6714342900837cab4dbee4e" contextRef="c20220331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember" unitRef="U002" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t record any income from payments under the CARES Act.</div>
</ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae648" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae649">
<div><br /></div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae649" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae650">
<div><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Significant Accounting Policies </span></div>
</ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae650" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae651">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae651" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae652"><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="Text_43ed52d0055f4ed3939bd381feea7e32" contextRef="c20220101to20220331" escape="true" continuedAt="Text_c6b4087768f24a4aa7fb501434325ec41">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cash Equivalents</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae652" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae653"><ix:continuation id="Text_c6b4087768f24a4aa7fb501434325ec41" continuedAt="Text_c6b4087768f24a4aa7fb501434325ec42">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae653" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae654"><ix:continuation id="Text_c6b4087768f24a4aa7fb501434325ec42">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company maintains its cash and cash equivalents at financial institutions.&#160; The Company considers all highly liquid investments with a maturity of three months or less
      when purchased to be cash equivalents.&#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related on
      deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae654" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae655">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae655" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae656"><ix:nonNumeric name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="Text_6dc1ba6c717e4d3eb417159abb972b94" contextRef="c20220101to20220331" escape="true" continuedAt="Text_37345ec40c46458fb78b203ac919c93e1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Long-Lived Assets</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae656" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae657"><ix:continuation id="Text_37345ec40c46458fb78b203ac919c93e1" continuedAt="Text_37345ec40c46458fb78b203ac919c93e2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae657" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae658"><ix:continuation id="Text_37345ec40c46458fb78b203ac919c93e2" continuedAt="Text_37345ec40c46458fb78b203ac919c93e3">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture
      and equipment range from <span style="-sec-ix-hidden:Fact_b13cf1c74cd446babb6cdd78fa4c8294">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_8e8517c99bb24f729929c7ec95763c97" contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">eight years</ix:nonNumeric> and for purchased software from <span style="-sec-ix-hidden:Fact_c14f91b399c145c8a8ea00d2ca948500">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_94a710374ef249bb836ee69f6fe1aa82" contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">seven years</ix:nonNumeric>. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally <span style="-sec-ix-hidden:Fact_02de141ed1d4420c98a9952012a0ab54">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_da89691607d1475f858e44baa0324b49" contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae658" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae659"><ix:continuation id="Text_37345ec40c46458fb78b203ac919c93e3" continuedAt="Text_37345ec40c46458fb78b203ac919c93e4">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae659" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae660"><ix:continuation id="Text_37345ec40c46458fb78b203ac919c93e4" continuedAt="Text_37345ec40c46458fb78b203ac919c93e5">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that
      the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae660" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae661"><ix:continuation id="Text_37345ec40c46458fb78b203ac919c93e5" continuedAt="Text_37345ec40c46458fb78b203ac919c93e6">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae661" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae662"><ix:continuation id="Text_37345ec40c46458fb78b203ac919c93e6">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company did </span><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" id="Fact_5895060f175d48abbe4f9e6df1d7185d" contextRef="c20220101to20220331" unitRef="U002" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman';">t note an impairment to long-lived assets during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended March</span> 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae662" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae663">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae663" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae664"><ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="Text_47321e7bde3f431aa54b52e1d8cf1e7f" contextRef="c20220101to20220331" escape="true" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Goodwill</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae664" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae665"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c1" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c2">
<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>
</ix:continuation></ix:continuation>
    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae665" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae666"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c2" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c3">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the
          fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to </span>2009<span style="font-size: 10pt; font-family: 'Times New Roman';">,
          from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective </span>January 1, 2009<span style="font-size: 10pt; font-family: 'Times New Roman';">, if the purchase price of a
          non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae666" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae667"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c3" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c4">
<div><br /></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae667" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae668"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c4" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c5">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic
          impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair
          value if considered impaired. These events or conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined
          with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of </span>one<span style="font-size: 10pt; font-family: 'Times New Roman';"> of these
          events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae668" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae669"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c5" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c6">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae669" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae670"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c6" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c7">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company has a <ix:nonFraction name="us-gaap:NumberOfOperatingSegments" id="Fact_ba98973431c94649bf214c7c85950f52" contextRef="c20220101to20220331" unitRef="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> operating segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The partnerships are components of regions
          and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In 2021 and 2020, there were </span><ix:nonFraction name="usph:NumberOfRegions" id="Fact_d0dfb5392f384ea48fd97cba7274d38b" contextRef="c20200101to20200331" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="usph:NumberOfRegions" id="Fact_6305d4b42b384a70b349a99ca52de4d9" contextRef="c20210101to20210331" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman';"> regions. In addition to the </span><ix:nonFraction name="usph:NumberOfRegions" id="Fact_d298893d535849f28ab55db77b14e018" contextRef="c20210101to20210331" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman';"> regions, the impairment analysis included a separate analysis for the industrial injury prevention services business, as a
          separate reporting unit.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae670" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae671"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c7" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c8">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">9</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

        </div>

      </div>

      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae671" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae672"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c8" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c9">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">As part of the impairment analysis, the Company is </span>first<span style="font-size: 10pt; font-family: 'Times New Roman';"> required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether
          a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that
          affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae672" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae673"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c9" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c10">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae673" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae674"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c10" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c11">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting
          unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in </span>2021<span style="font-size: 10pt; font-family: 'Times New Roman';"> and </span>2020<span style="font-size: 10pt; font-family: 'Times New Roman';"> did not result in any goodwill amounts that were deemed impaired.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae674" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae675"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c11" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c12">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
          </span></span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae675" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae676"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c12" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c13">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that
            the fair value of the reporting units were reduced below their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting
            units were impaired as of December 31, 2021.<br />
          </span></span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae676" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae677"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c13" continuedAt="Text_666948601eaf4085ac268b8dbd5d237c14">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
          </span></span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae677" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae678"><ix:continuation id="Text_666948601eaf4085ac268b8dbd5d237c14">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> The Company will continue to monitor for any triggering events or other indicators of impairment.<br />
          </span></span></div>
</ix:continuation></ix:continuation>
       </div>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae678" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae679">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae679" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae680"><ix:nonNumeric name="usph:RedeemableNonControllingInterestsPolicyTextBlock" id="Text_951f675a25514db5abd8d444ec99994c" contextRef="c20220101to20220331" escape="true" continuedAt="Text_a817a09e820e44b2945e85bf6accea851">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Redeemable Non-Controlling Interest</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae680" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae681"><ix:continuation id="Text_a817a09e820e44b2945e85bf6accea851" continuedAt="Text_a817a09e820e44b2945e85bf6accea852">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae681" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae682"><ix:continuation id="Text_a817a09e820e44b2945e85bf6accea852" continuedAt="Text_a817a09e820e44b2945e85bf6accea853">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The non-controlling interests that are reflected as redeemable non-controlling interest in the consolidated financial statements consist of those that the owners and the
      Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met.&#160;
      The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights can be triggered by the owner or the
      Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction,
      typically <span style="-sec-ix-hidden:Fact_40b721ca5dc3493aaa09b990a340fe57">three</span> to <ix:nonNumeric name="usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="Fact_56529cde47b2477ca0da4a88cca4a88a" contextRef="c20220101to20220331_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>,
      as defined in the limited partnership agreement.&#160; The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been
      satisfied.</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae682" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae683"><ix:continuation id="Text_a817a09e820e44b2945e85bf6accea853" continuedAt="Text_a817a09e820e44b2945e85bf6accea854">
<div><br /></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae683" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae684"><ix:continuation id="Text_a817a09e820e44b2945e85bf6accea854">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under
      the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; Redeemable non-controlling interest &#8211; temporary equity.&#160; Then, in each reporting period thereafter until it
      is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership
      agreement.&#160; As a result, the value of the non-controlling interest is not adjusted below its initial carrying value.&#160; The Company records any adjustments in the redemption value, net of tax, directly to retained earnings and the adjustments are not
      reflected in the consolidated statements of income.&#160; Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per
      share calculation.&#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e.
      the carrying amount) and fair value are the same.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae684" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae685">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae685" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae686"><ix:nonNumeric name="usph:NonControllingInterestsPolicyPolicyTextBlock" id="Text_b89cb8bad14347f6a184bd4f88fbc236" contextRef="c20220101to20220331" escape="true" continuedAt="Text_2b82269cbca8431a8e105791b1e9a0731">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Controlling Interest</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae686" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae687"><ix:continuation id="Text_2b82269cbca8431a8e105791b1e9a0731" continuedAt="Text_2b82269cbca8431a8e105791b1e9a0732">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae687" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae688"><ix:continuation id="Text_2b82269cbca8431a8e105791b1e9a0732" continuedAt="Text_2b82269cbca8431a8e105791b1e9a0733">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the non-controlling interest, as permanent equity in the
      consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interest is included in consolidated net income on the face of the statements of net income. Changes in a parent
      entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a
      subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae688" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae689"><ix:continuation id="Text_2b82269cbca8431a8e105791b1e9a0733" continuedAt="Text_2b82269cbca8431a8e105791b1e9a0734">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">10</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae689" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae690"><ix:continuation id="Text_2b82269cbca8431a8e105791b1e9a0734">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment
      to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae690" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae691">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae691" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae692"><ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="Text_cf63d3c1bc8941b99a13694fb993b03b" contextRef="c20220101to20220331" escape="true" continuedAt="Text_74dc3c314b08410ca949f1b12ccb0ae21">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Revenue Recognition</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae692" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae693"><ix:continuation id="Text_74dc3c314b08410ca949f1b12ccb0ae21" continuedAt="Text_74dc3c314b08410ca949f1b12ccb0ae22">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae693" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae694"><ix:continuation id="Text_74dc3c314b08410ca949f1b12ccb0ae22">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered. See Note 3- Revenue Recognition, for further discussion of revenue recognition.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae694" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae695">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae695" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae696"><ix:nonNumeric name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="Text_1e25efbfe0904b469a7d4ec126eff865" contextRef="c20220101to20220331" escape="true" continuedAt="Text_3e896c7a59754ad082dc346505d041831">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Provision for Credit Losses</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae696" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae697"><ix:continuation id="Text_3e896c7a59754ad082dc346505d041831" continuedAt="Text_3e896c7a59754ad082dc346505d041832">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae697" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae698"><ix:continuation id="Text_3e896c7a59754ad082dc346505d041832">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he Company determines provisions for credit losses based on the specific agings and payor classifications at
        each clinic. The provision for credit losses is included in operating cost in the consolidated statements of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and
        provisions for credit losses, includes only those amounts the Company estimates to be collectible</span>.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae698" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae699">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae699" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6100"><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" id="Text_57e552f3d3a948e280cfdfafd54fca6a" contextRef="c20220101to20220331" escape="true" continuedAt="Text_e74c47545eb54681b400b959afea99561">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Income Taxes</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6100" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6101"><ix:continuation id="Text_e74c47545eb54681b400b959afea99561" continuedAt="Text_e74c47545eb54681b400b959afea99562">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6101" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6102"><ix:continuation id="Text_e74c47545eb54681b400b959afea99562" continuedAt="Text_e74c47545eb54681b400b959afea99563">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to
      differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates
      expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that
      includes the enactment date.</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6102" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6103"><ix:continuation id="Text_e74c47545eb54681b400b959afea99563" continuedAt="Text_e74c47545eb54681b400b959afea99564">
<div><br /></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6103" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6104"><ix:continuation id="Text_e74c47545eb54681b400b959afea99564" continuedAt="Text_e74c47545eb54681b400b959afea99565">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the
      position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate
      settlement with the relevant tax authority.</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6104" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6105"><ix:continuation id="Text_e74c47545eb54681b400b959afea99565" continuedAt="Text_e74c47545eb54681b400b959afea99566">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6105" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6106"><ix:continuation id="Text_e74c47545eb54681b400b959afea99566" continuedAt="Text_e74c47545eb54681b400b959afea99567">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of
        interest expense and depreciation. ASC 740</span>,<span style="font-size: 10pt; font-family: 'Times New Roman';"> Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which
        the legislation is enacted. The legislation had no effect on the Company&#8217;s deferred income taxes and current income taxes payable during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended March 31, 2022</span>.</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6106" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6107"><ix:continuation id="Text_e74c47545eb54681b400b959afea99567" continuedAt="Text_e74c47545eb54681b400b959afea99568">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6107" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6108"><ix:continuation id="Text_e74c47545eb54681b400b959afea99568">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company did <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" id="Fact_937d07e966a04f46b9bed08bfe25b910" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_0164604cca9a4e5fb7f96ee5e0e4c69b" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t have any accrued interest or
      penalties associated with any unrecognized tax benefits <ix:nonFraction name="us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" id="Fact_4206d3e3c91e41ccb34c473d748b357b" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>r was any interest expense recognized <span style="font-size: 10pt; font-family: 'Times New Roman';">during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended</span> March 31, 2022. The Company records any interest or penalties, if required, in interest and other expense,
      as appropriate.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6108" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6109">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6109" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6110"><ix:nonNumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Text_1aef8f87878b45c9933b567bb9a991c0" contextRef="c20220101to20220331" escape="true" continuedAt="Text_b95495cbe65448be8288690d5182b1231">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6110" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6111"><ix:continuation id="Text_b95495cbe65448be8288690d5182b1231" continuedAt="Text_b95495cbe65448be8288690d5182b1232">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6111" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6112"><ix:continuation id="Text_b95495cbe65448be8288690d5182b1232" continuedAt="Text_b95495cbe65448be8288690d5182b1233">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out
        payments, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement (as defined in Note 9)
        approximates the fair value. The interest rate on the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#8220;LIBOR&#8221;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different
        reference rate in the event LIBOR ceases to exist.<br />
      </span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6112" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6113"><ix:continuation id="Text_b95495cbe65448be8288690d5182b1233" continuedAt="Text_b95495cbe65448be8288690d5182b1234">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6113" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6114"><ix:continuation id="Text_b95495cbe65448be8288690d5182b1234" continuedAt="Text_b95495cbe65448be8288690d5182b1235">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The redeemable non-controlling interest included on the consolidated balance sheets and the put right
        associated with the potential future purchase of the separate company in the November 2021 acquisition (as described in Note 2) are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of redeemable
        non-controlling interests approximates the fair value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable
        inputs such as asset volatility and discount rates. The unobservable inputs in the valuation include asset volatility of <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" id="Fact_d4f986ca0e3a419987bfd4ed1eceefa3" contextRef="c20220331_MeasurementInputTypeAxis_MeasurementInputOptionVolatilityMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>% and a
        discount rate of <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" id="Fact_4699260ec06d4be1a04fa34a55f36fe4" contextRef="c20220331_MeasurementInputTypeAxis_MeasurementInputDiscountRateMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">9.93</ix:nonFraction>%. See Note 5 for the changes in the fair value of redeemable non-controlling interest.<br />
      </span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6114" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6115"><ix:continuation id="Text_b95495cbe65448be8288690d5182b1235" continuedAt="Text_b95495cbe65448be8288690d5182b1236">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>
</ix:continuation></ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">11</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6115" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6116"><ix:continuation id="Text_b95495cbe65448be8288690d5182b1236">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The put right decreased $<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" id="Fact_8372c7cc8e39446aae1795b56f50fb1b" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">603</ix:nonFraction> thousand for the three months ended March 31, 2022 and was valued at $<ix:nonFraction name="us-gaap:ContractWithCustomerAssetNet" id="Fact_850a73b32e6441e7b208b859a035d439" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.9</ix:nonFraction>
        million on March 31, 2022.<br />
      </span></div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6116" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6117">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6117" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6118"><ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="Text_ac2d5bd083a94c26a8a6a420dfe7122f" contextRef="c20220101to20220331" escape="true" continuedAt="Text_e853ca6e2ca84824878b6c9b240392371">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Segment Reporting</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6118" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6119"><ix:continuation id="Text_e853ca6e2ca84824878b6c9b240392371" continuedAt="Text_e853ca6e2ca84824878b6c9b240392372">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <div>
      <ix:continuation id="Text_e853ca6e2ca84824878b6c9b240392372"><ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6119" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6120">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Operating segments are components of an enterprise for which separate financial information is available
          that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance.&#160; The Company currently operates through </span><ix:nonFraction name="us-gaap:NumberOfOperatingSegments" id="Fact_f9ebe2db730f424bbb7ea4c83c982273" contextRef="c20220101to20220331" unitRef="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman';"> segments: physical therapy operations and industrial injury prevention services.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6120" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6121">
<div><br />
      </div>
</ix:continuation>
    </div>


    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6121" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6122"><ix:nonNumeric name="us-gaap:UseOfEstimates" id="Text_b0364ec9f4f04af692eb3021d10c02a6" contextRef="c20220101to20220331" escape="true" continuedAt="Text_d8a72d49c42b42f78dba623d44ee75f71">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Use of Estimates</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6122" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6123"><ix:continuation id="Text_d8a72d49c42b42f78dba623d44ee75f71" continuedAt="Text_d8a72d49c42b42f78dba623d44ee75f72">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6123" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6124"><ix:continuation id="Text_d8a72d49c42b42f78dba623d44ee75f72">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">I<span style="font-size: 10pt; font-family: 'Times New Roman';">n preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and
        assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames and other intangible assets, allocations of purchase price, provision for credit losses, tax provision and contractual allowances, that affect the amounts
        reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates</span>.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6124" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6125">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6125" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6126"><ix:nonNumeric name="usph:SelfInsuranceProgramPolicyPolicyTextBlock" id="Text_dadd79fb58e74715af810a1358d26408" contextRef="c20220101to20220331" escape="true" continuedAt="Text_c707c006f73d451e807b5a23da5efc8a1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Self-Insurance Program</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6126" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6127"><ix:continuation id="Text_c707c006f73d451e807b5a23da5efc8a1" continuedAt="Text_c707c006f73d451e807b5a23da5efc8a2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6127" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6128"><ix:continuation id="Text_c707c006f73d451e807b5a23da5efc8a2">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with
      an insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued
      amounts are sufficient to pay claims arising from self-insurance claims incurred through March 31, 2022.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6128" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6129">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6129" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6130"><ix:nonNumeric name="usph:RestrictedStockPolicyPolicyTextBlock" id="Text_5fb1f272773141568a0cebe4cfc90b48" contextRef="c20220101to20220331" escape="true" continuedAt="Text_d71d96bacb9446cab5aa8a61d82c1fa91">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted Stock</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6130" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6131"><ix:continuation id="Text_d71d96bacb9446cab5aa8a61d82c1fa91" continuedAt="Text_d71d96bacb9446cab5aa8a61d82c1fa92">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6131" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6132"><ix:continuation id="Text_d71d96bacb9446cab5aa8a61d82c1fa92">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock
      granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_5ace032f12924d2eb4cdbde0f9b532c6">four</span> anniversaries of the date of grant. For those shares granted
      to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_e7d74d21eab74c899fb44317a7932e6a">first</span> year after the date of grant. For those granted
      to officers, the restriction will lapse in equal quarterly installments during the <ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_c0c8d7548207448bbc34fb8444e74a00" contextRef="c20220101to20220331_TitleOfIndividualAxis_OfficerMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric> following the date of grant. Compensation
      expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and
      diluted shares for the earnings per share computation.</div>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6132" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6133">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6133" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6134"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Text_e897797f437047a88f385c8988b68915" contextRef="c20220101to20220331" escape="true" continuedAt="Text_3ff2462f8aac4c82a0472328c70810201">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recently Adopted Accounting Guidance</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6134" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6135"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810201" continuedAt="Text_3ff2462f8aac4c82a0472328c70810202">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6135" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6136"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810202" continuedAt="Text_3ff2462f8aac4c82a0472328c70810203">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740)&#8211;Simplifying the Accounting for Income
        Taxes (&#8220;ASU 2019-12&#8221;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of
        financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6136" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6137"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810203" continuedAt="Text_3ff2462f8aac4c82a0472328c70810204">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6137" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6138"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810204" continuedAt="Text_3ff2462f8aac4c82a0472328c70810205">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In August 2020, the FASB issued ASU 2020-06 Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and
        Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of
        liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the
        treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive,
        regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.</span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6138" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6139"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810205" continuedAt="Text_3ff2462f8aac4c82a0472328c70810206">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">12</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6139" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6140"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810206" continuedAt="Text_3ff2462f8aac4c82a0472328c70810207">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">This pronouncement was effective for fiscal years, and for interim periods within those fiscal years,
        beginning after December 15, 2021.The Board specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or
        fully retrospective method of transition is permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6140" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6141"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810207" continuedAt="Text_3ff2462f8aac4c82a0472328c70810208">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6141" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6142"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810208" continuedAt="Text_3ff2462f8aac4c82a0472328c70810209">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recently Issued Accounting Guidance</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6142" continuedAt="Text_0540ec6dcebb4b718abfa1b1e5a22ae6143"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c70810209" continuedAt="Text_3ff2462f8aac4c82a0472328c708102010">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <div>
      <ix:continuation id="Text_0540ec6dcebb4b718abfa1b1e5a22ae6143"><ix:continuation id="Text_3ff2462f8aac4c82a0472328c708102010">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In </span>March 2020<span style="font-size: 10pt; font-family: 'Times New Roman';">, the FASB issued ASU </span>2020-04<span style="font-size: 10pt; font-family: 'Times New Roman';">, Reference Rate Reform (Topic </span>848<span style="font-size: 10pt; font-family: 'Times New Roman';">): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This
          ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to
          alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through </span>December 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';">.
          Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event
          LIBOR ceases to exist.</span></div>
</ix:continuation></ix:continuation>

    </div>

    <div><br /></div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:BusinessCombinationDisclosureTextBlock" id="Text_56cd42f1fda04e0083ba64a8dc072d90" contextRef="c20220101to20220331" escape="true" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f501">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2. ACQUISITIONS OF BUSINESSES</div>
</ix:nonNumeric>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f501" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f502">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f502" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f503">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">On
        March 31, 2022, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_a115efd0848146e4ba7bc443f9ba206f" contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest in a <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_a4c073d8c04f4945a2da6916ef0ae025" contextRef="c20220331to20220331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction>-clinic physical therapy practice in South Central Pennsylvania &#8211; Madden and Gilbert Physical Therapy, LLC. The practice&#8217;s owners retained <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" id="Fact_670cd018cf1b464f8f78d3fab932ac47" contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>% of the equity interests. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_1c8aade6c957420d95f2a45f94b63520" contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%
        equity interest was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_d49d1ba2d89d4b29978d61f939f18695" contextRef="c20220331to20220331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">11.5</ix:nonFraction> million. of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_3568316c4a66455bb6530fa9f1a9a08c" contextRef="c20220331to20220331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">11.2</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_448018838b5848ad96ded878e051ff02" contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in the form of a note payable.&#160; The note accrues
        interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_e8690790ba02411082ff0eda16e5859a" contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">3.5</ix:nonFraction>% per annum and the principal and interest are payable on March 31, 2024.</span></div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f503" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f504">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f504" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f505"><ix:nonNumeric name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="Text_7ac473fca7d04a80b9312901e701edfb" contextRef="c20220101to20220331" escape="true" continuedAt="Text_39034341f20c4c208cb9dfeb78fdc4471">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he purchase price for the 2022 acquisition has been preliminarily allocated as follows (in thousands)</span>:
    </div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f505" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f506"><ix:continuation id="Text_39034341f20c4c208cb9dfeb78fdc4471" continuedAt="Text_39034341f20c4c208cb9dfeb78fdc4472">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f506" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f507"><ix:continuation id="Text_39034341f20c4c208cb9dfeb78fdc4472">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_f0d7720aa2df42138825f49588a81780" contextRef="c20220101to20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,242</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Seller notes</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_8c55185d868843989c6a483f1e1a95a4" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">300</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_fa13f074a3a944e2920cbbd2d0f243fc" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,542</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 12.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_c7f77ab6c25845649dadb8b0784b6e3d" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">300</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_d63525aa647f4c55ba6ebaee183cfca1" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,743</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_9abfc500351c47cb8339e29276ef44e5" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">247</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_c6ec877f3c344b5ab010e22b8200968b" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">659</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_db85214a147844a4a8ab511749e94b18" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,539</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_b299e717303b4de798fb1bbd1faafe06" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,946</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_abf4d6f786164cd88eaec60e1a8b65c0" contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,542</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f507" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f508">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
      </span></div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f508" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f509">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On December 31, 2021, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_6b741262309c4092862f13d3072bf80c" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>% in <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_8bd4816ce8b943c580b1363ad7127fae" contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction>-clinic physical therapy practice with the practice
        founder retaining <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" id="Fact_56a9c0d058e143728566929b90b0a760" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>%. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_0e9fbe9791cd48c5a97b5306da062dc5" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>% interest was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_cb522e7801c142d0b783b0663f79c559" contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_3ee3e72a9b364c8fa3ac73bd6972dbe8" contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_6fa9155613af44e7bb9d21d53af7db25" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million in the form of a
        note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_2a5fadf47b334078ad7cd0e73aca1281" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the principal and interest are payable on December 31, 2023.</span></div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f509" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5010">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5010" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5011">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On November 30, 2021, the Company acquired an approximate <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_e63df1c6c5a9407fb048cc607485247f" contextRef="c20211130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest in a leading provider of industrial injury prevention services. The previous owners retained the remaining interest. The purchase price for the approximate 70%
        equity interest, not inclusive of a $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_1d1f71efb12a4321a512897672d2b913" contextRef="c20211130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction> million contingent payment, was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_a36377f747064c0daf210dc4f1753555" contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">63.2</ix:nonFraction> million of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_ac6c3b53b3a5453b8b9293ece11878ee" contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">62.2</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_5c75f33f435f4bf4b9c9097cf2aa9f42" contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million in the form of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_aba7a0093c454903a5ae660f962fc591" contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the principal and interest is payable on November 30, 2023. As part of the transaction, the Company also agreed to the potential future purchase of a separate company under the same ownership
        that provides physical therapy and rehabilitation services to hospitals and other ancillary providers in a distinct market area. The current owners have the right to put this transaction to the Company in approximately <ix:nonNumeric name="usph:RemainingContractTerm" id="Fact_9c9b7cec4d11408aaf67de50fd272798" contextRef="c20220101to20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>, with such right having an initial fair value of $<ix:nonFraction name="us-gaap:BusinessCombinationAcquiredReceivablesFairValue" id="Fact_e79f113423f7433e99dce533ed478083" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction> million value on December 31, 2021, as reflected on the Company&#8217;s consolidated balance sheet in Other long-term liabilities. The value of this right will be adjusted in future periods, as appropriate, with any
        change in value reflected in the Company&#8217;s consolidated statement of income. The Company does not currently possess any of the controlling interests in this separate company, does not control this company through contract or governance rights and
        currently does not exercise significant influence over this separate company. Due to these reasons, and based on current accounting guidance, the Company did not consolidate the separate company through the variable interest or voting interest
        model. On March 31, 2022, the fair value of this right was $<ix:nonFraction name="us-gaap:BusinessCombinationAcquiredReceivablesFairValue" id="Fact_374392475c5143ada4c3e2557aeb50d7" contextRef="c20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.9</ix:nonFraction> million.&#160; The decrease was reflected in the consolidated statement of
        income in the line item - Gain on revaluation of put-right liability</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">.</span></div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5011" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5012">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> <br />
      </span></div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">13</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <div>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5012" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5013">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On September 30, 2021, the Company
          acquired a company that specializes in return-to-work and ergonomic services, among other offerings. The Company acquired the company&#8217;s assets at a purchase price of approximately $<ix:nonFraction name="usph:BusinessCombinationConsiderationTransferredIncludesContingentConsideration" id="Fact_e53cc3545aa54d89ae7d5c003e42c98b" contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction> million (which includes the obligation to pay an amount up to $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_3b6527f0503c4137a859432fca8d5605" contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction>
          million in contingent payment consideration in conjunction with the acquisition if specified future operational objectives are met) and contributed those assets to the industrial injury services business. The initial purchase price, not inclusive
          of the $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_af9e13cba8ac4dadb809d5ffe73dc893" contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million contingent payment, was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_d99776e9b4aa40568fc4a3a76a6e2b3a" contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_7a9d94bbd8f14f079ffcab44740968e0" contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction> million was paid in cash, and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_dc10607ba93949c69bb47e62934f36eb" contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million is in the form of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_3079907755a24ede81051d4a01da5750" contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the principal and interest are payable on September 30, 2023.<br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5013" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5014">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5014" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5015">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On June 30, 2021, the Company
          acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_9d836ef86bae40f699ef4fccdf55d1d8" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>% interest in an <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_8f6429b4bde74bd4867ba712b2ad544b" contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">eight</ix:nonFraction>-clinic

















          physical therapy with the previous owners retaining <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" id="Fact_92360e77d146444e8b2afaf111164cda" contextRef="c20210630_OwnershipAxis_PreviousOwnersMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>%. The purchase price was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_f8ab80bde5c34403a83c25740b75ad4e" contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">10.3</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_7de28c3688ba45548925ec3acd120a29" contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction> million was
          paid in cash, $<ix:nonFraction name="usph:BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" id="Fact_5532efa6def84df2bb0f8ea7e686e031" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million is payable based on the achievement of certain business criteria and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_41a1cadff62747359f007d30709ff004" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million is in the form of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_e53129e16a8e4b6586972711ad14969d" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the principal and interest are payable on June 30, 2023. Additionally, the Company has an obligation to pay an additional amount up to $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_048b7efe5efa42de98a27eb7715e107e" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million in contingent payment consideration in conjunction with the acquisition if specified future operational objectives are met. The Company
          recorded acquisition-date fair value of this contingent liability based on the likelihood of the contingent earn-out payment. The earn-out payment will subsequently be remeasured to fair value each reporting date.<br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5015" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5016">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5016" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5017">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> On March 31, 2021, the Company
          acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_846a417c211a4a40b0f929e398c8648e" contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest in a <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_5b09bddb06c6493dad223caa749d92e1" contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction>-clinic

















          physical therapy practice with the previous owners retaining <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" id="Fact_ef264cbe2a114c45a8548e06b2615f4a" contextRef="c20210331_OwnershipAxis_PreviousOwnersMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>%. When acquired, the practice was developing a sixth clinic which has
          been completed. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_90faeeaf784745eeab8d317e8a58a9bb" contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_5de81c33154349ef906a59a6d34cac75" contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_4ba4946e17464d2c8d407f2069545c93" contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">11.7</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_d70e3c4afe6643c183c9e59d954f0ef1" contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in the form of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_9a92e1551b3a41918aec168f305134ba" contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the principal and interest are payable on March 31, 2023.</span><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5017" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5018">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5018" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5019">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The <span style="font-size: 10pt; font-family: 'Times New Roman';">purchase price for the 2021 acquisitions has been preliminarily allocated as follows (in thousands):</span></div>
</ix:continuation>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5019" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5020">
<div><br /></div>
</ix:continuation>
        <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5020" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5021">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Physical Therapy</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> IIPS*</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operations</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Cash paid, net of cash acquired</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_f746be88a8e04e8e93c2d060b41e7ffd" contextRef="c20210101to20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">63,193</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_fe3237deac24468a9f34aea8286ceae3" contextRef="c20210101to20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">23,544</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_511caba5bcb847858f5aab45c9c90611" contextRef="c20210101to20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">86,737</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Seller notes</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_b78ab4e4488a42088efca947c8a4d214" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,250</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_6a64f2906d304fc5a64a7b4c0c0bf998" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">800</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_1a672b4815694f848f2966df8536bc72" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,050</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Contingent payments</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_7eeced21a3bf49b6b7cea15928eef383" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,520</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_ef8b7ce4a3d8444d861d2c56066e2b78" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">837</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_926f4605d729443b817265db63b7d9a6" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,357</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Other payable</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_693f99992f5a43bdbf253cd7cd64b971" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_dd6074522f76437cad1b83f29f616fcd" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_e0a6c467a49b40bfa983831dd36a46b2" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Seller put right</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetPurchase" id="Fact_fe86c41d0a8e40589aee50f8b258e5e3" contextRef="c20210101to20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,522</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetPurchase" id="Fact_92c079d140cf456185bbf59572061dfc" contextRef="c20210101to20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetPurchase" id="Fact_c9f04592065c45cb9818835e7efd017d" contextRef="c20210101to20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,522</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 4px;">
                <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total consideration</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_c9ccddd842e04e09b614b6e5f3295a3a" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">70,485</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_e8d719d5587f47d7b5d78bf5db497868" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26,181</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_0c8d7b23a66f4262a563c2571ba2454f" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">96,666</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Estimated fair value of net tangible assets acquired:</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total current assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_539c6bc318bc4fb6a6708940d611942a" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,588</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_aa82bd7f50e84ab6b76b06e6a8981ed9" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,041</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_428c7912c2904afc9d6485831a3a05d5" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,629</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
                <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total non-current assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_bccf762daaa94483b40081c81b457ca0" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,620</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_7eae9d6980b445059949e2a2f9f2a3fa" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,153</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_4f41357125a642c99e2078dfe6776686" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">19,773</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_449b5876417b495586b69cf0134fddcd" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,842</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_bfb6d16e7bf54d328ab20819fad48274" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,413</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_786413d867704f8bbd355676d7518ee2" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">13,255</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
                <div style="text-indent: -7.2pt; margin-left: 34.2pt; color: rgb(0, 0, 0);">Net tangible assets acquired</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_118b64f338854f27b3f6923be9878e34" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13,366</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_5d2283de0fe04ed1ab46b7d8ddf2aa1f" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">781</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_726e635bd44f415488ba19407822a115" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,147</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Customer and referral relationships</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_be7f633d83a2408a9ca0e8336e9f12af" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21,127</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_dfd94181fd764d42a03b0164da15411c" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,090</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_5c5834f009c24be9a62e15dfddfdaddf" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">27,217</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Non-compete agreements</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_34be6c8c2f1344f682ff5a6e05e0b232" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">500</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_b5ffed6cdd9644a7966d4b57528d6a8f" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">539</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_795666aea7114d6ba497e9db1ccc86dd" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,039</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Tradenames</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_435e62fbec4649a6b558725ff793bd1c" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,141</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_b0008ccf470b416395fcd08f9e251caa" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,762</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_3f36d2b081af4e2e8846e22fa5334dcb" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,903</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Goodwill</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_fa848cbb3cef4ce9ac4701987e6c1c17" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">58,257</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_68dcac3e561642609ab16d422ee3b249" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">28,965</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_2e6a64e0fff949f7ac2bd16ad8262bf5" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">87,222</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_1712aa9b24ae465e9fb9172ba536bd78" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">27,906</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_f113d8eef2534e36a630af89ad0d8534" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,956</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_10268471b06a445c8ffce30c2a3968b5" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">39,862</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_2ca63305da874a06a17209af72a504b1" contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">70,485</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_93333fe9707d4a2597346655a0549249" contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26,181</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_ddf7fe5f09cb4058945759bba83a87ae" contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">96,666</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation>
        <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5021" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5022">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5022" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5023">
<div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 9pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left;">*</div>
                </td>

    <td style="vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left;"><ix:footnote id="Foot_5e0179a59a7444dfb4650c9e2788869a" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Industrial injusry prevention services</ix:footnote></div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
        <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5023" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5024">
<div><br /></div>
</ix:continuation>
      </div>

    </div>

    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5024" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5025">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the date of their respective acquisition.<br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5025" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5026">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5026" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5027">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> For the 2022 and 2021 acquisitions, a majority of total current assets primarily represents accounts receivable. Total non-current assets are fixed assets and equipment
      used in the practice.<br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5027" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5028">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">14</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5028" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5029">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2021 were allocated to the fair value of the assets acquired, inclusive of
      identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill.</div>
</ix:continuation>
    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5029" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5030">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5030" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5031">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">For the acquisitions in 2021, the values assigned to the customer and referral relationships and
          non-compete agreements are being amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period w</span>as <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_e36a15dd7aec4206a1012b923b5f791a" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" format="ixt-sec:duryear">13.8</ix:nonNumeric> years. For non-compete agreements, the weighted-average amortization period was <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_f30bf5ba37fb477ca231b753b3980f5c" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" format="ixt-sec:duryear">5.6</ix:nonNumeric> years<span style="font-size: 10pt; font-family: 'Times New Roman';"> at the end of the year. The values assigned to tradenames are tested annually for impairment</span>.</div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5031" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5032">
<div> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5032" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5033">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The consideration paid for each of the
          acquisitions was derived through arm&#8217;s length negotiations. Funding for the cash portions was derived from proceeds from the Company&#8217;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#8217;s
          consolidated financial statements since their respective date of acquisition. Unaudited proforma consolidated financial information for the acquisitions in 2022 and 2021 have not been included, as the results, individually and in the aggregate,
          were not material to current operations.<br />
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5033" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5034">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5034" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5035">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The purchase price plus the fair
          value of the non-controlling interest for the acquisitions in 2022 and those acquired after March 31, 2021 was allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. tradenames, referral
          relationships and non-compete agreements, and liabilities assumed based on the estimated fair values at the acquisition date, with the amount in excess of fair values being recorded as goodwill. The Company is in the process of completing its
          formal valuation analysis of the acquisitions, to identify and determine the fair value of tangible and identifiable intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the
          preliminary estimates used on March 31, 2022 based on additional information obtained and completion of the valuation of the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the
          valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in
          adjustments to goodwill. The Company does not expect the adjustments to be material.&#160; The purchase price allocation for the March 2021 Acquisition has been finalized. The Company continues to evaluate the components for the purchase price
          allocations for other acquisitions in 2021.<br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5035" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5036">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5036" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5037">
<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">For the acquisitions in 2022, the
          values assigned to the customer and referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period is
          <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_455554f96bd84fa5919530a8ffeeba67" contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" format="ixt-sec:duryear">12.0</ix:nonNumeric> years. For non-compete agreements, the weighted-average amortization period is <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_1b10f591bd3047ae96c2f3cbed4d180c" contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" format="ixt-sec:duryear">5.0</ix:nonNumeric> years. The values assigned to tradenames are tested annually for impairment.<br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5037" continuedAt="Text_06c40d0464ad4810bb54961d2ca08f5038">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br />
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_06c40d0464ad4810bb54961d2ca08f5038">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the date of their respective acquisition.</div>
</ix:continuation>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="Text_b7d4bb0c518e49f9aef95c6bc728e713" contextRef="c20220101to20220331" escape="true" continuedAt="Text_203af78f335048fda7a633c222c715b31">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3. REVENUE RECOGNITION</div>
</ix:nonNumeric>
    <ix:continuation id="Text_203af78f335048fda7a633c222c715b31" continuedAt="Text_203af78f335048fda7a633c222c715b32">
<div><br />
    </div>
</ix:continuation>
    <div>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b32" continuedAt="Text_203af78f335048fda7a633c222c715b33">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Categories</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b33" continuedAt="Text_203af78f335048fda7a633c222c715b34">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b34" continuedAt="Text_203af78f335048fda7a633c222c715b35">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b35" continuedAt="Text_203af78f335048fda7a633c222c715b36">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b36" continuedAt="Text_203af78f335048fda7a633c222c715b37">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">N<span style="font-size: 10pt; font-family: 'Times New Roman';">et patient revenue consists of revenue for physical therapy and occupational therapy clinics that provide
          pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenue (patient revenue less estimated
          contractual adjustments) is recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied
          contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on
          previously rendered services. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of
          payor contracts and historical collection and write-off experience.</span></div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b37" continuedAt="Text_203af78f335048fda7a633c222c715b38">
<div><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">15</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

        </div>

      </div>

      <ix:continuation id="Text_203af78f335048fda7a633c222c715b38" continuedAt="Text_203af78f335048fda7a633c222c715b39">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenue, which is included in other revenue in the consolidated statements of net income, is derived from contractual arrangements whereby the Company
        manages a clinic owned by a third party. The Company does not have any ownership interest in these clinics. Typically, revenue is determined based on the number of visits conducted at the clinic and recognized at the point in time when services are
        performed. Costs, typically salaries for our employees, are recorded when incurred.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b39" continuedAt="Text_203af78f335048fda7a633c222c715b310">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b310" continuedAt="Text_203af78f335048fda7a633c222c715b311">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Revenue from the industrial injury prevention services segment, which is also included in other revenue in the consolidated statements of net income, is derived from
        onsite services the Company provides to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the industrial injury prevention services segment is recognized when
        obligations under the terms of the contract are satisfied. Revenue is recognized at an amount equal to the consideration the Company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined
        and recognized based on the number of hours and respective rate for services provided in a given period.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b311" continuedAt="Text_203af78f335048fda7a633c222c715b312">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b312" continuedAt="Text_203af78f335048fda7a633c222c715b313">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Additionally, other revenue includes services the Company provides on-site, such as schools, for physical or occupational therapy services, and fees from athletic
        trainers. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance,
        revenue is recorded as a liability over the period of the agreement and recognized at the point in time, when the services are performed.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b313" continuedAt="Text_203af78f335048fda7a633c222c715b314">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b314" continuedAt="Text_203af78f335048fda7a633c222c715b315">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company determines credit losses based on the specific agings and payor classifications at each clinic.
          The provision for credit losses is included in clinic operating cost in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and provision for
          credit losses, includes only those amounts the Company estimates to be collectibl</span>e.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b315" continuedAt="Text_203af78f335048fda7a633c222c715b316">
<div><br />
      </div>
</ix:continuation>
    </div>


    <ix:continuation id="Text_203af78f335048fda7a633c222c715b316" continuedAt="Text_203af78f335048fda7a633c222c715b317"><ix:nonNumeric name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="Text_38d5b8605db34c7a930ee41ad88143a3" contextRef="c20220101to20220331" escape="true" continuedAt="Text_0024ed19936145ca898d222eb3a0c6831">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the revenue related to the various categories (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_203af78f335048fda7a633c222c715b317" continuedAt="Text_203af78f335048fda7a633c222c715b318"><ix:continuation id="Text_0024ed19936145ca898d222eb3a0c6831" continuedAt="Text_0024ed19936145ca898d222eb3a0c6832">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_203af78f335048fda7a633c222c715b318" continuedAt="Text_203af78f335048fda7a633c222c715b319"><ix:continuation id="Text_0024ed19936145ca898d222eb3a0c6832">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenue</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_944a6fc55c914954a59eb453357514e7" contextRef="c20220101to20220331_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">109,538</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_e52d963677b24276a43e2c0f4a203369" contextRef="c20210101to20210331_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">99,254</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(255, 255, 255); padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other revenue<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_5f6d29d23d40424cbc2ac4d36387c4d9" contextRef="c20220101to20220331_ProductOrServiceAxis_OtherRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">872</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_a4226a5e1f854536a6255ee24806e152" contextRef="c20210101to20210331_ProductOrServiceAxis_OtherRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">546</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="margin: 0px 0px 0px 14.4pt; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: -7.2pt;">Physical therapy operations<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_6ea7536d89a54571920109779b1ac478" contextRef="c20220101to20220331_ProductOrServiceAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">110,410</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_b9e12a25cfca4fc6b95cb5a2b752f296" contextRef="c20210101to20210331_ProductOrServiceAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">99,800</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #FFFFFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">Management contract revenue<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;"><br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_a64862fb867645cdad1f0a8cfefc88a8" contextRef="c20220101to20220331_ProductOrServiceAxis_ManagementContractRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,226</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;"><br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_b7d2c1bce6b74033a5f6099c30355d3e" contextRef="c20210101to20210331_ProductOrServiceAxis_ManagementContractRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,559</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services revenue</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_fd1c137cab674fe38c06178bdebe0ca1" contextRef="c20220101to20220331_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">19,068</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_a77f77665d904dd1bf401381fc977c5c" contextRef="c20210101to20210331_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,009</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_49d1077decc445ae90dba1b3206d2eaf" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">131,704</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_cc5b27b3243448edadd463748e3614f7" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">112,368</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b319" continuedAt="Text_203af78f335048fda7a633c222c715b320">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Medicare Reimbursement</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b320" continuedAt="Text_203af78f335048fda7a633c222c715b321">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b321" continuedAt="Text_203af78f335048fda7a633c222c715b322">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee
          Schedule (&#8220;MPFS&#8221;). For services provided in 2017 through 2019, a</span>&#160;<ix:nonFraction name="usph:PercentageOfMedicarePaymentIncrease" id="Fact_5adc9c18c3f845c8926fd3aebf04563f" contextRef="c20220101to20220331_UnusualOrInfrequentItemAxis_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">0.5</ix:nonFraction>% increase <span style="font-size: 10pt; font-family: 'Times New Roman';">was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025</span> <ix:nonFraction name="usph:PercentageOfMedicarePaymentIncrease" id="Fact_64335fe919d046feb31097cd1f281027" contextRef="c20220101to20220331_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" unitRef="U006" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> <span style="font-size: 10pt; font-family: 'Times New Roman';">adjustment is expected to be applied each year to the fee schedule payment rates, before applying the
          mandatory budget neutrality adjustment.</span></div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b322" continuedAt="Text_203af78f335048fda7a633c222c715b323">
<div><br />
      </div>
</ix:continuation>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:continuation id="Text_203af78f335048fda7a633c222c715b323" continuedAt="Text_203af78f335048fda7a633c222c715b324">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">In



          the 2020 MPFS Final Rule, The Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) revised coding, documentation guidelines, and increased the code values for office/outpatient evaluation and management (&#8220;E/M&#8221;) codes and cuts to other codes to
          maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office visit codes and made cuts to other specialty codes to maintain budget neutrality. As a result, CMS projected a <ix:nonFraction name="usph:EstimatedPercentageOfDecreaseInPayment" id="Fact_aab37428a1914276a610fd86584e40d8" contextRef="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">9</ix:nonFraction>% decrease in fee schedule payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the
          Consolidated Appropriations Act, 2021 and reimbursement for the codes applicable to&#160; physical/occupational therapy services provided by our clinics received an estimated <ix:nonFraction name="usph:EstimatedPercentageOfDecreaseInPayment" id="Fact_ea607b2b9c144835ad18456efcf88963" contextRef="c20220101to20220331" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">3.5</ix:nonFraction>% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020. </span></div>
</ix:continuation>
        <ix:continuation id="Text_203af78f335048fda7a633c222c715b324" continuedAt="Text_203af78f335048fda7a633c222c715b325">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">16</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_203af78f335048fda7a633c222c715b325" continuedAt="Text_203af78f335048fda7a633c222c715b326">
<div style="color: #1F497D; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In the 2022 MPFS Final Rule published on November 2, 2021, there
              was to be an approximately <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_f874043749e1403f80718b0c813f8839" contextRef="c20211102_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.75</ix:nonFraction>% reduction to Medicare payments for physical/occupational therapy services. This was due to the
              expiration of the additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021.</span> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">However, this reduction was addressed in the Protecting Medicare and American Farmers from Sequester Cuts Act (&#8220;2021 Act&#8221;) signed into law on December 10, 2021.
              Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year of 2022 will be approximately <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_38f68bf4ea964277847bc3874868ac9f" contextRef="c20221231_StatementScenarioAxis_ScenarioForecastMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">0.75</ix:nonFraction>%. The 2021 Act did not address the <ix:nonFraction name="usph:PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" id="Fact_466d430051d547d483121f29a6278b20" contextRef="c20211231" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">15</ix:nonFraction>% reduction in Medicare payments for services
              performed by a physical or occupational therapist assistant, which began on January 1, 2022.</span></div>
</ix:continuation>
          <div style="color: #1F497D; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><ix:continuation id="Text_203af78f335048fda7a633c222c715b326" continuedAt="Text_203af78f335048fda7a633c222c715b327">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br /></div>
</ix:continuation>
            <ix:continuation id="Text_203af78f335048fda7a633c222c715b327" continuedAt="Text_203af78f335048fda7a633c222c715b328">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In addition, the Consolidated Appropriations Act, 2021 includes reductions in Medicare payment rates of approximately <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_25003f3fa7384eba9a4b26431698f66e" contextRef="c20240930_StatementScenarioAxis_ScenarioForecastMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction>% in each of calendar years 2023 and 2024, unless regulatory or Congressional action results in modifications to such rates as has occurred in
              2021 and 2022.</div>
</ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_203af78f335048fda7a633c222c715b328" continuedAt="Text_203af78f335048fda7a633c222c715b329">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_203af78f335048fda7a633c222c715b329" continuedAt="Text_203af78f335048fda7a633c222c715b330">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions
          over the next</span>&#160;<ix:nonNumeric name="usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" id="Fact_1542cfe506844472bf6f998a1c3bae3f" contextRef="c20220101to20220331" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> and requires automatic reductions in federal spending by approximately $<ix:nonFraction name="usph:AmountOfReductionsInFederalSpending" id="Fact_daf68a34de3b445f9e2644c2d93d4557" contextRef="c20220101to20220331" unitRef="U002" decimals="-11" scale="12" format="ixt:numdotdecimal">1.2</ix:nonFraction> trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a <ix:nonFraction name="usph:ReductionInMedicareSpendingPercentage" id="Fact_72e431cd259d4d5e9f5d9249f3d54725" contextRef="c20220101to20220331" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% cap. On April 1, 2013, a <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_db67958fa98345e8923a4cbc5a036b17" contextRef="c20130401" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% reduction to Medicare payments
        was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_a5119162a1214184aa5e3c09c720feed" contextRef="c20151102" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% reductions to Medicare payments through
        fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_75e19e87e1f24d4bbec8cc2bbf249b92" contextRef="c20180209" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% reductions to Medicare payments through
        fiscal year 2027. T<span style="font-size: 10pt; font-family: 'Times New Roman';">he CARES Act suspended the </span><ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_9eed8121e4fc4c05857fc5ef1f82a956" contextRef="c20220331" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction to Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the </span><ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_3ff65cd0885c4c7588e326d766f918e2" contextRef="c20220331" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction until March 31, 2021. On April 14, 2021, additional legislation was
          enacted that waived the </span><ix:nonFraction name="usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation" id="Fact_84358f3bde3d4cf889e0090c5014b231" contextRef="c20210401to20210414" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction for the remainder
          of calendar 2021</span>. The 2021 Act, which was signed into law on December 10, 2021, included a <ix:nonNumeric name="usph:ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" id="Fact_ed2af09450254eabb897aefd273da416" contextRef="c20220101to20220331" format="ixt-sec:durwordsen">three-month</ix:nonNumeric> extension of the <ix:nonFraction name="usph:PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" id="Fact_31f98d64b61348d7b0d31de12b445bd5" contextRef="c20211210" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% sequester relief applied to all Medicare payments through March 31, 2022, followed by <ix:nonNumeric name="usph:ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" id="Fact_9ac3866f6fd5418db2ed25e963ee3c57" contextRef="c20220101to20220331" format="ixt-sec:durwordsen">three months</ix:nonNumeric> of <ix:nonFraction name="usph:PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" id="Fact_c1cb936eb668496abb08e79a1f003551" contextRef="c20211210" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% sequester relief through June 30, 2022.
        Sequester relief is scheduled to then end on June 30, 2022.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b330" continuedAt="Text_203af78f335048fda7a633c222c715b331">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b331" continuedAt="Text_203af78f335048fda7a633c222c715b332">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice)
          paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health
          records. Therapists eligible to participate in MIPS include only those therapists who are enrolled with Medicare as private practice providers, and does not include therapists in facility-based providers, such as our clinics enrolled as certified
          rehabilitation agencies. Less than </span><ix:nonFraction name="usph:PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" id="Fact_7766f60694f44444b8407aa71ec09cb3" contextRef="c20220101to20220331_RangeAxis_MaximumMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> of the Company&#8217;s therapist
          providers currently participate in MIPS. Under the MIPS requirements, a provider<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span>s performance is assessed according to established performance standards each year and then is
          used to determine an adjustment factor that is applied to the professional<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span>s payment for the corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine
          the payment adjustment in 2021. For those therapist providers who actually participated in MIPS during 2019, the resulting average payment adjustment was an increase of </span><ix:nonFraction name="usph:PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" id="Fact_17323c14d0e64c7187e9c2602858bf73" contextRef="c20220101to20220331" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b332" continuedAt="Text_203af78f335048fda7a633c222c715b333">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b333" continuedAt="Text_203af78f335048fda7a633c222c715b334">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Under the Middle-Class Tax Relief and Job Creation Act of 2012 (&#8220;MCTRA&#8221;), since October 1, 2012, patients
          who met or exceede</span>d $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_d373f0838c994207bef7fce4deb8c39a" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> in therapy expenditures during a calendar year have been subject to a manual medical review to
        determine whether applicable payment criteria are satisfied. The $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_fe9ccfc2ac9e4839b9f8403cbb4a1379" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold is applied to Physical Therapy and Speech Language
        Pathology Services; a separate $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_7149a2692aa142ccbd9f557873bdfdd0" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual
        medical review process such that those reviews will no longer apply to all claims exceeding the $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_7380215146844663a753d889e8da2677" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold and instead will be
        determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to $<ix:nonFraction name="usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_873fd840dd01467395b22361d83f9fdf" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">3,000</ix:nonFraction> through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for 2028 and in subsequent
        years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b334" continuedAt="Text_203af78f335048fda7a633c222c715b335">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b335" continuedAt="Text_203af78f335048fda7a633c222c715b336">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">CMS adopted a multiple procedure payment reduction (<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;</span>MPPR<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8221;</span>) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language
        pathology. Under the policy, the Medicare program pays <ix:nonFraction name="usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit" id="Fact_44ae03d50d6d432989c7734e0e69e2c6" contextRef="c20220101to20220331" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the practice expense component of the Relative Value Unit (<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;</span>RVU<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8221;</span>) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the
        practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. In 2013, the
        practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by <ix:nonFraction name="usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" id="Fact_3c637ae8b48e4fb3b59d109ac6e87b57" contextRef="c20220101to20220331" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>%.</div>
</ix:continuation>
    </div>

    <div>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b336" continuedAt="Text_203af78f335048fda7a633c222c715b337">
<div><br />
      </div>
</ix:continuation>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">17</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <div>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b337" continuedAt="Text_203af78f335048fda7a633c222c715b338">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Medicare claims for outpatient therapy services furnished by therapist assistants on or after January 1, 2020 must include a modifier indicating the service was furnished
        by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022, in whole or part by a therapist assistant are paid at an amount equal to <ix:nonFraction name="usph:PercentageOfPaymentForOutpatientTherapyServices" id="Fact_7a0e096ec9bd44cf98019491c0401660" contextRef="c20220101to20220331" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">85</ix:nonFraction>% of the payment amount otherwise applicable for the service.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b338" continuedAt="Text_203af78f335048fda7a633c222c715b339">
<div><br />
      </div>
</ix:continuation>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_203af78f335048fda7a633c222c715b339" continuedAt="Text_203af78f335048fda7a633c222c715b340">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare
            beneficiaries are complex and subject to interpretation. The Company believes that the Company is in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations
            involving allegations of potential wrongdoing that would have a material effect on the Company<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span>s financial statements as of March 31, 2022. Compliance with such laws and
            regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the three months ended March 31, 2022, and 2021,
            respectively, net patient revenue from Medicare was approximately $</span><ix:nonFraction name="usph:NetRevenueFromMedicare" id="Fact_0ca8bec2cbe4420fbcac4c753fdb302c" contextRef="c20220101to20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">35.6</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman';"> million and $</span><ix:nonFraction name="usph:NetRevenueFromMedicare" id="Fact_5f18ae43615e44569bedc8f70c55fa4a" contextRef="c20210101to20210331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">26.6</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman';"> million, respectively.<br />
          </span><br />
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_203af78f335048fda7a633c222c715b340" continuedAt="Text_203af78f335048fda7a633c222c715b341">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, the Company may not continue to receive reimbursement rates from
        Medicare that sufficiently compensate us for the Company<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span></span>s services or, in some instances, cover the Company<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span></span>s operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a
        material adverse effect on the Company<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span></span>s revenue, financial condition and results of operations.
        Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect the Company<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span></span>s business, financial condition and results of operations.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b341" continuedAt="Text_203af78f335048fda7a633c222c715b342">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b342" continuedAt="Text_203af78f335048fda7a633c222c715b343">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Contractual Allowances</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b343" continuedAt="Text_203af78f335048fda7a633c222c715b344">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b344" continuedAt="Text_203af78f335048fda7a633c222c715b345">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Contractual allowances result from the differences between the rates charged for services performed and
          expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple
          reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the
          Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable
          balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with
          its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised
          necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy
          of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the
          difference between net revenues and corresponding cash collections has generally reflected a difference within approximately </span><ix:nonFraction name="usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="Fact_f9378fd6f1504efd8d09b3ccab88f162" contextRef="c20220101to20220331_RangeAxis_MinimumMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">1.0</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> to </span><ix:nonFraction name="usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="Fact_1ba9c05cfcac4bbf8ad3e1e675e6aee5" contextRef="c20220101to20220331_RangeAxis_MaximumMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';">
          of net revenue. Additionally, analysis of subsequent periods&#8217; contractual write-offs on a payor basis reflects a difference within approximately </span><ix:nonFraction name="usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="Fact_c0afc92409aa4500bfd0c1bd1302ad8c" contextRef="c20220101to20220331_RangeAxis_MinimumMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">1.0</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> to </span><ix:nonFraction name="usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="Fact_65c5c7a6095f46d7900f06cbcb4114cd" contextRef="c20220101to20220331_RangeAxis_MaximumMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';">
          between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual
          allowance reserve estimate would not likely be more than </span><ix:nonFraction name="usph:MaximumContractualAllowanceReserveEstimate" id="Fact_bac0b404456c48799077910000f73492" contextRef="c20220101to20220331_RangeAxis_MinimumMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">1.0</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> to
        </span><ix:nonFraction name="usph:MaximumContractualAllowanceReserveEstimate" id="Fact_73a23146ed684ea383b36800485f42c2" contextRef="c20220101to20220331_RangeAxis_MaximumMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> at March 31, 2022.</span></div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b345" continuedAt="Text_203af78f335048fda7a633c222c715b346">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b346" continuedAt="Text_203af78f335048fda7a633c222c715b347">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized when, or as, the performance obligation is satisfied. To determine the
        transaction price, the Company includes the effects of any variable consideration, such as the probability of collecting that amount. The Company applies established rates to the services provided, and adjusts for the terms of payor contracts, as
        applicable. These contracted amounts are different from the Company&#8217;s established rates.&#160; The Company has established a &#8220;contractual allowance&#8221; for this difference. The allowance is based on the terms of payor contracts, historical and current
        reimbursement information and current experience with the clinic and partners. The Company&#8217;s established rates less the contractual allowance is the revenue that is recognized in the period in which the service is rendered. This revenue is deemed
        the transaction price and stated as &#8220;Net Patient Revenue&#8221; on the Company&#8217;s consolidated statements of income.</div>
</ix:continuation>
      <ix:continuation id="Text_203af78f335048fda7a633c222c715b347" continuedAt="Text_203af78f335048fda7a633c222c715b348">
<div><br />
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_203af78f335048fda7a633c222c715b348">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company&#8217;s performance obligations are satisfied at a point in time. After the clinic has provided
        services and satisfied its obligation to the customer for the reimbursement rates stipulated in the payor contracts (i.e. the transaction price), the Company recognizes the revenue, net of contractual allowances, in the period in which the services
        are rendered. The Company recognizes the full amount of revenue and reports the contractual allowances as a contra (or offset) revenue account to report a net revenue number based on the expected collection</span>s.</div>
</ix:continuation>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">18</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_70531d37d40a4778820f419c06f6580b" contextRef="c20220101to20220331" escape="true" continuedAt="Text_9d1e89ee4c6748bc8d2af0fce8c93aa41">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4. EARNINGS PER SHARE</div>
</ix:nonNumeric>
    <ix:continuation id="Text_9d1e89ee4c6748bc8d2af0fce8c93aa41" continuedAt="Text_9d1e89ee4c6748bc8d2af0fce8c93aa42">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_9d1e89ee4c6748bc8d2af0fce8c93aa42" continuedAt="Text_9d1e89ee4c6748bc8d2af0fce8c93aa43"><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="Text_385de745272441058c476cf37a12991e" contextRef="c20220101to20220331" escape="true" continuedAt="Text_102b43bd56bd4247b1a10f321c85cb891">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with current accounting guidance, the revaluation of redeemable non-controlling interest (see Note 5 &#8211; Redeemable Non-Controlling Interest), net of tax,
      charged directly to retained earnings is included in the earnings per basic and diluted share calculation. The following table provides a detail of the basic and diluted earnings per share computation (in thousands, except per share data).</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_9d1e89ee4c6748bc8d2af0fce8c93aa43" continuedAt="Text_9d1e89ee4c6748bc8d2af0fce8c93aa44"><ix:continuation id="Text_102b43bd56bd4247b1a10f321c85cb891" continuedAt="Text_102b43bd56bd4247b1a10f321c85cb892">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9d1e89ee4c6748bc8d2af0fce8c93aa44"><ix:continuation id="Text_102b43bd56bd4247b1a10f321c85cb892">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_88c8ff299cca46d3bfd244cb4372197d" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,799</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_3fb82b94ad4a4c89b300e39e637b3eec" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,173</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">(Charges) credit to retained earnings:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">(<ix:nonFraction name="usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="Fact_f34e09b5df934e7b9bed0845da3ba256" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">153</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">(<ix:nonFraction name="usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="Fact_b6b3101d1e224478a3110f5829607fa6" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">7,270</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_2c9be130669c44af881008f0d3166189" contextRef="c20220101to20220331" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_60f2d83d944d408c8c38aa4d7c990690" contextRef="c20220101to20220331" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">25.55</ix:nonFraction></ix:nonFraction></span>%<br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_754e68b88e7f4424a3d0511bdd6eca6f" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">39</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_be6ce6a5e3e9404a876d846b028ea049" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,857</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="Fact_19f040b07af740e9902763a75f570c12" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,685</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="Fact_2ba3963adf004114ae324f643abd1d6c" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,760</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_93b9427b6e4d4bc7be354f60d554fd1d" contextRef="c20220101to20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_687869a89b644f62902550f56dd52cb1" contextRef="c20220101to20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.67</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_526ba8515f2c4deda2d9456bd4c608e5" contextRef="c20210101to20210331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_1c0bd630ab684b97a1b7ca28314cddbd" contextRef="c20210101to20210331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.21</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_844ea1299444436fbd084d3f53609df5" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_56eda95a607c400388238a62f0b66961" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,937</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_65a27af7b1d8466eb0de76666b60a9fe" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_3c30669018b14ffc9fe1afade8ec50ff" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,870</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="usph:RedeemableNonControllingInterestTextBlock" id="Text_62c985dc6dde4f79b07cef0a23104a3b" contextRef="c20220101to20220331" escape="true" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8821">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5. REDEEMABLE NON-CONTROLLING INTEREST</div>
</ix:nonNumeric>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8821" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8822">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8822" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8823">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Since October 2017, when the Company acquires a majority interest (the &#8220;Acquisition&#8221;) in a physical therapy clinic business (referred to as &#8220;Therapy Practice&#8221;), these
      Acquisitions occur in a series of steps which are described below.</div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8823" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8824">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8824" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8825">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#8220;Seller Entity&#8221;). The Seller Entity is owned by one or more individuals (the &#8220;Selling
              Shareholders&#8221;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8825" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8826">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8826" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8827">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&#8220;NewCo&#8221;), in exchange for one hundred percent (<ix:nonFraction name="usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="Fact_e8afd9fbe5154a99b166cf868a8e771b" contextRef="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller
              Entity.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8827" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8828">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8828" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f8829">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Company enters into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Seller Entity a majority (ranges from <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="Fact_83319094de174428b509aab24b533287" contextRef="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% to <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="Fact_4c9dc58972bc4cbe8faf71cec4856adf" contextRef="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">90</ix:nonFraction>%) of the limited partnership interest and in <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">all</span></span> cases <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" id="Fact_f2c94b87e4464431939f5f6a058eb51a" contextRef="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the general partnership interest in
              NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in
              the form of cash at closing and a small, <ix:nonNumeric name="usph:BusinessAcquisitionConsiderationPayableTermOfNote" id="Fact_400a93376b744c7982c3a25f04a1064b" contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">two-year</ix:nonNumeric> note in lieu of an escrow (the &#8220;Purchase Price&#8221;). The Purchase Agreement does
              not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f8829" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88210">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88210" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88211">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Seller Entity also execute a partnership agreement (the &#8220;Partnership Agreement&#8221;) for NewCo that sets forth the rights and obligations of the limited and general
              partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88211" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88212">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88212" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88213">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo
              (&#8220;Seller Entity Interest&#8221;).</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88213" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88214">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88214" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88215">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#8220;Employment Agreement&#8221;) with NewCo with an initial term that ranges from <span style="-sec-ix-hidden:Fact_366532ba69814de1ad518109bf840391">three</span> to <ix:nonNumeric name="usph:TermOfEmploymentAgreement" id="Fact_a021fe64f29a4c089f384d75ef51f808" contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> (the
              &#8220;Employment Term&#8221;), with automatic <ix:nonNumeric name="usph:EmploymentAgreementRenewalTerm" id="Fact_178cb875db2b45578176325ade91a5c9" contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">one-year</ix:nonNumeric> renewals, unless employment is terminated prior to the end of the Employment Term. As
              a result, a Selling Shareholder becomes an employee (&#8220;Employed Selling Shareholder&#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any
              time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity
              as of the closing of the Acquisition.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88215" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88216">
<div> <br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">19</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88216" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88217">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other
              employees in similar capacities within NewCo, the Company and the industry.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88217" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88218">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88218" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88219">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the
              &#8220;Non-Compete Agreement&#8221;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &#8220;Non-Compete Term&#8221;). A Non-Compete Agreement is executed with the Selling Shareholders in all
              cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88219" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88220">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88220" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88221">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and&#160; expires on the <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">later</span></span> of :</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88221" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88222">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88222" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88223">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="Fact_f3a24344e7f54aada2e7f3d01bf54062" contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">Two years</ix:nonNumeric> after the date an Employed Selling Shareholders&#8217; employment
              is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88223" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88224">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88224" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88225">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_384e0904d90e46f581ffc1a642cdf595">Five</span> to <ix:nonNumeric name="usph:NonCompeteAgreementBasicTerm" id="Fact_e5cf8202a2284a8ba7fe3642b4a4e4c2" contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">six years</ix:nonNumeric> from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88225" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88226">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88226" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88227">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">10.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to a restricted region which is defined as a defined mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to
              engage in competing businesses or activities outside the defined mileage (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the
              competing business or activities outside the defined mileage.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88227" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88228">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88228" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88229">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#8220;Call Right&#8221;) or at the option of
      the Seller Entity (the &#8220;Put Right&#8221;) as follows:</div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88229" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88230">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88230" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88231">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88231" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88232">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88232" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88233">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment is terminated under certain circumstances prior to a specified date (the &#8220;Specified Date&#8221;), the Seller Entity thereafter may
              have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88233" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88234">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88234" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88235">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder is not employed by NewCo as of the Specified Date and the Company has not exercised its Call Right with respect to the Terminated Selling
              Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s
              Interest at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88235" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88236">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88236" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88237">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">c)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the Specified Date, the Seller Entity shall have the Put Right, and upon
              the exercise of the Put Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88237" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88238">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88238" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88239">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88239" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88240">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88240" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88241">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s employment by NewCo is terminated prior to the Specified Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the
              Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88241" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88242">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88242" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88243">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after Specified Date, the Company shall have the Call Right, and upon the
              exercise of the Call Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88243" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88244">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88244" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88245">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings before interest, taxes,
              depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on available cash within
              NewCo.&#894; Therefore, the undistributed earnings amount is small, if any.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88245" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88246">
<div> <br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">20</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88246" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88247">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company <span style="font-size: 10pt; font-family: 'Times New Roman';">is, in almost all cases, also</span> based
              on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88247" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88248">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88248" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88249">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date, and the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity unless
              either the Put Right or the Call Right is exercised.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88249" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88250">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88250" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88251">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire
              ownership interest in the Seller Entity at the closing of the Acquisition.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88251" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88252">
<div><br />
    </div>
</ix:continuation>
    <div>
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88252" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88253">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ProgressiveHealth Acquisition</div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88253" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88254">
<div><br />
    </div>
</ix:continuation>
    <div>
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88254" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88255">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2021, the Company acquired a majority interest in ProgressiveHealth Companies, LLC (&#8220;Progressive&#8221;), which owns a majority interest in
        certain subsidiaries (&#8220;Progressive Subsidiaries&#8221;) that operate in the industrial injury prevention and therapy services businesses.&#160; The Progressive transaction was completed in a series of steps which are described below.</div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88255" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88256">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88256" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88257">
<div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Prior to the acquisition, the Progressive Subsidiaries were owned by a legal entity (&#8220;Progressive Parent&#8221;) controlled by its individual
                  owners (the &#8220;Selling Shareholders&#8221;), who work in and manage the Progressive business.</div>
              </div>
            </td>

  </tr>


</table>
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88257" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88258">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88258" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88259">
<div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the acquisition, the Selling Shareholders caused the Progressive Parent to transfer its ownership of the Progressive
                  Subsidiaries into a newly-formed limited liability company (&#8220;NewCo&#8221;), in exchange for one hundred percent (<ix:nonFraction name="usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="Fact_d071f838c8ec49da9870e97ef55e158c" contextRef="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%) of the
                  membership interests in NewCo. Therefore, in this step, NewCo became wholly-owned by the Selling Shareholders.</div>
              </div>
            </td>

  </tr>


</table>
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88259" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88260">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88260" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88261">
<div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company entered into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Selling Shareholders a majority of the membership
                      interest in NewCo. The consideration for the acquisition is primarily payable in the form of cash at closing, a relatively small portion paid in cash after the closing contingent on certain performance criteria, and a small note in
                      lieu of an escrow (the &#8220;Purchase Price&#8221;).</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88261" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88262">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88262" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88263">
<div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholders also executed an operating agreement (the &#8220;Operating Agreement&#8221;) for NewCo that sets forth the
                      rights and obligations of the members of NewCo.</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88263" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88264">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88264" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88265">
<div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company did not purchase <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="Fact_6210ca62212b4a4193ffc4b161c11a4a" contextRef="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the membership interests in NewCo and the Selling Shareholders retained a portion of the membership interest in NewCo (&#8220;Selling Shareholders&#8217; Interest&#8221;).</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88265" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88266">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88266" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88267">
<div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholders executed a non-compete agreement (the &#8220;Non-Compete Agreement&#8221;) which restricts the Selling
                          Shareholders from competing for a specified period of time (the &#8220;Non-Compete Term&#8221;).</div>
                      </div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88267" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88268">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88268" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88269">
<div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and expires on the <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">later</span></span> of:</div>
                </div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88269" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88270">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88270" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88271">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="Fact_0d1a2b4ea2c34fba95560f40ec975f2a" contextRef="c20220101to20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">Two years</ix:nonNumeric> after the date a
                  Selling Shareholder no longer is involved in the management of NewCo or</div>
              </div>
            </td>

  </tr>


</table>
    </div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88271" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88272">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88272" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88273">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="usph:NonCompeteAgreementBasicTerm" id="Fact_c82dda85aad84d9dbe7c77fb096c99c7" contextRef="c20220101to20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">Seven years</ix:nonNumeric> from the
                      date of the acquisition.</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88273" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88274">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88274" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88275">
<div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                  </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to the entire United States.</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </td>

  </tr>


</table>
          </div>
</ix:continuation>
        </div>

      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88275" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88276">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88276" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88277">
<div>
              <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                    </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.</div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>

  </tr>


</table>
            </div>
</ix:continuation>
          </div>

        </div>

      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88277" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88278">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88278" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88279">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Operating Agreement contains provisions for the redemption of the Selling Shareholder&#8217;s Interest, either at the option of the Company (the &#8220;Call
        Right&#8221;) or at the option of the Selling Shareholder (the &#8220;Put Right&#8221;) as follows:</div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88279" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88280">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88280" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88281">
<div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88281" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88282">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88282" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88283">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each of the Selling Shareholders has the right to sell <ix:nonFraction name="usph:PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" id="Fact_e532e64a083144d3889514a11dd9562c" contextRef="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>% of their respective residual interests on each of the 4th and 5th anniversaries of the acquisition closing, and then <ix:nonFraction name="usph:PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" id="Fact_b6d203d8a49446cf99230da791d63a09" contextRef="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% on each of the 6th and 7th anniversaries</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88283" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88284">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88284" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88285">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder terminates his management relationship with NewCo for any reason on or after the seventh
                          anniversary of the Closing Date, the Selling Shareholder has the Put Right, and upon the exercise of the Put Right, the Selling Shareholder&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
                      </div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88285" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88286">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">21</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88286" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88287">
<div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                  </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div>
                        </div>
                      </div>
                    </div>
                  </td>

  </tr>


</table>
          </div>
</ix:continuation>
        </div>

      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88287" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88288">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88288" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88289">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s ceases to perform management services on behalf of NewCo, the Company thereafter shall have an
                          irrevocable right to purchase from such Selling Shareholder his Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
                      </div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88289" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88290">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88290" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88291">
<div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing
                      twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings
                      are distributed monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88291" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88292">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88292" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88293">
<div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the
                          trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.</div>
                      </div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88293" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88294">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88294" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88295">
<div>
              <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                    </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.</div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>

  </tr>


</table>
            </div>
</ix:continuation>
          </div>

        </div>

      </div>

    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88295" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88296">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88296" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88297">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Neither the Operating Agreement nor the Non-Compete Agreement contain any provision to escrow or &#8220;claw back&#8221; the equity interest in NewCo held by the
        Selling Shareholders, in the event of a breach of the operating agreement or non-compete terms, or the management services agreement pursuant to which the Selling Shareholders perform services on behalf of NewCo. The Company&#8217;s only recourse against
        the Selling Shareholder for breach of any of these agreements is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with a Selling Shareholder that would result in a forfeiture of the
        equity interest in NewCo held by a Selling Shareholder.</div>
</ix:continuation>
      <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88297" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88298">
<div><br /></div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88298" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f88299">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#8217;s purchase of its partnership
      interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in
      NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her
      full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment
      Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest
      held in the Seller Entity or of the Seller Entity Interest.</div>
</ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f88299" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f882100">
<div><br />
    </div>
</ix:continuation>
    <ix:nonNumeric name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="Text_badb20328c804d2d86241547eb1f9ccc" contextRef="c20220101to20220331" escape="true" continuedAt="Text_529f34031b204737ab7f1e02dd766a631"><ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f882100" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f882101">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">For the </span>dates indicated,<span style="font-size: 10pt; font-family: 'Times New Roman';"> the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interest (in</span> thousand<span style="font-size: 10pt; font-family: 'Times New Roman';">s):</span></div>
</ix:continuation></ix:nonNumeric>
    <ix:continuation id="Text_529f34031b204737ab7f1e02dd766a631" continuedAt="Text_529f34031b204737ab7f1e02dd766a632"><ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f882101" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f882102">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_529f34031b204737ab7f1e02dd766a632"><ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f882102" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f882103">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_504685e45b4042aebb5f464a047c74b8" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">155,262</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_df1ad10813d94f2684389e57850f2014" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">132,340</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_ac6d131f02c04df5b2cac3d472a6858e" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,557</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_ba6e6ceda47a4b179af9a823210b0926" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,358</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="Fact_fca9a91883f64043a6968215c112577e" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,403</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="Fact_ce659acb12574f2b9c560bb665cfc7ac" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,359</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:MinorityInterestChangeInRedemptionValue" id="Fact_31e465f6cada40e2b2cbe51e78f69018" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">153</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:MinorityInterestChangeInRedemptionValue" id="Fact_4dfcca2e33954af5a796133213f419eb" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">13,011</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" id="Fact_744434cc72fc41ed9fb8d9c6e7679689" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,457</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" id="Fact_0f125f47577f40a2a41a5f016fc825f4" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">30,204</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" id="Fact_2eab67dfb82c4cddb0ec69c1d74527f0" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,946</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" id="Fact_d1494a4bd3fe48aeb8790b3bc03b5a75" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">39,862</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_7daaa576807248ffb2f4b5e7dbfc4a3d" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_5fd498d92e0144b68d95194ffeed2127" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">982</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><ix:nonFraction name="usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_650ced3c9ecd44cd877cc7c8fb05b54d" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;">(<ix:nonFraction name="usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_b7238e50df014710b5ba6106aeddba93" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">914</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">(<ix:nonFraction name="usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_127229c3e4c047599b1530a25bb5252f" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">50</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><ix:nonFraction name="usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_f0c4f238e80b4fb2aea0283cc75ee8e9" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">186</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(255, 255, 255);">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">Other <br />
            </div>
          </td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);"><ix:nonFraction name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" id="Fact_cf114e44558c48cc896c625f58cdbb53" contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);"><ix:nonFraction name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" id="Fact_ee0c9c2aaa7042de87a088e618d1487c" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_dc44395e8ac94ac7b4a6efe0727d268d" contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">158,008</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_9bbc3ca01aec4870b24f7917bd29a08d" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">155,262</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f882103" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f882104">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">22</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>


    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f882104" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f882105"><ix:nonNumeric name="usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" id="Text_856c5088ad344a39808d5b7a1571f58c" contextRef="c20220101to20220331" escape="true" continuedAt="Text_c9c89fb434604e41873f233a1d2a13b41">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interest (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f882105" continuedAt="Text_757db98c1f8f42b9b1b3091fab38f882106"><ix:continuation id="Text_c9c89fb434604e41873f233a1d2a13b41" continuedAt="Text_c9c89fb434604e41873f233a1d2a13b42">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_757db98c1f8f42b9b1b3091fab38f882106"><ix:continuation id="Text_c9c89fb434604e41873f233a1d2a13b42">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder&#8217;s employment has not terminated</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="Fact_6a54f118ea5e4fd6bc87f810b57639aa" contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">92,320</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="Fact_b850622001634555b7c2419056d4132f" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">80,781</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder&#8217;s employment has not terminated</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="Fact_64335711bec247c2a1ea543ba8525592" contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">65,688</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="Fact_560cbc1309e649779d5f6250353d75bb" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">74,481</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Holder&#8217;s employment has terminated and contractual time period has expired</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="Fact_f695bbf7ef2445e1ba4d4846bda9157b" contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="Fact_aee06ff4e4d5407b842080e0c39aa498" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Holder&#8217;s employment has terminated and contractual time period has not expired</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="Fact_095b2f63dc034a03900415da5bb08982" contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="Fact_6149b414f97b4fbd9d1debf637f11833" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_5ef3dd494a4b43fa9ab67972adfa94cb" contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">158,008</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_474f3e29d28a4b84a84b41d2aed24e6e" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">155,262</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:GoodwillDisclosureTextBlock" id="Text_1c7b351e10ac4855bca068fa24aa2647" contextRef="c20220101to20220331" escape="true" continuedAt="Text_84ef55f7e7dd454eb8c6473e8a0cf0f31">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6. GOODWILL</div>
</ix:nonNumeric>
    <ix:continuation id="Text_84ef55f7e7dd454eb8c6473e8a0cf0f31" continuedAt="Text_84ef55f7e7dd454eb8c6473e8a0cf0f32">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_84ef55f7e7dd454eb8c6473e8a0cf0f32" continuedAt="Text_84ef55f7e7dd454eb8c6473e8a0cf0f33"><ix:nonNumeric name="us-gaap:ScheduleOfGoodwillTextBlock" id="Text_f56f94313f8a4523a5290f021dc75535" contextRef="c20220101to20220331" escape="true" continuedAt="Text_cb1ebf883aef477c9ecd4d6deb8fdd2f1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The changes in the carrying amount of goodwill consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_84ef55f7e7dd454eb8c6473e8a0cf0f33" continuedAt="Text_84ef55f7e7dd454eb8c6473e8a0cf0f34"><ix:continuation id="Text_cb1ebf883aef477c9ecd4d6deb8fdd2f1" continuedAt="Text_cb1ebf883aef477c9ecd4d6deb8fdd2f2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_84ef55f7e7dd454eb8c6473e8a0cf0f34"><ix:continuation id="Text_cb1ebf883aef477c9ecd4d6deb8fdd2f2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom;"></td>

    <td valign="bottom" colspan="1" style="white-space: nowrap; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Three Months Ended</span></div>
          </td>

    <td valign="bottom" colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="white-space: nowrap; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td valign="bottom" colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_4fa7a2d89a9e48bda36dc9ca8dba4702" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">434,679</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_f20bd2a4818644858c387dde31056f3e" contextRef="c20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">345,646</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" id="Fact_89d41249fada469181691c5b91b4126a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,539</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" id="Fact_67552a3a265d4952b42c019027e1f139" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">89,746</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:GoodwillPurchaseAccountingAdjustments" id="Fact_dce49278cc964c4ea42563fb862ad07a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,526</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:GoodwillPurchaseAccountingAdjustments" id="Fact_8ea4b0d55ea44259b5f1dd9fa125eba6" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">713</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_0c6a52eb0a764563b0cc6284c546c6a9" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">443,692</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_dd61d8c7c74041ccafab85e92b3ad5fc" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">434,679</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="Text_e77b3293d2ec4bdf8263dcf6c7c5611e" contextRef="c20220101to20220331" escape="true" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7. INTANGIBLE ASSETS, NET</div>
</ix:nonNumeric>
    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa1" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa2">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa2" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa3"><ix:nonNumeric name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="Text_28c62c2551524dad83b3d8751d1a1f30" contextRef="c20220101to20220331" escape="true" continuedAt="Text_6e754a5ca9db4afd987b10e66d99913e1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Intangible assets, net as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa3" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa4"><ix:continuation id="Text_6e754a5ca9db4afd987b10e66d99913e1" continuedAt="Text_6e754a5ca9db4afd987b10e66d99913e2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa4" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa5"><ix:continuation id="Text_6e754a5ca9db4afd987b10e66d99913e2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_6afc9455832645c3ab6c5438c8361c7a" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">39,456</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_72908122b777440ebe7cb02d8296996f" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">38,790</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships, net of accumulated amortization of $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_adcb3c6838f149d58673ec5381700bf8" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">19,959</ix:nonFraction></span> and $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_48187abdbea94617b359590304700301" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">17,762</ix:nonFraction></span>, respectively</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_ebc9fa8339d44902b0e99a4ea1e1273d" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">50,076</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_57bedffed51c434795d23f620083dbd1" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">45,643</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_45061e9e2b8a4363a1a14c62853d2fc2" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,597</ix:nonFraction></span> and $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_a29ec45089be49499a42d474797669dc" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,450</ix:nonFraction></span>, respectively</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_2b2ab3ad31c5478080dac5fd21e40e22" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,014</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_fe3e0a66206843bf974fb14285a70ecd" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,949</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_cdbf4919498544b494a09e830164ed5f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">91,546</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_0d5fdde954bc4e129d478746542e6c51" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">86,382</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa5" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa6">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa6" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa7">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. The value assigned to tradenames has an indefinite life and is tested
      at least annually for impairment using the relief from royalty method in conjunction with the Company&#8217;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives
      which range from <span style="-sec-ix-hidden:Fact_c5b38f9523db408b8ed6c53ba95605c1">six</span> to <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_e644ab8829a842be9cbf3727624efcab" contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">fourteen years</ix:nonNumeric>.
      Non-compete agreements are amortized over the respective term of the agreements which range from <span style="-sec-ix-hidden:Fact_c992237d92cd47c78ded2f3204d6bdd7">five</span> to <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_b5bae1175a5a453a92c55ce74c1dd54c" contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">six years</ix:nonNumeric>.</div>
</ix:continuation>
    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa7" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa8">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa8" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa9"><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="Text_09f45d7a4afa4c009ff26d9f4f78bfe8" contextRef="c20220101to20220331" escape="true" continuedAt="Text_ca65b9dcc7e24712883b0f12342a61d51">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the amount of amortization expense recorded for intangible assets for the three months ended March 31, 2022 and 2021 (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa9" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa10"><ix:continuation id="Text_ca65b9dcc7e24712883b0f12342a61d51" continuedAt="Text_ca65b9dcc7e24712883b0f12342a61d52">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa10" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa11"><ix:continuation id="Text_ca65b9dcc7e24712883b0f12342a61d52">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_8bf293cde0154b81acf972321c5539b1" contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,050</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_b46d8ff084b04f78807429f4c8f55042" contextRef="c20210101to20210331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">783</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_cbfb3ffd75734bc2b64c73475deb2adc" contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">147</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_b136d46ba85c467398f5365e1a4521a8" contextRef="c20210101to20210331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">39</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_a63bbde76e7f45d894b061d7f419caff" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,197</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_65751e0fcbf6436eb58aabc7aeae563b" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">822</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa11" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa12">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">23</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:nonNumeric name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="Text_21f7996076ca4fd897674425aa02d7b3" contextRef="c20220101to20220331" escape="true" continuedAt="Text_cc1542956cee463cb52da63a2c433d5d1"><ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa12" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa13">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Based on the balance of referral relationships and non-compete agreements as of
        March </span>31,<span style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</span>2022,<span style="font-size: 10pt; font-family: 'Times New Roman';"> the expected amount to be amortized in </span>2022<span style="font-size: 10pt; font-family: 'Times New Roman';"> and thereafter by year is as follows (in</span> thousand<span style="font-size: 10pt; font-family: 'Times New Roman';">s):</span></div>
</ix:continuation></ix:nonNumeric>
    <ix:continuation id="Text_cc1542956cee463cb52da63a2c433d5d1" continuedAt="Text_cc1542956cee463cb52da63a2c433d5d2"><ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa13" continuedAt="Text_d8af0c64c4104ad0b536d12b76bd46aa14">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_cc1542956cee463cb52da63a2c433d5d2"><ix:continuation id="Text_d8af0c64c4104ad0b536d12b76bd46aa14">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" colspan="4" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Customer and Referral Relationships</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="5" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 37%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 37%; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 37%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending December 31,</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 37%; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ending December 31,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2022</span>
              (excluding the three months ended March 31, 2022)</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" id="Fact_db620b2519494b63aa85f081bcb66faf" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,851</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"><span style="text-indent: 0pt;">2022</span>
              (excluding the three months ended March 31, 2022)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" id="Fact_881e5d0b09a84e318e3d7ee2461337b1" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">413</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2023</span></div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" id="Fact_353099f228614a9487156d0d57bb14e8" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,200</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2023</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" id="Fact_08000d320bdd4468b11c6a4961884078" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">494</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2024</span></div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" id="Fact_f099483855644cd497d2661c2e566709" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,036</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2024</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" id="Fact_f6c01f6d23bc413f80e5249b12c2ede8" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">438</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2025</span></div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" id="Fact_b5008df15340402f807cec18081d3d99" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,892</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2025</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" id="Fact_4155e0b2775d47a28b09728b8d3f71fb" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">371</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2026</span></div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" id="Fact_c97a2f6a579a4bc88ba37891fc2ae352" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,424</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2026</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" id="Fact_7d634592b2504bf8aff01be0dc94e97a" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">243</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" id="Fact_9f662865edca4cd2a1f5f25db94dc9d6" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26,673</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" id="Fact_cec566f39b1b4b9f91f25a6eb5b60a20" contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">55</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_e3383c49100c4e83ab22f9a4751c2b82" contextRef="c20220101to20220331" escape="true" continuedAt="Text_55a261083f9a4d77b246f089d037f9ed1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8. ACCRUED EXPENSES</div>
</ix:nonNumeric>
    <ix:continuation id="Text_55a261083f9a4d77b246f089d037f9ed1" continuedAt="Text_55a261083f9a4d77b246f089d037f9ed2">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_55a261083f9a4d77b246f089d037f9ed2" continuedAt="Text_55a261083f9a4d77b246f089d037f9ed3"><ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_75214a15876349f7956962b5c2652f14" contextRef="c20220101to20220331" escape="true" continuedAt="Text_79efc33dbbfd4bfdb2113e00b945a3e81">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Accrued expenses as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_55a261083f9a4d77b246f089d037f9ed3" continuedAt="Text_55a261083f9a4d77b246f089d037f9ed4"><ix:continuation id="Text_79efc33dbbfd4bfdb2113e00b945a3e81" continuedAt="Text_79efc33dbbfd4bfdb2113e00b945a3e82">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_55a261083f9a4d77b246f089d037f9ed4"><ix:continuation id="Text_79efc33dbbfd4bfdb2113e00b945a3e82">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_b3cbb3625557463cba423831a879b73d" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,272</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_1eece48e625b4288b0c5662900f3d421" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">23,569</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PatientsAndPayorsRelatedLiability" id="Fact_319d579e6b99490b918935a8175b2b36" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,788</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PatientsAndPayorsRelatedLiability" id="Fact_0b04362c685e41448be0629600bbcc82" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,649</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedInsuranceCurrent" id="Fact_576817cccbe14e2b8ad68b693131e7e5" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,766</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedInsuranceCurrent" id="Fact_0f69a51aa1b34381b1796abf5734b143" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,984</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" id="Fact_bd482cbc306841b09a7ae9846acf3aef" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">379</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" id="Fact_69fff73878d34f0cb3855cd8aa9624e3" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">498</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Federal taxes payable</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" id="Fact_359fad7e4867421abaf47c26f4dd549e" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,590</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" id="Fact_40eb714b225b44bf982238d01a6e1542" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,716</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Dividend payable to USPH shareholders<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsPayableCurrentAndNoncurrent" id="Fact_3ac5bf3460b4494f8b37086ce34391f6" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,327</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsPayableCurrentAndNoncurrent" id="Fact_0c862cab6e664c9486eeb3d0a593d584" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contingent payments related to acquisition<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent" id="Fact_48a4da1999984619a3fc23bc9f615e2e" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,520</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent" id="Fact_fca5b866b8a44fcaa85878a74124157e" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%;">Settlement of a legal matter <br />
          </td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:LitigationReserveCurrent" id="Fact_38b536d6896c4594961dfbc4e98b863d" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:LitigationReserveCurrent" id="Fact_d9e7ea7648b2466ea0b8deb716e91bf6" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,750</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_f041e148f0354ccaa9aaf0e1c5604ca8" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,479</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_17f21c35a2cf44da93d43c514bf82465" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,539</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_0a35fed00a1e4358a04b2d0c95b2dcd4" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">51,121</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_4cfe826161534798894bd904152f40cd" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">45,705</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" id="Text_cd41f5feea9a439aaccbde5cb1b9a60f" contextRef="c20220101to20220331" escape="true" continuedAt="Text_99dce8cc46274eafb28688d73be0f5421">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9. NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</div>
</ix:nonNumeric>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5421" continuedAt="Text_99dce8cc46274eafb28688d73be0f5422">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5422" continuedAt="Text_99dce8cc46274eafb28688d73be0f5423"><ix:nonNumeric name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="Text_e5ca2a24d30948b79aa32a10c4b5c5f6" contextRef="c20220101to20220331" escape="true" continuedAt="Text_460829ef45cb4684a777f191025243921">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Amounts outstanding under the Amended Credit Agreement (as defined below) and notes payable as of March 31, 2022 and December 31, 2021 consisted of the following (in
      thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5423" continuedAt="Text_99dce8cc46274eafb28688d73be0f5424"><ix:continuation id="Text_460829ef45cb4684a777f191025243921" continuedAt="Text_460829ef45cb4684a777f191025243922">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5424" continuedAt="Text_99dce8cc46274eafb28688d73be0f5425"><ix:continuation id="Text_460829ef45cb4684a777f191025243922">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_52a22de34a964dcfbf48826686715b46" contextRef="c20220101to20220331_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_2147763b3e3a4d62b5f9316b0dec9c86" contextRef="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">1.74</ix:nonFraction></ix:nonFraction></span>% for March 31, 2022 and December 31, 2021, (inclusive of unused fee)</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_fe63a789816f42ddab70e186d7781167" contextRef="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">118,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_879a9699cd6e4ee7b0ee0ecc8bf5f6d6" contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">114,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:DebtInstrumentAnnualPrincipalPayment" id="Fact_424ba282453f4ba487bda659ee12b9c3" contextRef="c20220331_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,927</ix:nonFraction></span>
              plus accrued interest due in the next year, interest accrues in the range of <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_478a0d1127324ae68ea9f21a25ba087e" contextRef="c20220331_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction></span>% through <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_3a62afb2757d490882fb1b3d753b3ec1" contextRef="c20220331_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">3.5</ix:nonFraction></span>% per annum</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_d152a82a1cbb48a58ea46a201595e58b" contextRef="c20220331_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,927</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_f299d356e40b45d98d0ed6ef32215f57" contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,417</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_eeb31e526f584babb5acdd7973e95db4" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">122,927</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_2e02d92dbbb34eeb944cda7adc615e3a" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">118,417</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_ab3255b0c37c4739a29bcbc2a81544b8" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">799</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_fc656310fc664da3a761620f6fc236ad" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">830</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" id="Fact_5d93683915a04e919a388aaf4e09cbd4" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">122,128</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" id="Fact_8e47c74a8fa541b793700e03c1c3dfb5" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">117,587</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <div>
      <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5425" continuedAt="Text_99dce8cc46274eafb28688d73be0f5426">
<div><br />
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5426" continuedAt="Text_99dce8cc46274eafb28688d73be0f5427">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Effective December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_f2d731f259a342c6af8ba11bbfb6904c" contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">125.0</ix:nonFraction> million revolving credit facility. This agreement was amended and/or restated in August 2015, January 2016, March 2017, November 2017 and January 2021 (hereafter referred
      to as &#8220;Amended Credit Agreement&#8221;).<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> In
        November 2021, the Company exercised the accordion feature in the Amended Credit Agreement to increase the limit on the facility from $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_165f951710e043e69419c95b643556e3" contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">125.0</ix:nonFraction>
        million to $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_ee1f591cdab9486ca25297b052a171c5" contextRef="c20211130_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">150.0</ix:nonFraction> million, with an updated accordion feature providing for additional capacity of <ix:nonFraction name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" id="Fact_945f8065bb7646d494f708e2feecff7d" contextRef="c20220101to20220331_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">25.0</ix:nonFraction> million, therefore increasing the availability up to $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_8f385064de5148fab76cc20932010720" contextRef="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">175.0</ix:nonFraction>
        million.</span></div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5427" continuedAt="Text_99dce8cc46274eafb28688d73be0f5428">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5428" continuedAt="Text_99dce8cc46274eafb28688d73be0f5429">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and
      consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#8217;s common stock, dividend payments to the Company&#8217;s common stockholders, capital expenditures and other
      corporate purposes. The pricing grid is based on the Company&#8217;s consolidated leverage ratio with the applicable spread over LIBOR ranging from <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" id="Fact_e6aee967f0064c02888e6566afea560a" contextRef="c20220101to20220331_RangeAxis_MinimumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">1.25</ix:nonFraction>%
      to <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" id="Fact_25b07d49e7c044b785fda5fc7569dc28" contextRef="c20220101to20220331_RangeAxis_MaximumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">2.0</ix:nonFraction>% or the applicable spread over the Base Rate ranging from <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" id="Fact_b358d9fe95aa4de9903846c6ca96d8b2" contextRef="c20220101to20220331_RangeAxis_MinimumMember_VariableRateAxis_BaseRateMember" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">0.1</ix:nonFraction>% to <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" id="Fact_8b77f3136bd84671b65ba7a5cfea5296" contextRef="c20220101to20220331_RangeAxis_MaximumMember_VariableRateAxis_BaseRateMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%. Fees under the Amended Credit Agreement include an
      unused commitment fee of <ix:nonFraction name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" id="Fact_6e6864102a88420d9ea06bb2b8392d9a" contextRef="c20220101to20220331" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">0.3</ix:nonFraction>% of the amount of funds outstanding under the Amended Credit Agreement.</div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f5429" continuedAt="Text_99dce8cc46274eafb28688d73be0f54210">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">24</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54210" continuedAt="Text_99dce8cc46274eafb28688d73be0f54211">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The January 2021 amendment to the Amended Credit Agreement allows the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under
      the Amended Credit Agreement to $<ix:nonFraction name="usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" id="Fact_b7d7a1f62fbc407c8a82b5b16fa5219a" contextRef="c20210101to20210131_DebtInstrumentAxis_CreditAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">50,000,000</ix:nonFraction> for any fiscal year, and the amount the Company may pay in cash dividends to its shareholders
      in an aggregate amount not to exceed $<ix:nonFraction name="usph:DividendsCashAfterAmendment" id="Fact_808ab376dfb2431db3616b192070724c" contextRef="c20210101to20210131_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">50,000,000</ix:nonFraction> in any fiscal year. The Amended Credit Agreement is unsecured and includes certain
      financial covenants which include a consolidated fixed charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.</div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54211" continuedAt="Text_99dce8cc46274eafb28688d73be0f54212">
<div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54212" continuedAt="Text_99dce8cc46274eafb28688d73be0f54213">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As of <span style="font-size: 10pt; font-family: 'Times New Roman';">March 31, 2022</span>,<span style="font-size: 10pt; font-family: 'Times New Roman';"> $<ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_a447b350936b4466b5a944399426a398" contextRef="c20220331_DebtInstrumentAxis_CreditAgreementMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">118.0</ix:nonFraction> million was outstanding on the Amended Credit Agreement, resulting in $</span><ix:nonFraction name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" id="Fact_b1ffd60342db415482db814051ea4011" contextRef="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">32.0</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman';"> million of availability. As of March 31, 2022, the Company was in compliance with all of the covenants
        contained in the Amended Credit Agreement.</span></div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54213" continuedAt="Text_99dce8cc46274eafb28688d73be0f54214">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54214" continuedAt="Text_99dce8cc46274eafb28688d73be0f54215">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company generally enters into various notes payable as a means of financing a portion of its acquisitions
        and purchasing of non-controlling interests. In conjunction with these transactions in 2022 and 2021, the Company entered into notes payable in the aggregate amount of </span>$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_e869ace83049453db29dc09c86cf6fa0" contextRef="c20220331_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.9</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman';"> of which an aggregate principal payment of </span>$<ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" id="Fact_172719b26766437ca2f5fef488119fb6" contextRef="c20220331_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman';"> is due in </span>2022, $<ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" id="Fact_e473e4894fab42f48df4cf3bc2a5f3dc" contextRef="c20220331_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.1</ix:nonFraction> million is due in 2023.<span style="font-size: 10pt; font-family: 'Times New Roman';"> Interest accrues in the range of </span><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_22e2620b1b6c45468988caed755681ae" contextRef="c20220101to20220331_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> to </span><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_f5d8069c3911495cb30bd47f4afcc452" contextRef="c20220101to20220331_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">3.50</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> per annum and is payable with each principal installment. </span><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54215" continuedAt="Text_99dce8cc46274eafb28688d73be0f54216">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54216" continuedAt="Text_99dce8cc46274eafb28688d73be0f54217"><ix:nonNumeric name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="Text_88124a445241466c9bb27bbf0fc5eb27" contextRef="c20220101to20220331" escape="true" continuedAt="Text_8876443833264d4a994b4325b7df5d4f1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subsequent aggregate annual payments of principal required pursuant to the Amended Credit Agreement and outstanding notes payable at March 31, 2022 are as follows (in
      thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54217" continuedAt="Text_99dce8cc46274eafb28688d73be0f54218"><ix:continuation id="Text_8876443833264d4a994b4325b7df5d4f1" continuedAt="Text_8876443833264d4a994b4325b7df5d4f2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54218" continuedAt="Text_99dce8cc46274eafb28688d73be0f54219"><ix:continuation id="Text_8876443833264d4a994b4325b7df5d4f2">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="margin: 0px auto 0px 0px; width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" id="Fact_0ce71c2ebcc04c0b98ac5cc3a7e86760" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">799</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2023</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" id="Fact_647a91e099a54a11bcfd8579af056b21" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,128</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2025</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" id="Fact_e32c7204300b4dcd8c18a897d9645e03" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">118,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_ed4767ce3275450d9fa3b11fd22cd85f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">122,927</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54219" continuedAt="Text_99dce8cc46274eafb28688d73be0f54220">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_99dce8cc46274eafb28688d73be0f54220">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The outstanding amount under the Amended Credit Agreement facility (balance on March 31, 2022 of</span> $<ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_303f57bfc9f3451bb3d31056129e656d" contextRef="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">118.0</ix:nonFraction> million) matures on <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_ec969edcb49a40b5b61f0e000cbaa2e8" contextRef="c20220101to20220331_CreditFacilityAxis_RevolvingCreditFacilityMember" format="ixt:datemonthdayyearen">November 30, 2025</ix:nonNumeric>.</div>
</ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_c45a78ab63f24d4abd1a4169e8d442a4" contextRef="c20220101to20220331" escape="true" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c01">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">10. LEASES</div>
</ix:nonNumeric>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c01" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c02">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c02" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c03">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a lease at the inception of a contract.
      Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#8217;s right to use an underlying asset during the lease term and operating lease
      liabilities represent net present value of the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the net present value of the fixed
      lease payments over the lease term. The Company&#8217;s operating lease terms are generally <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Fact_87608c9af75e4a138742de4bfc2676c9" contextRef="c20220331_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> or less. The Company&#8217;s lease terms
      include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#8217;s operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the
      information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.</div>
</ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c03" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c04">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c04" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c05">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The Company has elected, in compliance with
      current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable lease components. The Company has elected
      the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included in the measurement of the right-of-use
      assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment
      amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease liabilities. These are expensed as incurred
      and recorded as variable lease expense.</div>
</ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c05" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c06">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c06" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c07"><ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" id="Text_eba6ae76dcb646e3ac59de0c124f53a2" contextRef="c20220101to20220331" escape="true" continuedAt="Text_1388b5843bd2465db8fa2b8573dfee631">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For the three months ended March 31, 2022, the components of lease expense were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c07" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c08"><ix:continuation id="Text_1388b5843bd2465db8fa2b8573dfee631" continuedAt="Text_1388b5843bd2465db8fa2b8573dfee632">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c08" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c09"><ix:continuation id="Text_1388b5843bd2465db8fa2b8573dfee632" continuedAt="Text_1388b5843bd2465db8fa2b8573dfee633">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">Three Months Ended</span></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">March 31, 2021</span></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_7bafc283b7b8427f980cd873b3577282" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,404</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_ffa4e10b01694d1ab1f52736e583a840" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,729</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" id="Fact_05adf7edeaeb431b93cfe743e1c5020f" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">321</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" id="Fact_57b9cd5c2bcf4bd9a6bca2d11995ba37" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">368</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_5d030c18870b4189abd4a866124c6838" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,932</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_9b49ead6c1414cab871ada8caa962940" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,611</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost *</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_a86a9f81f8e6415ba5caf3f8f5a6c41a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,657</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_e1dc057bc3e04a67ae8164ee0e07cd9b" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">9,708</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c09" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c010"><ix:continuation id="Text_1388b5843bd2465db8fa2b8573dfee633" continuedAt="Text_1388b5843bd2465db8fa2b8573dfee634">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_1388b5843bd2465db8fa2b8573dfee634"><ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c010" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c011">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">* <ix:footnote id="Foot_73f4cf38380b4d879f24c52224424feb" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Sublease income was immaterial</ix:footnote></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c011" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c012">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">25</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c012" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c013">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Lease cost is reflected in the consolidated statement of net income in the line item &#8211; rent, supplies, contract labor and other.</div>
</ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c013" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c014">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c014" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c015"><ix:nonNumeric name="usph:OperatingLeaseSupplementalInformationTableTextBlock" id="Text_4b0368e3bac045a18b12d5d9b697d8e3" contextRef="c20220101to20220331" escape="true" continuedAt="Text_7786b8dd8c2a44e3a153521c750c9d451">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Supplemental information related to leases was as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c015" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c016"><ix:continuation id="Text_7786b8dd8c2a44e3a153521c750c9d451" continuedAt="Text_7786b8dd8c2a44e3a153521c750c9d452">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c016" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c017"><ix:continuation id="Text_7786b8dd8c2a44e3a153521c750c9d452">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">Three Months Ended</span></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:OperatingLeasePayments" id="Fact_cf2e65a428c342749dfd30f3087632aa" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,617</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:OperatingLeasePayments" id="Fact_b2d9bcbdd5cd45e294a53cfffcfaf70f" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,112</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" id="Fact_1c31d67dd0614e3bbf75589a2babd8ef" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,011</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" id="Fact_a28f5a09906741e8bb17ad023ddd7113" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,867</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c017" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c018">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c018" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c019"><ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_3ff5a45238e440798d6190268b78daa4" contextRef="c20220101to20220331" escape="true" continuedAt="Text_962e730002ae4058a4a10f084bc725851">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The aggregate future lease payments for operating leases as of March 31, 2022 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c019" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c020"><ix:continuation id="Text_962e730002ae4058a4a10f084bc725851" continuedAt="Text_962e730002ae4058a4a10f084bc725852">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c020" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c021"><ix:continuation id="Text_962e730002ae4058a4a10f084bc725852">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Fiscal Year</span></div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2022 (excluding the three months ended March 31, 2022)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" id="Fact_28b273b0c4914b41a95e8736c3d79f3c" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,297</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_3896f7d5f29b4f39a16320bb40a27540" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">28,724</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_d3b7f88359a34a3592bd25f44ee50aaf" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,109</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_cea2952a93664c4ca3f732438347fc62" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,808</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" id="Fact_0c467ecd9b3546ffa682f32c91a2f7d4" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">9,285</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2027 and thereafter</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" id="Fact_0563961df6af49a1b174cbccec1a6ab4" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,292</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_da8375122bbc4143a3987b431ae07199" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">108,515</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed&#160; interest</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" colspan="1"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_7a2fcf1e76124a2fa20cd44d2f6162b2" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,728</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 28.85pt; font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_9997b2cd8eca4ed580278838fe6d2550" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">102,787</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c021" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c022">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c022" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c023"><ix:nonNumeric name="usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" id="Text_4f49996f61874a96bc213a9cb7b4ec98" contextRef="c20220101to20220331" escape="true" continuedAt="Text_4c0c1ae01c754ec78fa11cf775bb4e8e1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Average lease terms and discount rates were as follows:</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c023" continuedAt="Text_2044f330f02e4964aee6b51f17dd51c024"><ix:continuation id="Text_4c0c1ae01c754ec78fa11cf775bb4e8e1" continuedAt="Text_4c0c1ae01c754ec78fa11cf775bb4e8e2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_2044f330f02e4964aee6b51f17dd51c024"><ix:continuation id="Text_4c0c1ae01c754ec78fa11cf775bb4e8e2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_002373e37a2b479798777778f862e37e" contextRef="c20220331" format="ixt-sec:duryear">4.1</ix:nonNumeric> Years</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"><span style="text-indent: 0pt;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_a0488ca424ea4a93955d040f95e27d68" contextRef="c20210331" format="ixt-sec:duryear">4.0</ix:nonNumeric></span> Years</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_039745498db447e1a56b176b65ab3865" contextRef="c20220331" unitRef="U006" decimals="4" scale="-2" format="ixt:numdotdecimal">2.70</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_6771f3515a2c44e1b7705306775837b0" contextRef="c20210331" unitRef="U006" decimals="3" scale="-2" format="ixt:numdotdecimal">3.0</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:SegmentReportingDisclosureTextBlock" id="Text_2e964287d83d40d68c3826bbeda47e3d" contextRef="c20220101to20220331" escape="true" continuedAt="Text_ee9ceb0562a047feb11d0da29a3fa3e51">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11. SEGMENT INFORMATION</div>
</ix:nonNumeric>
    <ix:continuation id="Text_ee9ceb0562a047feb11d0da29a3fa3e51" continuedAt="Text_ee9ceb0562a047feb11d0da29a3fa3e52">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ee9ceb0562a047feb11d0da29a3fa3e52" continuedAt="Text_ee9ceb0562a047feb11d0da29a3fa3e53">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Also included in the physical
      therapy operations segment are revenues from management contract services and other services which include services the Company provides on-site, such as schools for athletic trainers.</div>
</ix:continuation>
    <ix:continuation id="Text_ee9ceb0562a047feb11d0da29a3fa3e53" continuedAt="Text_ee9ceb0562a047feb11d0da29a3fa3e54">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ee9ceb0562a047feb11d0da29a3fa3e54" continuedAt="Text_ee9ceb0562a047feb11d0da29a3fa3e55">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company evaluates performance of the segments based on gross profit. The Company has provided additional information regarding its reportable segments which contributes
      to the understanding of the Company and provides useful information.</div>
</ix:continuation>
    <ix:continuation id="Text_ee9ceb0562a047feb11d0da29a3fa3e55" continuedAt="Text_ee9ceb0562a047feb11d0da29a3fa3e56">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">26</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>


    <ix:continuation id="Text_ee9ceb0562a047feb11d0da29a3fa3e56" continuedAt="Text_ee9ceb0562a047feb11d0da29a3fa3e57"><ix:nonNumeric name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="Text_8eb438da539c451386273766558af8bd" contextRef="c20220101to20220331" escape="true" continuedAt="Text_9cc7c5ead7fb4e688aa3b54d1df3af8b1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes selected financial data for the Company&#8217;s reportable segments.<br />
    </div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_ee9ceb0562a047feb11d0da29a3fa3e57" continuedAt="Text_ee9ceb0562a047feb11d0da29a3fa3e58"><ix:continuation id="Text_9cc7c5ead7fb4e688aa3b54d1df3af8b1" continuedAt="Text_9cc7c5ead7fb4e688aa3b54d1df3af8b2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_ee9ceb0562a047feb11d0da29a3fa3e58"><ix:continuation id="Text_9cc7c5ead7fb4e688aa3b54d1df3af8b2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended March 31,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenue:</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_c53972f037c34d06b93c5428f7c9abb1" contextRef="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">112,636</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_0291504402f74a09b40b889b9a9f963f" contextRef="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">102,359</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_47dc6be51e3746d0a28509a3a101bbe3" contextRef="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">19,068</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_d4e17ca9292645d48658148ddc14ac51" contextRef="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,009</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_fefea78e666f4035acbe7e08dcc9cd4a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">131,704</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_26a52f205cb04d51a4a085e01edeaac4" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">112,368</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_b2809a94988c4ebdb69b1c5521d1650e" contextRef="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,436</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_92aed951016a406babd6636b9f190970" contextRef="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">23,174</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_b723e2320b8f410f81ae01b3f50dfe2d" contextRef="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,152</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_08bca272b2264f5da8e4d285bf715ac2" contextRef="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,722</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_8ccbfbcc15ac4166a649fc359abcf1b7" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26,588</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_aec9ff9a6f3a43de9ccec8ef0f0c1de0" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,896</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Assets" id="Fact_44149318c0994ec695d1c147612147f7" contextRef="c20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">608,240</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Assets" id="Fact_6889f76dd5f84b3badb9f0b43e8e7eb7" contextRef="c20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">723,530</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Assets" id="Fact_b69ec47ed97b404d8a54063e627bf37b" contextRef="c20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">155,623</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Assets" id="Fact_74c4e41636bd4289aa4d91d30c6e7369" contextRef="c20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,896</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Assets" id="Fact_f72ba6805e3c441ab0478c325efae85f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">763,863</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Assets" id="Fact_f12d18a444634e6aa9bb8ce6d2924141" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">749,426</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" id="Text_4a17531adbca49b38739dec07a90a4c0" contextRef="c20220101to20220331" escape="true" continuedAt="Text_53b20f5e7feb4bffa3845163ba012dfc1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12. INVESTMENT IN UNCONSOLIDATED AFFILIATE</div>
</ix:nonNumeric>
      <ix:continuation id="Text_53b20f5e7feb4bffa3845163ba012dfc1" continuedAt="Text_53b20f5e7feb4bffa3845163ba012dfc2">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_53b20f5e7feb4bffa3845163ba012dfc2">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Through one of the subsidiaries, the Company has a <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_e8cb2e683254443199ed26f0ecb07422" contextRef="c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">49</ix:nonFraction>%
        joint venture interest in a company which provides physical therapy services for patients at hospitals. Since the Company is deemed to not have a controlling interest in the company, the Company&#8217;s investment is accounted for using the equity method
        of accounting. The investment balance of this joint venture as of March 31, 2022, is $<ix:nonFraction name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" id="Fact_a6317c6db7e4420e9070111aa4ac6881" contextRef="c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:EquityMethodInvestmentQuotedMarketValue" id="Fact_d22db0b729974b78afba3f37b36fc2c6" contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.2</ix:nonFraction> million related to the fair value at December 31, 2021. The $<ix:nonFraction name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" id="Fact_cf3def01a9334a3fbcef7543debb7aba" contextRef="c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction> million includes earnings of $<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_43971f2c6baf460cb38b0ff0e364ffed" contextRef="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">339</ix:nonFraction> thousand less a distribution received of $<ix:nonFraction name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" id="Fact_cbea43d064e947e39e9adf531fb39372" contextRef="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">132</ix:nonFraction> thousand.</div>
</ix:continuation>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_b59292921617498abe034fb28dd15d4e" contextRef="c20220101to20220331" escape="true" continuedAt="Text_8b36a558d45c45739ec318e34b87399b1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13. COMMON STOCK</div>
</ix:nonNumeric>
    <ix:continuation id="Text_8b36a558d45c45739ec318e34b87399b1" continuedAt="Text_8b36a558d45c45739ec318e34b87399b2">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_8b36a558d45c45739ec318e34b87399b2" continuedAt="Text_8b36a558d45c45739ec318e34b87399b3">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_8af1ce932dfe4f668aea856d75c1e95b" contextRef="c20081231_RangeAxis_MaximumMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">2,250,000</ix:nonFraction> shares of the Company&#8217;s common stock. In March 2009, the Board authorized the repurchase of up to <ix:nonFraction name="usph:PercentageOfRepurchaseOfCommonStock" id="Fact_5776ff8c768846e5b8773a8f8d73001d" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U006" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% or approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_7bf64444b32b423b929dd7207553b384" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,200,000</ix:nonFraction> shares of its common stock (&#8220;March
      2009 Authorization&#8221;). The Amended Credit Agreement permits share repurchases of up to $<ix:nonFraction name="usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock" id="Fact_139bf8735d644f17834ff0f1e1e67206" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">15,000,000</ix:nonFraction>, subject to compliance with covenants.
      The Company is required to retire shares purchased under the March 2009 Authorization.</div>
</ix:continuation>
    <ix:continuation id="Text_8b36a558d45c45739ec318e34b87399b3" continuedAt="Text_8b36a558d45c45739ec318e34b87399b4">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_8b36a558d45c45739ec318e34b87399b4">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Under the March 2009 Authorization, the Company has purchased a total of <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact_dc05ce77ed4f4a6f8c6057bb9f7ab1c4" contextRef="c20090301to20090331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">859,499</ix:nonFraction>
      shares. There is no expiration date for the share repurchase program. There are currently an additional estimated <ix:nonFraction name="usph:AdditionalEstimatedRepurchaseOfCommonStock" id="Fact_00ddc1416141494d87d014aea0fcbe88" contextRef="c20220101to20220331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">150,830</ix:nonFraction> shares (based on
      the closing price of $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" id="Fact_45c8a15e0d4845b7a3df31ef2975b9e8" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">99.45</ix:nonFraction> on March 31, 2022) that may be purchased from time to time in the open market or private transactions depending
      on price, availability and the Company&#8217;s cash position. The Company did <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact_f98a8a6b1f0146b89ad89c4db4e70a1d" contextRef="c20220101to20220331" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>t purchase any shares of its common stock during the three
      months ended March 31, 2022.</div>
</ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div>
      <ix:nonNumeric name="us-gaap:ErrorCorrectionTextBlock" id="Text_8cb933edf4ef46c69e7da9d839c7ef4f" contextRef="c20220101to20220331" escape="true" continuedAt="Text_bcaf6b52a8c147f4a3b0786f64b2356e1">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14. RECLASSIFICATION OF PRIOR PERIOD PRESENTATION</div>
</ix:nonNumeric>
      <ix:continuation id="Text_bcaf6b52a8c147f4a3b0786f64b2356e1" continuedAt="Text_bcaf6b52a8c147f4a3b0786f64b2356e2">
<div><br />
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_bcaf6b52a8c147f4a3b0786f64b2356e2">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of
      operations.</div>
</ix:continuation>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">27</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <a id="MANAGEMENTSDISCUSSIONANDA"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 2.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">The following is a discussion of our historical consolidated financial condition and results of operations, and should be read in conjunction with (i) our historical consolidated financial statements and
          accompanying notes thereto included elsewhere in this Quarterly Report on Form 10-Q; (ii) our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 1, 2022 (&#8220;2021
          Annual Report&#8221;); and (iii) our management&#8217;s discussion and analysis of financial condition and results of operations included in our 2021 Annual Report. This discussion includes forward-looking statements that are subject to risk and
          uncertainties. Actual results may differ substantially from the statements we make in this section due to a number of factors that are discussed in &#8220;Forward-Looking Statements&#8221; herein and in Part II, Item 1A. Risk Factors of this report.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">References to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and the &#8220;Company&#8221; shall mean U.S. Physical Therapy, Inc. and its subsidiaries.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">EXECUTIVE SUMMARY</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Our Business</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We operate outpatient physical therapy clinics that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries, neurologically-related injuries and
          rehabilitation of injured workers. We also operate an industrial injury prevention services business which includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments services.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Selected Operating and Financial Data</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Our reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Our physical operations consist of physical therapy and occupational therapy clinics
          that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by industrial injury prevention
          services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">At March 31, 2022, we operated 601 clinics in 39 states.&#160; In addition to our ownership and operation of outpatient physical therapy clinics, we also manage physical therapy facilities for third parties, such as
          physicians and hospitals, with 38 such third-party facilities under management as of March 31, 2022.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">During the 2021 year and three months ended March 31, 2022, we completed the acquisitions of four multi-clinic practices and two industrial injury services businesses as detailed below.</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div>Acquisition</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center;">Date</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center;">Acquired</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center;">Clinics</div>
              </td>

  </tr>

  <tr>

    <td style="width: 28%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>March 2022 Acquisition</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">March 31, 2022</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">70%</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">6</div>
              </td>

  </tr>

  <tr>

    <td style="width: 28%; vertical-align: bottom; white-space: nowrap;">
                <div>December 2021 Acquisition</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">December 31, 2021</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">75%</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">3</div>
              </td>

  </tr>

  <tr>

    <td style="width: 28%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>November 2021 Acquisition</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">November 30, 2021</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">70%</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">IIPS*</div>
              </td>

  </tr>

  <tr>

    <td style="width: 28%; vertical-align: bottom; white-space: nowrap;">
                <div>September 2021 Acquisition</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">September 30, 2021</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">100%</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">IIPS*</div>
              </td>

  </tr>

  <tr>

    <td style="width: 28%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>June 2021 Acquisition</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">June 30, 2021</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">65%</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center;">8</div>
              </td>

  </tr>

  <tr>

    <td style="width: 28%; vertical-align: bottom; white-space: nowrap;">
                <div>March 2021 Acquisition</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">March 31, 2021</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">70%</div>
              </td>

    <td style="width: 2%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 22%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center;">6</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="margin-left: 9pt;">* Industrial injury prevention services business<br />
        </div>

        <div> <br />
        </div>

        <div style="color: rgb(0, 0, 0);">During the 2022 First Quarter, we closed two clinics.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Employees</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Our strategy to acquire physical therapy practices, develop outpatient physical therapy clinics as satellites within existing partnerships, acquire industrial injury prevention services businesses, and to continue
          to support the growth of our existing businesses requires a talented workforce that can grow with us. As of March 31, 2022 we employed approximately 5,519 people nationwide, of which approximately 3,060 were full-time employees.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">28</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0);">It is crucial that we continue to attract and retain top talent. To attract and retain talented employees, we strive to make our corporate office and all of our practices and businesses a diverse and healthy
          workplace, with opportunities for our employees to receive continuing education, skill development, encouragement to grow and develop their career, all supported by competitive compensation, incentives, and benefits. Our clinical professionals
          are all licensed and a vast majority have advanced degrees. Our operational leadership teams have long-standing relationships with local and regional universities, professional affiliations, and other applicable sources that provide our practices
          with a talent pipeline.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We provide competitive compensation and benefits programs to help meet our employees&#8217; needs in the practices and communities in which they serve. These programs (which can vary by practice and employment
          classification) include incentive compensation plans, a 401(k) plan, healthcare and insurance benefits, health savings and flexible spending accounts, paid time off, family leave, education assistance, mental health, and other employee assistance
          benefits.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We invest resources to develop the talent needed to support our business strategy. Resources include a multitude of training and development programs delivered internally and externally, online and instructor-led,
          and on-the-job learning formats.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We expect to continue adding personnel in the future as we focus on potential acquisition targets and organic growth opportunities.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">RESULTS OF OPERATIONS</div>

        <div><br />
        </div>

        <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;"><span style="text-decoration: underline;">Summary of 2022 First Quarter Compared to the 2021 First Quarter Results</span></div>

        <div><br />
        </div>

        <div style="text-align: justify; color: rgb(0, 0, 0);">For the three months ended March 31, 2022 (&#8220;2022 First Quarter&#8221;), our net income attributable to our shareholders was $8.8 million as compared to $8.2 million for the three months ended March
          31, 2021 (&#8220;2021 First Quarter&#8221;).&#160; In accordance with current GAAP accounting guidance, the revaluation of redeemable non-controlling interest, net of taxes, is not included in net income but charged directly to retained earnings; however, the
          charge for this change is included in the earnings per basic and diluted share calculation. Inclusive of the charge for revaluation of non-controlling interest, net of taxes, the amount is $8.2 million, or $0.64 per diluted share, for the 2022
          First Quarter, and $2.8 million, or $0.21 per diluted share, for the 2021 First Quarter.</div>

        <div><br />
        </div>

        <div style="text-align: justify; color: rgb(0, 0, 0);">For the 2022 First Quarter, our Operating Results, were $8.7 million, or $0.67 per diluted share, an increase of 2.0%, as compared to $8.2 million, or $0.64 per diluted share, for the 2021
          First Quarter. Operating Results, a non-GAAP measure, equals net income attributable to our shareholders per the consolidated statements of income, less the gain on the revaluation of the put-right liability. In accordance with GAAP, the
          revaluation of redeemable non-controlling interest, net of tax, is included in the earnings per basic and diluted share calculation, although it is not included in net income but charged directly to retained earnings. See table on page 30.</div>

        <div><br />
        </div>

        <div style="text-align: justify; color: rgb(0, 0, 0);">We believe providing Operating Results is useful to investors for comparing the Company&#8217;s period-to-period results and for comparing with other similar businesses since most do not have
          redeemable instruments and therefore have different equity structures. We use Operating Results, which eliminates certain items described above that can be subject to volatility and unusual costs, as one of the principal measures to evaluate and
          monitor financial performance.</div>

        <div>&#160;</div>

        <div style="text-align: justify; color: rgb(0, 0, 0);">Operating Results is not a measure of financial performance under GAAP and should not be considered in isolation or as an alternative to, or substitute for, net income attributable to our
          shareholders presented in the consolidated financial statements.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">29</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0);">The following tables provide detail of the diluted earnings per share computation and reconcile net income attributable to our shareholders calculated in accordance with GAAP to Operating
            Results (in thousands, except per share data):</div>

          <div style="text-align: justify; color: rgb(0, 0, 0);"> <br />
          </div>

          <div style="text-align: justify; color: rgb(0, 0, 0);">
            <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Three Months Ended March 31,</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2021</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" colspan="4" style="vertical-align: top;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> Computation of earnings per share - USPH shareholders:</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 9pt;">Net income attributable to USPH shareholders</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,799</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,173</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 9pt;">Credit (charges) to retained earnings:</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 18pt;">Revaluation of redeemable non-controlling interest</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(153</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(7,270</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 18pt;">Tax effect at statutory rate (federal and state) of 25.55%</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">39</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,857</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,685</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,760</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Earnings per share (basic&#160;and diluted)</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.67</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.21</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Adjustments:</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 9pt;">Gain on revaluation of put-right liability</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(603</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 9pt;">Revaluation of redeemable non-controlling interest</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">153</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">7,270</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 18pt;">Tax effect at statutory rate (federal and state)</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">115</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1,857</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Operating Results (a non-GAAP measure)</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,350</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,173</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Basic&#160;and diluted Operating Results per share (a non-GAAP measure)</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.65</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.64</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Shares used in computation - basic and diluted</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">12,937</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">12,870</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
          </div>

        </div>

        <div> <br />
        </div>

        <div style="color: rgb(0, 0, 0);">The following table summarizes financial data by segment for the periods indicated and reconciles the data to our consolidated financial statements (in thousands):</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended March 31,</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net operating revenue:</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Physical therapy operations</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">112,636</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">102,359</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Industrial injury prevention services</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">19,068</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">10,009</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Total Company</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">131,704</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">112,368</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Gross profit:</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Physical therapy operations</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">22,436</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">23,174</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Industrial injury prevention services</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">4,152</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">2,722</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Gross profit</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">26,588</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">25,896</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total Assets:</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Physical therapy operations</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">608,240</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">723,530</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Industrial injury prevention services</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">155,623</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">25,896</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Total Company</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">763,863</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">749,426</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">30</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div>
          <div style="color: rgb(0, 0, 0); font-weight: bold;">Revenue</div>

          <div><br />
          </div>

          <div style="color: rgb(0, 0, 0);">Reported total revenue for the 2022 First Quarter was $131.7 million, an increase of 17.2% as compared to $112.4 million for the 2021 First Quarter.&#160; See table below for a detail of reported total revenue (in
            thousands):</div>

          <div style="color: rgb(0, 0, 0);"> <br />
          </div>

        </div>

        <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31, 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31, 2021</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Revenue related to Mature Clinics</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">102,321</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">98,649</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Revenue related to 2022 Clinic Additions</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">195</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Revenue related to 2021 Clinic Additions</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">6,823</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">149</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Revenue from clinics sold or closed in 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">199</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">190</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Revenue from clinics sold or closed in 2021</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">266</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Net patient revenue from physical therapy operations</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">109,538</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">99,254</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Other revenue</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">872</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">546</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Revenue from physical therapy operations</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">110,410</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">99,800</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Management contract revenue</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">2,226</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">2,559</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Industrial injury prevention services</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">19,068</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">10,009</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total Revenue</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">131,704</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">112,368</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Revenue from physical therapy operations increased $10.6 million, or 10.5%, to $110.4 million for the 2022 First Quarter from $99.8 million for the 2021 First Quarter. Net patient revenue related to clinics opened
          or acquired prior to 2021 and still in operation at March 31, 2022 (&#8220;Mature Clinics&#8221;) increased $3.7 million, or 3.7%, to $102.3 million for the 2022 First Quarter compared to $98.6 million for the 2021 First Quarter.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">The average net patient revenue per visit was $103.00 for the 2022 First Quarter as compared to $104.72 for the 2021 First Quarter. Total patient visits increased 12.2% to 1,063,519 for the 2022 First Quarter from
          947,788 for the 2021 First Quarter. Net patient revenue is based on established billing rates less allowances for patients covered by contractual programs and workers&#8217; compensation. Net patient revenue is determined after contractual and other
          adjustments relating to patient discounts from certain payors. Payments received under contractual programs and workers&#8217; compensation are based on predetermined rates and are generally less than the established billing rates.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Visits for Mature Clinics (same store) for the 2022 First Quarter increased 5.9% as compared to the 2021 First Quarter.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Revenue from physical therapy management contracts decreased 13.0% to $2.2 million for the 2022 First Quarter as compared to $2.6 million for the 2021 First Quarter. Other miscellaneous revenue was $0.9 million for
          the 2022 First Quarter and $0.5 million for the 2021 First Quarter.&#160; Other miscellaneous revenue includes a variety of services, including athletic trainers provided for schools and athletic events.&#160; Other miscellaneous revenue includes a variety
          of services, including athletic trainers provided for schools and athletic events.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">
<div>Revenue from the industrial injury prevention services business increased 90.5% to $19.1 million for the 2022 First Quarter as compared to $10.0 million for the 2021 First Quarter. Excluding $6.8 million of revenue
          related to the industrial injury prevention services acquisition in November 2021, industrial injury prevention services revenue increased 22.4% in the 2022 First Quarter as compared to the 2021 First Quarter.
          </div>
<div>&#160;</div>

        </div>

        <div><br /></div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">31</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div>
          <div style="color: rgb(0, 0, 0); font-weight: bold;">Operating Cost</div>

          <div><br />
          </div>

          <div style="color: rgb(0, 0, 0);">Total operating cost was $105.1 million for the 2022 First Quarter, or 79.8% of total revenue, as compared to $86.5 million, or 77.0% of total revenue, for the 2021 First Quarter. Operating cost related to Mature
            Clinics increased by $4.8 million for the 2022 First Quarter compared to the 2021 First Quarter. On a per visit basis, operating cost related to Mature Clinics increased 0.4% from $80.78 in the 2021 First Quarter to $81.08 in the 2022 First
            Quarter.&#160; In addition, operating cost related to the industrial injury prevention services business increased by $7.6 million of which $5.6 million related to the recent industrial injury prevention services acquisition in November 2021.&#160; See
            table below for a detail of operating cost (in thousands):</div>

          <div style="color: rgb(0, 0, 0);"> <br />
          </div>

        </div>

        <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31, 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31, 2021</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating cost related to Mature Clinics</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">81,034</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">76,221</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating cost related to 2022 Clinic Additions</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);">840</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating cost related to 2021 Clinic Additions</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">6,209</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">136</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating cost related to clinics sold or closed in 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);">286</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);">249</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating cost related to clinics sold or closed in 2021</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">334</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating cost related to physical therapy operations</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);">88,369</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);">76,940</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating cost related to management contracts</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">1,831</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">2,245</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating cost related to industrial injury prevention services</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">14,916</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">7,287</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total operating cost</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">105,116</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">86,472</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Each component of operating cost is discussed below:</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold; margin-left: 36pt;">Operating Cost&#8212;Salaries and Related Costs</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Salaries and related costs, including physical therapy operations and the industrial injury prevention services business, was 57.1% of net revenue for the 2022 First Quarter versus 56.8% for the 2021 First Quarter.
          Salaries and related costs for the physical therapy operations was $62.4 million in the 2022 First Quarter, or 56.6% of physical therapy operations revenue, as compared to $55.6 million in the 2021 First Quarter, or 55.7% of physical therapy
          operations revenue. Included in salaries and related costs for the physical therapy operations for the 2022 First Quarter was $3.7 million related to 2022 and 2021 Clinic Additions.&#160; Adjusted for the salaries and related costs for clinics closed
          or sold in 2022 and 2021, salaries and related costs related to Mature Clinics increased by $3.4 million in the 2022 First Quarter compared to the 2021 First Quarter.&#160; Salaries and related costs related to management contracts decreased by $0.3
          million for the 2022 First Quarter.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Salaries and related costs for the industrial injury prevention services business was $11.1 million in the 2022 First Quarter, or 58.2% of industrial injury prevention services revenue, as compared to $6.3 million
          in the 2021 First Quarter, or 62.5% of industrial injury prevention services revenue.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold; margin-left: 18pt;">Operating Cost&#8212;Rent, Supplies, Contract Labor and Other</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Rent, supplies, contract labor and other costs, including physical therapy operations and the industrial injury prevention services business, was 21.8% of net revenue in the 2022 First Quarter versus 19.1% in the
          2021 First Quarter. Rent, supplies, contract labor and other costs for the physical therapy operations was $24.6 million in the 2022&#160; First Quarter, or 22.3% of physical therapy operations revenue, as compared to $20.1 million in the 2021 First
          Quarter, or 20.1% of physical therapy operations revenue. Included in rent, supplies, contract labor and other costs related to physical therapy operations for the 2022 First Quarter was $3.2 million related to 2022 and 2021 Clinic Additions.&#160;
          Adjusted for the rent, supplies, contract labor and other costs for clinics related to the clinics closed or sold in 2022 and 2021 of $0.1 million in the 2022 First Quarter and $0.3 million in the 2021 First Quarter, rent, supplies, contract
          labor and other costs for Mature Clinics increased by $1.4 million in the 2022 First Quarter compared to the 2021 First Quarter.&#160; Rent, supplies, contract labor and other costs, related to management contracts increased $0.1 million in the 2022
          First Quarter.</div>

        <div><br />
        </div>

        <div style="text-align: justify; color: rgb(0, 0, 0);">Rent, supplies, contract labor and other costs for the industrial injury prevention services business was $3.8 million in the 2022 First Quarter, or 20.1% of industrial injury prevention
          services revenue, as compared to $1.0 million in the 2021 First Quarter, or 10.3% of net industrial injury prevention services revenue.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Operating Cost&#8212;Provision for Credit Losses</div>

        <div><br />
        </div>

        <div style="text-align: justify; color: rgb(0, 0, 0);">The provision for credit losses as a percentage of net revenue was 1.0% in the 2022 First Quarter and 1.1% for the comparable period in 2021.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Our provision for credit losses for patient accounts receivable as a percentage of total patient accounts receivable was 5.37% at March 31, 2022, as compared to 5.64% at December 31, 2021. Our days&#8217; sales
          outstanding was 34 days at March 31, 2022 and 32 days at December 31, 2021.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">32</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Gross Profit</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Gross profit for the 2022 First Quarter, was $26.6 million, an increase of $0.7 million, or approximately 2.7%, as compared to $25.9 million for the 2021 First Quarter. The gross profit percentage was 20.2% of
          total revenue for the 2022 First Quarter as compared to 23.0% for the 2021 First Quarter. The gross profit percentage for physical therapy operations was 20.0% for the 2022 First Quarter as compared to 22.9% for the 2021 First Quarter. The gross
          profit percentage on management contracts was 17.7% for the 2022 First Quarter as compared to 12.3% for the 2021 First Quarter.&#160; The gross profit percentage for industrial injury prevention services was 21.8% for the 2022 First Quarter as
          compared to 27.2% for the 2021 First Quarter. The table below details the gross profit (in thousands):</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three Months Ended</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31, 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31, 2021</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Physical therapy operations</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">22,041</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0);">22,860</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Management contracts</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);">395</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);">314</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Industrial injury prevention services</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">4,152</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">2,722</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Gross profit</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                <div style="color: rgb(0, 0, 0);">26,588</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                <div style="color: rgb(0, 0, 0);">25,896</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Corporate Office Costs</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Corporate office costs were $11.6 million for the 2022 First Quarter compared to $10.9 million for the 2021 First Quarter. Corporate office costs were 8.8% of total revenue for the 2022 First Quarter as compared to
          9.7% for the 2021 First Quarter.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Operating Income</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Operating income for the 2022 First Quarter and 2021 First Quarter was $15.0 million. Operating income as a percentage of total revenue was 11.4% for the 2022 First Quarter as compared to 13.4% for the 2021 First
          Quarter.</div>

        <div style="color: rgb(0, 0, 0);"> <br />
        </div>

        <div style="color: rgb(0, 0, 0);">
          <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Gain on Revaluation of Put-Right Liability</div>

          <div>&#160;</div>

          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The gain on revaluation of put-right liability was $603,000.&#160; As part of the industrial injury prevention services business acquisition on November 30,
            2021, the Company also agreed to the potential future purchase of a separate company under the same ownership that provides physical therapy and rehabilitation services to hospitals and other ancillary providers in a distinct market area. The
            owners have the right to put this transaction to us in approximately five years, with such right having a $2.9 million value on March 31, 2022, as reflected on the Company's consolidated balance sheet in Other long-term liabilities. The value
            of this right will continue to be adjusted in future periods, as appropriate.</div>

        </div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Provision for Income Taxes</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">The provision for income tax was $3.5 million for the 2022 First Quarter and $2.9 million for the 2021 First Quarter. The provision for income tax as a percentage of income before taxes less net income attributable
          to non-controlling interest (effective tax rate) was 28.4% for the 2022 First Quarter and 26.5% for the 2021 First Quarter.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">See table below detailing calculation of the provision for income taxes as a percentage of income before taxes less net income attributable to non-controlling interest ($ in thousands):</div>

        <div><br />
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> Three Months Ended</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Income before taxes</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">15,480</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">14,830</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Less: net income attributable to non-controlling interest:</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 9pt;">Redeemable non-controlling interest - temporary equity</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2,557</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2,453</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 9pt;">Non-controlling interest - permanent equity</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(626</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1,260</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3,183</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3,713</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Income before taxes less net income attributable to non-controlling interest</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">12,297</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">11,117</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Provision for income taxes</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,498</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,944</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Percentage</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">28.4</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">26.5</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">%</div>
                </td>

  </tr>


</table>
        </div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Net Income Attributable to Non-controlling Interest</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Net income attributable to redeemable non-controlling interest (temporary equity) was $2.6 million for the 2022 First Quarter and $2.5 million for the 2021 First Quarter.&#160; Net income attributable to non-controlling
          interest (permanent equity) was $0.6 million for the 2022 First Quarter and $1.3 million for the 2021 First Quarter.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">33</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">LIQUIDITY AND CAPITAL RESOURCES</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We believe that our business has sufficient cash to allow us to meet our short-term cash requirements. At March 31, 2022 and December 31, 2021, we had $24.2 million and $28.6 million, respectively, in cash.&#160; We
          believe that our cash and cash equivalents and availability under our revolving credit facility are sufficient to fund the working capital needs of our operating subsidiaries through at least March 31, 2022.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Cash and cash equivalents decreased by $4.3 million from December 31, 2021 to March 31, 2022.&#160; During the 2022 Three Months, $11.6 million was provided by operations and $35.0 million from proceeds on our Amended
          Credit Agreement (described below). The major uses of cash for investing and financing activities included: distributions to non-controlling interests inclusive of those classified as redeemable non-controlling interest ($2.2 million), purchase
          of business and non-controlling interest ($11.3 million), and purchase of fixed assets ($3.0 million).</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Effective December 5, 2013, we entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility. This agreement was amended and/or restated in August 2015,
          January 2016, March 2017, November 2017 and January 2021 (hereafter referred to as &#8220;Amended Credit Agreement&#8221;). In November 2021, the Company exercised the accordion feature in the Amended Credit Agreement to increase the limit on the facility
          from $125.0 million to $150.0 million, with an updated accordion feature providing for additional capacity of $25.0 million, therefore increasing the availability up to $175.0 million.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">The Amended Credit Agreement is unsecured and has loan covenants, including requirements that we comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended
          Credit Agreement may be used for working capital, acquisitions, purchases of our common stock, dividend payments to&#160; our common stockholders, capital expenditures and other corporate purposes. The pricing grid is based on our consolidated
          leverage ratio with the applicable spread over LIBOR ranging from 1.25% to 2.0% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee of 0.3% of the amount of
          funds outstanding under the Amended Credit Agreement.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">The 2021 amendment to the Amended Credit Agreement allows for cash and noncash consideration for acquisitions permitted under the Amended Credit Agreement of up to $50,000,000 for any fiscal year, and allows for
          payments in cash dividends to shareholders in an aggregate amount not to exceed $50,000,000 in any fiscal year.&#160; The Amended Credit Agreement is unsecured and includes certain financial covenants which include a consolidated fixed charge coverage
          ratio and a consolidated leverage ratio, as defined in the agreement.</div>

        <div><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <div style="color: rgb(0, 0, 0);">On March 31, 2022, $118.0 million was outstanding on the Amended Credit Agreement resulting in $32.0 million of availability. As of March 31, 2022, we were in compliance with all of the covenants thereunder.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">On March 31, 2022, we acquired a 70% interest in a six-clinic physical therapy practice in South Central Pennsylvania &#8211; Madden and Gilbert Physical Therapy, LLC. The practice&#8217;s owners retained 30% of the equity
          interests. The purchase price for the 70% equity interest was approximately $11.5 million. of which $11.2 million was paid in cash and $0.3 million in the form of a note payable.&#160; The note accrues interest at 3.5% per annum and the principal and
          interest are payable on March 31, 2024.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">On December 31, 2021, we acquired a 75% interest in a three-clinic physical therapy practice with the practice founder retaining 25%. The purchase price for the 75% interest was approximately $3.7 million, of which
          $3.5 million was paid in cash and $0.2 million in the form of a note payable.&#160; The note accrues interest at 3.25% per annum and the principal and interest are payable on December 31, 2023.</div>

        <div><br />
        </div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">On November 30, 2021, we acquired an approximate 70% interest in a leading provider of industrial injury prevention services. The previous owners retained the remaining
          interest. The initial purchase price for the 70% equity interest, not inclusive of the $2.0 million contingent payment in conjunction with the acquisition if specified future operational objectives are met, was approximately $63.2 million, of
          which $62.2 million was paid in cash, and $1.0 million is in the form of a note payable. The note accrues interest at 3.25% and the principal and interest is payable on November 30, 2023. The business generates approximately $27.0 million in
          annual revenue at a margin of approximately 20%. As part of the transaction, we also agreed to the future purchase of a separate company under the same ownership that provides physical therapy and rehabilitation services to hospitals and other
          ancillary providers in a distinct market area.&#160; The current owners have the right to put this transaction to us in approximately five years, with such right having an initial $3.5 million fair value at December 31, 2021, as reflected on the
          Company&#8217;s consolidated balance sheet in Other long-term liabilities.&#160; The value of this right will be adjusted in future periods, as appropriate, with any change in fair value reflected in the Company&#8217;s consolidated statement of income.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">34</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0);">On September 30, 2021, the Company acquired a company that specializes in return-to-work and ergonomic services, among other offerings. The business generates more than $2.0 million in annual revenue. We acquired
          the company&#8217;s assets at a purchase price of approximately $3.3 million (which includes the obligation to pay an amount up to $0.6 million in contingent payment consideration in conjunction with the acquisition if specified future operational
          objectives are met) and contributed those assets to industrial injury prevention services subsidiary. The initial purchase price, not inclusive of the $0.6 million contingent payment, was approximately $2.7 million, of which $2.4 million was paid
          in cash, and $0.3 million is in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on September 30, 2023.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">On June 30, 2021, the Company acquired a 65% interest in an eight-clinic physical therapy practice with the practice founder retaining 35%. The purchase price was approximately $10.3 million, of which $9.0 million
          was paid in cash, $1.0 million is payable based on the achievement of certain business criteria and $0.3 million is in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on June 30,
          2023. Additionally, the Company has an obligation to pay an additional amount up to $0.8 million in contingent payment consideration in conjunction with the acquisition if specified future operational objectives are met. The Company recorded
          acquisition-date fair value of this contingent liability based on the likelihood of the contingent earn-out payment. The earn-out payment will subsequently be remeasured to fair value each reporting date.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">On March 31, 2021, the Company acquired a 70% interest in a five-clinic physical therapy practice with the practice founder retaining 30%.&#160; When acquired, the practice was developing a sixth clinic which has been
          completed. The purchase price for the 70% interest was approximately $12.0 million, of which $11.7 million was paid in cash and $0.3 million in the form of a note payable.&#160; The note accrues interest at 3.25% per annum and the principal and
          interest are payable on March 31, 2023.</div>

        <div><br />
        </div>

        <div style="text-align: justify; margin-right: 18pt;"><span style="color: rgb(0, 0, 0);">On March 27, 2020, </span><span style="color: rgb(33, 37, 41);">in response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid,
            Relief, and Economic Security Act (&#8220;CARES Act&#8221;). </span><span style="color: rgb(0, 0, 0);">The CARES Act provided waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0
            billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care
            providers for lost revenues and health care related expenses that are attributable to COVID-19.</span></div>

        <div><br />
        </div>

        <div style="margin-right: 18pt;"><span style="color: rgb(33, 37, 41);">The CARES Act allowed for qualified healthcare providers to receive advanced payments under the Medicare</span><span style="color: rgb(0, 0, 0);"><span style="text-decoration: underline;">&#160;</span>Accelerated and Advance
            Payment Program (&#8220;MAAPP Funds&#8221;) </span><span style="color: rgb(33, 37, 41);">during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. The Company
            applied for and received approval from</span><span style="color: rgb(34, 34, 34);">&#160;</span><span style="color: rgb(33, 37, 41);">Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. T</span><span style="color: rgb(33, 29, 30);">he


            Company recorded the $14.1 million in advance payments received as a liability.</span><span style="color: rgb(33, 37, 41);"> During the 2021 First Quarter, the Company repaid the MAAPP Funds of $14.1 million rather than applying them to future
            services performed.</span></div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Historically, we have generated sufficient cash from operations to fund our development activities and to cover operational needs. We plan to continue developing new clinics and making additional acquisitions. We
          have from time to time purchased the non-controlling interests of limited partners in our Clinic Partnerships. We may purchase additional non-controlling interests in the future. Generally, any acquisition or purchase of non-controlling interests
          is expected to be accomplished using a combination of cash and financing. Any large acquisition would likely require financing.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We make reasonable and appropriate efforts to collect accounts receivable, including applicable deductible and co-payment amounts, in a consistent manner for all payor types. Claims are submitted to payors daily,
          weekly or monthly in accordance with our policy or payor&#8217;s requirements. When possible, we submit our claims electronically. The collection process is time consuming and typically involves the submission of claims to multiple payors whose payment
          of claims may be dependent upon the payment of another payor. Claims under litigation and vehicular incidents can take a year or longer to collect. Medicare and other payor claims relating to new clinics awaiting payor credentialing approval
          initially may be delayed for a relatively short transition period. When all reasonable internal collection efforts have been exhausted, accounts are written off prior to sending them to outside collection firms. With managed care, commercial
          health plans and self-pay payor type receivables, the write-off generally occurs after the accounts receivable has been outstanding for at least 120 days.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">35</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0);">We generally enter into various notes payable as a means of financing our acquisitions. Our outstanding notes payable as of March 31, 2022 relate to certain of the acquisitions of businesses and purchases of
          redeemable non-controlling interest that occurred in 2018 through March 2022. Typically, the notes are payable over two years plus any accrued and unpaid interest. Interest accrues at various interest rates ranging from 3.25% to 5.5% per annum,
          subject to adjustment. At March 31, 2022, the balance on these notes payable was $4.9 million.&#160; In addition, we assumed leases with remaining terms of 1 month to 6 years for the operating facilities.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">In conjunction with the above-mentioned acquisitions, in the event that a limited minority partner&#8217;s employment ceases at any time after a specified date that is typically between three and five years from the
          acquisition date, we have agreed to certain contractual provisions which enable such minority partners to exercise their right to trigger our repurchase of that partner&#8217;s non-controlling interest at a predetermined multiple of earnings before
          interest and taxes.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">As of March 31, 2022, we have accrued $6.8 million related to credit balances due to patients and payors.&#160; This amount is expected to be paid in the next twelve months.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">From September 2001 through December 31, 2008, our Board of Directors (&#8220;Board&#8221;) authorized us to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of our common stock. In
          March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of our common stock (&#8220;March 2009 Authorization&#8221;). Our Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance
          with covenants. We are required to retire shares purchased under the March 2009 Authorization.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">There is no expiration date for the share repurchase program. As of March 31, 2022, there are currently an additional estimated 150,830 shares (based on the closing price of $99.45 on March 31, 2022) that may be
          purchased from time to time in the open market or private transactions depending on price, availability and our cash position. We did not purchase any shares of our common stock during the three months ended March 31, 2022.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">FACTORS AFFECTING FUTURE RESULTS</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">The risks related to our business and operations include:</div>

        <div><br />
        </div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; the multiple effects of the impact of public health crises and epidemics/pandemics, such as the novel strain of COVID-19 and its variants, for which the total financial
          magnitude cannot be currently estimated;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification and/or enrollment status;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; changes in reimbursement rates or payment methods from third party payors including government agencies, and changes in the deductibles and co-pays owed by patients;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for
          failure to comply;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs
          including the possible write-down or write-off of goodwill and other intangible assets; &#8226; the impact of COVID-19 related vaccination and/or testing mandates at the federal, state and/or local level, which could have an adverse impact on staffing,
          revenue, costs and the results of operations;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; changes as the result of government enacted national healthcare reform; &#8226; business and regulatory conditions including federal and state regulations;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; governmental and other third party payor inspections, reviews, investigations and audits, which may result in sanctions or reputational harm and increased costs;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; revenue and earnings expectations;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; legal actions, which could subject us to increased operating costs and uninsured liabilities;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; general economic conditions;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; availability and cost of qualified physical therapists;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; personnel productivity and retaining key personnel;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">36</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; competitive environment in the industrial injury prevention services business, which could result in the termination or nonrenewal of contractual service arrangements and
          other adverse financial consequences for that service line;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; acquisitions, and the successful integration of the operations of the acquired businesses; &#8226; impact on the business and cash reserves resulting from retirement or
          resignation of key partners and resulting purchase of their non-controlling interest (minority interests);</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; maintaining our information technology systems with adequate safeguards to protect against cyber-attacks;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; a security breach of our or our third party vendors&#8217; information technology systems may subject us to potential legal action and reputational harm and may result in a
          violation of the Health Insurance Portability and Accountability Act of 1996 of the Health Information Technology for Economic and Clinical Health Act;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; maintaining clients for which we perform management and other services, as a breach or termination of those contractual arrangements by such clients could cause operating
          results to be less than expected;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; maintaining adequate internal controls;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; maintaining necessary insurance coverage;</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; availability, terms, and use of capital; and</div>

        <div style="text-align: justify; margin-right: 18pt; color: rgb(0, 0, 0);">&#8226; weather and other seasonal factors.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">See also Risk Factors in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021 and our subsequent current and periodic reports.</div>

        <div><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">Forward-Looking Statements</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We make statements in this report that are considered to be forward-looking statements within the meaning given such term under Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).
          These statements contain forward-looking information relating to the financial condition, results of operations, plans, objectives, future performance and business of our Company. These statements (often using words such as &#8220;believes&#8221;, &#8220;expects&#8221;,
          &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;appear&#8221;, &#8220;should&#8221; and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we project. Included among such statements are those relating to opening new clinics,
          availability of personnel and the reimbursement environment.&#160; The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a
          result of certain risks, uncertainties, and factors, which include, but are not limited to the risks listed above.</div>

        <div><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see the other sections of this report and our other periodic reports
          filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as required by law, we are
          under no obligation to update any forward-looking statement, regardless of the reason the statement may no longer be accurate.</div>

        <div><br />
        </div>

        <a id="QUANTITATIVEANDQUALITATIV"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold; color: rgb(0, 0, 0);">ITEM 3.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We do not maintain any derivative instruments, interest rate swap arrangements, hedging contracts, futures contracts or the like. Our primary market risk exposure is the changes in interest rates obtainable on our
          Amended Credit Agreement. The interest on our Amended Credit Agreement is based on a variable rate. At March 31, 2022, $118.0 million was outstanding under our Amended Credit Agreement. Based on the balance of the Amended Credit Agreement at
          March 31, 2022, any change in the interest rate of 1% would yield a decrease or increase in annual interest expense of $1,180,000.</div>

        <div><br /></div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">37</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0);">
          <a id="CONTROLSANDPROCEDURES."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold; color: rgb(0, 0, 0);">ITEM 4.</span></td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">CONTROLS AND PROCEDURES.</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">(a)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0);">Evaluation of Disclosure Controls and Procedures</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

        </div>

        <div style="color: rgb(0, 0, 0);">As of the end of the period covered by this report, the Company&#8217;s management completed an evaluation, under the supervision and with the participation of our principal executive officer and principal financial
          officer, of the effectiveness of our disclosure controls and procedures. Based on this evaluation, our principal executive officer and principal financial officer concluded (i) that our disclosure controls and procedures are designed to ensure
          that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms
          and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding
          required disclosure and (ii) that our disclosure controls and procedures are effective.</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">(b)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="color: rgb(0, 0, 0);">Changes in Internal Control over Financial Reporting</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">There have been no changes in our internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal
          control over financial reporting.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">38</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-weight: bold;">PART II&#8212;OTHER INFORMATION</div>

        <div><br />
        </div>

        <a id="LEGALPROCEEDINGS."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 1.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">LEGAL PROCEEDINGS.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">We are a party to various legal actions, proceedings, and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of our business. We cannot
          predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject us to sanctions, damages, recoupments, fines, and other penalties. The
          Department of Justice, CMS, or other federal and state enforcement and regulatory agencies may conduct additional investigations related to our businesses in the future that may, either individually or in the aggregate, have a material adverse
          effect on our business, financial position, results of operations, and liquidity.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal for some time while the government decides whether or not to
          intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the
          suits. We are and have been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-style: italic;">Florida Litigation</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">In 2019 a qui tam lawsuit (the &#8220;Complaint&#8221;) was filed by a relator on behalf of the United States, titled U.S. ex rel. Bonnie Elsdon, v. U.S. Physical Therapy, Inc., U.S. Physical Therapy, Ltd., Rehab Partners #2,
          Inc., The Hale Hand Center, Limited Partnership (the &#8220;Hale Partnership&#8221;), and Suzanne Hale.&#160;&#160; This whistleblower lawsuit was filed in the U.S. District Court for the Southern District of Texas, seeking damages and civil penalties under the
          federal False Claim Act.&#160; The U.S Government declined to intervene in the case. The Complaint alleged that the Hale Partnership engaged in conduct to &#8220;upcode&#8221; its billings for services provided to Medicare patients. The plaintiff - relator also
          claimed that similar false claims occurred on other days and at other Company-owned partnerships.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">In January 2022, to avoid the legal fees and discovery costs in defending this matter and the uncertainty of protracted litigation, the Company entered into a settlement agreement with the plaintiff- relator. In
          the settlement agreement, the plaintiff-relator released all defendants from liability for all conduct alleged in the Complaint, and the Company admitted no liability or wrongdoing.&#160; In connection with the settlement, the Office of the United
          States Attorney for the Southern District of Texas agreed to a dismissal of the claims against the Hale Partnership and the Company. Under the terms of the settlement, the Company agreed to make payments to the government, the plaintiff-relator
          and her counsel. Such payments, in the aggregate, amounted to $2.75 million of which $2.6 million was recorded as an expense in 2021.</div>

        <div style="color: rgb(0, 0, 0);"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">39</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-style: italic; font-size: 8pt;"><a href="#PARTI">Index</a></span></div>

          </div>

        </div>

        <a id="EXHIBITS."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold; background-color: rgb(255, 255, 255);">ITEM 6.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">EXHIBITS.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);"><span style="text-decoration: underline;">Exhibit</span></div>
                <div style="color: rgb(0, 0, 0);"><span style="text-decoration: underline;">Number</span></div>
              </td>

    <td style="width: 88%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);"><span style="text-decoration: underline;">Description</span></div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">&#160;</td>

    <td style="width: 88%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597822000018/ex10-1.htm">10.1+<br />
                </a></td>

    <td rowspan="1" style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">Employment Agreement by and between the Company and Rick Binstein entered into on March 23, 2022 [incorporated by reference to Exhibit 10.1 to the
                Company Current Report on Form 8-K filed with the SEC on March 23, 2022].<br />
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);"><a href="brhc10037138_ex31-1.htm">31.1*</a></div>
              </td>

    <td style="width: 88%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><a href="brhc10037138_ex31-2.htm">31.2*</a></div>
              </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);">Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);"><a href="brhc10037138_ex32.htm">32*</a></div>
              </td>

    <td style="width: 88%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Certification Pursuant to 18 U.S.C 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);">101.INS*</div>
              </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);">XBRL Instance Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">101.SCH*</div>
              </td>

    <td style="width: 88%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Schema Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);">101.CAL*</div>
              </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Calculation Linkbase Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">101.DEF*</div>
              </td>

    <td style="width: 88%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Definition Linkbase Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);">101.LAB*</div>
              </td>

    <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Label Linkbase Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 12%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">101.PRE*</div>
              </td>

    <td style="width: 88%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">XBRL Taxonomy Extension Presentation Linkbase Document</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div style="color: rgb(0, 0, 0);">*</div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0);">Filed herewith</div>
                </td>

  </tr>


</table>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div style="color: rgb(0, 0, 0);">+<br />
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">Management contract or compensatory plan or arrangement</td>

  </tr>


</table>
        </div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SIGNATURES<a id="SIGNATURES"><!--Anchor--></a></div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0);">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on our behalf by the undersigned thereunto duly authorized.</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.96%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="width: 50.04%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">U.S. PHYSICAL THERAPY, INC.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: bottom;">&#160;</td>

    <td style="width: 3.09%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: bottom;">
                <div style="text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">Date: May 9, 2022</div>
              </td>

    <td style="width: 3.09%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0);">By:</div>
              </td>

    <td style="width: 46.96%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">/s/ CAREY HENDRICKSON</div>
              </td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: bottom;">&#160;</td>

    <td style="width: 3.09%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0);">Carey Hendrickson</div>
              </td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: bottom;">&#160;</td>

    <td style="width: 3.09%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
              </td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: bottom;">&#160;</td>

    <td style="width: 3.09%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">
                <div style="color: rgb(0, 0, 0);">(principal financial and accounting officer)</div>
              </td>

  </tr>


</table>
      </div>

      <div> <br />
      </div>

      <div> <br />
      </div>

      <div style="text-align: center;"> <span style="font-size: 8pt;">40</span><br />
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /> </div>

    </div>

  </div>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>brhc10037138_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">EXHIBIT 31.1</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">CERTIFICATION</div>
      <div><br>
      </div>
      <div style="color: rgb(0, 0, 0);">I, Christopher Reading, certify that:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z54b2e8af0a654e9ca28f82f18453c93e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">I have reviewed this quarterly report on Form 10-Q of U.S. Physical Therapy, Inc.;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze3307f481ae34aabaa2d7f0715c74626" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
                such statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zb201d18d31854476878d217bef9616f4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows
                of the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z0aae9b75bf824f618890376afe14a508" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
                control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z3df671b5426741df89c6172738d2e1e8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">a.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
                including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z513d1530c7014202825b43b864ed6fda" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">b.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the
                reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z6056d70135454ddf827f8ad644f4ec56" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">c.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
                of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z32a0ee244ab94cacb326b6f755078e37" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">d.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in
                the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z468204ac8d1b43a09e6de42e3375d703" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the
                registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z372ddff491d64df985c64c9b980f16a5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">a.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record,
                process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z84ef155ed620441f9a4285cdbb5770dd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">b.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zf970dcea15e24ff89d5b99e2226e0627" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">/s/ CHRISTOPHER READING</div>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Christopher Reading</div>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">President and Chief Executive Officer</div>
              <div style="color: rgb(0, 0, 0);">(principal executive officer)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="color: rgb(0, 0, 0);">Date: May 9, 2022</div>
      <div><br>
      </div>
    </div>
    <div><br>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>brhc10037138_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">EXHIBIT 31.2</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">CERTIFICATION</div>
      <div><br>
      </div>
      <div style="color: rgb(0, 0, 0);">I, Carey Hendrickson, certify that:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc6a0936721a432797b2bea1718f5ea5">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">I have reviewed this quarterly report on Form 10-Q of U.S. Physical Therapy, Inc.;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0673afe3487c4c7fb0e3d88d3ed7b3c6">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
                such statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4eca6ecd98f842b2a207ef0234ee4503">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows
                of the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f77d277b12c4672908a09982a365465">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
                control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4865282c50014e888b09918989c4241a">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">a.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
                including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd559894973df4684a3d8a1040a4c7ea8">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">b.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the
                reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb6ea4f48ab1f429ea6daf163ca6be50a">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">c.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
                of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb73bc19235604592a5ce22b8bf64340b">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">d.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in
                the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z708e931276694796846ee2d4b30dcef9">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the
                registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z316338ec218c47eba3e7d02a9bc6deda">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">a.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record,
                process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z92ea68aa57db443fa97802be10e348d8">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">b.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0);">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);"> </font><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zad52b216fb804c1682263b856246d8d8">

          <tr>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">/s/ CAREY HENDRICKSON</div>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Carey Hendrickson</div>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">(principal financial and accounting officer)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="color: rgb(0, 0, 0);">Date: May 9, 2022</div>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>brhc10037138_ex32.htm
<DESCRIPTION>EXHIBIT 32
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">EXHIBIT 32</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">CERTIFICATION OF PERIODIC REPORT</div>
      <div><br>
      </div>
      <div style="color: rgb(0, 0, 0);">In connection with the Quarterly Report of U.S. Physical Therapy, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended March 31, 2022, as filed with the Securities and Exchange Commission on the date
        hereof (the &#8220;Report&#8221;), I, Christopher J. Reading, President and Chief Executive Officer of the Company, and Carey Hendrickson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
        of the Sarbanes-Oxley Act of 2002, that:</div>
      <div><br>
      </div>
      <div>
        <div style="color: rgb(0, 0, 0);">(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="color: rgb(0, 0, 0);">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
      </div>
      <div><br>
      </div>
      <div style="color: rgb(0, 0, 0);">May 9, 2022</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zd760429e2ff4415d8c438edda9d3e8bc" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">/s/ CHRISTOPHER J. READING</div>
            </td>
            <td style="width: 70%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Christopher J. Reading</div>
            </td>
            <td style="width: 70%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Chief Executive Officer</div>
            </td>
            <td style="width: 70%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: middle;">&#160;</td>
            <td style="width: 70%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">/s/ CAREY HENDRICKSON</div>
            </td>
            <td style="width: 70%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Carey Hendrickson</div>
            </td>
            <td style="width: 70%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>
            <td style="width: 70%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="color: rgb(0, 0, 0);">This certification is made solely pursuant to the requirement of Section 1350 of 18 U.S.C., and is not for any other purpose. A signed original of this written statement required by Section 906 has been provided to
        U. S. Physical Therapy, Inc. and will be retained by U. S. Physical Therapy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</div>
      <div><font style="color: rgb(0, 0, 0);"> </font><br>
      </div>
      <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>usph-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://usph.com/20220331" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:usph="http://usph.com/20220331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://usph.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>010000 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <!--Parent Role: CONSOLIDATED BALANCE SHEETS-->
        <link:definition>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
        <link:definition>020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>030000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" id="ConsolidatedStatementsOfChangesInEquity">
        <link:definition>040000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies" id="BasisOfPresentationAndSignificantAccountingPolicies">
        <link:definition>060100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinesses" id="AcquisitionsOfBusinesses">
        <link:definition>060200 - Disclosure - ACQUISITIONS OF BUSINESSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RevenueRecognition" id="RevenueRecognition">
        <link:definition>060300 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShare" id="EarningsPerShare">
        <link:definition>060400 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" id="RedeemableNoncontrollingInterest">
        <link:definition>060500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/Goodwill" id="Goodwill">
        <link:definition>060600 - Disclosure - GOODWILL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
        <link:definition>060700 - Disclosure - INTANGIBLE ASSETS, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>060800 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreement" id="NotesPayableAndAmendedCreditAgreement">
        <link:definition>060900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/Leases" id="Leases">
        <link:definition>061000 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformation" id="SegmentInformation">
        <link:definition>061100 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliate" id="InvestmentInUnconsolidatedAffiliate">
        <link:definition>061200 - Disclosure - INVESTMENT IN UNCONSOLIDATED AFFILIATE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommonStock" id="CommonStock">
        <link:definition>061300 - Disclosure - COMMON STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ReclassificationOfPriorPeriodPresentation" id="ReclassificationOfPriorPeriodPresentation">
        <link:definition>061400 - Disclosure - RECLASSIFICATION OF PRIOR PERIOD PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" id="BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
        <!--Parent Role: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES-->
        <link:definition>070100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" id="BasisOfPresentationAndSignificantAccountingPoliciesTables">
        <!--Parent Role: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES-->
        <link:definition>080100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" id="AcquisitionsOfBusinessesTables">
        <!--Parent Role: ACQUISITIONS OF BUSINESSES-->
        <link:definition>080200 - Disclosure - ACQUISITIONS OF BUSINESSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RevenueRecognitionTables" id="RevenueRecognitionTables">
        <!--Parent Role: REVENUE RECOGNITION-->
        <link:definition>080300 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShareTables" id="EarningsPerShareTables">
        <!--Parent Role: EARNINGS PER SHARE-->
        <link:definition>080400 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" id="RedeemableNoncontrollingInterestTables">
        <!--Parent Role: REDEEMABLE NON-CONTROLLING INTEREST-->
        <link:definition>080500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/GoodwillTables" id="GoodwillTables">
        <!--Parent Role: GOODWILL-->
        <link:definition>080600 - Disclosure - GOODWILL (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
        <!--Parent Role: INTANGIBLE ASSETS, NET-->
        <link:definition>080700 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: ACCRUED EXPENSES-->
        <link:definition>080800 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables" id="NotesPayableAndAmendedCreditAgreementTables">
        <!--Parent Role: NOTES PAYABLE AND AMENDED CREDIT AGREEMENT-->
        <link:definition>080900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesTables" id="LeasesTables">
        <!--Parent Role: LEASES-->
        <link:definition>081000 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformationTables" id="SegmentInformationTables">
        <!--Parent Role: SEGMENT INFORMATION-->
        <link:definition>081100 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails" id="BasisOfPresentationAndSignificantAccountingPoliciesDetails">
        <!--Parent Role: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES-->
        <link:definition>090100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" id="AcquisitionsOfBusinessesDetails">
        <!--Parent Role: ACQUISITIONS OF BUSINESSES-->
        <link:definition>090200 - Disclosure - ACQUISITIONS OF BUSINESSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RevenueRecognitionDetails" id="RevenueRecognitionDetails">
        <!--Parent Role: REVENUE RECOGNITION-->
        <link:definition>090300 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShareDetails" id="EarningsPerShareDetails">
        <!--Parent Role: EARNINGS PER SHARE-->
        <link:definition>090400 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" id="RedeemableNoncontrollingInterestDetails">
        <!--Parent Role: REDEEMABLE NON-CONTROLLING INTEREST-->
        <link:definition>090500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/GoodwillDetails" id="GoodwillDetails">
        <!--Parent Role: GOODWILL-->
        <link:definition>090600 - Disclosure - GOODWILL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" id="IntangibleAssetsNetIntangibleAssetsNetDetails">
        <!--Parent Role: INTANGIBLE ASSETS, NET-->
        <link:definition>090700 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" id="IntangibleAssetsNetAmortizationExpensesDetails">
        <!--Parent Role: INTANGIBLE ASSETS, NET-->
        <link:definition>090702 - Disclosure - INTANGIBLE ASSETS, NET - Amortization Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" id="IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
        <!--Parent Role: INTANGIBLE ASSETS, NET-->
        <link:definition>090704 - Disclosure - INTANGIBLE ASSETS, NET - Amortization of Referral Relationships and Non-Competition Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: ACCRUED EXPENSES-->
        <link:definition>090800 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" id="NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails">
        <!--Parent Role: NOTES PAYABLE AND AMENDED CREDIT AGREEMENT-->
        <link:definition>090900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails" id="NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails">
        <!--Parent Role: NOTES PAYABLE AND AMENDED CREDIT AGREEMENT-->
        <link:definition>090902 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Amended Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" id="NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails">
        <!--Parent Role: NOTES PAYABLE AND AMENDED CREDIT AGREEMENT-->
        <link:definition>090904 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesDetails" id="LeasesDetails">
        <!--Parent Role: LEASES-->
        <link:definition>091000 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesDetailsCalc2" id="LeasesDetailsCalc2">
        <!--Parent Role: LEASES (Details)-->
        <link:definition>091002 - Disclosure - LEASES (Details) Calc 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformationDetails" id="SegmentInformationDetails">
        <!--Parent Role: SEGMENT INFORMATION-->
        <link:definition>091100 - Disclosure - SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails" id="InvestmentInUnconsolidatedAffiliateDetails">
        <!--Parent Role: INVESTMENT IN UNCONSOLIDATED AFFILIATE-->
        <link:definition>091200 - Disclosure - INVESTMENT IN UNCONSOLIDATED AFFILIATE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommonStockDetails" id="CommonStockDetails">
        <!--Parent Role: COMMON STOCK-->
        <link:definition>091300 - Disclosure - COMMON STOCK (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="RevaluationOfRedeemableNonControllingInterestNetOfTax" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ShortSwingProfitSettlement" id="usph_ShortSwingProfitSettlement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SaleOfNonControllingInterestNetOfPurchasesAndTax" id="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AccountsPayableDueToSellerOfAcquiredBusiness" id="usph_AccountsPayableDueToSellerOfAcquiredBusiness" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="CashPaidDuringPeriodForAbstract" id="usph_CashPaidDuringPeriodForAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PurchaseOfBusinessSellerFinancingPortion" id="usph_PurchaseOfBusinessSellerFinancingPortion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PaymentsToAcquireRedeemableNonControllingInterest" id="usph_PaymentsToAcquireRedeemableNonControllingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="DistributionsFromUnconsolidatedAffiliate" id="usph_DistributionsFromUnconsolidatedAffiliate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PaymentOfMedicareAcceleratedAndAdvanceFunds" id="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ProceedsFromSalesOfNonControllingInterestPermanent" id="usph_ProceedsFromSalesOfNonControllingInterestPermanent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="GainLossOnRevaluationOfPutRightLiability" id="usph_GainLossOnRevaluationOfPutRightLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="REDEEMABLENONCONTROLLINGINTERESTAbstract" id="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestTextBlock" id="usph_RedeemableNonControllingInterestTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InterestExpenseDebtAndOther" id="usph_InterestExpenseDebtAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RentSuppliesContractLaborAndOther" id="usph_RentSuppliesContractLaborAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NetPatientRevenuesMember" id="usph_NetPatientRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfRepurchaseOfCommonStock" id="usph_PercentageOfRepurchaseOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AdditionalEstimatedRepurchaseOfCommonStock" id="usph_AdditionalEstimatedRepurchaseOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DepreciationAmortizationImpairmentTable" id="usph_DepreciationAmortizationImpairmentTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MedicareAcceleratedAndAdvancePaymentsProgramMember" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DepreciationAmortizationImpairmentLineItems" id="usph_DepreciationAmortizationImpairmentLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfRegions" id="usph_NumberOfRegions" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LeadingProviderOfIndustrialInjuryPreventionMember" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ReturnToWorkAndErgonomicServicesMember" id="usph_ReturnToWorkAndErgonomicServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BasisOfPresentationAbstract" id="usph_BasisOfPresentationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfLimitedPartnershipInterestOwned" id="usph_PercentageOfLimitedPartnershipInterestOwned" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="GrantsAndOtherFunds" id="usph_GrantsAndOtherFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NumberOfOperatingClinicLocations" id="usph_NumberOfOperatingClinicLocations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EmployeeMember" id="usph_EmployeeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NonControllingInterestRedeemableAbstract" id="usph_NonControllingInterestRedeemableAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ManagementContractsMember" id="usph_ManagementContractsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NotesPayableOneMember" id="usph_NotesPayableOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NotesPayableTwoMember" id="usph_NotesPayableTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClinicPracticeMember" id="usph_ClinicPracticeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PublicHealthAndSocialServicesEmergencyFundMember" id="usph_PublicHealthAndSocialServicesEmergencyFundMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RepaymentOfFunds" id="usph_RepaymentOfFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="NumberOfThirdPartyFacilities" id="usph_NumberOfThirdPartyFacilities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfGeneralPartnershipInterestOwned" id="usph_PercentageOfGeneralPartnershipInterestOwned" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BriotixHealthLimitedPartnershipMember" id="usph_BriotixHealthLimitedPartnershipMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MultiClinicPracticesMember" id="usph_MultiClinicPracticesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="December2021AcquisitionMember" id="usph_December2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="November2021AcquisitionMember" id="usph_November2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="September2021AcquisitionMember" id="usph_September2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="June2021AcquisitionMember" id="usph_June2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="March2021AcquisitionMember" id="usph_March2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="March2022AcquisitionMember" id="usph_March2022AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JointVentureInterestMember" id="usph_JointVentureInterestMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" id="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" id="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RemainingContractTerm" id="usph_RemainingContractTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReferralRelationshipMember" id="usph_ReferralRelationshipMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PaymentsToAcquireBusinessesConsideration" id="usph_PaymentsToAcquireBusinessesConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" id="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PhysicalTherapyOperationsMember" id="usph_PhysicalTherapyOperationsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PreviousOwnersMember" id="usph_PreviousOwnersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="RedeemableNonControllingInterestsPolicyTextBlock" id="usph_RedeemableNonControllingInterestsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NonControllingInterestsPolicyPolicyTextBlock" id="usph_NonControllingInterestsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SelfInsuranceProgramPolicyPolicyTextBlock" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RestrictedStockPolicyPolicyTextBlock" id="usph_RestrictedStockPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AverageLeaseTermsAndDiscountRatesAbstract" id="usph_AverageLeaseTermsAndDiscountRatesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SupplementalInformationRelatedToOperatingLeasesAbstract" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContractualAllowancesAbstract" id="usph_ContractualAllowancesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MaximumContractualAllowanceReserveEstimate" id="usph_MaximumContractualAllowanceReserveEstimate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" id="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MedicareReimbursementAbstract" id="usph_MedicareReimbursementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" id="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ReductionInMedicareSpendingPercentage" id="usph_ReductionInMedicareSpendingPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" id="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AmountOfReductionsInFederalSpending" id="usph_AmountOfReductionsInFederalSpending" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" id="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPaymentForOutpatientTherapyServices" id="usph_PercentageOfPaymentForOutpatientTherapyServices" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfMedicarePaymentIncrease" id="usph_PercentageOfMedicarePaymentIncrease" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" id="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" id="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" id="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NetRevenueFromMedicare" id="usph_NetRevenueFromMedicare" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CentersForMedicareAndMedicaidServicesMember" id="usph_CentersForMedicareAndMedicaidServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="OtherRevenuesMember" id="usph_OtherRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IndustrialInjuryPreventionServicesRevenuesMember" id="usph_IndustrialInjuryPreventionServicesRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ManagementContractRevenuesMember" id="usph_ManagementContractRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExpectedReductionInMedicareSpendingPercentage" id="usph_ExpectedReductionInMedicareSpendingPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EstimatedPercentageOfDecreaseInPayment" id="usph_EstimatedPercentageOfDecreaseInPayment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="OperatingLeaseSupplementalInformationTableTextBlock" id="usph_OperatingLeaseSupplementalInformationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CreditAgreementMember" id="usph_CreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DividendsCashAfterAmendment" id="usph_DividendsCashAfterAmendment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="DebtInstrumentBasisSpreadOnLiborVariableRate" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NotesPayableMember" id="usph_NotesPayableMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PatientsAndPayorsRelatedLiability" id="usph_PatientsAndPayorsRelatedLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PromissoryNotesMember" id="usph_PromissoryNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ChargesToRetainedEarningsAbstract" id="usph_ChargesToRetainedEarningsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="TherapyPracticeMember" id="usph_TherapyPracticeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EmploymentAgreementRenewalTerm" id="usph_EmploymentAgreementRenewalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ProgressiveHealthCompaniesLLCMember" id="usph_ProgressiveHealthCompaniesLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TermOfEmploymentAgreement" id="usph_TermOfEmploymentAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NonCompeteAgreementBasicTerm" id="usph_NonCompeteAgreementBasicTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RedeemableNonControllingInterestMember" id="usph_RedeemableNonControllingInterestMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="CarryingAmountOfRedeemableNonControllingInterestAbstract" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionConsiderationPayableTermOfNote" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>usph-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc2" xlink:type="simple" xlink:href="usph-20220331.xsd#LeasesDetailsCalc2" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedBalanceSheets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: Assets to OtherAssetsNoncurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="FurnitureAndFixturesGross" xlink:title="calculation: PropertyPlantAndEquipmentGross to FurnitureAndFixturesGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="LeaseholdImprovementsGross" xlink:title="calculation: PropertyPlantAndEquipmentGross to LeaseholdImprovementsGross" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="calculation: PropertyPlantAndEquipmentNet to PropertyPlantAndEquipmentGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: PropertyPlantAndEquipmentNet to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="calculation: AssetsCurrent to CashAndCashEquivalentsAtCarryingValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsAndOtherReceivablesNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsAndOtherReceivablesNetCurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsReceivableNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsReceivableNetCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to OtherAssetsCurrent" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="calculation: Assets to IntangibleAssetsNetExcludingGoodwill" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="calculation: Assets to OperatingLeaseRightOfUseAsset" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="calculation: Assets to InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="TreasuryStockValue" xlink:title="calculation: StockholdersEquity to TreasuryStockValue" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="PreferredStockValue" xlink:title="calculation: StockholdersEquity to PreferredStockValue" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="StockholdersEquity" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to StockholdersEquity" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="MinorityInterest" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to MinorityInterest" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="calculation: LiabilitiesAndStockholdersEquity to RedeemableNoncontrollingInterestEquityCarryingAmount" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="LongTermDebtCurrent" xlink:title="calculation: LiabilitiesCurrent to LongTermDebtCurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableTradeCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableTradeCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AccountsPayableDueToSellerOfAcquiredBusiness" xlink:label="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="AccountsPayableDueToSellerOfAcquiredBusiness" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableDueToSellerOfAcquiredBusiness" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermLineOfCredit" xlink:title="calculation: Liabilities to LongTermLineOfCredit" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermNotesPayable" xlink:title="calculation: Liabilities to LongTermNotesPayable" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DeferredIncomeTaxLiabilitiesNet" xlink:title="calculation: Liabilities to DeferredIncomeTaxLiabilitiesNet" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: Liabilities to OperatingLeaseLiabilityNoncurrent" order="5.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: ProfitLoss to IncomeTaxExpenseBenefit" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="calculation: GrossProfit to RevenueFromContractWithCustomerExcludingAssessedTax" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="calculation: CostsAndExpenses to RentSuppliesContractLaborAndOther" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="calculation: CostsAndExpenses to ProvisionForDoubtfulAccounts" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="LaborAndRelatedExpense" xlink:title="calculation: CostsAndExpenses to LaborAndRelatedExpense" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="CostsAndExpenses" xlink:title="calculation: GrossProfit to CostsAndExpenses" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="GrossProfit" xlink:title="calculation: OperatingIncomeLoss to GrossProfit" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="calculation: OperatingIncomeLoss to SellingGeneralAndAdministrativeExpense" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InterestExpenseDebtAndOther" xlink:title="calculation: NonoperatingIncomeExpense to InterestExpenseDebtAndOther" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InterestAndOtherIncome" xlink:title="calculation: NonoperatingIncomeExpense to InterestAndOtherIncome" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="calculation: NonoperatingIncomeExpense to IncomeLossFromEquityMethodInvestments" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GainLossOnRevaluationOfPutRightLiability" xlink:label="GainLossOnRevaluationOfPutRightLiability" xlink:title="GainLossOnRevaluationOfPutRightLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="GainLossOnRevaluationOfPutRightLiability" xlink:title="calculation: NonoperatingIncomeExpense to GainLossOnRevaluationOfPutRightLiability" order="5.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="NonoperatingIncomeExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to NonoperatingIncomeExpense" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: ProfitLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="ProfitLoss" xlink:title="calculation: NetIncomeLoss to ProfitLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="calculation: NetIncomeLossAttributableToNoncontrollingInterest to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="calculation: NetIncomeLossAttributableToNoncontrollingInterest to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to NetIncomeLossAttributableToNoncontrollingInterest" order="0.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromPaymentsForOtherFinancingActivities" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromLinesOfCredit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromLinesOfCredit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfLinesOfCredit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfLinesOfCredit" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:label="PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:title="PaymentOfMedicareAcceleratedAndAdvanceFunds" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentOfMedicareAcceleratedAndAdvanceFunds" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsMinorityInterest" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsMinorityInterest" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfNotesPayable" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfNotesPayable" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsCommonStock" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProfitLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProfitLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationDepletionAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationDepletionAndAmortization" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProvisionForDoubtfulAccounts" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncomeLossFromEquityMethodInvestments" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OtherOperatingActivitiesCashFlowStatement" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OtherOperatingActivitiesCashFlowStatement" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DeferredIncomeTaxExpenseBenefit" order="12.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivable" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherNoncurrentLiabilities" order="11.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingAssets" order="9.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" order="8.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GainLossOnRevaluationOfPutRightLiability" xlink:label="GainLossOnRevaluationOfPutRightLiability" xlink:title="GainLossOnRevaluationOfPutRightLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnRevaluationOfPutRightLiability" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnRevaluationOfPutRightLiability" order="3.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireProductiveAssets" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromDivestitureOfBusinesses" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DistributionsFromUnconsolidatedAffiliate" xlink:label="DistributionsFromUnconsolidatedAffiliate" xlink:title="DistributionsFromUnconsolidatedAffiliate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="DistributionsFromUnconsolidatedAffiliate" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to DistributionsFromUnconsolidatedAffiliate" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireInterestInSubsidiariesAndAffiliates" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireRedeemableNonControllingInterest" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireBusinessesNetOfCashAcquired" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProceedsFromSalesOfNonControllingInterestPermanent" xlink:label="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="ProceedsFromSalesOfNonControllingInterestPermanent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSalesOfNonControllingInterestPermanent" order="7.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to ChargesToRetainedEarningsRevaluationOfNonControllingInterests" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="NetIncomeLoss" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to NetIncomeLoss" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="TaxesPayableCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to TaxesPayableCurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedInsuranceCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedInsuranceCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent" xlink:label="LitigationReserveCurrent" xlink:title="LitigationReserveCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="LitigationReserveCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to LitigationReserveCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="AssetAcquisitionContingentConsiderationLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AssetAcquisitionContingentConsiderationLiabilityCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to OtherAccruedLiabilitiesCurrent" order="11.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="DividendsPayableCurrentAndNoncurrent" xlink:title="DividendsPayableCurrentAndNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="DividendsPayableCurrentAndNoncurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to DividendsPayableCurrentAndNoncurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="PatientsAndPayorsRelatedLiability" xlink:title="calculation: AccruedLiabilitiesCurrent to PatientsAndPayorsRelatedLiability" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtCurrent" xlink:title="calculation: LongTermDebt to LongTermDebtCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtNoncurrent" xlink:title="calculation: LongTermDebt to LongTermDebtNoncurrent" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="ShortTermLeaseCost" xlink:title="calculation: LeaseCost to ShortTermLeaseCost" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="OperatingLeaseCost" xlink:title="calculation: LeaseCost to OperatingLeaseCost" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="VariableLeaseCost" xlink:title="calculation: LeaseCost to VariableLeaseCost" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc2">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="0.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>usph-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://usph.com/role/CommonStockDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#CommonStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#InvestmentInUnconsolidatedAffiliateDetails" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#SegmentInformationDetails" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc2" xlink:type="simple" xlink:href="usph-20220331.xsd#LeasesDetailsCalc2" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNetAmortizationExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNetIntangibleAssetsNetDetails" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#GoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/RevenueRecognitionDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#RevenueRecognitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#BasisOfPresentationAndSignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="usph-20220331.xsd#SegmentInformationTables" />
  <link:roleRef roleURI="http://usph.com/role/LeasesTables" xlink:type="simple" xlink:href="usph-20220331.xsd#LeasesTables" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementTables" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="usph-20220331.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNetTables" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillTables" xlink:type="simple" xlink:href="usph-20220331.xsd#GoodwillTables" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" xlink:type="simple" xlink:href="usph-20220331.xsd#RedeemableNoncontrollingInterestTables" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="usph-20220331.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://usph.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="usph-20220331.xsd#RevenueRecognitionTables" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" xlink:type="simple" xlink:href="usph-20220331.xsd#AcquisitionsOfBusinessesTables" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="usph-20220331.xsd#BasisOfPresentationAndSignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="usph-20220331.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ReclassificationOfPriorPeriodPresentation" xlink:type="simple" xlink:href="usph-20220331.xsd#ReclassificationOfPriorPeriodPresentation" />
  <link:roleRef roleURI="http://usph.com/role/CommonStock" xlink:type="simple" xlink:href="usph-20220331.xsd#CommonStock" />
  <link:roleRef roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliate" xlink:type="simple" xlink:href="usph-20220331.xsd#InvestmentInUnconsolidatedAffiliate" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformation" xlink:type="simple" xlink:href="usph-20220331.xsd#SegmentInformation" />
  <link:roleRef roleURI="http://usph.com/role/Leases" xlink:type="simple" xlink:href="usph-20220331.xsd#Leases" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreement" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreement" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpenses" xlink:type="simple" xlink:href="usph-20220331.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNet" />
  <link:roleRef roleURI="http://usph.com/role/Goodwill" xlink:type="simple" xlink:href="usph-20220331.xsd#Goodwill" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" xlink:type="simple" xlink:href="usph-20220331.xsd#RedeemableNoncontrollingInterest" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShare" xlink:type="simple" xlink:href="usph-20220331.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://usph.com/role/RevenueRecognition" xlink:type="simple" xlink:href="usph-20220331.xsd#RevenueRecognition" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses" xlink:type="simple" xlink:href="usph-20220331.xsd#AcquisitionsOfBusinesses" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="simple" xlink:href="usph-20220331.xsd#BasisOfPresentationAndSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedStatementsOfChangesInEquity" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20220331.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevenuesAbstract" xlink:title="definition: StatementLineItems to RevenuesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CostsAndExpensesAbstract" xlink:title="definition: StatementLineItems to CostsAndExpensesAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GrossProfit" xlink:title="definition: StatementLineItems to GrossProfit" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="definition: StatementLineItems to SellingGeneralAndAdministrativeExpense" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingIncomeLoss" xlink:title="definition: StatementLineItems to OperatingIncomeLoss" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherNonoperatingIncomeExpenseAbstract" xlink:title="definition: StatementLineItems to OtherNonoperatingIncomeExpenseAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="definition: StatementLineItems to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncomeTaxExpenseBenefit" xlink:title="definition: StatementLineItems to IncomeTaxExpenseBenefit" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="definition: StatementLineItems to ProfitLoss" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="definition: StatementLineItems to MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EarningsPerShareBasic" xlink:title="definition: StatementLineItems to EarningsPerShareBasic" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EarningsPerShareDiluted" xlink:title="definition: StatementLineItems to EarningsPerShareDiluted" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="definition: StatementLineItems to WeightedAverageNumberOfSharesOutstandingBasic" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="definition: StatementLineItems to WeightedAverageNumberOfDilutedSharesOutstanding" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockDividendsPerShareDeclared" xlink:title="definition: StatementLineItems to CommonStockDividendsPerShareDeclared" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterest" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="definition: StatementLineItems to IncomeLossFromEquityMethodInvestments" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="InterestAndOtherIncome" xlink:title="definition: StatementLineItems to InterestAndOtherIncome" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GainLossOnRevaluationOfPutRightLiability" xlink:label="GainLossOnRevaluationOfPutRightLiability" xlink:title="GainLossOnRevaluationOfPutRightLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GainLossOnRevaluationOfPutRightLiability" xlink:title="definition: StatementLineItems to GainLossOnRevaluationOfPutRightLiability" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="InterestExpenseDebtAndOther" xlink:title="definition: StatementLineItems to InterestExpenseDebtAndOther" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NonoperatingIncomeExpense" xlink:title="definition: StatementLineItems to NonoperatingIncomeExpense" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LaborAndRelatedExpense" xlink:title="definition: StatementLineItems to LaborAndRelatedExpense" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="definition: StatementLineItems to RentSuppliesContractLaborAndOther" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="definition: StatementLineItems to ProvisionForDoubtfulAccounts" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CostsAndExpenses" xlink:title="definition: StatementLineItems to CostsAndExpenses" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="definition: StatementLineItems to RevenueFromContractWithCustomerExcludingAssessedTax" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="ProductOrServiceAxis" xlink:title="definition: StatementTable to ProductOrServiceAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_2" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_2" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to NetPatientRevenuesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="definition: StatementLineItems to RevaluationOfRedeemableNonControllingInterestNetOfTax" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="definition: StatementLineItems to RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="definition: StatementLineItems to TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="MinorityInterestDecreaseFromRedemptions" xlink:title="MinorityInterestDecreaseFromRedemptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestDecreaseFromRedemptions" xlink:title="definition: StatementLineItems to MinorityInterestDecreaseFromRedemptions" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:label="SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:title="SaleOfNonControllingInterestNetOfPurchasesAndTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:title="definition: StatementLineItems to SaleOfNonControllingInterestNetOfPurchasesAndTax" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DividendsCommonStockCash" xlink:title="definition: StatementLineItems to DividendsCommonStockCash" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="definition: StatementLineItems to MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ShortSwingProfitSettlement" xlink:label="ShortSwingProfitSettlement" xlink:title="ShortSwingProfitSettlement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ShortSwingProfitSettlement" xlink:title="definition: StatementLineItems to ShortSwingProfitSettlement" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityOther" xlink:title="definition: StatementLineItems to StockholdersEquityOther" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="18.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="TreasuryStockMember" xlink:title="definition: EquityComponentDomain to TreasuryStockMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="ParentMember" xlink:title="definition: EquityComponentDomain to ParentMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="NoncontrollingInterestMember" xlink:title="definition: EquityComponentDomain to NoncontrollingInterestMember" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RevenueRecognition" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterest" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/Goodwill" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNet" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreement" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/Leases" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/InvestmentInUnconsolidatedAffiliate" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStock" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ReclassificationOfPriorPeriodPresentation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RevenueRecognitionTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementsAbstract" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="DirectorMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to DirectorMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="OfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to OfficerMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BasisOfPresentationAbstract" xlink:label="BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BasisOfPresentationAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to BasisOfPresentationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PropertyPlantAndEquipmentAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PropertyPlantAndEquipmentAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract" xlink:label="BusinessCombinationGoodwillAbstract" xlink:title="BusinessCombinationGoodwillAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BusinessCombinationGoodwillAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to BusinessCombinationGoodwillAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NonControllingInterestRedeemableAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NonControllingInterestRedeemableAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="IncomeTaxDisclosureAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to IncomeTaxDisclosureAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="FairValueDisclosuresAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to FairValueDisclosuresAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfOperatingSegments" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfOperatingSegments" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="DebtInstrumentMeasurementInput" xlink:title="DebtInstrumentMeasurementInput" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DebtInstrumentMeasurementInput" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DebtInstrumentMeasurementInput" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="IncreaseDecreaseInContractWithCustomerAsset" xlink:title="IncreaseDecreaseInContractWithCustomerAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="IncreaseDecreaseInContractWithCustomerAsset" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to IncreaseDecreaseInContractWithCustomerAsset" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="ContractWithCustomerAssetNet" xlink:title="ContractWithCustomerAssetNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ContractWithCustomerAssetNet" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to ContractWithCustomerAssetNet" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfRegions" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfRegions" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:title="ImpairmentOfLongLivedAssetsToBeDisposedOf" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to ImpairmentOfLongLivedAssetsToBeDisposedOf" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfReportableSegments" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfReportableSegments" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfOperatingClinicLocations" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfOperatingClinicLocations" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to BusinessAcquisitionDateOfAcquisitionAgreement1" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfBusinessesAcquired" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfStatesInWhichEntityOperates" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfStatesInWhichEntityOperates" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfGeneralPartnershipInterestOwned" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfGeneralPartnershipInterestOwned" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfLimitedPartnershipInterestOwned" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfLimitedPartnershipInterestOwned" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfThirdPartyFacilities" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfThirdPartyFacilities" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="GrantsAndOtherFunds" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to GrantsAndOtherFunds" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RepaymentOfFunds" xlink:label="RepaymentOfFunds" xlink:title="RepaymentOfFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="RepaymentOfFunds" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to RepaymentOfFunds" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="GrantsReceivable" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to GrantsReceivable" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DepreciationAmortizationImpairmentTable" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DepreciationAmortizationImpairmentTable" order="31.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="RangeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to BusinessAcquisitionAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MultiClinicPracticesMember" xlink:label="MultiClinicPracticesMember" xlink:title="MultiClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MultiClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to MultiClinicPracticesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_March2022AcquisitionMember" xlink:label="March2022AcquisitionMember" xlink:title="March2022AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="March2022AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to March2022AcquisitionMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_December2021AcquisitionMember" xlink:label="December2021AcquisitionMember" xlink:title="December2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="December2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to December2021AcquisitionMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_November2021AcquisitionMember" xlink:label="November2021AcquisitionMember" xlink:title="November2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to November2021AcquisitionMember" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_September2021AcquisitionMember" xlink:label="September2021AcquisitionMember" xlink:title="September2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to September2021AcquisitionMember" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_June2021AcquisitionMember" xlink:label="June2021AcquisitionMember" xlink:title="June2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="June2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to June2021AcquisitionMember" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_March2021AcquisitionMember" xlink:label="March2021AcquisitionMember" xlink:title="March2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="March2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to March2021AcquisitionMember" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReturnToWorkAndErgonomicServicesMember" xlink:label="ReturnToWorkAndErgonomicServicesMember" xlink:title="ReturnToWorkAndErgonomicServicesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ReturnToWorkAndErgonomicServicesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ReturnToWorkAndErgonomicServicesMember" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BriotixHealthLimitedPartnershipMember" xlink:label="BriotixHealthLimitedPartnershipMember" xlink:title="BriotixHealthLimitedPartnershipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="BriotixHealthLimitedPartnershipMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to BriotixHealthLimitedPartnershipMember" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to AdjustmentsForNewAccountingPronouncementsAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember_2" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember_2" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="definition: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to PropertyPlantAndEquipmentByTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerSoftwareIntangibleAssetMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerSoftwareIntangibleAssetMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to UnusualOrInfrequentItemAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain_2" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain_2" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="definition: UnusualOrInfrequentItemDomain to MedicareAcceleratedAndAdvancePaymentsProgramMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="definition: UnusualOrInfrequentItemDomain to PublicHealthAndSocialServicesEmergencyFundMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="MeasurementInputTypeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to MeasurementInputTypeAxis" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain_2" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain_2" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="MeasurementInputOptionVolatilityMember" xlink:title="MeasurementInputOptionVolatilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputOptionVolatilityMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputOptionVolatilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="MeasurementInputDiscountRateMember" xlink:title="MeasurementInputDiscountRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputDiscountRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputDiscountRateMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to ShortTermDebtTypeAxis" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain_2" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain_2" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableOneMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableTwoMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableTwoMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="definition: BusinessAcquisitionLineItems to MinorityInterestOwnershipPercentageByNoncontrollingOwners" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:label="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferred1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationContingentConsiderationLiability" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationContingentConsiderationLiability" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:label="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferredIncludesContingentConsideration" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesGross" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:label="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: BusinessAcquisitionLineItems to DebtInstrumentInterestRateStatedPercentage" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="RemainingContractTerm" xlink:title="definition: BusinessAcquisitionLineItems to RemainingContractTerm" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:label="BusinessCombinationAcquiredReceivablesFairValue" xlink:title="BusinessCombinationAcquiredReceivablesFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquiredReceivablesFairValue" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquiredReceivablesFairValue" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesNetOfCashAcquired" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase" xlink:label="ContractWithCustomerAssetPurchase" xlink:title="ContractWithCustomerAssetPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ContractWithCustomerAssetPurchase" xlink:title="definition: BusinessAcquisitionLineItems to ContractWithCustomerAssetPurchase" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesConsideration" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="definition: BusinessAcquisitionLineItems to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReturnToWorkAndErgonomicServicesMember" xlink:label="ReturnToWorkAndErgonomicServicesMember" xlink:title="ReturnToWorkAndErgonomicServicesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ReturnToWorkAndErgonomicServicesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ReturnToWorkAndErgonomicServicesMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PreviousOwnersMember" xlink:label="PreviousOwnersMember" xlink:title="PreviousOwnersMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="PreviousOwnersMember" xlink:title="definition: OwnershipDomain to PreviousOwnersMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementBusinessSegmentsAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain_2" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain_2" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="MedicareReimbursementAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to MedicareReimbursementAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualAllowancesAbstract" xlink:label="ContractualAllowancesAbstract" xlink:title="ContractualAllowancesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractualAllowancesAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractualAllowancesAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="definition: DisaggregationOfRevenueLineItems to DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="definition: DisaggregationOfRevenueLineItems to DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="MaximumContractualAllowanceReserveEstimate" xlink:title="definition: DisaggregationOfRevenueLineItems to MaximumContractualAllowanceReserveEstimate" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfMedicarePaymentIncrease" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfMedicarePaymentIncrease" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="EstimatedPercentageOfDecreaseInPayment" xlink:title="definition: DisaggregationOfRevenueLineItems to EstimatedPercentageOfDecreaseInPayment" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="definition: DisaggregationOfRevenueLineItems to PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="AmountOfReductionsInFederalSpending" xlink:title="definition: DisaggregationOfRevenueLineItems to AmountOfReductionsInFederalSpending" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ReductionInMedicareSpendingPercentage" xlink:title="definition: DisaggregationOfRevenueLineItems to ReductionInMedicareSpendingPercentage" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ExpectedReductionInMedicareSpendingPercentage" xlink:title="definition: DisaggregationOfRevenueLineItems to ExpectedReductionInMedicareSpendingPercentage" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:label="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:title="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfPaymentReductionWaivedThroughEnactedLegislation" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:label="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:title="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:title="definition: DisaggregationOfRevenueLineItems to ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:label="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:title="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:label="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:title="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="definition: DisaggregationOfRevenueLineItems to CombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="definition: DisaggregationOfRevenueLineItems to ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfPracticeExpenseComponentOfRelativeValueUnit" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfPaymentForOutpatientTherapyServices" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="NetRevenueFromMedicare" xlink:title="definition: DisaggregationOfRevenueLineItems to NetRevenueFromMedicare" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="definition: DisaggregationOfRevenueLineItems to RevenueFromContractWithCustomerExcludingAssessedTax" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueTable" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueTable" order="27.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="ProductOrServiceAxis" xlink:title="definition: DisaggregationOfRevenueTable to ProductOrServiceAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_2" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_2" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to NetPatientRevenuesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to OtherRevenuesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: ProductsAndServicesDomain to PhysicalTherapyOperationsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="ManagementContractRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to ManagementContractRevenuesMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="definition: DisaggregationOfRevenueTable to UnusualOrInfrequentItemAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain_2" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain_2" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:label="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="definition: UnusualOrInfrequentItemDomain to FromTwoThousandSeventeenThroughTwoThousandNineteenMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="definition: UnusualOrInfrequentItemDomain to FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="StatementScenarioAxis" xlink:title="definition: DisaggregationOfRevenueTable to StatementScenarioAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain_2" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain_2" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="definition: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="definition: DisaggregationOfRevenueTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: DisaggregationOfRevenueTable to RelatedPartyTransactionsByRelatedPartyAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CentersForMedicareAndMedicaidServicesMember" xlink:label="CentersForMedicareAndMedicaidServicesMember" xlink:title="CentersForMedicareAndMedicaidServicesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="CentersForMedicareAndMedicaidServicesMember" xlink:title="definition: RelatedPartyDomain to CentersForMedicareAndMedicaidServicesMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to CarryingAmountOfRedeemableNonControllingInterestAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmount" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="MinorityInterestChangeInRedemptionValue" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to MinorityInterestChangeInRedemptionValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ProceedsFromPaymentsToMinorityShareholders" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ProceedsFromPaymentsToMinorityShareholders" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="PaymentsToMinorityShareholders" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to PaymentsToMinorityShareholders" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestByLegalEntityTable" order="17.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="OwnershipAxis" xlink:title="definition: RedeemableNoncontrollingInterestByLegalEntityTable to OwnershipAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="RedeemableNonControllingInterestMember" xlink:title="definition: OwnershipDomain to RedeemableNonControllingInterestMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionConsiderationPayableTermOfNote" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="TermOfEmploymentAgreement" xlink:title="definition: BusinessAcquisitionLineItems to TermOfEmploymentAgreement" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EmploymentAgreementRenewalTerm" xlink:title="definition: BusinessAcquisitionLineItems to EmploymentAgreementRenewalTerm" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="definition: BusinessAcquisitionLineItems to NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementBasicTerm" xlink:title="definition: BusinessAcquisitionLineItems to NonCompeteAgreementBasicTerm" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TherapyPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to TherapyPracticeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProgressiveHealthCompaniesLLCMember" xlink:label="ProgressiveHealthCompaniesLLCMember" xlink:title="ProgressiveHealthCompaniesLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ProgressiveHealthCompaniesLLCMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ProgressiveHealthCompaniesLLCMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ConsolidatedEntitiesAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ConsolidatedEntitiesAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain" xlink:title="definition: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain_2" xlink:title="ConsolidatedEntitiesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain_2" xlink:title="definition: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidatedEntitiesDomain" xlink:to="SubsidiariesMember" xlink:title="definition: ConsolidatedEntitiesDomain to SubsidiariesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to IntangibleAssetsNetExcludingGoodwill" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetUsefulLife" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfDeferredChargesAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to AmortizationOfDeferredChargesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfIntangibleAssets" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to AmortizationOfIntangibleAssets" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtCurrent" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtCurrent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtNoncurrent" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtNoncurrent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentAnnualPrincipalPayment" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentInterestRateStatedPercentage" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="PromissoryNotesMember" xlink:title="definition: DebtInstrumentNameDomain to PromissoryNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityMaximumBorrowingCapacity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityIncreaseDecreaseForPeriodNet" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentBasisSpreadOnLiborVariableRate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentBasisSpreadOnVariableRate1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="definition: DebtInstrumentLineItems to CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DividendsCashAfterAmendment" xlink:title="definition: DebtInstrumentLineItems to DividendsCashAfterAmendment" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityRemainingBorrowingCapacity" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentFaceAmount" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="15.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="CreditAgreementMember" xlink:title="definition: DebtInstrumentNameDomain to CreditAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="definition: DebtInstrumentTable to ShortTermDebtTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain_2" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain_2" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="VariableRateAxis" xlink:title="VariableRateAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="VariableRateAxis" xlink:title="definition: DebtInstrumentTable to VariableRateAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain" xlink:title="VariableRateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="VariableRateAxis" xlink:to="VariableRateDomain" xlink:title="definition: VariableRateAxis to VariableRateDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain_2" xlink:title="VariableRateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="VariableRateAxis" xlink:to="VariableRateDomain_2" xlink:title="definition: VariableRateAxis to VariableRateDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="LondonInterbankOfferedRateLIBORMember" xlink:title="LondonInterbankOfferedRateLIBORMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VariableRateDomain" xlink:to="LondonInterbankOfferedRateLIBORMember" xlink:title="definition: VariableRateDomain to LondonInterbankOfferedRateLIBORMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember" xlink:label="BaseRateMember" xlink:title="BaseRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VariableRateDomain" xlink:to="BaseRateMember" xlink:title="definition: VariableRateDomain to BaseRateMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtByMaturityAbstract" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtByMaturityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentMaturityDate" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCostAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseCostAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to SupplementalInformationRelatedToOperatingLeasesAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to AverageLeaseTermsAndDiscountRatesAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseWeightedAverageDiscountRatePercent" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDue" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiability" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeasePayments" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeasePayments" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseCost" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="ShortTermLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to ShortTermLeaseCost" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="VariableLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to VariableLeaseCost" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseCost" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseTermOfContract" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeLeaseDescriptionTable" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeLeaseDescriptionTable" order="24.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="definition: LesseeLeaseDescriptionTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc2" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="definition: SegmentReportingInformationLineItems to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="Revenues" xlink:title="definition: SegmentReportingInformationLineItems to Revenues" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="GrossProfit" xlink:title="definition: SegmentReportingInformationLineItems to GrossProfit" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="Assets" xlink:title="definition: SegmentReportingInformationLineItems to Assets" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SegmentReportingInformationLineItems" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="definition: SegmentReportingInformationLineItems to ScheduleOfSegmentReportingInformationBySegmentTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="ConsolidationItemsAxis" xlink:title="definition: ScheduleOfSegmentReportingInformationBySegmentTable to ConsolidationItemsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain" xlink:title="definition: ConsolidationItemsAxis to ConsolidationItemsDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain_2" xlink:title="ConsolidationItemsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain_2" xlink:title="definition: ConsolidationItemsAxis to ConsolidationItemsDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationItemsDomain" xlink:to="OperatingSegmentsMember" xlink:title="definition: ConsolidationItemsDomain to OperatingSegmentsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="definition: ScheduleOfSegmentReportingInformationBySegmentTable to StatementBusinessSegmentsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain_2" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain_2" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: SegmentDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="ScheduleOfEquityMethodInvestmentsLineItems" xlink:title="ScheduleOfEquityMethodInvestmentsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentQuotedMarketValue" xlink:label="EquityMethodInvestmentQuotedMarketValue" xlink:title="EquityMethodInvestmentQuotedMarketValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="EquityMethodInvestmentQuotedMarketValue" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to EquityMethodInvestmentQuotedMarketValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to IncomeLossFromEquityMethodInvestments" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:label="EquityMethodInvestmentDividendsOrDistributions" xlink:title="EquityMethodInvestmentDividendsOrDistributions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="EquityMethodInvestmentDividendsOrDistributions" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to EquityMethodInvestmentDividendsOrDistributions" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="ScheduleOfEquityMethodInvestmentsTable" xlink:title="ScheduleOfEquityMethodInvestmentsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="ScheduleOfEquityMethodInvestmentsTable" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to ScheduleOfEquityMethodInvestmentsTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfEquityMethodInvestmentsTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfEquityMethodInvestmentsTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_JointVentureInterestMember" xlink:label="JointVentureInterestMember" xlink:title="JointVentureInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="JointVentureInterestMember" xlink:title="definition: EquityMethodInvesteeNameDomain to JointVentureInterestMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfStockDisclosuresAbstract" xlink:title="definition: EquityClassOfTreasuryStockLineItems to ClassOfStockDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: EquityClassOfTreasuryStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="PercentageOfRepurchaseOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to PercentageOfRepurchaseOfCommonStock" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to BankCreditAgreementToPermitShareRepurchasesOfCommonStock" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchasedDuringPeriodShares" xlink:title="definition: EquityClassOfTreasuryStockLineItems to StockRepurchasedDuringPeriodShares" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to AdditionalEstimatedRepurchaseOfCommonStock" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="SharesIssuedPricePerShare" xlink:title="definition: EquityClassOfTreasuryStockLineItems to SharesIssuedPricePerShare" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfTreasuryStockTable" xlink:title="definition: EquityClassOfTreasuryStockLineItems to ClassOfTreasuryStockTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfTreasuryStockTable" xlink:to="RangeAxis" xlink:title="definition: ClassOfTreasuryStockTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>usph-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US" id="us-gaap_AccountingStandardsUpdate201602Member_lbl">ASU 2016-02 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:title="label: AccountingStandardsUpdate201602Member to us-gaap_AccountingStandardsUpdate201602Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountingPoliciesAbstract_lbl">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:title="label: AccountingPoliciesAbstract to us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">ACCRUED EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableTradeCurrent_lbl">Accounts payable - trade</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:title="label: AccountsPayableTradeCurrent to us-gaap_AccountsPayableTradeCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableTradeCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableTradeCurrent_lbl1">Accounts Payable, Trade, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl1" xlink:title="label: AccountsPayableTradeCurrent to us-gaap_AccountsPayableTradeCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl">Payables and Accruals [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl">Accounts receivable - other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1">Accounts and Other Receivables, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsReceivableNetCurrent_lbl">Patient accounts receivable, less allowance for credit losses of $2,799 and $2,768, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:title="label: AccountsReceivableNetCurrent to us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedInsuranceCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedInsuranceCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedInsuranceCurrent_lbl">Group health insurance claims</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedInsuranceCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent_lbl" xlink:title="label: AccruedInsuranceCurrent to us-gaap_AccruedInsuranceCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedInsuranceCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedInsuranceCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedInsuranceCurrent_lbl1">Accrued Insurance, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedInsuranceCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent_lbl1" xlink:title="label: AccruedInsuranceCurrent to us-gaap_AccruedInsuranceCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl">Less accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl1">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid-In Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl">Compensation expense - equity-based awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:title="label: AdjustmentsForNewAccountingPronouncementsAxis to us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl">Allowance for credit losses, patient accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:title="label: AllowanceForDoubtfulAccountsReceivableCurrent to us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xlink:title="label: AllowanceForDoubtfulAccountsReceivableCurrent to us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl">Total amortization expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl1">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfDeferredChargesAbstract_lbl">Amortization of Deferred Charges [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xlink:title="label: AmortizationOfDeferredChargesAbstract to us-gaap_AmortizationOfDeferredChargesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="AssetAcquisitionContingentConsiderationLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl">Contingent payments related to acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" xlink:title="label: AssetAcquisitionContingentConsiderationLiabilityCurrent to us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember" xlink:label="BaseRateMember" xlink:title="BaseRateMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BaseRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BaseRateMember_lbl" xml:lang="en-US" id="us-gaap_BaseRateMember_lbl">Base Rate [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRateMember" xlink:to="us-gaap_BaseRateMember_lbl" xlink:title="label: BaseRateMember to us-gaap_BaseRateMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl">Other payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl">Total non-current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl">Acquisition date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:title="label: BusinessAcquisitionDateOfAcquisitionAgreement1 to us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1">Business Acquisition, Date of Acquisition Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xlink:title="label: BusinessAcquisitionDateOfAcquisitionAgreement1 to us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl">Contingent payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:title="label: BusinessCombinationContingentConsiderationLiability to us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1">Contingent payment consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1" xlink:title="label: BusinessCombinationContingentConsiderationLiability to us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationConsiderationTransferred1_lbl">Aggregate purchase price for the acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:title="label: BusinessCombinationConsiderationTransferred1 to us-gaap_BusinessCombinationConsiderationTransferred1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1">Business Combination, Consideration Transferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xlink:title="label: BusinessCombinationConsiderationTransferred1 to us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract" xlink:label="BusinessCombinationGoodwillAbstract" xlink:title="BusinessCombinationGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationGoodwillAbstract_lbl">Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xlink:title="label: BusinessCombinationGoodwillAbstract to us-gaap_BusinessCombinationGoodwillAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationGoodwillAbstract_lbl1">Business Combination, Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xlink:title="label: BusinessCombinationGoodwillAbstract to us-gaap_BusinessCombinationGoodwillAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl">Percentage of interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationsAbstract_lbl">ACQUISITIONS OF BUSINESSES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:title="label: BusinessCombinationsAbstract to us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionLineItems_lbl">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:title="label: BusinessAcquisitionLineItems to us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount to us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount to us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl">Business Combination, Description [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="BusinessCombinationDisclosureTextBlock" xlink:title="BusinessCombinationDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDisclosureTextBlock_lbl">ACQUISITIONS OF BUSINESSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:title="label: BusinessCombinationDisclosureTextBlock to us-gaap_BusinessCombinationDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:label="BusinessCombinationAcquiredReceivablesFairValue" xlink:title="BusinessCombinationAcquiredReceivablesFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAcquiredReceivablesFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationAcquiredReceivablesFairValue_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationAcquiredReceivablesFairValue_lbl">Initial fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredReceivablesFairValue" xlink:to="us-gaap_BusinessCombinationAcquiredReceivablesFairValue_lbl" xlink:title="label: BusinessCombinationAcquiredReceivablesFairValue to us-gaap_BusinessCombinationAcquiredReceivablesFairValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl">Net decrease in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl">Cash and cash equivalents - end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1">Cash and cash equivalents - beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl">Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl">Non-cash investing and financing transactions during the period:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfTreasuryStockTable_lbl" xml:lang="en-US" id="us-gaap_ClassOfTreasuryStockTable_lbl">Class of Treasury Stock [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfTreasuryStockTable" xlink:to="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:title="label: ClassOfTreasuryStockTable to us-gaap_ClassOfTreasuryStockTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDisclosuresAbstract_lbl">Class of Treasury Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xlink:title="label: ClassOfStockDisclosuresAbstract to us-gaap_ClassOfStockDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_ClassOfStockDisclosuresAbstract_lbl1">Class of Stock Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ClassOfStockDisclosuresAbstract_lbl1" xlink:title="label: ClassOfStockDisclosuresAbstract to us-gaap_ClassOfStockDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingencies_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl1">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl1" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US" id="us-gaap_CommonStockDividendsPerShareDeclared_lbl">Dividends declared per common share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:title="label: CommonStockDividendsPerShareDeclared to us-gaap_CommonStockDividendsPerShareDeclared_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xml:lang="en-US" id="us-gaap_CommonStockDividendsPerShareDeclared_lbl1">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xlink:title="label: CommonStockDividendsPerShareDeclared to us-gaap_CommonStockDividendsPerShareDeclared_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl1">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl1">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $.01 par value, 20,000,000 shares authorized, 15,206,173 and 15,126,160 shares issued, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl1">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US" id="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl">Software [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:title="label: ComputerSoftwareIntangibleAssetMember to us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xml:lang="en-US" id="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1">Computer Software, Intangible Asset [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xlink:title="label: ComputerSoftwareIntangibleAssetMember to us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase" xlink:label="ContractWithCustomerAssetPurchase" xlink:title="ContractWithCustomerAssetPurchase" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ContractWithCustomerAssetPurchase_lbl" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetPurchase_lbl">Seller put right</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetPurchase" xlink:to="us-gaap_ContractWithCustomerAssetPurchase_lbl" xlink:title="label: ContractWithCustomerAssetPurchase to us-gaap_ContractWithCustomerAssetPurchase_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetPurchase_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerAssetPurchase_lbl1" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetPurchase_lbl1">Contract with Customer, Asset, Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetPurchase" xlink:to="us-gaap_ContractWithCustomerAssetPurchase_lbl1" xlink:title="label: ContractWithCustomerAssetPurchase to us-gaap_ContractWithCustomerAssetPurchase_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="ContractWithCustomerAssetNet" xlink:title="ContractWithCustomerAssetNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerAssetNet_lbl" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetNet_lbl">Put right value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetNet" xlink:to="us-gaap_ContractWithCustomerAssetNet_lbl" xlink:title="label: ContractWithCustomerAssetNet to us-gaap_ContractWithCustomerAssetNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl">Total operating cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpenses_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl1">Costs and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl1" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpensesAbstract_lbl">Operating cost:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:title="label: CostsAndExpensesAbstract to us-gaap_CostsAndExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpensesAbstract_lbl1">Costs and Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl1" xlink:title="label: CostsAndExpensesAbstract to us-gaap_CostsAndExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityAxis_lbl">Credit Facility [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:title="label: CreditFacilityAxis to us-gaap_CreditFacilityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityDomain_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityDomain_lbl">Credit Facility [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl" xlink:title="label: CreditFacilityDomain to us-gaap_CreditFacilityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl">Customer and Referral Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CustomerRelationshipsMember_lbl1" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl1">Customer Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl1" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueLineItems_lbl">Disaggregation of Revenue [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:title="label: DisaggregationOfRevenueLineItems to us-gaap_DisaggregationOfRevenueLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTable_lbl">Disaggregation of Revenue [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:title="label: DisaggregationOfRevenueTable to us-gaap_DisaggregationOfRevenueTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="DisaggregationOfRevenueTableTextBlock" xlink:title="DisaggregationOfRevenueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl">Disaggregation of Revenue, Categories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:title="label: DisaggregationOfRevenueTableTextBlock to us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueAbstract_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueAbstract_lbl">Revenue from Contract with Customer, Excluding Assessed Tax [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueAbstract" xlink:to="us-gaap_DisaggregationOfRevenueAbstract_lbl" xlink:title="label: DisaggregationOfRevenueAbstract to us-gaap_DisaggregationOfRevenueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl">Spread on variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="DebtInstrumentMeasurementInput" xlink:title="DebtInstrumentMeasurementInput" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentMeasurementInput_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentMeasurementInput_lbl">Debt instrument, measurement input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:title="label: DebtInstrumentMeasurementInput to us-gaap_DebtInstrumentMeasurementInput_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureAbstract_lbl">NOTES PAYABLE AND AMENDED CREDIT AGREEMENT [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:title="label: DebtDisclosureAbstract to us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl">NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl1">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAxis_lbl">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:title="label: DebtInstrumentAxis to us-gaap_DebtInstrumentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl">Annual installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:title="label: DebtInstrumentAnnualPrincipalPayment to us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1">Debt Instrument, Annual Principal Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xlink:title="label: DebtInstrumentAnnualPrincipalPayment to us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl">Aggregate amount of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl1">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentTable_lbl">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:title="label: DebtInstrumentTable to us-gaap_DebtInstrumentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentLineItems_lbl">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:title="label: DebtInstrumentLineItems to us-gaap_DebtInstrumentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentsAbstract_lbl">Debt Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentsAbstract_lbl" xlink:title="label: DebtInstrumentsAbstract to us-gaap_DebtInstrumentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl">Percentage of interest accrued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate_lbl">Revolving credit facility maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentMaturityDate_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate_lbl1">Debt Instrument, Maturity Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl1" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentNameDomain_lbl">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xlink:title="label: DebtInstrumentNameDomain to us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl">Deferred taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:title="label: DeferredIncomeTaxLiabilitiesNet to us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl">Period in which restrictions lapse on stock granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xlink:title="label: DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1 to us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:title="label: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementsAbstract_lbl">Restricted Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementsAbstract" xlink:to="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xlink:title="label: DeferredCompensationArrangementsAbstract to us-gaap_DeferredCompensationArrangementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl">Deferred income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1">Deferred Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl1">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsCommonStockCash_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DividendsCommonStockCash_lbl" xml:lang="en-US" id="us-gaap_DividendsCommonStockCash_lbl">Dividends payable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl" xlink:title="label: DividendsCommonStockCash to us-gaap_DividendsCommonStockCash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsCommonStockCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsCommonStockCash_lbl1" xml:lang="en-US" id="us-gaap_DividendsCommonStockCash_lbl1">Dividends, Common Stock, Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl1" xlink:title="label: DividendsCommonStockCash to us-gaap_DividendsCommonStockCash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="DividendsPayableCurrentAndNoncurrent" xlink:title="DividendsPayableCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl">Dividend payable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xlink:title="label: DividendsPayableCurrentAndNoncurrent to us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl1">Dividends payable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl1" xlink:title="label: DividendsPayableCurrentAndNoncurrent to us-gaap_DividendsPayableCurrentAndNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl">EARNINGS PER SHARE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl">Basic earnings per share attributable to USPH shareholders (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl1">Earnings per share basic (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract_lbl">EARNINGS PER SHARE [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl">Diluted earnings per share attributable to USPH shareholders (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl1">Earnings per share diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl">Federal statutory income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl">State statutory income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes to us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Salaries and related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1">Employee-related Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl">COMMON STOCK [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentQuotedMarketValue" xlink:label="EquityMethodInvestmentQuotedMarketValue" xlink:title="EquityMethodInvestmentQuotedMarketValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl">Fair value of investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentQuotedMarketValue" xlink:to="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl" xlink:title="label: EquityMethodInvestmentQuotedMarketValue to us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1">Equity Method Investment, Quoted Market Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentQuotedMarketValue" xlink:to="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1" xlink:title="label: EquityMethodInvestmentQuotedMarketValue to us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:label="EquityMethodInvestmentDividendsOrDistributions" xlink:title="EquityMethodInvestmentDividendsOrDistributions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl">Distribution received from investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentDividendsOrDistributions" xlink:to="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl" xlink:title="label: EquityMethodInvestmentDividendsOrDistributions to us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentDividendsOrDistributions" xlink:to="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1" xlink:title="label: EquityMethodInvestmentDividendsOrDistributions to us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl">Percentage of ownership in joint venture interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1">Equity Method Investment, Ownership Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xml:lang="en-US" id="us-gaap_EquityClassOfTreasuryStockLineItems_lbl">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:title="label: EquityClassOfTreasuryStockLineItems to us-gaap_EquityClassOfTreasuryStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="ErrorCorrectionTextBlock" xlink:title="ErrorCorrectionTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ErrorCorrectionTextBlock_lbl" xml:lang="en-US" id="us-gaap_ErrorCorrectionTextBlock_lbl">RECLASSIFICATION OF PRIOR PERIOD PRESENTATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl" xlink:title="label: ErrorCorrectionTextBlock to us-gaap_ErrorCorrectionTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ErrorCorrectionTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ErrorCorrectionTextBlock_lbl1">Error Correction [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl1" xlink:title="label: ErrorCorrectionTextBlock to us-gaap_ErrorCorrectionTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract_lbl">Fair Value of Financial Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract_lbl1">Fair Value Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl1" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xlink:title="label: FiniteLivedIntangibleAssetsNetAbstract to us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl">2022 (excluding the three months ended March 31, 2022)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl">Estimated useful life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl">Accumulated amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:title="label: FiniteLivedIntangibleAssetsLineItems to us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl">Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xlink:title="label: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:label="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl">Preliminary Purchase Prices Allocation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock to us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock to us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl">Amortization Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl">Furniture &amp; Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl1">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesGross_lbl">Furniture and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" xlink:title="label: FurnitureAndFixturesGross to us-gaap_FurnitureAndFixturesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesGross_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesGross_lbl1">Furniture and Fixtures, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl1" xlink:title="label: FurnitureAndFixturesGross to us-gaap_FurnitureAndFixturesGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Goodwill_lbl" xml:lang="en-US" id="us-gaap_Goodwill_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_Goodwill_lbl1" xml:lang="en-US" id="us-gaap_Goodwill_lbl1">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl1" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_Goodwill_lbl2" xml:lang="en-US" id="us-gaap_Goodwill_lbl2">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl2" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Goodwill_lbl3" xml:lang="en-US" id="us-gaap_Goodwill_lbl3">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl3" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="GoodwillPurchaseAccountingAdjustments" xlink:title="GoodwillPurchaseAccountingAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xml:lang="en-US" id="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillPurchaseAccountingAdjustments" xlink:to="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:title="label: GoodwillPurchaseAccountingAdjustments to us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="GoodwillDisclosureTextBlock" xlink:title="GoodwillDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillDisclosureTextBlock_lbl">GOODWILL</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:title="label: GoodwillDisclosureTextBlock to us-gaap_GoodwillDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillDisclosureTextBlock_lbl1">Goodwill Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl1" xlink:title="label: GoodwillDisclosureTextBlock to us-gaap_GoodwillDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:title="label: GoodwillAndIntangibleAssetsPolicyTextBlock to us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsPolicyTextBlock to us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="GoodwillRollForward" xlink:title="GoodwillRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillRollForward_lbl" xml:lang="en-US" id="us-gaap_GoodwillRollForward_lbl">Goodwill [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl" xlink:title="label: GoodwillRollForward to us-gaap_GoodwillRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillRollForward_lbl1" xml:lang="en-US" id="us-gaap_GoodwillRollForward_lbl1">Goodwill [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl1" xlink:title="label: GoodwillRollForward to us-gaap_GoodwillRollForward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl">GOODWILL [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="GoodwillAcquiredDuringPeriod" xlink:title="GoodwillAcquiredDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US" id="us-gaap_GoodwillAcquiredDuringPeriod_lbl">Goodwill acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:title="label: GoodwillAcquiredDuringPeriod to us-gaap_GoodwillAcquiredDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAcquiredDuringPeriod_lbl1">Goodwill, Acquired During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xlink:title="label: GoodwillAcquiredDuringPeriod to us-gaap_GoodwillAcquiredDuringPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrantsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrantsReceivable_lbl" xml:lang="en-US" id="us-gaap_GrantsReceivable_lbl">Advance payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl" xlink:title="label: GrantsReceivable to us-gaap_GrantsReceivable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_GrossProfit_lbl" xml:lang="en-US" id="us-gaap_GrossProfit_lbl">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrossProfit_lbl1" xml:lang="en-US" id="us-gaap_GrossProfit_lbl1">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl1" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:title="ImpairmentOfLongLivedAssetsToBeDisposedOf" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl">Impairment of long lived assets to be disposed of</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:title="label: ImpairmentOfLongLivedAssetsToBeDisposedOf to us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl">Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl">Income before taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl1">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromEquityMethodInvestments_lbl">Earnings in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:title="label: IncomeLossFromEquityMethodInvestments to us-gaap_IncomeLossFromEquityMethodInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeLossFromEquityMethodInvestments_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromEquityMethodInvestments_lbl1">Earnings from investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl1" xlink:title="label: IncomeLossFromEquityMethodInvestments to us-gaap_IncomeLossFromEquityMethodInvestments_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromEquityMethodInvestments_lbl2" xml:lang="en-US" id="us-gaap_IncomeLossFromEquityMethodInvestments_lbl2">Equity in earnings of unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl2" xlink:title="label: IncomeLossFromEquityMethodInvestments to us-gaap_IncomeLossFromEquityMethodInvestments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">CONSOLIDATED STATEMENTS OF INCOME [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl">Provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl1">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl1">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl1">Income Taxes Paid, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="IncreaseDecreaseInContractWithCustomerAsset" xlink:title="IncreaseDecreaseInContractWithCustomerAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl">Decrease in put right</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInContractWithCustomerAsset" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl" xlink:title="label: IncreaseDecreaseInContractWithCustomerAsset to us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl">Decrease in other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOtherNoncurrentLiabilities to us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl">Increase in patient accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:title="label: IncreaseDecreaseInAccountsReceivable to us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1">Increase (Decrease) in Accounts Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xlink:title="label: IncreaseDecreaseInAccountsReceivable to us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl">(Increase) decrease in accounts receivable - other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets to us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1">Increase (Decrease) in Accounts Receivable and Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets to us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl">Increase in accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl">(Increase) decrease in other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1">Increase (Decrease) in Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl">INTANGIBLE ASSETS, NET [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:title="label: IntangibleAssetsNetExcludingGoodwillAbstract to us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl">Other identifiable intangible assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="IntangibleAssetsDisclosureTextBlock" xlink:title="IntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl">INTANGIBLE ASSETS, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:title="label: IntangibleAssetsDisclosureTextBlock to us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1">Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xlink:title="label: IntangibleAssetsDisclosureTextBlock to us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US" id="us-gaap_InterestAndOtherIncome_lbl">Interest and other income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:title="label: InterestAndOtherIncome to us-gaap_InterestAndOtherIncome_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestAndOtherIncome_lbl1" xml:lang="en-US" id="us-gaap_InterestAndOtherIncome_lbl1">Interest and Other Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl1" xlink:title="label: InterestAndOtherIncome to us-gaap_InterestAndOtherIncome_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xml:lang="en-US" id="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl">Interest expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:to="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xlink:title="label: InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations to us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xml:lang="en-US" id="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1">Interest Expense on Prepetition Liabilities Recognized in Statement of Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:to="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xlink:title="label: InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations to us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Interest paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl">Investments in Unconsolidated Affiliate [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl" xlink:title="label: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xml:lang="en-US" id="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl">Investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xlink:title="label: InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures to us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" xml:lang="en-US" id="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" xlink:title="label: InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures to us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl" xml:lang="en-US" id="us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl">INVESTMENT IN UNCONSOLIDATED AFFILIATE [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl" xlink:title="label: InvestmentsInAndAdvancesToAffiliatesAbstract to us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl">INVESTMENT IN UNCONSOLIDATED AFFILIATE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl" xlink:title="label: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock to us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1">Investments in and Advances to Affiliates, Schedule of Investments [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1" xlink:title="label: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock to us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="LondonInterbankOfferedRateLIBORMember" xlink:title="LondonInterbankOfferedRateLIBORMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xml:lang="en-US" id="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LondonInterbankOfferedRateLIBORMember" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xlink:title="label: LondonInterbankOfferedRateLIBORMember to us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl">LEASES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl1">Lessee, Operating Leases [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl1" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl">2027 and thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl">Total lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl">Less: imputed interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseTermOfContract_lbl">Lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:title="label: LesseeOperatingLeaseTermOfContract to us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl">2022 (excluding the three months ended March 31, 2022)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl">Future Lease Payments for Operating Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionTable_lbl">Lessee, Lease, Description [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:title="label: LesseeLeaseDescriptionTable to us-gaap_LesseeLeaseDescriptionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionLineItems_lbl">Lessee, Lease, Description [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:title="label: LesseeLeaseDescriptionLineItems to us-gaap_LesseeLeaseDescriptionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl">Operating Lease [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xlink:title="label: LesseeOperatingLeaseDescriptionAbstract to us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US" id="us-gaap_LaborAndRelatedExpense_lbl">Salaries and related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:title="label: LaborAndRelatedExpense to us-gaap_LaborAndRelatedExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LaborAndRelatedExpense_lbl1" xml:lang="en-US" id="us-gaap_LaborAndRelatedExpense_lbl1">Labor and Related Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl1" xlink:title="label: LaborAndRelatedExpense to us-gaap_LaborAndRelatedExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US" id="us-gaap_LeaseCostAbstract_lbl">Components of Lease Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:title="label: LeaseCostAbstract to us-gaap_LeaseCostAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LeaseCost_lbl" xml:lang="en-US" id="us-gaap_LeaseCost_lbl">Total lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCost_lbl1" xml:lang="en-US" id="us-gaap_LeaseCost_lbl1">Lease, Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl1" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LeaseCostTableTextBlock_lbl">Components of Lease Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:title="label: LeaseCostTableTextBlock to us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl1">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl">Leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl1">Leasehold Improvements, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" id="us-gaap_LeasesAbstract_lbl">LEASES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTEREST</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl">Closure costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:title="label: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent to us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl1">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl">Percentage of unused commitment fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:title="label: LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage to us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xlink:title="label: LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage to us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl">Revolving credit facility commitment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl">Increase on limit of credit facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:title="label: LineOfCreditFacilityIncreaseDecreaseForPeriodNet to us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl">Remaining revolving credit outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityRemainingBorrowingCapacity to us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xlink:title="label: LineOfCreditFacilityRemainingBorrowingCapacity to us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl">Average effective interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1">Average effective interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent" xlink:label="LitigationReserveCurrent" xlink:title="LitigationReserveCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationReserveCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LitigationReserveCurrent_lbl" xml:lang="en-US" id="us-gaap_LitigationReserveCurrent_lbl">Settlement of a legal matter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationReserveCurrent" xlink:to="us-gaap_LitigationReserveCurrent_lbl" xlink:title="label: LitigationReserveCurrent to us-gaap_LitigationReserveCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationReserveCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LitigationReserveCurrent_lbl1" xml:lang="en-US" id="us-gaap_LitigationReserveCurrent_lbl1">Estimated Litigation Liability, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationReserveCurrent" xlink:to="us-gaap_LitigationReserveCurrent_lbl1" xlink:title="label: LitigationReserveCurrent to us-gaap_LitigationReserveCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebt_lbl" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl">Outstanding amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LongTermDebt_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl1">Payments/Long term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebt_lbl2" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl2">Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl2" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtByMaturityAbstract_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtByMaturityAbstract_lbl">Long Term Debt By Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:title="label: LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtByMaturityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtByMaturityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtByMaturityAbstract_lbl1">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl1" xlink:title="label: LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtByMaturityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl">Aggregate principal payment due in 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1">During the twelve months ended March 31, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl2" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl2">Long-Term Debt, Maturity, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl2" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl">Current portion of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LongTermDebtCurrent_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl1">Less current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl1" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtCurrent_lbl2" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl2">Long-term Debt, Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl2" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl">During the twelve months ended March 31, 2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1">Long-Term Debt, Maturity, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl">Aggregate principal payment due in 2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1">During the twelve months ended March 31, 2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2">Long-Term Debt, Maturity, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US" id="us-gaap_LongTermLineOfCredit_lbl">Revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:title="label: LongTermLineOfCredit to us-gaap_LongTermLineOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermLineOfCredit_lbl1" xml:lang="en-US" id="us-gaap_LongTermLineOfCredit_lbl1">Long-term Line of Credit, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl1" xlink:title="label: LongTermLineOfCredit to us-gaap_LongTermLineOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl">Long term portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:title="label: LongTermDebtNoncurrent to us-gaap_LongTermDebtNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl1">Long-term Debt, Excluding Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl1" xlink:title="label: LongTermDebtNoncurrent to us-gaap_LongTermDebtNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US" id="us-gaap_LongTermNotesPayable_lbl">Notes payable, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:title="label: LongTermNotesPayable to us-gaap_LongTermNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_LongTermNotesPayable_lbl1">Notes Payable, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl1" xlink:title="label: LongTermNotesPayable to us-gaap_LongTermNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US" id="us-gaap_MeasurementInputTypeAxis_lbl">Measurement Input Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:title="label: MeasurementInputTypeAxis to us-gaap_MeasurementInputTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="MeasurementInputOptionVolatilityMember" xlink:title="MeasurementInputOptionVolatilityMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputOptionVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputOptionVolatilityMember_lbl" xml:lang="en-US" id="us-gaap_MeasurementInputOptionVolatilityMember_lbl">Volatility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputOptionVolatilityMember" xlink:to="us-gaap_MeasurementInputOptionVolatilityMember_lbl" xlink:title="label: MeasurementInputOptionVolatilityMember to us-gaap_MeasurementInputOptionVolatilityMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputTypeDomain_lbl" xml:lang="en-US" id="us-gaap_MeasurementInputTypeDomain_lbl">Measurement Input Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" xlink:title="label: MeasurementInputTypeDomain to us-gaap_MeasurementInputTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="MeasurementInputDiscountRateMember" xlink:title="MeasurementInputDiscountRateMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US" id="us-gaap_MeasurementInputDiscountRateMember_lbl">Discount Rate [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:title="label: MeasurementInputDiscountRateMember to us-gaap_MeasurementInputDiscountRateMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl">Distributions to non-controlling interest partners - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:title="label: MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders to us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xlink:title="label: MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders to us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl">Less: net income attributable to non-controlling interest:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xlink:title="label: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="MinorityInterestDecreaseFromRedemptions" xlink:title="MinorityInterestDecreaseFromRedemptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl">Purchase of partnership interests - non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromRedemptions" xlink:to="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" xlink:title="label: MinorityInterestDecreaseFromRedemptions to us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromRedemptions" xlink:to="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1" xlink:title="label: MinorityInterestDecreaseFromRedemptions to us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestChangeInRedemptionValue_lbl">Changes in the fair value of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestChangeInRedemptionValue" xlink:to="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xlink:title="label: MinorityInterestChangeInRedemptionValue to us-gaap_MinorityInterestChangeInRedemptionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestChangeInRedemptionValue" xlink:to="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xlink:title="label: MinorityInterestChangeInRedemptionValue to us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MinorityInterest_lbl" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl">Non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl1">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl1" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl">Percentage of retained interest by previous owners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:title="label: MinorityInterestOwnershipPercentageByNoncontrollingOwners to us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl1">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl1" xlink:title="label: MinorityInterestOwnershipPercentageByNoncontrollingOwners to us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash used in financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">FINANCING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash provided by operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">INVESTING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">OPERATING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl">Computation of earnings per share - USPH shareholders [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl">Net income attributable to non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">Recently Adopted Accounting Guidance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US" id="us-gaap_NoncompeteAgreementsMember_lbl">Non-compete Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:title="label: NoncompeteAgreementsMember to us-gaap_NoncompeteAgreementsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl">Total other income and expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl1">Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US" id="us-gaap_NumberOfReportableSegments_lbl">Number of reportable segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" xlink:title="label: NumberOfReportableSegments to us-gaap_NumberOfReportableSegments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfReportableSegments_lbl1" xml:lang="en-US" id="us-gaap_NumberOfReportableSegments_lbl1">Number of Reportable Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl1" xlink:title="label: NumberOfReportableSegments to us-gaap_NumberOfReportableSegments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xml:lang="en-US" id="us-gaap_NumberOfStatesInWhichEntityOperates_lbl">Number of states where clinics are operated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesInWhichEntityOperates" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xlink:title="label: NumberOfStatesInWhichEntityOperates to us-gaap_NumberOfStatesInWhichEntityOperates_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments_lbl">Number of business segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xlink:title="label: NumberOfOperatingSegments to us-gaap_NumberOfOperatingSegments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfOperatingSegments_lbl1" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments_lbl1">Number of Operating Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl1" xlink:title="label: NumberOfOperatingSegments to us-gaap_NumberOfOperatingSegments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl">Number of businesses acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl1" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl1">Number of clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl1" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl2" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl2">Number of Businesses Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl2" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xlink:title="label: NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable to us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1">Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xlink:title="label: NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable to us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl">Non-Controlling Interests [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestMember_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl1">Noncontrolling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl1" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl">Current portion of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl">Weighted-average discount rate - Operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl">Operating lease liabilities, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl">Future Lease Payments for Operating Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US" id="us-gaap_OperatingLeasePayments_lbl">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:title="label: OperatingLeasePayments to us-gaap_OperatingLeasePayments_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl">Operating lease right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseCost_lbl">Operating lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:title="label: OperatingLeaseCost to us-gaap_OperatingLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl">Weighted-average remaining lease term - Operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl1">Operating Lease, Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingSegmentsMember_lbl" xml:lang="en-US" id="us-gaap_OperatingSegmentsMember_lbl">Reportable Segments [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl" xlink:title="label: OperatingSegmentsMember to us-gaap_OperatingSegmentsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Operating income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xml:lang="en-US" id="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherOperatingActivitiesCashFlowStatement" xlink:to="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:title="label: OtherOperatingActivitiesCashFlowStatement to us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsCurrent_lbl">Other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:title="label: OtherAssetsCurrent to us-gaap_OtherAssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsCurrent_lbl1">Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl1" xlink:title="label: OtherAssetsCurrent to us-gaap_OtherAssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl1">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl">Other income and expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:title="label: OtherNonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xlink:title="label: OtherNonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1">Other Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ParentMember_lbl" xml:lang="en-US" id="us-gaap_ParentMember_lbl">Total Shareholders' Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ParentMember_lbl1" xml:lang="en-US" id="us-gaap_ParentMember_lbl1">Parent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl1" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract_lbl">ACCRUED EXPENSES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsMinorityInterest_lbl">Distributions to non-controlling interest, permanent and temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:title="label: PaymentsOfDividendsMinorityInterest to us-gaap_PaymentsOfDividendsMinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xlink:title="label: PaymentsOfDividendsMinorityInterest to us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsCommonStock_lbl">Cash dividends paid to shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:title="label: PaymentsOfDividendsCommonStock to us-gaap_PaymentsOfDividendsCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsCommonStock_lbl1">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xlink:title="label: PaymentsOfDividendsCommonStock to us-gaap_PaymentsOfDividendsCommonStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl">Purchase of non-controlling interest, permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xlink:title="label: PaymentsToAcquireInterestInSubsidiariesAndAffiliates to us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xlink:title="label: PaymentsToAcquireInterestInSubsidiariesAndAffiliates to us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesGross_lbl">Cash paid for acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:title="label: PaymentsToAcquireBusinessesGross to us-gaap_PaymentsToAcquireBusinessesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesGross_lbl1">Payments to Acquire Businesses, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xlink:title="label: PaymentsToAcquireBusinessesGross to us-gaap_PaymentsToAcquireBusinessesGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl">Cash paid, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1">Purchase of majority interest in businesses, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_PaymentsToMinorityShareholders_lbl">Acquired interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:title="label: PaymentsToMinorityShareholders to us-gaap_PaymentsToMinorityShareholders_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl">Purchase of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl1">Payments to Acquire Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl1">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl1" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl">Preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl">Preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl">Preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract" xlink:label="PriorPeriodAdjustmentAbstract" xlink:title="PriorPeriodAdjustmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PriorPeriodAdjustmentAbstract_lbl" xml:lang="en-US" id="us-gaap_PriorPeriodAdjustmentAbstract_lbl">RECLASSIFICATION OF PRIOR PERIOD PRESENTATION [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_PriorPeriodAdjustmentAbstract_lbl" xlink:title="label: PriorPeriodAdjustmentAbstract to us-gaap_PriorPeriodAdjustmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:title="label: ProceedsFromPaymentsForOtherFinancingActivities to us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xlink:title="label: ProceedsFromPaymentsForOtherFinancingActivities to us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl">Purchases of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsToMinorityShareholders" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:title="label: ProceedsFromPaymentsToMinorityShareholders to us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl">Proceeds on sales of partnership interest, clinics and fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:title="label: ProceedsFromDivestitureOfBusinesses to us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromLinesOfCredit_lbl">Proceeds from revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:title="label: ProceedsFromLinesOfCredit to us-gaap_ProceedsFromLinesOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromLinesOfCredit_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromLinesOfCredit_lbl1">Proceeds from Lines of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl1" xlink:title="label: ProceedsFromLinesOfCredit to us-gaap_ProceedsFromLinesOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="ProceedsFromMinorityShareholders" xlink:title="ProceedsFromMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromMinorityShareholders_lbl">Notes receivable related to sale of partnership interest - redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromMinorityShareholders" xlink:to="us-gaap_ProceedsFromMinorityShareholders_lbl" xlink:title="label: ProceedsFromMinorityShareholders to us-gaap_ProceedsFromMinorityShareholders_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromMinorityShareholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromMinorityShareholders_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromMinorityShareholders_lbl1">Proceeds from Noncontrolling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromMinorityShareholders" xlink:to="us-gaap_ProceedsFromMinorityShareholders_lbl1" xlink:title="label: ProceedsFromMinorityShareholders to us-gaap_ProceedsFromMinorityShareholders_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProfitLoss_lbl" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl">Net income including non-controlling interest and earnings from unconsolidated affiliates, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_ProfitLoss_lbl1" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl1">Net income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl1" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProfitLoss_lbl2" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl2">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl2" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl">Estimated useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentAbstract_lbl">Long-Lived Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Fixed assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl1">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl">Fixed assets, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl1">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl">Fixed assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl">Provision for credit losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl1">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:title="label: RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability to us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:title="ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xml:lang="en-US" id="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl">Provision for Credit Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xlink:title="label: ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy to us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl">Redeemable Noncontrolling Interest, by Legal Entity [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xlink:title="label: RedeemableNoncontrollingInterestByLegalEntityTable to us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl">Redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3">Fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="RedeemableNoncontrollingInterestTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl">Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:title="label: RedeemableNoncontrollingInterestTableTextBlock to us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xlink:title="label: RedeemableNoncontrollingInterestTableTextBlock to us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl">Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xlink:title="label: RedeemableNoncontrollingInterestLineItems to us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl">Changes in Carrying Amount of Redeemable Non-Controlling Interests [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:title="label: RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyDomain_lbl">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xlink:title="label: RelatedPartyDomain to us-gaap_RelatedPartyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl">Principal payments on notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl1">Repayments of Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfLinesOfCredit_lbl">Payments on revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:title="label: RepaymentsOfLinesOfCredit to us-gaap_RepaymentsOfLinesOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfLinesOfCredit_lbl1">Repayments of Lines of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xlink:title="label: RepaymentsOfLinesOfCredit to us-gaap_RepaymentsOfLinesOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Retained earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerAbstract_lbl">REVENUE RECOGNITION [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:title="label: RevenueFromContractWithCustomerAbstract to us-gaap_RevenueFromContractWithCustomerAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:title="label: RevenueFromContractWithCustomerPolicyTextBlock to us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xlink:title="label: RevenueFromContractWithCustomerPolicyTextBlock to us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl">Net revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1">Revenue related to the various categories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="RevenueFromContractWithCustomerTextBlock" xlink:title="RevenueFromContractWithCustomerTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl">REVENUE RECOGNITION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:title="label: RevenueFromContractWithCustomerTextBlock to us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US" id="us-gaap_RevenuesAbstract_lbl">Revenues [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:title="label: RevenuesAbstract to us-gaap_RevenuesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Revenues_lbl" xml:lang="en-US" id="us-gaap_Revenues_lbl">Net operating revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:title="label: Revenues to us-gaap_Revenues_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US" id="us-gaap_RevolvingCreditFacilityMember_lbl">Credit Facility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:title="label: RevolvingCreditFacilityMember to us-gaap_RevolvingCreditFacilityMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevolvingCreditFacilityMember_lbl1" xml:lang="en-US" id="us-gaap_RevolvingCreditFacilityMember_lbl1">Revolving Credit Facility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl1" xlink:title="label: RevolvingCreditFacilityMember to us-gaap_RevolvingCreditFacilityMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl">Amortization of Customer and Referral Relationships and Non Competition Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:title="label: ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock to us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xlink:title="label: ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock to us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl">Aggregate Annual Payments of Principal Required to Revolving Credit Facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl">Intangible Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl">Schedule of Finite Lived Intangible Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTable to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl">Computations of Basic and Diluted Earnings Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="ScheduleOfDebtInstrumentsTextBlock" xlink:title="ScheduleOfDebtInstrumentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl">Credit Agreement and Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:title="label: ScheduleOfDebtInstrumentsTextBlock to us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xlink:title="label: ScheduleOfDebtInstrumentsTextBlock to us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:title="label: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="ScheduleOfEquityMethodInvestmentsLineItems" xlink:title="ScheduleOfEquityMethodInvestmentsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentsLineItems to us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="ScheduleOfEquityMethodInvestmentsTable" xlink:title="ScheduleOfEquityMethodInvestmentsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl">Schedule of Equity Method Investments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentsTable to us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="ScheduleOfGoodwillTextBlock" xlink:title="ScheduleOfGoodwillTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfGoodwillTextBlock_lbl">Changes in Carrying Amount of Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:title="label: ScheduleOfGoodwillTextBlock to us-gaap_ScheduleOfGoodwillTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfGoodwillTextBlock_lbl1">Schedule of Goodwill [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xlink:title="label: ScheduleOfGoodwillTextBlock to us-gaap_ScheduleOfGoodwillTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:title="label: ScheduleOfSegmentReportingInformationBySegmentTable to us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl">Selected Financial Data for Reportable Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:title="label: ScheduleOfSegmentReportingInformationBySegmentTextBlock to us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentDomain_lbl" xml:lang="en-US" id="us-gaap_SegmentDomain_lbl">Segments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl" xlink:title="label: SegmentDomain to us-gaap_SegmentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingInformationLineItems_lbl">Segment Reporting Information [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:title="label: SegmentReportingInformationLineItems to us-gaap_SegmentReportingInformationLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingAbstract_lbl">SEGMENT INFORMATION [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:title="label: SegmentReportingAbstract to us-gaap_SegmentReportingAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="SegmentReportingDisclosureTextBlock" xlink:title="SegmentReportingDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureTextBlock_lbl">SEGMENT INFORMATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:title="label: SegmentReportingDisclosureTextBlock to us-gaap_SegmentReportingDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl">Segment Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xlink:title="label: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1">Segment Reporting [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xlink:title="label: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl2" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl2">Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl2" xlink:title="label: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl">Segment Reporting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl">Corporate office costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1">Selling, General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US" id="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl">Acquisitions [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xlink:title="label: SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember to us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl">Equity-based awards compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US" id="us-gaap_SharesIssuedPricePerShare_lbl">Closing price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:title="label: SharesIssuedPricePerShare to us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeAxis_lbl">Short-term Debt, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:title="label: ShortTermDebtTypeAxis to us-gaap_ShortTermDebtTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US" id="us-gaap_ShortTermLeaseCost_lbl">Short-term lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:title="label: ShortTermLeaseCost to us-gaap_ShortTermLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeDomain_lbl" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeDomain_lbl">Short-term Debt, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:title="label: ShortTermDebtTypeDomain to us-gaap_ShortTermDebtTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementBusinessSegmentsAxis_lbl">Segments [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:title="label: StatementBusinessSegmentsAxis to us-gaap_StatementBusinessSegmentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl">Common stock authorized by the Board of Directors (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl">Issuance of restricted stock, net of cancellations (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl">Issuance of restricted stock, net of cancellations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US" id="us-gaap_StockRepurchasedDuringPeriodShares_lbl">Total purchased shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:title="label: StockRepurchasedDuringPeriodShares to us-gaap_StockRepurchasedDuringPeriodShares_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total USPH shareholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl">COMMON STOCK</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl">Total USPH shareholders' equity and non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityOther_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityOther_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl" xlink:title="label: StockholdersEquityOther to us-gaap_StockholdersEquityOther_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityOther_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityOther_lbl1">Stockholders' Equity, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl1" xlink:title="label: StockholdersEquityOther to us-gaap_StockholdersEquityOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl">U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl1">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl1" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_TaxesPayableCurrent_lbl">Federal taxes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:title="label: TaxesPayableCurrent to us-gaap_TaxesPayableCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TrademarksMember_lbl" xml:lang="en-US" id="us-gaap_TrademarksMember_lbl">Tradenames [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:title="label: TrademarksMember to us-gaap_TrademarksMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TrademarksMember_lbl1" xml:lang="en-US" id="us-gaap_TrademarksMember_lbl1">Trademarks [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl1" xlink:title="label: TrademarksMember to us-gaap_TrademarksMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl">Treasury stock at cost, 2,214,737 shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockValue_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl1">Treasury Stock, Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl1" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl">Treasury stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockShares_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl1">Treasury Stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl1" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockMember_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl1">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl1" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US" id="us-gaap_TypeOfAdoptionMember_lbl">Type of Adoption [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" xlink:title="label: TypeOfAdoptionMember to us-gaap_TypeOfAdoptionMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl">Accrued interest and penalties associated with any unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl">Unrecognized tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemDomain_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemDomain_lbl">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:title="label: UnusualOrInfrequentItemDomain to us-gaap_UnusualOrInfrequentItemDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemAxis_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemAxis_lbl">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:title="label: UnusualOrInfrequentItemAxis to us-gaap_UnusualOrInfrequentItemAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UseOfEstimates_lbl1" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl1">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl1" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US" id="us-gaap_VariableLeaseCost_lbl">Variable lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:title="label: VariableLeaseCost to us-gaap_VariableLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="VariableRateAxis" xlink:title="VariableRateAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableRateAxis_lbl" xml:lang="en-US" id="us-gaap_VariableRateAxis_lbl">Variable Rate [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" xlink:title="label: VariableRateAxis to us-gaap_VariableRateAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain" xlink:title="VariableRateDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableRateDomain_lbl" xml:lang="en-US" id="us-gaap_VariableRateDomain_lbl">Variable Rate [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl" xlink:title="label: VariableRateDomain to us-gaap_VariableRateDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl">Shares used in computation - diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1">Diluted earnings per share - weighted-average shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl">Shares used in computation - basic (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1">Basic earnings per share - weighted-average shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl">Shares used in computation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US" id="srt_ConsolidatedEntitiesDomain_lbl">Consolidated Entities [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl" xlink:title="label: ConsolidatedEntitiesDomain to srt_ConsolidatedEntitiesDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US" id="srt_ConsolidatedEntitiesAxis_lbl">Consolidated Entities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:title="label: ConsolidatedEntitiesAxis to srt_ConsolidatedEntitiesAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidationItemsDomain_lbl" xml:lang="en-US" id="srt_ConsolidationItemsDomain_lbl">Consolidation Items [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl" xlink:title="label: ConsolidationItemsDomain to srt_ConsolidationItemsDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidationItemsAxis_lbl" xml:lang="en-US" id="srt_ConsolidationItemsAxis_lbl">Consolidation Items [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl" xlink:title="label: ConsolidationItemsAxis to srt_ConsolidationItemsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:label xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_DirectorMember_lbl" xml:lang="en-US" id="srt_DirectorMember_lbl">Director [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:title="label: DirectorMember to srt_DirectorMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:label xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US" id="srt_EquityMethodInvesteeNameDomain_lbl">Investment, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl" xlink:title="label: EquityMethodInvesteeNameDomain to srt_EquityMethodInvesteeNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_MaximumMember_lbl" xml:lang="en-US" id="srt_MaximumMember_lbl">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:title="label: MaximumMember to srt_MaximumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember_lbl1" xml:lang="en-US" id="srt_MaximumMember_lbl1">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl1" xlink:title="label: MaximumMember to srt_MaximumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_MinimumMember_lbl" xml:lang="en-US" id="srt_MinimumMember_lbl">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:title="label: MinimumMember to srt_MinimumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember_lbl1" xml:lang="en-US" id="srt_MinimumMember_lbl1">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl1" xlink:title="label: MinimumMember to srt_MinimumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipDomain_lbl" xml:lang="en-US" id="srt_OwnershipDomain_lbl">Ownership [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl" xlink:title="label: OwnershipDomain to srt_OwnershipDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipAxis_lbl" xml:lang="en-US" id="srt_OwnershipAxis_lbl">Ownership [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:title="label: OwnershipAxis to srt_OwnershipAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:label xlink:type="resource" xlink:label="srt_OfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OfficerMember_lbl" xml:lang="en-US" id="srt_OfficerMember_lbl">Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OfficerMember" xlink:to="srt_OfficerMember_lbl" xlink:title="label: OfficerMember to srt_OfficerMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US" id="srt_ProductsAndServicesDomain_lbl">Products and Services [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" xlink:title="label: ProductsAndServicesDomain to srt_ProductsAndServicesDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ProductOrServiceAxis_lbl" xml:lang="en-US" id="srt_ProductOrServiceAxis_lbl">Products and Services [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:title="label: ProductOrServiceAxis to srt_ProductOrServiceAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember_lbl" xml:lang="en-US" id="srt_RangeMember_lbl">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl" xlink:title="label: RangeMember to srt_RangeMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis_lbl" xml:lang="en-US" id="srt_RangeAxis_lbl">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:title="label: RangeAxis to srt_RangeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioForecastMember_lbl" xml:lang="en-US" id="srt_ScenarioForecastMember_lbl">Forecast [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:title="label: ScenarioForecastMember to srt_ScenarioForecastMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" id="srt_ScenarioUnspecifiedDomain_lbl">Scenario [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xlink:title="label: ScenarioUnspecifiedDomain to srt_ScenarioUnspecifiedDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US" id="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl">Investment, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:label xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_StatementScenarioAxis_lbl" xml:lang="en-US" id="srt_StatementScenarioAxis_lbl">Scenario [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:title="label: StatementScenarioAxis to srt_StatementScenarioAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:label xlink:type="resource" xlink:label="srt_SubsidiariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_SubsidiariesMember_lbl" xml:lang="en-US" id="srt_SubsidiariesMember_lbl">NewCo. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiariesMember" xlink:to="srt_SubsidiariesMember_lbl" xlink:title="label: SubsidiariesMember to srt_SubsidiariesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl">Relationship to Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:title="label: TitleOfIndividualWithRelationshipToEntityDomain to srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="srt_TitleOfIndividualAxis_lbl">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:title="label: TitleOfIndividualAxis to srt_TitleOfIndividualAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="DocumentQuarterlyReport" xlink:title="DocumentQuarterlyReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US" id="dei_DocumentQuarterlyReport_lbl">Document Quarterly Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:title="label: DocumentQuarterlyReport to dei_DocumentQuarterlyReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentTransitionReport_lbl" xml:lang="en-US" id="dei_DocumentTransitionReport_lbl">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:title="label: DocumentTransitionReport to dei_DocumentTransitionReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" id="dei_EntityInteractiveDataCurrent_lbl">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:title="label: EntityInteractiveDataCurrent to dei_EntityInteractiveDataCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityShellCompany_lbl" xml:lang="en-US" id="dei_EntityShellCompany_lbl">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:title="label: EntityShellCompany to dei_EntityShellCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="dei_EntitySmallBusiness_lbl">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl">Amount of distributions during the period on mandatorily redeemable securities net of tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1">Revaluation of Redeemable Non-controlling Interest Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2">Revaluation of redeemable non-controlling interest, net of tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl">Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1">Net Income Loss Attributable To Noncontrolling Interest, Permanent Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2">Non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3">Net income attributable to non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ShortSwingProfitSettlement" xlink:label="ShortSwingProfitSettlement" xlink:title="ShortSwingProfitSettlement" />
    <link:label xlink:type="resource" xlink:label="usph_ShortSwingProfitSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShortSwingProfitSettlement_lbl" xml:lang="en-US" id="usph_ShortSwingProfitSettlement_lbl">Amount of short swing profit settlement from any purchase or sale (or sale and purchase) of the company's equity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortSwingProfitSettlement" xlink:to="usph_ShortSwingProfitSettlement_lbl" xlink:title="label: ShortSwingProfitSettlement to usph_ShortSwingProfitSettlement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShortSwingProfitSettlement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShortSwingProfitSettlement_lbl1" xml:lang="en-US" id="usph_ShortSwingProfitSettlement_lbl1">Short Swing Profit Settlement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortSwingProfitSettlement" xlink:to="usph_ShortSwingProfitSettlement_lbl1" xlink:title="label: ShortSwingProfitSettlement to usph_ShortSwingProfitSettlement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShortSwingProfitSettlement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ShortSwingProfitSettlement_lbl2" xml:lang="en-US" id="usph_ShortSwingProfitSettlement_lbl2">Short swing profit settlement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortSwingProfitSettlement" xlink:to="usph_ShortSwingProfitSettlement_lbl2" xlink:title="label: ShortSwingProfitSettlement to usph_ShortSwingProfitSettlement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl">Number of shares issued during the period related to redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1">Revaluation of Redeemable Non-controlling Interest Net of Tax, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2">Revaluation of redeemable non-controlling interest, net of tax (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:label="SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:title="SaleOfNonControllingInterestNetOfPurchasesAndTax" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl">Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:to="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl" xlink:title="label: SaleOfNonControllingInterestNetOfPurchasesAndTax to usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl1" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl1">Sale of Non-controlling Interest, Net of Purchases and Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:to="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl1" xlink:title="label: SaleOfNonControllingInterestNetOfPurchasesAndTax to usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl2" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl2">Sale of non-controlling interest, net of purchases and tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:to="usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl2" xlink:title="label: SaleOfNonControllingInterestNetOfPurchasesAndTax to usph_SaleOfNonControllingInterestNetOfPurchasesAndTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl">Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1">Transfer of Compensation Liability for Certain Stock Issued Pursuant to Incentive Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AccountsPayableDueToSellerOfAcquiredBusiness" xlink:label="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="AccountsPayableDueToSellerOfAcquiredBusiness" />
    <link:label xlink:type="resource" xlink:label="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl" xml:lang="en-US" id="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl">Carrying value as of the balance sheet date of obligations incurred related to accounts payable due to seller of acquired business.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:to="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl" xlink:title="label: AccountsPayableDueToSellerOfAcquiredBusiness to usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1" xml:lang="en-US" id="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1">Accounts Payable Due to Seller of Acquired Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:to="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1" xlink:title="label: AccountsPayableDueToSellerOfAcquiredBusiness to usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2" xml:lang="en-US" id="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2">Accounts payable - due to seller of acquired business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:to="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2" xlink:title="label: AccountsPayableDueToSellerOfAcquiredBusiness to usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CashPaidDuringPeriodForAbstract" xlink:label="CashPaidDuringPeriodForAbstract" xlink:title="CashPaidDuringPeriodForAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CashPaidDuringPeriodForAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashPaidDuringPeriodForAbstract_lbl1" xml:lang="en-US" id="usph_CashPaidDuringPeriodForAbstract_lbl1">Cash Paid During Period For [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="usph_CashPaidDuringPeriodForAbstract_lbl1" xlink:title="label: CashPaidDuringPeriodForAbstract to usph_CashPaidDuringPeriodForAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashPaidDuringPeriodForAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashPaidDuringPeriodForAbstract_lbl2" xml:lang="en-US" id="usph_CashPaidDuringPeriodForAbstract_lbl2">Cash paid during the period for:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="usph_CashPaidDuringPeriodForAbstract_lbl2" xlink:title="label: CashPaidDuringPeriodForAbstract to usph_CashPaidDuringPeriodForAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PurchaseOfBusinessSellerFinancingPortion" xlink:label="PurchaseOfBusinessSellerFinancingPortion" xlink:title="PurchaseOfBusinessSellerFinancingPortion" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl">Purchase of business - seller financing portion in noncash investing or financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1">Purchase of Business Seller Financing Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2">Purchase of businesses - seller financing portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl">The cash outflow associated with the acquisition of a redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1">Payments to Acquire Redeemable Non-controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2">Purchase of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DistributionsFromUnconsolidatedAffiliate" xlink:label="DistributionsFromUnconsolidatedAffiliate" xlink:title="DistributionsFromUnconsolidatedAffiliate" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsFromUnconsolidatedAffiliate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DistributionsFromUnconsolidatedAffiliate_lbl" xml:lang="en-US" id="usph_DistributionsFromUnconsolidatedAffiliate_lbl">The cash inflow associated with the distributions from unconsolidated affiliate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsFromUnconsolidatedAffiliate" xlink:to="usph_DistributionsFromUnconsolidatedAffiliate_lbl" xlink:title="label: DistributionsFromUnconsolidatedAffiliate to usph_DistributionsFromUnconsolidatedAffiliate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsFromUnconsolidatedAffiliate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DistributionsFromUnconsolidatedAffiliate_lbl1" xml:lang="en-US" id="usph_DistributionsFromUnconsolidatedAffiliate_lbl1">Distributions from Unconsolidated Affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsFromUnconsolidatedAffiliate" xlink:to="usph_DistributionsFromUnconsolidatedAffiliate_lbl1" xlink:title="label: DistributionsFromUnconsolidatedAffiliate to usph_DistributionsFromUnconsolidatedAffiliate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsFromUnconsolidatedAffiliate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DistributionsFromUnconsolidatedAffiliate_lbl2" xml:lang="en-US" id="usph_DistributionsFromUnconsolidatedAffiliate_lbl2">Distributions from unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsFromUnconsolidatedAffiliate" xlink:to="usph_DistributionsFromUnconsolidatedAffiliate_lbl2" xlink:title="label: DistributionsFromUnconsolidatedAffiliate to usph_DistributionsFromUnconsolidatedAffiliate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Notes Payable Related to Purchase of Redeemable Non-controlling Interest, Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Notes payable related to purchase of redeemable non-controlling interest, temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:label="PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:title="PaymentOfMedicareAcceleratedAndAdvanceFunds" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl" xml:lang="en-US" id="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl">Amount of cash outflow for payment of medicare accelerated and advance funds.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:to="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl" xlink:title="label: PaymentOfMedicareAcceleratedAndAdvanceFunds to usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl1" xml:lang="en-US" id="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl1">Payment of Medicare Accelerated and Advance Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:to="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl1" xlink:title="label: PaymentOfMedicareAcceleratedAndAdvanceFunds to usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl2" xml:lang="en-US" id="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl2">(Payment) receipt of Medicare Accelerated and Advance Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:to="usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl2" xlink:title="label: PaymentOfMedicareAcceleratedAndAdvanceFunds to usph_PaymentOfMedicareAcceleratedAndAdvanceFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:label="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl">The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1">Notes Payable Related to Purchase of Non-Controlling Interest, Permanent Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2">Notes payable due to purchase of non-controlling interest, permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProceedsFromSalesOfNonControllingInterestPermanent" xlink:label="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="ProceedsFromSalesOfNonControllingInterestPermanent" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl" xml:lang="en-US" id="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl">The cash inflow associated with the sales of non-controlling interest-permanent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:to="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl" xlink:title="label: ProceedsFromSalesOfNonControllingInterestPermanent to usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1" xml:lang="en-US" id="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1">Proceeds from Sales of Non-controlling Interest Permanent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:to="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1" xlink:title="label: ProceedsFromSalesOfNonControllingInterestPermanent to usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2" xml:lang="en-US" id="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2">Sales of non-controlling interest-permanent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:to="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2" xlink:title="label: ProceedsFromSalesOfNonControllingInterestPermanent to usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GainLossOnRevaluationOfPutRightLiability" xlink:label="GainLossOnRevaluationOfPutRightLiability" xlink:title="GainLossOnRevaluationOfPutRightLiability" />
    <link:label xlink:type="resource" xlink:label="usph_GainLossOnRevaluationOfPutRightLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_GainLossOnRevaluationOfPutRightLiability_lbl" xml:lang="en-US" id="usph_GainLossOnRevaluationOfPutRightLiability_lbl">Gain (loss) on revaluation of put-right liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRevaluationOfPutRightLiability" xlink:to="usph_GainLossOnRevaluationOfPutRightLiability_lbl" xlink:title="label: GainLossOnRevaluationOfPutRightLiability to usph_GainLossOnRevaluationOfPutRightLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_GainLossOnRevaluationOfPutRightLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_GainLossOnRevaluationOfPutRightLiability_lbl1" xml:lang="en-US" id="usph_GainLossOnRevaluationOfPutRightLiability_lbl1">Gain (loss) on revaluation of put-right liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRevaluationOfPutRightLiability" xlink:to="usph_GainLossOnRevaluationOfPutRightLiability_lbl1" xlink:title="label: GainLossOnRevaluationOfPutRightLiability to usph_GainLossOnRevaluationOfPutRightLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_GainLossOnRevaluationOfPutRightLiability_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_GainLossOnRevaluationOfPutRightLiability_lbl2" xml:lang="en-US" id="usph_GainLossOnRevaluationOfPutRightLiability_lbl2">Gain on revaluation of put-right liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRevaluationOfPutRightLiability" xlink:to="usph_GainLossOnRevaluationOfPutRightLiability_lbl2" xlink:title="label: GainLossOnRevaluationOfPutRightLiability to usph_GainLossOnRevaluationOfPutRightLiability_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_GainLossOnRevaluationOfPutRightLiability_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_GainLossOnRevaluationOfPutRightLiability_lbl3" xml:lang="en-US" id="usph_GainLossOnRevaluationOfPutRightLiability_lbl3">Gain on revaluation of put-right liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRevaluationOfPutRightLiability" xlink:to="usph_GainLossOnRevaluationOfPutRightLiability_lbl3" xlink:title="label: GainLossOnRevaluationOfPutRightLiability to usph_GainLossOnRevaluationOfPutRightLiability_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1" xml:lang="en-US" id="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1">REDEEMABLE NON-CONTROLLING INTEREST [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1" xlink:title="label: REDEEMABLENONCONTROLLINGINTERESTAbstract to usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestTextBlock" xlink:label="RedeemableNonControllingInterestTextBlock" xlink:title="RedeemableNonControllingInterestTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl">The entire disclosure for a redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl1">Redeemable Non-Controlling Interest [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl1" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl2">REDEEMABLE NON-CONTROLLING INTEREST</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl2" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:label="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl">Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1">Carrying Amount of Redeemable Non-Controlling Interest [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2">Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl">Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1">Net Income Loss Attributable To Redeemable Noncontrolling Interest temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2">Redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3">Operating results allocated to redeemable non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_InterestExpenseDebtAndOther_lbl" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl">Debt related expenses and other expenses associated with nonoperating financing activities of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_InterestExpenseDebtAndOther_lbl1" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl1">Interest Expense, Debt and Other Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl1" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_InterestExpenseDebtAndOther_lbl2" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl2">Interest expense - debt and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl2" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl">Amount of expense related to rent, supplies, contract labor and other.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl1" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl1">Rent Supplies Contract Labor And Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl1" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl2" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl2">Rent, supplies, contract labor and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl2" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetPatientRevenuesMember_lbl" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl">Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetPatientRevenuesMember_lbl1" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl1">Net Patient Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl1" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetPatientRevenuesMember_lbl2" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl2">Net Patient Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl2" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl">Other revenues includes management contract revenues, industrial injury prevention services revenues and services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1">Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2">Other Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl">Percentage of repurchase of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl1">Percentage Of Repurchase Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl2">Percentage of repurchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl">Bank credit agreement to permit share repurchases of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1">Bank Credit Agreement To Permit Share Repurchases Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2">Bank credit agreement to permit share repurchases of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl">Additional estimated repurchase of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1">Additional Estimated Repurchase Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2">Additional estimated shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DepreciationAmortizationImpairmentTable_lbl" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentTable_lbl">A table or schedule providing information pertaining to depreciation amortization impairment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="usph_DepreciationAmortizationImpairmentTable_lbl" xlink:title="label: DepreciationAmortizationImpairmentTable to usph_DepreciationAmortizationImpairmentTable_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DepreciationAmortizationImpairmentTable_lbl1" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentTable_lbl1">Depreciation Amortization Impairment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="usph_DepreciationAmortizationImpairmentTable_lbl1" xlink:title="label: DepreciationAmortizationImpairmentTable to usph_DepreciationAmortizationImpairmentTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl">Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1">Medicare Accelerated and Advance Payments Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2">Medicare Accelerated and Advance Payments Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DepreciationAmortizationImpairmentLineItems_lbl" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentLineItems_lbl">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="usph_DepreciationAmortizationImpairmentLineItems_lbl" xlink:title="label: DepreciationAmortizationImpairmentLineItems to usph_DepreciationAmortizationImpairmentLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentLineItems_lbl1">Depreciation Amortization Impairment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xlink:title="label: DepreciationAmortizationImpairmentLineItems to usph_DepreciationAmortizationImpairmentLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfRegions_lbl" xml:lang="en-US" id="usph_NumberOfRegions_lbl">Number of regions of the entity operates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfRegions_lbl1" xml:lang="en-US" id="usph_NumberOfRegions_lbl1">Number of regions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl1" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfRegions_lbl2" xml:lang="en-US" id="usph_NumberOfRegions_lbl2">Number of regions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl2" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl">Acquisition of part of a company which provides services include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1">Leading Provider of Industrial Injury Prevention [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2">IIPS [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReturnToWorkAndErgonomicServicesMember" xlink:label="ReturnToWorkAndErgonomicServicesMember" xlink:title="ReturnToWorkAndErgonomicServicesMember" />
    <link:label xlink:type="resource" xlink:label="usph_ReturnToWorkAndErgonomicServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReturnToWorkAndErgonomicServicesMember_lbl" xml:lang="en-US" id="usph_ReturnToWorkAndErgonomicServicesMember_lbl">Acquisition of a company which has return-to-work and ergonomic services among other offerings.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReturnToWorkAndErgonomicServicesMember" xlink:to="usph_ReturnToWorkAndErgonomicServicesMember_lbl" xlink:title="label: ReturnToWorkAndErgonomicServicesMember to usph_ReturnToWorkAndErgonomicServicesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReturnToWorkAndErgonomicServicesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReturnToWorkAndErgonomicServicesMember_lbl1" xml:lang="en-US" id="usph_ReturnToWorkAndErgonomicServicesMember_lbl1">Return to Work and Ergonomic Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReturnToWorkAndErgonomicServicesMember" xlink:to="usph_ReturnToWorkAndErgonomicServicesMember_lbl1" xlink:title="label: ReturnToWorkAndErgonomicServicesMember to usph_ReturnToWorkAndErgonomicServicesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReturnToWorkAndErgonomicServicesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReturnToWorkAndErgonomicServicesMember_lbl2" xml:lang="en-US" id="usph_ReturnToWorkAndErgonomicServicesMember_lbl2">Return-to-work and Ergonomic Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReturnToWorkAndErgonomicServicesMember" xlink:to="usph_ReturnToWorkAndErgonomicServicesMember_lbl2" xlink:title="label: ReturnToWorkAndErgonomicServicesMember to usph_ReturnToWorkAndErgonomicServicesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BasisOfPresentationAbstract" xlink:label="BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_BasisOfPresentationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BasisOfPresentationAbstract_lbl1" xml:lang="en-US" id="usph_BasisOfPresentationAbstract_lbl1">Basis of Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfPresentationAbstract" xlink:to="usph_BasisOfPresentationAbstract_lbl1" xlink:title="label: BasisOfPresentationAbstract to usph_BasisOfPresentationAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BasisOfPresentationAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BasisOfPresentationAbstract_lbl2" xml:lang="en-US" id="usph_BasisOfPresentationAbstract_lbl2">Basis of Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfPresentationAbstract" xlink:to="usph_BasisOfPresentationAbstract_lbl2" xlink:title="label: BasisOfPresentationAbstract to usph_BasisOfPresentationAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl">Percentage of limited partnership interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1">Percentage Of Limited Partnership Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2">Percentage of limited partnership interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_GrantsAndOtherFunds_lbl" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl">Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_GrantsAndOtherFunds_lbl1" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl1">Grants and Other Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl1" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_GrantsAndOtherFunds_lbl2" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl2">Grants and other funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl2" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfOperatingClinicLocations_lbl" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl">Number of operating clinic locations during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfOperatingClinicLocations_lbl1" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl1">Number of Operating Clinic Locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl1" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfOperatingClinicLocations_lbl2" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl2">Number of operating clinic locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl2" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeeMember_lbl" xml:lang="en-US" id="usph_EmployeeMember_lbl">Person who is employed by the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="usph_EmployeeMember_lbl" xlink:title="label: EmployeeMember to usph_EmployeeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeeMember_lbl1" xml:lang="en-US" id="usph_EmployeeMember_lbl1">Employee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="usph_EmployeeMember_lbl1" xlink:title="label: EmployeeMember to usph_EmployeeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestRedeemableAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonControllingInterestRedeemableAbstract_lbl1" xml:lang="en-US" id="usph_NonControllingInterestRedeemableAbstract_lbl1">Non-Controlling Interest, Redeemable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="usph_NonControllingInterestRedeemableAbstract_lbl1" xlink:title="label: NonControllingInterestRedeemableAbstract to usph_NonControllingInterestRedeemableAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestRedeemableAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NonControllingInterestRedeemableAbstract_lbl2" xml:lang="en-US" id="usph_NonControllingInterestRedeemableAbstract_lbl2">Redeemable Non-Controlling Interests [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="usph_NonControllingInterestRedeemableAbstract_lbl2" xlink:title="label: NonControllingInterestRedeemableAbstract to usph_NonControllingInterestRedeemableAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl">The commencement period of redemption rights for redeemable non controlling interest, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1">Redeemable Non-controlling Interest, Redemption Rights, Commencement Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2">Redeemable non-controlling interest, redemption rights, commencement period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ManagementContractsMember_lbl" xml:lang="en-US" id="usph_ManagementContractsMember_lbl">Acquisition of part of a company which holds management contracts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractsMember" xlink:to="usph_ManagementContractsMember_lbl" xlink:title="label: ManagementContractsMember to usph_ManagementContractsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ManagementContractsMember_lbl1" xml:lang="en-US" id="usph_ManagementContractsMember_lbl1">Management Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractsMember" xlink:to="usph_ManagementContractsMember_lbl1" xlink:title="label: ManagementContractsMember to usph_ManagementContractsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableOneMember_lbl" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableOneMember_lbl1" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl1">Notes Payable One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl1" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableOneMember_lbl2" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl2">Notes Payable One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl2" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableTwoMember_lbl" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableTwoMember_lbl1" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl1">Notes Payable Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl1" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableTwoMember_lbl2" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl2">Notes Payable Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl2" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:label xlink:type="resource" xlink:label="usph_ClinicPracticeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ClinicPracticeMember_lbl" xml:lang="en-US" id="usph_ClinicPracticeMember_lbl">Acquisition of part of a company which provides clinic practice services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClinicPracticeMember" xlink:to="usph_ClinicPracticeMember_lbl" xlink:title="label: ClinicPracticeMember to usph_ClinicPracticeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ClinicPracticeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ClinicPracticeMember_lbl1" xml:lang="en-US" id="usph_ClinicPracticeMember_lbl1">Clinic Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClinicPracticeMember" xlink:to="usph_ClinicPracticeMember_lbl1" xlink:title="label: ClinicPracticeMember to usph_ClinicPracticeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl">Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1">Public Health and Social Services Emergency Fund [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2">Public Health and Social Services Emergency Fund [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RepaymentOfFunds" xlink:label="RepaymentOfFunds" xlink:title="RepaymentOfFunds" />
    <link:label xlink:type="resource" xlink:label="usph_RepaymentOfFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RepaymentOfFunds_lbl" xml:lang="en-US" id="usph_RepaymentOfFunds_lbl">The amount of repayment to Medicare Accelerated and Advance Payment Program ("MAAPP Funds") rather than applying them to future services performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentOfFunds" xlink:to="usph_RepaymentOfFunds_lbl" xlink:title="label: RepaymentOfFunds to usph_RepaymentOfFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RepaymentOfFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RepaymentOfFunds_lbl1" xml:lang="en-US" id="usph_RepaymentOfFunds_lbl1">Repayment of Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentOfFunds" xlink:to="usph_RepaymentOfFunds_lbl1" xlink:title="label: RepaymentOfFunds to usph_RepaymentOfFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RepaymentOfFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RepaymentOfFunds_lbl2" xml:lang="en-US" id="usph_RepaymentOfFunds_lbl2">Repayment of funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentOfFunds" xlink:to="usph_RepaymentOfFunds_lbl2" xlink:title="label: RepaymentOfFunds to usph_RepaymentOfFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfThirdPartyFacilities_lbl" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl">Number of third party facilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfThirdPartyFacilities_lbl1" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl1">Number Of Third Party Facilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl1" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfThirdPartyFacilities_lbl2" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl2">Number of third party facilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl2" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl">Percentage of general partnership interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1">Percentage Of General Partnership Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2">Percentage of general partnership interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BriotixHealthLimitedPartnershipMember" xlink:label="BriotixHealthLimitedPartnershipMember" xlink:title="BriotixHealthLimitedPartnershipMember" />
    <link:label xlink:type="resource" xlink:label="usph_BriotixHealthLimitedPartnershipMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BriotixHealthLimitedPartnershipMember_lbl" xml:lang="en-US" id="usph_BriotixHealthLimitedPartnershipMember_lbl">Name of the entity in which interest is acquired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BriotixHealthLimitedPartnershipMember" xlink:to="usph_BriotixHealthLimitedPartnershipMember_lbl" xlink:title="label: BriotixHealthLimitedPartnershipMember to usph_BriotixHealthLimitedPartnershipMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BriotixHealthLimitedPartnershipMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BriotixHealthLimitedPartnershipMember_lbl1" xml:lang="en-US" id="usph_BriotixHealthLimitedPartnershipMember_lbl1">Briotix Health, Limited Partnership [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BriotixHealthLimitedPartnershipMember" xlink:to="usph_BriotixHealthLimitedPartnershipMember_lbl1" xlink:title="label: BriotixHealthLimitedPartnershipMember to usph_BriotixHealthLimitedPartnershipMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BriotixHealthLimitedPartnershipMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BriotixHealthLimitedPartnershipMember_lbl2" xml:lang="en-US" id="usph_BriotixHealthLimitedPartnershipMember_lbl2">Briotix Health [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BriotixHealthLimitedPartnershipMember" xlink:to="usph_BriotixHealthLimitedPartnershipMember_lbl2" xlink:title="label: BriotixHealthLimitedPartnershipMember to usph_BriotixHealthLimitedPartnershipMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MultiClinicPracticesMember" xlink:label="MultiClinicPracticesMember" xlink:title="MultiClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_MultiClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MultiClinicPracticesMember_lbl" xml:lang="en-US" id="usph_MultiClinicPracticesMember_lbl">Acquisition of part of a company which provides multi-clinic practice services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MultiClinicPracticesMember" xlink:to="usph_MultiClinicPracticesMember_lbl" xlink:title="label: MultiClinicPracticesMember to usph_MultiClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MultiClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MultiClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_MultiClinicPracticesMember_lbl1">Multi-Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MultiClinicPracticesMember" xlink:to="usph_MultiClinicPracticesMember_lbl1" xlink:title="label: MultiClinicPracticesMember to usph_MultiClinicPracticesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MultiClinicPracticesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MultiClinicPracticesMember_lbl2" xml:lang="en-US" id="usph_MultiClinicPracticesMember_lbl2">Multi-Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MultiClinicPracticesMember" xlink:to="usph_MultiClinicPracticesMember_lbl2" xlink:title="label: MultiClinicPracticesMember to usph_MultiClinicPracticesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_December2021AcquisitionMember" xlink:label="December2021AcquisitionMember" xlink:title="December2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_December2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_December2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_December2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2021AcquisitionMember" xlink:to="usph_December2021AcquisitionMember_lbl" xlink:title="label: December2021AcquisitionMember to usph_December2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_December2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_December2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_December2021AcquisitionMember_lbl1">December 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2021AcquisitionMember" xlink:to="usph_December2021AcquisitionMember_lbl1" xlink:title="label: December2021AcquisitionMember to usph_December2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_November2021AcquisitionMember" xlink:label="November2021AcquisitionMember" xlink:title="November2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_November2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_November2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_November2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2021AcquisitionMember" xlink:to="usph_November2021AcquisitionMember_lbl" xlink:title="label: November2021AcquisitionMember to usph_November2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_November2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_November2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_November2021AcquisitionMember_lbl1">November 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2021AcquisitionMember" xlink:to="usph_November2021AcquisitionMember_lbl1" xlink:title="label: November2021AcquisitionMember to usph_November2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_September2021AcquisitionMember" xlink:label="September2021AcquisitionMember" xlink:title="September2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_September2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_September2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_September2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2021AcquisitionMember" xlink:to="usph_September2021AcquisitionMember_lbl" xlink:title="label: September2021AcquisitionMember to usph_September2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_September2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_September2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_September2021AcquisitionMember_lbl1">September 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2021AcquisitionMember" xlink:to="usph_September2021AcquisitionMember_lbl1" xlink:title="label: September2021AcquisitionMember to usph_September2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_June2021AcquisitionMember" xlink:label="June2021AcquisitionMember" xlink:title="June2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_June2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_June2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_June2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="June2021AcquisitionMember" xlink:to="usph_June2021AcquisitionMember_lbl" xlink:title="label: June2021AcquisitionMember to usph_June2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_June2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_June2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_June2021AcquisitionMember_lbl1">June 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="June2021AcquisitionMember" xlink:to="usph_June2021AcquisitionMember_lbl1" xlink:title="label: June2021AcquisitionMember to usph_June2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_March2021AcquisitionMember" xlink:label="March2021AcquisitionMember" xlink:title="March2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_March2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_March2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_March2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="March2021AcquisitionMember" xlink:to="usph_March2021AcquisitionMember_lbl" xlink:title="label: March2021AcquisitionMember to usph_March2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_March2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_March2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_March2021AcquisitionMember_lbl1">March 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="March2021AcquisitionMember" xlink:to="usph_March2021AcquisitionMember_lbl1" xlink:title="label: March2021AcquisitionMember to usph_March2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_March2022AcquisitionMember" xlink:label="March2022AcquisitionMember" xlink:title="March2022AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_March2022AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_March2022AcquisitionMember_lbl" xml:lang="en-US" id="usph_March2022AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="March2022AcquisitionMember" xlink:to="usph_March2022AcquisitionMember_lbl" xlink:title="label: March2022AcquisitionMember to usph_March2022AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_March2022AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_March2022AcquisitionMember_lbl1" xml:lang="en-US" id="usph_March2022AcquisitionMember_lbl1">March 2022 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="March2022AcquisitionMember" xlink:to="usph_March2022AcquisitionMember_lbl1" xlink:title="label: March2022AcquisitionMember to usph_March2022AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_JointVentureInterestMember" xlink:label="JointVentureInterestMember" xlink:title="JointVentureInterestMember" />
    <link:label xlink:type="resource" xlink:label="usph_JointVentureInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_JointVentureInterestMember_lbl" xml:lang="en-US" id="usph_JointVentureInterestMember_lbl">The joint venture interest in entity which provides physical therapy services for patients at hospitals</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JointVentureInterestMember" xlink:to="usph_JointVentureInterestMember_lbl" xlink:title="label: JointVentureInterestMember to usph_JointVentureInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_JointVentureInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_JointVentureInterestMember_lbl1" xml:lang="en-US" id="usph_JointVentureInterestMember_lbl1">Joint Venture Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JointVentureInterestMember" xlink:to="usph_JointVentureInterestMember_lbl1" xlink:title="label: JointVentureInterestMember to usph_JointVentureInterestMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_JointVentureInterestMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_JointVentureInterestMember_lbl2" xml:lang="en-US" id="usph_JointVentureInterestMember_lbl2">Joint Venture Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JointVentureInterestMember" xlink:to="usph_JointVentureInterestMember_lbl2" xlink:title="label: JointVentureInterestMember to usph_JointVentureInterestMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:label="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl" xml:lang="en-US" id="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl">Amount of consideration transferred including contingent consideration, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:to="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl" xlink:title="label: BusinessCombinationConsiderationTransferredIncludesContingentConsideration to usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1" xml:lang="en-US" id="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1">Business Combination, Consideration Transferred, Includes Contingent Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:to="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1" xlink:title="label: BusinessCombinationConsiderationTransferredIncludesContingentConsideration to usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2" xml:lang="en-US" id="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2">Aggregate purchase price for the acquisition including contingent consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:to="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2" xlink:title="label: BusinessCombinationConsiderationTransferredIncludesContingentConsideration to usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:label="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl" xml:lang="en-US" id="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl">Amount of liability recognized arising from contingent consideration upon on achievement of certain business criteria in a business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:to="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl" xlink:title="label: BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria to usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1" xml:lang="en-US" id="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1">Business Combination, Contingent Consideration, Payable on Achievement of Certain Business Criteria</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:to="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1" xlink:title="label: BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria to usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2" xml:lang="en-US" id="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2">Amount payable upon achievement of certain business criteria</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:to="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2" xlink:title="label: BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria to usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl">Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1">Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2">Estimated useful lives of acquired intangibles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RemainingContractTerm_lbl" xml:lang="en-US" id="usph_RemainingContractTerm_lbl">Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RemainingContractTerm_lbl1" xml:lang="en-US" id="usph_RemainingContractTerm_lbl1">Remaining Contract Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl1" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RemainingContractTerm_lbl2" xml:lang="en-US" id="usph_RemainingContractTerm_lbl2">Remaining contract term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl2" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReferralRelationshipMember_lbl" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl">Referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReferralRelationshipMember_lbl1" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl1">Referral Relationship [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl1" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ReferralRelationshipMember_lbl2" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl2">Referral Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl2" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xml:lang="en-US" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1">Estimated Fair Value Of Net Tangible Assets Acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xlink:title="label: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xml:lang="en-US" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2">Estimated fair value of net tangible assets acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xlink:title="label: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl">The amount of non-competition agreements recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2">Non-compete agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl">Amount of net tangible asset acquired at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1">Business Acquisition Purchase Price Allocation Net Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2">Net tangible assets acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl">The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1">Business Acquisition Cost Of Acquired Entity Debt Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2">Seller notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl">The amount of tradename recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2">Tradenames</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl">Amount of referral relationships at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2">Customer and referral relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl">Payments to acquire businesses total consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl1">Payments To Acquire Businesses Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl2">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl3">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:label="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl">Percentage of voting equity interests retained by practice founder at the acquisition date in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:to="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl" xlink:title="label: BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder to usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1">Business Acquisition, Percentage of Interest Retained by Practice Founder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:to="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder to usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2">Percentage of interest retained by practice founder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:to="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder to usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PhysicalTherapyOperationsMember_lbl" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl">Physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PhysicalTherapyOperationsMember_lbl1" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl1">Physical Therapy Operations [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl1" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PhysicalTherapyOperationsMember_lbl2" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl2">Physical Therapy Operations [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl2" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PreviousOwnersMember" xlink:label="PreviousOwnersMember" xlink:title="PreviousOwnersMember" />
    <link:label xlink:type="resource" xlink:label="usph_PreviousOwnersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PreviousOwnersMember_lbl" xml:lang="en-US" id="usph_PreviousOwnersMember_lbl">Refers to the previous owners who maintain a minority interest after acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreviousOwnersMember" xlink:to="usph_PreviousOwnersMember_lbl" xlink:title="label: PreviousOwnersMember to usph_PreviousOwnersMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PreviousOwnersMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PreviousOwnersMember_lbl1" xml:lang="en-US" id="usph_PreviousOwnersMember_lbl1">Previous Owners [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreviousOwnersMember" xlink:to="usph_PreviousOwnersMember_lbl1" xlink:title="label: PreviousOwnersMember to usph_PreviousOwnersMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PreviousOwnersMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PreviousOwnersMember_lbl2" xml:lang="en-US" id="usph_PreviousOwnersMember_lbl2">Previous Owners [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreviousOwnersMember" xlink:to="usph_PreviousOwnersMember_lbl2" xlink:title="label: PreviousOwnersMember to usph_PreviousOwnersMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl">This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1">Business Combination Acquisition Fair Value of Redeemable Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestsPolicyTextBlock" xlink:label="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="RedeemableNonControllingInterestsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl">Disclosure of accounting policy for redeemable non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1">Redeemable Non Controlling Interests [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2">Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonControllingInterestsPolicyPolicyTextBlock" xlink:label="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="NonControllingInterestsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1">Non controlling Interests Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2">Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_SelfInsuranceProgramPolicyPolicyTextBlock" xlink:label="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="SelfInsuranceProgramPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for self-insurance program.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1">Self Insurance Program Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2">Self-Insurance Program</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RestrictedStockPolicyPolicyTextBlock" xlink:label="RestrictedStockPolicyPolicyTextBlock" xlink:title="RestrictedStockPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for restricted stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl1">Restricted Stock Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl2">Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xml:lang="en-US" id="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1">Average Lease Terms and Discount Rates [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xlink:title="label: AverageLeaseTermsAndDiscountRatesAbstract to usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xml:lang="en-US" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1">Supplemental Information Related to Operating Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xlink:title="label: SupplementalInformationRelatedToOperatingLeasesAbstract to usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xml:lang="en-US" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2">Supplemental Information Related to Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xlink:title="label: SupplementalInformationRelatedToOperatingLeasesAbstract to usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualAllowancesAbstract" xlink:label="ContractualAllowancesAbstract" xlink:title="ContractualAllowancesAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualAllowancesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualAllowancesAbstract_lbl1" xml:lang="en-US" id="usph_ContractualAllowancesAbstract_lbl1">Contractual Allowances [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualAllowancesAbstract" xlink:to="usph_ContractualAllowancesAbstract_lbl1" xlink:title="label: ContractualAllowancesAbstract to usph_ContractualAllowancesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl">Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1">Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl">Maximum contractual allowance reserve estimate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl1">Maximum Contractual Allowance Reserve Estimate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl2">Maximum contractual allowance reserve estimate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:label="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl" xml:lang="en-US" id="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl">Insurance products service years.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:to="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl" xlink:title="label: FromTwoThousandSeventeenThroughTwoThousandNineteenMember to usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1" xml:lang="en-US" id="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1">From Two Thousand Seventeen Through Two Thousand Nineteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:to="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1" xlink:title="label: FromTwoThousandSeventeenThroughTwoThousandNineteenMember to usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2" xml:lang="en-US" id="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2">From 2017 through 2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:to="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2" xlink:title="label: FromTwoThousandSeventeenThroughTwoThousandNineteenMember to usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareReimbursementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareReimbursementAbstract_lbl1" xml:lang="en-US" id="usph_MedicareReimbursementAbstract_lbl1">Medicare Reimbursement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareReimbursementAbstract" xlink:to="usph_MedicareReimbursementAbstract_lbl1" xlink:title="label: MedicareReimbursementAbstract to usph_MedicareReimbursementAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl">Percentage of payment reduction waived through enacted additional legislation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislation to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1">Percentage of Payment Reduction Waived Through Enacted Legislation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislation to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2">Percentage of payment reduction waived through enacted legislation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislation to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:label="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:title="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl" xml:lang="en-US" id="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl">Percentage of reduction in Medicare payments for services performed by a physical or occupational therapist.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:to="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl" xlink:title="label: PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist to usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl1" xml:lang="en-US" id="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl1">Percentage of reduction in Medicare payments for services performed by a physical or occupational therapist</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:to="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl1" xlink:title="label: PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist to usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl2" xml:lang="en-US" id="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl2">Percentage of reduction in Medicare payments for services performed by a physical or occupational therapist</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:to="usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl2" xlink:title="label: PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist to usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl">Reduction in Medicare spending percentage during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl1" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl1">Reduction In Medicare Spending Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl1" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl2" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl2">Medicare spending cut percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl2" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl" xml:lang="en-US" id="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl">Percentage of increase in payment adjustment for therapists participating in Merit Based Incentive Payment System (MIPS).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl" xlink:title="label: PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xml:lang="en-US" id="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1">Percentage of Increase in Payment Adjustment for Therapists Participating in Merit Based Incentive Payment System</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xlink:title="label: PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xml:lang="en-US" id="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2">Percentage of increase in payment adjustment for therapists participating in MIPS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xlink:title="label: PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl">Amount of reductions in federal spending during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl1" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl1">Amount Of Reductions In Federal Spending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl1" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl2" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl2">Reductions in federal spending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl2" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl" xml:lang="en-US" id="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl">Percentage of therapist providers participating in Merit Based Incentive Payment System (MIPS).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl" xlink:title="label: PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xml:lang="en-US" id="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1">Percentage of Therapist Providers Participating in Merit Based Incentive Payment System</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xlink:title="label: PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xml:lang="en-US" id="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2">Percentage of therapist providers participating in MIPS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xlink:title="label: PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl">Refers to the percentage of payment for outpatient therapy services to the therapy assistant.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1">Percentage of Payment for Outpatient Therapy Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2">Percentage of payment for outpatient therapy services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl">Percentage of Medicare payment increase during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl1" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl1">Percentage Of Medicare Payment increase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl1" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl2" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl2">Percentage of increase in Medicare payment rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl2" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl">Percentage reduction for service in office or other non institutional settings during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1">Percentage Reduction For Service In Office Or Other Non Institutional Settings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2">Percentage reduction for service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl">Insurance products service years.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1">From Two Thousand Twenty Through Two Thousand Twenty Five [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2">From 2020 through 2025 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:label="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:title="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" />
    <link:label xlink:type="resource" xlink:label="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl" xml:lang="en-US" id="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl">Extension term for sequester relief applied to all Medicare payments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:to="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl" xlink:title="label: ExtensionTermForSequesterReliefAppliedToAllMedicarePayments to usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl1" xml:lang="en-US" id="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl1">Extension term for sequester relief applied to all Medicare payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:to="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl1" xlink:title="label: ExtensionTermForSequesterReliefAppliedToAllMedicarePayments to usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl2" xml:lang="en-US" id="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl2">Term for sequester relief applied to all Medicare payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:to="usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl2" xlink:title="label: ExtensionTermForSequesterReliefAppliedToAllMedicarePayments to usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:label="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:title="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl" xml:lang="en-US" id="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl">The percentage of sequester relief applied to all Medicare payments through June 30, 2022.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:to="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl" xlink:title="label: PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo to usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl1" xml:lang="en-US" id="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl1">Percentage Of Sequester Relief Applied To All Medicare Payments Through Period Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:to="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl1" xlink:title="label: PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo to usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl2" xml:lang="en-US" id="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl2">Percentage of sequester relief applied to all Medicare payments through June 30, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:to="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl2" xlink:title="label: PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo to usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:label="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:title="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl" xml:lang="en-US" id="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl">The percentage of sequester relief applied to all Medicare payments through March 31, 2022.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:to="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl" xlink:title="label: PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne to usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl1" xml:lang="en-US" id="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl1">Percentage of sequester relief applied to all Medicare payments through Period One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:to="usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl1" xlink:title="label: PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne to usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl">Difference between net revenues and corresponding cash collections reflected percentage of net revenues.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1">Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2">Difference between net revenues and corresponding cash collections, approximately of net revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetRevenueFromMedicare_lbl" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl">Net revenue from Medicare.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetRevenueFromMedicare_lbl1" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl1">Net revenue from Medicare</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl1" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetRevenueFromMedicare_lbl2" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl2">Net patient revenue from Medicare accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl2" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl">Combined physical therapy/speech language pathology expenses during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1">Combined Physical Therapy Speech Language Pathology Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2">Combined physical therapy/speech language pathology expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl">Percentage of practice expense component of relative value unit during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1">Percentage Of Practice Expense Component Of Relative Value Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2">Percentage of practice expense component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CentersForMedicareAndMedicaidServicesMember" xlink:label="CentersForMedicareAndMedicaidServicesMember" xlink:title="CentersForMedicareAndMedicaidServicesMember" />
    <link:label xlink:type="resource" xlink:label="usph_CentersForMedicareAndMedicaidServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CentersForMedicareAndMedicaidServicesMember_lbl" xml:lang="en-US" id="usph_CentersForMedicareAndMedicaidServicesMember_lbl">An approval authority for Medicare services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CentersForMedicareAndMedicaidServicesMember" xlink:to="usph_CentersForMedicareAndMedicaidServicesMember_lbl" xlink:title="label: CentersForMedicareAndMedicaidServicesMember to usph_CentersForMedicareAndMedicaidServicesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CentersForMedicareAndMedicaidServicesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CentersForMedicareAndMedicaidServicesMember_lbl1" xml:lang="en-US" id="usph_CentersForMedicareAndMedicaidServicesMember_lbl1">Centers for Medicare and Medicaid Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CentersForMedicareAndMedicaidServicesMember" xlink:to="usph_CentersForMedicareAndMedicaidServicesMember_lbl1" xlink:title="label: CentersForMedicareAndMedicaidServicesMember to usph_CentersForMedicareAndMedicaidServicesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CentersForMedicareAndMedicaidServicesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CentersForMedicareAndMedicaidServicesMember_lbl2" xml:lang="en-US" id="usph_CentersForMedicareAndMedicaidServicesMember_lbl2">CMS [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CentersForMedicareAndMedicaidServicesMember" xlink:to="usph_CentersForMedicareAndMedicaidServicesMember_lbl2" xlink:title="label: CentersForMedicareAndMedicaidServicesMember to usph_CentersForMedicareAndMedicaidServicesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl">This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1">Period Of Federal Debt Ceiling In Connection With Deficit Reductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2">Federal debt ceiling in connection with deficit reductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OtherRevenuesMember_lbl" xml:lang="en-US" id="usph_OtherRevenuesMember_lbl">Other revenues include services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesMember" xlink:to="usph_OtherRevenuesMember_lbl" xlink:title="label: OtherRevenuesMember to usph_OtherRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OtherRevenuesMember_lbl1" xml:lang="en-US" id="usph_OtherRevenuesMember_lbl1">Other Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesMember" xlink:to="usph_OtherRevenuesMember_lbl1" xlink:title="label: OtherRevenuesMember to usph_OtherRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_OtherRevenuesMember_lbl2" xml:lang="en-US" id="usph_OtherRevenuesMember_lbl2">Other Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesMember" xlink:to="usph_OtherRevenuesMember_lbl2" xlink:title="label: OtherRevenuesMember to usph_OtherRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl">Revenues from the industrial injury prevention business are derived from onsite services provided to clients' employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenues are determined based on the number of hours and respective rate for services provided. The Company has agreements with third-party payers that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payer contracts and historical collection and write-off experience.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1">Industrial Injury Prevention Services Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2">Industrial Injury Prevention Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3">Industrial Injury Prevention Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ManagementContractRevenuesMember_lbl" xml:lang="en-US" id="usph_ManagementContractRevenuesMember_lbl">Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. Revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractRevenuesMember" xlink:to="usph_ManagementContractRevenuesMember_lbl" xlink:title="label: ManagementContractRevenuesMember to usph_ManagementContractRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ManagementContractRevenuesMember_lbl1" xml:lang="en-US" id="usph_ManagementContractRevenuesMember_lbl1">Management Contract Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractRevenuesMember" xlink:to="usph_ManagementContractRevenuesMember_lbl1" xlink:title="label: ManagementContractRevenuesMember to usph_ManagementContractRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ManagementContractRevenuesMember_lbl2" xml:lang="en-US" id="usph_ManagementContractRevenuesMember_lbl2">Management Contract [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractRevenuesMember" xlink:to="usph_ManagementContractRevenuesMember_lbl2" xlink:title="label: ManagementContractRevenuesMember to usph_ManagementContractRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl">Expected reduction in Medicare spending percentage during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1">Expected Reduction In Medicare Spending Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2">Expected reduction in Medicare spending percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl">Estimated percentage of decrease in payment during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl1">Estimated Percentage of Decrease in Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl2">Estimated percentage of decrease in payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl">Reduction in Combined physical therapy/speech language pathology expenses during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1">Reduction In Combined Physical Therapy Speech Language Pathology Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2">Reduction in combined physical therapy/speech language pathology expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl">Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour to usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl1">Finite Lived Intangible Assets Amortization Expense After Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour to usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl2">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour to usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_OperatingLeaseSupplementalInformationTableTextBlock" xlink:label="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="OperatingLeaseSupplementalInformationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl">Tabular disclosure of supplemental information related to leases.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1">Operating Lease, Supplemental Information [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2">Supplemental Information Related to Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:label="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl">Tabular disclosure of information related to weighted average lease terms and discount rates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1">Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2">Average Lease Terms and Discount Rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:label xlink:type="resource" xlink:label="usph_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CreditAgreementMember_lbl" xml:lang="en-US" id="usph_CreditAgreementMember_lbl">A credit agreement is a legal contract in which a bank arranges to loan a customer a certain amount of money for a specified amount of time.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditAgreementMember" xlink:to="usph_CreditAgreementMember_lbl" xlink:title="label: CreditAgreementMember to usph_CreditAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CreditAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CreditAgreementMember_lbl1" xml:lang="en-US" id="usph_CreditAgreementMember_lbl1">Credit Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditAgreementMember" xlink:to="usph_CreditAgreementMember_lbl1" xlink:title="label: CreditAgreementMember to usph_CreditAgreementMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DividendsCashAfterAmendment_lbl" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl">Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DividendsCashAfterAmendment_lbl1" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl1">Dividends Cash After Amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl1" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DividendsCashAfterAmendment_lbl2" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl2">Cash dividends after amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl2" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl">Amount of cash and noncash consideration that could pay with respect to acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1">Cash And Noncash Consideration With Respect To Acquisition After Amendement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2">Cash and noncash consideration with respect to acquisition after amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl">The percentage points added to the reference rate to compute the variable rate on the debt instrument.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1">Debt Instrument Basis Spread On Libor Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2">Spread on Libor variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableMember_lbl" xml:lang="en-US" id="usph_NotesPayableMember_lbl">A written promise to pay a note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableMember" xlink:to="usph_NotesPayableMember_lbl" xlink:title="label: NotesPayableMember to usph_NotesPayableMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableMember_lbl1" xml:lang="en-US" id="usph_NotesPayableMember_lbl1">Notes Payable [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableMember" xlink:to="usph_NotesPayableMember_lbl1" xlink:title="label: NotesPayableMember to usph_NotesPayableMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl">Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl1" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl1">Patients And Payors Related Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl1" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl2" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl2">Credit balances due to patients and payors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl2" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PromissoryNotesMember_lbl" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PromissoryNotesMember_lbl1" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl1">Promissory Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl1" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PromissoryNotesMember_lbl2" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl2">3.25% through 3.5% Notes Payable due in Next Year [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl2" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ChargesToRetainedEarningsAbstract" xlink:label="ChargesToRetainedEarningsAbstract" xlink:title="ChargesToRetainedEarningsAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ChargesToRetainedEarningsAbstract_lbl1" xml:lang="en-US" id="usph_ChargesToRetainedEarningsAbstract_lbl1">Charges to Retained Earnings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsAbstract" xlink:to="usph_ChargesToRetainedEarningsAbstract_lbl1" xlink:title="label: ChargesToRetainedEarningsAbstract to usph_ChargesToRetainedEarningsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ChargesToRetainedEarningsAbstract_lbl2" xml:lang="en-US" id="usph_ChargesToRetainedEarningsAbstract_lbl2">(Charges) credit to retained earnings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsAbstract" xlink:to="usph_ChargesToRetainedEarningsAbstract_lbl2" xlink:title="label: ChargesToRetainedEarningsAbstract to usph_ChargesToRetainedEarningsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl">The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1">Income Loss From Operations After Revaluation Of NonControlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2">Net income attributable to common shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl">The amount of income (loss) from revaluation of redeemable noncontrolling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1">Charges To Retained Earnings Revaluation Of Non Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2">Revaluation of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl">The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1">Income Tax Reconciliation Income Tax Expense Benefit At Federal and State Statutory Income Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2">Tax effect at statutory rate (federal and state) of 25.55%</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl">The term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1">Non-Compete Agreement Term under Condition of Termination of Employment of Employed Selling Shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl">Refers to the percentage of equity interest in subsidiary contributed for acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1">Business Acquisition Percentage Of Equity Interest In Subsidiary Contributed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2">Percentage of equity interest of subsidiary contributed for acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl">Refers to the percentage of general partnership interest acquired in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1">Business Acquisition, Percentage of General Partnership Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2">Business acquisition, percentage of general partnership interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl">The percentage of right to sell equity interest on each of the 4th and 5th anniversaries by shareholders.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1">Percentage of Right to Sell Equity Interest on Each of the 4th and 5th Anniversaries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2">Percentage of right to sell equity interest on each of the 4th and 5th anniversaries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl">The percentage of right to sell equity interest on each of the 6th and 7th anniversaries by shareholders.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1">Percentage of Right to Sell Equity Interest on Each of the 6th and 7th Anniversaries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2">Percentage of right to sell equity interest on each of the 6th and 7th anniversaries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TherapyPracticeMember_lbl" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl">Refers to the acquiree entity Therapy Practice.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TherapyPracticeMember_lbl1" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl1">Therapy Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl1" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl">Refers to the percentage of limited partnership interest acquired in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1">Business Acquisition, Percentage of Limited Partnership Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2">Business acquisition, percentage of limited partnership acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl">The renewal term of the employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl1">Employment Agreement Renewal Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl1" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl2">Employment agreement renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl2" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProgressiveHealthCompaniesLLCMember" xlink:label="ProgressiveHealthCompaniesLLCMember" xlink:title="ProgressiveHealthCompaniesLLCMember" />
    <link:label xlink:type="resource" xlink:label="usph_ProgressiveHealthCompaniesLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ProgressiveHealthCompaniesLLCMember_lbl" xml:lang="en-US" id="usph_ProgressiveHealthCompaniesLLCMember_lbl">Refers to the acquiree entity Therapy Practice.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressiveHealthCompaniesLLCMember" xlink:to="usph_ProgressiveHealthCompaniesLLCMember_lbl" xlink:title="label: ProgressiveHealthCompaniesLLCMember to usph_ProgressiveHealthCompaniesLLCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ProgressiveHealthCompaniesLLCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ProgressiveHealthCompaniesLLCMember_lbl1" xml:lang="en-US" id="usph_ProgressiveHealthCompaniesLLCMember_lbl1">ProgressiveHealth Companies, LLC [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressiveHealthCompaniesLLCMember" xlink:to="usph_ProgressiveHealthCompaniesLLCMember_lbl1" xlink:title="label: ProgressiveHealthCompaniesLLCMember to usph_ProgressiveHealthCompaniesLLCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ProgressiveHealthCompaniesLLCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ProgressiveHealthCompaniesLLCMember_lbl2" xml:lang="en-US" id="usph_ProgressiveHealthCompaniesLLCMember_lbl2">ProgressiveHealth [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressiveHealthCompaniesLLCMember" xlink:to="usph_ProgressiveHealthCompaniesLLCMember_lbl2" xlink:title="label: ProgressiveHealthCompaniesLLCMember to usph_ProgressiveHealthCompaniesLLCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TermOfEmploymentAgreement_lbl" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl">The term of employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TermOfEmploymentAgreement_lbl1" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl1">Term of Employment Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl1" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TermOfEmploymentAgreement_lbl2" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl2">Employment agreement term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl2" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl">The term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl1" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl1">Non-Compete Agreement Term under Condition Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl1" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl2" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl2">Non-Compete agreement term regardless of whether the selling shareholder is employed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl2" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Notes Receivable Related to Sale of Redeemable Non-controlling Interest Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestMember_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestMember_lbl">Represents the upper bound of a range for the estimate of fair value as of the reporting date of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestMember" xlink:to="usph_RedeemableNonControllingInterestMember_lbl" xlink:title="label: RedeemableNonControllingInterestMember to usph_RedeemableNonControllingInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestMember_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestMember_lbl1">Redeemable Non-Controlling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestMember" xlink:to="usph_RedeemableNonControllingInterestMember_lbl1" xlink:title="label: RedeemableNonControllingInterestMember to usph_RedeemableNonControllingInterestMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl">The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Proceeds from Sale of Redeemable Non-controlling Interest Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1">Carrying Amount of Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestAbstract to usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2">Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestAbstract to usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl">Refers to holder's employment has terminated and contractual time period has expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1">Holders Employment Has Terminated and Contractual Time Period Has Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2">Holder's employment has terminated and contractual time period has expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl">Refers to holder's employment has terminated and contractual time period has not expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1">Holders Employment Has Terminated and Contractual Time Period Has Not Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2">Holder's employment has terminated and contractual time period has not expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl">Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1">Contractual Time Period Has Lapsed But Holders Employment Has Not Been Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2">Contractual time period has lapsed but holder's employment has not terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Decrease in Note Receivable form sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl">The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1">Distributions to Limited Partners and Redeemable Noncontrolling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2">Distributions to redeemable non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl">The term of the note issued for consideration payable for the acquisition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1">Business Acquisition Consideration Payable, Term of Note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2">Business acquisition, consideration payable, term of note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl">Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1">Contractual Time Period Has Not Lapsed And Holders Employment Has Not Been Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2">Contractual time period has not lapsed and holder's employment has not terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl">Tabular disclosure of business combination completed within the physical therapy operations segment during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1">Schedule of Business Acquisitions Within Physical Therapy Operations Segment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2">Acquisitions Within Physical Therapy Operations Segment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>usph-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://usph.com/role/CommonStockDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#CommonStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#InvestmentInUnconsolidatedAffiliateDetails" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#SegmentInformationDetails" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc2" xlink:type="simple" xlink:href="usph-20220331.xsd#LeasesDetailsCalc2" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNetAmortizationExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNetIntangibleAssetsNetDetails" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#GoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/RevenueRecognitionDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#RevenueRecognitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="usph-20220331.xsd#BasisOfPresentationAndSignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="usph-20220331.xsd#SegmentInformationTables" />
  <link:roleRef roleURI="http://usph.com/role/LeasesTables" xlink:type="simple" xlink:href="usph-20220331.xsd#LeasesTables" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreementTables" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="usph-20220331.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNetTables" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillTables" xlink:type="simple" xlink:href="usph-20220331.xsd#GoodwillTables" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" xlink:type="simple" xlink:href="usph-20220331.xsd#RedeemableNoncontrollingInterestTables" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="usph-20220331.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://usph.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="usph-20220331.xsd#RevenueRecognitionTables" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" xlink:type="simple" xlink:href="usph-20220331.xsd#AcquisitionsOfBusinessesTables" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="usph-20220331.xsd#BasisOfPresentationAndSignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="usph-20220331.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ReclassificationOfPriorPeriodPresentation" xlink:type="simple" xlink:href="usph-20220331.xsd#ReclassificationOfPriorPeriodPresentation" />
  <link:roleRef roleURI="http://usph.com/role/CommonStock" xlink:type="simple" xlink:href="usph-20220331.xsd#CommonStock" />
  <link:roleRef roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliate" xlink:type="simple" xlink:href="usph-20220331.xsd#InvestmentInUnconsolidatedAffiliate" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformation" xlink:type="simple" xlink:href="usph-20220331.xsd#SegmentInformation" />
  <link:roleRef roleURI="http://usph.com/role/Leases" xlink:type="simple" xlink:href="usph-20220331.xsd#Leases" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreement" xlink:type="simple" xlink:href="usph-20220331.xsd#NotesPayableAndAmendedCreditAgreement" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpenses" xlink:type="simple" xlink:href="usph-20220331.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="usph-20220331.xsd#IntangibleAssetsNet" />
  <link:roleRef roleURI="http://usph.com/role/Goodwill" xlink:type="simple" xlink:href="usph-20220331.xsd#Goodwill" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" xlink:type="simple" xlink:href="usph-20220331.xsd#RedeemableNoncontrollingInterest" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShare" xlink:type="simple" xlink:href="usph-20220331.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://usph.com/role/RevenueRecognition" xlink:type="simple" xlink:href="usph-20220331.xsd#RevenueRecognition" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses" xlink:type="simple" xlink:href="usph-20220331.xsd#AcquisitionsOfBusinesses" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="simple" xlink:href="usph-20220331.xsd#BasisOfPresentationAndSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedStatementsOfChangesInEquity" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20220331.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20220331.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="DocumentQuarterlyReport" xlink:title="DocumentQuarterlyReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentQuarterlyReport" xlink:title="presentation: CoverAbstract to DocumentQuarterlyReport" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentTransitionReport" xlink:title="presentation: CoverAbstract to DocumentTransitionReport" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: CoverAbstract to EntityCurrentReportingStatus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityInteractiveDataCurrent" xlink:title="presentation: CoverAbstract to EntityInteractiveDataCurrent" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityShellCompany" xlink:title="presentation: CoverAbstract to EntityShellCompany" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: CoverAbstract to EntityCommonStockSharesOutstanding" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: AssetsCurrentAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsReceivableNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsReceivableNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsAndOtherReceivablesNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsAndOtherReceivablesNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="FurnitureAndFixturesGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to FurnitureAndFixturesGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="LeaseholdImprovementsGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to LeaseholdImprovementsGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNetAbstract" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNetAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: AssetsAbstract to OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="presentation: AssetsAbstract to InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsAbstract to Goodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: AssetsAbstract to IntangibleAssetsNetExcludingGoodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableTradeCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AccountsPayableDueToSellerOfAcquiredBusiness" xlink:label="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="AccountsPayableDueToSellerOfAcquiredBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableDueToSellerOfAcquiredBusiness" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LongTermDebtCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LongTermDebtCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermNotesPayable" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermNotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermLineOfCredit" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermLineOfCredit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DeferredIncomeTaxLiabilitiesNet" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DeferredIncomeTaxLiabilitiesNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OperatingLeaseLiabilityNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockValue" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockValue" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="MinorityInterest" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to MinorityInterest" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="presentation: AssetsCurrentAbstract to AllowanceForDoubtfulAccountsReceivableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockShares" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to NetPatientRevenuesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="presentation: ProductOrServiceAxis to ProductsAndServicesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="ProductOrServiceAxis" xlink:title="presentation: StatementTable to ProductOrServiceAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: RevenuesAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="RevenuesAbstract" xlink:title="presentation: StatementLineItems to RevenuesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="LaborAndRelatedExpense" xlink:title="presentation: CostsAndExpensesAbstract to LaborAndRelatedExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="presentation: CostsAndExpensesAbstract to RentSuppliesContractLaborAndOther" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: CostsAndExpensesAbstract to ProvisionForDoubtfulAccounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="CostsAndExpenses" xlink:title="presentation: CostsAndExpensesAbstract to CostsAndExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="CostsAndExpensesAbstract" xlink:title="presentation: StatementLineItems to CostsAndExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="GrossProfit" xlink:title="presentation: StatementLineItems to GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="presentation: StatementLineItems to SellingGeneralAndAdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="OperatingIncomeLoss" xlink:title="presentation: StatementLineItems to OperatingIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to IncomeLossFromEquityMethodInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="InterestAndOtherIncome" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to InterestAndOtherIncome" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GainLossOnRevaluationOfPutRightLiability" xlink:label="GainLossOnRevaluationOfPutRightLiability" xlink:title="GainLossOnRevaluationOfPutRightLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="GainLossOnRevaluationOfPutRightLiability" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to GainLossOnRevaluationOfPutRightLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="InterestExpenseDebtAndOther" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to InterestExpenseDebtAndOther" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to NonoperatingIncomeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="OtherNonoperatingIncomeExpenseAbstract" xlink:title="presentation: StatementLineItems to OtherNonoperatingIncomeExpenseAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: StatementLineItems to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: StatementLineItems to IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="presentation: StatementLineItems to ProfitLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="presentation: StatementLineItems to MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="presentation: StatementLineItems to NetIncomeLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="EarningsPerShareBasic" xlink:title="presentation: StatementLineItems to EarningsPerShareBasic" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: StatementLineItems to EarningsPerShareDiluted" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: StatementLineItems to WeightedAverageNumberOfSharesOutstandingBasic" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: StatementLineItems to WeightedAverageNumberOfDilutedSharesOutstanding" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="CommonStockDividendsPerShareDeclared" xlink:title="presentation: StatementLineItems to CommonStockDividendsPerShareDeclared" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="StatementTable" xlink:title="presentation: IncomeStatementAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProfitLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationDepletionAndAmortization" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ProvisionForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DeferredIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GainLossOnRevaluationOfPutRightLiability" xlink:label="GainLossOnRevaluationOfPutRightLiability" xlink:title="GainLossOnRevaluationOfPutRightLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnRevaluationOfPutRightLiability" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnRevaluationOfPutRightLiability" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncomeLossFromEquityMethodInvestments" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OtherOperatingActivitiesCashFlowStatement" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OtherOperatingActivitiesCashFlowStatement" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherNoncurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireProductiveAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireRedeemableNonControllingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireInterestInSubsidiariesAndAffiliates" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromDivestitureOfBusinesses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DistributionsFromUnconsolidatedAffiliate" xlink:label="DistributionsFromUnconsolidatedAffiliate" xlink:title="DistributionsFromUnconsolidatedAffiliate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="DistributionsFromUnconsolidatedAffiliate" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to DistributionsFromUnconsolidatedAffiliate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProceedsFromSalesOfNonControllingInterestPermanent" xlink:label="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="ProceedsFromSalesOfNonControllingInterestPermanent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSalesOfNonControllingInterestPermanent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsMinorityInterest" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsMinorityInterest" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromLinesOfCredit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromLinesOfCredit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfLinesOfCredit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfLinesOfCredit" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfNotesPayable" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfNotesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:label="PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:title="PaymentOfMedicareAcceleratedAndAdvanceFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentOfMedicareAcceleratedAndAdvanceFunds" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentOfMedicareAcceleratedAndAdvanceFunds" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromPaymentsForOtherFinancingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CashPaidDuringPeriodForAbstract" xlink:label="CashPaidDuringPeriodForAbstract" xlink:title="CashPaidDuringPeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="IncomeTaxesPaidNet" xlink:title="presentation: CashPaidDuringPeriodForAbstract to IncomeTaxesPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: CashPaidDuringPeriodForAbstract to InterestPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashPaidDuringPeriodForAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashPaidDuringPeriodForAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PurchaseOfBusinessSellerFinancingPortion" xlink:label="PurchaseOfBusinessSellerFinancingPortion" xlink:title="PurchaseOfBusinessSellerFinancingPortion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="PurchaseOfBusinessSellerFinancingPortion" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PurchaseOfBusinessSellerFinancingPortion" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:label="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="ProceedsFromMinorityShareholders" xlink:title="ProceedsFromMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ProceedsFromMinorityShareholders" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to ProceedsFromMinorityShareholders" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="DividendsPayableCurrentAndNoncurrent" xlink:title="DividendsPayableCurrentAndNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="DividendsPayableCurrentAndNoncurrent" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to DividendsPayableCurrentAndNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="TreasuryStockMember" xlink:title="presentation: StatementEquityComponentsAxis to TreasuryStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="ParentMember" xlink:title="presentation: StatementEquityComponentsAxis to ParentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="NoncontrollingInterestMember" xlink:title="presentation: StatementEquityComponentsAxis to NoncontrollingInterestMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to RevaluationOfRedeemableNonControllingInterestNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="MinorityInterestDecreaseFromRedemptions" xlink:title="MinorityInterestDecreaseFromRedemptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="MinorityInterestDecreaseFromRedemptions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to MinorityInterestDecreaseFromRedemptions" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:label="SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:title="SaleOfNonControllingInterestNetOfPurchasesAndTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SaleOfNonControllingInterestNetOfPurchasesAndTax" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SaleOfNonControllingInterestNetOfPurchasesAndTax" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="DividendsCommonStockCash" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to DividendsCommonStockCash" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ShortSwingProfitSettlement" xlink:label="ShortSwingProfitSettlement" xlink:title="ShortSwingProfitSettlement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="ShortSwingProfitSettlement" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to ShortSwingProfitSettlement" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityOther" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityOther" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLoss" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="BusinessCombinationDisclosureTextBlock" xlink:title="BusinessCombinationDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="BusinessCombinationDisclosureTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to BusinessCombinationDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RevenueRecognition">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="RevenueFromContractWithCustomerTextBlock" xlink:title="RevenueFromContractWithCustomerTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="RevenueFromContractWithCustomerTextBlock" xlink:title="presentation: RevenueFromContractWithCustomerAbstract to RevenueFromContractWithCustomerTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShare">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterest">
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestTextBlock" xlink:label="RedeemableNonControllingInterestTextBlock" xlink:title="RedeemableNonControllingInterestTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="RedeemableNonControllingInterestTextBlock" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to RedeemableNonControllingInterestTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/Goodwill">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="GoodwillDisclosureTextBlock" xlink:title="GoodwillDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNet">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="IntangibleAssetsDisclosureTextBlock" xlink:title="IntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="IntangibleAssetsDisclosureTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to IntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreement">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtDisclosureTextBlock" xlink:title="presentation: DebtDisclosureAbstract to DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/Leases">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="SegmentReportingDisclosureTextBlock" xlink:title="SegmentReportingDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="SegmentReportingDisclosureTextBlock" xlink:title="presentation: SegmentReportingAbstract to SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/InvestmentInUnconsolidatedAffiliate">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:to="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesAbstract to InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStock">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: EquityAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ReclassificationOfPriorPeriodPresentation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract" xlink:label="PriorPeriodAdjustmentAbstract" xlink:title="PriorPeriodAdjustmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="ErrorCorrectionTextBlock" xlink:title="ErrorCorrectionTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PriorPeriodAdjustmentAbstract" xlink:to="ErrorCorrectionTextBlock" xlink:title="presentation: PriorPeriodAdjustmentAbstract to ErrorCorrectionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to GoodwillAndIntangibleAssetsPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestsPolicyTextBlock" xlink:label="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="RedeemableNonControllingInterestsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RedeemableNonControllingInterestsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonControllingInterestsPolicyPolicyTextBlock" xlink:label="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="NonControllingInterestsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NonControllingInterestsPolicyPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RevenueFromContractWithCustomerPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:title="ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="IncomeTaxPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to IncomeTaxPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FairValueOfFinancialInstrumentsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to FairValueOfFinancialInstrumentsPolicy" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingPolicyPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_SelfInsuranceProgramPolicyPolicyTextBlock" xlink:label="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="SelfInsuranceProgramPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SelfInsuranceProgramPolicyPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RestrictedStockPolicyPolicyTextBlock" xlink:label="RestrictedStockPolicyPolicyTextBlock" xlink:title="RestrictedStockPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RestrictedStockPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RestrictedStockPolicyPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:label="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RevenueRecognitionTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="DisaggregationOfRevenueTableTextBlock" xlink:title="DisaggregationOfRevenueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="DisaggregationOfRevenueTableTextBlock" xlink:title="presentation: RevenueFromContractWithCustomerAbstract to DisaggregationOfRevenueTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestTables">
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="RedeemableNoncontrollingInterestTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to RedeemableNoncontrollingInterestTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:label="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="ScheduleOfGoodwillTextBlock" xlink:title="ScheduleOfGoodwillTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ScheduleOfGoodwillTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ScheduleOfGoodwillTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="ScheduleOfDebtInstrumentsTextBlock" xlink:title="ScheduleOfDebtInstrumentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfDebtInstrumentsTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfDebtInstrumentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostTableTextBlock" xlink:title="presentation: LeasesAbstract to LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_OperatingLeaseSupplementalInformationTableTextBlock" xlink:label="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="OperatingLeaseSupplementalInformationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="presentation: LeasesAbstract to OperatingLeaseSupplementalInformationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:label="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="presentation: LeasesAbstract to WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="presentation: SegmentReportingAbstract to ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="RangeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MultiClinicPracticesMember" xlink:label="MultiClinicPracticesMember" xlink:title="MultiClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MultiClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to MultiClinicPracticesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_March2022AcquisitionMember" xlink:label="March2022AcquisitionMember" xlink:title="March2022AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="March2022AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to March2022AcquisitionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_December2021AcquisitionMember" xlink:label="December2021AcquisitionMember" xlink:title="December2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="December2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to December2021AcquisitionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_November2021AcquisitionMember" xlink:label="November2021AcquisitionMember" xlink:title="November2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to November2021AcquisitionMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_September2021AcquisitionMember" xlink:label="September2021AcquisitionMember" xlink:title="September2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to September2021AcquisitionMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_June2021AcquisitionMember" xlink:label="June2021AcquisitionMember" xlink:title="June2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="June2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to June2021AcquisitionMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_March2021AcquisitionMember" xlink:label="March2021AcquisitionMember" xlink:title="March2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="March2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to March2021AcquisitionMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReturnToWorkAndErgonomicServicesMember" xlink:label="ReturnToWorkAndErgonomicServicesMember" xlink:title="ReturnToWorkAndErgonomicServicesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ReturnToWorkAndErgonomicServicesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ReturnToWorkAndErgonomicServicesMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BriotixHealthLimitedPartnershipMember" xlink:label="BriotixHealthLimitedPartnershipMember" xlink:title="BriotixHealthLimitedPartnershipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="BriotixHealthLimitedPartnershipMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to BriotixHealthLimitedPartnershipMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="presentation: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="presentation: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to AdjustmentsForNewAccountingPronouncementsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerSoftwareIntangibleAssetMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerSoftwareIntangibleAssetMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to PropertyPlantAndEquipmentByTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to MedicareAcceleratedAndAdvancePaymentsProgramMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to PublicHealthAndSocialServicesEmergencyFundMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="presentation: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to UnusualOrInfrequentItemAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="MeasurementInputOptionVolatilityMember" xlink:title="MeasurementInputOptionVolatilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputOptionVolatilityMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputOptionVolatilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="MeasurementInputDiscountRateMember" xlink:title="MeasurementInputDiscountRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputDiscountRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputDiscountRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="presentation: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="MeasurementInputTypeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to MeasurementInputTypeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableOneMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableTwoMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="presentation: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to ShortTermDebtTypeAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BasisOfPresentationAbstract" xlink:label="BasisOfPresentationAbstract" xlink:title="BasisOfPresentationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="NumberOfReportableSegments" xlink:title="presentation: BasisOfPresentationAbstract to NumberOfReportableSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="NumberOfOperatingClinicLocations" xlink:title="presentation: BasisOfPresentationAbstract to NumberOfOperatingClinicLocations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="presentation: BasisOfPresentationAbstract to BusinessAcquisitionDateOfAcquisitionAgreement1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BasisOfPresentationAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BasisOfPresentationAbstract to NumberOfBusinessesAcquired" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="NumberOfStatesInWhichEntityOperates" xlink:title="presentation: BasisOfPresentationAbstract to NumberOfStatesInWhichEntityOperates" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="PercentageOfGeneralPartnershipInterestOwned" xlink:title="presentation: BasisOfPresentationAbstract to PercentageOfGeneralPartnershipInterestOwned" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="PercentageOfLimitedPartnershipInterestOwned" xlink:title="presentation: BasisOfPresentationAbstract to PercentageOfLimitedPartnershipInterestOwned" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="NumberOfThirdPartyFacilities" xlink:title="presentation: BasisOfPresentationAbstract to NumberOfThirdPartyFacilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="GrantsAndOtherFunds" xlink:title="presentation: BasisOfPresentationAbstract to GrantsAndOtherFunds" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RepaymentOfFunds" xlink:label="RepaymentOfFunds" xlink:title="RepaymentOfFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="RepaymentOfFunds" xlink:title="presentation: BasisOfPresentationAbstract to RepaymentOfFunds" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPresentationAbstract" xlink:to="GrantsReceivable" xlink:title="presentation: BasisOfPresentationAbstract to GrantsReceivable" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BasisOfPresentationAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to BasisOfPresentationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:title="ImpairmentOfLongLivedAssetsToBeDisposedOf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to ImpairmentOfLongLivedAssetsToBeDisposedOf" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PropertyPlantAndEquipmentAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PropertyPlantAndEquipmentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract" xlink:label="BusinessCombinationGoodwillAbstract" xlink:title="BusinessCombinationGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="NumberOfOperatingSegments" xlink:title="presentation: BusinessCombinationGoodwillAbstract to NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="NumberOfRegions" xlink:title="presentation: BusinessCombinationGoodwillAbstract to NumberOfRegions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BusinessCombinationGoodwillAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to BusinessCombinationGoodwillAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="presentation: NonControllingInterestRedeemableAbstract to RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NonControllingInterestRedeemableAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to NonControllingInterestRedeemableAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="presentation: IncomeTaxDisclosureAbstract to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="presentation: IncomeTaxDisclosureAbstract to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="presentation: IncomeTaxDisclosureAbstract to InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="IncomeTaxDisclosureAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to IncomeTaxDisclosureAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="DebtInstrumentMeasurementInput" xlink:title="DebtInstrumentMeasurementInput" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="DebtInstrumentMeasurementInput" xlink:title="presentation: FairValueDisclosuresAbstract to DebtInstrumentMeasurementInput" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="IncreaseDecreaseInContractWithCustomerAsset" xlink:title="IncreaseDecreaseInContractWithCustomerAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="IncreaseDecreaseInContractWithCustomerAsset" xlink:title="presentation: FairValueDisclosuresAbstract to IncreaseDecreaseInContractWithCustomerAsset" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="ContractWithCustomerAssetNet" xlink:title="ContractWithCustomerAssetNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="ContractWithCustomerAssetNet" xlink:title="presentation: FairValueDisclosuresAbstract to ContractWithCustomerAssetNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="FairValueDisclosuresAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to FairValueDisclosuresAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="NumberOfOperatingSegments" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="DepreciationAmortizationImpairmentLineItems" xlink:title="presentation: DepreciationAmortizationImpairmentTable to DepreciationAmortizationImpairmentLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DepreciationAmortizationImpairmentTable" xlink:title="presentation: AccountingPoliciesAbstract to DepreciationAmortizationImpairmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="DirectorMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to DirectorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="OfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to OfficerMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementsAbstract" xlink:to="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="presentation: DeferredCompensationArrangementsAbstract to DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementsAbstract" xlink:title="presentation: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReturnToWorkAndErgonomicServicesMember" xlink:label="ReturnToWorkAndErgonomicServicesMember" xlink:title="ReturnToWorkAndErgonomicServicesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ReturnToWorkAndErgonomicServicesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ReturnToWorkAndErgonomicServicesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PreviousOwnersMember" xlink:label="PreviousOwnersMember" xlink:title="PreviousOwnersMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="PreviousOwnersMember" xlink:title="presentation: OwnershipDomain to PreviousOwnersMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="presentation: StatementBusinessSegmentsAxis to SegmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementBusinessSegmentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="presentation: BusinessCombinationDescriptionAbstract to MinorityInterestOwnershipPercentageByNoncontrollingOwners" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:label="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationConsiderationTransferred1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationContingentConsiderationLiability" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationContingentConsiderationLiability" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:label="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationConsiderationTransferredIncludesContingentConsideration" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesGross" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:label="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to DebtInstrumentInterestRateStatedPercentage" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="RemainingContractTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to RemainingContractTerm" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:label="BusinessCombinationAcquiredReceivablesFairValue" xlink:title="BusinessCombinationAcquiredReceivablesFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationAcquiredReceivablesFairValue" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationAcquiredReceivablesFairValue" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability_2" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationContingentConsiderationLiability_2" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationContingentConsiderationLiability" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase" xlink:label="ContractWithCustomerAssetPurchase" xlink:title="ContractWithCustomerAssetPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ContractWithCustomerAssetPurchase" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ContractWithCustomerAssetPurchase" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesConsideration" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to PaymentsToAcquireBusinessesConsideration" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to NetPatientRevenuesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to OtherRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: ProductsAndServicesDomain to PhysicalTherapyOperationsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="ManagementContractRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to ManagementContractRevenuesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="presentation: ProductOrServiceAxis to ProductsAndServicesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="ProductOrServiceAxis" xlink:title="presentation: DisaggregationOfRevenueTable to ProductOrServiceAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:label="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to FromTwoThousandSeventeenThroughTwoThousandNineteenMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="presentation: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="presentation: DisaggregationOfRevenueTable to UnusualOrInfrequentItemAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="presentation: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="presentation: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="StatementScenarioAxis" xlink:title="presentation: DisaggregationOfRevenueTable to StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="presentation: DisaggregationOfRevenueTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CentersForMedicareAndMedicaidServicesMember" xlink:label="CentersForMedicareAndMedicaidServicesMember" xlink:title="CentersForMedicareAndMedicaidServicesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="CentersForMedicareAndMedicaidServicesMember" xlink:title="presentation: RelatedPartyDomain to CentersForMedicareAndMedicaidServicesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: DisaggregationOfRevenueTable to RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: DisaggregationOfRevenueAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfMedicarePaymentIncrease" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfMedicarePaymentIncrease" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="EstimatedPercentageOfDecreaseInPayment" xlink:title="presentation: MedicareReimbursementAbstract to EstimatedPercentageOfDecreaseInPayment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="presentation: MedicareReimbursementAbstract to PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="AmountOfReductionsInFederalSpending" xlink:title="presentation: MedicareReimbursementAbstract to AmountOfReductionsInFederalSpending" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ReductionInMedicareSpendingPercentage" xlink:title="presentation: MedicareReimbursementAbstract to ReductionInMedicareSpendingPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ExpectedReductionInMedicareSpendingPercentage" xlink:title="presentation: MedicareReimbursementAbstract to ExpectedReductionInMedicareSpendingPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:label="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:title="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPaymentReductionWaivedThroughEnactedLegislation" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:label="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:title="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" xlink:title="presentation: MedicareReimbursementAbstract to ExtensionTermForSequesterReliefAppliedToAllMedicarePayments" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:label="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:title="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:label="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:title="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="presentation: MedicareReimbursementAbstract to CombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="presentation: MedicareReimbursementAbstract to ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPracticeExpenseComponentOfRelativeValueUnit" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="presentation: MedicareReimbursementAbstract to PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPaymentForOutpatientTherapyServices" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="NetRevenueFromMedicare" xlink:title="presentation: MedicareReimbursementAbstract to NetRevenueFromMedicare" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="MedicareReimbursementAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to MedicareReimbursementAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualAllowancesAbstract" xlink:label="ContractualAllowancesAbstract" xlink:title="ContractualAllowancesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractualAllowancesAbstract" xlink:to="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="presentation: ContractualAllowancesAbstract to DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractualAllowancesAbstract" xlink:to="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="presentation: ContractualAllowancesAbstract to DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractualAllowancesAbstract" xlink:to="MaximumContractualAllowanceReserveEstimate" xlink:title="presentation: ContractualAllowancesAbstract to MaximumContractualAllowanceReserveEstimate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractualAllowancesAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to ContractualAllowancesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="DisaggregationOfRevenueLineItems" xlink:title="presentation: DisaggregationOfRevenueTable to DisaggregationOfRevenueLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="DisaggregationOfRevenueTable" xlink:title="presentation: RevenueFromContractWithCustomerAbstract to DisaggregationOfRevenueTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="presentation: EarningsPerShareAbstract to NetIncomeLossAvailableToCommonStockholdersBasicAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ChargesToRetainedEarningsAbstract" xlink:label="ChargesToRetainedEarningsAbstract" xlink:title="ChargesToRetainedEarningsAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChargesToRetainedEarningsAbstract" xlink:to="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="presentation: ChargesToRetainedEarningsAbstract to ChargesToRetainedEarningsRevaluationOfNonControllingInterests" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChargesToRetainedEarningsAbstract" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="presentation: ChargesToRetainedEarningsAbstract to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChargesToRetainedEarningsAbstract" xlink:to="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="presentation: ChargesToRetainedEarningsAbstract to IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ChargesToRetainedEarningsAbstract" xlink:title="presentation: EarningsPerShareAbstract to ChargesToRetainedEarningsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareBasic" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareDiluted" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="presentation: EarningsPerShareAbstract to WeightedAverageNumberOfSharesOutstandingAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: EarningsPerShareAbstract to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="presentation: EarningsPerShareAbstract to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TherapyPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to TherapyPracticeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProgressiveHealthCompaniesLLCMember" xlink:label="ProgressiveHealthCompaniesLLCMember" xlink:title="ProgressiveHealthCompaniesLLCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ProgressiveHealthCompaniesLLCMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ProgressiveHealthCompaniesLLCMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedEntitiesDomain" xlink:to="SubsidiariesMember" xlink:title="presentation: ConsolidatedEntitiesDomain to SubsidiariesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain" xlink:title="presentation: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ConsolidatedEntitiesAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionConsiderationPayableTermOfNote" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="TermOfEmploymentAgreement" xlink:title="presentation: BusinessCombinationDescriptionAbstract to TermOfEmploymentAgreement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EmploymentAgreementRenewalTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EmploymentAgreementRenewalTerm" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NonCompeteAgreementBasicTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NonCompeteAgreementBasicTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="RedeemableNonControllingInterestMember" xlink:title="presentation: OwnershipDomain to RedeemableNonControllingInterestMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="OwnershipAxis" xlink:title="presentation: RedeemableNoncontrollingInterestByLegalEntityTable to OwnershipAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="MinorityInterestChangeInRedemptionValue" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to MinorityInterestChangeInRedemptionValue" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="ProceedsFromPaymentsToMinorityShareholders" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to ProceedsFromPaymentsToMinorityShareholders" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="PaymentsToMinorityShareholders" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to PaymentsToMinorityShareholders" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount_2" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount_2" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="presentation: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="presentation: RedeemableNoncontrollingInterestLineItems to CarryingAmountOfRedeemableNonControllingInterestAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="RedeemableNoncontrollingInterestLineItems" xlink:title="presentation: RedeemableNoncontrollingInterestByLegalEntityTable to RedeemableNoncontrollingInterestLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to RedeemableNoncontrollingInterestByLegalEntityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="GoodwillRollForward" xlink:title="GoodwillRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="Goodwill" xlink:title="presentation: GoodwillRollForward to Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="GoodwillAcquiredDuringPeriod" xlink:title="GoodwillAcquiredDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillAcquiredDuringPeriod" xlink:title="presentation: GoodwillRollForward to GoodwillAcquiredDuringPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="GoodwillPurchaseAccountingAdjustments" xlink:title="GoodwillPurchaseAccountingAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillPurchaseAccountingAdjustments" xlink:title="presentation: GoodwillRollForward to GoodwillPurchaseAccountingAdjustments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill_2" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="Goodwill_2" xlink:title="presentation: GoodwillRollForward to Goodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillRollForward" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to IntangibleAssetsNetExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="AmortizationOfIntangibleAssets" xlink:title="presentation: AmortizationOfDeferredChargesAbstract to AmortizationOfIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfDeferredChargesAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to AmortizationOfDeferredChargesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="PatientsAndPayorsRelatedLiability" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to PatientsAndPayorsRelatedLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AccruedInsuranceCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AccruedInsuranceCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="TaxesPayableCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to TaxesPayableCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="DividendsPayableCurrentAndNoncurrent" xlink:title="DividendsPayableCurrentAndNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="DividendsPayableCurrentAndNoncurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to DividendsPayableCurrentAndNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="AssetAcquisitionContingentConsiderationLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AssetAcquisitionContingentConsiderationLiabilityCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent" xlink:label="LitigationReserveCurrent" xlink:title="LitigationReserveCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="LitigationReserveCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to LitigationReserveCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to OtherAccruedLiabilitiesCurrent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="PromissoryNotesMember" xlink:title="presentation: DebtInstrumentNameDomain to PromissoryNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebt" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtCurrent" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtNoncurrent" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityInterestRateDuringPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentAnnualPrincipalPayment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentInterestRateStatedPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="CreditAgreementMember" xlink:title="presentation: DebtInstrumentNameDomain to CreditAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="presentation: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="presentation: DebtInstrumentTable to ShortTermDebtTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="VariableRateAxis" xlink:title="VariableRateAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain" xlink:title="VariableRateDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="LondonInterbankOfferedRateLIBORMember" xlink:title="LondonInterbankOfferedRateLIBORMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VariableRateDomain" xlink:to="LondonInterbankOfferedRateLIBORMember" xlink:title="presentation: VariableRateDomain to LondonInterbankOfferedRateLIBORMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember" xlink:label="BaseRateMember" xlink:title="BaseRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VariableRateDomain" xlink:to="BaseRateMember" xlink:title="presentation: VariableRateDomain to BaseRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VariableRateAxis" xlink:to="VariableRateDomain" xlink:title="presentation: VariableRateAxis to VariableRateDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="VariableRateAxis" xlink:title="presentation: DebtInstrumentTable to VariableRateAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityMaximumBorrowingCapacity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityIncreaseDecreaseForPeriodNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentBasisSpreadOnLiborVariableRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentBasisSpreadOnVariableRate1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="presentation: DebtInstrumentsAbstract to CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DividendsCashAfterAmendment" xlink:title="presentation: DebtInstrumentsAbstract to DividendsCashAfterAmendment" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebt" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebt" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityRemainingBorrowingCapacity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentFaceAmount" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityInterestRateDuringPeriod" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="presentation: LongTermDebtByMaturityAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="presentation: LongTermDebtByMaturityAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="presentation: LongTermDebtByMaturityAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="LongTermDebt" xlink:title="presentation: LongTermDebtByMaturityAbstract to LongTermDebt" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="DebtInstrumentMaturityDate" xlink:title="presentation: LongTermDebtByMaturityAbstract to DebtInstrumentMaturityDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtByMaturityAbstract" xlink:title="presentation: DebtInstrumentLineItems to LongTermDebtByMaturityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeOperatingLeaseTermOfContract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseCost" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="ShortTermLeaseCost" xlink:title="presentation: LeaseCostAbstract to ShortTermLeaseCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="VariableLeaseCost" xlink:title="presentation: LeaseCostAbstract to VariableLeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="LeaseCost" xlink:title="presentation: LeaseCostAbstract to LeaseCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCostAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LeaseCostAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="OperatingLeasePayments" xlink:title="presentation: SupplementalInformationRelatedToOperatingLeasesAbstract to OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="presentation: SupplementalInformationRelatedToOperatingLeasesAbstract to RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to SupplementalInformationRelatedToOperatingLeasesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: AverageLeaseTermsAndDiscountRatesAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: AverageLeaseTermsAndDiscountRatesAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to AverageLeaseTermsAndDiscountRatesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="LesseeLeaseDescriptionLineItems" xlink:title="presentation: LesseeLeaseDescriptionTable to LesseeLeaseDescriptionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeLeaseDescriptionTable" xlink:title="presentation: LeasesAbstract to LesseeLeaseDescriptionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc2" />
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationItemsDomain" xlink:to="OperatingSegmentsMember" xlink:title="presentation: ConsolidationItemsDomain to OperatingSegmentsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain" xlink:title="presentation: ConsolidationItemsAxis to ConsolidationItemsDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="ConsolidationItemsAxis" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to ConsolidationItemsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: SegmentDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="presentation: StatementBusinessSegmentsAxis to SegmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to StatementBusinessSegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="Revenues" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="GrossProfit" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to GrossProfit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="Assets" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingInformationLineItems" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="presentation: SegmentReportingInformationLineItems to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="SegmentReportingInformationLineItems" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to SegmentReportingInformationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="presentation: SegmentReportingAbstract to ScheduleOfSegmentReportingInformationBySegmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="ScheduleOfEquityMethodInvestmentsTable" xlink:title="ScheduleOfEquityMethodInvestmentsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_JointVentureInterestMember" xlink:label="JointVentureInterestMember" xlink:title="JointVentureInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="JointVentureInterestMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to JointVentureInterestMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentsTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfEquityMethodInvestmentsTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="ScheduleOfEquityMethodInvestmentsLineItems" xlink:title="ScheduleOfEquityMethodInvestmentsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentQuotedMarketValue" xlink:label="EquityMethodInvestmentQuotedMarketValue" xlink:title="EquityMethodInvestmentQuotedMarketValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="EquityMethodInvestmentQuotedMarketValue" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to EquityMethodInvestmentQuotedMarketValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to IncomeLossFromEquityMethodInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:label="EquityMethodInvestmentDividendsOrDistributions" xlink:title="EquityMethodInvestmentDividendsOrDistributions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="EquityMethodInvestmentDividendsOrDistributions" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to EquityMethodInvestmentDividendsOrDistributions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="presentation: ScheduleOfEquityMethodInvestmentsLineItems to InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentsTable" xlink:to="ScheduleOfEquityMethodInvestmentsLineItems" xlink:title="presentation: ScheduleOfEquityMethodInvestmentsTable to ScheduleOfEquityMethodInvestmentsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:to="ScheduleOfEquityMethodInvestmentsTable" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesAbstract to ScheduleOfEquityMethodInvestmentsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfTreasuryStockTable" xlink:to="RangeAxis" xlink:title="presentation: ClassOfTreasuryStockTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: ClassOfStockDisclosuresAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="PercentageOfRepurchaseOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to PercentageOfRepurchaseOfCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to BankCreditAgreementToPermitShareRepurchasesOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="StockRepurchasedDuringPeriodShares" xlink:title="presentation: ClassOfStockDisclosuresAbstract to StockRepurchasedDuringPeriodShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20220331.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to AdditionalEstimatedRepurchaseOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="SharesIssuedPricePerShare" xlink:title="presentation: ClassOfStockDisclosuresAbstract to SharesIssuedPricePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfStockDisclosuresAbstract" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to ClassOfStockDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfTreasuryStockTable" xlink:to="EquityClassOfTreasuryStockLineItems" xlink:title="presentation: ClassOfTreasuryStockTable to EquityClassOfTreasuryStockLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ClassOfTreasuryStockTable" xlink:title="presentation: EquityAbstract to ClassOfTreasuryStockTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776589229256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">U S PHYSICAL THERAPY INC /NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0364866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1300 WEST SAM HOUSTON PARKWAY SOUTH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">SUITE 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">HOUSTON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">297-7000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">USPH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,991,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776592212440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 24,229<span></span>
</td>
<td class="nump">$ 28,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Patient accounts receivable, less allowance for credit losses of $2,799 and $2,768, respectively</a></td>
<td class="nump">49,335<span></span>
</td>
<td class="nump">46,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts receivable - other</a></td>
<td class="nump">18,239<span></span>
</td>
<td class="nump">16,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">4,040<span></span>
</td>
<td class="nump">4,183<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">95,843<span></span>
</td>
<td class="nump">95,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Fixed assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and equipment</a></td>
<td class="nump">60,205<span></span>
</td>
<td class="nump">58,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">40,541<span></span>
</td>
<td class="nump">39,194<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Fixed assets, gross</a></td>
<td class="nump">100,746<span></span>
</td>
<td class="nump">97,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">76,601<span></span>
</td>
<td class="nump">74,958<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">24,145<span></span>
</td>
<td class="nump">22,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">94,243<span></span>
</td>
<td class="nump">96,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in unconsolidated affiliate</a></td>
<td class="nump">12,422<span></span>
</td>
<td class="nump">12,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">443,692<span></span>
</td>
<td class="nump">434,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other identifiable intangible assets, net</a></td>
<td class="nump">91,546<span></span>
</td>
<td class="nump">86,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">1,578<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">763,863<span></span>
</td>
<td class="nump">749,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">3,272<span></span>
</td>
<td class="nump">3,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AccountsPayableDueToSellerOfAcquiredBusiness', window );">Accounts payable - due to seller of acquired business</a></td>
<td class="nump">3,203<span></span>
</td>
<td class="nump">3,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">51,121<span></span>
</td>
<td class="nump">45,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">30,625<span></span>
</td>
<td class="nump">30,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">89,020<span></span>
</td>
<td class="nump">83,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">4,128<span></span>
</td>
<td class="nump">3,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Revolving line of credit</a></td>
<td class="nump">118,000<span></span>
</td>
<td class="nump">114,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred taxes</a></td>
<td class="nump">16,067<span></span>
</td>
<td class="nump">14,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">72,162<span></span>
</td>
<td class="nump">74,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">4,262<span></span>
</td>
<td class="nump">7,345<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">303,639<span></span>
</td>
<td class="nump">296,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable non-controlling interest - temporary equity</a></td>
<td class="nump">158,008<span></span>
</td>
<td class="nump">155,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value, 20,000,000 shares authorized, 15,206,173 and 15,126,160 shares issued, respectively</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">105,205<span></span>
</td>
<td class="nump">102,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">227,243<span></span>
</td>
<td class="nump">224,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost, 2,214,737 shares</a></td>
<td class="num">(31,628)<span></span>
</td>
<td class="num">(31,628)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total USPH shareholders' equity</a></td>
<td class="nump">300,971<span></span>
</td>
<td class="nump">295,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest - permanent equity</a></td>
<td class="nump">1,245<span></span>
</td>
<td class="nump">1,575<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total USPH shareholders' equity and non-controlling interest - permanent equity</a></td>
<td class="nump">302,216<span></span>
</td>
<td class="nump">297,181<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity</a></td>
<td class="nump">$ 763,863<span></span>
</td>
<td class="nump">$ 749,426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AccountsPayableDueToSellerOfAcquiredBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred related to accounts payable due to seller of acquired business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AccountsPayableDueToSellerOfAcquiredBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590901304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses, patient accounts receivable</a></td>
<td class="nump">$ 2,799<span></span>
</td>
<td class="nump">$ 2,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">15,206,173<span></span>
</td>
<td class="nump">15,126,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">2,214,737<span></span>
</td>
<td class="nump">2,214,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776589645368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 131,704<span></span>
</td>
<td class="nump">$ 112,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and related costs</a></td>
<td class="nump">75,149<span></span>
</td>
<td class="nump">63,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RentSuppliesContractLaborAndOther', window );">Rent, supplies, contract labor and other</a></td>
<td class="nump">28,662<span></span>
</td>
<td class="nump">21,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating cost</a></td>
<td class="nump">105,116<span></span>
</td>
<td class="nump">86,472<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">26,588<span></span>
</td>
<td class="nump">25,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Corporate office costs</a></td>
<td class="nump">11,556<span></span>
</td>
<td class="nump">10,874<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">15,032<span></span>
</td>
<td class="nump">15,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income and expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of unconsolidated affiliate</a></td>
<td class="nump">339<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_GainLossOnRevaluationOfPutRightLiability', window );">Gain on revaluation of put-right liability</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_InterestExpenseDebtAndOther', window );">Interest expense - debt and other</a></td>
<td class="num">(540)<span></span>
</td>
<td class="num">(246)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income and expense</a></td>
<td class="nump">448<span></span>
</td>
<td class="num">(192)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes</a></td>
<td class="nump">15,480<span></span>
</td>
<td class="nump">14,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">3,498<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">11,982<span></span>
</td>
<td class="nump">11,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract', window );"><strong>Less: net income attributable to non-controlling interest:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Redeemable non-controlling interest - temporary equity</a></td>
<td class="num">(2,557)<span></span>
</td>
<td class="num">(2,453)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Non-controlling interest - permanent equity</a></td>
<td class="num">(626)<span></span>
</td>
<td class="num">(1,260)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to non-controlling interest</a></td>
<td class="num">(3,183)<span></span>
</td>
<td class="num">(3,713)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">$ 8,799<span></span>
</td>
<td class="nump">$ 8,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share attributable to USPH shareholders (in dollars per share)</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share attributable to USPH shareholders (in dollars per share)</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computation - basic (in shares)</a></td>
<td class="nump">12,937<span></span>
</td>
<td class="nump">12,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computation - diluted (in shares)</a></td>
<td class="nump">12,937<span></span>
</td>
<td class="nump">12,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember', window );">Net Patient Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 109,538<span></span>
</td>
<td class="nump">$ 99,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember', window );">Other Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 22,166<span></span>
</td>
<td class="nump">$ 13,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_GainLossOnRevaluationOfPutRightLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on revaluation of put-right liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_GainLossOnRevaluationOfPutRightLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_InterestExpenseDebtAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt related expenses and other expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_InterestExpenseDebtAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RentSuppliesContractLaborAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to rent, supplies, contract labor and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RentSuppliesContractLaborAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776593444024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income including non-controlling interest and earnings from unconsolidated affiliates, net</a></td>
<td class="nump">$ 11,982<span></span>
</td>
<td class="nump">$ 11,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">2,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based awards compensation expense</a></td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">2,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_GainLossOnRevaluationOfPutRightLiability', window );">Gain on revaluation of put-right liability</a></td>
<td class="num">(603)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings in unconsolidated affiliate</a></td>
<td class="num">(339)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in patient accounts receivable</a></td>
<td class="num">(4,676)<span></span>
</td>
<td class="num">(4,688)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets', window );">(Increase) decrease in accounts receivable - other</a></td>
<td class="num">(2,145)<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">(Increase) decrease in other assets</a></td>
<td class="num">(735)<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase in accounts payable and accrued expenses</a></td>
<td class="nump">1,445<span></span>
</td>
<td class="nump">3,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Decrease in other long-term liabilities</a></td>
<td class="num">(2,480)<span></span>
</td>
<td class="num">(1,743)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">11,649<span></span>
</td>
<td class="nump">17,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase of fixed assets</a></td>
<td class="num">(2,528)<span></span>
</td>
<td class="num">(1,608)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchase of majority interest in businesses, net of cash acquired</a></td>
<td class="num">(11,242)<span></span>
</td>
<td class="num">(11,747)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireRedeemableNonControllingInterest', window );">Purchase of redeemable non-controlling interest - temporary equity</a></td>
<td class="num">(2,211)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase of non-controlling interest, permanent equity</a></td>
<td class="num">(99)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds on sales of partnership interest, clinics and fixed assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DistributionsFromUnconsolidatedAffiliate', window );">Distributions from unconsolidated affiliate</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ProceedsFromSalesOfNonControllingInterestPermanent', window );">Sales of non-controlling interest-permanent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(15,944)<span></span>
</td>
<td class="num">(13,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to non-controlling interest, permanent and temporary equity</a></td>
<td class="num">(3,711)<span></span>
</td>
<td class="num">(5,265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid to shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving line of credit</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving line of credit</a></td>
<td class="num">(31,000)<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on notes payable</a></td>
<td class="num">(332)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentOfMedicareAcceleratedAndAdvanceFunds', window );">(Payment) receipt of Medicare Accelerated and Advance Funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(19,452)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(4,338)<span></span>
</td>
<td class="num">(14,981)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of period</a></td>
<td class="nump">28,567<span></span>
</td>
<td class="nump">32,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">24,229<span></span>
</td>
<td class="nump">17,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing transactions during the period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PurchaseOfBusinessSellerFinancingPortion', window );">Purchase of businesses - seller financing portion</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity', window );">Notes payable related to purchase of redeemable non-controlling interest, temporary equity</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">4,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity', window );">Notes payable due to purchase of non-controlling interest, permanent equity</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Notes receivable related to sale of partnership interest - redeemable non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable to USPH shareholders</a></td>
<td class="nump">$ 5,327<span></span>
</td>
<td class="nump">$ 4,514<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables, and operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DistributionsFromUnconsolidatedAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the distributions from unconsolidated affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DistributionsFromUnconsolidatedAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_GainLossOnRevaluationOfPutRightLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on revaluation of put-right liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_GainLossOnRevaluationOfPutRightLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentOfMedicareAcceleratedAndAdvanceFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of medicare accelerated and advance funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentOfMedicareAcceleratedAndAdvanceFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireRedeemableNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireRedeemableNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ProceedsFromSalesOfNonControllingInterestPermanent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sales of non-controlling interest-permanent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ProceedsFromSalesOfNonControllingInterestPermanent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PurchaseOfBusinessSellerFinancingPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of business - seller financing portion in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PurchaseOfBusinessSellerFinancingPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776592726296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Total Shareholders' Equity [Member]</div></th>
<th class="th"><div>Non-Controlling Interests [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 95,622<span></span>
</td>
<td class="nump">$ 212,015<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">$ 276,160<span></span>
</td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">$ 277,630<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">15,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax', window );">Revaluation of redeemable non-controlling interest, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,413)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(5,413)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,413)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares', window );">Revaluation of redeemable non-controlling interest, net of tax (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends payable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,514)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,514)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,514)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest partners - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,672)<span></span>
</td>
<td class="num">(1,672)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShortSwingProfitSettlement', window );">Short swing profit settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Net income attributable to non-controlling interest - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,173<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,173<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,173<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">97,286<span></span>
</td>
<td class="nump">210,375<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">276,184<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
<td class="nump">277,241<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="nump">15,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">102,688<span></span>
</td>
<td class="nump">224,395<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">295,606<span></span>
</td>
<td class="nump">1,575<span></span>
</td>
<td class="nump">297,181<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">15,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax', window );">Revaluation of redeemable non-controlling interest, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares', window );">Revaluation of redeemable non-controlling interest, net of tax (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans', window );">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">706<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">706<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of partnership interests - non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="num">(380)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNonControllingInterestNetOfPurchasesAndTax', window );">Sale of non-controlling interest, net of purchases and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends payable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,327)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,327)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,327)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest partners - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,308)<span></span>
</td>
<td class="num">(1,308)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(511)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(500)<span></span>
</td>
<td class="nump">686<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Net income attributable to non-controlling interest - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">626<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,799<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,799<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,799<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 105,205<span></span>
</td>
<td class="nump">$ 227,243<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">$ 300,971<span></span>
</td>
<td class="nump">$ 1,245<span></span>
</td>
<td class="nump">$ 302,216<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="nump">15,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distributions during the period on mandatorily redeemable securities net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RevaluationOfRedeemableNonControllingInterestNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SaleOfNonControllingInterestNetOfPurchasesAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SaleOfNonControllingInterestNetOfPurchasesAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShortSwingProfitSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short swing profit settlement from any purchase or sale (or sale and purchase) of the company's equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShortSwingProfitSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590642536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#8220;Company&#8221;). All significant intercompany transactions
      and balances have been eliminated.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company operates its business through </span>two<span style="font-size: 10pt; font-family: 'Times New Roman';"> reportable business segments. The Company&#8217;s reportable segments include the physical therapy operations segment and the
          industrial injury prevention services segment. The Company&#8217;s physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders,
          sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance
          optimization and ergonomic assessments.</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">During the 2021 year and the three months ended March 31, 2022, the Company completed the acquisitions of four
          multi-clinic practices and two industrial injury prevention businesses as detailed below.</span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 48%; white-space: nowrap;" valign="bottom">
                <div>Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">Date</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">Acquired</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">Clinics</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>March 2022 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">March 31, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>70</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">6</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom">
                <div>December 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">December 31, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div>75</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">3</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 48%; white-space: nowrap;" valign="bottom">
                <div>November 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">November 30, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" valign="bottom">
                <div>70</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;"><br/>
                </div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;" valign="bottom">IIPS*</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom">
                <div>September 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">September 30, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div>100</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;"><br/>
                </div>
              </td>

    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom">IIPS*</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>June 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">June 30, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>65</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">8</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom">
                <div>March 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">March 31, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div>70</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">6</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div>
              <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 9pt;">
                      <div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"><span style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 7.2pt; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">*</span></span></div>
                    </td>

    <td style="align: left; vertical-align: top; width: auto;">
                      <div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Industrial injury prevention services business</span></div>
                    </td>

  </tr>


</table>
               </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">As of March 31, 2022, the Company operated 601 clinics in 39 states. The Company also manages physical therapy facilities for third parties,
          primarily hospital and physicians, with 38 third-party facilities under management as of March 31, 2022.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"> <br/>
        </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Physical Therapy Operations</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The physical therapy operations segment</span> primarily operates through subsidiary clinic partnerships, in
      which the Company generally owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests
      typically range from 10% to 35%
      in the Clinic Partnerships. The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, the Company
      operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources, by offering these
      therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue as employees to
      manage the clinic operations, retain a non-controlling ownership interest in the clinics and receive a competitive salary for managing the clinic operations. In addition, the Company has developed satellite clinic facilities as part of existing
      Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than one clinic location.</div>

<div><br/></div>

<div><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Clinic Partnerships </span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or
        indirectly, are recorded within the balance sheets as non-controlling interest &#8211; permanent equity and within the income statements as net income attributable to non-controlling interest &#8211; permanent equity<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For acquired Clinic Partnerships with redeemable non-controlling interest, the earnings attributable to the redeemable non-controlling interest are recorded within the
        consolidated statements of income line item &#8211; <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">net income attributable to non-controlling interest &#8211; redeemable non-controlling interest &#8211; temporary equity </span>and



        the equity interest is recorded on the consolidated balance sheet as <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">redeemable non-controlling interest &#8211; temporary equity</span>.&#160; In accordance with current
        accounting guidance, the revaluation of redeemable non-controlling interest, net of tax, is not included in net income but charged directly to retained earnings and is included in the basic and diluted earnings per share calculation<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Wholly-Owned Facilities</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due to the profit sharing therapists. The
      amount is expensed as compensation and included in operating cost &#8211; salaries and related costs. The respective liability is included in current liabilities &#8211; accrued expenses on the balance sheets.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Industrial Injury Prevention Services</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Services provided in the industrial injury prevention services segment include onsite services for clients&#8217; employees including injury prevention and rehabilitation,
      performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies.
      Other clients include large insurers and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and certified athletic trainers.</div>

<div><br/>

    <span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Basis of Presentation</span></div>

<div><br/>
      </div>

<div style="text-align: left; margin-right: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The accompanying unaudited consolidated financial statements were prepared in
          accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions for Form </span>10<span style="font-size: 10pt; font-family: 'Times New Roman';">-Q.


          However, the statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. Management believes this report contains all
          necessary adjustments (consisting only of normal recurring adjustments) to present fairly, in all material respects, the Company&#8217;s financial position, results of operations and cash flows for the interim periods presented. For further information
          regarding the Company&#8217;s accounting policies, please read the audited financial statements included in the Company&#8217;s Annual Report on Form </span>10<span style="font-size: 10pt; font-family: 'Times New Roman';">-K for the year ended </span>December


        31, 2021<span style="font-size: 10pt; font-family: 'Times New Roman';"> filed with the Securities and Exchange Commission on </span>March 1, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company believes, and the Chief Executive Officer and Chief Financial Officer have certified, that the financial statements included in this report present fairly, in
        all material respects, the Company&#8217;s financial position, results of operations and cash flows for the interim periods presented.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Operating results for the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';">
          months ended March</span> 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';"> are not necessarily indicative of the results the Company expects for the entire year.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Impact of COVID</span>-19</div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
    </div>

<div><span style="text-decoration: underline;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Medicare Accelerated and Advance
            Payment Program (&#8220;MAAPP Funds&#8221;)</span></span><br/>
      </div>

<div><span style="text-decoration: underline;"><span style="font-weight: bold;"> <br/>
          </span></span></div>

<div style="text-align: left; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On March 27, 2020, in response to the COVID-19 pandemic, the federal government
          approved the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act provided waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0 billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for
          preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.</span></div>

<div style="text-align: left; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
        </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The CARES <span style="font-size: 10pt; font-family: 'Times New Roman';">Act allowed for qualified healthcare providers to receive advanced payments under the MAAPP
          Funds during the COVID</span>-19<span style="font-size: 10pt; font-family: 'Times New Roman';"> pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. The Company
          applied for and received approval from Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. The Company recorded the $14.1
          million in advance payments received as a liability. During the three months ended March 31, 2021, the Company repaid the MAAPP Funds of </span>$14.1
        million <span style="font-size: 10pt; font-family: 'Times New Roman';">rather than applying them to future services performed</span>. During the three months ended March 31, 2022 and 2021, the Company did not record any income from payments under the CARES Act.</div>

<div><br/></div>

<div><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Significant Accounting Policies </span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cash Equivalents</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company maintains its cash and cash equivalents at financial institutions.&#160; The Company considers all highly liquid investments with a maturity of three months or less
      when purchased to be cash equivalents.&#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related on
      deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Long-Lived Assets</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture
      and equipment range from <span style="-sec-ix-hidden:Fact_b13cf1c74cd446babb6cdd78fa4c8294">three</span> to eight years and for purchased software from <span style="-sec-ix-hidden:Fact_c14f91b399c145c8a8ea00d2ca948500">three</span> to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally <span style="-sec-ix-hidden:Fact_02de141ed1d4420c98a9952012a0ab54">three</span> to five years.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that
      the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company did </span>no<span style="font-size: 10pt; font-family: 'Times New Roman';">t note an impairment to long-lived assets during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended March</span> 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Goodwill</div>

<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the
          fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to </span>2009<span style="font-size: 10pt; font-family: 'Times New Roman';">,
          from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective </span>January 1, 2009<span style="font-size: 10pt; font-family: 'Times New Roman';">, if the purchase price of a
          non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</span></div>

<div><br/></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic
          impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair
          value if considered impaired. These events or conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined
          with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of </span>one<span style="font-size: 10pt; font-family: 'Times New Roman';"> of these
          events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company has a two operating segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The partnerships are components of regions
          and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In 2021 and 2020, there were </span>six<span style="font-size: 10pt; font-family: 'Times New Roman';"> regions. In addition to the </span>six<span style="font-size: 10pt; font-family: 'Times New Roman';"> regions, the impairment analysis included a separate analysis for the industrial injury prevention services business, as a
          separate reporting unit.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">As part of the impairment analysis, the Company is </span>first<span style="font-size: 10pt; font-family: 'Times New Roman';"> required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether
          a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that
          affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting
          unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in </span>2021<span style="font-size: 10pt; font-family: 'Times New Roman';"> and </span>2020<span style="font-size: 10pt; font-family: 'Times New Roman';"> did not result in any goodwill amounts that were deemed impaired.</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that
            the fair value of the reporting units were reduced below their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting
            units were impaired as of December 31, 2021.<br/>
          </span></span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> The Company will continue to monitor for any triggering events or other indicators of impairment.<br/>
          </span></span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Redeemable Non-Controlling Interest</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The non-controlling interests that are reflected as redeemable non-controlling interest in the consolidated financial statements consist of those that the owners and the
      Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met.&#160;
      The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights can be triggered by the owner or the
      Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction,
      typically <span style="-sec-ix-hidden:Fact_40b721ca5dc3493aaa09b990a340fe57">three</span> to five years,
      as defined in the limited partnership agreement.&#160; The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been
      satisfied.</div>

<div><br/></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under
      the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; Redeemable non-controlling interest &#8211; temporary equity.&#160; Then, in each reporting period thereafter until it
      is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership
      agreement.&#160; As a result, the value of the non-controlling interest is not adjusted below its initial carrying value.&#160; The Company records any adjustments in the redemption value, net of tax, directly to retained earnings and the adjustments are not
      reflected in the consolidated statements of income.&#160; Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per
      share calculation.&#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e.
      the carrying amount) and fair value are the same.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Controlling Interest</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the non-controlling interest, as permanent equity in the
      consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interest is included in consolidated net income on the face of the statements of net income. Changes in a parent
      entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a
      subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment
      to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Revenue Recognition</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered. See Note 3- Revenue Recognition, for further discussion of revenue recognition.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Provision for Credit Losses</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he Company determines provisions for credit losses based on the specific agings and payor classifications at
        each clinic. The provision for credit losses is included in operating cost in the consolidated statements of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and
        provisions for credit losses, includes only those amounts the Company estimates to be collectible</span>.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Income Taxes</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to
      differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates
      expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that
      includes the enactment date.</div>

<div><br/></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the
      position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate
      settlement with the relevant tax authority.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of
        interest expense and depreciation. ASC 740</span>,<span style="font-size: 10pt; font-family: 'Times New Roman';"> Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which
        the legislation is enacted. The legislation had no effect on the Company&#8217;s deferred income taxes and current income taxes payable during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended March 31, 2022</span>.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company did not have any accrued interest or
      penalties associated with any unrecognized tax benefits nor was any interest expense recognized <span style="font-size: 10pt; font-family: 'Times New Roman';">during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended</span> March 31, 2022. The Company records any interest or penalties, if required, in interest and other expense,
      as appropriate.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out
        payments, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement (as defined in Note 9)
        approximates the fair value. The interest rate on the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#8220;LIBOR&#8221;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different
        reference rate in the event LIBOR ceases to exist.<br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The redeemable non-controlling interest included on the consolidated balance sheets and the put right
        associated with the potential future purchase of the separate company in the November 2021 acquisition (as described in Note 2) are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of redeemable
        non-controlling interests approximates the fair value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable
        inputs such as asset volatility and discount rates. The unobservable inputs in the valuation include asset volatility of 25% and a
        discount rate of 9.93%. See Note 5 for the changes in the fair value of redeemable non-controlling interest.<br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The put right decreased $603 thousand for the three months ended March 31, 2022 and was valued at $2.9
        million on March 31, 2022.<br/>
      </span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Segment Reporting</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Operating segments are components of an enterprise for which separate financial information is available
          that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance.&#160; The Company currently operates through </span>two<span style="font-size: 10pt; font-family: 'Times New Roman';"> segments: physical therapy operations and industrial injury prevention services.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Use of Estimates</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">I<span style="font-size: 10pt; font-family: 'Times New Roman';">n preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and
        assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames and other intangible assets, allocations of purchase price, provision for credit losses, tax provision and contractual allowances, that affect the amounts
        reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates</span>.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Self-Insurance Program</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with
      an insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued
      amounts are sufficient to pay claims arising from self-insurance claims incurred through March 31, 2022.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted Stock</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock
      granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_5ace032f12924d2eb4cdbde0f9b532c6">four</span> anniversaries of the date of grant. For those shares granted
      to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_e7d74d21eab74c899fb44317a7932e6a">first</span> year after the date of grant. For those granted
      to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation
      expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and
      diluted shares for the earnings per share computation.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recently Adopted Accounting Guidance</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740)&#8211;Simplifying the Accounting for Income
        Taxes (&#8220;ASU 2019-12&#8221;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of
        financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In August 2020, the FASB issued ASU 2020-06 Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and
        Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of
        liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the
        treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive,
        regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">This pronouncement was effective for fiscal years, and for interim periods within those fiscal years,
        beginning after December 15, 2021.The Board specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or
        fully retrospective method of transition is permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recently Issued Accounting Guidance</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In </span>March 2020<span style="font-size: 10pt; font-family: 'Times New Roman';">, the FASB issued ASU </span>2020-04<span style="font-size: 10pt; font-family: 'Times New Roman';">, Reference Rate Reform (Topic </span>848<span style="font-size: 10pt; font-family: 'Times New Roman';">): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This
          ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to
          alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through </span>December 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';">.
          Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event
          LIBOR ceases to exist.</span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776589835224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS OF BUSINESSES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>ACQUISITIONS OF BUSINESSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS OF BUSINESSES</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2. ACQUISITIONS OF BUSINESSES</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">On
        March 31, 2022, the Company acquired a 70% interest in a six-clinic physical therapy practice in South Central Pennsylvania &#8211; Madden and Gilbert Physical Therapy, LLC. The practice&#8217;s owners retained 30% of the equity interests. The purchase price for the 70%
        equity interest was approximately $11.5 million. of which $11.2 million was paid in cash and $0.3 million in the form of a note payable.&#160; The note accrues
        interest at 3.5% per annum and the principal and interest are payable on March 31, 2024.</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he purchase price for the 2022 acquisition has been preliminarily allocated as follows (in thousands)</span>:
    </div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,242</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Seller notes</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,542</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 12.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,743</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">247</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">659</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,539</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(4,946</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,542</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On December 31, 2021, the Company acquired a 75% in three-clinic physical therapy practice with the practice
        founder retaining 25%. The purchase price for the 75% interest was approximately $3.7 million, of which $3.5 million was paid in cash and $0.2 million in the form of a
        note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on December 31, 2023.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On November 30, 2021, the Company acquired an approximate 70% interest in a leading provider of industrial injury prevention services. The previous owners retained the remaining interest. The purchase price for the approximate 70%
        equity interest, not inclusive of a $2.0 million contingent payment, was approximately $63.2 million of which $62.2 million was paid in cash and $1.0 million in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest is payable on November 30, 2023. As part of the transaction, the Company also agreed to the potential future purchase of a separate company under the same ownership
        that provides physical therapy and rehabilitation services to hospitals and other ancillary providers in a distinct market area. The current owners have the right to put this transaction to the Company in approximately five years, with such right having an initial fair value of $3.5 million value on December 31, 2021, as reflected on the Company&#8217;s consolidated balance sheet in Other long-term liabilities. The value of this right will be adjusted in future periods, as appropriate, with any
        change in value reflected in the Company&#8217;s consolidated statement of income. The Company does not currently possess any of the controlling interests in this separate company, does not control this company through contract or governance rights and
        currently does not exercise significant influence over this separate company. Due to these reasons, and based on current accounting guidance, the Company did not consolidate the separate company through the variable interest or voting interest
        model. On March 31, 2022, the fair value of this right was $2.9 million.&#160; The decrease was reflected in the consolidated statement of
        income in the line item - Gain on revaluation of put-right liability</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">.</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> <br/>
      </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On September 30, 2021, the Company
          acquired a company that specializes in return-to-work and ergonomic services, among other offerings. The Company acquired the company&#8217;s assets at a purchase price of approximately $3.3 million (which includes the obligation to pay an amount up to $0.6
          million in contingent payment consideration in conjunction with the acquisition if specified future operational objectives are met) and contributed those assets to the industrial injury services business. The initial purchase price, not inclusive
          of the $0.6 million contingent payment, was approximately $2.7 million, of which $2.4 million was paid in cash, and $0.3 million is in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on September 30, 2023.<br/>
        </span></div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On June 30, 2021, the Company
          acquired a 65% interest in an eight-clinic

















          physical therapy with the previous owners retaining 35%. The purchase price was approximately $10.3 million, of which $9.0 million was
          paid in cash, $1.0 million is payable based on the achievement of certain business criteria and $0.3 million is in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on June 30, 2023. Additionally, the Company has an obligation to pay an additional amount up to $0.8 million in contingent payment consideration in conjunction with the acquisition if specified future operational objectives are met. The Company
          recorded acquisition-date fair value of this contingent liability based on the likelihood of the contingent earn-out payment. The earn-out payment will subsequently be remeasured to fair value each reporting date.<br/>
        </span></div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> On March 31, 2021, the Company
          acquired a 70% interest in a five-clinic

















          physical therapy practice with the previous owners retaining 30%. When acquired, the practice was developing a sixth clinic which has
          been completed. The purchase price for the 70% interest was approximately $12.0 million, of which $11.7 million was paid in cash and $0.3 million in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on March 31, 2023.</span><br/>
      </div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The <span style="font-size: 10pt; font-family: 'Times New Roman';">purchase price for the 2021 acquisitions has been preliminarily allocated as follows (in thousands):</span></div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Physical Therapy</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> IIPS*</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operations</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Cash paid, net of cash acquired</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">63,193</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">23,544</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">86,737</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Seller notes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,250</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">800</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">2,050</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Contingent payments</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">2,520</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">837</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">3,357</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Other payable</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Seller put right</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">3,522</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,000</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">4,522</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total consideration</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">70,485</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">26,181</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">96,666</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Estimated fair value of net tangible assets acquired:</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total current assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">5,588</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">2,041</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">7,629</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total non-current assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">12,620</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">7,153</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">19,773</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);">Total liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(4,842</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(8,413</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(13,255</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 34.2pt; color: rgb(0, 0, 0);">Net tangible assets acquired</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">13,366</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">781</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">14,147</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Customer and referral relationships</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">21,127</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">6,090</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">27,217</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Non-compete agreements</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">500</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">539</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,039</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Tradenames</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">5,141</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,762</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">6,903</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">58,257</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">28,965</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">87,222</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(27,906</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(11,956</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(39,862</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">70,485</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">26,181</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">96,666</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 9pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left;">*</div>
                </td>

    <td style="vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left;">Industrial injusry prevention services</div>
                </td>

  </tr>


</table>
        </div>

<div><br/></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the date of their respective acquisition.<br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> For the 2022 and 2021 acquisitions, a majority of total current assets primarily represents accounts receivable. Total non-current assets are fixed assets and equipment
      used in the practice.<br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2021 were allocated to the fair value of the assets acquired, inclusive of
      identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill.</div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">For the acquisitions in 2021, the values assigned to the customer and referral relationships and
          non-compete agreements are being amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period w</span>as 13.8 years. For non-compete agreements, the weighted-average amortization period was 5.6 years<span style="font-size: 10pt; font-family: 'Times New Roman';"> at the end of the year. The values assigned to tradenames are tested annually for impairment</span>.</div>

<div> <br/>
      </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The consideration paid for each of the
          acquisitions was derived through arm&#8217;s length negotiations. Funding for the cash portions was derived from proceeds from the Company&#8217;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#8217;s
          consolidated financial statements since their respective date of acquisition. Unaudited proforma consolidated financial information for the acquisitions in 2022 and 2021 have not been included, as the results, individually and in the aggregate,
          were not material to current operations.<br/>
        </span> </div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The purchase price plus the fair
          value of the non-controlling interest for the acquisitions in 2022 and those acquired after March 31, 2021 was allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. tradenames, referral
          relationships and non-compete agreements, and liabilities assumed based on the estimated fair values at the acquisition date, with the amount in excess of fair values being recorded as goodwill. The Company is in the process of completing its
          formal valuation analysis of the acquisitions, to identify and determine the fair value of tangible and identifiable intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the
          preliminary estimates used on March 31, 2022 based on additional information obtained and completion of the valuation of the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the
          valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in
          adjustments to goodwill. The Company does not expect the adjustments to be material.&#160; The purchase price allocation for the March 2021 Acquisition has been finalized. The Company continues to evaluate the components for the purchase price
          allocations for other acquisitions in 2021.<br/>
        </span></div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">For the acquisitions in 2022, the
          values assigned to the customer and referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period is
          12.0 years. For non-compete agreements, the weighted-average amortization period is 5.0 years. The values assigned to tradenames are tested annually for impairment.<br/>
        </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the date of their respective acquisition.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590627976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>REVENUE RECOGNITION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3. REVENUE RECOGNITION</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Categories</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">N<span style="font-size: 10pt; font-family: 'Times New Roman';">et patient revenue consists of revenue for physical therapy and occupational therapy clinics that provide
          pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenue (patient revenue less estimated
          contractual adjustments) is recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied
          contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on
          previously rendered services. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of
          payor contracts and historical collection and write-off experience.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenue, which is included in other revenue in the consolidated statements of net income, is derived from contractual arrangements whereby the Company
        manages a clinic owned by a third party. The Company does not have any ownership interest in these clinics. Typically, revenue is determined based on the number of visits conducted at the clinic and recognized at the point in time when services are
        performed. Costs, typically salaries for our employees, are recorded when incurred.</div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Revenue from the industrial injury prevention services segment, which is also included in other revenue in the consolidated statements of net income, is derived from
        onsite services the Company provides to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the industrial injury prevention services segment is recognized when
        obligations under the terms of the contract are satisfied. Revenue is recognized at an amount equal to the consideration the Company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined
        and recognized based on the number of hours and respective rate for services provided in a given period.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Additionally, other revenue includes services the Company provides on-site, such as schools, for physical or occupational therapy services, and fees from athletic
        trainers. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance,
        revenue is recorded as a liability over the period of the agreement and recognized at the point in time, when the services are performed.</div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company determines credit losses based on the specific agings and payor classifications at each clinic.
          The provision for credit losses is included in clinic operating cost in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and provision for
          credit losses, includes only those amounts the Company estimates to be collectibl</span>e.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the revenue related to the various categories (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenue</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">109,538</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">99,254</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other revenue<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">872</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">546</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="margin: 0px 0px 0px 14.4pt; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: -7.2pt;">Physical therapy operations<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">110,410</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">99,800</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">Management contract revenue<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"><br/>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">2,226</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"><br/>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">2,559</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services revenue</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">19,068</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">10,009</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">131,704</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">112,368</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Medicare Reimbursement</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee
          Schedule (&#8220;MPFS&#8221;). For services provided in 2017 through 2019, a</span>&#160;0.5% increase <span style="font-size: 10pt; font-family: 'Times New Roman';">was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025</span> no <span style="font-size: 10pt; font-family: 'Times New Roman';">adjustment is expected to be applied each year to the fee schedule payment rates, before applying the
          mandatory budget neutrality adjustment.</span></div>

<div><br/>
      </div>

<div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">In



          the 2020 MPFS Final Rule, The Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) revised coding, documentation guidelines, and increased the code values for office/outpatient evaluation and management (&#8220;E/M&#8221;) codes and cuts to other codes to
          maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office visit codes and made cuts to other specialty codes to maintain budget neutrality. As a result, CMS projected a 9% decrease in fee schedule payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the
          Consolidated Appropriations Act, 2021 and reimbursement for the codes applicable to&#160; physical/occupational therapy services provided by our clinics received an estimated 3.5% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020. </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="color: #1F497D; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In the 2022 MPFS Final Rule published on November 2, 2021, there
              was to be an approximately 3.75% reduction to Medicare payments for physical/occupational therapy services. This was due to the
              expiration of the additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021.</span> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">However, this reduction was addressed in the Protecting Medicare and American Farmers from Sequester Cuts Act (&#8220;2021 Act&#8221;) signed into law on December 10, 2021.
              Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year of 2022 will be approximately 0.75%. The 2021 Act did not address the 15% reduction in Medicare payments for services
              performed by a physical or occupational therapist assistant, which began on January 1, 2022.</span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In addition, the Consolidated Appropriations Act, 2021 includes reductions in Medicare payment rates of approximately 3% in each of calendar years 2023 and 2024, unless regulatory or Congressional action results in modifications to such rates as has occurred in
              2021 and 2022.</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions
          over the next</span>&#160;ten years and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments
        was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through
        fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through
        fiscal year 2027. T<span style="font-size: 10pt; font-family: 'Times New Roman';">he CARES Act suspended the </span>2%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction to Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the </span>2%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction until March 31, 2021. On April 14, 2021, additional legislation was
          enacted that waived the </span>2%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction for the remainder
          of calendar 2021</span>. The 2021 Act, which was signed into law on December 10, 2021, included a three-month extension of the 2% sequester relief applied to all Medicare payments through March 31, 2022, followed by three months of 1% sequester relief through June 30, 2022.
        Sequester relief is scheduled to then end on June 30, 2022.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice)
          paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health
          records. Therapists eligible to participate in MIPS include only those therapists who are enrolled with Medicare as private practice providers, and does not include therapists in facility-based providers, such as our clinics enrolled as certified
          rehabilitation agencies. Less than </span>3%<span style="font-size: 10pt; font-family: 'Times New Roman';"> of the Company&#8217;s therapist
          providers currently participate in MIPS. Under the MIPS requirements, a provider<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span>s performance is assessed according to established performance standards each year and then is
          used to determine an adjustment factor that is applied to the professional<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span>s payment for the corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine
          the payment adjustment in 2021. For those therapist providers who actually participated in MIPS during 2019, the resulting average payment adjustment was an increase of </span>1%<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Under the Middle-Class Tax Relief and Job Creation Act of 2012 (&#8220;MCTRA&#8221;), since October 1, 2012, patients
          who met or exceede</span>d $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to
        determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language
        Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual
        medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be
        determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for 2028 and in subsequent
        years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">CMS adopted a multiple procedure payment reduction (<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;</span>MPPR<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8221;</span>) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language
        pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;</span>RVU<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8221;</span>) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the
        practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. In 2013, the
        practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Medicare claims for outpatient therapy services furnished by therapist assistants on or after January 1, 2020 must include a modifier indicating the service was furnished
        by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022, in whole or part by a therapist assistant are paid at an amount equal to 85% of the payment amount otherwise applicable for the service.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare
            beneficiaries are complex and subject to interpretation. The Company believes that the Company is in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations
            involving allegations of potential wrongdoing that would have a material effect on the Company<span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span>s financial statements as of March 31, 2022. Compliance with such laws and
            regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the three months ended March 31, 2022, and 2021,
            respectively, net patient revenue from Medicare was approximately $</span>35.6<span style="font-size: 10pt; font-family: 'Times New Roman';"> million and $</span>26.6<span style="font-size: 10pt; font-family: 'Times New Roman';"> million, respectively.<br/>
          </span><br/>
        </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, the Company may not continue to receive reimbursement rates from
        Medicare that sufficiently compensate us for the Company<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span></span>s services or, in some instances, cover the Company<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span></span>s operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a
        material adverse effect on the Company<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span></span>s revenue, financial condition and results of operations.
        Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect the Company<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#8217;</span></span>s business, financial condition and results of operations.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Contractual Allowances</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Contractual allowances result from the differences between the rates charged for services performed and
          expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple
          reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the
          Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable
          balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with
          its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised
          necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy
          of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the
          difference between net revenues and corresponding cash collections has generally reflected a difference within approximately </span>1.0%<span style="font-size: 10pt; font-family: 'Times New Roman';"> to </span>1.5%<span style="font-size: 10pt; font-family: 'Times New Roman';">
          of net revenue. Additionally, analysis of subsequent periods&#8217; contractual write-offs on a payor basis reflects a difference within approximately </span>1.0%<span style="font-size: 10pt; font-family: 'Times New Roman';"> to </span>1.5%<span style="font-size: 10pt; font-family: 'Times New Roman';">
          between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual
          allowance reserve estimate would not likely be more than </span>1.0%<span style="font-size: 10pt; font-family: 'Times New Roman';"> to
        </span>1.5%<span style="font-size: 10pt; font-family: 'Times New Roman';"> at March 31, 2022.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized when, or as, the performance obligation is satisfied. To determine the
        transaction price, the Company includes the effects of any variable consideration, such as the probability of collecting that amount. The Company applies established rates to the services provided, and adjusts for the terms of payor contracts, as
        applicable. These contracted amounts are different from the Company&#8217;s established rates.&#160; The Company has established a &#8220;contractual allowance&#8221; for this difference. The allowance is based on the terms of payor contracts, historical and current
        reimbursement information and current experience with the clinic and partners. The Company&#8217;s established rates less the contractual allowance is the revenue that is recognized in the period in which the service is rendered. This revenue is deemed
        the transaction price and stated as &#8220;Net Patient Revenue&#8221; on the Company&#8217;s consolidated statements of income.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company&#8217;s performance obligations are satisfied at a point in time. After the clinic has provided
        services and satisfied its obligation to the customer for the reimbursement rates stipulated in the payor contracts (i.e. the transaction price), the Company recognizes the revenue, net of contractual allowances, in the period in which the services
        are rendered. The Company recognizes the full amount of revenue and reports the contractual allowances as a contra (or offset) revenue account to report a net revenue number based on the expected collection</span>s.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776674968136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>EARNINGS PER SHARE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4. EARNINGS PER SHARE</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with current accounting guidance, the revaluation of redeemable non-controlling interest (see Note 5 &#8211; Redeemable Non-Controlling Interest), net of tax,
      charged directly to retained earnings is included in the earnings per basic and diluted share calculation. The following table provides a detail of the basic and diluted earnings per share computation (in thousands, except per share data).</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8,799</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8,173</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">(Charges) credit to retained earnings:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(153</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(7,270</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of <span style="text-indent: 0pt;">25.55</span>%<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">39</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">1,857</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">8,685</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">2,760</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">0.67</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">0.21</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">12,937</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">12,870</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590627976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REDEEMABLE NON-CONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_REDEEMABLENONCONTROLLINGINTERESTAbstract', window );"><strong>REDEEMABLE NON-CONTROLLING INTEREST [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestTextBlock', window );">REDEEMABLE NON-CONTROLLING INTEREST</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5. REDEEMABLE NON-CONTROLLING INTEREST</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Since October 2017, when the Company acquires a majority interest (the &#8220;Acquisition&#8221;) in a physical therapy clinic business (referred to as &#8220;Therapy Practice&#8221;), these
      Acquisitions occur in a series of steps which are described below.</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#8220;Seller Entity&#8221;). The Seller Entity is owned by one or more individuals (the &#8220;Selling
              Shareholders&#8221;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&#8220;NewCo&#8221;), in exchange for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller
              Entity.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Company enters into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited partnership interest and in <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">all</span></span> cases 100% of the general partnership interest in
              NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in
              the form of cash at closing and a small, two-year note in lieu of an escrow (the &#8220;Purchase Price&#8221;). The Purchase Agreement does
              not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Seller Entity also execute a partnership agreement (the &#8220;Partnership Agreement&#8221;) for NewCo that sets forth the rights and obligations of the limited and general
              partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo
              (&#8220;Seller Entity Interest&#8221;).</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#8220;Employment Agreement&#8221;) with NewCo with an initial term that ranges from <span style="-sec-ix-hidden:Fact_366532ba69814de1ad518109bf840391">three</span> to five years (the
              &#8220;Employment Term&#8221;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment Term. As
              a result, a Selling Shareholder becomes an employee (&#8220;Employed Selling Shareholder&#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any
              time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity
              as of the closing of the Acquisition.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other
              employees in similar capacities within NewCo, the Company and the industry.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the
              &#8220;Non-Compete Agreement&#8221;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &#8220;Non-Compete Term&#8221;). A Non-Compete Agreement is executed with the Selling Shareholders in all
              cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and&#160; expires on the <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">later</span></span> of :</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Two years after the date an Employed Selling Shareholders&#8217; employment
              is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_384e0904d90e46f581ffc1a642cdf595">Five</span> to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">10.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to a restricted region which is defined as a defined mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to
              engage in competing businesses or activities outside the defined mileage (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the
              competing business or activities outside the defined mileage.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#8220;Call Right&#8221;) or at the option of
      the Seller Entity (the &#8220;Put Right&#8221;) as follows:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment is terminated under certain circumstances prior to a specified date (the &#8220;Specified Date&#8221;), the Seller Entity thereafter may
              have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder is not employed by NewCo as of the Specified Date and the Company has not exercised its Call Right with respect to the Terminated Selling
              Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s
              Interest at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">c)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the Specified Date, the Seller Entity shall have the Put Right, and upon
              the exercise of the Put Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s employment by NewCo is terminated prior to the Specified Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the
              Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after Specified Date, the Company shall have the Call Right, and upon the
              exercise of the Call Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings before interest, taxes,
              depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on available cash within
              NewCo.&#894; Therefore, the undistributed earnings amount is small, if any.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company <span style="font-size: 10pt; font-family: 'Times New Roman';">is, in almost all cases, also</span> based
              on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date, and the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity unless
              either the Put Right or the Call Right is exercised.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire
              ownership interest in the Seller Entity at the closing of the Acquisition.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ProgressiveHealth Acquisition</div>

<div><br/>
    </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2021, the Company acquired a majority interest in ProgressiveHealth Companies, LLC (&#8220;Progressive&#8221;), which owns a majority interest in
        certain subsidiaries (&#8220;Progressive Subsidiaries&#8221;) that operate in the industrial injury prevention and therapy services businesses.&#160; The Progressive transaction was completed in a series of steps which are described below.</div>

<div><br/>
    </div>

<div>
      <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Prior to the acquisition, the Progressive Subsidiaries were owned by a legal entity (&#8220;Progressive Parent&#8221;) controlled by its individual
                  owners (the &#8220;Selling Shareholders&#8221;), who work in and manage the Progressive business.</div>
              </div>
            </td>

  </tr>


</table>
    </div>

<div><br/>
    </div>

<div>
      <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the acquisition, the Selling Shareholders caused the Progressive Parent to transfer its ownership of the Progressive
                  Subsidiaries into a newly-formed limited liability company (&#8220;NewCo&#8221;), in exchange for one hundred percent (100%) of the
                  membership interests in NewCo. Therefore, in this step, NewCo became wholly-owned by the Selling Shareholders.</div>
              </div>
            </td>

  </tr>


</table>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company entered into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Selling Shareholders a majority of the membership
                      interest in NewCo. The consideration for the acquisition is primarily payable in the form of cash at closing, a relatively small portion paid in cash after the closing contingent on certain performance criteria, and a small note in
                      lieu of an escrow (the &#8220;Purchase Price&#8221;).</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholders also executed an operating agreement (the &#8220;Operating Agreement&#8221;) for NewCo that sets forth the
                      rights and obligations of the members of NewCo.</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company did not purchase 100% of the membership interests in NewCo and the Selling Shareholders retained a portion of the membership interest in NewCo (&#8220;Selling Shareholders&#8217; Interest&#8221;).</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholders executed a non-compete agreement (the &#8220;Non-Compete Agreement&#8221;) which restricts the Selling
                          Shareholders from competing for a specified period of time (the &#8220;Non-Compete Term&#8221;).</div>
                      </div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and expires on the <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">later</span></span> of:</div>
                </div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Two years after the date a
                  Selling Shareholder no longer is involved in the management of NewCo or</div>
              </div>
            </td>

  </tr>


</table>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seven years from the
                      date of the acquisition.</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
            <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                  </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to the entire United States.</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </td>

  </tr>


</table>
          </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
              <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                    </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.</div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>

  </tr>


</table>
            </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Operating Agreement contains provisions for the redemption of the Selling Shareholder&#8217;s Interest, either at the option of the Company (the &#8220;Call
        Right&#8221;) or at the option of the Selling Shareholder (the &#8220;Put Right&#8221;) as follows:</div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each of the Selling Shareholders has the right to sell 30% of their respective residual interests on each of the 4th and 5th anniversaries of the acquisition closing, and then 10% on each of the 6th and 7th anniversaries</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder terminates his management relationship with NewCo for any reason on or after the seventh
                          anniversary of the Closing Date, the Selling Shareholder has the Put Right, and upon the exercise of the Put Right, the Selling Shareholder&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
                      </div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
            <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                  </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div>
                        </div>
                      </div>
                    </div>
                  </td>

  </tr>


</table>
          </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s ceases to perform management services on behalf of NewCo, the Company thereafter shall have an
                          irrevocable right to purchase from such Selling Shareholder his Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
                      </div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing
                      twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings
                      are distributed monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div>
                  </div>
                </div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the
                          trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.</div>
                      </div>
                    </div>
                  </div>
                </td>

  </tr>


</table>
        </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div>
              <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                    </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.</div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </td>

  </tr>


</table>
            </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Neither the Operating Agreement nor the Non-Compete Agreement contain any provision to escrow or &#8220;claw back&#8221; the equity interest in NewCo held by the
        Selling Shareholders, in the event of a breach of the operating agreement or non-compete terms, or the management services agreement pursuant to which the Selling Shareholders perform services on behalf of NewCo. The Company&#8217;s only recourse against
        the Selling Shareholder for breach of any of these agreements is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with a Selling Shareholder that would result in a forfeiture of the
        equity interest in NewCo held by a Selling Shareholder.</div>

<div><br/></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#8217;s purchase of its partnership
      interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in
      NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her
      full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment
      Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest
      held in the Seller Entity or of the Seller Entity Interest.</div>

<div><br/>
    </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">For the </span>dates indicated,<span style="font-size: 10pt; font-family: 'Times New Roman';"> the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interest (in</span> thousand<span style="font-size: 10pt; font-family: 'Times New Roman';">s):</span></div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">155,262</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">132,340</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">2,557</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">11,358</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(2,403</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(11,359</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">153</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">13,011</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(2,457</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(30,204</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">4,946</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">39,862</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">982</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">(914</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">(50</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">186</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">Other <br/>
            </div>
          </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">158,008</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">155,262</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interest (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder&#8217;s employment has not terminated</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">92,320</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">80,781</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder&#8217;s employment has not terminated</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">65,688</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">74,481</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Holder&#8217;s employment has terminated and contractual time period has expired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Holder&#8217;s employment has terminated and contractual time period has not expired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">158,008</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">155,262</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_REDEEMABLENONCONTROLLINGINTERESTAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_REDEEMABLENONCONTROLLINGINTERESTAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776697589640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>GOODWILL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">GOODWILL</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6. GOODWILL</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The changes in the carrying amount of goodwill consisted of the following (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom;" valign="bottom"/>

    <td colspan="1" style="white-space: nowrap; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Three Months Ended</span></div>
          </td>

    <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="white-space: nowrap; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">434,679</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">345,646</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,539</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">89,746</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(2,526</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(713</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">443,692</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">434,679</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590828536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>INTANGIBLE ASSETS, NET [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS, NET</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7. INTANGIBLE ASSETS, NET</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Intangible assets, net as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">39,456</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">38,790</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships, net of accumulated amortization of $<span style="text-indent: 0pt;">19,959</span> and $<span style="text-indent: 0pt;">17,762</span>, respectively</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">50,076</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">45,643</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $<span style="text-indent: 0pt;">6,597</span> and $<span style="text-indent: 0pt;">6,450</span>, respectively</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">2,014</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,949</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">91,546</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">86,382</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. The value assigned to tradenames has an indefinite life and is tested
      at least annually for impairment using the relief from royalty method in conjunction with the Company&#8217;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives
      which range from <span style="-sec-ix-hidden:Fact_c5b38f9523db408b8ed6c53ba95605c1">six</span> to fourteen years.
      Non-compete agreements are amortized over the respective term of the agreements which range from <span style="-sec-ix-hidden:Fact_c992237d92cd47c78ded2f3204d6bdd7">five</span> to six years.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the amount of amortization expense recorded for intangible assets for the three months ended March 31, 2022 and 2021 (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">2,050</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">783</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">147</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">39</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">2,197</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">822</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Based on the balance of referral relationships and non-compete agreements as of
        March </span>31,<span style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</span>2022,<span style="font-size: 10pt; font-family: 'Times New Roman';"> the expected amount to be amortized in </span>2022<span style="font-size: 10pt; font-family: 'Times New Roman';"> and thereafter by year is as follows (in</span> thousand<span style="font-size: 10pt; font-family: 'Times New Roman';">s):</span></div>

<div><br/>
    </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td colspan="4" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Customer and Referral Relationships</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="5" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 37%; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending December 31,</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 37%; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ending December 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2022</span>
              (excluding the three months ended March 31, 2022)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,851</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"><span style="text-indent: 0pt;">2022</span>
              (excluding the three months ended March 31, 2022)</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">413</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2023</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,200</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2023</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">494</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2024</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,036</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2024</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">438</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2025</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,892</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2025</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">371</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2026</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,424</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2026</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">243</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">26,673</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">55</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776696775288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8. ACCRUED EXPENSES</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Accrued expenses as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">22,272</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">23,569</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">6,788</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">6,649</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,766</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,984</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">379</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">498</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Federal taxes payable</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,590</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">2,716</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Dividend payable to USPH shareholders<br/>
            </div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,327</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contingent payments related to acquisition<br/>
            </div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,520</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom">Settlement of a legal matter <br/>
          </td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">2,750</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">7,479</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">6,539</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">51,121</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">45,705</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590809752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9. NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Amounts outstanding under the Amended Credit Agreement (as defined below) and notes payable as of March 31, 2022 and December 31, 2021 consisted of the following (in
      thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of <span style="text-indent: 0pt;">1.74</span>% for March 31, 2022 and December 31, 2021, (inclusive of unused fee)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">118,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">114,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $<span style="text-indent: 0pt;">4,927</span>
              plus accrued interest due in the next year, interest accrues in the range of <span style="text-indent: 0pt;">3.25</span>% through <span style="text-indent: 0pt;">3.5</span>% per annum</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,927</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">122,927</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">118,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(799</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(830</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">122,128</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">117,587</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Effective December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility. This agreement was amended and/or restated in August 2015, January 2016, March 2017, November 2017 and January 2021 (hereafter referred
      to as &#8220;Amended Credit Agreement&#8221;).<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> In
        November 2021, the Company exercised the accordion feature in the Amended Credit Agreement to increase the limit on the facility from $125.0
        million to $150.0 million, with an updated accordion feature providing for additional capacity of 25.0 million, therefore increasing the availability up to $175.0
        million.</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and
      consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#8217;s common stock, dividend payments to the Company&#8217;s common stockholders, capital expenditures and other
      corporate purposes. The pricing grid is based on the Company&#8217;s consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.25%
      to 2.0% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an
      unused commitment fee of 0.3% of the amount of funds outstanding under the Amended Credit Agreement.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The January 2021 amendment to the Amended Credit Agreement allows the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under
      the Amended Credit Agreement to $50,000,000 for any fiscal year, and the amount the Company may pay in cash dividends to its shareholders
      in an aggregate amount not to exceed $50,000,000 in any fiscal year. The Amended Credit Agreement is unsecured and includes certain
      financial covenants which include a consolidated fixed charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.</div>

<div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As of <span style="font-size: 10pt; font-family: 'Times New Roman';">March 31, 2022</span>,<span style="font-size: 10pt; font-family: 'Times New Roman';"> $118.0 million was outstanding on the Amended Credit Agreement, resulting in $</span>32.0<span style="font-size: 10pt; font-family: 'Times New Roman';"> million of availability. As of March 31, 2022, the Company was in compliance with all of the covenants
        contained in the Amended Credit Agreement.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company generally enters into various notes payable as a means of financing a portion of its acquisitions
        and purchasing of non-controlling interests. In conjunction with these transactions in 2022 and 2021, the Company entered into notes payable in the aggregate amount of </span>$4.9 million<span style="font-size: 10pt; font-family: 'Times New Roman';"> of which an aggregate principal payment of </span>$0.8 million<span style="font-size: 10pt; font-family: 'Times New Roman';"> is due in </span>2022, $4.1 million is due in 2023.<span style="font-size: 10pt; font-family: 'Times New Roman';"> Interest accrues in the range of </span>3.25%<span style="font-size: 10pt; font-family: 'Times New Roman';"> to </span>3.50%<span style="font-size: 10pt; font-family: 'Times New Roman';"> per annum and is payable with each principal installment. </span><br/>
    </div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subsequent aggregate annual payments of principal required pursuant to the Amended Credit Agreement and outstanding notes payable at March 31, 2022 are as follows (in
      thousands):</div>

<div><br/>
    </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="margin: 0px auto 0px 0px; width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">


  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2022</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">799</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2023</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,128</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2025</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">118,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">122,927</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The outstanding amount under the Amended Credit Agreement facility (balance on March 31, 2022 of</span> $118.0 million) matures on November 30, 2025.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590852024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">10. LEASES</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a lease at the inception of a contract.
      Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#8217;s right to use an underlying asset during the lease term and operating lease
      liabilities represent net present value of the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the net present value of the fixed
      lease payments over the lease term. The Company&#8217;s operating lease terms are generally five years or less. The Company&#8217;s lease terms
      include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#8217;s operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the
      information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The Company has elected, in compliance with
      current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable lease components. The Company has elected
      the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included in the measurement of the right-of-use
      assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment
      amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease liabilities. These are expensed as incurred
      and recorded as variable lease expense.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For the three months ended March 31, 2022, the components of lease expense were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">Three Months Ended</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">March 31, 2021</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8,404</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">7,729</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">321</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">368</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">1,932</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">1,611</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost *</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">10,657</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">9,708</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">* Sublease income was immaterial</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Lease cost is reflected in the consolidated statement of net income in the line item &#8211; rent, supplies, contract labor and other.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Supplemental information related to leases was as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">Three Months Ended</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">8,617</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">8,112</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">6,011</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">7,867</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The aggregate future lease payments for operating leases as of March 31, 2022 were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Fiscal Year</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2022 (excluding the three months ended March 31, 2022)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">25,297</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">28,724</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">22,109</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">14,808</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">9,285</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2027 and thereafter</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">8,292</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">108,515</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed&#160; interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">5,728</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 28.85pt; font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">102,787</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Average lease terms and discount rates were as follows:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">4.1 Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"><span style="text-indent: 0pt;">4.0</span> Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">2.70</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590800264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>SEGMENT INFORMATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11. SEGMENT INFORMATION</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Also included in the physical
      therapy operations segment are revenues from management contract services and other services which include services the Company provides on-site, such as schools for athletic trainers.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company evaluates performance of the segments based on gross profit. The Company has provided additional information regarding its reportable segments which contributes
      to the understanding of the Company and provides useful information.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes selected financial data for the Company&#8217;s reportable segments.<br/>
    </div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended March 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenue:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">112,636</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">102,359</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">19,068</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">10,009</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">131,704</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">112,368</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">22,436</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">23,174</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">4,152</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,722</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">26,588</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">25,896</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">608,240</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">723,530</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">155,623</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">25,896</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">763,863</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">749,426</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590681240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN UNCONSOLIDATED AFFILIATE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract', window );"><strong>INVESTMENT IN UNCONSOLIDATED AFFILIATE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock', window );">INVESTMENT IN UNCONSOLIDATED AFFILIATE</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12. INVESTMENT IN UNCONSOLIDATED AFFILIATE</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Through one of the subsidiaries, the Company has a 49%
        joint venture interest in a company which provides physical therapy services for patients at hospitals. Since the Company is deemed to not have a controlling interest in the company, the Company&#8217;s investment is accounted for using the equity method
        of accounting. The investment balance of this joint venture as of March 31, 2022, is $12.4 million, of which $12.2 million related to the fair value at December 31, 2021. The $12.4 million includes earnings of $339 thousand less a distribution received of $132 thousand.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590805320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>COMMON STOCK [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">COMMON STOCK</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13. COMMON STOCK</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of the Company&#8217;s common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of its common stock (&#8220;March
      2009 Authorization&#8221;). The Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance with covenants.
      The Company is required to retire shares purchased under the March 2009 Authorization.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Under the March 2009 Authorization, the Company has purchased a total of 859,499
      shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 150,830 shares (based on
      the closing price of $99.45 on March 31, 2022) that may be purchased from time to time in the open market or private transactions depending
      on price, availability and the Company&#8217;s cash position. The Company did not purchase any shares of its common stock during the three
      months ended March 31, 2022.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590810584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECLASSIFICATION OF PRIOR PERIOD PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodAdjustmentAbstract', window );"><strong>RECLASSIFICATION OF PRIOR PERIOD PRESENTATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionTextBlock', window );">RECLASSIFICATION OF PRIOR PERIOD PRESENTATION</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14. RECLASSIFICATION OF PRIOR PERIOD PRESENTATION</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of
      operations.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting error correction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776592775800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cash Equivalents</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company maintains its cash and cash equivalents at financial institutions.&#160; The Company considers all highly liquid investments with a maturity of three months or less
      when purchased to be cash equivalents.&#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related on
      deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Long-Lived Assets</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture
      and equipment range from <span style="-sec-ix-hidden:Fact_b13cf1c74cd446babb6cdd78fa4c8294">three</span> to eight years and for purchased software from <span style="-sec-ix-hidden:Fact_c14f91b399c145c8a8ea00d2ca948500">three</span> to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally <span style="-sec-ix-hidden:Fact_02de141ed1d4420c98a9952012a0ab54">three</span> to five years.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that
      the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company did </span>no<span style="font-size: 10pt; font-family: 'Times New Roman';">t note an impairment to long-lived assets during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended March</span> 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Goodwill</div>

<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the
          fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to </span>2009<span style="font-size: 10pt; font-family: 'Times New Roman';">,
          from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective </span>January 1, 2009<span style="font-size: 10pt; font-family: 'Times New Roman';">, if the purchase price of a
          non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</span></div>

<div><br/></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic
          impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair
          value if considered impaired. These events or conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined
          with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of </span>one<span style="font-size: 10pt; font-family: 'Times New Roman';"> of these
          events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company has a two operating segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The partnerships are components of regions
          and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In 2021 and 2020, there were </span>six<span style="font-size: 10pt; font-family: 'Times New Roman';"> regions. In addition to the </span>six<span style="font-size: 10pt; font-family: 'Times New Roman';"> regions, the impairment analysis included a separate analysis for the industrial injury prevention services business, as a
          separate reporting unit.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">As part of the impairment analysis, the Company is </span>first<span style="font-size: 10pt; font-family: 'Times New Roman';"> required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether
          a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that
          affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.</span></div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting
          unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in </span>2021<span style="font-size: 10pt; font-family: 'Times New Roman';"> and </span>2020<span style="font-size: 10pt; font-family: 'Times New Roman';"> did not result in any goodwill amounts that were deemed impaired.</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that
            the fair value of the reporting units were reduced below their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting
            units were impaired as of December 31, 2021.<br/>
          </span></span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> The Company will continue to monitor for any triggering events or other indicators of impairment.<br/>
          </span></span></div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestsPolicyTextBlock', window );">Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Redeemable Non-Controlling Interest</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The non-controlling interests that are reflected as redeemable non-controlling interest in the consolidated financial statements consist of those that the owners and the
      Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met.&#160;
      The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights can be triggered by the owner or the
      Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction,
      typically <span style="-sec-ix-hidden:Fact_40b721ca5dc3493aaa09b990a340fe57">three</span> to five years,
      as defined in the limited partnership agreement.&#160; The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been
      satisfied.</div>

<div><br/></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under
      the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; Redeemable non-controlling interest &#8211; temporary equity.&#160; Then, in each reporting period thereafter until it
      is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership
      agreement.&#160; As a result, the value of the non-controlling interest is not adjusted below its initial carrying value.&#160; The Company records any adjustments in the redemption value, net of tax, directly to retained earnings and the adjustments are not
      reflected in the consolidated statements of income.&#160; Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per
      share calculation.&#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e.
      the carrying amount) and fair value are the same.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestsPolicyPolicyTextBlock', window );">Non-Controlling Interests</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Controlling Interest</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the non-controlling interest, as permanent equity in the
      consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interest is included in consolidated net income on the face of the statements of net income. Changes in a parent
      entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a
      subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment
      to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Revenue Recognition</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered. See Note 3- Revenue Recognition, for further discussion of revenue recognition.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Provision for Credit Losses</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Provision for Credit Losses</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he Company determines provisions for credit losses based on the specific agings and payor classifications at
        each clinic. The provision for credit losses is included in operating cost in the consolidated statements of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and
        provisions for credit losses, includes only those amounts the Company estimates to be collectible</span>.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Income Taxes</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to
      differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates
      expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that
      includes the enactment date.</div>

<div><br/></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the
      position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate
      settlement with the relevant tax authority.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of
        interest expense and depreciation. ASC 740</span>,<span style="font-size: 10pt; font-family: 'Times New Roman';"> Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which
        the legislation is enacted. The legislation had no effect on the Company&#8217;s deferred income taxes and current income taxes payable during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended March 31, 2022</span>.</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company did not have any accrued interest or
      penalties associated with any unrecognized tax benefits nor was any interest expense recognized <span style="font-size: 10pt; font-family: 'Times New Roman';">during the </span>three<span style="font-size: 10pt; font-family: 'Times New Roman';"> months ended</span> March 31, 2022. The Company records any interest or penalties, if required, in interest and other expense,
      as appropriate.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out
        payments, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement (as defined in Note 9)
        approximates the fair value. The interest rate on the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#8220;LIBOR&#8221;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different
        reference rate in the event LIBOR ceases to exist.<br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The redeemable non-controlling interest included on the consolidated balance sheets and the put right
        associated with the potential future purchase of the separate company in the November 2021 acquisition (as described in Note 2) are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of redeemable
        non-controlling interests approximates the fair value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable
        inputs such as asset volatility and discount rates. The unobservable inputs in the valuation include asset volatility of 25% and a
        discount rate of 9.93%. See Note 5 for the changes in the fair value of redeemable non-controlling interest.<br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The put right decreased $603 thousand for the three months ended March 31, 2022 and was valued at $2.9
        million on March 31, 2022.<br/>
      </span></div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Segment Reporting</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Operating segments are components of an enterprise for which separate financial information is available
          that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance.&#160; The Company currently operates through </span>two<span style="font-size: 10pt; font-family: 'Times New Roman';"> segments: physical therapy operations and industrial injury prevention services.</span></div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Use of Estimates</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">I<span style="font-size: 10pt; font-family: 'Times New Roman';">n preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and
        assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames and other intangible assets, allocations of purchase price, provision for credit losses, tax provision and contractual allowances, that affect the amounts
        reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates</span>.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SelfInsuranceProgramPolicyPolicyTextBlock', window );">Self-Insurance Program</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Self-Insurance Program</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with
      an insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued
      amounts are sufficient to pay claims arising from self-insurance claims incurred through March 31, 2022.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RestrictedStockPolicyPolicyTextBlock', window );">Restricted Stock</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted Stock</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock
      granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_5ace032f12924d2eb4cdbde0f9b532c6">four</span> anniversaries of the date of grant. For those shares granted
      to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_e7d74d21eab74c899fb44317a7932e6a">first</span> year after the date of grant. For those granted
      to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation
      expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and
      diluted shares for the earnings per share computation.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Guidance</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recently Adopted Accounting Guidance</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740)&#8211;Simplifying the Accounting for Income
        Taxes (&#8220;ASU 2019-12&#8221;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of
        financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In August 2020, the FASB issued ASU 2020-06 Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and
        Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of
        liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the
        treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive,
        regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">This pronouncement was effective for fiscal years, and for interim periods within those fiscal years,
        beginning after December 15, 2021.The Board specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or
        fully retrospective method of transition is permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recently Issued Accounting Guidance</div>

<div><br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">In </span>March 2020<span style="font-size: 10pt; font-family: 'Times New Roman';">, the FASB issued ASU </span>2020-04<span style="font-size: 10pt; font-family: 'Times New Roman';">, Reference Rate Reform (Topic </span>848<span style="font-size: 10pt; font-family: 'Times New Roman';">): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This
          ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to
          alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through </span>December 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman';">.
          Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event
          LIBOR ceases to exist.</span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonControllingInterestsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonControllingInterestsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RestrictedStockPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RestrictedStockPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SelfInsuranceProgramPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SelfInsuranceProgramPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590659768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock', window );">Acquisitions Within Physical Therapy Operations Segment</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">During the 2021 year and the three months ended March 31, 2022, the Company completed the acquisitions of four
          multi-clinic practices and two industrial injury prevention businesses as detailed below.</span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 48%; white-space: nowrap;" valign="bottom">
                <div>Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">Date</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">Acquired</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">Clinics</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>March 2022 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">March 31, 2022</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>70</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">6</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom">
                <div>December 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">December 31, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div>75</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">3</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 48%; white-space: nowrap;" valign="bottom">
                <div>November 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">November 30, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" valign="bottom">
                <div>70</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;"><br/>
                </div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;" valign="bottom">IIPS*</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom">
                <div>September 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">September 30, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div>100</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;"><br/>
                </div>
              </td>

    <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom">IIPS*</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>June 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">June 30, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>65</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">8</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom">
                <div>March 2021 Acquisition</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">March 31, 2021</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div>70</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>%</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom">
                <div style="text-align: center;">6</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div>
              <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 9pt;">
                      <div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"><span style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 7.2pt; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">*</span></span></div>
                    </td>

    <td style="align: left; vertical-align: top; width: auto;">
                      <div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Industrial injury prevention services business</span></div>
                    </td>

  </tr>


</table>
               </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of business combination completed within the physical therapy operations segment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590685016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS OF BUSINESSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>ACQUISITIONS OF BUSINESSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Preliminary Purchase Prices Allocation</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he purchase price for the 2022 acquisition has been preliminarily allocated as follows (in thousands)</span>:
    </div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,242</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Seller notes</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,542</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 12.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,743</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">247</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">659</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,539</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(4,946</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,542</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590783496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>REVENUE RECOGNITION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue, Categories</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the revenue related to the various categories (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenue</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">109,538</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">99,254</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other revenue<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">872</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">546</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="margin: 0px 0px 0px 14.4pt; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: -7.2pt;">Physical therapy operations<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">110,410</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">99,800</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">Management contract revenue<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"><br/>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">2,226</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"><br/>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">2,559</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services revenue</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">19,068</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">10,009</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">131,704</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">112,368</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590669816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>EARNINGS PER SHARE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computations of Basic and Diluted Earnings Per Share</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with current accounting guidance, the revaluation of redeemable non-controlling interest (see Note 5 &#8211; Redeemable Non-Controlling Interest), net of tax,
      charged directly to retained earnings is included in the earnings per basic and diluted share calculation. The following table provides a detail of the basic and diluted earnings per share computation (in thousands, except per share data).</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8,799</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8,173</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">(Charges) credit to retained earnings:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(153</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(7,270</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of <span style="text-indent: 0pt;">25.55</span>%<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">39</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">1,857</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">8,685</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">2,760</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">0.67</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">0.21</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">12,937</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">12,870</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776594368120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REDEEMABLE NON-CONTROLLING INTEREST (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_REDEEMABLENONCONTROLLINGINTERESTAbstract', window );"><strong>REDEEMABLE NON-CONTROLLING INTEREST [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">For the </span>dates indicated,<span style="font-size: 10pt; font-family: 'Times New Roman';"> the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interest (in</span> thousand<span style="font-size: 10pt; font-family: 'Times New Roman';">s):</span></div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">155,262</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">132,340</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">2,557</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">11,358</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(2,403</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(11,359</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">153</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">13,011</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(2,457</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(30,204</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">4,946</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">39,862</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">982</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">(914</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">(50</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">186</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;">Other <br/>
            </div>
          </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">158,008</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">155,262</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock', window );">Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interest (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder&#8217;s employment has not terminated</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">92,320</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">80,781</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder&#8217;s employment has not terminated</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">65,688</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">74,481</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Holder&#8217;s employment has terminated and contractual time period has expired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Holder&#8217;s employment has terminated and contractual time period has not expired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">158,008</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">155,262</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_REDEEMABLENONCONTROLLINGINTERESTAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_REDEEMABLENONCONTROLLINGINTERESTAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776697589640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>GOODWILL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The changes in the carrying amount of goodwill consisted of the following (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom;" valign="bottom"/>

    <td colspan="1" style="white-space: nowrap; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Three Months Ended</span></div>
          </td>

    <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="white-space: nowrap; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">434,679</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">345,646</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">11,539</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">89,746</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(2,526</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(713</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">443,692</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">434,679</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776595460840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>INTANGIBLE ASSETS, NET [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Intangible assets, net as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">39,456</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">38,790</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships, net of accumulated amortization of $<span style="text-indent: 0pt;">19,959</span> and $<span style="text-indent: 0pt;">17,762</span>, respectively</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">50,076</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">45,643</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $<span style="text-indent: 0pt;">6,597</span> and $<span style="text-indent: 0pt;">6,450</span>, respectively</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">2,014</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,949</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">91,546</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">86,382</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Amortization Expenses</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the amount of amortization expense recorded for intangible assets for the three months ended March 31, 2022 and 2021 (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">2,050</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">783</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">147</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">39</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">2,197</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">822</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Amortization of Customer and Referral Relationships and Non Competition Agreements</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Based on the balance of referral relationships and non-compete agreements as of
        March </span>31,<span style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</span>2022,<span style="font-size: 10pt; font-family: 'Times New Roman';"> the expected amount to be amortized in </span>2022<span style="font-size: 10pt; font-family: 'Times New Roman';"> and thereafter by year is as follows (in</span> thousand<span style="font-size: 10pt; font-family: 'Times New Roman';">s):</span></div>

<div><br/>
    </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td colspan="4" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Customer and Referral Relationships</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="5" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 37%; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Ending December 31,</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; width: 37%; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ending December 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2022</span>
              (excluding the three months ended March 31, 2022)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,851</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"><span style="text-indent: 0pt;">2022</span>
              (excluding the three months ended March 31, 2022)</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">413</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2023</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,200</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2023</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">494</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2024</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,036</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2024</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">438</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2025</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,892</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2025</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">371</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-indent: 0pt;">2026</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,424</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">2026</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">243</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">26,673</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">55</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590821176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Accrued expenses as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">22,272</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">23,569</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">6,788</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">6,649</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,766</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,984</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">379</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">498</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Federal taxes payable</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,590</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">2,716</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Dividend payable to USPH shareholders<br/>
            </div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,327</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Contingent payments related to acquisition<br/>
            </div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,520</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom">Settlement of a legal matter <br/>
          </td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">2,750</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">7,479</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">6,539</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">51,121</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">45,705</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590841816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Credit Agreement and Notes Payable</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Amounts outstanding under the Amended Credit Agreement (as defined below) and notes payable as of March 31, 2022 and December 31, 2021 consisted of the following (in
      thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of <span style="text-indent: 0pt;">1.74</span>% for March 31, 2022 and December 31, 2021, (inclusive of unused fee)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">118,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">114,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $<span style="text-indent: 0pt;">4,927</span>
              plus accrued interest due in the next year, interest accrues in the range of <span style="text-indent: 0pt;">3.25</span>% through <span style="text-indent: 0pt;">3.5</span>% per annum</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,927</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">122,927</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">118,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(799</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">(830</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">122,128</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">117,587</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Aggregate Annual Payments of Principal Required to Revolving Credit Facility</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Subsequent aggregate annual payments of principal required pursuant to the Amended Credit Agreement and outstanding notes payable at March 31, 2022 are as follows (in
      thousands):</div>

<div><br/>
    </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="margin: 0px auto 0px 0px; width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">


  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2022</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">799</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2023</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">4,128</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">During the twelve months ended March 31, 2025</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">118,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">122,927</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590636040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For the three months ended March 31, 2022, the components of lease expense were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">Three Months Ended</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">March 31, 2021</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8,404</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">7,729</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">321</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">368</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">1,932</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">1,611</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost *</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">10,657</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom">9,708</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">* Sublease income was immaterial</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_OperatingLeaseSupplementalInformationTableTextBlock', window );">Supplemental Information Related to Leases</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Supplemental information related to leases was as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">Three Months Ended</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">8,617</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">8,112</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">6,011</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">7,867</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Future Lease Payments for Operating Leases</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The aggregate future lease payments for operating leases as of March 31, 2022 were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Fiscal Year</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2022 (excluding the three months ended March 31, 2022)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">25,297</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">28,724</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">22,109</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom">14,808</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">9,285</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2027 and thereafter</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">8,292</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">108,515</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed&#160; interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom">5,728</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 28.85pt; font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">102,787</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock', window );">Average Lease Terms and Discount Rates</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Average lease terms and discount rates were as follows:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">March 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">4.1 Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"><span style="text-indent: 0pt;">4.0</span> Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">2.70</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_OperatingLeaseSupplementalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental information related to leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_OperatingLeaseSupplementalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to weighted average lease terms and discount rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776590804760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>SEGMENT INFORMATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Selected Financial Data for Reportable Segments</a></td>
<td class="text">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes selected financial data for the Company&#8217;s reportable segments.<br/>
    </div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended March 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenue:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">112,636</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">102,359</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">19,068</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">10,009</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">131,704</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">112,368</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">22,436</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">23,174</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">4,152</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,722</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">26,588</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">25,896</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">608,240</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">723,530</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">155,623</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">25,896</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">763,863</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">749,426</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776581763992">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Location </div>
<div>State</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Segment </div>
<div>Facility </div>
<div>Location </div>
<div>State</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>Region</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>Region</div>
</th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states where clinics are operated | State</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfGeneralPartnershipInterestOwned', window );">Percentage of general partnership interest owned</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of long lived assets to be disposed of | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationGoodwillAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments | Segment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfRegions', window );">Number of regions | Region</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefit | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties associated with any unrecognized tax benefits | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations', window );">Interest expense recognized | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Decrease in put right | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(603,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Put right value | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments | Segment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember', window );">Volatility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember', window );">Medicare Accelerated and Advance Payments Program [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RepaymentOfFunds', window );">Repayment of funds | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Advance payments | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember', window );">Public Health and Social Services Emergency Fund [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_GrantsAndOtherFunds', window );">Grants and other funds | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 100,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_MultiClinicPracticesMember', window );">Multi-Clinic Practices [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember', window );">IIPS [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_March2022AcquisitionMember', window );">March 2022 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember', window );">December 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember', window );">November 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember', window );">September 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember', window );">June 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember', window );">March 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfThirdPartyFacilities', window );">Number of third party facilities | Facility</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=usph_EmployeeMember', window );">Employee [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_OfficerMember', window );">Officer [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfLimitedPartnershipInterestOwned', window );">Percentage of limited partnership interest owned</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestRedeemableAbstract', window );"><strong>Redeemable Non-Controlling Interests [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Furniture &amp; Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Software [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Leasehold Improvements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BasisOfPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfOperatingClinicLocations', window );">Number of operating clinic locations | Location</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfLimitedPartnershipInterestOwned', window );">Percentage of limited partnership interest owned</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestRedeemableAbstract', window );"><strong>Redeemable Non-Controlling Interests [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Furniture &amp; Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Software [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Leasehold Improvements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Industrial injury prevention services business</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6409961&amp;loc=d3e20487-108367<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on prepetition obligations included in the statement of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124437977&amp;loc=d3e55733-112764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_GrantsAndOtherFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_GrantsAndOtherFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonControllingInterestRedeemableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonControllingInterestRedeemableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfOperatingClinicLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating clinic locations during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfOperatingClinicLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfRegions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of regions of the entity operates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfRegions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfThirdPartyFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of third party facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfThirdPartyFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfGeneralPartnershipInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of general partnership interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfGeneralPartnershipInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfLimitedPartnershipInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of limited partnership interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfLimitedPartnershipInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The commencement period of redemption rights for redeemable non controlling interest, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RepaymentOfFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of repayment to Medicare Accelerated and Advance Payment Program ("MAAPP Funds") rather than applying them to future services performed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RepaymentOfFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_MultiClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_MultiClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_March2022AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_March2022AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=usph_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=usph_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776581952616">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS OF BUSINESSES (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th" colspan="2">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th" colspan="2">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 11,242<span></span>
</td>
<td class="nump">$ 11,747<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">13 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember', window );">Physical Therapy Operations [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Other payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetPurchase', window );">Seller put right</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,041<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,413)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,413)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">781<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">781<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Customer and referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,090<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,090<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradenames</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,965<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,965<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,956)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,956)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=usph_PreviousOwnersMember', window );">Previous Owners [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Percentage of retained interest by previous owners</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder', window );">Percentage of interest retained by practice founder</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,500<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,300<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,200<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria', window );">Amount payable upon achievement of certain business criteria</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember', window );">IIPS [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RemainingContractTerm', window );">Remaining contract term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesFairValue', window );">Initial fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Other payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetPurchase', window );">Seller put right</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,588<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,588<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,842)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,842)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Customer and referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradenames</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,906)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,906)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ReturnToWorkAndErgonomicServicesMember', window );">Return-to-work and Ergonomic Services [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration', window );">Aggregate purchase price for the acquisition including contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Acquisitions [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,242<span></span>
</td>
<td class="nump">86,737<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">300<span></span>
</td>
<td class="nump">2,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Other payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetPurchase', window );">Seller put right</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,542<span></span>
</td>
<td class="nump">96,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,629<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,629<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">300<span></span>
</td>
<td class="nump">19,773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,255)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,255)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,147<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,147<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Customer and referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,743<span></span>
</td>
<td class="nump">27,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">247<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradenames</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,903<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">659<span></span>
</td>
<td class="nump">6,903<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,539<span></span>
</td>
<td class="nump">87,222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,946)<span></span>
</td>
<td class="num">(39,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 11,542<span></span>
</td>
<td class="nump">$ 96,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Industrial injusry prevention services</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of acquired receivable from business combination, excluding certain loans and debt securities acquired in transfer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase from purchase of right to consideration in exchange for good or service transferred to customer when right is conditioned on passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests retained by practice founder at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net tangible asset acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred including contingent consideration, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration upon on achievement of certain business criteria in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-competition agreements recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of referral relationships at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tradename recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireBusinessesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire businesses total consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireBusinessesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RemainingContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RemainingContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=usph_PreviousOwnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=usph_PreviousOwnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ReturnToWorkAndErgonomicServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ReturnToWorkAndErgonomicServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776583602472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 14, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 10, 2021</div></th>
<th class="th"><div>Nov. 02, 2021</div></th>
<th class="th"><div>Feb. 09, 2018</div></th>
<th class="th"><div>Nov. 02, 2015</div></th>
<th class="th"><div>Apr. 01, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue from Contract with Customer, Excluding Assessed Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,704,000<span></span>
</td>
<td class="nump">$ 112,368,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedPercentageOfDecreaseInPayment', window );">Estimated percentage of decrease in payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions', window );">Federal debt ceiling in connection with deficit reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AmountOfReductionsInFederalSpending', window );">Reductions in federal spending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReductionInMedicareSpendingPercentage', window );">Medicare spending cut percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist', window );">Percentage of reduction in Medicare payments for services performed by a physical or occupational therapist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation', window );">Percentage of payment reduction waived through enacted legislation</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments', window );">Term for sequester relief applied to all Medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne', window );">Percentage of sequester relief applied to all Medicare payments through Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo', window );">Percentage of sequester relief applied to all Medicare payments through June 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem', window );">Percentage of increase in payment adjustment for therapists participating in MIPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses', window );">Combined physical therapy/speech language pathology expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses', window );">Reduction in combined physical therapy/speech language pathology expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit', window );">Percentage of practice expense component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings', window );">Percentage reduction for service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPaymentForOutpatientTherapyServices', window );">Percentage of payment for outpatient therapy services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetRevenueFromMedicare', window );">Net patient revenue from Medicare accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,600,000<span></span>
</td>
<td class="nump">26,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=usph_CentersForMedicareAndMedicaidServicesMember', window );">CMS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedPercentageOfDecreaseInPayment', window );">Estimated percentage of decrease in payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualAllowancesAbstract', window );"><strong>Contractual Allowances [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues', window );">Difference between net revenues and corresponding cash collections, approximately of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage', window );">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MaximumContractualAllowanceReserveEstimate', window );">Maximum contractual allowance reserve estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem', window );">Percentage of therapist providers participating in MIPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualAllowancesAbstract', window );"><strong>Contractual Allowances [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues', window );">Difference between net revenues and corresponding cash collections, approximately of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage', window );">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MaximumContractualAllowanceReserveEstimate', window );">Maximum contractual allowance reserve estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember', window );">From 2017 through 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePaymentIncrease', window );">Percentage of increase in Medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember', window );">From 2020 through 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePaymentIncrease', window );">Percentage of increase in Medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember', window );">Net Patient Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue from Contract with Customer, Excluding Assessed Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,538,000<span></span>
</td>
<td class="nump">99,254,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_OtherRevenuesMember', window );">Other Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue from Contract with Customer, Excluding Assessed Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">872,000<span></span>
</td>
<td class="nump">546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember', window );">Physical Therapy Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue from Contract with Customer, Excluding Assessed Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,410,000<span></span>
</td>
<td class="nump">99,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember', window );">Management Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue from Contract with Customer, Excluding Assessed Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,226,000<span></span>
</td>
<td class="nump">2,559,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember', window );">Industrial Injury Prevention Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue from Contract with Customer, Excluding Assessed Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,068,000<span></span>
</td>
<td class="nump">$ 10,009,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AmountOfReductionsInFederalSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reductions in federal spending during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AmountOfReductionsInFederalSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Combined physical therapy/speech language pathology expenses during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualAllowancesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualAllowancesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between net revenues and corresponding cash collections reflected percentage of net revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedPercentageOfDecreaseInPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated percentage of decrease in payment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedPercentageOfDecreaseInPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ExpectedReductionInMedicareSpendingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected reduction in Medicare spending percentage during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ExpectedReductionInMedicareSpendingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extension term for sequester relief applied to all Medicare payments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MaximumContractualAllowanceReserveEstimate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum contractual allowance reserve estimate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MaximumContractualAllowanceReserveEstimate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MedicareReimbursementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MedicareReimbursementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetRevenueFromMedicare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net revenue from Medicare.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetRevenueFromMedicare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase in payment adjustment for therapists participating in Merit Based Incentive Payment System (MIPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfMedicarePaymentIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Medicare payment increase during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfMedicarePaymentIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPaymentForOutpatientTherapyServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of payment for outpatient therapy services to the therapy assistant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPaymentForOutpatientTherapyServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of payment reduction waived through enacted additional legislation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of practice expense component of relative value unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of reduction in Medicare payments for services performed by a physical or occupational therapist.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of sequester relief applied to all Medicare payments through March 31, 2022.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of sequester relief applied to all Medicare payments through June 30, 2022.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of therapist providers participating in Merit Based Incentive Payment System (MIPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage reduction for service in office or other non institutional settings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Combined physical therapy/speech language pathology expenses during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReductionInMedicareSpendingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Medicare spending percentage during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReductionInMedicareSpendingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=usph_CentersForMedicareAndMedicaidServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=usph_CentersForMedicareAndMedicaidServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_OtherRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_OtherRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776594336728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Computation of earnings per share - USPH shareholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">$ 8,799<span></span>
</td>
<td class="nump">$ 8,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ChargesToRetainedEarningsAbstract', window );"><strong>(Charges) credit to retained earnings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests', window );">Revaluation of redeemable non-controlling interest</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(7,270)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate', window );">Tax effect at statutory rate (federal and state) of 25.55%</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">1,857<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests', window );">Net income attributable to common shareholders</a></td>
<td class="nump">$ 8,685<span></span>
</td>
<td class="nump">$ 2,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share basic (in dollars per share)</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share diluted (in dollars per share)</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares used in computation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic earnings per share - weighted-average shares (in shares)</a></td>
<td class="nump">12,937<span></span>
</td>
<td class="nump">12,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted earnings per share - weighted-average shares (in shares)</a></td>
<td class="nump">12,937<span></span>
</td>
<td class="nump">12,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income tax rate</a></td>
<td class="nump">25.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State statutory income tax rate</a></td>
<td class="nump">25.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ChargesToRetainedEarningsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ChargesToRetainedEarningsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income (loss) from revaluation of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776589366360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REDEEMABLE NON-CONTROLLING INTEREST (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract', window );"><strong>Changes in Carrying Amount of Redeemable Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">$ 155,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Operating results allocated to redeemable non-controlling interest partners</a></td>
<td class="nump">2,557<span></span>
</td>
<td class="nump">$ 2,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance</a></td>
<td class="nump">158,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract', window );"><strong>Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Fair value</a></td>
<td class="nump">158,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember', window );">Redeemable Non-Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract', window );"><strong>Changes in Carrying Amount of Redeemable Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">155,262<span></span>
</td>
<td class="nump">$ 132,340<span></span>
</td>
<td class="nump">132,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Operating results allocated to redeemable non-controlling interest partners</a></td>
<td class="nump">2,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests', window );">Distributions to redeemable non-controlling interest partners</a></td>
<td class="num">(2,403)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,359)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Changes in the fair value of redeemable non-controlling interest</a></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Purchases of redeemable non-controlling interest</a></td>
<td class="num">(2,457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,204)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Acquired interest</a></td>
<td class="nump">4,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity', window );">Sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity', window );">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity', window );">Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance</a></td>
<td class="nump">158,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract', window );"><strong>Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated', window );">Contractual time period has lapsed but holder's employment has not terminated</a></td>
<td class="nump">92,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated', window );">Contractual time period has not lapsed and holder's employment has not terminated</a></td>
<td class="nump">65,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired', window );">Holder's employment has terminated and contractual time period has expired</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired', window );">Holder's employment has terminated and contractual time period has not expired</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Fair value</a></td>
<td class="nump">$ 158,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired', window );">Business acquisition, percentage of limited partnership acquired</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired', window );">Business acquisition, percentage of limited partnership acquired</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed', window );">Percentage of equity interest of subsidiary contributed for acquisition</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired', window );">Business acquisition, percentage of general partnership interest acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionConsiderationPayableTermOfNote', window );">Business acquisition, consideration payable, term of note</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementRenewalTerm', window );">Employment agreement renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder', window );">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TermOfEmploymentAgreement', window );">Employment agreement term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TermOfEmploymentAgreement', window );">Employment agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ProgressiveHealthCompaniesLLCMember', window );">ProgressiveHealth [Member] | NewCo. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed', window );">Percentage of equity interest of subsidiary contributed for acquisition</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder', window );">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries', window );">Percentage of right to sell equity interest on each of the 4th and 5th anniversaries</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries', window );">Percentage of right to sell equity interest on each of the 6th and 7th anniversaries</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionConsiderationPayableTermOfNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of the note issued for consideration payable for the acquisition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionConsiderationPayableTermOfNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of equity interest in subsidiary contributed for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of general partnership interest acquired in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of limited partnership interest acquired in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CarryingAmountOfRedeemableNonControllingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The renewal term of the employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to holder's employment has terminated and contractual time period has expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to holder's employment has terminated and contractual time period has not expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonCompeteAgreementBasicTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonCompeteAgreementBasicTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of right to sell equity interest on each of the 4th and 5th anniversaries by shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of right to sell equity interest on each of the 6th and 7th anniversaries by shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TermOfEmploymentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TermOfEmploymentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ProgressiveHealthCompaniesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ProgressiveHealthCompaniesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776594686440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 434,679<span></span>
</td>
<td class="nump">$ 345,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">11,539<span></span>
</td>
<td class="nump">89,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</a></td>
<td class="num">(2,526)<span></span>
</td>
<td class="num">(713)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 443,692<span></span>
</td>
<td class="nump">$ 434,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776583535000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 91,546<span></span>
</td>
<td class="nump">$ 86,382<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Tradenames [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">39,456<span></span>
</td>
<td class="nump">38,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">50,076<span></span>
</td>
<td class="nump">45,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 19,959<span></span>
</td>
<td class="nump">17,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 2,014<span></span>
</td>
<td class="nump">1,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 6,597<span></span>
</td>
<td class="nump">$ 6,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776594697848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET - Amortization Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">$ 2,197<span></span>
</td>
<td class="nump">$ 822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">2,050<span></span>
</td>
<td class="nump">783<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776584919768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET - Amortization of Referral Relationships and Non-Competition Agreements (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022 (excluding the three months ended March 31, 2022)</a></td>
<td class="nump">$ 3,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">5,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">5,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">4,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">4,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour', window );">Thereafter</a></td>
<td class="nump">26,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022 (excluding the three months ended March 31, 2022)</a></td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour', window );">Thereafter</a></td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776592774696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries and related costs</a></td>
<td class="nump">$ 22,272<span></span>
</td>
<td class="nump">$ 23,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PatientsAndPayorsRelatedLiability', window );">Credit balances due to patients and payors</a></td>
<td class="nump">6,788<span></span>
</td>
<td class="nump">6,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Group health insurance claims</a></td>
<td class="nump">1,766<span></span>
</td>
<td class="nump">1,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Closure costs</a></td>
<td class="nump">379<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Federal taxes payable</a></td>
<td class="nump">3,590<span></span>
</td>
<td class="nump">2,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividend payable to USPH shareholders</a></td>
<td class="nump">5,327<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 4,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent', window );">Contingent payments related to acquisition</a></td>
<td class="nump">3,520<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Settlement of a legal matter</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">7,479<span></span>
</td>
<td class="nump">6,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 51,121<span></span>
</td>
<td class="nump">$ 45,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PatientsAndPayorsRelatedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PatientsAndPayorsRelatedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776586399880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 122,927<span></span>
</td>
<td class="nump">$ 118,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(799)<span></span>
</td>
<td class="num">(830)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term portion</a></td>
<td class="nump">122,128<span></span>
</td>
<td class="nump">117,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 118,000<span></span>
</td>
<td class="nump">$ 114,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="nump">1.74%<span></span>
</td>
<td class="nump">1.74%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 3.5% Notes Payable due in Next Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 4,927<span></span>
</td>
<td class="nump">$ 4,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Annual installments</a></td>
<td class="nump">$ 4,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 3.5% Notes Payable due in Next Year [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 3.5% Notes Payable due in Next Year [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776592666120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Amended Credit Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Dec. 05, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Percentage of unused commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,927,000<span></span>
</td>
<td class="nump">$ 118,417,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Aggregate principal payment due in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">799,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate principal payment due in 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember', window );">Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Aggregate principal payment due in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate principal payment due in 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Base Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Base Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="nump">$ 125,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase on limit of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,000,000<span></span>
</td>
<td class="nump">$ 114,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining revolving credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.74%<span></span>
</td>
<td class="nump">1.74%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement', window );">Cash and noncash consideration with respect to acquisition after amendment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DividendsCashAfterAmendment', window );">Cash dividends after amendment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and noncash consideration that could pay with respect to acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DividendsCashAfterAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DividendsCashAfterAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776583532680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long Term Debt By Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">During the twelve months ended March 31, 2022</a></td>
<td class="nump">$ 799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">During the twelve months ended March 31, 2023</a></td>
<td class="nump">4,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">During the twelve months ended March 31, 2025</a></td>
<td class="nump">118,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">122,927<span></span>
</td>
<td class="nump">$ 118,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long Term Debt By Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 118,000<span></span>
</td>
<td class="nump">$ 114,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Revolving credit facility maturity date</a></td>
<td class="text">Nov. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776592135656">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Components of Lease Expense [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8,404<span></span>
</td>
<td class="nump">$ 7,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">321<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,932<span></span>
</td>
<td class="nump">1,611<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10,657<span></span>
</td>
<td class="nump">9,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SupplementalInformationRelatedToOperatingLeasesAbstract', window );"><strong>Supplemental Information Related to Leases [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,617<span></span>
</td>
<td class="nump">8,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,011<span></span>
</td>
<td class="nump">$ 7,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Future Lease Payments for Operating Leases [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022 (excluding the three months ended March 31, 2022)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2027 and thereafter</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 102,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AverageLeaseTermsAndDiscountRatesAbstract', window );"><strong>Average Lease Terms and Discount Rates [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term - Operating leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - Operating leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Operating Lease [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Sublease income was immaterial</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AverageLeaseTermsAndDiscountRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AverageLeaseTermsAndDiscountRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SupplementalInformationRelatedToOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SupplementalInformationRelatedToOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776592139128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenue</a></td>
<td class="nump">$ 131,704<span></span>
</td>
<td class="nump">$ 112,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">26,588<span></span>
</td>
<td class="nump">25,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">763,863<span></span>
</td>
<td class="nump">749,426<span></span>
</td>
<td class="nump">$ 749,426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member] | Physical Therapy Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenue</a></td>
<td class="nump">112,636<span></span>
</td>
<td class="nump">102,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">22,436<span></span>
</td>
<td class="nump">23,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">608,240<span></span>
</td>
<td class="nump">723,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member] | Industrial Injury Prevention Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenue</a></td>
<td class="nump">19,068<span></span>
</td>
<td class="nump">10,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">4,152<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 155,623<span></span>
</td>
<td class="nump">$ 25,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776592521512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT IN UNCONSOLIDATED AFFILIATE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract', window );"><strong>Investments in Unconsolidated Affiliate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in unconsolidated affiliate</a></td>
<td class="nump">$ 12,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings from investment in unconsolidated affiliate</a></td>
<td class="nump">$ 339<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=usph_JointVentureInterestMember', window );">Joint Venture Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract', window );"><strong>Investments in Unconsolidated Affiliate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership in joint venture interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in unconsolidated affiliate</a></td>
<td class="nump">$ 12,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentQuotedMarketValue', window );">Fair value of investment in unconsolidated affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings from investment in unconsolidated affiliate</a></td>
<td class="nump">339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distribution received from investment in unconsolidated affiliate</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentQuotedMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentQuotedMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=usph_JointVentureInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=usph_JointVentureInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139776583537064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2009</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2008</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Class of Treasury Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Total purchased shares (in shares)</a></td>
<td class="nump">859,499<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AdditionalEstimatedRepurchaseOfCommonStock', window );">Additional estimated shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Closing price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Class of Treasury Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Common stock authorized by the Board of Directors (in shares)</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfRepurchaseOfCommonStock', window );">Percentage of repurchase of common stock</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock', window );">Bank credit agreement to permit share repurchases of common stock</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AdditionalEstimatedRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional estimated repurchase of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AdditionalEstimatedRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bank credit agreement to permit share repurchases of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of repurchase of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>brhc10037138_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:usph="http://usph.com/20220331"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="usph-20220331.xsd" xlink:type="simple"/>
    <context id="c20220101to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2022-05-09</instant>
        </period>
    </context>
    <context id="c20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_ProductOrServiceAxis_NetPatientRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ProductOrServiceAxis_NetPatientRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_March2022AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2022AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_September2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_December2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:December2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_June2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:June2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_March2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_November2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_March2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_June2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:June2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_March2022AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2022AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_December2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:December2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_September2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_November2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_MultiClinicPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:MultiClinicPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_ManagementContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20200430_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="c20220331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20200101to20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_MeasurementInputTypeAxis_MeasurementInputOptionVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_MeasurementInputTypeAxis_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_TitleOfIndividualAxis_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_TitleOfIndividualAxis_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_TitleOfIndividualAxis_OfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20211130_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220331to20220331_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-30</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210331_OwnershipAxis_PreviousOwnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210630_OwnershipAxis_PreviousOwnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ReturnToWorkAndErgonomicServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-30</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ReturnToWorkAndErgonomicServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ProductOrServiceAxis_ManagementContractRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ProductOrServiceAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_ProductOrServiceAxis_OtherRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_ProductOrServiceAxis_ManagementContractRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ProductOrServiceAxis_OtherRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_ProductOrServiceAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_UnusualOrInfrequentItemAxis_FromTwoThousandSeventeenThroughTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandSeventeenThroughTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usph:CentersForMedicareAndMedicaidServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20130401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2013-04-01</instant>
        </period>
    </context>
    <context id="c20211102_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usph:CentersForMedicareAndMedicaidServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-02</instant>
        </period>
    </context>
    <context id="c20240930_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c20180209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2018-02-09</instant>
        </period>
    </context>
    <context id="c20221231_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20151102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2015-11-02</instant>
        </period>
    </context>
    <context id="c20210401to20210414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-14</endDate>
        </period>
    </context>
    <context id="c20211210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2021-12-10</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ProgressiveHealthCompaniesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ProgressiveHealthCompaniesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20211231_DebtInstrumentAxis_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220331_DebtInstrumentAxis_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220331_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20211130_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-05</instant>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MinimumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MinimumMember_VariableRateAxis_BaseRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MaximumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MaximumMember_VariableRateAxis_BaseRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210131_DebtInstrumentAxis_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210131_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="c20220331_DebtInstrumentAxis_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20090331_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-03-31</instant>
        </period>
    </context>
    <context id="c20081231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2008-12-31</instant>
        </period>
    </context>
    <context id="c20090301to20090331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2009-03-01</startDate>
            <endDate>2009-03-31</endDate>
        </period>
    </context>
    <unit id="U001">
        <measure>shares</measure>
    </unit>
    <unit id="U002">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U003">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U004">
        <measure>usph:Segment</measure>
    </unit>
    <unit id="U005">
        <measure>usph:Location</measure>
    </unit>
    <unit id="U006">
        <measure>pure</measure>
    </unit>
    <unit id="U007">
        <measure>usph:Clinic</measure>
    </unit>
    <unit id="U008">
        <measure>usph:State</measure>
    </unit>
    <unit id="U009">
        <measure>usph:Facility</measure>
    </unit>
    <unit id="U010">
        <measure>usph:Region</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="c20220101to20220331"
      id="Fact_afdb6aba6e4f4c2dbb99262c1237ae93">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20220101to20220331"
      id="Fact_f857e35cf36748209c4eacafb44c29c3">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="c20220101to20220331"
      id="Fact_50201d596e9040218dd2e34e9905e3dd">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="c20220101to20220331"
      id="Fact_b469147f93c143339645a6060867edfd">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityRegistrantName
      contextRef="c20220101to20220331"
      id="Fact_469b7c771c454cb09cd0a19f157c4dfb">U S PHYSICAL THERAPY INC /NV</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="c20220101to20220331"
      id="Fact_c4ade041a1924240a28ce9c66d6a85dc">0000885978</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220101to20220331"
      id="Fact_d1e892b91f6d423c82463ad2953c7c0d">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220101to20220331"
      id="Fact_beb2c2c75a9a4fe19363c09899aa39e5">TX</dei:EntityAddressStateOrProvince>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember"
      id="Fact_c14f91b399c145c8a8ea00d2ca948500">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember"
      id="Fact_02de141ed1d4420c98a9952012a0ab54">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember"
      id="Fact_b13cf1c74cd446babb6cdd78fa4c8294">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod
      contextRef="c20220101to20220331_RangeAxis_MinimumMember"
      id="Fact_40b721ca5dc3493aaa09b990a340fe57">P3Y</usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20220101to20220331_TitleOfIndividualAxis_DirectorMember"
      id="Fact_e7d74d21eab74c899fb44317a7932e6a">P1Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20220101to20220331_TitleOfIndividualAxis_EmployeeMember"
      id="Fact_5ace032f12924d2eb4cdbde0f9b532c6">P4Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <usph:TermOfEmploymentAgreement
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"
      id="Fact_366532ba69814de1ad518109bf840391">P3Y</usph:TermOfEmploymentAgreement>
    <usph:NonCompeteAgreementBasicTerm
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"
      id="Fact_384e0904d90e46f581ffc1a642cdf595">P5Y</usph:NonCompeteAgreementBasicTerm>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MinimumMember"
      id="Fact_c5b38f9523db408b8ed6c53ba95605c1">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember"
      id="Fact_c992237d92cd47c78ded2f3204d6bdd7">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <dei:DocumentType
      contextRef="c20220101to20220331"
      id="Fact_ee42d298997b4145b564e61ed3c6c67e">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="c20220101to20220331"
      id="Fact_18b8db23807c466589e4ebaf97cdf299">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="c20220101to20220331"
      id="Fact_82dc67adc894406fb5b4b9f19e65f84d">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="c20220101to20220331"
      id="Fact_17f52c9ceec94d518582d9cfb40cc990">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="c20220101to20220331"
      id="Fact_923ea2865fa3400b9392b6a3b0cbfb2e">1-11151</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220101to20220331"
      id="Fact_8fc937649c004e4ab4c18642aaa140c2">76-0364866</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220101to20220331"
      id="Fact_21798bc52c69492a9a3e196050da6fbd">1300 WEST SAM HOUSTON PARKWAY SOUTH</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20220101to20220331"
      id="Fact_e391b5fd93744de5b5a1aedcf2de682d">SUITE 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20220101to20220331"
      id="Fact_8b6a9950a6ca4435bd29d61a799cca07">HOUSTON</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220101to20220331"
      id="Fact_2ebbcb8fb6154a5a9f10220cf588d442">77042</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220101to20220331"
      id="Fact_2e3f53db9f944c42a1dff9f5e045ca89">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220101to20220331"
      id="Fact_6fa578accef449c98386e7c493594229">297-7000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20220101to20220331"
      id="Fact_303cdcc928444aafaee33a08471621e0">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220101to20220331"
      id="Fact_b20abf7154a347ecbe285552bdc563d8">USPH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220101to20220331"
      id="Fact_49866b8590e74496a24c1b6fc5b4e5c3">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="c20220101to20220331"
      id="Fact_f5ebe3408ab24c9ab9aa99bc031e3d2b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="c20220101to20220331"
      id="Fact_602f1641850247be87751ec8e2ae086d">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="c20220101to20220331"
      id="Fact_d74498ab9e614493bd04175b4e1fc6f2">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="c20220101to20220331"
      id="Fact_de0c820cca6943689c29f0bfa8cbc542">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220101to20220331"
      id="Fact_696ac05904a542af97835548c2eb6890">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="c20220101to20220331"
      id="Fact_48ad9a9d660f4fa0afb2f36b8d9f4228">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c20220509"
      decimals="INF"
      id="Fact_74dea15f6141483f8374e7af1d01e076"
      unitRef="U001">12991436</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8561396c88be4705b7cd93a9d57fbf44"
      unitRef="U002">24229000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c382f7f32c7446fe9626faea5b3fc443"
      unitRef="U002">28567000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_e2c8e2a564c64c9690e9906d84e822ae"
      unitRef="U002">2799000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_75686405ea744686b2b0e9ba7fd5c3f8"
      unitRef="U002">2768000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_63b9525d592a494897b275220a0e8b6c"
      unitRef="U002">49335000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a33badb328c94e929cc5568c1e79fcc0"
      unitRef="U002">46272000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_95f993755d19437ba4e6a8386ce8f796"
      unitRef="U002">18239000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f4bf838fd1ea43de9cb3a511b17d9bd7"
      unitRef="U002">16144000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_a68ddb8e7df8414e905432e96083dd3a"
      unitRef="U002">4040000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e1963d8dd490442bba14bd7f27cb4515"
      unitRef="U002">4183000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_521a066e27b547b1914e0180d2f9fdd8"
      unitRef="U002">95843000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_98e563d053854d758b2a9a6f74b93025"
      unitRef="U002">95166000</us-gaap:AssetsCurrent>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="c20220331"
      decimals="-3"
      id="Fact_2c345c41e33f41998afc2c8bded5ec2c"
      unitRef="U002">60205000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9de1223686124a9f83712b30d7e5db05"
      unitRef="U002">58743000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="c20220331"
      decimals="-3"
      id="Fact_acad4b3d757340f9810558284673990f"
      unitRef="U002">40541000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f8d643a3444a477c9513e073c086a8b3"
      unitRef="U002">39194000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20220331"
      decimals="-3"
      id="Fact_96d90d3088694460bac57a9891e73453"
      unitRef="U002">100746000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a947b36198f24b91ab803bb5aae2c7dc"
      unitRef="U002">97937000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20220331"
      decimals="-3"
      id="Fact_607cb574051c44aba9e94e85735d0f4e"
      unitRef="U002">76601000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0f4892455e674666b1cc54321acaea79"
      unitRef="U002">74958000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20220331"
      decimals="-3"
      id="Fact_7d0d8740e81241f9b6681f22f15bb44f"
      unitRef="U002">24145000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4483c25555a3453ba8b196817d29fb7d"
      unitRef="U002">22979000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220331"
      decimals="-3"
      id="Fact_d5ad9423b58941b9b905b15e8450f4c7"
      unitRef="U002">94243000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_95e7be2ed17744d695f199d575963109"
      unitRef="U002">96427000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c20220331"
      decimals="-3"
      id="Fact_d89bc5876e5443a6a644bafc70aacb0f"
      unitRef="U002">12422000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4564a7ce59094643b7a97bd04730e1b3"
      unitRef="U002">12215000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill
      contextRef="c20220331"
      decimals="-3"
      id="Fact_1909ce68dcf049e19be34fddb124fb6c"
      unitRef="U002">443692000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b03a91e46c124bf3a33b9be664061973"
      unitRef="U002">434679000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20220331"
      decimals="-3"
      id="Fact_7710454a343340bf885af3853072adc9"
      unitRef="U002">91546000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_96badc6c90df40549c2593e276f12438"
      unitRef="U002">86382000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_6e23e0bbd00443c0b4cb23a696ab8cc5"
      unitRef="U002">1972000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ae03d2ad1f6b4d20a7fe2c92d8f4d21d"
      unitRef="U002">1578000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f2396e94bd604bb798c41309c1ada184"
      unitRef="U002">763863000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c437e2f632ba4bdaab7290447a40ba7c"
      unitRef="U002">749426000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_0420515c240f41df9d75f385f871e375"
      unitRef="U002">3272000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e80a5e9a90074087843dfd7799b563d4"
      unitRef="U002">3268000</us-gaap:AccountsPayableTradeCurrent>
    <usph:AccountsPayableDueToSellerOfAcquiredBusiness
      contextRef="c20220331"
      decimals="-3"
      id="Fact_3a50a50c7bb04b588d6e16b43fe83a4e"
      unitRef="U002">3203000</usph:AccountsPayableDueToSellerOfAcquiredBusiness>
    <usph:AccountsPayableDueToSellerOfAcquiredBusiness
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b614be928c7a43548a17e4f82c28265c"
      unitRef="U002">3203000</usph:AccountsPayableDueToSellerOfAcquiredBusiness>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_c992809b3c96471185889b9ecbadc8ea"
      unitRef="U002">51121000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_abc4cf07f8ff436ca9f20e9642e6b90e"
      unitRef="U002">45705000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_36b098a2dd6f4578a358cbf08732a1c3"
      unitRef="U002">30625000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c4f20c759428431d81d0d7ad385479ae"
      unitRef="U002">30475000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_3e812a339b3d49a4b8ba9bacd806695b"
      unitRef="U002">799000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ba7f0a298b014a4584ff1e1523eb5dad"
      unitRef="U002">830000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_0dffdaf0744741648be3cb6bb8bb69b0"
      unitRef="U002">89020000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c823c78104084b1cada66996af06025d"
      unitRef="U002">83481000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="c20220331"
      decimals="-3"
      id="Fact_abee34b2fd894efea6347fccf3fbcacd"
      unitRef="U002">4128000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d021a2c4356b44b7af70ad8098c4b83c"
      unitRef="U002">3587000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermLineOfCredit
      contextRef="c20220331"
      decimals="-3"
      id="Fact_00eb079672ba44178301fa161f9b4dbb"
      unitRef="U002">118000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4beaf570e63e445cb6403252d178a7c3"
      unitRef="U002">114000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f922dc7dcf4247b6bb639e441a28e71f"
      unitRef="U002">16067000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ce071d6467cc44b0aefe92611e909a0a"
      unitRef="U002">14385000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_e54ef92ec4df4489be7f3dbb8458383d"
      unitRef="U002">72162000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b7b53204e0154d8b9fb1aa2aad488aa6"
      unitRef="U002">74185000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f9896e2cf8b54c3daf2ca59d73cfd04f"
      unitRef="U002">4262000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_916191bd806d4340b2e57dec93ee2ffb"
      unitRef="U002">7345000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20220331"
      decimals="-3"
      id="Fact_d970840db4bb4622bb704353e8440d7a"
      unitRef="U002">303639000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_aa94b0ccfc0b43ed989c1ad07fc727bc"
      unitRef="U002">296983000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20220331"
      decimals="-3"
      id="Fact_a2e6b567ae9640de994e4b23d5b5e543"
      unitRef="U002">158008000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20211231"
      decimals="-3"
      id="Fact_060c915c2a9e488a9814ec86114d4bd8"
      unitRef="U002">155262000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20220331"
      id="Fact_2f58095c069643339f81fc7004023662"
      unitRef="U002"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20211231"
      id="Fact_09158755baec4ec380f01cf40599643e"
      unitRef="U002"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="2"
      id="Fact_e661e292b4484ac9b86dde706aebf863"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20220331"
      decimals="2"
      id="Fact_1c961fe0ccd84135b14ffd888592e53a"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_416317c9057844c284d70d6e19981df8"
      unitRef="U001">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20220331"
      decimals="0"
      id="Fact_3205c7054ba64a1b9399f636bf2ff620"
      unitRef="U001">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20220331"
      decimals="INF"
      id="Fact_e2f766760766417f82d26801f968f2ed"
      unitRef="U001">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20211231"
      decimals="INF"
      id="Fact_cd8625a94fc045bf8a79dc4ec6aedb8d"
      unitRef="U001">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20220331"
      decimals="INF"
      id="Fact_9672728e875246549fd313e945b5c174"
      unitRef="U001">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20211231"
      decimals="INF"
      id="Fact_90e24575a5f643759c3bacc24797953e"
      unitRef="U001">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f9e6cec8c98347908c5921635d55df7d"
      unitRef="U002">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cfbe9d651e3c4ebf9630f00652329736"
      unitRef="U002">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20220331"
      decimals="2"
      id="Fact_5b7b8330f202445d826385cafb195b1f"
      unitRef="U003">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="2"
      id="Fact_4fc5f583d6554173b588f87ec9c63fb7"
      unitRef="U003">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20220331"
      decimals="0"
      id="Fact_50ae49a0f6e64db991383e1e727989da"
      unitRef="U001">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_298ac01db8174bc6a9e6478da9f7c921"
      unitRef="U001">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20220331"
      decimals="0"
      id="Fact_c246996a576243b0933f2d9910f0cd70"
      unitRef="U001">15206173</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20211231"
      decimals="0"
      id="Fact_ec9d179e963d4db0ad5b65b2800faf21"
      unitRef="U001">15126160</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_336110f448f0432b8d18992aa1e752e0"
      unitRef="U002">151000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f940e188d74040cc8e421c0d90d0c769"
      unitRef="U002">151000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f733303449084189b302e96be5ef14dc"
      unitRef="U002">105205000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a8eb9616d30a4a6389b14098ae306fba"
      unitRef="U002">102688000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20220331"
      decimals="-3"
      id="Fact_611a248b8e7a4146890a0212ac3fa7da"
      unitRef="U002">227243000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cad466ab94ef4a74aadd1d67eb8dbdc2"
      unitRef="U002">224395000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="c20220331"
      decimals="0"
      id="Fact_599daf18ed66483ea720dcffd067e677"
      unitRef="U001">2214737</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="c20211231"
      decimals="0"
      id="Fact_1fcf992ba5924feab5f83c8959342928"
      unitRef="U001">2214737</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f83e1aa020a5491396d23e64de98dc7c"
      unitRef="U002">31628000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5387b26a348c43558b98311428764d04"
      unitRef="U002">31628000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_702ebe2c60d4425d84090225a37c4d15"
      unitRef="U002">300971000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1a00bffa4d1143d0b987d319f29ea4eb"
      unitRef="U002">295606000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="c20220331"
      decimals="-3"
      id="Fact_997ec6d286e443d4803d59f60b58b66c"
      unitRef="U002">1245000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7ffdbe489fc64a6b842ba0d28129423f"
      unitRef="U002">1575000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8f6a2d4e21284881bbc5f7cb03ea07fe"
      unitRef="U002">302216000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_469f4ac21aec4bae8ecbcccc5e66fb7d"
      unitRef="U002">297181000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_4ac49a3868aa41959a984ab2e948ae0d"
      unitRef="U002">763863000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_22443dd67833480184f3349362dff19b"
      unitRef="U002">749426000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_2dd37337eafd407c87d01ee8d9cc547c"
      unitRef="U002">109538000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_fc30ba3c58bd4862bb2554194bd17537"
      unitRef="U002">99254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_8ffbd269610b4b92b7786267eebc3581"
      unitRef="U002">22166000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_6bd697cabb434e5682570c8056b83ecb"
      unitRef="U002">13114000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_243b13a5fcee4e9aa1aa72d2bde1220e"
      unitRef="U002">131704000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_1e5cfc3fd6314f1484706ab5f74e4180"
      unitRef="U002">112368000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_2258c5166017428ba1868ddb8695e0a2"
      unitRef="U002">75149000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_9359596dafe84736aa4a71791ebf913c"
      unitRef="U002">63815000</us-gaap:LaborAndRelatedExpense>
    <usph:RentSuppliesContractLaborAndOther
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_238f80d8f4ae42a3a11c207002a517c6"
      unitRef="U002">28662000</usph:RentSuppliesContractLaborAndOther>
    <usph:RentSuppliesContractLaborAndOther
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e032293d6aad495a9d259d1f38026bbf"
      unitRef="U002">21457000</usph:RentSuppliesContractLaborAndOther>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_b0d448eb678a4b4594d5c0529ecc9e33"
      unitRef="U002">1305000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_15d3cd228fa448c5a3f69917b52e9dcd"
      unitRef="U002">1200000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:CostsAndExpenses
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_f0cc043f4a2c4fd3abbabd231eb85c93"
      unitRef="U002">105116000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_b5a4e86677864f9ea7f1a476854c3702"
      unitRef="U002">86472000</us-gaap:CostsAndExpenses>
    <us-gaap:GrossProfit
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_c73319059c6c42a783d6b08a75f2b9d0"
      unitRef="U002">26588000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ef44c1443374467eb76eb0ef8aa7d95f"
      unitRef="U002">25896000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_62eac50a4e074616b646bcb10271dbd3"
      unitRef="U002">11556000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_a87f571e83084eccbddc41f22ba42b08"
      unitRef="U002">10874000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e37708849b814a3490420002236035f4"
      unitRef="U002">15032000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_b1741368bc0446eabe8edd17716fd484"
      unitRef="U002">15022000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_6f4c604922244db4b3a25c683ed8a2d6"
      unitRef="U002">339000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c22638e0788243ac837b8c5d8420c1b4"
      unitRef="U002">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InterestAndOtherIncome
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_92615c031560465eb6fe1ed6d6b4d9db"
      unitRef="U002">46000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_cabe0f81491b45d4b6dad40ff9e44431"
      unitRef="U002">54000</us-gaap:InterestAndOtherIncome>
    <usph:GainLossOnRevaluationOfPutRightLiability
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e9b0c18b5edb4fb2879e801c326122fc"
      unitRef="U002">603000</usph:GainLossOnRevaluationOfPutRightLiability>
    <usph:GainLossOnRevaluationOfPutRightLiability
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_5f853dae4def43cfbdc862b0c4d8be2a"
      unitRef="U002">0</usph:GainLossOnRevaluationOfPutRightLiability>
    <usph:InterestExpenseDebtAndOther
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_98897cd25117492ea917d45da4d48895"
      unitRef="U002">540000</usph:InterestExpenseDebtAndOther>
    <usph:InterestExpenseDebtAndOther
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_24dc7db48f9e4ddcb8f7f4846e07e531"
      unitRef="U002">246000</usph:InterestExpenseDebtAndOther>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_29742cf44954451e912ec53e7449b9af"
      unitRef="U002">448000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_a00d46dd2a58478a9fbc8764abfc0e14"
      unitRef="U002">-192000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a82f65c1e53f40b0834703028929f3a5"
      unitRef="U002">15480000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4a94579c62cc438a89ef0aa97d554154"
      unitRef="U002">14830000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_7f49048ccc674f0ab9217a40f2ff43fb"
      unitRef="U002">3498000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_53081d987803473fa650d1849c99bf6d"
      unitRef="U002">2944000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_3103bae7c7924e9395e98e43fcef47c7"
      unitRef="U002">11982000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_79dc646c50c24f189ecabd15d88fb4f4"
      unitRef="U002">11886000</us-gaap:ProfitLoss>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_3c3a8266b4744ca5961b7cbe15301302"
      unitRef="U002">2557000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_45b91a63cbba4cc3867f9617d5f8a4d7"
      unitRef="U002">2453000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_d8f20fe738b9454f8bd0880a110ee30b"
      unitRef="U002">626000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ceae4a1a34134d5cbd8aa0303e5a7f50"
      unitRef="U002">1260000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_6701d6ab66cf4179b69e50943cabdf08"
      unitRef="U002">3183000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_b6a3314ef201412e8b3fa707fb44a388"
      unitRef="U002">3713000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_264e671f5507413da912c39b6fa5b656"
      unitRef="U002">8799000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_379310f16d2b49fda29ebdc9b7f1460c"
      unitRef="U002">8173000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_25bd018a390f4e15861bf1c2af0ea43c"
      unitRef="U003">0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_10127377e2154cc7bc51de66b78706bf"
      unitRef="U003">0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_ae78532abd34469eb984c8d9df0b23d8"
      unitRef="U003">0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_661740cbfb444e2da1bd29e185d781ee"
      unitRef="U003">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_f002025b3d9f47c596bc13815ffffe6e"
      unitRef="U001">12937000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_1871917bf20e497f8b7cd645025e647a"
      unitRef="U001">12937000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_9dddded5d8614e6bb41982a9e315b9c8"
      unitRef="U001">12870000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_5cdb4654858f441da886cae5ce71b997"
      unitRef="U001">12870000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_860faf1d104349839f290701f790893a"
      unitRef="U003">0.41</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_64d518e51bb249beb49ebdb916c24afa"
      unitRef="U003">0.35</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_f0c13ff17a214c4f9df776e2cd6f80de"
      unitRef="U002">11982000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4653f81c8a3f4d148277bb6af025a904"
      unitRef="U002">11886000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_be731ed749c74eeaa16c716bb038d6f7"
      unitRef="U002">3824000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_bc9f4352a65940ffa48c9848d833bcb8"
      unitRef="U002">2681000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_f3b27e9ee8974c8fa16fe057a64bfdc2"
      unitRef="U002">1305000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_62993a01884142aaa8e62f87364685dd"
      unitRef="U002">1200000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_7a0c84a44a4e47a49ef5645bef379159"
      unitRef="U002">1846000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_8c22c860a47d499cac4297693f444818"
      unitRef="U002">1651000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_996134f15de24125ad02d7e6f41eab13"
      unitRef="U002">2132000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_2dcc27fa0322482cb8b385cf4009e354"
      unitRef="U002">2181000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <usph:GainLossOnRevaluationOfPutRightLiability
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_c2e0cefc4709418c914b2036a162ab5a"
      unitRef="U002">603000</usph:GainLossOnRevaluationOfPutRightLiability>
    <usph:GainLossOnRevaluationOfPutRightLiability
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_968d6d1c31a140c39c77393a88839532"
      unitRef="U002">0</usph:GainLossOnRevaluationOfPutRightLiability>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_23b8128366d04dcf9a7fb118f4b0cb50"
      unitRef="U002">339000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_fd8b35e838834643b42d61f06affea59"
      unitRef="U002">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_30f5da033d0a4e9fb062b31931832f5a"
      unitRef="U002">93000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_30da66c98ed542e184dda89d64c9e11d"
      unitRef="U002">96000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_22f3a501a6a54371bf227fe55f04710f"
      unitRef="U002">4676000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_bfdeb586c85e471b8fa3e1abfeb507ab"
      unitRef="U002">4688000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_1877e35d4c0e43518f2b36502e373bac"
      unitRef="U002">2145000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c4207c9c3c664057b849b1f1d90f420f"
      unitRef="U002">-220000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_d0b831ba1ac842578a5e1b28cf089211"
      unitRef="U002">735000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_5f2c2c1daa754beca86cef8f9caf5e2a"
      unitRef="U002">-221000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_376e02da40574b0fb5effb948e7627ea"
      unitRef="U002">1445000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_a66e1035e9044e2da5a50ac5f4cd4d04"
      unitRef="U002">3969000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a6ffa484c62d4dbb94a6cbdd1b0f63f1"
      unitRef="U002">-2480000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4b36f8448b1b428eb8d2092eda86ea4a"
      unitRef="U002">-1743000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e14a1f2856fc49db96ce17eb6a78b1d2"
      unitRef="U002">11649000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e21a609e4ff44a66a2b9367d6e2d6747"
      unitRef="U002">17674000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_f00703ee905e42fdb41cf8a89631bfda"
      unitRef="U002">2528000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_8a6c0d78461f453e8282895f40ff1dad"
      unitRef="U002">1608000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_4ba8ec8d7b224d79b8f1b61487fbcdd1"
      unitRef="U002">11242000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f34dad44ee2842698e5582913d84b528"
      unitRef="U002">11747000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:PaymentsToAcquireRedeemableNonControllingInterest
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_0634aef93d4f4993bdafe7986841e334"
      unitRef="U002">2211000</usph:PaymentsToAcquireRedeemableNonControllingInterest>
    <usph:PaymentsToAcquireRedeemableNonControllingInterest
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_a4b93a5737ea4efeb28a6c49679d0f99"
      unitRef="U002">0</usph:PaymentsToAcquireRedeemableNonControllingInterest>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_1711a52bb2f54b208cd41be0617223f8"
      unitRef="U002">99000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_2ff448df45d745e482af47f6c49be8b3"
      unitRef="U002">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_fa19e18483a74cb79aea19511bf68fd7"
      unitRef="U002">4000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_0301a40012534f2d9d7d467751a71ce8"
      unitRef="U002">152000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <usph:DistributionsFromUnconsolidatedAffiliate
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_d721d9c82c2b478f86975d14b7aee4e8"
      unitRef="U002">132000</usph:DistributionsFromUnconsolidatedAffiliate>
    <usph:DistributionsFromUnconsolidatedAffiliate
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ab9acf9fe7194ee7a61554cfeb32865f"
      unitRef="U002">0</usph:DistributionsFromUnconsolidatedAffiliate>
    <usph:ProceedsFromSalesOfNonControllingInterestPermanent
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_64ed33e04e69485d9e0107993c15de35"
      unitRef="U002">0</usph:ProceedsFromSalesOfNonControllingInterestPermanent>
    <usph:ProceedsFromSalesOfNonControllingInterestPermanent
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_dafe4e43c10d43b4a58a59dcb47912b0"
      unitRef="U002">0</usph:ProceedsFromSalesOfNonControllingInterestPermanent>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_94ef0c8230f8401a98da072be31edc00"
      unitRef="U002">-15944000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_13d50103b4ba40198cafb183efee69fe"
      unitRef="U002">-13203000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_d61da74eb3e9429eb594bdcfddf7aa03"
      unitRef="U002">3711000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_acc4ff8634134dde9f3baf4f41302414"
      unitRef="U002">5265000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_1c3c2c9e4c8b4b1a830991269c7c2e94"
      unitRef="U002">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_6a236e4482b5472687716a945db7acf6"
      unitRef="U002">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_4a99c25b3b42427b9344d8bb885ac7cd"
      unitRef="U002">35000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_d5879261dd734640a36425d6a73ec62b"
      unitRef="U002">60000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_008a55a6c89b468da2c410aac6a3ed89"
      unitRef="U002">31000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_b52dd0cb71c24cfea15a3e37c5114f1e"
      unitRef="U002">60000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_c7ca9cc58f844e1a93fb2d65f74cebce"
      unitRef="U002">332000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_58f0c7a3ab774d9391f6ad4b40f26794"
      unitRef="U002">145000</us-gaap:RepaymentsOfNotesPayable>
    <usph:PaymentOfMedicareAcceleratedAndAdvanceFunds
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_ffac465da7164dd8a3e09a8500b2d9a9"
      unitRef="U002">0</usph:PaymentOfMedicareAcceleratedAndAdvanceFunds>
    <usph:PaymentOfMedicareAcceleratedAndAdvanceFunds
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_7288a00742494f259e6e867d9e5bf0f2"
      unitRef="U002">14054000</usph:PaymentOfMedicareAcceleratedAndAdvanceFunds>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_c10babe75ab24f13bd1f3d7ca70bcf44"
      unitRef="U002">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_2f36d438fb1b464c9567a748a37e4ff6"
      unitRef="U002">12000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_4dec0786c77649c8861b48c002c66e9d"
      unitRef="U002">-43000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_5d5c5c2e8c7c4e8ca6859f0c7488968a"
      unitRef="U002">-19452000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_9f0a5421cf0f49858b92efb530860e33"
      unitRef="U002">-4338000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_5c6ac038701d4cc6bd3a6d29b0f259ce"
      unitRef="U002">-14981000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d79019a2053346c48df19a09a9619d82"
      unitRef="U002">28567000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_cfd478c2d07d40d88e338db7db1030d4"
      unitRef="U002">32918000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20220331"
      decimals="-3"
      id="Fact_2187887532084076914329feecfc1319"
      unitRef="U002">24229000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20210331"
      decimals="-3"
      id="Fact_72024558b43d4d0e9840d2697ab03685"
      unitRef="U002">17937000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_faa759c93548453f83be7f8a4351f07d"
      unitRef="U002">81000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_b1116b63ce314c76aaf7ebefc6daed2c"
      unitRef="U002">62000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_64a622d37ea04fef8513a5b9c9a6aed3"
      unitRef="U002">525000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ba23d3a721674d36a0a0840cd9e4727b"
      unitRef="U002">298000</us-gaap:InterestPaidNet>
    <usph:PurchaseOfBusinessSellerFinancingPortion
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e12a00d11a03423ca3924f5de2f24e1f"
      unitRef="U002">300000</usph:PurchaseOfBusinessSellerFinancingPortion>
    <usph:PurchaseOfBusinessSellerFinancingPortion
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_8d96a0da5c754fb880e45dda93c0d113"
      unitRef="U002">300000</usph:PurchaseOfBusinessSellerFinancingPortion>
    <usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_87edb7a51a5341beaa4d1800d92142aa"
      unitRef="U002">246000</usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20210331"
      decimals="-3"
      id="Fact_6891246fdf774a9c8585770d2875b043"
      unitRef="U002">4829000</usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_cdf452b7dd88499e902f01069e9aea82"
      unitRef="U002">296000</usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity>
    <usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
      contextRef="c20210331"
      decimals="-3"
      id="Fact_542e5dd8893346229844859b1f1b5a61"
      unitRef="U002">0</usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_0cd27103b667400294fe876890828c4f"
      unitRef="U002">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_16df3c72822548629d39fc4542542edb"
      unitRef="U002">287000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_0ba696a7c25346abbd920eb5728519cf"
      unitRef="U002">5327000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="c20210331"
      decimals="-3"
      id="Fact_b383c533459a441c91eefdbd3cd0e359"
      unitRef="U002">4514000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2cf2e837b028465aacb0227cb20e7699"
      unitRef="U001">15126000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c53ed5e99e4d43ddb20d9204f3f2494b"
      unitRef="U002">151000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_8a7086d7a7e943129ea95ec26d80ec71"
      unitRef="U002">102688000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_56c9db9a0c47400e98476cf668692fdf"
      unitRef="U002">224395000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_d5302120a59a45cd98e05d47446e6255"
      unitRef="U001">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_5d7903d9dba74201bbfb48cd2755d035"
      unitRef="U002">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c7f89ed3ed4e427d88d302bf54ae2860"
      unitRef="U002">295606000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_5bf7fb35a0264536ad1429bc9721fc04"
      unitRef="U002">1575000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a0d68c8679694482a5f07107c2754f52"
      unitRef="U002">297181000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7fef89c14e9b4345988a5718024e0a56"
      unitRef="U001">80000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_894f5a2e4ddb44049b0f18bd2a38e2e9"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_9446c5af9c2347b79f269f1d376c9cf6"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_2e1bf32bfefe4d3a95527cc7f5489a36"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_5d478a0c4e2e49389dd48c65125a6619"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_a511165ad7fe4787b37ba6df7f2149d4"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_84a9b0d010a34c2ca61cb3ea40cd382b"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_bdafc29b17214b60857cd9eb47142ee6"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_115c6027a4834b0bb2e5776396f1de3e"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_95f378fb0e6f4dbbae752e18c5c04d2b"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_3ae2506044d04606874e1f0b965016b7"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_dbab644ed28649a6af3116e92f8800bc"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_25eef081cca44bdba8a3cd6608fa1a74"
      unitRef="U002">-113000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_e9a9464d23bc48e7be482d45ee7f516f"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_c12de7f92aa04fb8824d7c01d122cd5e"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_f6332a81bb9e4533bb9801d0b463730e"
      unitRef="U002">-113000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_74f4885b82414e9ca0c115a217b1ed64"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_c1d31e2a7d2949239cca30bc3c178963"
      unitRef="U002">-113000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b91aec925335405d8bb4a2452721bfaa"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b0beb5546af24985b70a1365fc1e05f5"
      unitRef="U002">1846000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_cd1f7596f512422a971075953b5db463"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_9a959ecabca645c395e3b8c06b4a098d"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_36fb5cbcf81546f3b6b865a4ca922e93"
      unitRef="U002">1846000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_7a48bde1c0c64f41afd1d96a54643840"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_989f7c98645b4144ad9f5116f742b5c3"
      unitRef="U002">1846000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_898a7c41dbd547739402626f34223622"
      unitRef="U002">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_1cb550e51c774efa98f5ed0f154f217d"
      unitRef="U002">706000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_991d311060c948a594dd65d2dab5c802"
      unitRef="U002">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_cc87d9e625e6443e9494b1f59d276e6e"
      unitRef="U002">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_5935aafa2f5f4799a8005579431aa9f6"
      unitRef="U002">706000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_39f0dee0f95f4cff859f1fcf4dce225b"
      unitRef="U002">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_fadffa57068a41a99da8edd2300e9196"
      unitRef="U002">706000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_910b626e73004f1b8b875530f6bfea6f"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_5ec9d516dbc34ad0824dd5f6065287fa"
      unitRef="U002">46000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_fa2a9b6344d2410dbc8720c1fee76ca1"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_4465697560de4af687b15fbecda83ec1"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_d8487720d9904273a9f0af836296cc35"
      unitRef="U002">46000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_325c64bc9d23401aaaaa9750d2998681"
      unitRef="U002">334000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_48e2e18e3d0e4f249d1f3963c1c40823"
      unitRef="U002">380000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <usph:SaleOfNonControllingInterestNetOfPurchasesAndTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_70917b248eae46648eee1210e5ebdaaf"
      unitRef="U002">0</usph:SaleOfNonControllingInterestNetOfPurchasesAndTax>
    <usph:SaleOfNonControllingInterestNetOfPurchasesAndTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_6c76a7cac6a049f7b5bf95796da5286f"
      unitRef="U002">0</usph:SaleOfNonControllingInterestNetOfPurchasesAndTax>
    <usph:SaleOfNonControllingInterestNetOfPurchasesAndTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_9679bf28f1734c89bbf29a5962372ebf"
      unitRef="U002">0</usph:SaleOfNonControllingInterestNetOfPurchasesAndTax>
    <usph:SaleOfNonControllingInterestNetOfPurchasesAndTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_a8f6f1d03dab4d4088532a7681d8ca16"
      unitRef="U002">0</usph:SaleOfNonControllingInterestNetOfPurchasesAndTax>
    <usph:SaleOfNonControllingInterestNetOfPurchasesAndTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_cd3faf4bbbca47e9acb3531002393d26"
      unitRef="U002">0</usph:SaleOfNonControllingInterestNetOfPurchasesAndTax>
    <usph:SaleOfNonControllingInterestNetOfPurchasesAndTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_280b9103072b4ca2ad0687e6b7f8563b"
      unitRef="U002">0</usph:SaleOfNonControllingInterestNetOfPurchasesAndTax>
    <usph:SaleOfNonControllingInterestNetOfPurchasesAndTax
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_600c07cdd4e44a1695f8381e680854f9"
      unitRef="U002">0</usph:SaleOfNonControllingInterestNetOfPurchasesAndTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_8b46354337eb41d7937d173b858ccd51"
      unitRef="U002">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_03d2c6fc6799493f925687fd29a75d24"
      unitRef="U002">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ebbbbabf01154bd88019b8b5d33aba04"
      unitRef="U002">5327000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_0a896d4277da4d0f8abe6118abb1968e"
      unitRef="U002">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_e1ac9e627770416bb9f1618485c98650"
      unitRef="U002">5327000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_e6c4a8298a404e9295d191038e300fe0"
      unitRef="U002">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_72beac2c6f3d4c3f85f963d153d47fce"
      unitRef="U002">5327000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0fa57d23efd74a69a0373e016d1cdff5"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_9893c29117ef482b8ad765e2f4226271"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_73019957c80c4ccf85ade38116a398eb"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_6d7bf888924340b0adde1659eebf24a0"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_781b5147cb4b45629be849d0a58e5ca2"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_5761493ad7be431d87c9c32882c2272b"
      unitRef="U002">1308000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_8d96551342464a4380dd684ed715f259"
      unitRef="U002">1308000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityOther
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a665cb5da9234bcabba47ea4c4c0f7fb"
      unitRef="U002">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_ed3d198a8197402c9c69795cac1311e8"
      unitRef="U002">11000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_64de025f2679473ea835ec5886318b39"
      unitRef="U002">-511000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_f826af9ad213424fb47377b8401d0716"
      unitRef="U002">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_ba0c97253eee4dc2b7aa32c824451c0b"
      unitRef="U002">-500000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_64b07eeec2fd4840977c52af304767cf"
      unitRef="U002">686000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_57ab21603ee84778b25c28f14ac6797d"
      unitRef="U002">186000</us-gaap:StockholdersEquityOther>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1ec6aba99a9c43c697cf470f0d47da6a"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_6a79f7333a0a4cd7a39f0dcd5b4cfe1b"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_4747057d2ff54be9a28bbfcdf7ac7575"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_6f8550d49c2243ceae3acf6d31720f4a"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_395d42fd718e43bab7298d1ab90828c0"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_ea03aa070c4346e5ae6d460f830fa725"
      unitRef="U002">626000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_8d9385b7549c4e189ad9d9d2a9c4d40b"
      unitRef="U002">626000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0a4f475712c04555a5e2767032b46baf"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4934fa6e36f640cd836b556cb4495c74"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_e523db27ab28484da88ff1dd8c81fb89"
      unitRef="U002">8799000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_b21947f5f6c84edc897d3257963bade1"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_0abbee72dcaf4b4baddf0b81eec0d0ae"
      unitRef="U002">8799000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6a072279b67340f1b77687cb206df900"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_ea68f31794bb436291ca6376b8eba279"
      unitRef="U002">8799000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2788f61fe613420581eb6806e9c8b074"
      unitRef="U001">15206000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_82f0eec4d51f46a086e7290c03ce537c"
      unitRef="U002">151000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_743c86d21b0641f5bbae924fd028bef4"
      unitRef="U002">105205000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_7bd570de8f7347e6b45cadcfd5fe37a5"
      unitRef="U002">227243000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_c90231581cb04ed287e7f594f4f28c60"
      unitRef="U001">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_a7b4d6d893b948d98319b5f8e297807e"
      unitRef="U002">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_f11e90c5d5b749fabd05bb8bc6253ddd"
      unitRef="U002">300971000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_2e175a5f68ba4afe81ecd214b1d7ff3e"
      unitRef="U002">1245000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331"
      decimals="-3"
      id="Fact_07ff0f19b8ac44bebaefdee84789bb20"
      unitRef="U002">302216000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_619d0a908dc541e8a480345309025ed7"
      unitRef="U001">15065000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c9bacfb7a7fb4109872c9a972716cb5f"
      unitRef="U002">151000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_ec0cda55ef6446ffa9323576c6a47ddf"
      unitRef="U002">95622000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_fda6739c74bd468e87eae1e7ab01570a"
      unitRef="U002">212015000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_1a1a97c41fe54cedbdef47215862c241"
      unitRef="U001">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_fe91b33de615478e928bff975b5cf056"
      unitRef="U002">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_829f4eb9c52641e6a31371ddf86a4d86"
      unitRef="U002">276160000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_49a8c88ca0f24e23be113b87de392819"
      unitRef="U002">1470000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b133a4f5420a41eea8d55bc527bec3dd"
      unitRef="U002">277630000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_af63d00f740d4de2aec75de9949cc816"
      unitRef="U001">46000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1cc2c57b4f654cdd801ac63b54d7a4f3"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_3a15288034474ae39c25aad7387aaf72"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_5dbbe695911d495abf6a99d059291ac5"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_5e7e368ea772476e995d2436c7bdb3d0"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_81eac31184544eed9e4b1319793e36c3"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_156773c87f1e4c66a2f92535abb4f3f3"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_51c8991788eb44fdb5a06bb2436a950a"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_be54096ce0854268b9303591b86f4442"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f5a34657f6194e94a07a0c9ac97b3c08"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_baa1d03aade540d4bcf2e110e49c664b"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_01b39f7234fe44738fac42189bb897fd"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d13ff828154b468e9779bcb637d3590b"
      unitRef="U002">-5413000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_52c00ba72dfb418b8d8fa9e1fe676228"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_ba1bfb948b6b42cb836fddebaa1de398"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_07ead7ab48c6467da2838987debf0bf1"
      unitRef="U002">-5413000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6597fb62f16e4067bd8f38d8c49394d1"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_cce87546740447cfa2238f466e42647f"
      unitRef="U002">-5413000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_8070ace992ff49f0a31676258835397e"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_649e7cb68ca344f886663017cd13eb9f"
      unitRef="U002">1651000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_e9ee4417f822428691069f4e801f7c6d"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_e767a90cff544cdeb43b0c2ea7e107c7"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_1a160231ebde4edfa779903913f8aea2"
      unitRef="U002">1651000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_593306c0dd384a5cbeb807b38bff904f"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_75bf4de9b34141269ef7060555a5f9e7"
      unitRef="U002">1651000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_45901373a62c400d97abe41766128cd1"
      unitRef="U002">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_bd47eb18aa7941e1912b6585071b8381"
      unitRef="U002">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_a54504bafdfe46d0bde05e5c57c84119"
      unitRef="U002">4514000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_50abcba85e724629b3cb02d03f4895a0"
      unitRef="U002">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_676bc9fd4dd04d8cb9a8122d6cde107e"
      unitRef="U002">4514000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_87a64f9723024d96a94147ef1ccadc27"
      unitRef="U002">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_39403a5d225f4f67954cf56603461ac2"
      unitRef="U002">4514000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_366391b70ee64e7495803513041b3996"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_c1b34f94d29a4194a8ff472be8f15010"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0780fd61e99f48b99a9c03403dc34677"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_2c671126b7be405fac60eb127131c1b3"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_3b2f9980a3ca48afa57e9b0c303dfce1"
      unitRef="U002">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_9b426d5843fe497281fe6514cf18b346"
      unitRef="U002">1672000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e82f283a2c5d44b897970bfeea6c430d"
      unitRef="U002">1672000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_39751bd17b414bbc9664edd434e3c32f"
      unitRef="U002">0</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0dfebb173ce4486e989c527b261b6d67"
      unitRef="U002">13000</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_51b59adac95448b4a6465d92c3a41288"
      unitRef="U002">0</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_22a1cbc9ac7546e59975b8cc3a9f52e1"
      unitRef="U002">0</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_25825b87d0f2473faa21158992208ddc"
      unitRef="U002">13000</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_a34f41140e984e3d9273800e0664c681"
      unitRef="U002">0</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ddc212d1cd7a448d97f2674dbfde9473"
      unitRef="U002">13000</usph:ShortSwingProfitSettlement>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f81e6ad44f1e4b109263872390cec200"
      unitRef="U002">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_6115705a4ec6497f8a5f3feb96f3f8c1"
      unitRef="U002">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_6adb588501b141d1ab670c22b86e2265"
      unitRef="U002">114000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_1834dbd1e17a410a84c375ee94136ac7"
      unitRef="U002">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_586efe39514c49f39a3820a0663dc3e1"
      unitRef="U002">114000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_cdb768fb657540caa759c76dcb18f8c1"
      unitRef="U002">-1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_1d1263ad8fad474f8e2ac6db11ec1d86"
      unitRef="U002">113000</us-gaap:StockholdersEquityOther>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f36d7106e1f040debbae786bae2c690f"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_5054248594e74d4c9c5b81b3c12bf829"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_bbce184bf4e941abab9c4cc7a9b86398"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_af823ef1280b42c5b86762c36a1d68f4"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_60e9a522ed5443d3b6d5d88039617a33"
      unitRef="U002">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_ef396419040d4bb8b4a8cf789abb9109"
      unitRef="U002">1260000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ec45917eeb604449b98268e8354a17cf"
      unitRef="U002">1260000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_06edd65024c64f9a81b829d24a20e911"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_3564dabca3864512a2a4d2f1974ee462"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0388af69cd28467c8e64c379b770867f"
      unitRef="U002">8173000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_a187a9ee168a4141b46c04270aa78b50"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_2f24589d4fb947dd8ce612939ed5ea88"
      unitRef="U002">8173000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_566f9e8be9764641a502e5b0a0a2cf41"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4a33329afcf641358a8b0fa2a15156de"
      unitRef="U002">8173000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_88b8d5740df04f43a6691d405abfa8f7"
      unitRef="U001">15111000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2d42ef83eb71432d818cdc7840084857"
      unitRef="U002">151000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_a9f8ecc56404427aa3490909946859c1"
      unitRef="U002">97286000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_33813016db5748fbb38a971b03192d7f"
      unitRef="U002">210375000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_535dee3a4e9e417d9ee5d43cc5c3a616"
      unitRef="U001">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_5f687a822006473883321b588702e1ae"
      unitRef="U002">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_49046fb4b19b4943b980427941db02fd"
      unitRef="U002">276184000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_0e8f2fdd9fb8420b9ae417a1ad54a189"
      unitRef="U002">1057000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331"
      decimals="-3"
      id="Fact_578e2f2621724ee69c289b324748935d"
      unitRef="U002">277241000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_f8c8c378a1854161b798b6296dc4e750">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#x201c;Company&#x201d;). All significant intercompany transactions
      and balances have been eliminated.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company operates its business through &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; reportable business segments. The Company&#x2019;s reportable segments include the physical therapy operations segment and the
          industrial injury prevention services segment. The Company&#x2019;s physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders,
          sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance
          optimization and ergonomic assessments.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;During the 2021 year and the three months ended March 31, 2022, the Company completed the acquisitions of four
          multi-clinic practices and two industrial injury prevention businesses as detailed below.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;Date&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;Acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;Clinics&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;March 2022 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;March 31, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;70&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;6&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;December 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;December 31, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;75&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;November 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;November 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;70&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;" valign="bottom"&gt;IIPS*&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;September 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;September 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;100&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"&gt;IIPS*&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;June 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;June 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;65&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;8&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;March 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;March 31, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;70&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;6&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 9pt;"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"&gt;&lt;span style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 7.2pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"&gt;&lt;span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Industrial injury prevention services business&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
               &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;As of March 31, 2022, the Company operated 601 clinics in 39 states. The Company also manages physical therapy facilities for third parties,
          primarily hospital and physicians, with 38 third-party facilities under management as of March 31, 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Physical Therapy Operations&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The physical therapy operations segment&lt;/span&gt; primarily operates through subsidiary clinic partnerships, in
      which the Company generally owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests
      typically range from 10% to 35%
      in the Clinic Partnerships. The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#x201c;Clinic Partnerships&#x201d;). To a lesser extent, the Company
      operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#x201c;Wholly-Owned Facilities&#x201d;).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources, by offering these
      therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue as employees to
      manage the clinic operations, retain a non-controlling ownership interest in the clinics and receive a competitive salary for managing the clinic operations. In addition, the Company has developed satellite clinic facilities as part of existing
      Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than one clinic location.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Clinic Partnerships &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or
        indirectly, are recorded within the balance sheets as non-controlling interest &#x2013; permanent equity and within the income statements as net income attributable to non-controlling interest &#x2013; permanent equity&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For acquired Clinic Partnerships with redeemable non-controlling interest, the earnings attributable to the redeemable non-controlling interest are recorded within the
        consolidated statements of income line item &#x2013; &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;net income attributable to non-controlling interest &#x2013; redeemable non-controlling interest &#x2013; temporary equity &lt;/span&gt;and



        the equity interest is recorded on the consolidated balance sheet as &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;redeemable non-controlling interest &#x2013; temporary equity&lt;/span&gt;.&#160; In accordance with current
        accounting guidance, the revaluation of redeemable non-controlling interest, net of tax, is not included in net income but charged directly to retained earnings and is included in the basic and diluted earnings per share calculation&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Wholly-Owned Facilities&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due to the profit sharing therapists. The
      amount is expensed as compensation and included in operating cost &#x2013; salaries and related costs. The respective liability is included in current liabilities &#x2013; accrued expenses on the balance sheets.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Industrial Injury Prevention Services&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Services provided in the industrial injury prevention services segment include onsite services for clients&#x2019; employees including injury prevention and rehabilitation,
      performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies.
      Other clients include large insurers and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and certified athletic trainers.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;

    &lt;span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; margin-right: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The accompanying unaudited consolidated financial statements were prepared in
          accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions for Form &lt;/span&gt;10&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-Q.


          However, the statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. Management believes this report contains all
          necessary adjustments (consisting only of normal recurring adjustments) to present fairly, in all material respects, the Company&#x2019;s financial position, results of operations and cash flows for the interim periods presented. For further information
          regarding the Company&#x2019;s accounting policies, please read the audited financial statements included in the Company&#x2019;s Annual Report on Form &lt;/span&gt;10&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-K for the year ended &lt;/span&gt;December


        31, 2021&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; filed with the Securities and Exchange Commission on &lt;/span&gt;March 1, 2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company believes, and the Chief Executive Officer and Chief Financial Officer have certified, that the financial statements included in this report present fairly, in
        all material respects, the Company&#x2019;s financial position, results of operations and cash flows for the interim periods presented.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Operating results for the &lt;/span&gt;three&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;
          months ended March&lt;/span&gt; 31, 2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; are not necessarily indicative of the results the Company expects for the entire year.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Impact of COVID&lt;/span&gt;-19&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Medicare Accelerated and Advance
            Payment Program (&#x201c;MAAPP Funds&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="font-weight: bold;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;On March 27, 2020, in response to the COVID-19 pandemic, the federal government
          approved the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). The CARES Act provided waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0 billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for
          preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The CARES &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Act allowed for qualified healthcare providers to receive advanced payments under the MAAPP
          Funds during the COVID&lt;/span&gt;-19&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. The Company
          applied for and received approval from Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) in April 2020. The Company recorded the $14.1
          million in advance payments received as a liability. During the three months ended March 31, 2021, the Company repaid the MAAPP Funds of &lt;/span&gt;$14.1
        million &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;rather than applying them to future services performed&lt;/span&gt;. During the three months ended March 31, 2022 and 2021, the Company did not record any income from payments under the CARES Act.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Significant Accounting Policies &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Cash Equivalents&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company maintains its cash and cash equivalents at financial institutions.&#160; The Company considers all highly liquid investments with a maturity of three months or less
      when purchased to be cash equivalents.&#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insurance coverage and, as a result, there is a concentration of credit risk related on
      deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Long-Lived Assets&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fixed assets are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture
      and equipment range from &lt;span style="-sec-ix-hidden:Fact_b13cf1c74cd446babb6cdd78fa4c8294"&gt;three&lt;/span&gt; to eight years and for purchased software from &lt;span style="-sec-ix-hidden:Fact_c14f91b399c145c8a8ea00d2ca948500"&gt;three&lt;/span&gt; to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally &lt;span style="-sec-ix-hidden:Fact_02de141ed1d4420c98a9952012a0ab54"&gt;three&lt;/span&gt; to five years.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that
      the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company did &lt;/span&gt;no&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;t note an impairment to long-lived assets during the &lt;/span&gt;three&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; months ended March&lt;/span&gt; 31, 2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Goodwill&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the
          fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to &lt;/span&gt;2009&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;,
          from the purchase of some or all of a particular local management&#x2019;s equity interest in an existing clinic. Effective &lt;/span&gt;January 1, 2009&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;, if the purchase price of a
          non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic
          impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair
          value if considered impaired. These events or conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined
          with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of &lt;/span&gt;one&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; of these
          events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company has a two operating segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The partnerships are components of regions
          and are aggregated to the operating segment level for the purpose of determining the Company&#x2019;s reporting units when performing its annual goodwill impairment test. In 2021 and 2020, there were &lt;/span&gt;six&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; regions. In addition to the &lt;/span&gt;six&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; regions, the impairment analysis included a separate analysis for the industrial injury prevention services business, as a
          separate reporting unit.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;As part of the impairment analysis, the Company is &lt;/span&gt;first&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether
          a reporting unit&#x2019;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that
          affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting
          unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in &lt;/span&gt;2021&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; and &lt;/span&gt;2020&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; did not result in any goodwill amounts that were deemed impaired.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that
            the fair value of the reporting units were reduced below their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting
            units were impaired as of December 31, 2021.&lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; The Company will continue to monitor for any triggering events or other indicators of impairment.&lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Redeemable Non-Controlling Interest&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The non-controlling interests that are reflected as redeemable non-controlling interest in the consolidated financial statements consist of those that the owners and the
      Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met.&#160;
      The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights can be triggered by the owner or the
      Company at such time as both of the following events have occurred: 1) termination of the owner&#x2019;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction,
      typically &lt;span style="-sec-ix-hidden:Fact_40b721ca5dc3493aaa09b990a340fe57"&gt;three&lt;/span&gt; to five years,
      as defined in the limited partnership agreement.&#160; The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been
      satisfied.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under
      the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#x2013; Redeemable non-controlling interest &#x2013; temporary equity.&#160; Then, in each reporting period thereafter until it
      is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership
      agreement.&#160; As a result, the value of the non-controlling interest is not adjusted below its initial carrying value.&#160; The Company records any adjustments in the redemption value, net of tax, directly to retained earnings and the adjustments are not
      reflected in the consolidated statements of income.&#160; Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per
      share calculation.&#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e.
      the carrying amount) and fair value are the same.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Non-Controlling Interest&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the non-controlling interest, as permanent equity in the
      consolidated financial statements separate from the parent entity&#x2019;s equity. The amount of net income attributable to non-controlling interest is included in consolidated net income on the face of the statements of net income. Changes in a parent
      entity&#x2019;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a
      subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment
      to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Revenue Recognition&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenues are recognized in the period in which services are rendered. See Note 3- Revenue Recognition, for further discussion of revenue recognition.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Provision for Credit Losses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he Company determines provisions for credit losses based on the specific agings and payor classifications at
        each clinic. The provision for credit losses is included in operating cost in the consolidated statements of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and
        provisions for credit losses, includes only those amounts the Company estimates to be collectible&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Income Taxes&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to
      differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates
      expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that
      includes the enactment date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the
      position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate
      settlement with the relevant tax authority.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of
        interest expense and depreciation. ASC 740&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which
        the legislation is enacted. The legislation had no effect on the Company&#x2019;s deferred income taxes and current income taxes payable during the &lt;/span&gt;three&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; months ended March 31, 2022&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company did not have any accrued interest or
      penalties associated with any unrecognized tax benefits nor was any interest expense recognized &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;during the &lt;/span&gt;three&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; months ended&lt;/span&gt; March 31, 2022. The Company records any interest or penalties, if required, in interest and other expense,
      as appropriate.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out
        payments, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement (as defined in Note 9)
        approximates the fair value. The interest rate on the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different
        reference rate in the event LIBOR ceases to exist.&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; The redeemable non-controlling interest included on the consolidated balance sheets and the put right
        associated with the potential future purchase of the separate company in the November 2021 acquisition (as described in Note 2) are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of redeemable
        non-controlling interests approximates the fair value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable
        inputs such as asset volatility and discount rates. The unobservable inputs in the valuation include asset volatility of 25% and a
        discount rate of 9.93%. See Note 5 for the changes in the fair value of redeemable non-controlling interest.&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; The put right decreased $603 thousand for the three months ended March 31, 2022 and was valued at $2.9
        million on March 31, 2022.&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Segment Reporting&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Operating segments are components of an enterprise for which separate financial information is available
          that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance.&#160; The Company currently operates through &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; segments: physical therapy operations and industrial injury prevention services.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Use of Estimates&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;I&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;n preparing the Company&#x2019;s consolidated financial statements, management makes certain estimates and
        assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames and other intangible assets, allocations of purchase price, provision for credit losses, tax provision and contractual allowances, that affect the amounts
        reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Self-Insurance Program&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with
      an insurance company to minimize the Company&#x2019;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued
      amounts are sufficient to pay claims arising from self-insurance claims incurred through March 31, 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Restricted Stock&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock
      granted to employees lapse in equal annual installments on the following &lt;span style="-sec-ix-hidden:Fact_5ace032f12924d2eb4cdbde0f9b532c6"&gt;four&lt;/span&gt; anniversaries of the date of grant. For those shares granted
      to directors, the restrictions will lapse in equal quarterly installments during the &lt;span style="-sec-ix-hidden:Fact_e7d74d21eab74c899fb44317a7932e6a"&gt;first&lt;/span&gt; year after the date of grant. For those granted
      to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation
      expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and
      diluted shares for the earnings per share computation.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Recently Adopted Accounting Guidance&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740)&#x2013;Simplifying the Accounting for Income
        Taxes (&#x201c;ASU 2019-12&#x201d;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of
        financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In August 2020, the FASB issued ASU 2020-06 Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and
        Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of
        liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the
        treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive,
        regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;This pronouncement was effective for fiscal years, and for interim periods within those fiscal years,
        beginning after December 15, 2021.The Board specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or
        fully retrospective method of transition is permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Recently Issued Accounting Guidance&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In &lt;/span&gt;March 2020&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;, the FASB issued ASU &lt;/span&gt;2020-04&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;, Reference Rate Reform (Topic &lt;/span&gt;848&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This
          ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to
          alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through &lt;/span&gt;December 31, 2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.
          Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event
          LIBOR ceases to exist.&lt;/span&gt;&lt;/div&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_5e22b210f5344209a0bd1d67821b39d0"
      unitRef="U004">2</us-gaap:NumberOfReportableSegments>
    <usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_459d04a2ecf74b2cbd20d216b393f3c1">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;During the 2021 year and the three months ended March 31, 2022, the Company completed the acquisitions of four
          multi-clinic practices and two industrial injury prevention businesses as detailed below.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;Date&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;Acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;Clinics&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;March 2022 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;March 31, 2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;70&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;6&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;December 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;December 31, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;75&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;November 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;November 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;70&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;" valign="bottom"&gt;IIPS*&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;September 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;September 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;100&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"&gt;IIPS*&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;June 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;June 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;65&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;8&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 48%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;March 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;March 31, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;70&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 15%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center;"&gt;6&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 9pt;"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"&gt;&lt;span style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 7.2pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left; font-family: 'Times New Roman';"&gt;&lt;span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Industrial injury prevention services business&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
               &lt;/div&gt;
</usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_MultiClinicPracticesMember"
      decimals="INF"
      id="Fact_724fecc6c1294d1e95f1610b47947a18"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="INF"
      id="Fact_df8ef88f36d54071a785a32f2d5396ca"
      unitRef="U007">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_March2022AcquisitionMember"
      id="Fact_8fcb5dbaa9874ecaaa3a46d608fd238c">2022-03-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_March2022AcquisitionMember"
      decimals="2"
      id="Fact_42842e95572745e98a3f84336ec4db83"
      unitRef="U006">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_March2022AcquisitionMember"
      decimals="INF"
      id="Fact_e070ba4470244407bff0ac6d7914774c"
      unitRef="U007">6</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_December2021AcquisitionMember"
      id="Fact_29e13c5545c3412199ad7db9aed9235c">2021-12-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_December2021AcquisitionMember"
      decimals="2"
      id="Fact_14f2f3dffcd94fffac685ab8927bc644"
      unitRef="U006">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_December2021AcquisitionMember"
      decimals="INF"
      id="Fact_f8876f5bd03245488ff606b751897182"
      unitRef="U007">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_November2021AcquisitionMember"
      id="Fact_8d3dd52a9c2f41efacba83fa79584979">2021-11-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_November2021AcquisitionMember"
      decimals="2"
      id="Fact_88a3c2c37da345ccb21c95f197060398"
      unitRef="U006">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_November2021AcquisitionMember"
      id="Fact_d858a7400c8b4646aabbd6bf18a9f0a4"
      unitRef="U007"
      xsi:nil="true"/>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_September2021AcquisitionMember"
      id="Fact_e49056cd1a0340428d0e7682d3073d0e">2021-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_September2021AcquisitionMember"
      decimals="2"
      id="Fact_586d44e098f44ca696aa5cfac7ef5024"
      unitRef="U006">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_September2021AcquisitionMember"
      id="Fact_fb559091d7c74f0785b5cc150f4935e4"
      unitRef="U007"
      xsi:nil="true"/>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_June2021AcquisitionMember"
      id="Fact_d4e41a0e5a9949b69a5450657857417b">2021-06-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_June2021AcquisitionMember"
      decimals="2"
      id="Fact_2f6b36ddd90c4e0199e43f6b2f58d0ea"
      unitRef="U006">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_June2021AcquisitionMember"
      decimals="INF"
      id="Fact_8066777ced20487abdebb56c7b727c32"
      unitRef="U007">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_March2021AcquisitionMember"
      id="Fact_11d4b7f42d0148cfb3c556b649312615">2021-03-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_March2021AcquisitionMember"
      decimals="2"
      id="Fact_c6329705ab3e4436bcd7e6b82718b188"
      unitRef="U006">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_March2021AcquisitionMember"
      decimals="INF"
      id="Fact_e8fc0fc279c9449b9b3ebe29d3f64e92"
      unitRef="U007">6</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_ced41f05862b4872a31cfa6c7ade5cc7"
      unitRef="U007">601</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="c20220331"
      decimals="0"
      id="Fact_faea8a7d6aec491b974e9c5599138ca1"
      unitRef="U008">39</us-gaap:NumberOfStatesInWhichEntityOperates>
    <usph:NumberOfThirdPartyFacilities
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="0"
      id="Fact_310d269962664063b42b69172214ef20"
      unitRef="U009">38</usph:NumberOfThirdPartyFacilities>
    <usph:PercentageOfGeneralPartnershipInterestOwned
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_486d4d1ad5464e238a11b5f885888674"
      unitRef="U006">0.01</usph:PercentageOfGeneralPartnershipInterestOwned>
    <usph:PercentageOfLimitedPartnershipInterestOwned
      contextRef="c20220101to20220331_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_2ff387af9cad45bdaf80cbfe5f958312"
      unitRef="U006">0.10</usph:PercentageOfLimitedPartnershipInterestOwned>
    <usph:PercentageOfLimitedPartnershipInterestOwned
      contextRef="c20220101to20220331_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_818eb86bb3f04f61af10ad1a1265d84b"
      unitRef="U006">0.35</usph:PercentageOfLimitedPartnershipInterestOwned>
    <usph:NumberOfOperatingClinicLocations
      contextRef="c20220331_RangeAxis_MaximumMember"
      decimals="INF"
      id="Fact_c765432ac0834d95b364965e142b3655"
      unitRef="U005">1</usph:NumberOfOperatingClinicLocations>
    <usph:GrantsAndOtherFunds
      contextRef="c20220331_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"
      decimals="-8"
      id="Fact_7323cd95660842f5928605e04eb479ac"
      unitRef="U002">100000000000.0</usph:GrantsAndOtherFunds>
    <us-gaap:GrantsReceivable
      contextRef="c20200430_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"
      decimals="-5"
      id="Fact_5f496f65478d40969d44fd91388ad7da"
      unitRef="U002">14100000</us-gaap:GrantsReceivable>
    <usph:RepaymentOfFunds
      contextRef="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"
      decimals="-5"
      id="Fact_ffd38b2ff1044a5aabd5cbee97cee22f"
      unitRef="U002">14100000</usph:RepaymentOfFunds>
    <us-gaap:GrantsReceivable
      contextRef="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"
      decimals="-6"
      id="Fact_ee01b1720c544c26ac892f8ef1e5ee91"
      unitRef="U002">0</us-gaap:GrantsReceivable>
    <us-gaap:GrantsReceivable
      contextRef="c20220331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"
      decimals="-6"
      id="Fact_69371f90a6714342900837cab4dbee4e"
      unitRef="U002">0</us-gaap:GrantsReceivable>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_43ed52d0055f4ed3939bd381feea7e32">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Cash Equivalents&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company maintains its cash and cash equivalents at financial institutions.&#160; The Company considers all highly liquid investments with a maturity of three months or less
      when purchased to be cash equivalents.&#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insurance coverage and, as a result, there is a concentration of credit risk related on
      deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.&lt;/div&gt;
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_6dc1ba6c717e4d3eb417159abb972b94">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Long-Lived Assets&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fixed assets are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture
      and equipment range from &lt;span style="-sec-ix-hidden:Fact_b13cf1c74cd446babb6cdd78fa4c8294"&gt;three&lt;/span&gt; to eight years and for purchased software from &lt;span style="-sec-ix-hidden:Fact_c14f91b399c145c8a8ea00d2ca948500"&gt;three&lt;/span&gt; to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally &lt;span style="-sec-ix-hidden:Fact_02de141ed1d4420c98a9952012a0ab54"&gt;three&lt;/span&gt; to five years.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that
      the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company did &lt;/span&gt;no&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;t note an impairment to long-lived assets during the &lt;/span&gt;three&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; months ended March&lt;/span&gt; 31, 2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;
</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember"
      id="Fact_8e8517c99bb24f729929c7ec95763c97">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember"
      id="Fact_94a710374ef249bb836ee69f6fe1aa82">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20220101to20220331_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember"
      id="Fact_da89691607d1475f858e44baa0324b49">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="c20220101to20220331"
      decimals="-6"
      id="Fact_5895060f175d48abbe4f9e6df1d7185d"
      unitRef="U002">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_47321e7bde3f431aa54b52e1d8cf1e7f">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Goodwill&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the
          fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to &lt;/span&gt;2009&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;,
          from the purchase of some or all of a particular local management&#x2019;s equity interest in an existing clinic. Effective &lt;/span&gt;January 1, 2009&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;, if the purchase price of a
          non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic
          impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair
          value if considered impaired. These events or conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined
          with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of &lt;/span&gt;one&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; of these
          events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company has a two operating segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The partnerships are components of regions
          and are aggregated to the operating segment level for the purpose of determining the Company&#x2019;s reporting units when performing its annual goodwill impairment test. In 2021 and 2020, there were &lt;/span&gt;six&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; regions. In addition to the &lt;/span&gt;six&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; regions, the impairment analysis included a separate analysis for the industrial injury prevention services business, as a
          separate reporting unit.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;As part of the impairment analysis, the Company is &lt;/span&gt;first&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether
          a reporting unit&#x2019;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that
          affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting
          unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in &lt;/span&gt;2021&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; and &lt;/span&gt;2020&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; did not result in any goodwill amounts that were deemed impaired.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that
            the fair value of the reporting units were reduced below their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting
            units were impaired as of December 31, 2021.&lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; The Company will continue to monitor for any triggering events or other indicators of impairment.&lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_ba98973431c94649bf214c7c85950f52"
      unitRef="U004">2</us-gaap:NumberOfOperatingSegments>
    <usph:NumberOfRegions
      contextRef="c20200101to20200331"
      decimals="INF"
      id="Fact_d0dfb5392f384ea48fd97cba7274d38b"
      unitRef="U010">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20210101to20210331"
      decimals="INF"
      id="Fact_6305d4b42b384a70b349a99ca52de4d9"
      unitRef="U010">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20210101to20210331"
      decimals="INF"
      id="Fact_d298893d535849f28ab55db77b14e018"
      unitRef="U010">6</usph:NumberOfRegions>
    <usph:RedeemableNonControllingInterestsPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_951f675a25514db5abd8d444ec99994c">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Redeemable Non-Controlling Interest&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The non-controlling interests that are reflected as redeemable non-controlling interest in the consolidated financial statements consist of those that the owners and the
      Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met.&#160;
      The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights can be triggered by the owner or the
      Company at such time as both of the following events have occurred: 1) termination of the owner&#x2019;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction,
      typically &lt;span style="-sec-ix-hidden:Fact_40b721ca5dc3493aaa09b990a340fe57"&gt;three&lt;/span&gt; to five years,
      as defined in the limited partnership agreement.&#160; The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been
      satisfied.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under
      the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#x2013; Redeemable non-controlling interest &#x2013; temporary equity.&#160; Then, in each reporting period thereafter until it
      is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership
      agreement.&#160; As a result, the value of the non-controlling interest is not adjusted below its initial carrying value.&#160; The Company records any adjustments in the redemption value, net of tax, directly to retained earnings and the adjustments are not
      reflected in the consolidated statements of income.&#160; Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per
      share calculation.&#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e.
      the carrying amount) and fair value are the same.&lt;/div&gt;
</usph:RedeemableNonControllingInterestsPolicyTextBlock>
    <usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod
      contextRef="c20220101to20220331_RangeAxis_MaximumMember"
      id="Fact_56529cde47b2477ca0da4a88cca4a88a">P5Y</usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
    <usph:NonControllingInterestsPolicyPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_b89cb8bad14347f6a184bd4f88fbc236">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Non-Controlling Interest&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the non-controlling interest, as permanent equity in the
      consolidated financial statements separate from the parent entity&#x2019;s equity. The amount of net income attributable to non-controlling interest is included in consolidated net income on the face of the statements of net income. Changes in a parent
      entity&#x2019;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a
      subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment
      to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.&lt;/div&gt;
</usph:NonControllingInterestsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_cf63d3c1bc8941b99a13694fb993b03b">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Revenue Recognition&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenues are recognized in the period in which services are rendered. See Note 3- Revenue Recognition, for further discussion of revenue recognition.&lt;/div&gt;
</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="c20220101to20220331"
      id="Text_1e25efbfe0904b469a7d4ec126eff865">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Provision for Credit Losses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he Company determines provisions for credit losses based on the specific agings and payor classifications at
        each clinic. The provision for credit losses is included in operating cost in the consolidated statements of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and
        provisions for credit losses, includes only those amounts the Company estimates to be collectible&lt;/span&gt;.&lt;/div&gt;
</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_57e552f3d3a948e280cfdfafd54fca6a">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Income Taxes&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to
      differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates
      expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that
      includes the enactment date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the
      position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate
      settlement with the relevant tax authority.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of
        interest expense and depreciation. ASC 740&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which
        the legislation is enacted. The legislation had no effect on the Company&#x2019;s deferred income taxes and current income taxes payable during the &lt;/span&gt;three&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; months ended March 31, 2022&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company did not have any accrued interest or
      penalties associated with any unrecognized tax benefits nor was any interest expense recognized &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;during the &lt;/span&gt;three&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; months ended&lt;/span&gt; March 31, 2022. The Company records any interest or penalties, if required, in interest and other expense,
      as appropriate.&lt;/div&gt;
</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_937d07e966a04f46b9bed08bfe25b910"
      unitRef="U002">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20220331"
      decimals="0"
      id="Fact_0164604cca9a4e5fb7f96ee5e0e4c69b"
      unitRef="U002">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_4206d3e3c91e41ccb34c473d748b357b"
      unitRef="U002">0</us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="c20220101to20220331"
      id="Text_1aef8f87878b45c9933b567bb9a991c0">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out
        payments, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement (as defined in Note 9)
        approximates the fair value. The interest rate on the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different
        reference rate in the event LIBOR ceases to exist.&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; The redeemable non-controlling interest included on the consolidated balance sheets and the put right
        associated with the potential future purchase of the separate company in the November 2021 acquisition (as described in Note 2) are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of redeemable
        non-controlling interests approximates the fair value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable
        inputs such as asset volatility and discount rates. The unobservable inputs in the valuation include asset volatility of 25% and a
        discount rate of 9.93%. See Note 5 for the changes in the fair value of redeemable non-controlling interest.&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; The put right decreased $603 thousand for the three months ended March 31, 2022 and was valued at $2.9
        million on March 31, 2022.&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="c20220331_MeasurementInputTypeAxis_MeasurementInputOptionVolatilityMember"
      decimals="2"
      id="Fact_d4f986ca0e3a419987bfd4ed1eceefa3"
      unitRef="U006">0.25</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="c20220331_MeasurementInputTypeAxis_MeasurementInputDiscountRateMember"
      decimals="4"
      id="Fact_4699260ec06d4be1a04fa34a55f36fe4"
      unitRef="U006">0.0993</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_8372c7cc8e39446aae1795b56f50fb1b"
      unitRef="U002">-603000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="c20220331"
      decimals="-5"
      id="Fact_850a73b32e6441e7b208b859a035d439"
      unitRef="U002">2900000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_ac2d5bd083a94c26a8a6a420dfe7122f">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Segment Reporting&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Operating segments are components of an enterprise for which separate financial information is available
          that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance.&#160; The Company currently operates through &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; segments: physical therapy operations and industrial injury prevention services.&lt;/span&gt;&lt;/div&gt;
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_f9ebe2db730f424bbb7ea4c83c982273"
      unitRef="U004">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:UseOfEstimates
      contextRef="c20220101to20220331"
      id="Text_b0364ec9f4f04af692eb3021d10c02a6">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Use of Estimates&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;I&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;n preparing the Company&#x2019;s consolidated financial statements, management makes certain estimates and
        assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames and other intangible assets, allocations of purchase price, provision for credit losses, tax provision and contractual allowances, that affect the amounts
        reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates&lt;/span&gt;.&lt;/div&gt;
</us-gaap:UseOfEstimates>
    <usph:SelfInsuranceProgramPolicyPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_dadd79fb58e74715af810a1358d26408">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Self-Insurance Program&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with
      an insurance company to minimize the Company&#x2019;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued
      amounts are sufficient to pay claims arising from self-insurance claims incurred through March 31, 2022.&lt;/div&gt;
</usph:SelfInsuranceProgramPolicyPolicyTextBlock>
    <usph:RestrictedStockPolicyPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_5fb1f272773141568a0cebe4cfc90b48">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Restricted Stock&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock
      granted to employees lapse in equal annual installments on the following &lt;span style="-sec-ix-hidden:Fact_5ace032f12924d2eb4cdbde0f9b532c6"&gt;four&lt;/span&gt; anniversaries of the date of grant. For those shares granted
      to directors, the restrictions will lapse in equal quarterly installments during the &lt;span style="-sec-ix-hidden:Fact_e7d74d21eab74c899fb44317a7932e6a"&gt;first&lt;/span&gt; year after the date of grant. For those granted
      to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation
      expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and
      diluted shares for the earnings per share computation.&lt;/div&gt;
</usph:RestrictedStockPolicyPolicyTextBlock>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20220101to20220331_TitleOfIndividualAxis_OfficerMember"
      id="Fact_c0c8d7548207448bbc34fb8444e74a00">P4Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_e897797f437047a88f385c8988b68915">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Recently Adopted Accounting Guidance&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740)&#x2013;Simplifying the Accounting for Income
        Taxes (&#x201c;ASU 2019-12&#x201d;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of
        financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In August 2020, the FASB issued ASU 2020-06 Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and
        Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of
        liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the
        treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive,
        regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;This pronouncement was effective for fiscal years, and for interim periods within those fiscal years,
        beginning after December 15, 2021.The Board specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or
        fully retrospective method of transition is permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Recently Issued Accounting Guidance&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In &lt;/span&gt;March 2020&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;, the FASB issued ASU &lt;/span&gt;2020-04&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;, Reference Rate Reform (Topic &lt;/span&gt;848&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This
          ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to
          alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through &lt;/span&gt;December 31, 2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.
          Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event
          LIBOR ceases to exist.&lt;/span&gt;&lt;/div&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_56cd42f1fda04e0083ba64a8dc072d90">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2. ACQUISITIONS OF BUSINESSES&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;On
        March 31, 2022, the Company acquired a 70% interest in a six-clinic physical therapy practice in South Central Pennsylvania &#x2013; Madden and Gilbert Physical Therapy, LLC. The practice&#x2019;s owners retained 30% of the equity interests. The purchase price for the 70%
        equity interest was approximately $11.5 million. of which $11.2 million was paid in cash and $0.3 million in the form of a note payable.&#160; The note accrues
        interest at 3.5% per annum and the principal and interest are payable on March 31, 2024.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he purchase price for the 2022 acquisition has been preliminarily allocated as follows (in thousands)&lt;/span&gt;:
    &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,242&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller notes&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,542&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 12.6pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,743&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;247&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;659&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,539&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,946&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,542&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;On December 31, 2021, the Company acquired a 75% in three-clinic physical therapy practice with the practice
        founder retaining 25%. The purchase price for the 75% interest was approximately $3.7 million, of which $3.5 million was paid in cash and $0.2 million in the form of a
        note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on December 31, 2023.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;On November 30, 2021, the Company acquired an approximate 70% interest in a leading provider of industrial injury prevention services. The previous owners retained the remaining interest. The purchase price for the approximate 70%
        equity interest, not inclusive of a $2.0 million contingent payment, was approximately $63.2 million of which $62.2 million was paid in cash and $1.0 million in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest is payable on November 30, 2023. As part of the transaction, the Company also agreed to the potential future purchase of a separate company under the same ownership
        that provides physical therapy and rehabilitation services to hospitals and other ancillary providers in a distinct market area. The current owners have the right to put this transaction to the Company in approximately five years, with such right having an initial fair value of $3.5 million value on December 31, 2021, as reflected on the Company&#x2019;s consolidated balance sheet in Other long-term liabilities. The value of this right will be adjusted in future periods, as appropriate, with any
        change in value reflected in the Company&#x2019;s consolidated statement of income. The Company does not currently possess any of the controlling interests in this separate company, does not control this company through contract or governance rights and
        currently does not exercise significant influence over this separate company. Due to these reasons, and based on current accounting guidance, the Company did not consolidate the separate company through the variable interest or voting interest
        model. On March 31, 2022, the fair value of this right was $2.9 million.&#160; The decrease was reflected in the consolidated statement of
        income in the line item - Gain on revaluation of put-right liability&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On September 30, 2021, the Company
          acquired a company that specializes in return-to-work and ergonomic services, among other offerings. The Company acquired the company&#x2019;s assets at a purchase price of approximately $3.3 million (which includes the obligation to pay an amount up to $0.6
          million in contingent payment consideration in conjunction with the acquisition if specified future operational objectives are met) and contributed those assets to the industrial injury services business. The initial purchase price, not inclusive
          of the $0.6 million contingent payment, was approximately $2.7 million, of which $2.4 million was paid in cash, and $0.3 million is in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on September 30, 2023.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On June 30, 2021, the Company
          acquired a 65% interest in an eight-clinic

















          physical therapy with the previous owners retaining 35%. The purchase price was approximately $10.3 million, of which $9.0 million was
          paid in cash, $1.0 million is payable based on the achievement of certain business criteria and $0.3 million is in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on June 30, 2023. Additionally, the Company has an obligation to pay an additional amount up to $0.8 million in contingent payment consideration in conjunction with the acquisition if specified future operational objectives are met. The Company
          recorded acquisition-date fair value of this contingent liability based on the likelihood of the contingent earn-out payment. The earn-out payment will subsequently be remeasured to fair value each reporting date.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; On March 31, 2021, the Company
          acquired a 70% interest in a five-clinic

















          physical therapy practice with the previous owners retaining 30%. When acquired, the practice was developing a sixth clinic which has
          been completed. The purchase price for the 70% interest was approximately $12.0 million, of which $11.7 million was paid in cash and $0.3 million in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest are payable on March 31, 2023.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;purchase price for the 2021 acquisitions has been preliminarily allocated as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Physical Therapy&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; IIPS*&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operations&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Cash paid, net of cash acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;63,193&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;23,544&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;86,737&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Seller notes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,250&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;800&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;2,050&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Contingent payments&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;2,520&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;837&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;3,357&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Other payable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Seller put right&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;3,522&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,000&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;4,522&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);"&gt;Total consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;70,485&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;26,181&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;96,666&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);"&gt;Total current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;5,588&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;2,041&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;7,629&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);"&gt;Total non-current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;12,620&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;7,153&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;19,773&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0);"&gt;Total liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(4,842&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(8,413&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(13,255&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 34.2pt; color: rgb(0, 0, 0);"&gt;Net tangible assets acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;13,366&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;14,147&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Customer and referral relationships&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;21,127&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;6,090&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;27,217&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Non-compete agreements&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;500&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;539&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,039&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Tradenames&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;5,141&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,762&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;6,903&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;58,257&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;28,965&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;87,222&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(27,906&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(11,956&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(39,862&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;70,485&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;26,181&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;96,666&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 9pt;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left;"&gt;*&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="vertical-align: top; width: auto;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: left;"&gt;Industrial injusry prevention services&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The results of operations of the acquired clinics have been included in the Company&#x2019;s consolidated financial statements since the date of their respective acquisition.&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; For the 2022 and 2021 acquisitions, a majority of total current assets primarily represents accounts receivable. Total non-current assets are fixed assets and equipment
      used in the practice.&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2021 were allocated to the fair value of the assets acquired, inclusive of
      identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill.&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;For the acquisitions in 2021, the values assigned to the customer and referral relationships and
          non-compete agreements are being amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period w&lt;/span&gt;as 13.8 years. For non-compete agreements, the weighted-average amortization period was 5.6 years&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; at the end of the year. The values assigned to tradenames are tested annually for impairment&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The consideration paid for each of the
          acquisitions was derived through arm&#x2019;s length negotiations. Funding for the cash portions was derived from proceeds from the Company&#x2019;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#x2019;s
          consolidated financial statements since their respective date of acquisition. Unaudited proforma consolidated financial information for the acquisitions in 2022 and 2021 have not been included, as the results, individually and in the aggregate,
          were not material to current operations.&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The purchase price plus the fair
          value of the non-controlling interest for the acquisitions in 2022 and those acquired after March 31, 2021 was allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. tradenames, referral
          relationships and non-compete agreements, and liabilities assumed based on the estimated fair values at the acquisition date, with the amount in excess of fair values being recorded as goodwill. The Company is in the process of completing its
          formal valuation analysis of the acquisitions, to identify and determine the fair value of tangible and identifiable intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the
          preliminary estimates used on March 31, 2022 based on additional information obtained and completion of the valuation of the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the
          valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in
          adjustments to goodwill. The Company does not expect the adjustments to be material.&#160; The purchase price allocation for the March 2021 Acquisition has been finalized. The Company continues to evaluate the components for the purchase price
          allocations for other acquisitions in 2021.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;For the acquisitions in 2022, the
          values assigned to the customer and referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period is
          12.0 years. For non-compete agreements, the weighted-average amortization period is 5.0 years. The values assigned to tradenames are tested annually for impairment.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The results of operations of the acquired clinics have been included in the Company&#x2019;s consolidated financial statements since the date of their respective acquisition.&lt;/div&gt;
</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_a115efd0848146e4ba7bc443f9ba206f"
      unitRef="U006">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20220331to20220331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_a4c073d8c04f4945a2da6916ef0ae025"
      unitRef="U007">6</us-gaap:NumberOfBusinessesAcquired>
    <usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder
      contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_670cd018cf1b464f8f78d3fab932ac47"
      unitRef="U006">0.30</usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_1c8aade6c957420d95f2a45f94b63520"
      unitRef="U006">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20220331to20220331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_d49d1ba2d89d4b29978d61f939f18695"
      unitRef="U002">11500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20220331to20220331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_3568316c4a66455bb6530fa9f1a9a08c"
      unitRef="U002">11200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_448018838b5848ad96ded878e051ff02"
      unitRef="U002">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20220331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="3"
      id="Fact_e8690790ba02411082ff0eda16e5859a"
      unitRef="U006">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_7ac473fca7d04a80b9312901e701edfb">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he purchase price for the 2022 acquisition has been preliminarily allocated as follows (in thousands)&lt;/span&gt;:
    &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,242&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller notes&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,542&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 12.6pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,743&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;247&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;659&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,539&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,946&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,542&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_f0d7720aa2df42138825f49588a81780"
      unitRef="U002">11242000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_8c55185d868843989c6a483f1e1a95a4"
      unitRef="U002">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_fa13f074a3a944e2920cbbd2d0f243fc"
      unitRef="U002">11542000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_c7f77ab6c25845649dadb8b0784b6e3d"
      unitRef="U002">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_d63525aa647f4c55ba6ebaee183cfca1"
      unitRef="U002">3743000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_9abfc500351c47cb8339e29276ef44e5"
      unitRef="U002">247000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_c6ec877f3c344b5ab010e22b8200968b"
      unitRef="U002">659000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_db85214a147844a4a8ab511749e94b18"
      unitRef="U002">11539000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_b299e717303b4de798fb1bbd1faafe06"
      unitRef="U002">4946000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20220331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_abf4d6f786164cd88eaec60e1a8b65c0"
      unitRef="U002">11542000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_6b741262309c4092862f13d3072bf80c"
      unitRef="U006">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_8bd4816ce8b943c580b1363ad7127fae"
      unitRef="U007">3</us-gaap:NumberOfBusinessesAcquired>
    <usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_56a9c0d058e143728566929b90b0a760"
      unitRef="U006">0.25</usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_0e9fbe9791cd48c5a97b5306da062dc5"
      unitRef="U006">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_cb522e7801c142d0b783b0663f79c559"
      unitRef="U002">3700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_3ee3e72a9b364c8fa3ac73bd6972dbe8"
      unitRef="U002">3500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_6fa9155613af44e7bb9d21d53af7db25"
      unitRef="U002">200000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_2a5fadf47b334078ad7cd0e73aca1281"
      unitRef="U006">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_e63df1c6c5a9407fb048cc607485247f"
      unitRef="U006">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20211130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_1d1f71efb12a4321a512897672d2b913"
      unitRef="U002">2000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_a36377f747064c0daf210dc4f1753555"
      unitRef="U002">63200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_ac6c3b53b3a5453b8b9293ece11878ee"
      unitRef="U002">62200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_5c75f33f435f4bf4b9c9097cf2aa9f42"
      unitRef="U002">1000000.0</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="4"
      id="Fact_aba7a0093c454903a5ae660f962fc591"
      unitRef="U006">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <usph:RemainingContractTerm
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      id="Fact_9c9b7cec4d11408aaf67de50fd272798">P5Y</usph:RemainingContractTerm>
    <us-gaap:BusinessCombinationAcquiredReceivablesFairValue
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_e79f113423f7433e99dce533ed478083"
      unitRef="U002">3500000</us-gaap:BusinessCombinationAcquiredReceivablesFairValue>
    <us-gaap:BusinessCombinationAcquiredReceivablesFairValue
      contextRef="c20220331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_374392475c5143ada4c3e2557aeb50d7"
      unitRef="U002">2900000</us-gaap:BusinessCombinationAcquiredReceivablesFairValue>
    <usph:BusinessCombinationConsiderationTransferredIncludesContingentConsideration
      contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_e53cc3545aa54d89ae7d5c003e42c98b"
      unitRef="U002">3300000</usph:BusinessCombinationConsiderationTransferredIncludesContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_3b6527f0503c4137a859432fca8d5605"
      unitRef="U002">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_af9e13cba8ac4dadb809d5ffe73dc893"
      unitRef="U002">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_d99776e9b4aa40568fc4a3a76a6e2b3a"
      unitRef="U002">2700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_7a9d94bbd8f14f079ffcab44740968e0"
      unitRef="U002">2400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_dc10607ba93949c69bb47e62934f36eb"
      unitRef="U002">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="4"
      id="Fact_3079907755a24ede81051d4a01da5750"
      unitRef="U006">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_9d836ef86bae40f699ef4fccdf55d1d8"
      unitRef="U006">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_8f6429b4bde74bd4867ba712b2ad544b"
      unitRef="U007">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="c20210630_OwnershipAxis_PreviousOwnersMember"
      decimals="2"
      id="Fact_92360e77d146444e8b2afaf111164cda"
      unitRef="U006">0.35</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_f8ab80bde5c34403a83c25740b75ad4e"
      unitRef="U002">10300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_7de28c3688ba45548925ec3acd120a29"
      unitRef="U002">9000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_5532efa6def84df2bb0f8ea7e686e031"
      unitRef="U002">1000000.0</usph:BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_41a1cadff62747359f007d30709ff004"
      unitRef="U002">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_e53129e16a8e4b6586972711ad14969d"
      unitRef="U006">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="-5"
      id="Fact_048b7efe5efa42de98a27eb7715e107e"
      unitRef="U002">800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_846a417c211a4a40b0f929e398c8648e"
      unitRef="U006">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_5b09bddb06c6493dad223caa749d92e1"
      unitRef="U007">5</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="c20210331_OwnershipAxis_PreviousOwnersMember"
      decimals="2"
      id="Fact_ef264cbe2a114c45a8548e06b2615f4a"
      unitRef="U006">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_90faeeaf784745eeab8d317e8a58a9bb"
      unitRef="U006">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_5de81c33154349ef906a59a6d34cac75"
      unitRef="U002">12000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_4ba4946e17464d2c8d407f2069545c93"
      unitRef="U002">11700000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_d70e3c4afe6643c183c9e59d954f0ef1"
      unitRef="U002">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_9a92e1551b3a41918aec168f305134ba"
      unitRef="U006">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20210101to20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_f746be88a8e04e8e93c2d060b41e7ffd"
      unitRef="U002">63193000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20210101to20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_fe3237deac24468a9f34aea8286ceae3"
      unitRef="U002">23544000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20210101to20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_511caba5bcb847858f5aab45c9c90611"
      unitRef="U002">86737000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_b78ab4e4488a42088efca947c8a4d214"
      unitRef="U002">1250000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_6a64f2906d304fc5a64a7b4c0c0bf998"
      unitRef="U002">800000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_1a672b4815694f848f2966df8536bc72"
      unitRef="U002">2050000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_7eeced21a3bf49b6b7cea15928eef383"
      unitRef="U002">2520000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_ef8b7ce4a3d8444d861d2c56066e2b78"
      unitRef="U002">837000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_926f4605d729443b817265db63b7d9a6"
      unitRef="U002">3357000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_693f99992f5a43bdbf253cd7cd64b971"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_dd6074522f76437cad1b83f29f616fcd"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_e0a6c467a49b40bfa983831dd36a46b2"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="c20210101to20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_fe86c41d0a8e40589aee50f8b258e5e3"
      unitRef="U002">3522000</us-gaap:ContractWithCustomerAssetPurchase>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="c20210101to20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_92c079d140cf456185bbf59572061dfc"
      unitRef="U002">1000000</us-gaap:ContractWithCustomerAssetPurchase>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="c20210101to20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_c9f04592065c45cb9818835e7efd017d"
      unitRef="U002">4522000</us-gaap:ContractWithCustomerAssetPurchase>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_c9ccddd842e04e09b614b6e5f3295a3a"
      unitRef="U002">70485000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_e8d719d5587f47d7b5d78bf5db497868"
      unitRef="U002">26181000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_0c8d7b23a66f4262a563c2571ba2454f"
      unitRef="U002">96666000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_539c6bc318bc4fb6a6708940d611942a"
      unitRef="U002">5588000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_aa82bd7f50e84ab6b76b06e6a8981ed9"
      unitRef="U002">2041000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_428c7912c2904afc9d6485831a3a05d5"
      unitRef="U002">7629000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_bccf762daaa94483b40081c81b457ca0"
      unitRef="U002">12620000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_7eae9d6980b445059949e2a2f9f2a3fa"
      unitRef="U002">7153000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_4f41357125a642c99e2078dfe6776686"
      unitRef="U002">19773000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_449b5876417b495586b69cf0134fddcd"
      unitRef="U002">-4842000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_bfb6d16e7bf54d328ab20819fad48274"
      unitRef="U002">-8413000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_786413d867704f8bbd355676d7518ee2"
      unitRef="U002">-13255000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_118b64f338854f27b3f6923be9878e34"
      unitRef="U002">13366000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_5d2283de0fe04ed1ab46b7d8ddf2aa1f"
      unitRef="U002">781000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_726e635bd44f415488ba19407822a115"
      unitRef="U002">14147000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_be7f633d83a2408a9ca0e8336e9f12af"
      unitRef="U002">21127000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_dfd94181fd764d42a03b0164da15411c"
      unitRef="U002">6090000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_5c5834f009c24be9a62e15dfddfdaddf"
      unitRef="U002">27217000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_34be6c8c2f1344f682ff5a6e05e0b232"
      unitRef="U002">500000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_b5ffed6cdd9644a7966d4b57528d6a8f"
      unitRef="U002">539000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_795666aea7114d6ba497e9db1ccc86dd"
      unitRef="U002">1039000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_435e62fbec4649a6b558725ff793bd1c"
      unitRef="U002">5141000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_b0008ccf470b416395fcd08f9e251caa"
      unitRef="U002">1762000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_3f36d2b081af4e2e8846e22fa5334dcb"
      unitRef="U002">6903000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_fa848cbb3cef4ce9ac4701987e6c1c17"
      unitRef="U002">58257000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_68dcac3e561642609ab16d422ee3b249"
      unitRef="U002">28965000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_2e6a64e0fff949f7ac2bd16ad8262bf5"
      unitRef="U002">87222000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_1712aa9b24ae465e9fb9172ba536bd78"
      unitRef="U002">27906000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_f113d8eef2534e36a630af89ad0d8534"
      unitRef="U002">11956000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_10268471b06a445c8ffce30c2a3968b5"
      unitRef="U002">39862000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20210331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_2ca63305da874a06a17209af72a504b1"
      unitRef="U002">70485000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20210331_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_93333fe9707d4a2597346655a0549249"
      unitRef="U002">26181000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20210331_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_ddf7fe5f09cb4058945759bba83a87ae"
      unitRef="U002">96666000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      id="Fact_e36a15dd7aec4206a1012b923b5f791a">P13Y9M18D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      id="Fact_f30bf5ba37fb477ca231b753b3980f5c">P5Y7M6D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      id="Fact_455554f96bd84fa5919530a8ffeeba67">P12Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      id="Fact_1b10f591bd3047ae96c2f3cbed4d180c">P5Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="c20220101to20220331"
      id="Text_b7d4bb0c518e49f9aef95c6bc728e713">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;3. REVENUE RECOGNITION&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Categories&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenues are recognized in the period in which services are rendered.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;N&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;et patient revenue consists of revenue for physical therapy and occupational therapy clinics that provide
          pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenue (patient revenue less estimated
          contractual adjustments) is recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied
          contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on
          previously rendered services. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of
          payor contracts and historical collection and write-off experience.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Management contract revenue, which is included in other revenue in the consolidated statements of net income, is derived from contractual arrangements whereby the Company
        manages a clinic owned by a third party. The Company does not have any ownership interest in these clinics. Typically, revenue is determined based on the number of visits conducted at the clinic and recognized at the point in time when services are
        performed. Costs, typically salaries for our employees, are recorded when incurred.&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenue from the industrial injury prevention services segment, which is also included in other revenue in the consolidated statements of net income, is derived from
        onsite services the Company provides to clients&#x2019; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the industrial injury prevention services segment is recognized when
        obligations under the terms of the contract are satisfied. Revenue is recognized at an amount equal to the consideration the Company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined
        and recognized based on the number of hours and respective rate for services provided in a given period.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Additionally, other revenue includes services the Company provides on-site, such as schools, for physical or occupational therapy services, and fees from athletic
        trainers. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance,
        revenue is recorded as a liability over the period of the agreement and recognized at the point in time, when the services are performed.&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company determines credit losses based on the specific agings and payor classifications at each clinic.
          The provision for credit losses is included in clinic operating cost in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and provision for
          credit losses, includes only those amounts the Company estimates to be collectibl&lt;/span&gt;e.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the revenue related to the various categories (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net patient revenue&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;109,538&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;99,254&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other revenue&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;872&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;546&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="margin: 0px 0px 0px 14.4pt; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: -7.2pt;"&gt;Physical therapy operations&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;110,410&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;99,800&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;Management contract revenue&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;2,226&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;2,559&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services revenue&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;19,068&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;10,009&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;131,704&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;112,368&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Medicare Reimbursement&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee
          Schedule (&#x201c;MPFS&#x201d;). For services provided in 2017 through 2019, a&lt;/span&gt;&#160;0.5% increase &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025&lt;/span&gt; no &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;adjustment is expected to be applied each year to the fee schedule payment rates, before applying the
          mandatory budget neutrality adjustment.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;In



          the 2020 MPFS Final Rule, The Centers for Medicare and Medicaid Services (&#x201c;CMS&#x201d;) revised coding, documentation guidelines, and increased the code values for office/outpatient evaluation and management (&#x201c;E/M&#x201d;) codes and cuts to other codes to
          maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office visit codes and made cuts to other specialty codes to maintain budget neutrality. As a result, CMS projected a 9% decrease in fee schedule payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the
          Consolidated Appropriations Act, 2021 and reimbursement for the codes applicable to&#160; physical/occupational therapy services provided by our clinics received an estimated 3.5% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020. &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="color: #1F497D; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;In the 2022 MPFS Final Rule published on November 2, 2021, there
              was to be an approximately 3.75% reduction to Medicare payments for physical/occupational therapy services. This was due to the
              expiration of the additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021.&lt;/span&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;However, this reduction was addressed in the Protecting Medicare and American Farmers from Sequester Cuts Act (&#x201c;2021 Act&#x201d;) signed into law on December 10, 2021.
              Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year of 2022 will be approximately 0.75%. The 2021 Act did not address the 15% reduction in Medicare payments for services
              performed by a physical or occupational therapist assistant, which began on January 1, 2022.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In addition, the Consolidated Appropriations Act, 2021 includes reductions in Medicare payment rates of approximately 3% in each of calendar years 2023 and 2024, unless regulatory or Congressional action results in modifications to such rates as has occurred in
              2021 and 2022.&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions
          over the next&lt;/span&gt;&#160;ten years and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments
        was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through
        fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through
        fiscal year 2027. T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he CARES Act suspended the &lt;/span&gt;2%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; payment reduction to Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the &lt;/span&gt;2%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; payment reduction until March 31, 2021. On April 14, 2021, additional legislation was
          enacted that waived the &lt;/span&gt;2%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; payment reduction for the remainder
          of calendar 2021&lt;/span&gt;. The 2021 Act, which was signed into law on December 10, 2021, included a three-month extension of the 2% sequester relief applied to all Medicare payments through March 31, 2022, followed by three months of 1% sequester relief through June 30, 2022.
        Sequester relief is scheduled to then end on June 30, 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice)
          paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#x201c;MIPS&#x201d;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health
          records. Therapists eligible to participate in MIPS include only those therapists who are enrolled with Medicare as private practice providers, and does not include therapists in facility-based providers, such as our clinics enrolled as certified
          rehabilitation agencies. Less than &lt;/span&gt;3%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; of the Company&#x2019;s therapist
          providers currently participate in MIPS. Under the MIPS requirements, a provider&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x2019;&lt;/span&gt;s performance is assessed according to established performance standards each year and then is
          used to determine an adjustment factor that is applied to the professional&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x2019;&lt;/span&gt;s payment for the corresponding payment year. The provider&#x2019;s MIPS performance in 2019 will determine
          the payment adjustment in 2021. For those therapist providers who actually participated in MIPS during 2019, the resulting average payment adjustment was an increase of &lt;/span&gt;1%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Under the Middle-Class Tax Relief and Job Creation Act of 2012 (&#x201c;MCTRA&#x201d;), since October 1, 2012, patients
          who met or exceede&lt;/span&gt;d $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to
        determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language
        Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual
        medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be
        determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#x201c;MEI&#x201d;) for 2028 and in subsequent
        years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;CMS adopted a multiple procedure payment reduction (&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x201c;&lt;/span&gt;MPPR&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x201d;&lt;/span&gt;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#x2014; occupational therapy, physical therapy and speech-language
        pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x201c;&lt;/span&gt;RVU&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x201d;&lt;/span&gt;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the
        practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. In 2013, the
        practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Medicare claims for outpatient therapy services furnished by therapist assistants on or after January 1, 2020 must include a modifier indicating the service was furnished
        by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022, in whole or part by a therapist assistant are paid at an amount equal to 85% of the payment amount otherwise applicable for the service.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare
            beneficiaries are complex and subject to interpretation. The Company believes that the Company is in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations
            involving allegations of potential wrongdoing that would have a material effect on the Company&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x2019;&lt;/span&gt;s financial statements as of March 31, 2022. Compliance with such laws and
            regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the three months ended March 31, 2022, and 2021,
            respectively, net patient revenue from Medicare was approximately $&lt;/span&gt;35.6&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; million and $&lt;/span&gt;26.6&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; million, respectively.&lt;br/&gt;
          &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, the Company may not continue to receive reimbursement rates from
        Medicare that sufficiently compensate us for the Company&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x2019;&lt;/span&gt;&lt;/span&gt;s services or, in some instances, cover the Company&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x2019;&lt;/span&gt;&lt;/span&gt;s operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a
        material adverse effect on the Company&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x2019;&lt;/span&gt;&lt;/span&gt;s revenue, financial condition and results of operations.
        Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect the Company&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#x2019;&lt;/span&gt;&lt;/span&gt;s business, financial condition and results of operations.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Contractual Allowances&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Contractual allowances result from the differences between the rates charged for services performed and
          expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple
          reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the
          Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable
          balances for each payor of the clinic. Based on the Company&#x2019;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with
          its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#x2019;s estimates. Payor terms are periodically revised
          necessitating continual review and assessment of the estimates made by management. The Company&#x2019;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy
          of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the
          difference between net revenues and corresponding cash collections has generally reflected a difference within approximately &lt;/span&gt;1.0%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; to &lt;/span&gt;1.5%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;
          of net revenue. Additionally, analysis of subsequent periods&#x2019; contractual write-offs on a payor basis reflects a difference within approximately &lt;/span&gt;1.0%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; to &lt;/span&gt;1.5%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;
          between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual
          allowance reserve estimate would not likely be more than &lt;/span&gt;1.0%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; to
        &lt;/span&gt;1.5%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; at March 31, 2022.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized when, or as, the performance obligation is satisfied. To determine the
        transaction price, the Company includes the effects of any variable consideration, such as the probability of collecting that amount. The Company applies established rates to the services provided, and adjusts for the terms of payor contracts, as
        applicable. These contracted amounts are different from the Company&#x2019;s established rates.&#160; The Company has established a &#x201c;contractual allowance&#x201d; for this difference. The allowance is based on the terms of payor contracts, historical and current
        reimbursement information and current experience with the clinic and partners. The Company&#x2019;s established rates less the contractual allowance is the revenue that is recognized in the period in which the service is rendered. This revenue is deemed
        the transaction price and stated as &#x201c;Net Patient Revenue&#x201d; on the Company&#x2019;s consolidated statements of income.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company&#x2019;s performance obligations are satisfied at a point in time. After the clinic has provided
        services and satisfied its obligation to the customer for the reimbursement rates stipulated in the payor contracts (i.e. the transaction price), the Company recognizes the revenue, net of contractual allowances, in the period in which the services
        are rendered. The Company recognizes the full amount of revenue and reports the contractual allowances as a contra (or offset) revenue account to report a net revenue number based on the expected collection&lt;/span&gt;s.&lt;/div&gt;
</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_38d5b8605db34c7a930ee41ad88143a3">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the revenue related to the various categories (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net patient revenue&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;109,538&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;99,254&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other revenue&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;872&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;546&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="margin: 0px 0px 0px 14.4pt; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: -7.2pt;"&gt;Physical therapy operations&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;110,410&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;99,800&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;Management contract revenue&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;2,226&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;2,559&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services revenue&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;19,068&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;10,009&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;131,704&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;112,368&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_944a6fc55c914954a59eb453357514e7"
      unitRef="U002">109538000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_e52d963677b24276a43e2c0f4a203369"
      unitRef="U002">99254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331_ProductOrServiceAxis_OtherRevenuesMember"
      decimals="-3"
      id="Fact_5f6d29d23d40424cbc2ac4d36387c4d9"
      unitRef="U002">872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331_ProductOrServiceAxis_OtherRevenuesMember"
      decimals="-3"
      id="Fact_a4226a5e1f854536a6255ee24806e152"
      unitRef="U002">546000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331_ProductOrServiceAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_6ea7536d89a54571920109779b1ac478"
      unitRef="U002">110410000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331_ProductOrServiceAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_b9e12a25cfca4fc6b95cb5a2b752f296"
      unitRef="U002">99800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331_ProductOrServiceAxis_ManagementContractRevenuesMember"
      decimals="-3"
      id="Fact_a64862fb867645cdad1f0a8cfefc88a8"
      unitRef="U002">2226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331_ProductOrServiceAxis_ManagementContractRevenuesMember"
      decimals="-3"
      id="Fact_b7d2c1bce6b74033a5f6099c30355d3e"
      unitRef="U002">2559000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_fd1c137cab674fe38c06178bdebe0ca1"
      unitRef="U002">19068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_a77f77665d904dd1bf401381fc977c5c"
      unitRef="U002">10009000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_49d1077decc445ae90dba1b3206d2eaf"
      unitRef="U002">131704000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_cc5b27b3243448edadd463748e3614f7"
      unitRef="U002">112368000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <usph:PercentageOfMedicarePaymentIncrease
      contextRef="c20220101to20220331_UnusualOrInfrequentItemAxis_FromTwoThousandSeventeenThroughTwoThousandNineteenMember"
      decimals="3"
      id="Fact_5adc9c18c3f845c8926fd3aebf04563f"
      unitRef="U006">0.005</usph:PercentageOfMedicarePaymentIncrease>
    <usph:PercentageOfMedicarePaymentIncrease
      contextRef="c20220101to20220331_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember"
      decimals="0"
      id="Fact_64335fe919d046feb31097cd1f281027"
      unitRef="U006">0</usph:PercentageOfMedicarePaymentIncrease>
    <usph:EstimatedPercentageOfDecreaseInPayment
      contextRef="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember"
      decimals="2"
      id="Fact_aab37428a1914276a610fd86584e40d8"
      unitRef="U006">0.09</usph:EstimatedPercentageOfDecreaseInPayment>
    <usph:EstimatedPercentageOfDecreaseInPayment
      contextRef="c20220101to20220331"
      decimals="3"
      id="Fact_ea607b2b9c144835ad18456efcf88963"
      unitRef="U006">0.035</usph:EstimatedPercentageOfDecreaseInPayment>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20211102_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember"
      decimals="4"
      id="Fact_f874043749e1403f80718b0c813f8839"
      unitRef="U006">0.0375</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20221231_StatementScenarioAxis_ScenarioForecastMember"
      decimals="4"
      id="Fact_38f68bf4ea964277847bc3874868ac9f"
      unitRef="U006">0.0075</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist
      contextRef="c20211231"
      decimals="2"
      id="Fact_466d430051d547d483121f29a6278b20"
      unitRef="U006">0.15</usph:PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20240930_StatementScenarioAxis_ScenarioForecastMember"
      decimals="2"
      id="Fact_25003f3fa7384eba9a4b26431698f66e"
      unitRef="U006">0.03</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions
      contextRef="c20220101to20220331"
      id="Fact_1542cfe506844472bf6f998a1c3bae3f">P10Y</usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions>
    <usph:AmountOfReductionsInFederalSpending
      contextRef="c20220101to20220331"
      decimals="-11"
      id="Fact_daf68a34de3b445f9e2644c2d93d4557"
      unitRef="U002">1200000000000</usph:AmountOfReductionsInFederalSpending>
    <usph:ReductionInMedicareSpendingPercentage
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_72e431cd259d4d5e9f5d9249f3d54725"
      unitRef="U006">0.02</usph:ReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20130401"
      decimals="2"
      id="Fact_db67958fa98345e8923a4cbc5a036b17"
      unitRef="U006">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20151102"
      decimals="2"
      id="Fact_a5119162a1214184aa5e3c09c720feed"
      unitRef="U006">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20180209"
      decimals="2"
      id="Fact_75e19e87e1f24d4bbec8cc2bbf249b92"
      unitRef="U006">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20220331"
      decimals="2"
      id="Fact_9eed8121e4fc4c05857fc5ef1f82a956"
      unitRef="U006">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20220331"
      decimals="2"
      id="Fact_3ff65cd0885c4c7588e326d766f918e2"
      unitRef="U006">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation
      contextRef="c20210401to20210414"
      decimals="2"
      id="Fact_84358f3bde3d4cf889e0090c5014b231"
      unitRef="U006">0.02</usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation>
    <usph:ExtensionTermForSequesterReliefAppliedToAllMedicarePayments
      contextRef="c20220101to20220331"
      id="Fact_ed2af09450254eabb897aefd273da416">P3M</usph:ExtensionTermForSequesterReliefAppliedToAllMedicarePayments>
    <usph:PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne
      contextRef="c20211210"
      decimals="2"
      id="Fact_31f98d64b61348d7b0d31de12b445bd5"
      unitRef="U006">0.02</usph:PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne>
    <usph:ExtensionTermForSequesterReliefAppliedToAllMedicarePayments
      contextRef="c20220101to20220331"
      id="Fact_9ac3866f6fd5418db2ed25e963ee3c57">P3M</usph:ExtensionTermForSequesterReliefAppliedToAllMedicarePayments>
    <usph:PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo
      contextRef="c20211210"
      decimals="2"
      id="Fact_c1cb936eb668496abb08e79a1f003551"
      unitRef="U006">0.01</usph:PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo>
    <usph:PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem
      contextRef="c20220101to20220331_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_7766f60694f44444b8407aa71ec09cb3"
      unitRef="U006">0.03</usph:PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem>
    <usph:PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_17323c14d0e64c7187e9c2602858bf73"
      unitRef="U006">0.01</usph:PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_d373f0838c994207bef7fce4deb8c39a"
      unitRef="U002">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_fe9ccfc2ac9e4839b9f8403cbb4a1379"
      unitRef="U002">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_7149a2692aa142ccbd9f557873bdfdd0"
      unitRef="U002">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_7380215146844663a753d889e8da2677"
      unitRef="U002">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_873fd840dd01467395b22361d83f9fdf"
      unitRef="U002">3000</usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_44ae03d50d6d432989c7734e0e69e2c6"
      unitRef="U006">1</usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit>
    <usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_3c637ae8b48e4fb3b59d109ac6e87b57"
      unitRef="U006">0.50</usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings>
    <usph:PercentageOfPaymentForOutpatientTherapyServices
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_7a0e096ec9bd44cf98019491c0401660"
      unitRef="U006">0.85</usph:PercentageOfPaymentForOutpatientTherapyServices>
    <usph:NetRevenueFromMedicare
      contextRef="c20220101to20220331"
      decimals="-5"
      id="Fact_0ca8bec2cbe4420fbcac4c753fdb302c"
      unitRef="U002">35600000</usph:NetRevenueFromMedicare>
    <usph:NetRevenueFromMedicare
      contextRef="c20210101to20210331"
      decimals="-5"
      id="Fact_5f18ae43615e44569bedc8f70c55fa4a"
      unitRef="U002">26600000</usph:NetRevenueFromMedicare>
    <usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
      contextRef="c20220101to20220331_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_f9378fd6f1504efd8d09b3ccab88f162"
      unitRef="U006">0.010</usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues>
    <usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
      contextRef="c20220101to20220331_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_1ba9c05cfcac4bbf8ad3e1e675e6aee5"
      unitRef="U006">0.015</usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues>
    <usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
      contextRef="c20220101to20220331_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_c0afc92409aa4500bfd0c1bd1302ad8c"
      unitRef="U006">0.010</usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage>
    <usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
      contextRef="c20220101to20220331_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_65c5c7a6095f46d7900f06cbcb4114cd"
      unitRef="U006">0.015</usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage>
    <usph:MaximumContractualAllowanceReserveEstimate
      contextRef="c20220101to20220331_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_bac0b404456c48799077910000f73492"
      unitRef="U006">0.010</usph:MaximumContractualAllowanceReserveEstimate>
    <usph:MaximumContractualAllowanceReserveEstimate
      contextRef="c20220101to20220331_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_73a23146ed684ea383b36800485f42c2"
      unitRef="U006">0.015</usph:MaximumContractualAllowanceReserveEstimate>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20220101to20220331"
      id="Text_70531d37d40a4778820f419c06f6580b">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;4. EARNINGS PER SHARE&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In accordance with current accounting guidance, the revaluation of redeemable non-controlling interest (see Note 5 &#x2013; Redeemable Non-Controlling Interest), net of tax,
      charged directly to retained earnings is included in the earnings per basic and diluted share calculation. The following table provides a detail of the basic and diluted earnings per share computation (in thousands, except per share data).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Computation of earnings per share - USPH shareholders:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net income attributable to USPH shareholders&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;8,799&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;8,173&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(Charges) credit to retained earnings:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revaluation of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(153&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(7,270&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax effect at statutory rate (federal and state) of &lt;span style="text-indent: 0pt;"&gt;25.55&lt;/span&gt;%&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;39&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;1,857&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;8,685&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;2,760&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Earnings per share (basic and diluted)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;0.67&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;0.21&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Shares used in computation:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basic and diluted earnings per share - weighted-average shares&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;12,937&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;12,870&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_385de745272441058c476cf37a12991e">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In accordance with current accounting guidance, the revaluation of redeemable non-controlling interest (see Note 5 &#x2013; Redeemable Non-Controlling Interest), net of tax,
      charged directly to retained earnings is included in the earnings per basic and diluted share calculation. The following table provides a detail of the basic and diluted earnings per share computation (in thousands, except per share data).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Computation of earnings per share - USPH shareholders:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net income attributable to USPH shareholders&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;8,799&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;8,173&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(Charges) credit to retained earnings:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revaluation of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(153&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(7,270&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax effect at statutory rate (federal and state) of &lt;span style="text-indent: 0pt;"&gt;25.55&lt;/span&gt;%&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;39&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;1,857&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;8,685&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;2,760&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Earnings per share (basic and diluted)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;0.67&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;0.21&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Shares used in computation:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basic and diluted earnings per share - weighted-average shares&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;12,937&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;12,870&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_88c8ff299cca46d3bfd244cb4372197d"
      unitRef="U002">8799000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_3fb82b94ad4a4c89b300e39e637b3eec"
      unitRef="U002">8173000</us-gaap:NetIncomeLoss>
    <usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_f34e09b5df934e7b9bed0845da3ba256"
      unitRef="U002">-153000</usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests>
    <usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_b6b3101d1e224478a3110f5829607fa6"
      unitRef="U002">-7270000</usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20220101to20220331"
      decimals="4"
      id="Fact_2c9be130669c44af881008f0d3166189"
      unitRef="U006">0.2555</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20220101to20220331"
      decimals="4"
      id="Fact_60f2d83d944d408c8c38aa4d7c990690"
      unitRef="U006">0.2555</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_754e68b88e7f4424a3d0511bdd6eca6f"
      unitRef="U002">-39000</usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_be6ce6a5e3e9404a876d846b028ea049"
      unitRef="U002">-1857000</usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_19f040b07af740e9902763a75f570c12"
      unitRef="U002">8685000</usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests>
    <usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_2ba3963adf004114ae324f643abd1d6c"
      unitRef="U002">2760000</usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_93b9427b6e4d4bc7be354f60d554fd1d"
      unitRef="U003">0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_687869a89b644f62902550f56dd52cb1"
      unitRef="U003">0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_526ba8515f2c4deda2d9456bd4c608e5"
      unitRef="U003">0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_1c0bd630ab684b97a1b7ca28314cddbd"
      unitRef="U003">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_844ea1299444436fbd084d3f53609df5"
      unitRef="U001">12937000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_56eda95a607c400388238a62f0b66961"
      unitRef="U001">12937000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_65a27af7b1d8466eb0de76666b60a9fe"
      unitRef="U001">12870000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_3c30669018b14ffc9fe1afade8ec50ff"
      unitRef="U001">12870000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <usph:RedeemableNonControllingInterestTextBlock
      contextRef="c20220101to20220331"
      id="Text_62c985dc6dde4f79b07cef0a23104a3b">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;5. REDEEMABLE NON-CONTROLLING INTEREST&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Since October 2017, when the Company acquires a majority interest (the &#x201c;Acquisition&#x201d;) in a physical therapy clinic business (referred to as &#x201c;Therapy Practice&#x201d;), these
      Acquisitions occur in a series of steps which are described below.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#x201c;Seller Entity&#x201d;). The Seller Entity is owned by one or more individuals (the &#x201c;Selling
              Shareholders&#x201d;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&#x201c;NewCo&#x201d;), in exchange for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller
              Entity.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company enters into an agreement (the &#x201c;Purchase Agreement&#x201d;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited partnership interest and in &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;all&lt;/span&gt;&lt;/span&gt; cases 100% of the general partnership interest in
              NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in
              the form of cash at closing and a small, two-year note in lieu of an escrow (the &#x201c;Purchase Price&#x201d;). The Purchase Agreement does
              not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Seller Entity also execute a partnership agreement (the &#x201c;Partnership Agreement&#x201d;) for NewCo that sets forth the rights and obligations of the limited and general
              partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo
              (&#x201c;Seller Entity Interest&#x201d;).&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#x201c;Employment Agreement&#x201d;) with NewCo with an initial term that ranges from &lt;span style="-sec-ix-hidden:Fact_366532ba69814de1ad518109bf840391"&gt;three&lt;/span&gt; to five years (the
              &#x201c;Employment Term&#x201d;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment Term. As
              a result, a Selling Shareholder becomes an employee (&#x201c;Employed Selling Shareholder&#x201d;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any
              time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity
              as of the closing of the Acquisition.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;7.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other
              employees in similar capacities within NewCo, the Company and the industry.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the
              &#x201c;Non-Compete Agreement&#x201d;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &#x201c;Non-Compete Term&#x201d;). A Non-Compete Agreement is executed with the Selling Shareholders in all
              cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;9.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Term commences as of the date of the Acquisition and&#160; expires on the &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;later&lt;/span&gt;&lt;/span&gt; of :&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;Two years after the date an Employed Selling Shareholders&#x2019; employment
              is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_384e0904d90e46f581ffc1a642cdf595"&gt;Five&lt;/span&gt; to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Agreement applies to a restricted region which is defined as a defined mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to
              engage in competing businesses or activities outside the defined mileage (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the
              competing business or activities outside the defined mileage.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#x201c;Call Right&#x201d;) or at the option of
      the Seller Entity (the &#x201c;Put Right&#x201d;) as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;Put Right&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment is terminated under certain circumstances prior to a specified date (the &#x201c;Specified Date&#x201d;), the Seller Entity thereafter may
              have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder is not employed by NewCo as of the Specified Date and the Company has not exercised its Call Right with respect to the Terminated Selling
              Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s
              Interest at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;c)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment with NewCo is terminated for any reason on or after the Specified Date, the Seller Entity shall have the Put Right, and upon
              the exercise of the Put Right, the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest shall be redeemed by the Company at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;Call Right&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;If any Selling Shareholder&#x2019;s employment by NewCo is terminated prior to the Specified Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the
              Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest, in each case at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment with NewCo is terminated for any reason on or after Specified Date, the Company shall have the Call Right, and upon the
              exercise of the Call Right, the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest shall be redeemed by the Company at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#x2019;s trailing twelve months of earnings before interest, taxes,
              depreciation, amortization, and the Company&#x2019;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#x201c;Redemption Amount&#x201d;). NewCo&#x2019;s earnings are distributed monthly based on available cash within
              NewCo.&#x37e; Therefore, the undistributed earnings amount is small, if any.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Purchase Price for the initial equity interest purchased by the Company &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;is, in almost all cases, also&lt;/span&gt; based
              on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right do not have an expiration date, and the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity unless
              either the Put Right or the Call Right is exercised.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire
              ownership interest in the Seller Entity at the closing of the Acquisition.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;ProgressiveHealth Acquisition&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;On November 30, 2021, the Company acquired a majority interest in ProgressiveHealth Companies, LLC (&#x201c;Progressive&#x201d;), which owns a majority interest in
        certain subsidiaries (&#x201c;Progressive Subsidiaries&#x201d;) that operate in the industrial injury prevention and therapy services businesses.&#160; The Progressive transaction was completed in a series of steps which are described below.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Prior to the acquisition, the Progressive Subsidiaries were owned by a legal entity (&#x201c;Progressive Parent&#x201d;) controlled by its individual
                  owners (the &#x201c;Selling Shareholders&#x201d;), who work in and manage the Progressive business.&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In conjunction with the acquisition, the Selling Shareholders caused the Progressive Parent to transfer its ownership of the Progressive
                  Subsidiaries into a newly-formed limited liability company (&#x201c;NewCo&#x201d;), in exchange for one hundred percent (100%) of the
                  membership interests in NewCo. Therefore, in this step, NewCo became wholly-owned by the Selling Shareholders.&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company entered into an agreement (the &#x201c;Purchase Agreement&#x201d;) to acquire from the Selling Shareholders a majority of the membership
                      interest in NewCo. The consideration for the acquisition is primarily payable in the form of cash at closing, a relatively small portion paid in cash after the closing contingent on certain performance criteria, and a small note in
                      lieu of an escrow (the &#x201c;Purchase Price&#x201d;).&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Selling Shareholders also executed an operating agreement (the &#x201c;Operating Agreement&#x201d;) for NewCo that sets forth the
                      rights and obligations of the members of NewCo.&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;As noted above, the Company did not purchase 100% of the membership interests in NewCo and the Selling Shareholders retained a portion of the membership interest in NewCo (&#x201c;Selling Shareholders&#x2019; Interest&#x201d;).&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                        &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Selling Shareholders executed a non-compete agreement (the &#x201c;Non-Compete Agreement&#x201d;) which restricts the Selling
                          Shareholders from competing for a specified period of time (the &#x201c;Non-Compete Term&#x201d;).&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;7.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Term commences as of the date of the Acquisition and expires on the &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;later&lt;/span&gt;&lt;/span&gt; of:&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;
      &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Two years after the date a
                  Selling Shareholder no longer is involved in the management of NewCo or&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seven years from the
                      date of the acquisition.&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                        &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                          &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Agreement applies to the entire United States.&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                    &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;9.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                      &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                        &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                          &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right do not have an expiration date.&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
            &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Operating Agreement contains provisions for the redemption of the Selling Shareholder&#x2019;s Interest, either at the option of the Company (the &#x201c;Call
        Right&#x201d;) or at the option of the Selling Shareholder (the &#x201c;Put Right&#x201d;) as follows:&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Put Right&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Each of the Selling Shareholders has the right to sell 30% of their respective residual interests on each of the 4th and 5th anniversaries of the acquisition closing, and then 10% on each of the 6th and 7th anniversaries&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                        &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder terminates his management relationship with NewCo for any reason on or after the seventh
                          anniversary of the Closing Date, the Selling Shareholder has the Put Right, and upon the exercise of the Put Right, the Selling Shareholder&#x2019;s Interest shall be redeemed by the Company at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                        &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                          &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Call Right&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                        &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;If any Selling Shareholder&#x2019;s ceases to perform management services on behalf of NewCo, the Company thereafter shall have an
                          irrevocable right to purchase from such Selling Shareholder his Interest, in each case at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#x2019;s trailing
                      twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#x2019;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#x201c;Redemption Amount&#x201d;). NewCo&#x2019;s earnings
                      are distributed monthly based on available cash within NewCo&#x37e; therefore, the undistributed earnings amount is small, if any.&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                        &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the
                          trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                    &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                      &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                        &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                          &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right do not have an expiration date.&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
            &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Neither the Operating Agreement nor the Non-Compete Agreement contain any provision to escrow or &#x201c;claw back&#x201d; the equity interest in NewCo held by the
        Selling Shareholders, in the event of a breach of the operating agreement or non-compete terms, or the management services agreement pursuant to which the Selling Shareholders perform services on behalf of NewCo. The Company&#x2019;s only recourse against
        the Selling Shareholder for breach of any of these agreements is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with a Selling Shareholder that would result in a forfeiture of the
        equity interest in NewCo held by a Selling Shareholder.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;An Employed Selling Shareholder&#x2019;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#x2019;s purchase of its partnership
      interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#x201c;claw back&#x201d; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in
      NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#x201c;cause&#x201d; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her
      full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#x2019;s only recourse against the Employed Selling Shareholder for breach of either the Employment
      Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest
      held in the Seller Entity or of the Seller Entity Interest.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;For the &lt;/span&gt;dates indicated,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interest (in&lt;/span&gt; thousand&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;s):&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;155,262&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;132,340&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating results allocated to redeemable non-controlling interest partners&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;2,557&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;11,358&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Distributions to redeemable non-controlling interest partners&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(2,403&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(11,359&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Changes in the fair value of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;153&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;13,011&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Purchases of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(2,457&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(30,204&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;4,946&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;39,862&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;982&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notes receivable related to sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;(914&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;(50&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;186&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;"&gt;Other &lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;158,008&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;155,262&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interest (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has lapsed but holder&#x2019;s employment has not terminated&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;92,320&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;80,781&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has not lapsed and holder&#x2019;s employment has not terminated&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;65,688&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;74,481&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder&#x2019;s employment has terminated and contractual time period has expired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder&#x2019;s employment has terminated and contractual time period has not expired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;158,008&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;155,262&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:RedeemableNonControllingInterestTextBlock>
    <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed
      contextRef="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_e8afd9fbe5154a99b166cf868a8e771b"
      unitRef="U006">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
    <usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_83319094de174428b509aab24b533287"
      unitRef="U006">0.50</usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired>
    <usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_4c9dc58972bc4cbe8faf71cec4856adf"
      unitRef="U006">0.90</usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired>
    <usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired
      contextRef="c20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_f2c94b87e4464431939f5f6a058eb51a"
      unitRef="U006">1</usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired>
    <usph:BusinessAcquisitionConsiderationPayableTermOfNote
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_400a93376b744c7982c3a25f04a1064b">P2Y</usph:BusinessAcquisitionConsiderationPayableTermOfNote>
    <usph:TermOfEmploymentAgreement
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"
      id="Fact_a021fe64f29a4c089f384d75ef51f808">P5Y</usph:TermOfEmploymentAgreement>
    <usph:EmploymentAgreementRenewalTerm
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_178cb875db2b45578176325ade91a5c9">P1Y</usph:EmploymentAgreementRenewalTerm>
    <usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_f3a24344e7f54aada2e7f3d01bf54062">P2Y</usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder>
    <usph:NonCompeteAgreementBasicTerm
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"
      id="Fact_e5cf8202a2284a8ba7fe3642b4a4e4c2">P6Y</usph:NonCompeteAgreementBasicTerm>
    <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed
      contextRef="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_d071f838c8ec49da9870e97ef55e158c"
      unitRef="U006">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
    <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed
      contextRef="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_6210ca62212b4a4193ffc4b161c11a4a"
      unitRef="U006">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
    <usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_0d1a2b4ea2c34fba95560f40ec975f2a">P2Y</usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder>
    <usph:NonCompeteAgreementBasicTerm
      contextRef="c20220101to20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_c82dda85aad84d9dbe7c77fb096c99c7">P7Y</usph:NonCompeteAgreementBasicTerm>
    <usph:PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries
      contextRef="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_e532e64a083144d3889514a11dd9562c"
      unitRef="U006">0.30</usph:PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries>
    <usph:PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries
      contextRef="c20220331_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_b6d203d8a49446cf99230da791d63a09"
      unitRef="U006">0.10</usph:PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_badb20328c804d2d86241547eb1f9ccc">
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;For the &lt;/span&gt;dates indicated,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interest (in&lt;/span&gt; thousand&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;s):&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;155,262&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;132,340&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating results allocated to redeemable non-controlling interest partners&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;2,557&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;11,358&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Distributions to redeemable non-controlling interest partners&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(2,403&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(11,359&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Changes in the fair value of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;153&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;13,011&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Purchases of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(2,457&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(30,204&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;4,946&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;39,862&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;982&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notes receivable related to sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;(914&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;(50&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;186&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="margin: 0px 0px 0px 14.4pt; text-indent: -7.2pt;"&gt;Other &lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(255, 255, 255);" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;158,008&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;155,262&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_504685e45b4042aebb5f464a047c74b8"
      unitRef="U002">155262000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_df1ad10813d94f2684389e57850f2014"
      unitRef="U002">132340000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ac6d131f02c04df5b2cac3d472a6858e"
      unitRef="U002">2557000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ba6e6ceda47a4b179af9a823210b0926"
      unitRef="U002">11358000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_fca9a91883f64043a6968215c112577e"
      unitRef="U002">2403000</usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests>
    <usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ce659acb12574f2b9c560bb665cfc7ac"
      unitRef="U002">11359000</usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_31e465f6cada40e2b2cbe51e78f69018"
      unitRef="U002">-153000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_4dfcca2e33954af5a796133213f419eb"
      unitRef="U002">-13011000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_744434cc72fc41ed9fb8d9c6e7679689"
      unitRef="U002">-2457000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_0f125f47577f40a2a41a5f016fc825f4"
      unitRef="U002">-30204000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_2eab67dfb82c4cddb0ec69c1d74527f0"
      unitRef="U002">4946000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_d1494a4bd3fe48aeb8790b3bc03b5a75"
      unitRef="U002">39862000</us-gaap:PaymentsToMinorityShareholders>
    <usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_7daaa576807248ffb2f4b5e7dbfc4a3d"
      unitRef="U002">0</usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_5fd498d92e0144b68d95194ffeed2127"
      unitRef="U002">982000</usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_650ced3c9ecd44cd877cc7c8fb05b54d"
      unitRef="U002">0</usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_b7238e50df014710b5ba6106aeddba93"
      unitRef="U002">-914000</usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_127229c3e4c047599b1530a25bb5252f"
      unitRef="U002">-50000</usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_f0c4f238e80b4fb2aea0283cc75ee8e9"
      unitRef="U002">186000</usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_cf114e44558c48cc896c625f58cdbb53"
      unitRef="U002">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ee0c9c2aaa7042de87a088e618d1487c"
      unitRef="U002">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_dc44395e8ac94ac7b4a6efe0727d268d"
      unitRef="U002">158008000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_9bbc3ca01aec4870b24f7917bd29a08d"
      unitRef="U002">155262000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_856c5088ad344a39808d5b7a1571f58c">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interest (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has lapsed but holder&#x2019;s employment has not terminated&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;92,320&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;80,781&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has not lapsed and holder&#x2019;s employment has not terminated&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;65,688&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;74,481&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder&#x2019;s employment has terminated and contractual time period has expired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder&#x2019;s employment has terminated and contractual time period has not expired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;158,008&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;155,262&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock>
    <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated
      contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_6a54f118ea5e4fd6bc87f810b57639aa"
      unitRef="U002">92320000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
    <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_b850622001634555b7c2419056d4132f"
      unitRef="U002">80781000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
    <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated
      contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_64335711bec247c2a1ea543ba8525592"
      unitRef="U002">65688000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
    <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_560cbc1309e649779d5f6250353d75bb"
      unitRef="U002">74481000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired
      contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_f695bbf7ef2445e1ba4d4846bda9157b"
      unitRef="U002">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_aee06ff4e4d5407b842080e0c39aa498"
      unitRef="U002">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired
      contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_095b2f63dc034a03900415da5bb08982"
      unitRef="U002">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_6149b414f97b4fbd9d1debf637f11833"
      unitRef="U002">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20220331_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_5ef3dd494a4b43fa9ab67972adfa94cb"
      unitRef="U002">158008000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_474f3e29d28a4b84a84b41d2aed24e6e"
      unitRef="U002">155262000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_1c7b351e10ac4855bca068fa24aa2647">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;6. GOODWILL&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The changes in the carrying amount of goodwill consisted of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"/&gt;

    &lt;td colspan="1" style="white-space: nowrap; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;434,679&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;345,646&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,539&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;89,746&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill adjustments for purchase price allocation of businesses acquired in prior year&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,526&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(713&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;443,692&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;434,679&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="c20220101to20220331"
      id="Text_f56f94313f8a4523a5290f021dc75535">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The changes in the carrying amount of goodwill consisted of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"/&gt;

    &lt;td colspan="1" style="white-space: nowrap; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;434,679&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;345,646&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,539&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;89,746&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill adjustments for purchase price allocation of businesses acquired in prior year&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,526&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(713&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;443,692&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;434,679&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4fa7a2d89a9e48bda36dc9ca8dba4702"
      unitRef="U002">434679000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f20bd2a4818644858c387dde31056f3e"
      unitRef="U002">345646000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_89d41249fada469181691c5b91b4126a"
      unitRef="U002">11539000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_67552a3a265d4952b42c019027e1f139"
      unitRef="U002">89746000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_dce49278cc964c4ea42563fb862ad07a"
      unitRef="U002">-2526000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_8ea4b0d55ea44259b5f1dd9fa125eba6"
      unitRef="U002">-713000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="c20220331"
      decimals="-3"
      id="Fact_0c6a52eb0a764563b0cc6284c546c6a9"
      unitRef="U002">443692000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_dd61d8c7c74041ccafab85e92b3ad5fc"
      unitRef="U002">434679000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_e77b3293d2ec4bdf8263dcf6c7c5611e">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;7. INTANGIBLE ASSETS, NET&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Intangible assets, net as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,456&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;38,790&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships, net of accumulated amortization of $&lt;span style="text-indent: 0pt;"&gt;19,959&lt;/span&gt; and $&lt;span style="text-indent: 0pt;"&gt;17,762&lt;/span&gt;, respectively&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;50,076&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;45,643&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements, net of accumulated amortization of $&lt;span style="text-indent: 0pt;"&gt;6,597&lt;/span&gt; and $&lt;span style="text-indent: 0pt;"&gt;6,450&lt;/span&gt;, respectively&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,014&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,949&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;91,546&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,382&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. The value assigned to tradenames has an indefinite life and is tested
      at least annually for impairment using the relief from royalty method in conjunction with the Company&#x2019;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives
      which range from &lt;span style="-sec-ix-hidden:Fact_c5b38f9523db408b8ed6c53ba95605c1"&gt;six&lt;/span&gt; to fourteen years.
      Non-compete agreements are amortized over the respective term of the agreements which range from &lt;span style="-sec-ix-hidden:Fact_c992237d92cd47c78ded2f3204d6bdd7"&gt;five&lt;/span&gt; to six years.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the amount of amortization expense recorded for intangible assets for the three months ended March 31, 2022 and 2021 (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;2,050&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;783&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;147&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;39&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;2,197&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;822&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Based on the balance of referral relationships and non-compete agreements as of
        March &lt;/span&gt;31,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; the expected amount to be amortized in &lt;/span&gt;2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; and thereafter by year is as follows (in&lt;/span&gt; thousand&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;s):&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td colspan="4" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Customer and Referral Relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="5" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Non-Compete Agreements&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 37%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 37%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2022&lt;/span&gt;
              (excluding the three months ended March 31, 2022)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,851&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2022&lt;/span&gt;
              (excluding the three months ended March 31, 2022)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;413&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,200&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;494&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,036&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;438&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2025&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,892&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;371&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2026&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,424&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;2026&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;243&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,673&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;55&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_28c62c2551524dad83b3d8751d1a1f30">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Intangible assets, net as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,456&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;38,790&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships, net of accumulated amortization of $&lt;span style="text-indent: 0pt;"&gt;19,959&lt;/span&gt; and $&lt;span style="text-indent: 0pt;"&gt;17,762&lt;/span&gt;, respectively&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;50,076&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;45,643&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements, net of accumulated amortization of $&lt;span style="text-indent: 0pt;"&gt;6,597&lt;/span&gt; and $&lt;span style="text-indent: 0pt;"&gt;6,450&lt;/span&gt;, respectively&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,014&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,949&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;91,546&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,382&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      decimals="-3"
      id="Fact_6afc9455832645c3ab6c5438c8361c7a"
      unitRef="U002">39456000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      decimals="-3"
      id="Fact_72908122b777440ebe7cb02d8296996f"
      unitRef="U002">38790000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_adcb3c6838f149d58673ec5381700bf8"
      unitRef="U002">19959000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_48187abdbea94617b359590304700301"
      unitRef="U002">17762000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_ebc9fa8339d44902b0e99a4ea1e1273d"
      unitRef="U002">50076000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_57bedffed51c434795d23f620083dbd1"
      unitRef="U002">45643000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_45061e9e2b8a4363a1a14c62853d2fc2"
      unitRef="U002">6597000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_a29ec45089be49499a42d474797669dc"
      unitRef="U002">6450000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_2b2ab3ad31c5478080dac5fd21e40e22"
      unitRef="U002">2014000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_fe3e0a66206843bf974fb14285a70ecd"
      unitRef="U002">1949000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20220331"
      decimals="-3"
      id="Fact_cdbf4919498544b494a09e830164ed5f"
      unitRef="U002">91546000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0d5fdde954bc4e129d478746542e6c51"
      unitRef="U002">86382000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MaximumMember"
      id="Fact_e644ab8829a842be9cbf3727624efcab">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember"
      id="Fact_b5bae1175a5a453a92c55ce74c1dd54c">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_09f45d7a4afa4c009ff26d9f4f78bfe8">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the amount of amortization expense recorded for intangible assets for the three months ended March 31, 2022 and 2021 (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;2,050&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;783&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;147&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;39&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;2,197&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;822&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_8bf293cde0154b81acf972321c5539b1"
      unitRef="U002">2050000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20210101to20210331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_b46d8ff084b04f78807429f4c8f55042"
      unitRef="U002">783000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_cbfb3ffd75734bc2b64c73475deb2adc"
      unitRef="U002">147000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20210101to20210331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_b136d46ba85c467398f5365e1a4521a8"
      unitRef="U002">39000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a63bbde76e7f45d894b061d7f419caff"
      unitRef="U002">2197000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_65751e0fcbf6436eb58aabc7aeae563b"
      unitRef="U002">822000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_21f7996076ca4fd897674425aa02d7b3">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Based on the balance of referral relationships and non-compete agreements as of
        March &lt;/span&gt;31,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; the expected amount to be amortized in &lt;/span&gt;2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; and thereafter by year is as follows (in&lt;/span&gt; thousand&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;s):&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td colspan="4" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Customer and Referral Relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="5" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Non-Compete Agreements&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 37%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 37%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2022&lt;/span&gt;
              (excluding the three months ended March 31, 2022)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,851&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2022&lt;/span&gt;
              (excluding the three months ended March 31, 2022)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;413&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,200&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;494&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,036&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;438&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2025&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,892&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(255, 255, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;371&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(255, 255, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2026&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,424&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 37%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;2026&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;243&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,673&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 37%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(255, 255, 255); width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;55&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(255, 255, 255); width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_db620b2519494b63aa85f081bcb66faf"
      unitRef="U002">3851000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_881e5d0b09a84e318e3d7ee2461337b1"
      unitRef="U002">413000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_353099f228614a9487156d0d57bb14e8"
      unitRef="U002">5200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_08000d320bdd4468b11c6a4961884078"
      unitRef="U002">494000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_f099483855644cd497d2661c2e566709"
      unitRef="U002">5036000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_f6c01f6d23bc413f80e5249b12c2ede8"
      unitRef="U002">438000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_b5008df15340402f807cec18081d3d99"
      unitRef="U002">4892000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_4155e0b2775d47a28b09728b8d3f71fb"
      unitRef="U002">371000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_c97a2f6a579a4bc88ba37891fc2ae352"
      unitRef="U002">4424000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_7d634592b2504bf8aff01be0dc94e97a"
      unitRef="U002">243000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <usph:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_9f662865edca4cd2a1f5f25db94dc9d6"
      unitRef="U002">26673000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour>
    <usph:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
      contextRef="c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_cec566f39b1b4b9f91f25a6eb5b60a20"
      unitRef="U002">55000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_e3383c49100c4e83ab22f9a4751c2b82">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;8. ACCRUED EXPENSES&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Accrued expenses as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Salaries and related costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,272&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,569&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit balances due to patients and payors&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,788&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,649&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Group health insurance claims&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,766&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,984&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Closure costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;379&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;498&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal taxes payable&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,590&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,716&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Dividend payable to USPH shareholders&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,327&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contingent payments related to acquisition&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,520&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;Settlement of a legal matter &lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;2,750&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,479&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,539&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;51,121&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;45,705&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_75214a15876349f7956962b5c2652f14">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Accrued expenses as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Salaries and related costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,272&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,569&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit balances due to patients and payors&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,788&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,649&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Group health insurance claims&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,766&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,984&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Closure costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;379&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;498&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal taxes payable&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,590&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,716&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Dividend payable to USPH shareholders&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,327&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contingent payments related to acquisition&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,520&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;Settlement of a legal matter &lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;2,750&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,479&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,539&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;51,121&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;45,705&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_b3cbb3625557463cba423831a879b73d"
      unitRef="U002">22272000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1eece48e625b4288b0c5662900f3d421"
      unitRef="U002">23569000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <usph:PatientsAndPayorsRelatedLiability
      contextRef="c20220331"
      decimals="-3"
      id="Fact_319d579e6b99490b918935a8175b2b36"
      unitRef="U002">6788000</usph:PatientsAndPayorsRelatedLiability>
    <usph:PatientsAndPayorsRelatedLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0b04362c685e41448be0629600bbcc82"
      unitRef="U002">6649000</usph:PatientsAndPayorsRelatedLiability>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_576817cccbe14e2b8ad68b693131e7e5"
      unitRef="U002">1766000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0f69a51aa1b34381b1796abf5734b143"
      unitRef="U002">1984000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_bd482cbc306841b09a7ae9846acf3aef"
      unitRef="U002">379000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_69fff73878d34f0cb3855cd8aa9624e3"
      unitRef="U002">498000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_359fad7e4867421abaf47c26f4dd549e"
      unitRef="U002">3590000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_40eb714b225b44bf982238d01a6e1542"
      unitRef="U002">2716000</us-gaap:TaxesPayableCurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_3ac5bf3460b4494f8b37086ce34391f6"
      unitRef="U002">5327000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0c862cab6e664c9486eeb3d0a593d584"
      unitRef="U002">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_48a4da1999984619a3fc23bc9f615e2e"
      unitRef="U002">3520000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_fca5b866b8a44fcaa85878a74124157e"
      unitRef="U002">1000000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_38b536d6896c4594961dfbc4e98b863d"
      unitRef="U002">0</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d9e7ea7648b2466ea0b8deb716e91bf6"
      unitRef="U002">2750000</us-gaap:LitigationReserveCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f041e148f0354ccaa9aaf0e1c5604ca8"
      unitRef="U002">7479000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_17f21c35a2cf44da93d43c514bf82465"
      unitRef="U002">6539000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_0a35fed00a1e4358a04b2d0c95b2dcd4"
      unitRef="U002">51121000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4cfe826161534798894bd904152f40cd"
      unitRef="U002">45705000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_cd41f5feea9a439aaccbde5cb1b9a60f">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;9. NOTES PAYABLE AND AMENDED CREDIT AGREEMENT&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amounts outstanding under the Amended Credit Agreement (as defined below) and notes payable as of March 31, 2022 and December 31, 2021 consisted of the following (in
      thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit Agreement average effective interest rate of &lt;span style="text-indent: 0pt;"&gt;1.74&lt;/span&gt;% for March 31, 2022 and December 31, 2021, (inclusive of unused fee)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;118,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;114,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Various notes payable with $&lt;span style="text-indent: 0pt;"&gt;4,927&lt;/span&gt;
              plus accrued interest due in the next year, interest accrues in the range of &lt;span style="text-indent: 0pt;"&gt;3.25&lt;/span&gt;% through &lt;span style="text-indent: 0pt;"&gt;3.5&lt;/span&gt;% per annum&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,927&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;122,927&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;118,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less current portion&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(799&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(830&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Long term portion&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;122,128&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;117,587&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Effective December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility. This agreement was amended and/or restated in August 2015, January 2016, March 2017, November 2017 and January 2021 (hereafter referred
      to as &#x201c;Amended Credit Agreement&#x201d;).&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; In
        November 2021, the Company exercised the accordion feature in the Amended Credit Agreement to increase the limit on the facility from $125.0
        million to $150.0 million, with an updated accordion feature providing for additional capacity of 25.0 million, therefore increasing the availability up to $175.0
        million.&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and
      consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#x2019;s common stock, dividend payments to the Company&#x2019;s common stockholders, capital expenditures and other
      corporate purposes. The pricing grid is based on the Company&#x2019;s consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.25%
      to 2.0% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an
      unused commitment fee of 0.3% of the amount of funds outstanding under the Amended Credit Agreement.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The January 2021 amendment to the Amended Credit Agreement allows the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under
      the Amended Credit Agreement to $50,000,000 for any fiscal year, and the amount the Company may pay in cash dividends to its shareholders
      in an aggregate amount not to exceed $50,000,000 in any fiscal year. The Amended Credit Agreement is unsecured and includes certain
      financial covenants which include a consolidated fixed charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;/span&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;March 31, 2022&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; $118.0 million was outstanding on the Amended Credit Agreement, resulting in $&lt;/span&gt;32.0&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; million of availability. As of March 31, 2022, the Company was in compliance with all of the covenants
        contained in the Amended Credit Agreement.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company generally enters into various notes payable as a means of financing a portion of its acquisitions
        and purchasing of non-controlling interests. In conjunction with these transactions in 2022 and 2021, the Company entered into notes payable in the aggregate amount of &lt;/span&gt;$4.9 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; of which an aggregate principal payment of &lt;/span&gt;$0.8 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; is due in &lt;/span&gt;2022, $4.1 million is due in 2023.&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; Interest accrues in the range of &lt;/span&gt;3.25%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; to &lt;/span&gt;3.50%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; per annum and is payable with each principal installment. &lt;/span&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Subsequent aggregate annual payments of principal required pursuant to the Amended Credit Agreement and outstanding notes payable at March 31, 2022 are as follows (in
      thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="margin: 0px auto 0px 0px; width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the twelve months ended March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;799&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the twelve months ended March 31, 2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,128&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the twelve months ended March 31, 2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;118,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;122,927&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The outstanding amount under the Amended Credit Agreement facility (balance on March 31, 2022 of&lt;/span&gt; $118.0 million) matures on November 30, 2025.&lt;/div&gt;
</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="c20220101to20220331"
      id="Text_e5ca2a24d30948b79aa32a10c4b5c5f6">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amounts outstanding under the Amended Credit Agreement (as defined below) and notes payable as of March 31, 2022 and December 31, 2021 consisted of the following (in
      thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit Agreement average effective interest rate of &lt;span style="text-indent: 0pt;"&gt;1.74&lt;/span&gt;% for March 31, 2022 and December 31, 2021, (inclusive of unused fee)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;118,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;114,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Various notes payable with $&lt;span style="text-indent: 0pt;"&gt;4,927&lt;/span&gt;
              plus accrued interest due in the next year, interest accrues in the range of &lt;span style="text-indent: 0pt;"&gt;3.25&lt;/span&gt;% through &lt;span style="text-indent: 0pt;"&gt;3.5&lt;/span&gt;% per annum&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,927&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;122,927&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;118,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less current portion&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(799&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(830&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Long term portion&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;122,128&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;117,587&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20220101to20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="4"
      id="Fact_52a22de34a964dcfbf48826686715b46"
      unitRef="U006">0.0174</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="4"
      id="Fact_2147763b3e3a4d62b5f9316b0dec9c86"
      unitRef="U006">0.0174</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-3"
      id="Fact_fe63a789816f42ddab70e186d7781167"
      unitRef="U002">118000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-3"
      id="Fact_879a9699cd6e4ee7b0ee0ecc8bf5f6d6"
      unitRef="U002">114000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c20220331_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_424ba282453f4ba487bda659ee12b9c3"
      unitRef="U002">4927000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20220331_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember"
      decimals="4"
      id="Fact_478a0d1127324ae68ea9f21a25ba087e"
      unitRef="U006">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20220331_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_3a62afb2757d490882fb1b3d753b3ec1"
      unitRef="U006">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="c20220331_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_d152a82a1cbb48a58ea46a201595e58b"
      unitRef="U002">4927000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_f299d356e40b45d98d0ed6ef32215f57"
      unitRef="U002">4417000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20220331"
      decimals="-3"
      id="Fact_eeb31e526f584babb5acdd7973e95db4"
      unitRef="U002">122927000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2e02d92dbbb34eeb944cda7adc615e3a"
      unitRef="U002">118417000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_ab3255b0c37c4739a29bcbc2a81544b8"
      unitRef="U002">799000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_fc656310fc664da3a761620f6fc236ad"
      unitRef="U002">830000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_5d93683915a04e919a388aaf4e09cbd4"
      unitRef="U002">122128000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_8e47c74a8fa541b793700e03c1c3dfb5"
      unitRef="U002">117587000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_f2d731f259a342c6af8ba11bbfb6904c"
      unitRef="U002">125000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_165f951710e043e69419c95b643556e3"
      unitRef="U002">125000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20211130_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_ee1f591cdab9486ca25297b052a171c5"
      unitRef="U002">150000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="c20220101to20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_945f8065bb7646d494f708e2feecff7d"
      unitRef="U002">25000000.0</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_8f385064de5148fab76cc20932010720"
      unitRef="U002">175000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c20220101to20220331_RangeAxis_MinimumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember"
      decimals="4"
      id="Fact_e6aee967f0064c02888e6566afea560a"
      unitRef="U006">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c20220101to20220331_RangeAxis_MaximumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember"
      decimals="3"
      id="Fact_25b07d49e7c044b785fda5fc7569dc28"
      unitRef="U006">0.020</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c20220101to20220331_RangeAxis_MinimumMember_VariableRateAxis_BaseRateMember"
      decimals="3"
      id="Fact_b358d9fe95aa4de9903846c6ca96d8b2"
      unitRef="U006">0.001</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c20220101to20220331_RangeAxis_MaximumMember_VariableRateAxis_BaseRateMember"
      decimals="2"
      id="Fact_8b77f3136bd84671b65ba7a5cfea5296"
      unitRef="U006">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c20220101to20220331"
      decimals="3"
      id="Fact_6e6864102a88420d9ea06bb2b8392d9a"
      unitRef="U006">0.003</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement
      contextRef="c20210101to20210131_DebtInstrumentAxis_CreditAgreementMember"
      decimals="0"
      id="Fact_b7d7a1f62fbc407c8a82b5b16fa5219a"
      unitRef="U002">50000000</usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement>
    <usph:DividendsCashAfterAmendment
      contextRef="c20210101to20210131_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_808ab376dfb2431db3616b192070724c"
      unitRef="U002">50000000</usph:DividendsCashAfterAmendment>
    <us-gaap:LongTermDebt
      contextRef="c20220331_DebtInstrumentAxis_CreditAgreementMember"
      decimals="-5"
      id="Fact_a447b350936b4466b5a944399426a398"
      unitRef="U002">118000000.0</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_b1ffd60342db415482db814051ea4011"
      unitRef="U002">32000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20220331_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_e869ace83049453db29dc09c86cf6fa0"
      unitRef="U002">4900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="c20220331_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_172719b26766437ca2f5fef488119fb6"
      unitRef="U002">800000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="c20220331_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_e473e4894fab42f48df4cf3bc2a5f3dc"
      unitRef="U002">4100000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20220101to20220331_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="4"
      id="Fact_22e2620b1b6c45468988caed755681ae"
      unitRef="U006">0.0325</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20220101to20220331_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="4"
      id="Fact_f5d8069c3911495cb30bd47f4afcc452"
      unitRef="U006">0.0350</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_88124a445241466c9bb27bbf0fc5eb27">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Subsequent aggregate annual payments of principal required pursuant to the Amended Credit Agreement and outstanding notes payable at March 31, 2022 are as follows (in
      thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="margin: 0px auto 0px 0px; width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the twelve months ended March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;799&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the twelve months ended March 31, 2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,128&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the twelve months ended March 31, 2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;118,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;122,927&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="c20220331"
      decimals="-3"
      id="Fact_0ce71c2ebcc04c0b98ac5cc3a7e86760"
      unitRef="U002">799000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="c20220331"
      decimals="-3"
      id="Fact_647a91e099a54a11bcfd8579af056b21"
      unitRef="U002">4128000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="c20220331"
      decimals="-3"
      id="Fact_e32c7204300b4dcd8c18a897d9645e03"
      unitRef="U002">118000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebt
      contextRef="c20220331"
      decimals="-3"
      id="Fact_ed4767ce3275450d9fa3b11fd22cd85f"
      unitRef="U002">122927000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_303f57bfc9f3451bb3d31056129e656d"
      unitRef="U002">118000000.0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20220101to20220331_CreditFacilityAxis_RevolvingCreditFacilityMember"
      id="Fact_ec969edcb49a40b5b61f0e000cbaa2e8">2025-11-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20220101to20220331"
      id="Text_c45a78ab63f24d4abd1a4169e8d442a4">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;10. LEASES&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a lease at the inception of a contract.
      Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset during the lease term and operating lease
      liabilities represent net present value of the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the net present value of the fixed
      lease payments over the lease term. The Company&#x2019;s operating lease terms are generally five years or less. The Company&#x2019;s lease terms
      include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#x2019;s operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the
      information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The Company has elected, in compliance with
      current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable lease components. The Company has elected
      the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included in the measurement of the right-of-use
      assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment
      amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease liabilities. These are expensed as incurred
      and recorded as variable lease expense.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the three months ended March 31, 2022, the components of lease expense were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;March 31, 2021&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;8,404&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;7,729&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Short-term lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;321&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;368&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Variable lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;1,932&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;1,611&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease cost *&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;10,657&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;9,708&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;* Sublease income was immaterial&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Lease cost is reflected in the consolidated statement of net income in the line item &#x2013; rent, supplies, contract labor and other.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Supplemental information related to leases was as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;8,617&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;8,112&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;6,011&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;7,867&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The aggregate future lease payments for operating leases as of March 31, 2022 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="text-decoration: underline;"&gt;Fiscal Year&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022 (excluding the three months ended March 31, 2022)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;25,297&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;28,724&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;22,109&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;14,808&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;9,285&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2027 and thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;8,292&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease payments&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;108,515&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less: imputed&#160; interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;5,728&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 28.85pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total operating lease liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;102,787&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Average lease terms and discount rates were as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average remaining lease term - Operating leases&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.1 Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;4.0&lt;/span&gt; Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average discount rate - Operating leases&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;2.70&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="c20220331_RangeAxis_MaximumMember"
      id="Fact_87608c9af75e4a138742de4bfc2676c9">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_eba6ae76dcb646e3ac59de0c124f53a2">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the three months ended March 31, 2022, the components of lease expense were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;March 31, 2021&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;8,404&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;7,729&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Short-term lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;321&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;368&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Variable lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;1,932&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;1,611&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease cost *&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;10,657&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF;" valign="bottom"&gt;9,708&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;* Sublease income was immaterial&lt;/div&gt;
</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_7bafc283b7b8427f980cd873b3577282"
      unitRef="U002">8404000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ffa4e10b01694d1ab1f52736e583a840"
      unitRef="U002">7729000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_05adf7edeaeb431b93cfe743e1c5020f"
      unitRef="U002">321000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_57b9cd5c2bcf4bd9a6bca2d11995ba37"
      unitRef="U002">368000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_5d030c18870b4189abd4a866124c6838"
      unitRef="U002">1932000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_9b49ead6c1414cab871ada8caa962940"
      unitRef="U002">1611000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a86a9f81f8e6415ba5caf3f8f5a6c41a"
      unitRef="U002">10657000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e1dc057bc3e04a67ae8164ee0e07cd9b"
      unitRef="U002">9708000</us-gaap:LeaseCost>
    <usph:OperatingLeaseSupplementalInformationTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_4b0368e3bac045a18b12d5d9b697d8e3">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Supplemental information related to leases was as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;8,617&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;8,112&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;6,011&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;7,867&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:OperatingLeaseSupplementalInformationTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_cf2e65a428c342749dfd30f3087632aa"
      unitRef="U002">8617000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_b2d9bcbdd5cd45e294a53cfffcfaf70f"
      unitRef="U002">8112000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_1c31d67dd0614e3bbf75589a2babd8ef"
      unitRef="U002">6011000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_a28f5a09906741e8bb17ad023ddd7113"
      unitRef="U002">7867000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_3ff5a45238e440798d6190268b78daa4">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The aggregate future lease payments for operating leases as of March 31, 2022 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="text-decoration: underline;"&gt;Fiscal Year&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022 (excluding the three months ended March 31, 2022)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;25,297&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;28,724&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;22,109&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;" valign="bottom"&gt;14,808&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;9,285&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2027 and thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;8,292&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease payments&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;108,515&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 21.6pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less: imputed&#160; interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"&gt;5,728&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 28.85pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total operating lease liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;102,787&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="c20220331"
      decimals="-3"
      id="Fact_28b273b0c4914b41a95e8736c3d79f3c"
      unitRef="U002">25297000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20220331"
      decimals="-3"
      id="Fact_3896f7d5f29b4f39a16320bb40a27540"
      unitRef="U002">28724000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20220331"
      decimals="-3"
      id="Fact_d3b7f88359a34a3592bd25f44ee50aaf"
      unitRef="U002">22109000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20220331"
      decimals="-3"
      id="Fact_cea2952a93664c4ca3f732438347fc62"
      unitRef="U002">14808000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c20220331"
      decimals="-3"
      id="Fact_0c467ecd9b3546ffa682f32c91a2f7d4"
      unitRef="U002">9285000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="c20220331"
      decimals="-3"
      id="Fact_0563961df6af49a1b174cbccec1a6ab4"
      unitRef="U002">8292000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_da8375122bbc4143a3987b431ae07199"
      unitRef="U002">108515000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20220331"
      decimals="-3"
      id="Fact_7a2fcf1e76124a2fa20cd44d2f6162b2"
      unitRef="U002">5728000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220331"
      decimals="-3"
      id="Fact_9997b2cd8eca4ed580278838fe6d2550"
      unitRef="U002">102787000</us-gaap:OperatingLeaseLiability>
    <usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_4f49996f61874a96bc213a9cb7b4ec98">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Average lease terms and discount rates were as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;March 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average remaining lease term - Operating leases&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.1 Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;4.0&lt;/span&gt; Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average discount rate - Operating leases&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;2.70&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20220331"
      id="Fact_002373e37a2b479798777778f862e37e">P4Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20210331"
      id="Fact_a0488ca424ea4a93955d040f95e27d68">P4Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20220331"
      decimals="4"
      id="Fact_039745498db447e1a56b176b65ab3865"
      unitRef="U006">0.0270</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20210331"
      decimals="3"
      id="Fact_6771f3515a2c44e1b7705306775837b0"
      unitRef="U006">0.030</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_2e964287d83d40d68c3826bbeda47e3d">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;11. SEGMENT INFORMATION&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company&#x2019;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Also included in the physical
      therapy operations segment are revenues from management contract services and other services which include services the Company provides on-site, such as schools for athletic trainers.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company evaluates performance of the segments based on gross profit. The Company has provided additional information regarding its reportable segments which contributes
      to the understanding of the Company and provides useful information.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table summarizes selected financial data for the Company&#x2019;s reportable segments.&lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended March 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net operating revenue:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;112,636&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;102,359&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;19,068&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;10,009&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;131,704&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;112,368&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;22,436&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;23,174&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;4,152&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,722&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;26,588&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;25,896&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Assets:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;608,240&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;723,530&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;155,623&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;25,896&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;763,863&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;749,426&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="c20220101to20220331"
      id="Text_8eb438da539c451386273766558af8bd">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table summarizes selected financial data for the Company&#x2019;s reportable segments.&lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three Months Ended March 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net operating revenue:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;112,636&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;102,359&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;19,068&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;10,009&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;131,704&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;112,368&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;22,436&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;23,174&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;4,152&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,722&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;26,588&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;25,896&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Assets:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;608,240&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;723,530&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;155,623&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;25,896&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;763,863&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;749,426&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_c53972f037c34d06b93c5428f7c9abb1"
      unitRef="U002">112636000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_0291504402f74a09b40b889b9a9f963f"
      unitRef="U002">102359000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_47dc6be51e3746d0a28509a3a101bbe3"
      unitRef="U002">19068000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_d4e17ca9292645d48658148ddc14ac51"
      unitRef="U002">10009000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_fefea78e666f4035acbe7e08dcc9cd4a"
      unitRef="U002">131704000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_26a52f205cb04d51a4a085e01edeaac4"
      unitRef="U002">112368000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_b2809a94988c4ebdb69b1c5521d1650e"
      unitRef="U002">22436000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_92aed951016a406babd6636b9f190970"
      unitRef="U002">23174000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20220101to20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_b723e2320b8f410f81ae01b3f50dfe2d"
      unitRef="U002">4152000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20210101to20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_08bca272b2264f5da8e4d285bf715ac2"
      unitRef="U002">2722000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_8ccbfbcc15ac4166a649fc359abcf1b7"
      unitRef="U002">26588000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_aec9ff9a6f3a43de9ccec8ef0f0c1de0"
      unitRef="U002">25896000</us-gaap:GrossProfit>
    <us-gaap:Assets
      contextRef="c20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_44149318c0994ec695d1c147612147f7"
      unitRef="U002">608240000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_6889f76dd5f84b3badb9f0b43e8e7eb7"
      unitRef="U002">723530000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20220331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_b69ec47ed97b404d8a54063e627bf37b"
      unitRef="U002">155623000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20210331_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_74c4e41636bd4289aa4d91d30c6e7369"
      unitRef="U002">25896000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f72ba6805e3c441ab0478c325efae85f"
      unitRef="U002">763863000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20210331"
      decimals="-3"
      id="Fact_f12d18a444634e6aa9bb8ce6d2924141"
      unitRef="U002">749426000</us-gaap:Assets>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock
      contextRef="c20220101to20220331"
      id="Text_4a17531adbca49b38739dec07a90a4c0">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;12. INVESTMENT IN UNCONSOLIDATED AFFILIATE&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Through one of the subsidiaries, the Company has a 49%
        joint venture interest in a company which provides physical therapy services for patients at hospitals. Since the Company is deemed to not have a controlling interest in the company, the Company&#x2019;s investment is accounted for using the equity method
        of accounting. The investment balance of this joint venture as of March 31, 2022, is $12.4 million, of which $12.2 million related to the fair value at December 31, 2021. The $12.4 million includes earnings of $339 thousand less a distribution received of $132 thousand.&lt;/div&gt;
</us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="2"
      id="Fact_e8cb2e683254443199ed26f0ecb07422"
      unitRef="U006">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-5"
      id="Fact_a6317c6db7e4420e9070111aa4ac6881"
      unitRef="U002">12400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:EquityMethodInvestmentQuotedMarketValue
      contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-5"
      id="Fact_d22db0b729974b78afba3f37b36fc2c6"
      unitRef="U002">12200000</us-gaap:EquityMethodInvestmentQuotedMarketValue>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-5"
      id="Fact_cf3def01a9334a3fbcef7543debb7aba"
      unitRef="U002">12400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-3"
      id="Fact_43971f2c6baf460cb38b0ff0e364ffed"
      unitRef="U002">339000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-3"
      id="Fact_cbea43d064e947e39e9adf531fb39372"
      unitRef="U002">132000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_b59292921617498abe034fb28dd15d4e">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;13. COMMON STOCK&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of the Company&#x2019;s common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of its common stock (&#x201c;March
      2009 Authorization&#x201d;). The Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance with covenants.
      The Company is required to retire shares purchased under the March 2009 Authorization.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Under the March 2009 Authorization, the Company has purchased a total of 859,499
      shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 150,830 shares (based on
      the closing price of $99.45 on March 31, 2022) that may be purchased from time to time in the open market or private transactions depending
      on price, availability and the Company&#x2019;s cash position. The Company did not purchase any shares of its common stock during the three
      months ended March 31, 2022.&lt;/div&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20081231_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_8af1ce932dfe4f668aea856d75c1e95b"
      unitRef="U001">2250000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <usph:PercentageOfRepurchaseOfCommonStock
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_5776ff8c768846e5b8773a8f8d73001d"
      unitRef="U006">0.10</usph:PercentageOfRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_7bf64444b32b423b929dd7207553b384"
      unitRef="U001">1200000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_139bf8735d644f17834ff0f1e1e67206"
      unitRef="U002">15000000</usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c20090301to20090331"
      decimals="0"
      id="Fact_dc05ce77ed4f4a6f8c6057bb9f7ab1c4"
      unitRef="U001">859499</us-gaap:StockRepurchasedDuringPeriodShares>
    <usph:AdditionalEstimatedRepurchaseOfCommonStock
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_00ddc1416141494d87d014aea0fcbe88"
      unitRef="U001">150830</usph:AdditionalEstimatedRepurchaseOfCommonStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c20220331"
      decimals="2"
      id="Fact_45c8a15e0d4845b7a3df31ef2975b9e8"
      unitRef="U003">99.45</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_f98a8a6b1f0146b89ad89c4db4e70a1d"
      unitRef="U001">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ErrorCorrectionTextBlock
      contextRef="c20220101to20220331"
      id="Text_8cb933edf4ef46c69e7da9d839c7ef4f">
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;14. RECLASSIFICATION OF PRIOR PERIOD PRESENTATION&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of
      operations.&lt;/div&gt;
</us-gaap:ErrorCorrectionTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_693f99992f5a43bdbf253cd7cd64b971"
          xlink:label="Fact_693f99992f5a43bdbf253cd7cd64b971"
          xlink:type="locator"/>
        <link:footnote id="Foot_5e0179a59a7444dfb4650c9e2788869a" xlink:label="Foot_5e0179a59a7444dfb4650c9e2788869a" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Industrial injusry prevention services</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_693f99992f5a43bdbf253cd7cd64b971"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_bccf762daaa94483b40081c81b457ca0"
          xlink:label="Fact_bccf762daaa94483b40081c81b457ca0"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_bccf762daaa94483b40081c81b457ca0"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_539c6bc318bc4fb6a6708940d611942a"
          xlink:label="Fact_539c6bc318bc4fb6a6708940d611942a"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_539c6bc318bc4fb6a6708940d611942a"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_7eeced21a3bf49b6b7cea15928eef383"
          xlink:label="Fact_7eeced21a3bf49b6b7cea15928eef383"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_7eeced21a3bf49b6b7cea15928eef383"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_fa848cbb3cef4ce9ac4701987e6c1c17"
          xlink:label="Fact_fa848cbb3cef4ce9ac4701987e6c1c17"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_fa848cbb3cef4ce9ac4701987e6c1c17"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_449b5876417b495586b69cf0134fddcd"
          xlink:label="Fact_449b5876417b495586b69cf0134fddcd"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_449b5876417b495586b69cf0134fddcd"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_fe86c41d0a8e40589aee50f8b258e5e3"
          xlink:label="Fact_fe86c41d0a8e40589aee50f8b258e5e3"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_fe86c41d0a8e40589aee50f8b258e5e3"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_f746be88a8e04e8e93c2d060b41e7ffd"
          xlink:label="Fact_f746be88a8e04e8e93c2d060b41e7ffd"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_f746be88a8e04e8e93c2d060b41e7ffd"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_34be6c8c2f1344f682ff5a6e05e0b232"
          xlink:label="Fact_34be6c8c2f1344f682ff5a6e05e0b232"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_34be6c8c2f1344f682ff5a6e05e0b232"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_118b64f338854f27b3f6923be9878e34"
          xlink:label="Fact_118b64f338854f27b3f6923be9878e34"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_118b64f338854f27b3f6923be9878e34"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_b78ab4e4488a42088efca947c8a4d214"
          xlink:label="Fact_b78ab4e4488a42088efca947c8a4d214"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_b78ab4e4488a42088efca947c8a4d214"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_435e62fbec4649a6b558725ff793bd1c"
          xlink:label="Fact_435e62fbec4649a6b558725ff793bd1c"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_435e62fbec4649a6b558725ff793bd1c"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_be7f633d83a2408a9ca0e8336e9f12af"
          xlink:label="Fact_be7f633d83a2408a9ca0e8336e9f12af"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_be7f633d83a2408a9ca0e8336e9f12af"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_c9ccddd842e04e09b614b6e5f3295a3a"
          xlink:label="Fact_c9ccddd842e04e09b614b6e5f3295a3a"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_c9ccddd842e04e09b614b6e5f3295a3a"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_2ca63305da874a06a17209af72a504b1"
          xlink:label="Fact_2ca63305da874a06a17209af72a504b1"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_2ca63305da874a06a17209af72a504b1"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_1712aa9b24ae465e9fb9172ba536bd78"
          xlink:label="Fact_1712aa9b24ae465e9fb9172ba536bd78"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_1712aa9b24ae465e9fb9172ba536bd78"
          xlink:to="Foot_5e0179a59a7444dfb4650c9e2788869a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_a86a9f81f8e6415ba5caf3f8f5a6c41a"
          xlink:label="Fact_a86a9f81f8e6415ba5caf3f8f5a6c41a"
          xlink:type="locator"/>
        <link:footnote id="Foot_73f4cf38380b4d879f24c52224424feb" xlink:label="Foot_73f4cf38380b4d879f24c52224424feb" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Sublease income was immaterial</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_a86a9f81f8e6415ba5caf3f8f5a6c41a"
          xlink:to="Foot_73f4cf38380b4d879f24c52224424feb"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_e1dc057bc3e04a67ae8164ee0e07cd9b"
          xlink:label="Fact_e1dc057bc3e04a67ae8164ee0e07cd9b"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_e1dc057bc3e04a67ae8164ee0e07cd9b"
          xlink:to="Foot_73f4cf38380b4d879f24c52224424feb"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_d858a7400c8b4646aabbd6bf18a9f0a4"
          xlink:label="Fact_d858a7400c8b4646aabbd6bf18a9f0a4"
          xlink:type="locator"/>
        <link:footnote id="Foot_78cb7964484c42eaaaccb3a7770e93b6" xlink:label="Foot_78cb7964484c42eaaaccb3a7770e93b6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Industrial injury prevention services business</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_d858a7400c8b4646aabbd6bf18a9f0a4"
          xlink:to="Foot_78cb7964484c42eaaaccb3a7770e93b6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_fb559091d7c74f0785b5cc150f4935e4"
          xlink:label="Fact_fb559091d7c74f0785b5cc150f4935e4"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_fb559091d7c74f0785b5cc150f4935e4"
          xlink:to="Foot_78cb7964484c42eaaaccb3a7770e93b6"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>60
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
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M% KA&_DJ=K6LN)0-?_W^Q:#7Q\@JCZ>X29>5WI,*9EA6Z\^(J\$MB%1D+%-
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M:QEEFVO!?:',!7!^*:7>[Y@;E(O"P_\ 4$L#!!0    ( )5EJ50\66$> @@
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MC9U-,8RQ^01I#/#Y2@C].C'M3=W.3OX'4$L#!!0    ( )5EJ52B:]D4608
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MS=4%&J-O\W/T_MT'I-9,<H72 MVOQ5:Q(E$'Z-W>_?%$ R@3>K*L 9Q5 ,@
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MS)BL/CQ4-UILRK/[A=!:Y.7EFC,0 V, _U\)H5]OS #-YY_3?P%02P,$%
M  @ E66I5"U.HMV8"   B20  !@   !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6REFFEOVS@0AO\*8>R'+5#7XN&K2 *D3KHUL'&".NU^5B0ZUJX.+T4YR?[Z
M'=('%?&P%PL4]9$A]<Z0FF>&UL5+)?ZJUYQ+]%KD97W96TNY^3P8U,F:%W']
MJ=KP$OZRJD012_@HG@?U1O XU8.*?$"B:#0HXJSL75WH[Q[$U475R#PK^8-
M=5,4L7C[PO/JY;*'>X<OOF?/:ZF^&%Q=;.)GON3RQ^9!P*?!<98T*WA99U6)
M!%]=]J[QYQF;J@':XF?&7^K6>Z1<>:JJO]2'>7K9BY0BGO-$JBEB>-GR&<]S
M-1/H^'L_:>]X336P_?XP^U?M/#CS%-=\5N5_9*E<7_8F/93R5=SD\GOU\HWO
M'1JJ^9(JK_7_Z&5O&_50TM2R*O:#04&1E;O7^'4?B-8 F,<]@.P'D.X YAE
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M&?MF(HW-I#=E,5V6!:O*G/_TA*X+1KFMF7''R8B%]H?-N*.>O)6<O)4T/,X
MSP?ZE!5"?AZO\K184Y0R%-#U.V3CMXA8Q-)YW9'3:SA%+'^^PBZ^F#V?NY2*
M6;@>(7U4H*(()A9V^[!0A4UM[)%Y'Q9IV'P/>U8?%FN6[_@2*-%Q^9[=P7IZ
MVR>][3^I]\_\B!\/_YM1VA_YW9[VEB<+IJ*FA)S)VEN\<UJ\TPRS!Q9_7:S%
M0>-KYJML/KT1 :HY=,IQN>/>COC=\"6M-K\;/-4]3>X:E;NNZT,C6/F(Q.FI
MLC7CT:,6D[]%!4]*^ ]K@<CS5$0K;;QT%:M*=E^ZBG(2(@ 1(3A+!'+$("(Q
M(7H2>R>)O>\L\;GWZN3VE"4ZGJ25"AG8A7_:A6_<Q1U]3O-#L[[C1C:49Z</
M.44%#\3KLT"<M8'XM#>6?M7MP@>=Q@>=1D5,70?;DAC@3-$HGAA<3P+Q]*2?
MGZ2?_T#I(6>:@^?.A.AM:'':T,*X(9Y \9JF/NZ(?A6?*4_::!/CIB+%WZ!4
M1#AML%F ?K-0@[DGWTD#%23O&YPH&C-1#$Z4 #0]C;'59<R64>4@>\XVE&>X
M:)]^:]R%E3PQODV.WM#>6K3IKP4M>0E# @UDZKC8D52&F:)Q3#',E(!,?:W/
MJA,,:"WB^L/A&+ZYSD,GD]NB8@77G?O[GO*BMJ %:SU?:PH,FP*$!# DA"$1
M#(DUD"GV?"*; 8+US="EW=B<=Z^V9<50_2(4WU?E8\8O*&,YW7&5M?(26%X5
M(M\8 I@FA"'1B)EBF"8QT_25[1)L;,ZP/[$MK;0*JCFQHB ("300K$8*D"<:
MPQ-K0%,LBZ@C&E*QR_2Q8U3QAM^5LV)=[D1!> P8KX%Y,&",C!,.; 80$L"0
M$(9$,"360#"1*\H$0O6MT)4\V%SS&*PP[O8(%A%+&!)H('/LRZDK3!2-(HIA
MH@0BZLO=E3_87/^$Q4;JA'Q,JU,UCK4*>R-:(5BM<18^F7NRSBJ,8,OVY=I>
M,Z>V&Z+C\ST\5Z*,BL.6Z\N:Z]A\X@QE?UVYALWUFJ2ZU ^!+:!6,MP"&,NB
M:0J>X8X([BH>;"YYP ::?M'S,6ZCEC/8(MY\+ON-BB/$L1>*WZB3ZOU&P[=P
M/<N3_4:S/E?VUD3+YN/YD-]TI1DVUV9_JI6FMX*FG'%YW)9U4V$&UR%=V4.L
M?[Z=1KI*@)@K@>_34&LG,16Y!$[[84@(3Q3!+#$,28R0OM9G779SNO_].VM$
MS9WGBF2F%+R_DRZ])N;T^OMWU]H)C1X$Y^4:R!0K_35XKF@440RO*(&(^@;H
M,G-BSLQ_;(^-P'FU$=+?5)?H$G.B^_?Z; 3NZA,U8^2)D)R!:5#*[N'>_JBY
M8GBN!"+JB]VEN<2<YMY7:5$_TJJ).>?"YUGZD.7B=O-85FA-*_&$]ABD4,8C
M&#?"_E")2,9$"9*7Q=.4N]A.U"B\Z,N>*=KS.['>1J8^?VLC%>++24< \X0P
M)!HS50SS) !/WT!=1DS,&?'MH5IO16+ #?3:A=MF^].!%BVYH<.NU1Y\'+#4
M0*;J\0!Y0A@2C9DJUH%LVY'EUZ'F0]&HR^F).:=?I7FC/1A0]ZVA:I06F\'[
M&_C<8@E# A@2PI (AL0P)#%"^IIWV3PQ9_-__1D  1];+&%(H(%,79OXLL8@
M4S2.*8:9$I"I_PI"5WC8T/.6'_0,P(8?Q\"0 (:$,"2"(;$&,L6V)=7#"0CK
MFZ$KP&QS 3;8J;;A1RD:B-SR"#28J:LT1N#)(BV1I:BIHCRYQY7HUCT?N&':
M77EEF\NK']>MMN''+C D@"$A#(E@2*R!>'(_(P% ?1N<O=AD+@S_;J_:AA_/
MP)!  YG[BX4L-OQ\9A11#!,E$%%?[JX,M,UEH+E73;0*.R.:CCJ0Y1++E856
M<83XQ)$K;@U.VW34X&S+6OCR.PJZ]1%';CIJV0C!0U[>%:JVN5 =WZS6FT!3
MT7%QY8ZC!J;K.,[.WE(6[\7SZ9\R?D?/Z2,?9[WS.4%U?-7\>,'*??/B\D/)
M6+EK/FYIRD^D /#?'\N2O5Z(=Z%/+_Q?_1]02P,$%     @ E66I5/GE'9Z.
M(   !68  !@   !X;"]W;W)K<VAE971S+W-H965T-RYX;6S-75MSW#:6?N>O
M0'DS4_%4JRW)L1W'2:IDV4XTFUA:2YEYV-H'-(GN1LPF.P I6?GU>VZXD,V6
MY,G,[+[8$B_ P<&Y?N> ^O:F=1_]VIA.?=K4C?_NT;KKMM\\>>++M=EH/V^W
MIH$[R]9M= >_NM43OW5&5_32IGYR?'CX_,E&V^;1]]_2M0OW_;=MW]6V,1=.
M^7ZST>[VM:G;F^\>'3T*%S[8U;K#"T^^_W:K5^;2=+]L+QS\]B2.4MF-:;QM
M&^7,\KM')T??O/X*GZ<'_F;-C<]^5KB21=M^Q%_.JN\>'2)!IC9EAR-H^._:
MG)JZQH& C-]DS$=Q2GPQ_SF,_H[6#FM9:&].V_KOMNK6WSWZ^I&JS%+W=?>A
MO?G1R'J>X7AE6WOZ5]WPL\]?/E)E[[MV(R\#!1O;\/_ZD_ A>^'KPSTO',L+
MQT0W3T14OM&=_OY;U]XHAT_#:/@#+97>!N)L@YMRV3FX:^&][OO7)Y=GE^K\
MG;KX\/;R[?NKDZNS\_?JY/T;=7GVP_NS=V>G)^^OU,GIZ?DO[Z_.WO^@+LY_
M.CL]>WOY[9,.IL=!GI0RU6N>ZGC/5$_5SVW3K;UZVU2F&K[_!,B.M!\'VE\?
MWSG@S]K-U=.CF3H^/#Z^8[RGD1=/:;RG_VQ>J/\^6?C.@83]SQUD?!7)^(K(
M^.K?L25W3W4T5__XHJ_61I5MX]O:5KHSE5K:1C>EU;7R'5P U>V\LDU9]Y51
M'3RMR[+M\6*[5+_,+^?J8GWK;0DOP%A.;V]GZJPIYTHWE;+PF.\7WE96.VN\
M^A)'^/-_?'U\?/CJM-UL=7-+OQV]>CQ7)S5,:E>-7<)P30>S=L:5_)2"G6F\
M)BO@"QQ[H6L@%,9<ZVNC%L8TRM06M N7,:>%R0P*K)^#JY[H6?0>&.@]+,:U
M_6H-5FG;NDXO:I/N>;.BE0_&04J/7KSR^1OAP0&+MH$C'7-$"$#2PPO$'KA=
MV*8" ^&0X;;YM7>W"NSR-3R!YLX;=VUQC?+6-#EW38=[:WV'F[7S&)+0EF6_
MI6>S&R6(F"V10[H#<MIK"PL#L@[PC6WKNP.9 1A?:F=X,>!..EH:>!D%_%G#
M0Y4M#YRI2;(JZUM7&>=GA4?^^7B'%@[B,8MKEX%GP.JU7MC:=D0C+H,>AI?0
M4<!@-'=C>M?6[8J6%T:;J\O /ED#",TM;=!G,3UN+;*R,Q-O( E#0F$EQI&W
M!1$MVFT'@OF[C@\;MVJ;=F-+I;T'>1-9>P-T-RNB$*SAD;HUV@5!07$U1FW8
M^AJTO@IL9[F.QG-&CP691[VI#7*7E?:WW@+U)!/ Q&7;NV(#3L\>\&;#<E"Y
M<-DTX4U[-Y."IN#S'CQHIVV-_,4 85Z<I.D*\&B&+\"N%:<L6@63CF2K_.'A
MBHH7A\6?BN?%&U.:S<(XYLI@\'!'7CDJ7CR#5YX6[]OK/:_$.T\/PRLXR]G9
MQ>5?BDNS[?:\EV[%%X\.TYM_[1NS^Q)=C<\_1]J^3FL_VK_VH[#VOQ1G#Q+6
M:+I.:(/O$@TQAY5Z?G@4==TVZNE+MOE#JZ=T[5N(5AH([R9LS5*7*/5HW%'O
MN[5U8".TPRNS8NLLA(FVOE7KUF]!.6H2+Q[%@D6?0:C4 :%?\YL'^.9@T!XD
MW<GT;#@GUK?KA-1YLH%7#S3)5P/U ?XV/1#0M?" ^8C_ZX[B UJH ?5J;^F]
MT=A@;KVZ6;?LF(Q'1V$AN$,;4?.4:[OUO/#$"3;'. 3&R<8Y=,&@IB7:1;!;
M[1(NBGGPILCFTJ3LIK-D-SWX1<?&'0P7&U-/02\,W[!_<NT2]H+,%0Y,%\4.
MD,V'WV^%YW,%@;-B4T'F;\=>@.3<K"WLAB:N@2&ND4SRWK!Z93V;'Y?LKW!Y
M)M18=!@W#5KS[G:+K*S3#N"&,[,-[4;!=.4TI[U$AP&F"*RL:MKF(*>')P#.
M9Y0UV2A>S'AID(N3/,5]I]F#E=Z9?PZQC])59=D)Y%JW)CMY#082W"*,V$$2
MD_$S$WEX$-4 -\9\@AV&V<1NJ@NX+LM@>O^^AN7='IS#XBKU+HXA:H7SPTIA
M\WA?-45C'017:$V:GLP93/.9HP<+ M[(X49H<,Q-7$G=EL2,^>2P*$VX-5$D
M)AYBQH'S:V#I3$EM65R)/Z"&=M%S  9JB0^/=SOL,8X51:JE=8@,YAO)FC2#
M$ 7VO\,G'09F\MM,88P#/V/X4A%G17(D!E64NM'&[:.#@MZCHU<8%\#,:#8,
M,*!C1<V&!)UM-R8/OG%4TX4;X\5__H2LT7?QGX4';AJSH7GV33+>J(F->< H
M^]A;#!*3C",4!1(W,!>"J-YLXG+_"*L>0FMX%N:$(!:M@K#U#[T\WZMJN%?[
M[K$'(6,.(JC).VAP' V[2I!]T$R]A2? QJ*^0N[F>HPC?.(W>VVXM\&TCA*%
MX8A5'S=S="?Y((H8"AD"1C>?MJ9!CZ,]&U+(W6+T*_$T_A!,)PQ6MAF#R.!:
M$VPRIPGXA,0FP,VM(2PH6H9;G#<?NNR=0['/34<8GQ@!CPF=/GC&H4*C-8^Q
MUQG'7A<I]HKIQ6Z>$97Y#^09\3[N$-A6W%')^3*'R"^QE#T@+RFRO$3E><F,
M$CN.,O+@!L)!W)Z96O9-*7EBJ;<@A,!Q<ZWK/GC>.Q*;*[*WO[8NQ1L^6R#J
M/^D+A!1B 3A,U);E,]IEL-VR=$@CL[7KS)F!QG08=C\[/%2,'F R6)Q3:"5\
MC+P&,5OA/GG(*269A.>LB_2T;A0."P/]>!$!3LA$YI+27/4SIL%HJ"Y ?8 I
MQ$0@7W)S"DZ6:M'&<' 82B)-I8& >FE1H;HUI'48J#F(<PQ2]UK#,#@$R*:'
MU;&F70E60U3C''VC@5FL2/<!/C=@KU"2( XA:2YP)%>1U/#V, J$XX)M@?<A
MV?1J98 B<K5P'_.EJ F_-#3S)>472.O)!J+94M/VDGVTFXP4VS!4G4R&&E/
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M$5\MZ#S03IZR$ 4"]K=0XNK]JJ<^+CQR.QQOG43.)-S,8[V4)?UA>^%284W
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MC(+;39[N,8FYQH780ROQR B][078G[FHIBQ.5#H/>4L37+!#X</E!,[,'6U
MQU"[E(V%!Y=W*Y=.E0["69 &^305'G GKE=] 6FY$\J=W8[=K8BXZ91")GSG
M\@27H:9F8[+YS\_W,M5241^A!MPMD)84F)W+?(C9UC<A&<LK!8%TGVFLB#5=
MJ[[W1"&OKV[??^6Y[&"YQQO:UEZ=CT-2%30>VLP.866P^6P2^5:,+4_A9Z'\
M>XH'+(?.Y=I'!$4QHVLQ+A6FXDN+D3M\<7X94#E#OQH,PM8R0%"A6NE(((7L
M5G*^.3Q;B-E.4<*'88K<OUCP=_OT9#)J<.,M#60=\H "=POUR=F7/.2^Q9##
M6#<=JLJ>\)'\L53/"Z[S$QB/N$,#BP!"[+ @JD$S9\PWE@)Y^TV'R@ 5IG @
M^!'W6^X$W7A5?-T!:YM4'GR\B60S@$$#WQTZRNG9X''&4G7,DZA;1LRN42B?
M2DL]0XO$CT<'JQP=Q4"D1^ CW2.?X\WMSE"9OE8@8.O"M3-<_RLH$Y1VI0/]
MH)9,J3>>%I"\ 5SRJC@SQ79MN&!7;4=EL&=**1-1/G"&V'A#I!K+R1T[XV&B
M;'3-&99;+J=.)]G+H>F5$Z H!K$4Z$Y30[+8*_+ X=J2.T__X[* C$G?)R??
MP+5)EB)5A@Q4;4\=JOOJRMDUJZ]#QM6=:X90F1?&$:%)'/Z/WM155:O3:VK9
MB&_R.PI<5%I+UM??S$)<T[XH+24!X3QYV?6WVZOD9E:31WT!3^'$/>&'TPYA
M019LJ(O245]5 3^9=<O*;!SG;@#C>E.SX4J$2W<HU)\)/[OP,]^[CCY1UE(W
M8:,@5D?W."X@K76TT>V_[&=3ZM.0T'))=&:<2F<0VB:/DCX#X3D"E-(UK++&
M&U.K.&'AMW+N30FD?)+ QP6;3]S^NX$Z>2^OZ\6QV5)S\G#G_!68BW?;8 __
M"-==6VU57ET$,(Z]T*\(AX%K<I_-*:=,0L?0V1?8:,6*,F,;5$8U,*Y#E3G6
M098(BP4J)TJR;E^(+8_HJM5WGB*#6JZS-IWJ_5Y&WO5<D./?Y00Q?,/]2#>D
MYKXM]W!!!8G5<(_)M^:I#4B@1-]E^@"E#1W\N'J^#ONZ<DN?B"U1SUVY$H"5
M2-&G'#>^(PKKMTD*7)KZCKN3 *&P>8(1-N#HR R0:0L\7E7&*9/RIQGJRF\*
M)LE];;JW&1*0H@'A#5V$/X6K2;834:.,_H4W&U+WE.VU)#3R'4'/T7U-<Z]=
MQAT.[L_FM:OG;*0U<HTQHZ<D2HJC'J!N76T5=FT.#<-;:W%B5H<=J*V@';R2
M;55K"5V'U'S8U\:Q_]=92_@JMH1'MU.GV+/5M'T6MM!+[K6EK0PG>;F6W8HV
M!T>=M%@90#]%[)6-5FXIVA>(3[@.TCXG>ZZF6^WUZH*-M60WQ/V(%+OTG=O'
M5R5#=HYGFM5.>RZ=-YFS+>IPQB"UHRIW]B;;R^<0@/>.@I<L'< UI(=B;.)&
MT1Z=MI 4LQQ"H''O,9@U;7T?;+D?;O0GPJ1[NX<GL9Y/H3_"N\=.+\BZ# ]/
MQ7LJDAKJPOL6T+Y\?M?]OHSN@$7:<,E8Y0$!]G<]TA&*=&@B[L*F/7W7D;6Q
MA\*E@CHB$%R>VEODM\1;J;/EP6#5&?". ULTQ4+63N%Q-4[ZD2A3\2YOGN]S
MJFQ=:3&3I&B?9YXL=-A;8T%J)(N:<D-"$F;S-, (/HCM^E,UKN;#JBPE:K=?
MX]1)1:DL=YP_"F=:-D38!HQV'S5M\OV\ 8RY<UN ;94<WN4=MPDTCAO>_3J6
M&QU(EIPS/&*E[IW/D0ZY$I+MJS^3^895YK=TN["9Z;=??3.\<)IA[LR[?(SM
MG%WOZ%@MZRD>4PB.D *"&\*+7=;N'H5V%&M!:0P36%<RQ:J@E!L^?\6C?J>=
M);_WK]L'@BVX29##J<-OUI+IXUE(/C[(+L*+<%#A[4[EJLN!X6 E80/'WJ-3
MV]&9)H<XG4]JL@M((>TZ"VYWAL1TE,F-XQONX)^?WM>*5<@@>XU</O76QG-)
MIXO=:<(:;6.7-KXQR6*1BSM5I+P7T]Y(!-Z0&$EX;PW4SEF%@WMT-+L.W?ML
M<(HHO=_I[4WAMXO]?/NG)*#0&I6_ZZ@,"^O9C+-F/':3VR7; &;5.)1@?031
M[-,DRUE ,'I4?3[E(8@:]\SS"*G^#:"SUI2:W_&G!>G431,/(8"B"@_0>]LH
M.?"-&;7,PFD/=8L'PLG15HK/6O]."EJ "!C'XJ@=5F#H\?XT)(J#I_(:#,CZ
M?B%R5>D.CV+:,FR/<XZ)YS%'YY_B^:3]PQ9TK&+"%9@GJ$=>HRR1'5XUZ8@%
MA\(]X<9ZC$U7MB83=ANJ!>):S#1&)YM2RZ)W9RT6\3C),D90* Q<*3>F02&]
MWSO,&9SJ'K-RY9SK924*'0]Q[5$/.A5;))[$D]OD$Q3#_CP$98N]4Z9'<LVA
M4Z?Y$=C\$1F:!@=#(C02W"JTS8)V_S"KWMN_/[[@C(RXO5;N[>QQ6=VZW[<$
M7_-/Y5PL!F3&QHACN^-3AQ+>?2/6(?\<1@0]/D/"7C(^87?DH'_>Z-#I +/?
M"!L=@\-Z*]YCOQ^97+3[8SDV&(I.F80C/?[47S#3$?;WP G,<$;HD+8.A[ =
MGSSD1LGXD!5@A]LPF6G6,L5'D9@:+2\.1,DY0XJP\<>_N"%R%1O;]ZM:0-5F
M"+\5R)AI(OC/]!1R'=3R\S'&1-N.3#]Y[-33XWZ ,!_]Z./;\4EYPRTTEM*O
M/QSF\F\NCONL=>?FW'?BF3L6857_/ WCB@S7*J#1\'A& ,*1RU$TQ](ZL8Y#
M/](YRW[W!*.M^-==Y("8S_T$*MZ-/R"[<K^;2H^[7Y\AE:U0L"-"EWB5MA9/
M1.=^T>4N>K/A7U&!F,%#^"-J=BB7'L#W2V/Z<$$3Q)_5O?T74$L#!!0    (
M )5EJ52#?@,EH0,   H(   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM
M;*55WX_B-A!^SU\Q2JL*I"R!!!:6 A)LN>X^'$*PUSY4?3#)A$3GV*GM /O?
M=^RP'*O=6YU:"1'_F.^;;\8S]N0HU5>=(QHXE5SHJ9\;4XW#4"<YEDQW9(6"
M=C*I2F9HJO:AKA2RU(%*'D;=[FU8LD+XLXE;6ZO91-:&%P+7"G1=EDP]+Y#+
MX]3O^2\+FV*?&[L0SB85V^,6S9=JK6@67EC2HD2A"RE 83;UY[WQHF_MG<$?
M!1[UU1AL)#LIO]K)8SKUNU80<DR,96#T.> ]<FZ)2,8_9T[_XM("K\<O[)]<
M[!3+CFF\E_S/(C7YU!_YD&+&:FXV\OB YW@&EB^17+M_.#:V<=>'I-9&EF<P
M*2@+T7S9Z9R'*\#H>X#H#(B<[L:14_D;,VPV4?((REH3FQVX4!V:Q!7"'LK6
M*-HM"&=FR_EF];CZ?0OKY0:V#_/-<A(:XK6[87+F6#0<T7<X8O@LA<DU+$6*
MZ6M\2'HNHJ(748OH0\+/3'4@[@40=:/H [[X$F3L^.(?#A+^FN^T4503?W_
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MH]@-)B$)W2G&X]2:P4G<29J:Q<1-9TE/=Z44:/4],HF?NF'LXVJ*=":1?VV
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M"[3;N;R(@!JK-P';.MAK8UG,&K:%3$<DGR#WN;5\#'R!=MZ.?P)02P,$%
M  @ E66I5)C4A!0N&0  \4\  !D   !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&ULQ5Q;<QLWEG[O7X'RSFS9590LR?'=<94L6XFF',ME.3,/6_L =H,DXF:#
M ;I%*[]^SPUH--FDI&1G]R$QQ6X !P??N1_PS=KY;V%A3*N^+^LF_/A@T;:K
M5X\?AW)AECH<NI5IX,G,^:5NX4\_?QQ6WNB*!BWKQR='1\\>+[5M'KQ]0]]]
M]F_?N*ZM;6,^>Q6ZY5+[FW>F=NL?'QP_B%]\L?-%BU\\?OMFI>?FRK2_KCY[
M^.MQFJ6R2],$ZQKES>S'!Z?'K]X=/\<!],8_K5F'[+/"K4R=^X9_7%0_/CA"
MBDQMRA:GT/#/M3DS=8TS 1V_RZ0/TIHX,/\<9S^GS<-FICJ8,U?_RU;MXL<'
M+QZHRLQT5[=?W/IG(QMZBO.5K@[T?[7F=Y^]?*#*+K1N*8.!@J5M^%_]71B1
M#7AQM&/ B0PX(;IY(:+RO6[UVS?>K97'MV$V_$!;I=% G&WP5*Y:#T\MC&O?
MOCN]NKA2E^?J\Y</5Q\^?3W]>G'Y29U^>J^N+G[Z='%^<7;ZZ:LZ/3N[_/73
MUXM//ZG/EQ\OSBX^7*F'GUUM2VO"HS>/6Z $YWM<RJKO>-63':L^4;^XIET$
M]:&I3#4<_QAVD+9Q$K?Q[F3OA+]H?ZB>'$_4R=')R9[YGB2V/*'YGOROL^6_
M3J>A]0"V_]Y#Q@^)C!^(C!]VD'&FPT)]^+VSU[HV31O&.'V_&=37A5%G;KG2
MS8U"J6WAOZ L/"GQ5=U4_,%D8W2K9K;136EUK>#UUK8=RE0X'$Q7PC>V,AX&
MU+5:@#S4-ZJV,%$%HZY-:)<TW=JVL!"LWG;>MC?*S52[\,:H)8/">56;$(KU
MPC1JU?ER 6)7J=:IJ=DBCDDHW7(*.Z] RDO7-2U(:@WT&J(]F&OC-RA7[<W*
MED#GC3+?2P,CSTU%;[TW*Q=LJRZ:T'F< _;G5\YKTB(/__,_7IR<'+T^?W]Q
M1A^/7S_"B>75TN%2<X-\G"@-RX/J"J A)K!%XXVR^!4PJ@3:94K8?NE-!4MZ
M&[[!^[5N@1[7%!63 L?3$)4AX,NX],B2A^H7W<"_R&-@5&UAU[#-!3  EN:Y
M8?7& 4/LO+$SV'[3'NY!Z=.$TJ=[,?;1-?.#CZ!<*W4:@AF'Z3VG4.?V.QXG
M_Z&!<Z$EML!V2A?:0SPG;P"1Q$/8&$!@U>$;7;#-G/:,@HA:^0"74TO3+ASP
M%=A%3P&/=JEYA)EU-4 5.49H-++RH?HP_A;80S7K? -X\J9 J4%,KHCY<"Z
M@)EW2\%U_O]<8+RY1BNC5AZLK =)&,Z#?Z& -G,[K2-%+#T@CK8U&2T69K2>
MAG4K8 ANP95EY[U!D"#&8 6-0+HF(80QI?5EMP2^DJ"L%[9<P'H5X*(U!)R"
M&+%$@0H@KC<H?[R0J0[C0;%85C8 5A&V,SHM#]#U<EXX"UA_8+OPMM3>W^ A
M\=Q(RPPF52#2G2'9IS.FN<& UT,U4X$Z:1''*&7YQN'M&G%4$XZ$717H&(&#
MJ!>#-@>$!?2*V@?_9PG^S_9B]R?GJK6MZS'4WVVD2A\\@CK0 1%$D]#W)Z%@
MOQ5A(^.9O-&XY@"42^M=7>.N 3V@=)"3$?7%]B!= N+@1-44)0?78]9-$B3*
MNJM, A"H^*8%]:$1E%OX/%0_6_!:/"O7B9K'K8$2!Z" 1@<U2P=$ D*+@XXC
MG4Q*<^4MX '.<E*(")ED!)#DX)8&$8,V!L$&_/"M+;M:@]EPL"H@->I!U-#'
MSU\'$BJ0K\@/5*@:=2J0BGPJ@5NV!&&?S0RYB6JB[&RX--#%@J2+76Q6TQL:
M$Y'*EH5D#104X1K$BH43'54Y!Q$1T#,T?UP1[(?,$6B*L ")FN&V83)0?0Z4
M^!\$=-R+KG[KV, B[W15$4^!&PB7 ]AOJ5>VU2!+"6R((8=F":7>L$H1X=E6
M.RC4:#L A,#N/P@N+7V+9A7B 7#LI[\!]W!YT&;6@2(I,NDTN%F=N0U#),Y'
MJ-H+-%:$/>6B#)$B60HQ-E2-P.G:Z("JM>G(^.-J=U>8KJEZJ-)2:_!@6@2U
M6S>X<]Q4P9L" $6/"#F:]";L/9CQ6:.H1=8BPVN[M"VY/Z\ [)GIAD,&H8:I
M "UH<*P *TJQ::ZM=PUN? )XF8.$@%S>#+\G7VL.,)F!R^I\>(WN"3&AE5-4
M:)LTB0D2B^[7#+0YR!JI:?:["O'I%B3[Y-*%#G0'OF1HEQJMW&\2BSEB#<S9
MX;3\TFM^*X!;AY_8H-CX^G#G:%O2 S8U.%$'.&!L#4^2%5TPQ2C3P6&LJWQZ
M@ 6>5MENV!?$70C,M\:@6() T<+#]^ \//ICN=&*D R;B(6#]1J KI?T# G[
MK6N838QP%#Z":R\CN=$SH1TNM2"WLUV[[.2"F;-?&,$AJAW-.N"M6R&/KC6<
M=Q=$&[*  46H7QL VL*NPH2!W^ N0-UX#@A^Z^#(P7 A=Y'N8/RU19\B+L<$
MYA,1O-%E<PT?R0PABN=11-'2\SE\I1G[+)];^ZEAS9JD7'0U.B$X665 )4.\
M'&V_,"<9A"%HD!\8:QB/>0Y2Z7?A^D6#\>8Q\00^'$4G?VW( YJSKKMHDCJ.
M&Y%G]/X 8:"P;X)-BJ!"W!O@FR9G1Q[&[=[O##@<*=)TFV)S&NB HE<P0M5D
M8-S("(GG@!:'A$/]#APCJ8!SN4$5"&$-R!2%/*3:@-&DW'NN @:=1V'XAD/(
M0*+>ZQ7FQ>SN;V_1V.+!YH0BZ&J#_$1B@5E,;<]>8( 066PJEP2?S'8-+#O'
MT0/OE@ 0C1]\&QD C-FUF12T#4WD)C6W+CUD1A^>0X@)!)%-'H\%R/G7Y QM
MT>&WW?==6GA[Y2E8=L%NB7X<2LY2^V\&4+8" Z')W]R2WB$?<*>WR>^.PP68
M#U0U&;&Y:3#RAQ-8DRF8FMR]HIE'HQ;QN4T;/9(A(PJD;,*B')"(/^/E3)(3
M.0Q9M]WXL0/H?:[!XN3]5A1((=PX0\'?WF0D2N!':"255AGPJJM!"#C0&:(P
M<SO9CMC *LG +OS%*+3BQ0'J:[U'5HIMC&QS)$2U7'4E>J^8D,;7; 9H\<?I
M)-^#A5].@4A)*Q[3=F,^)T\3C.TU(GAC"TCQ;I$?H"-S"S;W4V3[B8>QF^I<
M$FEV<;T,:D.(B6V+\3<Z7_ "F)/YW%#(W!]."A+P4,!))"%,0K0OAGZ>8NCG
M>R/A+P:Q12+P"8*KLRRXNI#@:BR\_LN3$G-V1\UT*IS.F&$=@=GL^WEW1H+B
MC*/F<[6M6&93#I5R69P,)=T8!$_HO"3E#Q$%Y5(1"Q"X]^[==1^+(RG+%0FX
MQTP7!>TL6^+%4X+3^-(&(AA.$^#&;AS[@.D]"@:$[EF'>:U)-)P]49&*/B+W
M/;&4K-F;B% +@PKVIA]#@7;<3AY@><K8'19?MX-PL'LQB8#G@VY/)F]H B#6
MH6(-IE$QU0P2:U<U:P:O+='4KDU]W6>%M$=S$Z(1H=RJQH5F-*LP!C:QDA1!
M#,PRMQ9\5F_X8%GNMLZ'G"$P,")G9L@,X68Z:TQ>8QA%J0$MYE.TP0Q8Z]:9
MH!(P)/"I7JGC1XI9DO1_6J9/BX KY&Y2A*A]56?Y)@^A,HQ$U<!4]-,Q@$X>
ML=L-2A!SWACT 7/ EL&VFH[4$'QW ZR%\YRUDG<MP>A2-,FKP'DT05/ ,RGZ
MK#QG2R^9ZQ5G)'OX2<Y*DNFCXJ?S@YE$,=I_:OU>\\>X E5)MD\357<' 9TO
M1-J1E+@S(78RXL+LE1%)[_BJA]U CTAM0W'9EI87!X5IH^,]?JV^W$%/Q7=!
M'6&- ],#E"HC^#83JCR@4];;4LD*4*3#API>@@6GHBV \+Y<,\R%3011=]"<
M07)9?=P'QZ-;!I-MQ:6/28KL3)*#BM$UJMFA79_T&H%0.ZHT[B7N10+.P#?@
MO=[YK"FK%G?,;@G7?,8V<;A10$"8!++<?0(P]-0/>3,A9Q5)TM\GX/[!<+0/
MP&5O$.&P?E*#45[R:24E5?36< R>F7'# R-''_A3@WGKYHM=DZK[3SI)()"J
M'W+)=Z#"=MLM625LDC%DC5"0VX0B+"AEH6M,-2-/^2CZ8  GB&%-"_I]VK6$
M=&+O[;@7<Y\'_VP1>R9D*PB(9[I,&-O#KW[@KBKA-EC40WMH#HN1R.?19O5!
M>];. ;S5?=[@B^0-OMCKN.WRUD8+BW]NJBTQHF@O[#P>P@0[3#F<%N33*S>M
M[9SM+*9NN=X*!H)RX=%WV:<'*#D#* .W@W+EL5Q!WL#M3F1*ZO05$TV"@:%E
M>[-1!KD'</?IK3\)T]W(/*,\=DC&&]XI-C; 0H)&>6CJ0S<-MK)HOTCD*[<1
MV5:F)Y&Z@1"R9%;(I1>&9[Y(2 6@G).B**5A(F-,WA_!A&UK:H&85G/T=3'S
MCMD'^)@QC+(-NLCV0\YNSM]#=84>RG 2B([!6^O\H/Y]N\^1@!:[,^*);?(+
M5SY4_XJYD)&JV&ZL[*B*_7NK8,4M5;#3](PBGY19EHH%):!KK">*'[([2$3W
MF\^-/$<9A4PK"6!XXNA6E#:UI:04[DZ>B9>Q3YN^3-KTY2UA,! (#/["S$+*
MQO3HO2=1\EV0"#D=A5A/<123WDP9:7Z]H;H8@-E@> ZZZ\F!&EEE$ELM**BM
M;"B[$"2@\?*Z[U_?Q[#CH[XI[FCO;C][=VUI%5S\C+MS/A(R1IO=_O1LZJL:
M2QI12PB/X72_- @). =^K(1<)40QR7%;Z1L<5$-@1C4M":E!G:(O'ZO=%%D/
M:!LNLZ'C>QG!YHP[>&FY;O]DDI=&8FOL-=J8V&,P;/#!>1>IBV K\2J>&LD-
M*&M*.6(L3+G#"95DS8&;S8@7Q3Y.3N(&@=Z&@D[,P/2)STQI2>8U]KN4(+ 8
M&, >]B$N:\,\WHN1"U;_7_7W'1"[^W E?[3T!RDR9KS4P_N D5+,!)C:ZJFM
MT11PEQ2V5\V,IY*)_IYZ +(W[;;<1Z7&R2,:B.@ &V.D%6_@7!25G<$:_&QJ
MVK41XS+BXFQB@/"5VC=VD<<A#-C +(Q#JE!^^/%0[_,())M!0HO"KM8:@JR[
MLV3#$IM&4UB#H]!)"X7YON)(!VW4:L4A&#R6$@"=GH@7)T\RWY-2A"E8SUE(
MG0_9S%+&N*8L$UI.T[:U-" HP\4=M.QWV!79]ZS-(.YDPP9C<]" ^I0K -63
M)(TB*^0)'2P[%CM<I5UHF)H&#*I4GI":OE4 Q9C3$L,B4FR#C*4OVFT'_*06
M5"[\C&;F S@46CSQM$R??$.GHZNPX'*.\,]H09?,M'WSF<?F&IS[ .<^X*P_
M('/A:BE;BG[KSVYH4$==?RYQJAI;#D+/&=HP=P+$[ GMZ.D1'DI)M2\DQBZ<
MHZ:]J:'HV>B:EJ2>&,R:HM(K&#K$>NI)V,U).<K3+Q^NU&G9]OJU%.<>*["2
M[<6!M5ZGCE?TLE"U;_EBDHJHL'0#*I<5E9L5R5M"V#>!RXE5UA<*;M[5F7K^
MPY$:*$C)#@@421((XV4?@/00)UG0Z[ E*ZG%>-=Y;3A %$K79FY#G9I613<P
MU_)G"XVUN4Q,,V.4HJ%$CAUH?&SAEL3(X %X!:1A]K=$QB[ZK9Y+!"SEF#D!
M6_J.&\4D?>$+. -=LQ8,P>$18*F/&H-@1-=D'"+^,50Q@/94'*.*_>:19H-V
MT+W/_I[T]O=DKP$]QU#IGS%4.D^2=M&$UG?+7<WW?WU6;E_?M&ZI?38V=>4I
M7W%D=K7K3Z3 -Z>P5?OFP'5M 8<OB:Y1-RQ]&4&",V./;?8-%NB_DT(0L]K'
ME]AG:V*ZED*T U2^&SW^V/<VO$@@3#@<XT+FJ)PN&:'B.Y^F?/W#886&XHB7
MCXJ,U+ 1"?-2"6:4-1'QVKD*ZEC;IZ,_NJ:"(91*FNKFF[HD(URI+SA9O"'P
M\>+=Y9=X1>!0?>[=4.FK(HV?UNC+=>2P5L-Z1]*ZT4VCI.*JQKP*+10O542'
M@)*T[!GP'F-*$VM%,J0TY ?!5.1)]16KVXN;$A6XVZH3O?)>=2WGQ(I-Y4!/
MX> :2G>+\YAW_!*F8H:KC*T]O/0G\&^HT,2-6'TWL4 CE.!R9N X>41^$A72
MJ/&DBEV;,5'24!X?CP/W#*XBG#X[<MQL]@3F@LUL%_A2HJ5GX<Y.X:!NA6AB
MV)8V_3<QC!)-J2#"6]9T40MPJ'WM5+!+R7V# JZ %UT+:/R#.RS<% -\VC4S
M2-(ATDZNKAT.)?!R\TG@FSID97G+^23"Y4AVW\@2>V2W9H6-GSS].S<H%H/I
M\='+PY=/_IYE&YZF<"6W^EM)LSN(P^9Q50;S/ABA_^W9T1-TV;M "7-9;W#7
M:=3R4G$>&$=44$3\MY/#E\72PL+DXVX,V)OTZ*^\'3_9:ZRNI*?R2RSUC1J\
M>\ZA+C=[-L=:/[$7'[FY\C9P<BRFC&)>.[,:?!55$*NOM:T)=-QF$[(N(^YY
M]J!2IS=PRM;,,M\23HGS'DO]S7"(M=EUEF7R" G!@8R)@X599VK]D9)H;!G8
M:'Q+2IT7)E'W5 :+W'BE5HN;0'D.S'#I57PWM9G?J<US+P3ZZX;'^V\+_LKZ
M(]YY&G=Y[C>%NE -$@P'N:L7]];ZQB2[TD'G%?KF_+0.YGK@2#K6QM@X1YDQ
M:B:@3AG17*V;4)%FV%L_&6OSG>1-6/EMB:TFO1XJ(4]><WI\LB_+-N&8,;U
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M)><5"LVE (6KH1_WWH[/K;]S^,)QHP_F8)4LI?QI%TD^]$-+"$O,C(W :'C
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MB!9V>T<E$Y4B<:.'7#&.1[A)>:*N!ZUU)@'>U;*%E8BSIA3OS:"UP/%18LK
M=4/[A01^W^U$/5SU^V[8:;<>D5\V#KW;D'3:W=8R.R@6T]RHD[0\$!PYTMZ?
M,B"![[8#OP;I^3Y2<QP7A:&*4:&I7 ,9NF'8Q6^GTV_->8+](QD",_Z[D@=2
M6C=;&'.%+,;43Y%!W_6[/93L^GZ_A;28VZW?M@)"-\*CCUZ'=]9Y!<C4SA>\
M6E%Q73=AL]N,L+NZ<_^YU_,/;S1EF'$.6PSU;VX[#I'U3*D-+4K;QQNA<2K8
M989C&*1QP/.M$/ID&()FL(__ E!+ P04    " "59:E4$ Z\%[T#   ?"
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MYUW,9K'MW[83Q0O3,RVYP@[,#!-L>4%H WR^XE@SJHDFJ)OHX3=02P,$%
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M@10-XJS%,.R!EJXEHI*HD52<_OM=4K9B9X[6#7M(1$J\Y]R/P^L[VPKY714
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M>S&=.JM"2'VN05:'IR(:DFB2.%^9Y$9<A]]";QI1_#\)0^=!:%8>?OP%@</
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MTN#H<V:%_QI0U@&_KZ4TAX4E&/Y>\Q]02P,$%     @ E66I5.>%=DB$"P
M5D4  !D   !X;"]W;W)K<VAE971S+W-H965T,S,N>&ULO9S=;]LX$L"?]_X*
MPM@[[ )M+>K;O21 ZGRY;5(C;GL/Q3XH,AWS5A*UE!0GB_[Q1TJR*=L223OV
MO;2.K1D.A\/?C"A2)PM"_\SF".7@.8Z2[+0WS_/T?;^?A7,4!]D[DJ*$_3(C
M- YR]B=][&<I1<&T%(JCOFD8;C\.<-([.RF_&].S$U+D$4[0F(*LB.. OGQ
M$5F<]F!O^<4]?ISG_(O^V4D:/*()RK^E8\K^ZJ^T3'&,D@R3!% T.^V=P_>?
M('2Y1'G)=XP66>,SX'UY(.1/_L=H>MHSN$DH0F'.=03LOR<T1%'$53%#_JJU
M]E:-<L'FYZ7VJ[+WK#</08:&)/H/GN;STY[? U,T"XHHOR>+&U3WR.'Z0A)E
MY;]@45]K]$!89#F):V%F08R3ZO_@N?9$0\#V.@3,6L#<%.AJP:H%K T!LTO
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M12.:!<E\Q4HM3G!<:&U\\ 6*?/F.WE<PV&]LZU7L.UO+TA&.,1_6W38X*YJ
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MN"-%/>_1PQ:=*1K3B)#$,LQIF^-'E%)-EIBY^R1F':">%FLY3@,"G7>>//:
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M\/^''+8/U8U14!\P//L;4$L#!!0    ( )5EJ50,!X)AO (  $4'   9
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M0KE+[R-T\A!)K+,S>#%;W'G\]*1OE^;9A8G.D3O:KA#BEER=1H>VF,SN(-E
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M;EWCKY(*3$!Q73[R_$A9"G/=0A5\(#'-J7J UQ$J0G/Y!M[!ETT$KU^]@5=
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M)R3J@I]DX];'X!I_;M<QD(V^3 I,67F5BROQ]6XEE= 7X]N% %X=P#,!O(X
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MLU;T '-*Z%R@F+-,Z7ZOA>8K<;[?VC;0?SW'V2W^I!)_4BO^&R-*Z;V2FW-
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MQHW:N%?M39HR>XF@9-"&X67P6LFK^(66, XFPPN"QHV@<:^@%9>:Y0=2*):
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MU[BGJGH'5!,C"]<9=])@GW7##-].H*P!?M]+:4X3ZZ!YC2W^ U!+ P04
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M96QS+W=O<FMB;V]K+GAM;"YR96QSS=D[;L) %(7AK2 O@.$^("&"5&G21FS
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M;Y^_+*\W$>?A!>< 1ZWOOU!+ P04    " "59:E4G"O3#[T!  !W'0  $P
M %M#;VYT96YT7U1Y<&5S72YX;6S-V<ENPC 4!=!?0=DB8CR4#@(V;;<MB_Z
MFSQ(1!);MJ'P]W7"(+6BJ(A*O9M$B>UW7VSI;#)^VUKRO4U=-7Z2%"'8!\9\
M5E"M?6HL-7%D;ERM0WQT"V9UMM0+8F(X'+',-(&:, AMC60Z?J*Y7E6A][R)
MKWUIFDGBJ/))[W$WL<V:)-K:JLQTB.-LW>3?4@;[A#2N[.;XHK2^'R<D[&1"
M._)SP'[=ZYJ<*W/JS;0++[J.L]BF8CYL*_+I^1(G>C3S>9E1;K)5'9>DWCK2
MN2^(0EVENZ+]\\DA[C#MKOSJ_*[,N< X<^:,]?'$'%T>=SB2=O7 QD+D0GG^
M$X^)L?35WT?M:>>4_S([;N^'<<ON/#SK;M?O\=<S/M:_L \!TH<$Z4.!]'$#
MTL<(I(];D#[N0/JX!^F##U$:01&5HY#*44SE**AR%%4Y"JL<Q56. BM'D56@
MR"I09!4HL@H4606*K )%5H$BJT"15:#(*E!DE2BR2A19)8JL$D56B2*K1)%5
MHL@J4625*+)*%%D5BJP*15:%(JM"D56AR*I09%4HLBH4616*K.H_97TW9OG7
MOP+;>UKKLCGDL^Y_Z_034$L! A0#%     @ E66I5 =!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "5
M9:E4CUL?0/     K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "59:E4F5R<(Q &  "<)P  $P
M@ '. 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )5EJ52JI.T*
M7 4  " 6   8              " @0\(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "59:E4/%EA'@((   N(0  &
M@(&A#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ E66I
M5+U;QTQ9 P  V@H  !@              ("!V14  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( )5EJ52B:]D4608   H:   8
M      " @6@9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" "59:E4+4ZBW9@(  "))   &               @('W'P  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ E66I5!Y\O<)7"   _"\  !@
M             ("!Q2@  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( )5EJ53YY1V>CB    5F   8              " @5(Q  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "59:E4+FR<*8L-  "_
M+   &               @($64@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ E66I5.+J4UL-$P  8C<  !@              ("!UU\
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( )5EJ52#?@,E
MH0,   H(   9              " @1IS  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ E66I5-?3)P1*$   23\  !D
M ("!\G8  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "5
M9:E4.K.]';0"  "O!0  &0              @(%SAP  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( )5EJ51CBE/GHP0  ,L*   9
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M970Q-RYX;6Q02P$"% ,4    " "59:E4S*^5-R$#  #M!@  &0
M    @(&?I0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M )5EJ51(!^@$T0,  (\(   9              " @?>H  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ E66I5-4"'_E> @  >P4  !D
M             ("!_ZP  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " "59:E4F-2$%"X9  #Q3P  &0              @(&4KP  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( )5EJ52]0Y#6$P,
M  ('   9              " @?G(  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ E66I5*0^'G,? P  :08  !D              ("!
M0\P  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "59:E4
M0>#O+]D"  #D!0  &0              @(&9SP  >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( )5EJ500#KP7O0,  !\(   9
M      " @:G2  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ E66I5'80:&0K!   4 L  !D              ("!G=8  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "59:E4K%.ZH,0"  #*!0
M&0              @('_V@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( )5EJ52"_?W%%@0  ',*   9              " @?K=  !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ E66I5*(8:L0N
M P  7 8  !D              ("!1^(  'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " "59:E4WJL=BI8#  "&"   &0
M@(&LY0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( )5E
MJ52+&1K,100  #D+   9              " @7GI  !X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ E66I5")(7P\7 P  R08  !D
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M=#,V+GAM;%!+ 0(4 Q0    ( )5EJ52YPKWIN@<  &PH   9
M  " @=$6 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
ME66I5 P'@F&\ @  10<  !D              ("!PAX! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    " "59:E4ON6!)ML#  "X$   &0
M            @(&U(0$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    ( )5EJ51 RK[-SP(  #4(   9              " @<<E 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ E66I5%40SII* P
MM0H  !D              ("!S2@! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    " "59:E4:=U@:WX#  #;"@  &0              @(%.
M+ $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( )5EJ50M
MQ&64W ,  !4.   9              " @0,P 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ E66I5.%^*QNF!0  1!L  !D
M     ("!%C0! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )5EJ51HC-[&/P,  )D)   9              "
M@?=) 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ E66I
M5":MV<H4 P  $A$   T              ( !;4T! 'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " "59:E4EXJ[',     3 @  "P              @ &L4 $
M7W)E;',O+G)E;'-02P$"% ,4    " "59:E4!27G5BT$  "4(   #P
M        @ &540$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ E66I5(YA
M./J] 0  >AT  !H              ( ![U4! 'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ E66I5)PKTP^] 0  =QT  !,
M     ( !Y%<! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #D .0"&#P
&TED!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>191</ContextCount>
  <ElementCount>357</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>59</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - ACQUISITIONS OF BUSINESSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinesses</Role>
      <ShortName>ACQUISITIONS OF BUSINESSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RevenueRecognition</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShare</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterest</Role>
      <ShortName>REDEEMABLE NON-CONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - GOODWILL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/Goodwill</Role>
      <ShortName>GOODWILL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNet</Role>
      <ShortName>INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpenses</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreement</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>061000 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>061100 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformation</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>061200 - Disclosure - INVESTMENT IN UNCONSOLIDATED AFFILIATE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/InvestmentInUnconsolidatedAffiliate</Role>
      <ShortName>INVESTMENT IN UNCONSOLIDATED AFFILIATE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>061300 - Disclosure - COMMON STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommonStock</Role>
      <ShortName>COMMON STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>061400 - Disclosure - RECLASSIFICATION OF PRIOR PERIOD PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ReclassificationOfPriorPeriodPresentation</Role>
      <ShortName>RECLASSIFICATION OF PRIOR PERIOD PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>070100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>080100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>080200 - Disclosure - ACQUISITIONS OF BUSINESSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinessesTables</Role>
      <ShortName>ACQUISITIONS OF BUSINESSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsOfBusinesses</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>080300 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RevenueRecognitionTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/RevenueRecognition</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>080400 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShareTables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/EarningsPerShare</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>080500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterestTables</Role>
      <ShortName>REDEEMABLE NON-CONTROLLING INTEREST (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/RedeemableNoncontrollingInterest</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>080600 - Disclosure - GOODWILL (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/GoodwillTables</Role>
      <ShortName>GOODWILL (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/Goodwill</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>080700 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/IntangibleAssetsNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>080800 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpensesTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/AccruedExpenses</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>080900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/NotesPayableAndAmendedCreditAgreement</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>081000 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/Leases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>081100 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformationTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/SegmentInformation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>090100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>090200 - Disclosure - ACQUISITIONS OF BUSINESSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinessesDetails</Role>
      <ShortName>ACQUISITIONS OF BUSINESSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsOfBusinessesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>090300 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RevenueRecognitionDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/RevenueRecognitionTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>090400 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/EarningsPerShareTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>090500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterestDetails</Role>
      <ShortName>REDEEMABLE NON-CONTROLLING INTEREST (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/RedeemableNoncontrollingInterestTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>090600 - Disclosure - GOODWILL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/GoodwillDetails</Role>
      <ShortName>GOODWILL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/GoodwillTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>090700 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails</Role>
      <ShortName>INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>090702 - Disclosure - INTANGIBLE ASSETS, NET - Amortization Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails</Role>
      <ShortName>INTANGIBLE ASSETS, NET - Amortization Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>090704 - Disclosure - INTANGIBLE ASSETS, NET - Amortization of Referral Relationships and Non-Competition Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails</Role>
      <ShortName>INTANGIBLE ASSETS, NET - Amortization of Referral Relationships and Non-Competition Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>090800 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpensesDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AccruedExpensesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>090900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>090902 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Amended Credit Agreement (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Amended Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>090904 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>091000 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/LeasesDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/LeasesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>091100 - Disclosure - SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformationDetails</Role>
      <ShortName>SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/SegmentInformationTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>091200 - Disclosure - INVESTMENT IN UNCONSOLIDATED AFFILIATE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails</Role>
      <ShortName>INVESTMENT IN UNCONSOLIDATED AFFILIATE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/InvestmentInUnconsolidatedAffiliate</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="brhc10037138_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>091300 - Disclosure - COMMON STOCK (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommonStockDetails</Role>
      <ShortName>COMMON STOCK (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/CommonStock</ParentRole>
      <Position>49</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="brhc10037138_10q.htm">brhc10037138_10q.htm</File>
    <File>brhc10037138_ex31-1.htm</File>
    <File>brhc10037138_ex31-2.htm</File>
    <File>brhc10037138_ex32.htm</File>
    <File>usph-20220331.xsd</File>
    <File>usph-20220331_cal.xml</File>
    <File>usph-20220331_def.xml</File>
    <File>usph-20220331_lab.xml</File>
    <File>usph-20220331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="669">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>66
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10037138_10q.htm": {
   "axisCustom": 0,
   "axisStandard": 20,
   "contextCount": 191,
   "dts": {
    "calculationLink": {
     "local": [
      "usph-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "usph-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10037138_10q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "usph-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "usph-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "usph-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 555,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 7,
    "http://usph.com/20220331": 3,
    "http://xbrl.sec.gov/dei/2021": 8,
    "total": 18
   },
   "keyCustom": 97,
   "keyStandard": 260,
   "memberCustom": 32,
   "memberStandard": 25,
   "nsprefix": "usph",
   "nsuri": "http://usph.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://usph.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060400 - Disclosure - EARNINGS PER SHARE",
     "role": "http://usph.com/role/EarningsPerShare",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:RedeemableNonControllingInterestTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterest",
     "shortName": "REDEEMABLE NON-CONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:RedeemableNonControllingInterestTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060600 - Disclosure - GOODWILL",
     "role": "http://usph.com/role/Goodwill",
     "shortName": "GOODWILL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060700 - Disclosure - INTANGIBLE ASSETS, NET",
     "role": "http://usph.com/role/IntangibleAssetsNet",
     "shortName": "INTANGIBLE ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060800 - Disclosure - ACCRUED EXPENSES",
     "role": "http://usph.com/role/AccruedExpenses",
     "shortName": "ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT",
     "role": "http://usph.com/role/NotesPayableAndAmendedCreditAgreement",
     "shortName": "NOTES PAYABLE AND AMENDED CREDIT AGREEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061000 - Disclosure - LEASES",
     "role": "http://usph.com/role/Leases",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061100 - Disclosure - SEGMENT INFORMATION",
     "role": "http://usph.com/role/SegmentInformation",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061200 - Disclosure - INVESTMENT IN UNCONSOLIDATED AFFILIATE",
     "role": "http://usph.com/role/InvestmentInUnconsolidatedAffiliate",
     "shortName": "INVESTMENT IN UNCONSOLIDATED AFFILIATE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061300 - Disclosure - COMMON STOCK",
     "role": "http://usph.com/role/CommonStock",
     "shortName": "COMMON STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010000 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://usph.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061400 - Disclosure - RECLASSIFICATION OF PRIOR PERIOD PRESENTATION",
     "role": "http://usph.com/role/ReclassificationOfPriorPeriodPresentation",
     "shortName": "RECLASSIFICATION OF PRIOR PERIOD PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies",
     "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables",
     "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080200 - Disclosure - ACQUISITIONS OF BUSINESSES (Tables)",
     "role": "http://usph.com/role/AcquisitionsOfBusinessesTables",
     "shortName": "ACQUISITIONS OF BUSINESSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080300 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://usph.com/role/RevenueRecognitionTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080400 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://usph.com/role/EarningsPerShareTables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST (Tables)",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterestTables",
     "shortName": "REDEEMABLE NON-CONTROLLING INTEREST (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080600 - Disclosure - GOODWILL (Tables)",
     "role": "http://usph.com/role/GoodwillTables",
     "shortName": "GOODWILL (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080700 - Disclosure - INTANGIBLE ASSETS, NET (Tables)",
     "role": "http://usph.com/role/IntangibleAssetsNetTables",
     "shortName": "INTANGIBLE ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080800 - Disclosure - ACCRUED EXPENSES (Tables)",
     "role": "http://usph.com/role/AccruedExpensesTables",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)",
     "role": "http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables",
     "shortName": "NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081000 - Disclosure - LEASES (Tables)",
     "role": "http://usph.com/role/LeasesTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081100 - Disclosure - SEGMENT INFORMATION (Tables)",
     "role": "http://usph.com/role/SegmentInformationTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "role": "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
     "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unitRef": "U007",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090200 - Disclosure - ACQUISITIONS OF BUSINESSES (Details)",
     "role": "http://usph.com/role/AcquisitionsOfBusinessesDetails",
     "shortName": "ACQUISITIONS OF BUSINESSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember",
      "decimals": null,
      "lang": "en-US",
      "name": "usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090300 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://usph.com/role/RevenueRecognitionDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "3",
      "lang": null,
      "name": "usph:EstimatedPercentageOfDecreaseInPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090400 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://usph.com/role/EarningsPerShareDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "lang": null,
      "name": "usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090500 - Disclosure - REDEEMABLE NON-CONTROLLING INTEREST (Details)",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
     "shortName": "REDEEMABLE NON-CONTROLLING INTEREST (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331_OwnershipAxis_RedeemableNonControllingInterestMember",
      "decimals": "-3",
      "lang": null,
      "name": "usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090600 - Disclosure - GOODWILL (Details)",
     "role": "http://usph.com/role/GoodwillDetails",
     "shortName": "GOODWILL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090700 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
     "shortName": "INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://usph.com/role/ConsolidatedStatementsOfIncome",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090702 - Disclosure - INTANGIBLE ASSETS, NET - Amortization Expenses (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
     "shortName": "INTANGIBLE ASSETS, NET - Amortization Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090704 - Disclosure - INTANGIBLE ASSETS, NET - Amortization of Referral Relationships and Non-Competition Agreements (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
     "shortName": "INTANGIBLE ASSETS, NET - Amortization of Referral Relationships and Non-Competition Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090800 - Disclosure - ACCRUED EXPENSES (Details)",
     "role": "http://usph.com/role/AccruedExpensesDetails",
     "shortName": "ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090900 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details)",
     "role": "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails",
     "shortName": "NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090902 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Amended Credit Agreement (Details)",
     "role": "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
     "shortName": "NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Amended Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090904 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details)",
     "role": "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails",
     "shortName": "NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091000 - Disclosure - LEASES (Details)",
     "role": "http://usph.com/role/LeasesDetails",
     "shortName": "LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091100 - Disclosure - SEGMENT INFORMATION (Details)",
     "role": "http://usph.com/role/SegmentInformationDetails",
     "shortName": "SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091200 - Disclosure - INVESTMENT IN UNCONSOLIDATED AFFILIATE (Details)",
     "role": "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails",
     "shortName": "INVESTMENT IN UNCONSOLIDATED AFFILIATE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20090301to20090331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091300 - Disclosure - COMMON STOCK (Details)",
     "role": "http://usph.com/role/CommonStockDetails",
     "shortName": "COMMON STOCK (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20090301to20090331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "030000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20201231_StatementEquityComponentsAxis_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "040000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "role": "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20201231_StatementEquityComponentsAxis_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies",
     "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060200 - Disclosure - ACQUISITIONS OF BUSINESSES",
     "role": "http://usph.com/role/AcquisitionsOfBusinesses",
     "shortName": "ACQUISITIONS OF BUSINESSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060300 - Disclosure - REVENUE RECOGNITION",
     "role": "http://usph.com/role/RevenueRecognition",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10037138_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 59,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r108",
      "r248",
      "r253",
      "r261",
      "r432",
      "r433",
      "r437",
      "r438",
      "r501",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r108",
      "r248",
      "r253",
      "r261",
      "r432",
      "r433",
      "r437",
      "r438",
      "r501",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r108",
      "r152",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r178",
      "r182",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r258",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r108",
      "r152",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r178",
      "r182",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r258",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r266",
      "r304",
      "r364",
      "r367",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r562",
      "r564",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r266",
      "r304",
      "r364",
      "r367",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r562",
      "r564",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officer [Member]"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r184",
      "r347",
      "r350",
      "r513",
      "r561",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and Services [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r184",
      "r347",
      "r350",
      "r513",
      "r561",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and Services [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r266",
      "r304",
      "r361",
      "r364",
      "r367",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r562",
      "r564",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r266",
      "r304",
      "r361",
      "r364",
      "r367",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r562",
      "r564",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r119",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r119",
      "r125",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r119",
      "r125",
      "r242",
      "r365",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r362",
      "r496",
      "r497",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NewCo. [Member]"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r189",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "ASU 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Accounts and Other Receivables, Net, Current",
        "terseLabel": "Accounts receivable - other"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r18",
      "r42"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable - trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r13",
      "r29",
      "r190",
      "r191"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Patient accounts receivable, less allowance for credit losses of $2,799 and $2,768, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r48"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "terseLabel": "Group health insurance claims"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails",
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r40",
      "r234"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r30",
      "r378",
      "r504"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r375",
      "r376",
      "r377",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r112",
      "r113",
      "r114",
      "r115",
      "r125",
      "r195",
      "r196",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r247",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r393",
      "r394",
      "r395",
      "r396",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r495",
      "r515",
      "r516",
      "r517",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r368",
      "r369",
      "r379",
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Compensation expense - equity-based awards"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r35",
      "r192",
      "r208"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for credit losses, patient accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Deferred Charges [Abstract]"
       }
      }
     },
     "localname": "AmortizationOfDeferredChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r94",
      "r219",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Total amortization expenses"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as current.",
        "label": "Contingent payments related to acquisition"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r104",
      "r160",
      "r173",
      "r180",
      "r201",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r261",
      "r262",
      "r432",
      "r437",
      "r458",
      "r502",
      "r504",
      "r533",
      "r548"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r59",
      "r104",
      "r201",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r261",
      "r262",
      "r432",
      "r437",
      "r458",
      "r502",
      "r504"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r363",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r363",
      "r366",
      "r405",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the business acquisition agreement was executed, in YYYY-MM-DD format.",
        "label": "Business Acquisition, Date of Acquisition Agreement",
        "terseLabel": "Acquisition date"
       }
      }
     },
     "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquiredReceivablesFairValue": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of acquired receivable from business combination, excluding certain loans and debt securities acquired in transfer.",
        "label": "Initial fair value"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredReceivablesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r415",
      "r416",
      "r418"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Aggregate purchase price for the acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r414",
      "r417",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Contingent payment consideration",
        "verboseLabel": "Contingent payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Description [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "ACQUISITIONS OF BUSINESSES"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Goodwill [Abstract]",
        "terseLabel": "Goodwill [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r409"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionsOfBusinessesDetails": {
       "order": 1.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "verboseLabel": "Other payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r407",
      "r409"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionsOfBusinessesDetails": {
       "order": 3.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r409"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionsOfBusinessesDetails": {
       "order": 2.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Total non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACQUISITIONS OF BUSINESSES [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r12",
      "r37",
      "r96"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r20",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r90",
      "r96",
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of period",
        "periodStartLabel": "Cash and cash equivalents - beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r90",
      "r467"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing transactions during the period:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]",
        "terseLabel": "Class of Treasury Stock [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r54",
      "r241",
      "r539",
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r28",
      "r504"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $.01 par value, 20,000,000 shares authorized, 15,206,173 and 15,126,160 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r220",
      "r224",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software [Member]"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r328",
      "r329",
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Put right value"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetPurchase": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase from purchase of right to consideration in exchange for good or service transferred to customer when right is conditioned on passage of time.",
        "label": "Contract with Customer, Asset, Purchase",
        "verboseLabel": "Seller put right"
       }
      }
     },
     "localname": "ContractWithCustomerAssetPurchase",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating cost"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating cost:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer and Referral Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOTES PAYABLE AND AMENDED CREDIT AGREEMENT [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r101",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r280",
      "r287",
      "r288",
      "r290",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "NOTES PAYABLE AND AMENDED CREDIT AGREEMENT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the total principal payments made during the annual reporting period.",
        "label": "Debt Instrument, Annual Principal Payment",
        "terseLabel": "Annual installments"
       }
      }
     },
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r103",
      "r108",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r292",
      "r293",
      "r294",
      "r295",
      "r476",
      "r534",
      "r536",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r263",
      "r292",
      "r293",
      "r475",
      "r476",
      "r477"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate amount of notes payable"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r50",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Percentage of interest accrued"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r51",
      "r266",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Revolving credit facility maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt instrument, measurement input"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r52",
      "r103",
      "r108",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r292",
      "r293",
      "r294",
      "r295",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r52",
      "r103",
      "r108",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r289",
      "r292",
      "r293",
      "r294",
      "r295",
      "r317",
      "r318",
      "r319",
      "r320",
      "r474",
      "r475",
      "r476",
      "r477",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": {
     "auth_ref": [
      "r360",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Period in which restrictions lapse on stock granted"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredCompensationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Abstract]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r94",
      "r105",
      "r391",
      "r398",
      "r399",
      "r400"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r94",
      "r155"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r347",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue, Categories"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends payable to USPH shareholders"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r24",
      "r26",
      "r535",
      "r549"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends payable to USPH shareholders",
        "terseLabel": "Dividend payable to USPH shareholders"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails",
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EARNINGS PER SHARE [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r70",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r126",
      "r128",
      "r130",
      "r131",
      "r132",
      "r136",
      "r137",
      "r452",
      "r453",
      "r543",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings per share basic (in dollars per share)",
        "terseLabel": "Basic earnings per share attributable to USPH shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r70",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r128",
      "r130",
      "r131",
      "r132",
      "r136",
      "r137",
      "r452",
      "r453",
      "r543",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings per share diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings per share attributable to USPH shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r106",
      "r386",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Federal statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r386",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Salaries and related costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMON STOCK [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r63",
      "r64",
      "r65",
      "r109",
      "r110",
      "r111",
      "r113",
      "r121",
      "r124",
      "r139",
      "r205",
      "r316",
      "r321",
      "r375",
      "r376",
      "r377",
      "r395",
      "r396",
      "r451",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r567",
      "r568",
      "r569",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r68",
      "r89",
      "r94",
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Distribution received from investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Percentage of ownership in joint venture interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentQuotedMarketValue": {
     "auth_ref": [
      "r200"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available.",
        "label": "Equity Method Investment, Quoted Market Value",
        "terseLabel": "Fair value of investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "EquityMethodInvestmentQuotedMarketValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting error correction.",
        "label": "Error Correction [Text Block]",
        "terseLabel": "RECLASSIFICATION OF PRIOR PERIOD PRESENTATION"
       }
      }
     },
     "localname": "ErrorCorrectionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ReclassificationOfPriorPeriodPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value of Financial Instruments [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Preliminary Purchase Prices Allocation"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2022 (excluding the three months ended March 31, 2022)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Amortization Expenses"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r220",
      "r221",
      "r225",
      "r228",
      "r514",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r220",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture &amp; Equipment [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r211",
      "r212",
      "r504",
      "r532"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GOODWILL [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r215",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "GOODWILL"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r214",
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill adjustments for purchase price allocation of businesses acquired in prior year"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrantsReceivable": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.",
        "label": "Advance payments"
       }
      }
     },
     "localname": "GrantsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r74",
      "r104",
      "r160",
      "r172",
      "r176",
      "r179",
      "r182",
      "r201",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r261",
      "r262",
      "r458"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r94",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of long lived assets to be disposed of"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r230",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r160",
      "r172",
      "r176",
      "r179",
      "r182",
      "r531",
      "r541",
      "r544",
      "r559"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r68",
      "r94",
      "r157",
      "r197",
      "r540",
      "r556"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Equity in earnings of unconsolidated affiliate",
        "negatedLabel": "Earnings in unconsolidated affiliate",
        "terseLabel": "Earnings from investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF INCOME [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r123",
      "r124",
      "r158",
      "r385",
      "r397",
      "r402",
      "r560"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r62",
      "r381",
      "r382",
      "r388",
      "r389",
      "r390",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Increase in patient accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables, and operating assets classified as other.",
        "label": "Increase (Decrease) in Accounts Receivable and Other Operating Assets",
        "negatedLabel": "(Increase) decrease in accounts receivable - other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Decrease in put right"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Decrease in other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "(Increase) decrease in other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r218",
      "r223"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other identifiable intangible assets, net",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INTANGIBLE ASSETS, NET [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest expense on prepetition obligations included in the statement of operations.",
        "label": "Interest Expense on Prepetition Liabilities Recognized in Statement of Operations",
        "terseLabel": "Interest expense recognized"
       }
      }
     },
     "localname": "InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r87",
      "r91",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVESTMENT IN UNCONSOLIDATED AFFILIATE [Abstract]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Unconsolidated Affiliate [Abstract]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities.",
        "label": "Investments in and Advances to Affiliates, Schedule of Investments [Text Block]",
        "terseLabel": "INVESTMENT IN UNCONSOLIDATED AFFILIATE"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliate"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Labor and Related Expense",
        "terseLabel": "Salaries and related costs"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r491",
      "r493"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Lease Expense [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r16",
      "r233"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease [Abstract]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Future Lease Payments for Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/LeasesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2027 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "2022 (excluding the three months ended March 31, 2022)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r47",
      "r104",
      "r174",
      "r201",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r261",
      "r262",
      "r433",
      "r437",
      "r438",
      "r458",
      "r502",
      "r503"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r34",
      "r104",
      "r201",
      "r458",
      "r504",
      "r538",
      "r553"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTEREST"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r49",
      "r104",
      "r201",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r261",
      "r262",
      "r433",
      "r437",
      "r438",
      "r458",
      "r502",
      "r503",
      "r504"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r8",
      "r9",
      "r10",
      "r232",
      "r236"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Closure costs"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of the credit facility.",
        "label": "Increase on limit of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Average effective interest rate",
        "verboseLabel": "Average effective interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility commitment"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining revolving credit outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Percentage of unused commitment fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r54",
      "r241",
      "r243"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Settlement of a legal matter"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r25",
      "r277",
      "r291",
      "r292",
      "r293",
      "r536",
      "r550"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Outstanding amount",
        "totalLabel": "Payments/Long term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Long Term Debt By Maturity [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r108",
      "r246",
      "r282"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "During the twelve months ended March 31, 2022",
        "verboseLabel": "Aggregate principal payment due in 2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r108",
      "r246",
      "r282"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "During the twelve months ended March 31, 2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r108",
      "r246",
      "r282"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "During the twelve months ended March 31, 2023",
        "verboseLabel": "Aggregate principal payment due in 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long term portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r52",
      "r244",
      "r245"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit, Noncurrent",
        "terseLabel": "Revolving line of credit"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputOptionVolatilityMember": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns.",
        "label": "Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputOptionVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r57",
      "r104",
      "r201",
      "r248",
      "r253",
      "r254",
      "r255",
      "r261",
      "r262",
      "r458",
      "r537",
      "r552"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "negatedLabel": "Changes in the fair value of redeemable non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to non-controlling interest partners - permanent equity"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r321",
      "r430",
      "r431"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Purchase of partnership interests - non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: net income attributable to non-controlling interest:"
       }
      }
     },
     "localname": "MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Percentage of retained interest by previous owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r90",
      "r92",
      "r95"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r10",
      "r60",
      "r61",
      "r65",
      "r69",
      "r95",
      "r104",
      "r112",
      "r116",
      "r117",
      "r118",
      "r119",
      "r123",
      "r124",
      "r129",
      "r160",
      "r172",
      "r176",
      "r179",
      "r182",
      "r201",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r261",
      "r262",
      "r453",
      "r458",
      "r542",
      "r557"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income attributable to USPH shareholders",
        "totalLabel": "Net income attributable to USPH shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r61",
      "r65",
      "r123",
      "r124",
      "r435",
      "r440"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTotalLabel": "Net income attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Computation of earnings per share - USPH shareholders [Abstract]"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently Adopted Accounting Guidance"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Non-compete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.",
        "label": "Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r321",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-Controlling Interests [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income and expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of clinics",
        "verboseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of states where clinics are operated"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r160",
      "r172",
      "r176",
      "r179",
      "r182"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r484",
      "r493"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future Lease Payments for Operating Leases [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r480"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetailsCalc2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r480"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r480"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r481",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r490",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted-average discount rate - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r489",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-average remaining lease term - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Reportable Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r11",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r48"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r58",
      "r504"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income and expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Shareholders' Equity [Member]"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCRUED EXPENSES [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends paid to shareholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to non-controlling interest, permanent and temporary equity"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r80",
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid for acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Purchase of majority interest in businesses, net of cash acquired",
        "terseLabel": "Cash paid, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedLabel": "Purchase of non-controlling interest, permanent equity"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r81",
      "r423",
      "r424",
      "r425"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Purchase of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Acquired interest"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r27",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r27",
      "r504"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RECLASSIFICATION OF PRIOR PERIOD PRESENTATION [Abstract]"
       }
      }
     },
     "localname": "PriorPeriodAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds on sales of partnership interest, clinics and fixed assets"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r82",
      "r103"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving line of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Notes receivable related to sale of partnership interest - redeemable non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r83",
      "r86"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.",
        "label": "Purchases of redeemable non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r10",
      "r60",
      "r61",
      "r65",
      "r88",
      "r104",
      "r112",
      "r123",
      "r124",
      "r160",
      "r172",
      "r176",
      "r179",
      "r182",
      "r201",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r261",
      "r262",
      "r429",
      "r434",
      "r436",
      "r440",
      "r441",
      "r453",
      "r458",
      "r544"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income including non-controlling interest and earnings from unconsolidated affiliates, net",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Assets [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r40",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r39",
      "r233"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Fixed assets, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r21",
      "r22",
      "r235",
      "r504",
      "r545",
      "r554"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Fixed assets, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Fixed assets:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r21",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r71",
      "r210"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r36",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Provision for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest, by Legal Entity [Table]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestByLegalEntityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r300"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable non-controlling interest - temporary equity",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Fair value"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in Carrying Amount of Redeemable Non-Controlling Interests [Roll Forward]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmountAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r362",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r362",
      "r496",
      "r499",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r85",
      "r103"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving line of credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Principal payments on notes payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r31",
      "r321",
      "r378",
      "r504",
      "r551",
      "r571",
      "r576"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r109",
      "r110",
      "r111",
      "r113",
      "r121",
      "r124",
      "r205",
      "r375",
      "r376",
      "r377",
      "r395",
      "r396",
      "r451",
      "r567",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUE RECOGNITION [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r151",
      "r152",
      "r171",
      "r177",
      "r178",
      "r184",
      "r185",
      "r187",
      "r346",
      "r347",
      "r513"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenue",
        "verboseLabel": "Revenue related to the various categories"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r100",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r349",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r66",
      "r104",
      "r151",
      "r152",
      "r171",
      "r177",
      "r178",
      "r184",
      "r185",
      "r187",
      "r201",
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r261",
      "r262",
      "r458",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Net operating revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "verboseLabel": "Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r488",
      "r493"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r405",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r52",
      "r108",
      "r292",
      "r294",
      "r317",
      "r318",
      "r319",
      "r320",
      "r474",
      "r475",
      "r477",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Credit Agreement and Notes Payable"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r358",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computations of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r10",
      "r104",
      "r199",
      "r201",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r220",
      "r224",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r220",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Aggregate Annual Payments of Principal Required to Revolving Credit Facility"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r160",
      "r163",
      "r175",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r160",
      "r163",
      "r175",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Selected Financial Data for Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Amortization of Customer and Referral Relationships and Non Competition Agreements"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r147",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r187",
      "r239",
      "r240",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT INFORMATION [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]",
        "terseLabel": "Segment Information [Abstract]",
        "verboseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r147",
      "r149",
      "r150",
      "r160",
      "r164",
      "r176",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Corporate office costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Acquisitions [Member]"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Equity-based awards compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Closing price (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r485",
      "r493"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r7",
      "r147",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r187",
      "r215",
      "r237",
      "r239",
      "r240",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r56",
      "r63",
      "r64",
      "r65",
      "r109",
      "r110",
      "r111",
      "r113",
      "r121",
      "r124",
      "r139",
      "r205",
      "r316",
      "r321",
      "r375",
      "r376",
      "r377",
      "r395",
      "r396",
      "r451",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r567",
      "r568",
      "r569",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED BALANCE SHEETS [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r139",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r27",
      "r28",
      "r316",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r316",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Common stock authorized by the Board of Directors (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r27",
      "r28",
      "r316",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Total purchased shares (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r28",
      "r32",
      "r33",
      "r104",
      "r194",
      "r201",
      "r458",
      "r504"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total USPH shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "U.S. Physical Therapy, Inc. (\"USPH\") shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r64",
      "r104",
      "r109",
      "r110",
      "r111",
      "r113",
      "r121",
      "r201",
      "r205",
      "r321",
      "r375",
      "r376",
      "r377",
      "r395",
      "r396",
      "r427",
      "r428",
      "r439",
      "r451",
      "r458",
      "r468",
      "r469",
      "r473",
      "r568",
      "r569",
      "r591"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total USPH shareholders' equity and non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r102",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r321",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "COMMON STOCK"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Federal taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Tradenames [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r55",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r55",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r55",
      "r323",
      "r326"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock at cost, 2,214,737 shares"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r112",
      "r113",
      "r114",
      "r115",
      "r125",
      "r195",
      "r196",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r247",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r393",
      "r394",
      "r395",
      "r396",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r495",
      "r515",
      "r516",
      "r517",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties associated with any unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Unrecognized tax benefit"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r486",
      "r493"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r127",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Diluted earnings per share - weighted-average shares (in shares)",
        "verboseLabel": "Shares used in computation - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares used in computation [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r126",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Basic earnings per share - weighted-average shares (in shares)",
        "terseLabel": "Shares used in computation - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_AccountsPayableDueToSellerOfAcquiredBusiness": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred related to accounts payable due to seller of acquired business.",
        "label": "Accounts Payable Due to Seller of Acquired Business",
        "terseLabel": "Accounts payable - due to seller of acquired business"
       }
      }
     },
     "localname": "AccountsPayableDueToSellerOfAcquiredBusiness",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_AdditionalEstimatedRepurchaseOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional estimated repurchase of common stock during the period.",
        "label": "Additional Estimated Repurchase Of Common Stock",
        "terseLabel": "Additional estimated shares (in shares)"
       }
      }
     },
     "localname": "AdditionalEstimatedRepurchaseOfCommonStock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_AmountOfReductionsInFederalSpending": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reductions in federal spending during the period.",
        "label": "Amount Of Reductions In Federal Spending",
        "terseLabel": "Reductions in federal spending"
       }
      }
     },
     "localname": "AmountOfReductionsInFederalSpending",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_AverageLeaseTermsAndDiscountRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Lease Terms and Discount Rates [Abstract]"
       }
      }
     },
     "localname": "AverageLeaseTermsAndDiscountRatesAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank credit agreement to permit share repurchases of common stock during the period.",
        "label": "Bank Credit Agreement To Permit Share Repurchases Of Common Stock",
        "terseLabel": "Bank credit agreement to permit share repurchases of common stock"
       }
      }
     },
     "localname": "BankCreditAgreementToPermitShareRepurchasesOfCommonStock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BasisOfPresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation [Abstract]",
        "terseLabel": "Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "BasisOfPresentationAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_BriotixHealthLimitedPartnershipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the entity in which interest is acquired.",
        "label": "Briotix Health, Limited Partnership [Member]",
        "terseLabel": "Briotix Health [Member]"
       }
      }
     },
     "localname": "BriotixHealthLimitedPartnershipMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_BusinessAcquisitionConsiderationPayableTermOfNote": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of the note issued for consideration payable for the acquisition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Business Acquisition Consideration Payable, Term of Note",
        "terseLabel": "Business acquisition, consideration payable, term of note"
       }
      }
     },
     "localname": "BusinessAcquisitionConsiderationPayableTermOfNote",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.",
        "label": "Business Acquisition Cost Of Acquired Entity Debt Issued",
        "verboseLabel": "Seller notes"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityDebtIssued",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of equity interest in subsidiary contributed for acquisition.",
        "label": "Business Acquisition Percentage Of Equity Interest In Subsidiary Contributed",
        "terseLabel": "Percentage of equity interest of subsidiary contributed for acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of general partnership interest acquired in the business combination.",
        "label": "Business Acquisition, Percentage of General Partnership Interest Acquired",
        "terseLabel": "Business acquisition, percentage of general partnership interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests retained by practice founder at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Interest Retained by Practice Founder",
        "terseLabel": "Percentage of interest retained by practice founder"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of limited partnership interest acquired in the business combination.",
        "label": "Business Acquisition, Percentage of Limited Partnership Interest Acquired",
        "verboseLabel": "Business acquisition, percentage of limited partnership acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AcquisitionsOfBusinessesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net tangible asset acquired at the acquisition date.",
        "label": "Business Acquisition Purchase Price Allocation Net Tangible Asset",
        "totalLabel": "Net tangible assets acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful lives of acquired intangibles"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination Acquisition Fair Value of Redeemable Non-Controlling Interests",
        "negatedLabel": "Fair value of non-controlling interest (classified as redeemable non-controlling interest)"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred including contingent consideration, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred, Includes Contingent Consideration",
        "terseLabel": "Aggregate purchase price for the acquisition including contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludesContingentConsideration",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration upon on achievement of certain business criteria in a business combination.",
        "label": "Business Combination, Contingent Consideration, Payable on Achievement of Certain Business Criteria",
        "terseLabel": "Amount payable upon achievement of certain business criteria"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-competition agreements recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of referral relationships at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships",
        "terseLabel": "Customer and referral relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of tradename recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename",
        "terseLabel": "Tradenames"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CarryingAmountOfRedeemableNonControllingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Amount of Redeemable Non-Controlling Interest [Abstract]",
        "verboseLabel": "Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]"
       }
      }
     },
     "localname": "CarryingAmountOfRedeemableNonControllingInterestAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.",
        "label": "Carrying Amount of Redeemable Non-Controlling Interest [Table Text Block]",
        "terseLabel": "Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "CarryingAmountOfRedeemableNonControllingInterestTableTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and noncash consideration that could pay with respect to acquisition.",
        "label": "Cash And Noncash Consideration With Respect To Acquisition After Amendement",
        "terseLabel": "Cash and noncash consideration with respect to acquisition after amendment"
       }
      }
     },
     "localname": "CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CashPaidDuringPeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During Period For [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodForAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_CentersForMedicareAndMedicaidServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An approval authority for Medicare services.",
        "label": "Centers for Medicare and Medicaid Services [Member]",
        "terseLabel": "CMS [Member]"
       }
      }
     },
     "localname": "CentersForMedicareAndMedicaidServicesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ChargesToRetainedEarningsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Charges to Retained Earnings [Abstract]",
        "verboseLabel": "(Charges) credit to retained earnings [Abstract]"
       }
      }
     },
     "localname": "ChargesToRetainedEarningsAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 0.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income (loss) from revaluation of redeemable noncontrolling interest.",
        "label": "Charges To Retained Earnings Revaluation Of Non Controlling Interests",
        "terseLabel": "Revaluation of redeemable non-controlling interest"
       }
      }
     },
     "localname": "ChargesToRetainedEarningsRevaluationOfNonControllingInterests",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ClinicPracticeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which provides clinic practice services.",
        "label": "Clinic Practice [Member]"
       }
      }
     },
     "localname": "ClinicPracticeMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combined physical therapy/speech language pathology expenses during the period.",
        "label": "Combined Physical Therapy Speech Language Pathology Expenses",
        "terseLabel": "Combined physical therapy/speech language pathology expenses"
       }
      }
     },
     "localname": "CombinedPhysicalTherapySpeechLanguagePathologyExpenses",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ContractualAllowancesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual Allowances [Abstract]"
       }
      }
     },
     "localname": "ContractualAllowancesAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.",
        "label": "Contractual Time Period Has Not Lapsed And Holders Employment Has Not Been Terminated",
        "terseLabel": "Contractual time period has not lapsed and holder's employment has not terminated"
       }
      }
     },
     "localname": "ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.",
        "label": "Contractual Time Period Has Lapsed But Holders Employment Has Not Been Terminated",
        "terseLabel": "Contractual time period has lapsed but holder's employment has not terminated"
       }
      }
     },
     "localname": "ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A credit agreement is a legal contract in which a bank arranges to loan a customer a certain amount of money for a specified amount of time.",
        "label": "Credit Agreement [Member]"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_DebtInstrumentBasisSpreadOnLiborVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument Basis Spread On Libor Variable Rate",
        "verboseLabel": "Spread on Libor variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnLiborVariableRate",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_December2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "December 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "December2021AcquisitionMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Decrease in Note Receivable form sales of redeemable non-controlling interest - temporary equity",
        "verboseLabel": "Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DepreciationAmortizationImpairmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Depreciation Amortization Impairment [Line Items]"
       }
      }
     },
     "localname": "DepreciationAmortizationImpairmentLineItems",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_DepreciationAmortizationImpairmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to depreciation amortization impairment.",
        "label": "Depreciation Amortization Impairment [Table]"
       }
      }
     },
     "localname": "DepreciationAmortizationImpairmentTable",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.",
        "label": "Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage",
        "terseLabel": "Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage"
       }
      }
     },
     "localname": "DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between net revenues and corresponding cash collections reflected percentage of net revenues.",
        "label": "Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues",
        "terseLabel": "Difference between net revenues and corresponding cash collections, approximately of net revenues"
       }
      }
     },
     "localname": "DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_DistributionsFromUnconsolidatedAffiliate": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the distributions from unconsolidated affiliate.",
        "label": "Distributions from Unconsolidated Affiliate",
        "terseLabel": "Distributions from unconsolidated affiliate"
       }
      }
     },
     "localname": "DistributionsFromUnconsolidatedAffiliate",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.",
        "label": "Distributions to Limited Partners and Redeemable Noncontrolling Interests",
        "negatedLabel": "Distributions to redeemable non-controlling interest partners"
       }
      }
     },
     "localname": "DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DividendsCashAfterAmendment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends Cash After Amendment",
        "terseLabel": "Cash dividends after amendment"
       }
      }
     },
     "localname": "DividendsCashAfterAmendment",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person who is employed by the company.",
        "label": "Employee [Member]"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_EmploymentAgreementRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The renewal term of the employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Employment Agreement Renewal Term",
        "terseLabel": "Employment agreement renewal term"
       }
      }
     },
     "localname": "EmploymentAgreementRenewalTerm",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Fair Value Of Net Tangible Assets Acquired [Abstract]",
        "terseLabel": "Estimated fair value of net tangible assets acquired [Abstract]"
       }
      }
     },
     "localname": "EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_EstimatedPercentageOfDecreaseInPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated percentage of decrease in payment during the period.",
        "label": "Estimated Percentage of Decrease in Payment",
        "terseLabel": "Estimated percentage of decrease in payment"
       }
      }
     },
     "localname": "EstimatedPercentageOfDecreaseInPayment",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ExpectedReductionInMedicareSpendingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected reduction in Medicare spending percentage during the period.",
        "label": "Expected Reduction In Medicare Spending Percentage",
        "terseLabel": "Expected reduction in Medicare spending percentage"
       }
      }
     },
     "localname": "ExpectedReductionInMedicareSpendingPercentage",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ExtensionTermForSequesterReliefAppliedToAllMedicarePayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension term for sequester relief applied to all Medicare payments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Extension term for sequester relief applied to all Medicare payments",
        "terseLabel": "Term for sequester relief applied to all Medicare payments"
       }
      }
     },
     "localname": "ExtensionTermForSequesterReliefAppliedToAllMedicarePayments",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite Lived Intangible Assets Amortization Expense After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance products service years.",
        "label": "From Two Thousand Seventeen Through Two Thousand Nineteen [Member]",
        "terseLabel": "From 2017 through 2019 [Member]"
       }
      }
     },
     "localname": "FromTwoThousandSeventeenThroughTwoThousandNineteenMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance products service years.",
        "label": "From Two Thousand Twenty Through Two Thousand Twenty Five [Member]",
        "terseLabel": "From 2020 through 2025 [Member]"
       }
      }
     },
     "localname": "FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_GainLossOnRevaluationOfPutRightLiability": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on revaluation of put-right liability.",
        "label": "Gain (loss) on revaluation of put-right liability",
        "negatedLabel": "Gain on revaluation of put-right liability",
        "terseLabel": "Gain on revaluation of put-right liability"
       }
      }
     },
     "localname": "GainLossOnRevaluationOfPutRightLiability",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_GrantsAndOtherFunds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.",
        "label": "Grants and Other Funds",
        "terseLabel": "Grants and other funds"
       }
      }
     },
     "localname": "GrantsAndOtherFunds",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to holder's employment has terminated and contractual time period has expired.",
        "label": "Holders Employment Has Terminated and Contractual Time Period Has Expired",
        "terseLabel": "Holder's employment has terminated and contractual time period has expired"
       }
      }
     },
     "localname": "HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to holder's employment has terminated and contractual time period has not expired.",
        "label": "Holders Employment Has Terminated and Contractual Time Period Has Not Expired",
        "terseLabel": "Holder's employment has terminated and contractual time period has not expired"
       }
      }
     },
     "localname": "HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.",
        "label": "Income Loss From Operations After Revaluation Of NonControlling Interests",
        "totalLabel": "Net income attributable to common shareholders"
       }
      }
     },
     "localname": "IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.",
        "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal and State Statutory Income Tax Rate",
        "negatedLabel": "Tax effect at statutory rate (federal and state) of 25.55%"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IndustrialInjuryPreventionServicesRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from the industrial injury prevention business are derived from onsite services provided to clients' employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenues are determined based on the number of hours and respective rate for services provided. The Company has agreements with third-party payers that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payer contracts and historical collection and write-off experience.",
        "label": "Industrial Injury Prevention Services Revenues [Member]",
        "terseLabel": "Industrial Injury Prevention Services [Member]",
        "verboseLabel": "Industrial Injury Prevention Services [Member]"
       }
      }
     },
     "localname": "IndustrialInjuryPreventionServicesRevenuesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_InterestExpenseDebtAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt related expenses and other expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest Expense, Debt and Other Expense",
        "negatedLabel": "Interest expense - debt and other"
       }
      }
     },
     "localname": "InterestExpenseDebtAndOther",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_JointVentureInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The joint venture interest in entity which provides physical therapy services for patients at hospitals",
        "label": "Joint Venture Interest [Member]",
        "terseLabel": "Joint Venture Interest [Member]"
       }
      }
     },
     "localname": "JointVentureInterestMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_June2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "June 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "June2021AcquisitionMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_LeadingProviderOfIndustrialInjuryPreventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which provides services include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.",
        "label": "Leading Provider of Industrial Injury Prevention [Member]",
        "verboseLabel": "IIPS [Member]"
       }
      }
     },
     "localname": "LeadingProviderOfIndustrialInjuryPreventionMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ManagementContractRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. Revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed.",
        "label": "Management Contract Revenues [Member]",
        "terseLabel": "Management Contract [Member]"
       }
      }
     },
     "localname": "ManagementContractRevenuesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ManagementContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which holds management contracts.",
        "label": "Management Contracts [Member]"
       }
      }
     },
     "localname": "ManagementContractsMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_March2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "March 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "March2021AcquisitionMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_March2022AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "March 2022 Acquisition [Member]"
       }
      }
     },
     "localname": "March2022AcquisitionMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_MaximumContractualAllowanceReserveEstimate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum contractual allowance reserve estimate.",
        "label": "Maximum Contractual Allowance Reserve Estimate",
        "terseLabel": "Maximum contractual allowance reserve estimate"
       }
      }
     },
     "localname": "MaximumContractualAllowanceReserveEstimate",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_MedicareAcceleratedAndAdvancePaymentsProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.",
        "label": "Medicare Accelerated and Advance Payments Program [Member]",
        "terseLabel": "Medicare Accelerated and Advance Payments Program [Member]"
       }
      }
     },
     "localname": "MedicareAcceleratedAndAdvancePaymentsProgramMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_MedicareReimbursementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare Reimbursement [Abstract]"
       }
      }
     },
     "localname": "MedicareReimbursementAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_MultiClinicPracticesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which provides multi-clinic practice services.",
        "label": "Multi-Clinic Practices [Member]",
        "terseLabel": "Multi-Clinic Practices [Member]"
       }
      }
     },
     "localname": "MultiClinicPracticesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.",
        "label": "Net Income Loss Attributable To Noncontrolling Interest, Permanent Equity",
        "negatedLabel": "Non-controlling interest - permanent equity",
        "verboseLabel": "Net income attributable to non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.",
        "label": "Net Income Loss Attributable To Redeemable Noncontrolling Interest temporary Equity",
        "negatedLabel": "Redeemable non-controlling interest - temporary equity",
        "terseLabel": "Operating results allocated to redeemable non-controlling interest partners"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NetPatientRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered.",
        "label": "Net Patient Revenues [Member]",
        "terseLabel": "Net Patient Revenue [Member]"
       }
      }
     },
     "localname": "NetPatientRevenuesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NetRevenueFromMedicare": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net revenue from Medicare.",
        "label": "Net revenue from Medicare",
        "terseLabel": "Net patient revenue from Medicare accounts"
       }
      }
     },
     "localname": "NetRevenueFromMedicare",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NonCompeteAgreementBasicTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Non-Compete Agreement Term under Condition Two",
        "terseLabel": "Non-Compete agreement term regardless of whether the selling shareholder is employed"
       }
      }
     },
     "localname": "NonCompeteAgreementBasicTerm",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Non-Compete Agreement Term under Condition of Termination of Employment of Employed Selling Shareholder",
        "terseLabel": "Non-Compete agreement term under condition of termination of employment of employed selling shareholder"
       }
      }
     },
     "localname": "NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_NonControllingInterestRedeemableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Controlling Interest, Redeemable [Abstract]",
        "verboseLabel": "Redeemable Non-Controlling Interests [Abstract]"
       }
      }
     },
     "localname": "NonControllingInterestRedeemableAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_NonControllingInterestsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for non-controlling interests.",
        "label": "Non controlling Interests Policy [Policy Text Block]",
        "terseLabel": "Non-Controlling Interests"
       }
      }
     },
     "localname": "NonControllingInterestsPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_NotesPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note.",
        "label": "Notes Payable [Member]"
       }
      }
     },
     "localname": "NotesPayableMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesPayableOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable One [Member]",
        "terseLabel": "Notes Payable One [Member]"
       }
      }
     },
     "localname": "NotesPayableOneMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.",
        "label": "Notes Payable Related to Purchase of Non-Controlling Interest, Permanent Equity",
        "terseLabel": "Notes payable due to purchase of non-controlling interest, permanent equity"
       }
      }
     },
     "localname": "NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.",
        "label": "Notes Payable Related to Purchase of Redeemable Non-controlling Interest, Temporary Equity",
        "verboseLabel": "Notes payable related to purchase of redeemable non-controlling interest, temporary equity"
       }
      }
     },
     "localname": "NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NotesPayableTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable Two [Member]",
        "terseLabel": "Notes Payable Two [Member]"
       }
      }
     },
     "localname": "NotesPayableTwoMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Notes Receivable Related to Sale of Redeemable Non-controlling Interest Temporary Equity",
        "terseLabel": "Notes receivable related to sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_November2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "November 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "November2021AcquisitionMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NumberOfOperatingClinicLocations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating clinic locations during the period.",
        "label": "Number of Operating Clinic Locations",
        "terseLabel": "Number of operating clinic locations"
       }
      }
     },
     "localname": "NumberOfOperatingClinicLocations",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfRegions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of regions of the entity operates.",
        "label": "Number of regions",
        "terseLabel": "Number of regions"
       }
      }
     },
     "localname": "NumberOfRegions",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfThirdPartyFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of third party facilities.",
        "label": "Number Of Third Party Facilities",
        "terseLabel": "Number of third party facilities"
       }
      }
     },
     "localname": "NumberOfThirdPartyFacilities",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_OperatingLeaseSupplementalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental information related to leases.",
        "label": "Operating Lease, Supplemental Information [Table Text Block]",
        "terseLabel": "Supplemental Information Related to Leases"
       }
      }
     },
     "localname": "OperatingLeaseSupplementalInformationTableTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues includes management contract revenues, industrial injury prevention services revenues and services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.",
        "label": "Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues [Member]",
        "terseLabel": "Other Revenue [Member]"
       }
      }
     },
     "localname": "OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_OtherRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues include services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.",
        "label": "Other Revenues [Member]",
        "terseLabel": "Other Revenue [Member]"
       }
      }
     },
     "localname": "OtherRevenuesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PatientsAndPayorsRelatedLiability": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Patients And Payors Related Liability",
        "terseLabel": "Credit balances due to patients and payors"
       }
      }
     },
     "localname": "PatientsAndPayorsRelatedLiability",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PaymentOfMedicareAcceleratedAndAdvanceFunds": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of medicare accelerated and advance funds.",
        "label": "Payment of Medicare Accelerated and Advance Funds",
        "negatedLabel": "(Payment) receipt of Medicare Accelerated and Advance Funds"
       }
      }
     },
     "localname": "PaymentOfMedicareAcceleratedAndAdvanceFunds",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PaymentsToAcquireBusinessesConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to acquire businesses total consideration.",
        "label": "Payments To Acquire Businesses Consideration",
        "terseLabel": "Total consideration",
        "verboseLabel": "Total consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesConsideration",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PaymentsToAcquireRedeemableNonControllingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a redeemable non-controlling interest.",
        "label": "Payments to Acquire Redeemable Non-controlling Interest",
        "negatedLabel": "Purchase of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "PaymentsToAcquireRedeemableNonControllingInterest",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PercentageOfGeneralPartnershipInterestOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of general partnership interest owned during the period.",
        "label": "Percentage Of General Partnership Interest Owned",
        "terseLabel": "Percentage of general partnership interest owned"
       }
      }
     },
     "localname": "PercentageOfGeneralPartnershipInterestOwned",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in payment adjustment for therapists participating in Merit Based Incentive Payment System (MIPS).",
        "label": "Percentage of Increase in Payment Adjustment for Therapists Participating in Merit Based Incentive Payment System",
        "terseLabel": "Percentage of increase in payment adjustment for therapists participating in MIPS"
       }
      }
     },
     "localname": "PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfLimitedPartnershipInterestOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of limited partnership interest owned during the period.",
        "label": "Percentage Of Limited Partnership Interest Owned",
        "terseLabel": "Percentage of limited partnership interest owned"
       }
      }
     },
     "localname": "PercentageOfLimitedPartnershipInterestOwned",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfMedicarePaymentIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Medicare payment increase during the period.",
        "label": "Percentage Of Medicare Payment increase",
        "terseLabel": "Percentage of increase in Medicare payment rates"
       }
      }
     },
     "localname": "PercentageOfMedicarePaymentIncrease",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPaymentForOutpatientTherapyServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of payment for outpatient therapy services to the therapy assistant.",
        "label": "Percentage of Payment for Outpatient Therapy Services",
        "terseLabel": "Percentage of payment for outpatient therapy services"
       }
      }
     },
     "localname": "PercentageOfPaymentForOutpatientTherapyServices",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of payment reduction waived through enacted additional legislation.",
        "label": "Percentage of Payment Reduction Waived Through Enacted Legislation",
        "terseLabel": "Percentage of payment reduction waived through enacted legislation"
       }
      }
     },
     "localname": "PercentageOfPaymentReductionWaivedThroughEnactedLegislation",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of practice expense component of relative value unit during the period.",
        "label": "Percentage Of Practice Expense Component Of Relative Value Unit",
        "terseLabel": "Percentage of practice expense component"
       }
      }
     },
     "localname": "PercentageOfPracticeExpenseComponentOfRelativeValueUnit",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reduction in Medicare payments for services performed by a physical or occupational therapist.",
        "label": "Percentage of reduction in Medicare payments for services performed by a physical or occupational therapist",
        "terseLabel": "Percentage of reduction in Medicare payments for services performed by a physical or occupational therapist"
       }
      }
     },
     "localname": "PercentageOfReductionInMedicarePaymentsForServicesPerformedByAPhysicalOrOccupationalTherapist",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfRepurchaseOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of repurchase of common stock during the period.",
        "label": "Percentage Of Repurchase Of Common Stock",
        "terseLabel": "Percentage of repurchase of common stock"
       }
      }
     },
     "localname": "PercentageOfRepurchaseOfCommonStock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of right to sell equity interest on each of the 4th and 5th anniversaries by shareholders.",
        "label": "Percentage of Right to Sell Equity Interest on Each of the 4th and 5th Anniversaries",
        "terseLabel": "Percentage of right to sell equity interest on each of the 4th and 5th anniversaries"
       }
      }
     },
     "localname": "PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of right to sell equity interest on each of the 6th and 7th anniversaries by shareholders.",
        "label": "Percentage of Right to Sell Equity Interest on Each of the 6th and 7th Anniversaries",
        "terseLabel": "Percentage of right to sell equity interest on each of the 6th and 7th anniversaries"
       }
      }
     },
     "localname": "PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of sequester relief applied to all Medicare payments through March 31, 2022.",
        "label": "Percentage of sequester relief applied to all Medicare payments through Period One"
       }
      }
     },
     "localname": "PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodOne",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of sequester relief applied to all Medicare payments through June 30, 2022.",
        "label": "Percentage Of Sequester Relief Applied To All Medicare Payments Through Period Two",
        "terseLabel": "Percentage of sequester relief applied to all Medicare payments through June 30, 2022"
       }
      }
     },
     "localname": "PercentageOfSequesterReliefAppliedToAllMedicarePaymentsThroughPeriodTwo",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of therapist providers participating in Merit Based Incentive Payment System (MIPS).",
        "label": "Percentage of Therapist Providers Participating in Merit Based Incentive Payment System",
        "terseLabel": "Percentage of therapist providers participating in MIPS"
       }
      }
     },
     "localname": "PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage reduction for service in office or other non institutional settings during the period.",
        "label": "Percentage Reduction For Service In Office Or Other Non Institutional Settings",
        "terseLabel": "Percentage reduction for service"
       }
      }
     },
     "localname": "PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Period Of Federal Debt Ceiling In Connection With Deficit Reductions",
        "terseLabel": "Federal debt ceiling in connection with deficit reductions"
       }
      }
     },
     "localname": "PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_PhysicalTherapyOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.",
        "label": "Physical Therapy Operations [Member]",
        "terseLabel": "Physical Therapy Operations [Member]"
       }
      }
     },
     "localname": "PhysicalTherapyOperationsMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/RevenueRecognitionDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PreviousOwnersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the previous owners who maintain a minority interest after acquisition.",
        "label": "Previous Owners [Member]",
        "terseLabel": "Previous Owners [Member]"
       }
      }
     },
     "localname": "PreviousOwnersMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Proceeds from Sale of Redeemable Non-controlling Interest Temporary Equity",
        "terseLabel": "Sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ProceedsFromSalesOfNonControllingInterestPermanent": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sales of non-controlling interest-permanent.",
        "label": "Proceeds from Sales of Non-controlling Interest Permanent",
        "terseLabel": "Sales of non-controlling interest-permanent"
       }
      }
     },
     "localname": "ProceedsFromSalesOfNonControllingInterestPermanent",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ProgressiveHealthCompaniesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the acquiree entity Therapy Practice.",
        "label": "ProgressiveHealth Companies, LLC [Member]",
        "terseLabel": "ProgressiveHealth [Member]"
       }
      }
     },
     "localname": "ProgressiveHealthCompaniesLLCMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Promissory Notes [Member]",
        "terseLabel": "3.25% through 3.5% Notes Payable due in Next Year [Member]"
       }
      }
     },
     "localname": "PromissoryNotesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PublicHealthAndSocialServicesEmergencyFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.",
        "label": "Public Health and Social Services Emergency Fund [Member]",
        "terseLabel": "Public Health and Social Services Emergency Fund [Member]"
       }
      }
     },
     "localname": "PublicHealthAndSocialServicesEmergencyFundMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PurchaseOfBusinessSellerFinancingPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of business - seller financing portion in noncash investing or financing activities.",
        "label": "Purchase of Business Seller Financing Portion",
        "terseLabel": "Purchase of businesses - seller financing portion"
       }
      }
     },
     "localname": "PurchaseOfBusinessSellerFinancingPortion",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_REDEEMABLENONCONTROLLINGINTERESTAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "REDEEMABLE NON-CONTROLLING INTEREST [Abstract]"
       }
      }
     },
     "localname": "REDEEMABLENONCONTROLLINGINTERESTAbstract",
     "nsuri": "http://usph.com/20220331",
     "xbrltype": "stringItemType"
    },
    "usph_RedeemableNonControllingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the upper bound of a range for the estimate of fair value as of the reporting date of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity.",
        "label": "Redeemable Non-Controlling Interest [Member]"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The commencement period of redemption rights for redeemable non controlling interest, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Redeemable Non-controlling Interest, Redemption Rights, Commencement Period",
        "terseLabel": "Redeemable non-controlling interest, redemption rights, commencement period"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestRedemptionRightsCommencementPeriod",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RedeemableNonControllingInterestTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a redeemable non-controlling interest.",
        "label": "Redeemable Non-Controlling Interest [Text Block]",
        "terseLabel": "REDEEMABLE NON-CONTROLLING INTEREST"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_RedeemableNonControllingInterestsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for redeemable non-controlling interests.",
        "label": "Redeemable Non Controlling Interests [Policy Text Block]",
        "terseLabel": "Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestsPolicyTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Combined physical therapy/speech language pathology expenses during the period.",
        "label": "Reduction In Combined Physical Therapy Speech Language Pathology Expenses",
        "terseLabel": "Reduction in combined physical therapy/speech language pathology expenses"
       }
      }
     },
     "localname": "ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ReductionInMedicareSpendingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Medicare spending percentage during the period.",
        "label": "Reduction In Medicare Spending Percentage",
        "terseLabel": "Medicare spending cut percentage"
       }
      }
     },
     "localname": "ReductionInMedicareSpendingPercentage",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ReferralRelationshipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Referral Relationship [Member]",
        "verboseLabel": "Referral Relationships [Member]"
       }
      }
     },
     "localname": "ReferralRelationshipMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_RemainingContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Remaining Contract Term",
        "terseLabel": "Remaining contract term"
       }
      }
     },
     "localname": "RemainingContractTerm",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RentSuppliesContractLaborAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to rent, supplies, contract labor and other.",
        "label": "Rent Supplies Contract Labor And Other",
        "terseLabel": "Rent, supplies, contract labor and other"
       }
      }
     },
     "localname": "RentSuppliesContractLaborAndOther",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RepaymentOfFunds": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of repayment to Medicare Accelerated and Advance Payment Program (\"MAAPP Funds\") rather than applying them to future services performed.",
        "label": "Repayment of Funds",
        "terseLabel": "Repayment of funds"
       }
      }
     },
     "localname": "RepaymentOfFunds",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RestrictedStockPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for restricted stock.",
        "label": "Restricted Stock Policy [Policy Text Block]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_ReturnToWorkAndErgonomicServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of a company which has return-to-work and ergonomic services among other offerings.",
        "label": "Return to Work and Ergonomic Services [Member]",
        "terseLabel": "Return-to-work and Ergonomic Services [Member]"
       }
      }
     },
     "localname": "ReturnToWorkAndErgonomicServicesMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_RevaluationOfRedeemableNonControllingInterestNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distributions during the period on mandatorily redeemable securities net of tax.",
        "label": "Revaluation of Redeemable Non-controlling Interest Net of Tax",
        "terseLabel": "Revaluation of redeemable non-controlling interest, net of tax"
       }
      }
     },
     "localname": "RevaluationOfRedeemableNonControllingInterestNetOfTax",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to redeemable non-controlling interest.",
        "label": "Revaluation of Redeemable Non-controlling Interest Net of Tax, Shares",
        "terseLabel": "Revaluation of redeemable non-controlling interest, net of tax (in shares)"
       }
      }
     },
     "localname": "RevaluationOfRedeemableNonControllingInterestNetOfTaxShares",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_SaleOfNonControllingInterestNetOfPurchasesAndTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Sale of Non-controlling Interest, Net of Purchases and Tax",
        "terseLabel": "Sale of non-controlling interest, net of purchases and tax"
       }
      }
     },
     "localname": "SaleOfNonControllingInterestNetOfPurchasesAndTax",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of business combination completed within the physical therapy operations segment during the period.",
        "label": "Schedule of Business Acquisitions Within Physical Therapy Operations Segment [Table Text Block]",
        "terseLabel": "Acquisitions Within Physical Therapy Operations Segment"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_SelfInsuranceProgramPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for self-insurance program.",
        "label": "Self Insurance Program Policy [Policy Text Block]",
        "terseLabel": "Self-Insurance Program"
       }
      }
     },
     "localname": "SelfInsuranceProgramPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_September2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "September 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "September2021AcquisitionMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ShortSwingProfitSettlement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short swing profit settlement from any purchase or sale (or sale and purchase) of the company's equity securities.",
        "label": "Short Swing Profit Settlement",
        "terseLabel": "Short swing profit settlement"
       }
      }
     },
     "localname": "ShortSwingProfitSettlement",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_SupplementalInformationRelatedToOperatingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Information Related to Operating Leases [Abstract]",
        "terseLabel": "Supplemental Information Related to Leases [Abstract]"
       }
      }
     },
     "localname": "SupplementalInformationRelatedToOperatingLeasesAbstract",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_TermOfEmploymentAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Term of Employment Agreement",
        "terseLabel": "Employment agreement term"
       }
      }
     },
     "localname": "TermOfEmploymentAgreement",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_TherapyPracticeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the acquiree entity Therapy Practice.",
        "label": "Therapy Practice [Member]"
       }
      }
     },
     "localname": "TherapyPracticeMember",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.",
        "label": "Transfer of Compensation Liability for Certain Stock Issued Pursuant to Incentive Plans",
        "terseLabel": "Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans"
       }
      }
     },
     "localname": "TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to weighted average lease terms and discount rates.",
        "label": "Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "terseLabel": "Average Lease Terms and Discount Rates"
       }
      }
     },
     "localname": "WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock",
     "nsuri": "http://usph.com/20220331",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55733-112764"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r581": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r582": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r583": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r584": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r585": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r586": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>67
<FILENAME>0001140361-22-018278-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-018278-xbrl.zip
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MH^C\8^>L??I[U#T^B-X<_^V9RSQPJ,M%OSO0YMM_FYNI=2KBQ P0Z-:&"")
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M6ZC @JW<)ENY+OT!FN=V@D6ZG4TQ%C-N]0+#AHI^_ZSV<SSC^81V>>.S5MG
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MIUCYEZG>C#-/\T,[.3PS/\S;QBH0 P*:T'#W;N,:8C\."2RJ1@%"@(( -%(
M[A\0 F@Q-"?5@<[;\JJ>,@/A?C^J2AF_<; :)8JRF93TOG'M^D>'\>J!6!)I
MR +/:4(&$.#-4C?,\9T#<3&LAZJ=S\!ZBZHD7=P1)!A[2] LUHL7J?6@M^3C
M' &!I &0WH^KR?QQ-=F%9$&I$^CPT0!DW#]9!U=R&K8:;>@^=R'Q:%RM']HD
M!JDICHX.Q@?A#YQKD/53[3V#CH? ?3M26$-9I#H5OJRQN<KJL>6/]=4#&![5
M57/[5T^7^LZ!\J6IRX7/+'B,K\99N7LM%0(G+923:I&\K;RS(>TXEC^#+_!$
M'4^\[L%16\L3\QT"WSIKLPRZKM;$;6B^<W4LMTD&;;,=G^79[,#DSV#RUVFA
M-U]\MIW)MSP%LORD1' LYF%'4&7^9SL[GQEMS)60?7.<#:JJPZS?3P<77;_=
M9IJ\ U#7ZWD^:)84=X"%=B,+M%KR9NY2.L<%JC6H]'&)1P4#B;?..@;";DY6
M[I[&;<#>:4.TU'-;'!P,BS*[\H<3[CI!-#R*>-&I]B?@W 1^?SYASW.AG:SG
M?VPC->\#MPDD?'[#B4#"AOGYH8/,6GN&-$<R UDW0%J?3];@#&T$87^DI=<3
MH(>-HDU@JH:D"I;15&Y3&'#5-F5Y$A'X[S'^:W(YR$;PWZLJWEB"!6XR RZ_
MP#98X/5P8-,X+?##\S<$ C\TB!^:TCTL9'<VKM'O(KFA2@4=&EEV!T69#_WJ
M)X5W5VE19/G-<58VO7SNX?KO*N<>0K$9F1P<Z-+ C/B(+@>YT6GY0:BTGXX[
MCYR9+UG_2SJXF/VNV?1Y",>=$GP2H$T@U4BU!5)MA+:;C5D"T;8X"@EBV1Q/
M<N$55O-Z+)N2T5_^EM*V^D@OX80FIS873*\7<=ZR4N?+<\$@!D'7+\\%@POK
M[88A G$@U7)(!;&WM"!>CK?\B"G]Y]]$GOJ2]C-GU*NOC[*!S@953;L4@S].
MK#4.!?[KH^[[D[-FDG3Y%O@^GNY892Z$;9VO_F+^>B^*ZDU@I/N,-(N9U\0Q
MTR[+%FNDQ6YR!XVT(/[:/(VT*D;:<HTTO<L)ZZ/1D?MWN\/73!;Y;M19"T4S
MDDONTG63<U.2"\O7!*^<@1[-204MT(!<8>\RR\MSDU]Y ,]OKLVXVJ0TQ:FX
M\0:LV72I7?^8- ^AV RZS.=Q;2KEEJ]PU\<3C7# YDTB;"H#+9C,+V+8K3[)
M<;].\:Y'F<.'GQTV*DD<CQ8<7/1& $YVE6ZG8$Q:JTV^KWZUZ=..;[GO*2@7
M/?IX+AZM)]-=W/D(O1KB<"Y/_P7V73*C-%-F@O:M8=\-FW7[',9YZ>#;H%N;
MHELWC#D;KTK7-0IZ?9KSM;-DT)>/E.LL_AQ"<"HW2!.NTZE<7KO)P(>!#[=2
M'VZ8U6T\VZW0$5SR;I6CJQ[VS8GM_&M858Z6EYGN#KZ8HO1+?/BI,<?B:I39
M_J\L'91_<U<-<]/\7LD_ NJ8[(\#O D4'YU6"A1O-,67>A8QT+YYM&]"H _X
M4QOC323OZD\3 ;Y 70Q8I8L#PI]".%N@*O0</E*%(UYOV"R!$7/-)?CW^?!Y
M@C\<I".<? ;@#@E71A1.R>V/'WXIG*J;W&#RW>2]OT/=W="#NZ5%1A!,WG[N
M'3[W9OCV9CK]XO Z?<WQ\,I[VUG^PN<]^+W_\- ,LJMT4'?;>9$R<XLWLZO_
M#KCD >XJ S0./)Z+O+C^;D>9JF*4Y]Z./L(FU^[E<^^5U"_MH)\.4O7<F[%'
ML.;CM^?>B]??:W*@[IFW@Z#^=F?FXKL$2+^]S:=:=T59KDW^ZP[< SN1R%6>
M]6>5DO_M7I9?O'&J ;\97_'&"E7NVBPK!UEI=B*;9U=GQA:_[CB(RG]2CBUW
M?\C&@F"II44Q5CI1FA+)$[@3E=GX<G>+?\8&P(2+F(N$$**M)#0&BAN4,,8H
M%SN1H]\?9T^OK%J6O\ZAYLT](%<#M53*)A1I(00GA&%)O!U6#$H2)TJ [80Z
MQEQ1J3!D4A$KJ: )8)P 32'D!(GMA#HQ1AF-H,#2$BZI3)01,.:(&6,QP]L)
MM16,,"4E5L829;A0) &0L\10!15,MA-JX@@<LX02F$C"XYA12;FR &)BM59Z
M.Z&VAE%%H :"&0)BQH4Q,;!,HIB9V&PKAR>$2L.8 QH0PPS'"FE @230)-9N
M*:TQD4Z"F4+6\32QE"'K+#<UP,$G$4;;"35T)HL2B[$+LXA%B<26<H2E<0J-
M&4RV$VJ9,"&)<0X*$P2Y$--8Y?R51+FWSJ!M*=0$QX8B*XTBE'!!I5/C"8JM
M3;CS3Z':3JBETUD48\VP0 0PP9T7:AC&U' +D;#;";7B2FFM&4%>AP/GG4$B
MJ8DM1CP6>$L]4J2$(S6(M6 )$8 *F"# A4V0B &16QISP<3QL> 2$6$<!(ZO
M)7> 2Q%C*G7"MA-JP:C@ED'+C/-*8P>M$A9;YHVV\]GN<WB"G;?NHQ+F_!C-
M$FX143%"B!!$K)$; K6!6H$X<;&FDVL79@K#("7&  ,2I;G<3J@UBYGC5@ 4
M<]Q*J!!2:BHM=.K< G'?7B<N/DLX=>:=**< A1!*22R2) '.F95T0Z"VSD!S
MP*%.5$(L2%@L8Z6@"T (=Z9\#5"//BFR8:Y,,7I[:82NDO$Z_;+_[__V[_\6
M1?[_[]S;J"AO_,-L-G!0BJNT?_,V^G_GZ94IHF/S-3K+KL3@__T25=\7Z?^9
MMQ$$U^4OD4^F[XI^>C%X&_6-=9^HK)_E;Z/\0OX$6I'_W\^_[.S[!\T^:OJ7
MROC]Q/'MYWP\\8^O/OAJTHO+\FTDL[Z^?91[V&4^>9:L:/XV&F0#\TLT>K<K
ML[+,KMR=KK]%56E-)/M"_7'[?9E=OXW(_2\OQP]SX'^[!?9/MOIS/W777.39
M<*!W[W]5!^^5R"_2P:Y'W-M(#,OL]J-\])3JLYWHC0/*XV[_\W'WO',8]<[;
MYYW>A)#3!%T1CGN=@\]GW?-NIQ>UCP^CSC\./K:/?^M$!R>?/G5[O>[)\?(6
MA1Y;U-_;O8_=X]_.3XY;T>'>P5Z$0$SX\A;"'EO(AY.S3Y'7.X[?JNV55$4#
MX7?/M$G?'F:J.N/O3Y3N5!GRD;DP!&G$&>>)B]Z)4R#.6%!H-%94T<1=.MZ[
M<GJDMIQA9Q^"W;]6DG[WW/WYP!^)[G.E?V?_IT_ML_^.3HX[/]][3ND/QCJL
M]OO%M5#IX.+7':=N_?MKH?7M>S^@X=>=P][IAZ.T*,_]CW9>K(N^IKJ\]&_
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MXY.][R/N&6Y],!H-5F9MK7-3%.-_CM*!@5.*#,&$,ZE<9$TYX4AP@0WD%,1
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M_>1NZZ@=%4-GX@H_Y\2M>]0JQ?U4E/=@B+Z*V<7ZE8Y^/ ;EYU8D!CKZ"8U
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M@@QOIQQN8=("P3WZ,H_B/"M%?ST>18B.-CDZ>D1EQ0@*0*E!B8Q)(B%W[@.
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ME(/LZBHMKXR?/R8&.CIP5SCS9P8J[!(%OVL1?M<4A[4'>H:_IMPK9&,&>*P
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M'ZYP;1P##)ROLUKG(T1O&Q:]/:W#/J6#+'?<,^FX/GTLF2=&48T8-<1I,,(
MUC&W%$@7Q5&ZU.*?%MK6>9A!"H,4/D<*$VNU-(1QJR@15#*"I !.*B'B!.&:
M W>+JS5JQ<F62N%:G8:MS'U4)[:>F 75('>E^6'97,IJ Z*WI<&QSB"O.U#]
MH6>JTRSW/VB799[*8>G'V)QG]8-LIA0ZLU0@30R"B!'&H)0JMHF2 !L!$EO3
M[66!*1R_&]R@P/#ETMD\]RMHE:!5UJ=5".66"(6@;P8OA6%&2>7^8D.IE76M
M=A:8;DI:D#4H,;QZK;(J=W+A/B';8_&/.(7]NUG6_HSZ=X>"ML(QLJ4IQLWK
MBAYH_7IHO;:(FZPDXN8/="M^8;2]'7'V,[#>&(_8K3G2V=#;KT:YDG]>)@V?
MY6LW%4-/.]M'=TY*>Z"?W+5U+C3A C/*A""0QUQP1H1$AA,F#%AHQ\I[;G1"
M<8O1!IU]>KE(-RLX#ZHHJ*(-5$4(^5U731.&,6$ ,F+="XXITM9"OLP"DH3P
M%D$-SA,N7Q4]<%='__[[O[D/?80[_MSSROX[F4=O)A^,473W=1W@RGB'[27>
M8<_XX+ITUY699X J\^5/ T8V'8B!2EU07OC>E]7TP+V'RQFO]O%UJKX1>46%
MRUN/UCG9XQ5,/IE08K2L2/5%X3CLL'?ZX51<F/>Y$7^TW7_N9.L[J'APB^/A
ME33YZ!XSY\F>@3-VZX%_-5Z?> 9P3-^?7.1O>/O9(RO8V<?C<U&S*)N%Z-I=
MORL]U+O".GC>BOY7<5,\@IEIC?/N,I_<9(3:D6H#U>;F6 ( N--_X\_ +]'E
M&*8JO366@#^!ZJ]..&Z_FB;PS@-6F(5K>@4/8/EHA/8(F@*F8K 'U!HCVG?1
M2-4#"CGZBN@R]QKK3Z?ML_/NSG[7A57?WKT1^X^A?I9[I]Y-OZ[>_X RCQ[J
MJBE%<U<TL+\<89_E7.G,1#4Q+?(CTS[^WNL>M(^B\X^=L_;I[ZVH>WRP%[6/
M#Z/>Y_>][F&W?=;M]):KC&K7=W!RW#LYZAZVSSMN+>?NGT^=X_->=/+!+_'D
M4\?1VINXNZ]./HR^<&SP'[N[[8&ZS/+=W?T1]5>^_I^ZQPZI)Y][#I>]5M3Y
MQT'G]#PZ[9Q%O8_MLT[D &O_O(YU#0=BJ)TITS5/?\H"5=;*K:7O#9YR1K0Z
M,.K?CXWJZ"CI4B4DJE4CRI;5XG;NV=A;\_NCJ:&)(U%?N+DXOW5YQ5B//?&>
M+SQ6[>-ML'N/I_.FM1;*KQ^R/"HO373N%+N)/KDK+HNHX]2Z7JT3N0E%0T_S
MZ:)YI]G<BM;"K9]$KBXC#%W0 !#:7 X-;+$\MH";RQ9+5EP+9XVE\MTL5ZT@
MR;=J40[86^LQYC\=''0Z'SXT9\CVL2F=-BE3OR>8FR]F,#2+5F7C;.V+CH+=
MXJM)QR#K%_7G]1U[K%_0]WJ'5<3^D&=7!WZSV%WT][2\/!@6;@DF[WP;5YRU
MB\*X_^ES\6TZ_ZPU3C!.C+":@$2Q1 -H#--<J9C4-V>! );99%/LGZ=YIH>J
M/,E[)O^2*M/^EA;_=-QX.F+&\?**3Z;*LRVD.2IOQ;BNY<.:V6B)1B"(X7:+
MH5482(%5S*0FC"(ID9]9Q8G4,(EQW:BJ6S&$ZQ%#SELH)MLCA2MS)E;1[>_%
M;L1)>6GR]3L0X>3C"DX^+E.A,6NE1I13""21',DD<6J-)L9(A6-6,W5K+K^B
M8L^)+KLMIO\D!N*BV@N=K'1R27N@NP/MEIRGHM\=_.\POSFMF-L#/+YQL7C=
MB% +TKJ=]8T[0ADD/$AXO813J2E/E)"28&)BRE"< ,5 3"7#1M55KLSCLFR(
MA$/<@G!MWL\FI W7F$1Y^2%HGT59N_.ST6';NCM'K2&%0K"$6,16&4,,%P(*
MD2"-I#;0^3*U1WUG7)W%Z"/82L 6A6-!NH)T51W63*RLPE93#(F%A)$$4-]9
M/2&&0%8SIO2>F[$0Z8*HA>D6I1Q79?2;D]>X-KDH_2DJ/[S@[=J,>SC'N!'G
M& /Y7S7YMS F>OG\EY[HBSQUE_DSJ;FIIA)56G0ATT*"$[=<X5N0$W<D9):W
M!_IL1/_.MVLS*,S,0::8J1A2"F!"$),",LJTEHSRV !1,Y5J"5%0$K<@X=OC
MI@7Y>37RPW',8TZUL,:%.)@*040"$PZ-M!SBFD*,)<0Y_G RK&L&N:'RLZEA
MSH],EAV4K:@87E_WJVX]:AQQ1WW/@)4)SWR&/01 Z_. '],4UY=O/?EZ8^)-
MDB43U5'MC$Q;7,PL YI9(@Q! @L(G5I(G.R+&":*KL3B(M:B%*U+8S3,K ;>
M7A1O&X 1XE@[,Z@)CP77*.8:6LP HE+6]4->O#5$L$7BNHF*3>;MM98Q;40\
M>YIG7]+",Z>C?:1RHU-G'C.??6Y6P5-#O?3O'>AIJA^_L'4_[>G?LM>'+#_,
MAK*TPWY;*7?;<GI6K/2SG9B1-&&"2!)SHF,%8L2-4MQ@O)I=PQ8&:W/WG\GR
M33/V061?F\C"6&.E$6)6.-%5L<"6<@X3&2/#M:KKOKN$K<@6 F#+17:M/DQS
MBI%&S7>SF9W+9GDHS=%IKZ)@\\!ONKAH:9P]G-9-%B@%"+9$($6LQD)*(37"
MT$@6*[XB=P+$+5@[>6#CJB*#&+U*,9*Q((91ZD\K$,N-2"P4)*$L)@HGH&87
M:PDFGM$62=:64]NZVN*PL]94]WZS4-4X4[)A^ NL%O8[%UW6^5N>%45TG6<V
M75]H%+9]ON-P550ZK8@TY6NIQ/E+',1<44602!C65 (FDM@BR75-9?<R]B]I
M*V9K*^QNF$4)C/PB1C:6$ 4)P3@AA"9&)M1(8"P3(M$\7M%F9=QB?&VA=\/M
M58@/@M/66*<ML%I@M2V+#YK=X^8@RZ^S7)0FRJQ-E5GW88:0$EY[2KAGJA%K
MOYF!R46_/=!M?94.TJ+T6V]?S,-R;8J,4#$0Q("$4$@E)50J"0%*H)9Z1?LM
ML!7'8;LER-9VR99@B8T3:!@&C!BEI-:*0(N0% 1)P%939P%:+ D-7IIYF/'E
M-15WY\#3@<JN0I>7;?+.G]9#MZ3O5I0_RHKIG5^#DP0P1KADD A,." (..6!
M, 4XMF0U!CUN ;RVG=\0V@;A>9GP2)@0B"F3"A!"C9"&&:UADD!J-6$UPK,,
MB^V$!VV1\*QN,R]L,BQ;"C>O!48@_ZLF_\8%#2]M=3T* ZJ#T684B8:08(N\
MFH:@JFE:>-/P%UAM>]S-*,^^WB[E<14_F9,,1G.2J_]/#OW698AV]D?#U9U&
MCXS(!RY6*:+,NL!B9H"VL#;MIW[S9WJ<ZIVF7UL-V116UN@B+7H5+W27'EO&
MTT'J76SJFXV.V.&3*2\SW1U\,45934N?WL2Q1%% .$*($"V)Q +%BC)L-!-(
MKZ:#!L8U#:L>L.9:O<5ELF:0D"9+B$*(8F9 PA@B6"B&$\E4K!E!0$&YI,3.
M_YD\TZ*XW-G?W2K1V+B@:IEM.+I^A*MCN;N>5.-8K!4-S!K/N6Z8N[<)GO'W
M=-*($29M@$8Z:KHU'J(P5@##V!EK&AM)K8%&4TTET5S73!I9@IDF:ZNS"%%E
MD)T7RXX2T@#+(.'.6L>:2*J%)L!:;@@AN&8.UQ)V9L*8P":%R;\)%R$[3LJ-
M6]I05%SEXN3K8;E;L6GDPF/I8F072C<L1)XBS@QVUK:+L)!5_/B.PLPRGNC
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M#E$<9V;7'+&%C:O&9Z:6Y6,ZWW&<M7IO!F:V/7-B?3,?II2B"7&>H>0()H(
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M]$)M6J]#3R?<^D"':F81L";!3'(2$\ND!HP! 2$P!H/55!-2]#J:8 0=$'1
M W6 ,L(0 04F$!,=*ZF9$  #;&*1V!BL9F>OA>CKZ'2U+!?L'EQ/=,-9?XUS
MX]5.\Q7*\[IB/%=;3(^520#45$A*E24PX9)R$P-.L-__MW7SRY=RX "RM859
M"VJ3$20L2%BMA$DJG)@0XUQQ2" R3&(K$I!828C K$;"EF" <2N!FRYA3=O&
M#EML88MM4[;8 EL&MFP@6ZXM84V6T#CTQ85(QX^7('WNG7Z,BDN1F\NL[[R:
M!IU8)XWR0]UJ(IT-/=J><//^O"8?=+[5/<,'G6X;2HFA";1Q#!("L18<(H5=
M(&=%+&F\FL&@K)7PFM&@Z_$OR7S^Y7H3)4%\FB$^..$8 @NI1I)PJP7B1FK%
M96(AH:!F:- 2PC/6@DECPK,?$9\0HVV\+Q><X1"C-1"K@2U#C+;&&.V]*%)5
MC7/0:7]8&AT9D0_<<@M?+30*T4+T%MS/Q]S/SIA;3DW>\PQQ..*BZ3@NEAI
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M^T;L?ZCCV=VP3U!M7!(WCX\CY+Z,]8;=TMN29V,_3>"2L+C#)G5(RMV]O_X
M15*B6B6)XK5(H7UIB:)854 ^3V8"#S*?NB>V$WO^S0[]9<5II\H+%_MKR\6
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MS/T7Y+02.2QXSU2TA#,&FGFG'=?"1R#$(!?;48(EY+1IB;_EOOG1Z' X^+2
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M'+;+<Y90OEVA_(1^:D,YG1V..[XY&_<Z@?U=;_#I?%8\=(Z".(DBV,0E@5A
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MR)TD6B@?##I0%!CBRLG[VH51!?@%^ 7XJP.?4N$E8<J"YN"(<PR%4I(;&6E
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MHA:2ET("!;<%MRW$K23$$^5#  1(X:\147--46JB!42S&8W P8-O987 8ZJ
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MM]>N/RC=GOMG-WU6_L!DXX-_XLVN0?,.69,CJG\[X6TP\>%'R<'[?V90_)
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MBKY-TB9P*.4;1[Y0S!?Y??[?^@)GKB._4G0"9 NAPA831RYGRE4.4V(4T]"
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M6)T8"!8%]HK^Q\YU&HR_6[U2[_YJ]7!P1!2%,T7O=5] &-CO!OG5'"95,JW
MSIKC:'LW0(J?24(.BEA$6R,6N[GX -;_>%3_HY!K4-0BWAJUV#WS >0::_]N
MNQWDYM;9VEVSUC+Q@X9^MNN*,IHF:1R0P&,IB4B:2=\C+&9)F(:N#/?).+:=
MH&1@=\3%YW4WJ,73:\SJ1FPT<>%[8!L@)I'1869\L:R:?IRF?4VW,[F2CK,]
MH;+KUVDN-N_TM53HT?<@G^OV-R"\D)-V"@:-**:WMX@4J06DEN=K4YMB;\\&
MBP","718XW.YP)"Y[J/<AP?7%2>521G5%4W*RMF#=6)G%ZPAJDN9W#I+4^'
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MML.6BYZ0)&\T]DW:<EW3P35O!L7\,]VBV7?AU]=UVG699KJN 8]?(FAA)C"
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M3U5KTU+) 3)=671R:D*=K@PG&13W3+;&/7<3>L#JG!\9)QD4%$JV!H5VSWH
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M JXMF0K=9:+6'T27/H; J[L ,00Q35K5O% 3W3'&GRRP^8"EAZ@M8Q*;.9R
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MX+Y+,R)MS1E@0!Q:+1U >YPM5H<XI?-*I76+_U)VVVRV-&GV\%2#WF?2GQI
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M:)5XKWY'.Y-\CYDT78^UX0%,272;0O,"V @J_%8#OP)U).0G#S6#[$M>J_0
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M<^$^(^ ^(O"#F O*?$*BA*8R(%30Q$\B)JCH#0=WN<^'&G*N?N$'<:M&HO-
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M3EYPY[-A\W"R3  (Y"]\Q?;)-P1^]!K= N(7&!Y_T_ =A:[R6R7D<OI++FT
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M/CO0P;5XX#N"NT)(&GE!"!I71B9.S30ILW<Q:L1S/!$&/B>1'U$K#$(2VF9
M(A;:?@2:_5"C1IQ+X_;ZE^OKWZ[>_WIM?/[R^>+#E\]WMU]^_?73YW\8GS[?
M7=]>?[WK.GMD]2X['$VWV2/=%]DZ=635A^Q]#.3X&N,@CB]\DN D+* Y;Z"F
M6#9&AC'^[VF<JA$4C^R/),5YD=6L#?S-?-3>%?YBIH:5YR/VWJ"?D!GCA^=,
MC32$7P99\UP,4 NG63S"V8*O4QG)-!]R7,WNN\M__4;)TW+BHAYIEI63,FOO
MS8R$\VFJ7YOA#$0]*7TBQUD^LTS-N@!N2N,0WA?*8?*T<K17][MNG7*QZD/T
MP 1)NRS2V6"R1&V4U:\QB$@U\:&S*&^,XEI7KC=U5JG.%GIJ\L45[\I'9RW6
MYRV_/Z>Z)\FX"Y>2R[7?RZ:39,%[YPYJF8=H\T7>I#&.,-1C#6L<J:?XS'*R
M(;_'.!!6S?#+Y)BI+@M#>0]"0@(E@HBI2Y:O0$\@H*[53PHIH ?F-'Z$<WB2
M)^P1&#X;R4CB,%XU4CP&+/DM%E. >7,/!B)M'H1A?*UU!RY%V6.2J>E 3P_)
MHY(B,V)-;4@-/WU*TC^+,4!S.U<#6/54GWG!6 Z/A(,<ZZFEU>#!VE7M )AM
M*S1:AU&O^E UB]HXC&AKG4.]ZD/>6;0=2+19IR#:/F&L<_3'=*3MV'*B\IR4
M:\HBU7@.&X_GTT[G) & J$3-)'T:/E^@M0ER:Q@_QN@B+T8T/\1CXW4YROCI
M0U)A(! P\CM_8*-[J<;'HKQ[ ',/8=18ICCAPEC6M>E]CKYJV[C1'P-[_$MT
M#=^=/!=6S:?1UVF8Q2)FZ?.'<F/US#;ILT@$42@=XE 6 %.Y+H]\UV>^]#S2
M:N. 9?.OEF5<@7+X5WY<Q6G])M%!\*\/M>',ZIP!X:E?+Y<'W]"_NZ3+2Y5G
MMJ++"S#BG%'_TYMB!EMQ62C2[^5(-0BJ7UR!DG$XG*%N3^DL +N@D_*ANC@,
M'M#I0/\<\"@6W*%6!#4S!+K0ZBPK#[]XMZ:U6<6E2:^G&J-ULO6J#_F'UAA^
MEU4&9XUQ((UAGX+&J,^\5H.&LES8@UEZGTH]W+N.0V^F*4CR#'1*\>,2=N+'
MM 5N1"D@SWE%4[/+7Z>H#C+]F]UE_Z]:L-U4LJS0 U=Z*77![X,4#\R "DD\
M2BT_=,R L="BH6/;EN_M1O#?XL;4SW^+1_'C]'%W0MYID?%X[ <Z/\H#P1T_
M\*R04QY*/V*11[CDU'=<)EJ[+&UU?NS[;L\O6$='MNE%I3A!"[;,L)[U,BYF
MOYFAY8JS86F)KE1_"_L#*PZ,/ F_R8;#<L:U^LO@P'39%C?]#ZWVU[OIR.(!
M#7U/4NI2"EQC!Y$3N<QT?!DZA+T<B%3<_C)4!/^8A2\51BK%ITC@?D;)Q!@7
M(A)5W5K4!5B*3>$#A<3$#M!URQY!>YI,[Q_F9>K >&(C-77@D<'S&/H31\JU
MH-\Q+DE KQ;N#8XV[XZ@T/B,@8">B7$*)Y8"&<-RGQ54F#^!B9H!G#[B!H$V
M'[ 7)1\F&:X=N849&9SZ<+ D0-%"+1_JR[O1+[^3Z2.V;6BT@**FR0+;]MP0
M1#GW M_B-K.<R*2,F"Y=':C8)ZW6B/ BD_RMF*9/22HR.7KU;O*47#Q+ELX&
M%)!T\)R!4N04#Q6N$9V_R5.[_KU):WYF?;?SNED1Y>S-(8WBX6A:>3:BZ62:
MZC'0%\ET@JZH!-T\.;J\Q^<TR4;YCI!.<NK(G6E-99^35AL]]Q3V!YW"5>:A
M<3\Q.ZV3G)'_@9 _/37DC_*Z!:T/L\20WR6?@F!B#<VUP#:H_<:\>8"Z1KL.
ME/C(Y"3#[^4N*I6]DJF5)"%LFN5!LH7^BUFI5BP//Y)K9]7[I]T!5NP\SMJT
M?_6,?@HJTBEZ3*R#2ZI. 61BGR75@225<PJ2ZDK!:N3^,/DFF_S;'717KLX%
MXD]/\4('YQBD5#ZR9264+QXZ*YY>MP4(C<($*W%<3^5-I^0 0@\N;SKE!Y!S
M@L"AY(U["O+FTTA'T)7'96!D.)H7L L8L_60QJQ-H]VGI?=4/HZ'R;."2.U@
MZ;KZA7FLI")W6CBI?\(#XQ' %PS @S6L$53#@UKW+*'->1%_OWB(A9"CMSH;
MU74=VPJ9&_@$':!,.,0G9A!&/C7M (R#R0.LHO V54[%%KM=&^35!LKUU^QS
M9EHDDBZ-K(!1;OI!9/M4>(Z,'.!#TS^B?;[8P[C,;H_B;]) PSV;L]SQ6F?E
M_?PMXZE5,5%]K4#C\$(XW<6'W7+,MX!6G]@0'UAO=^'Y//0]1X162!W'\XGG
MVI;#A P(<_CJZ1K'\H@D(]GN$4GU/H$'IZ,A9M_5F J!.^P_'C&EBNLY/1)M
M",VH,\</)L&<-X3!:[+I<#* ?[7P=17G+'A:RE*9Z\?#^UL^6/)R98^@R57;
M@O;Q+'L&B* 1+*"^T_"YMK$%GRH,K9S*X$O\&UT[RLTX0%<=@*<YCQ[(QDN
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M9U$_BD(KHJ$C/1%&G#);] B(_$>FB6#9PZMW%ST5@>>2F3-+;L^23B1HX(O
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MO8//IV"='S?VYW$H1H0CRAS;(F[@N-1V;>Q1@6V* T1J8$7'E8&P+-_S I_
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M):*DR:L /'#019^K?8]A_9OP:PCO]7/W0-W,_W'[^6]&,N*Q'$5C<"&28DG
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M.%:-BQ1B-D)NX%4>]9YZ8\SA>HY[71L#(40&KY?1/;4J=5+_?R"0N7N,BM)
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MG61EWO^N+S62]E_,*U78'%'.KO!&C5BA"I-4?N@2,"(*@E#DF!*+QS/E'^9
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MN8QXPL&4-9/<IIHZ\/O[6-ZKQA;!7+4F7.U>$*QW&M!I;E&PVN:Q,S#LU9U
M=_9GVUH#LGM_CMC4]A/@\%&E%Q@]AU2'),!]AZCJG0AN*[,HUG/$?-4[1&__
M+UF3._!*5'.'4+D"AFH'7R/P;@^8O/]>7>M;X![N>(<?J-O8G\%1DS:P+^4W
M=:6?-YO;V3GE>:=(/;1K#6QV,$+<$7@L6WW;_ [OBWS@BC7C3T&JG)5N+H2&
MF'G8L3Q3$!<1CR#N4LD<RQ:6[[B!):I<W)H"0DP'V&T-NN!LH5DVJ:ZNH;
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M73M:S.^'+8GO95JE;$3Q/5?9_;G?730[)PZG*NO6:YE"T:?])X0N8?!T %A
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M)N1T5I@J:![^TR^[..0 "J[=15=MU]%O7^'"_> ),HX6P4P_?SQ(P4[P@9)
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MN_VSG U-<[7H;Y4SJEW3@]W2G/\/3EBM1:DU,:J]<]2C$DPW^=E"JC*X;=4
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M;<CY59-.3A+-JAOGY4N8]4,(DF!H%//2V]5+(R7@12)P_Y_S9/:@9Z7%2JT
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M)QFLZ65F+PUY^D5'>2;K7]SJ9)1GNX:276:3W/%;ZDYP\'\@U9'NMOAOXW3
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MMPW-LHJ_(Q-#BYOIKN1*KLZCK<J1FPE,6#99'+$8*M1#;25?7I%646^'Z+*
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M%C/Y,-NUO/2TN'^4DH67EP93&47)5!5,)(6Z03X1(+5<TT._-E8%DC I/TQ
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M:#A4CTY_;K\!K.^G[DNJ8Q[55Y5',;( _#2,(E 2B.Y42#/^8IX]N.HUN!G
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MSS@(/1XNC%\[9Z]?F]S&*]'$&&&[K5HT\:;)US"J!)0\O' ]X)XG3 ]*]$4
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M4Z"OPH24O6*L*,H9G)+5G&3IB",%H P2W&/@/0YP>#^$(0  /L<<-HS.@'"
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MM HI"!ED'.)#5FZ0J&EEIK4,^+)EIZ27BEKL<3 P-.AS^3;60:3HX17<(PW
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MSQJUV/ZJX,X5W.C.A /$5 GF5@>)S4"..?%Y&4L%%+*,G*9BLAA]4('6GTF
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M*4\A3**L&@0S^$G7)$$0\10/LCF%UJS?&.YOE&4#RCJT#GYD2BGGKG!:]YO
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MT"P@C3BX'K[1/J",W9N9\3;J=?^HU^MMU.M'C'K5<V=O1=9.>J>?+L]/3RY
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MK#[Q2L#?]<3'=IB!K7NXXK" G5#@V CP^7D<?0G>H1VB0-/V;$?3P[JS*_-
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M<FAC,3 P,S<Q,SA?97@S,2TQ+FAT;>U;;6_CN!'^7J#_@?6B=PE@)WJ7[+P
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M8Z,[!@D/[\?#P;#7'2^,;J\W>1POAN-[8PHJT!OVV]&YEW#7@@'%14L@K]N
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M)38)BLXEO05R#8XL_7();.1 V\;\]?\ 4$L#!!0    ( )5EJ53EJ?-,NA4
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MD:,M-:$1HI^/_YNO!)X17CQEQ;)@O.:XRYX0W<C*AYN<4M:U6VVCI2ET5]!
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M@)<@*>C3\R)_()O+NSAX+B,"]M2G6XUZ/BI7\U+%AE(K^$PJ$Z8P,#U.YL"
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M(QZN4"Y*6ZU,8KTXV(Y>H3GS/F!>!3.5JE2VN?<7EO55V3HB*BE>0M"/T?P
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M'E-G/<2;;5XFS@%I6#)8O<3J0=H=P28JH3W!><'8>1=: -@%+V-EN*C/IQ[
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M=DJ4NN@Z(NHYMD;I.QT4NF+ ]JV+(\#^M63OW]T"5DS4$+ \HM\88)7Z;DS
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M.L5"'++J&UEBZ\+<YZXN:''Z39/65,E'=  "W?98)VF) A_ET99=^WX\K'\
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MBH'I?'UX?#$O M4*<Y?D;N$)KWQ=@(6Y+@NZ0P=6(@;8*W.WX6\"3H-[64\
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MA^*GQ_Y40!;P E<Y/0 S=B4C'J^+XR@L5X^D(CD[M&A;=A5-04\:[ !T3_3
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M*Q+E92.^)/L@C#1RBU!>DF4:\@[R3<V#Z\PC<F::@]HV@#%8(8D^9[+^$0V
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M;<?N)(>;K_/9,&40O&!3 T0MR/G0X4K1CKYQ2FI^RI^^YO"D1*-A7-)!A7E
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MV]*:Z+]P$%^%STT2]K)A&#D:-@8*&S6O8\0,40-L!(RV718M_I7/&K%7X'#
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M-JE*.U&VQL*L\ESGX/!Q7EB/9":\D5-!AFX[:'!1RS7,FT.A7J]-4/[H]<)
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M)9%& USP0;T 0@6_;1+86.ZP2 (O)FZN*V^7 ;6C2*11&]9%+%&[:M39I(G
MB0X[6VJ5PP=W^1N2V9DL?E!.V(<"2D'?N9@Q56D1(]K6'$'#^L2!R$$77-3V
M5E[77IV=H!O:;UZ\;=43)(KBPA0EWHRYR_Z1C*K;0H)Q<U7(8N%3FG4ZJ=QR
MHUN_-!2S+>V<"MXM\0FZ$:@XQ%\Z7%*4\E#1T+3H#"%.YE?;+KK!0[ -??XU
MOVG,Z_6_KM#1&).98L>+T'G#=G;<9AL[@, I$FF$S;J()4I4C3H+F0(G.HQH
MJ4UOJEMD)BC"V9&?/NZ2$':H@ 50!X@I4)46$:!MS1%.K =.D8,N(#DO4');
MH,2WHK(K,A31T10:HT;&CSA@MYFRV8!%=#BF]]3C[&O8?+%&)99_$[!83_1#
MADTCI8P "A\R#DA5IY6GB#]&[#GZS"1&?F%-V:_$K _JC( TJJR06_6'&,L#
M2VF_DUV09@>PX_T#;NX7,E,"2 ,I6::0V(U+0DD]FM!+8FA:?HH^9Y][1C$%
M)B2$4_>8G'YB?1D991[]H28+&9>$'0BKD;7J@I*\50@ZR%R9:=>YJ^;%-'M5
ME,'\E<EX1B]!'RMR6+LWU%DLTU'EL:IE?^C"[T8_1OR$/JTL!BL ]!$I6*91
MVX5+.H'>3&@%&)D6GV>G4_J9M"00D+!+WDEREK5U96R#/(W(NC B<>4\S-/=
M'/3[I:U-X_#AR))K<D_8N)A$*>T3VHS'0N'/9+?!<6L@9MELP6!K9OORW%)#
MM*.!_IM%EILF#1TV74UK&HQ%$8G.*DKE@<^'($XCJH?.T ''^R!B*1___3CZ
M10;684_<0JX1VRQYJ$5 JZWVB+76)C1M-VHHPO*)TZK,Z?SJ"2KL(D8+U"(V
MH(=RZ]\Y; 3 UT7B<:>1&W\(>V>>_F=-]OB:),ER>T'_"+(+-RS)SJ.4KY,"
MI_=9L074-8:V+(=%(^]6QS,6&F(2_LSM\]>L?^,+B2'70T&:P;]81H&*EM_\
MBFK=T"H)99U!(P]?1F9E,:M#^_R)4]6 >X<W>,\G/$T&70(MC3%53<MA\57Q
M,_"(J.VY:_W4M#2]I5_&$[]N='L:L3R%AU-$8,,7*%KX%2Q40-*L<(!>UJ]?
M*@9TRY.6S^%0/,@(0>#3$H#UZ_MJMY 857%?J'A<T]L#=(>*O#^BO:JG+YXH
M\/ B*MOX>[ [-KEDJ 7D*5#+,L,!/P/D*;EG$YK++$VSAPE[\Y6]"+@-PA@]
ML\>,P#'5P'M>W+Z.7*4"DX3:&CTM9S9@0,9LJ<_AD.PL5RE\6@*Q+%=E:@S=
MI2+BFM\"<#5SDEWD>I63%,E'D66LD]#ZIFG @0FSBLW2P'*+[ZLL.A31#^(R
MS#L)RT[C;Y= FT?454K6?WO*9F[_&<UYQZ-98[H+"+NO$R":P5*%$*_"W_)+
M/N]PBRDDHS1XQ.]?ZKV6B2CBI+$=(* :V+',,VW/SD.T:4M,R&MF>UI*9=5^
M&H01WI2Q_^$%'6+\')(C'=MS/;^H;0Y+20SHA!!YK- V*0LJANT:DS?.$IEQ
M*YR11C;8.!E"%6)1#C44EM^9),*,;U0:-9'?X/0B2)YN8_(<;O#F_<NG!&\6
MT548!=&:-G.V3L-GOFK5X+&Y8OZ]FRCVC#'ZKHR3L>K^3&/7LD!B:&Q*Y=&:
M*E!\\BR+MH4D"DZBX\:%#O A?3NV3GQ]&U6FFWH>%,'6TJ*Y6WOP/<_PRS10
MH<*2VX^?,C#_A$Z*:/8-HAG(8T/ ^95D*F K57<#QIG+VJ8I<Y?6AY6=FV G
M)-0W1ETM;F8W%XN;#VAV<;_X?7&_F*]>"_5E^YSZ]7/72"#:T=2U):, ?82$
M9W*G:U>K71*@-]>^CDF(WKG1'B-\S)7+ XZ#M,.H3J(HSXU"13>A0N!JJ%$=
M[+I#=(",E:.Z0R4HD$+:]Y&=#$)JWBLZ5XON AL:- <]#XIBUXE.XM8>A-6)
M[:3H^\C."9K-LI=5./N8K1;1,TY2:<4@SUH:!N392VK #?\E+H<:V:F;T"$D
MJ(Q.%S>_SU?WKV!DIX,J=0C0[&>M2""QI1$1E"T9!>BN$YZ&>_LH5R? DX%7
M-+(;A!!FN=$I(WS,E8*T;I8K-0P8C_1<YTJ)RZ%RI;H)=LKG>JY<WL[O9J\A
M5^J@JE.YW#E72FQUJYZ'R)4*MR,,#BWD2J75+H-%WW/E((3H/8ZTQP@?<Z4@
MO7<>3W8>1PY85@\U"PJ[ME-) WM;PE/)[/D,J P^G>IC&P/%;N7PP /#D0:$
M=@>"W0> WPZ:>X_RNL-Y[$Q5'AK23D;M9V6^J3[K3\C2FHNLT;*N8%9#GG,'
M.!#GT^KVSRAY"F+\Y,/Q7N).(QK?=0OYI5@#W$U]V[UO,^*V+1MU_?G;[GLX
M[&EVOC_!:_8<A#O6,??D@NSW)*J^W_<^2,(U/"_5QXHH()I8L4D>?;\NIJEZ
MM$.;DX:6IU3H0/G*7XHG6X2#.*().&%O_&;$16=M%OLTEN\%38CZW7 BB1'Z
M!L%H8MJF\7CC)CV9M\$1:?*4EZFC'YF!G]#)!.N_S BJ6ID@;N<[<\1(\8DZ
M'J7L2CD%':TJ3=8&^L(TK:5O-=!H>.QX\M*]T3#(H"'Z84;7IJRD]O,4INZP
M P.)(1)D$43#%!P[M-LQ!@\<I5H#[];1+TZOK^'8D?%(H)5'AV#!R+GSRVS-
M[U>AK;J-241_7//+5Y);L@O7+]E_[_'7]#UMQ]]:J;.;^BESFJKW#AAF#DV'
MM/)PT<FW/%AT,#F]P^PM_MT+FFW(@69Y5-I 'X[A)J VQHX*'6%%['1U,R28
M6:I'A"ZM&#$>L#"U/^ 4SQYCG#54>).86K#@N$2P+YM!TU9YJ_(B9:A<.3]
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M\9X=(0L>KN,?ZPW>>^C4O6JJ:[P/8>C9#WY?AL^TQ\/T&./EMGPS2D)LA8:
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M\4@" 0FGY)TDIU=;5T8UR-,@J',6K&%W_2$G#.(_5F11+CSR"3LND:@9Z6U
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ME%=8QA9:\=S @C4V:OMT4XB9NM?CKIG5&J7SI^BDBRK*?*JMD/"L9#.'GS
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M&\5[-J#7@P,\ :GH,.DDHT!7,I,(>AJ9@;4%3A'CA )5AC4$;#"J9M*X(&;
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MX/+1(3K?M 'C6KL:<B44P <:+NJ0DC8;Y<OV,%^@6[(-_2/Z7?Q_-CEBAT!
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M[=4(C#LHCZ46]QN\W5Z1W=Z+Y,L\L@8U%:@WL 9^E1PLW"64NT'>ZI!#F[]
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M<VR\A)_/3SRJXN_R/[PH*-Z^Y^M1&XS\[$+J+XE0\<I>Q\3!H@9^B-%(-\X
M*/L4NM='UATX8<*M?AX#84E#)-X \18H:X+*-J\$.(I0Q1HYEN%%-W' Q?=^
M1@/QL\CQH[!FKP0_"H?<&C^@*]>#UL^S8QP0QR;JE&P.3^241M_RRAC/XR!%
M31;8_:\*Z:4X\\Z]$GX2*DR2 PXDARIB5F2>OJ'(UM@J.\4S%0T$6^V2M:$$
ML%4F#JM9;9A5!9M0P28\<5$7PI5JV9Z^R(\FGO6HB9C9*=(4IS-*[E.?T:A+
MXDJ=K,]KH'=A).:X]V>=:F)G=CH%ZAG?>UM\L^Y@?2L64Y)5%+1/$0_MGJ^*
M&7>WBBD-N<&OH T30!V #J%766T+(S_&;!F-ZK_J= 5?<^-+:[2#AWCNX\S*
M< ?88RF1?TF0M"^)48#[6;Q;TX;XI[?;;_$%>CRDM&6*MN$NS)SJ"V'06"?:
M4BSOY3YX3B9A,C58<*.V(=N VO8+[K][+)M%Z=*_*WJ_1X]'3H]9S!?:9WM$
MY"6B B2'QR0,0B_+55K^:H2S6Q-,>D(?Q_2=%R'?2S87?!W2H[_E^.CY?\@8
M:O'C'U\TDGVZY/W4ZY=#]9\ Z&1CQ<&04KD.,4B$L0T1T&KI0,Z@)HBMK J#
MHO+V+W)WO^C.-6KRH]>3X%VU1#LFX&V7<P>PA%SD'<@>%/:+$O:]7OF^!OO)
MSU1/ GO5RO*8L ?UM1]B+TK6.+Y9LPRY.$JXH_@M]![#+74DOI+X"L>I%V:W
M"*_Y:B.5B3DMZ0.YIJ-#'8YG?$LAV5R6=D&ZS%( 2-K&B$!* N[;.Q!.:7W
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M&/6Z'NM2*-37C.58D(;QU$PY@H"9^F6?VTBM=T!%CS< 5(7GY12IEGZ6"2O
MQ3)3MB!X74CQJK*L;P"O"@_)*5YA"[>0%.<G2^ZR$Y@/I%RTZ_//'G(W65[&
MQ0GQO*@+,'&KO-R@LH#[:4[$4Z?LAN?&?3ZO2$Y2[)A6E_%\DJ2U8V<B!T>
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M)6'(O J]3#HN@??T7?(6S$^IMD&_YZTFUA6=,2:&@]&\C*WL5;EOW4?9(8A
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M4*VLN;'.B/=F54QI?_106]!.RH7OWW,B$ZNM'0@)&";JRCZ(7F$';*291#,
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M@CNJ['P-D[3HDGV039A0 \)=Y3*# '_S$M,A_T#6:WX<)P[99?.)W;/!-H@
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MN$(HJ#=3\:% ,I&#T1,?$X">C3I;LP?WG* D4EH!& ;+NVH<]*JRF<-!G+A
M6=T*69,N#!20D)-K(XQ3"":*6SV\K"KB=4413RY/^DRU3N&>SDSM+)U:$!D
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M$$A@(-'(M&).K,S$,E20"10"**G3<.;0JL"20N4]$>]Z@:J=4:4W^IWW1XP
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MWKU="VW79.)<76"F 6U6=HI")XF\'=_)R%H6=PV+MJ\2<8H9!1ARED&=%@_
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MZ_=G);)!S8R4"'0>_FM6=*.\ /%7+WG(=A)2'*RB@ M#.1^\[4.XP[<X#DE
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M!!1W'DH-=!@&5)X1U)D=E.F(!C*"B%)$BM""Q0N,;"7&."NH'M).1$-M#]R
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MQ%%.'0GRJ*2/! /T.V>!& _$F4R<B_UD38 B7#HY&V 90+D1"C"2<B?@R):
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MN$,25QM8J JHD8<<ZH;^R?F&OB:JI4%\GX3H[7^C=V9+<VAZ33VB<;6MQ<J
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MBI%K18?"U687*0)VL.@P:!K9_1.TYT,0Q\UC1V8C,REZC3R@<+6118J &GG
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MF$17?62-&?O^\)"EWWV6%2 T]0D%2&H(/4014\>I"&J8^NZZPM*-GZX<2"W
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M9>0N$Y1*]<P *.66.>@.:+F]Q@G4$NP" B,,"U@>-N#MBC4,P!I;I#66NU%
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M7LA<]C__?U!+ 0(4 Q0    ( )5EJ52TI@:77?4! ,3U%P 4
M  "  0    !B<FAC,3 P,S<Q,SA?,3!Q+FAT;5!+ 0(4 Q0    ( )5EJ51\
M.>-Z^@@  /8P   7              "  8_U 0!B<FAC,3 P,S<Q,SA?97@S
M,2TQ+FAT;5!+ 0(4 Q0    ( )5EJ533H!0X"@D  .XQ   7
M  "  ;[^ 0!B<FAC,3 P,S<Q,SA?97@S,2TR+FAT;5!+ 0(4 Q0    ( )5E
MJ52!R;:L"P4  -42   5              "  ?T' @!B<FAC,3 P,S<Q,SA?
M97@S,BYH=&U02P$"% ,4    " "59:E4\=,4&Z47   , 0$ $0
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M: , =7-P:"TR,#(R,#,S,5]P<F4N>&UL4$L%!@     )  D 6@(  #+1 P
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
